Citrus Sinensis ID: 005705
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 682 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.948 | 0.761 | 0.443 | 1e-157 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.939 | 0.756 | 0.439 | 1e-155 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.929 | 0.761 | 0.417 | 1e-153 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.951 | 0.769 | 0.431 | 1e-151 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.963 | 0.773 | 0.417 | 1e-149 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.907 | 0.790 | 0.402 | 1e-146 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.934 | 0.753 | 0.413 | 1e-144 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.963 | 0.766 | 0.403 | 1e-142 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.941 | 0.752 | 0.414 | 1e-139 | |
| Q9SYA0 | 804 | G-type lectin S-receptor- | no | no | 0.910 | 0.772 | 0.404 | 1e-137 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 556 bits (1434), Expect = e-157, Method: Compositional matrix adjust.
Identities = 321/724 (44%), Positives = 447/724 (61%), Gaps = 77/724 (10%)
Query: 22 SLAADTVTPAS--FIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVAN 78
S++A+T++ + I +VS FELGFF PG YLGI ++ I VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNP-VAQLRDDGNLVIRDNS 136
RD P+S + L IS++ NLV+L+Q++ +WSTN++ +V++P VA+L D+GN V+RD S
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-S 143
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP-DFLYK----- 190
+A + LWQSFD+PTDTLL +MKLGWD K R++ SW+S DDPS DF +K
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 191 ---------------------------------QFMMEN----KDECVYWYEAYNRPSIM 213
++M+ N K+E Y +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 214 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 273
L ++ SG + R W E + W++ + P C +Y CG C + P+C C++GFK
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 274 LES-QV--NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 330
+ QV + G C R L C GD F+ L ++K PD S+++ + +++C+ +CL
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 331 KNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLW 387
++C+C A+AN++++ S SGC+ W G+L D IRN+ GQ +Y+R+ A+ L +K+
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRS 439
Query: 388 ILVI---LVIPVVLLPSFYVFYRRRRKCQEKETENVETY---QDLLAFDINMN---ITTR 438
+I + + V+LL SF +F+ +RK +K + +ET L + D+ MN I++R
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKRK--QKRSILIETPIVDHQLRSRDLLMNEVVISSR 497
Query: 439 TNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 498
+ E N D D LPL + AT NFS KLG+GGFG VYKG+LL+GQE+
Sbjct: 498 RHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM 551
Query: 499 AVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 558
AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CCV+ GEK+LI EY+ N SL+ L
Sbjct: 552 AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHL 611
Query: 559 FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618
FD ++ LNWQ R II GIA+GLLYLHQ SRFRIIHRDLKASNILLDK M PKISDFG
Sbjct: 612 FDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFG 671
Query: 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678
+AR+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SSK+N G
Sbjct: 672 MARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFY 731
Query: 679 SMER 682
+ +R
Sbjct: 732 NSDR 735
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 550 bits (1418), Expect = e-155, Method: Compositional matrix adjust.
Identities = 315/717 (43%), Positives = 432/717 (60%), Gaps = 76/717 (10%)
Query: 27 TVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRDRPISD 85
+ T + I + ++S SQ FELGFF+P S YLGI ++ IP VWVANRD P+S
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGNLVIRDNSSGNATES 143
+N L IS+N NLV+ +Q++ +WSTN++ +V++PVA +L D GN V+RD S N
Sbjct: 91 SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSG 148
Query: 144 YLWQSFDYPTDTLLQDMKLGWDFKNR-LERYLSSWRSADDPS-------------PDF-- 187
+LWQSFD+PTDTLL DMK+GWD K+ R L SW++ DDPS P+F
Sbjct: 149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208
Query: 188 -------------LYKQF---------------MMENKDECVYWYEAYNRPSIMTLKLNP 219
L +F EN + VY Y L L+
Sbjct: 209 YNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSS 268
Query: 220 SGFVTRQIWNENSNKWDELFSVP----DQY--CGKYGYCGANTICSLDQKPMCECLEGFK 273
+G + R W E + W +L+ P D Y CG YGYC ANT P+C C++GF+
Sbjct: 269 TGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANT------SPICNCIKGFE 322
Query: 274 L--ESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 331
E + + C R L C D F+ L +++ PD + S+++ + L++C+ CLK
Sbjct: 323 PMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLK 382
Query: 332 NCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLWI 388
C+C A+AN++++ SGC++W G L D IRN+ GQ +Y+RV A L +K++
Sbjct: 383 GCNCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVRVAAGDLEDKRIKSK 438
Query: 389 LVI---LVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEA 445
+I + + ++LL SF +F+ +RK + T + + D MN + + +
Sbjct: 439 KIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTS 498
Query: 446 NGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN 505
+ D + LPL ++ AT NFS KLG+GGFG VYKG LL+G+E+AVKRLS
Sbjct: 499 KENKTDYLE---LPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555
Query: 506 QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR 565
S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI EY+ N SL+ LFD T+
Sbjct: 556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615
Query: 566 LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625
LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFG+AR+FG
Sbjct: 616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675
Query: 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 682
+E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G + R
Sbjct: 676 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 541 bits (1395), Expect = e-153, Method: Compositional matrix adjust.
Identities = 302/724 (41%), Positives = 425/724 (58%), Gaps = 90/724 (12%)
Query: 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVANRDR 81
++ DT+ +RDGE ++S+ +RF GFFS G S+ RY+GI + QI +VWVANRD
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PISDNNAVLTISNNGNLVLLNQTNGT--IWSTNVSSEVKNP--VAQLRDDGNLVIRDNSS 137
PI+D + ++ SN GNL + N T IWSTNVS + P VA L D GNLV+ D +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 138 GNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS------------- 184
G + W+SFD+PTDT L M+LG+ K+ L+R L+SW+S DP
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 185 --------------------------PD----FLYKQFMMENKDECVYWYEAYNRPSIMT 214
P+ +++ + N+DE + Y + I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 215 LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPM--CECLEGF 272
+N +G + R W +W++ +SVP + C Y +CG N C C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 273 KLES------QVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCK 326
+ + + + G K +R+ C D F++L +K PD D S++ + L++CK
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASI--CSEKDGFVKLKRMKIPDTSDASVDMNITLKECK 370
Query: 327 AECLKNCSCRAYANS---NVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL--- 380
CLKNCSC AYA++ + + + GCL W+G ++DAR + +GQ Y+RV +L
Sbjct: 371 QRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARW 428
Query: 381 ------GNKKLLWILVILVIPVVLLPS-FYVFYRRRRKCQEKETENVETYQDLLAFDINM 433
G +++L IL+ L+ V+LL + R RRK + + FD +
Sbjct: 429 NRNGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESF 488
Query: 434 NITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL 493
+DK+++ LPLF L +I AAT NFS Q KLG GGFGPVYKG L
Sbjct: 489 RFE-------------QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQ 535
Query: 494 NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 553
N E+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCCVE EK+L+ EY+PNKS
Sbjct: 536 NRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKS 595
Query: 554 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613
L+ F+F ++ L+W R+ I+ GIA+G+LYLHQ SR RIIHRDLKASNILLD +M PK
Sbjct: 596 LDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPK 655
Query: 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
ISDFG+AR+FGG++++G T ++VGT+GYM+PEYA++G FSIKSDV+SFG+LMLE ++ KK
Sbjct: 656 ISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKK 715
Query: 674 NTGL 677
N+
Sbjct: 716 NSAF 719
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1382), Expect = e-151, Method: Compositional matrix adjust.
Identities = 312/723 (43%), Positives = 439/723 (60%), Gaps = 74/723 (10%)
Query: 18 SMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWV 76
+ VS + T + I + ++S SQ FELGFF+P S YLGI ++ IP VWV
Sbjct: 22 AFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWV 81
Query: 77 ANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGNLVIRD 134
ANRD P+S +N L IS N NLV+ +Q++ +WSTN++ +V++PVA +L D+GN ++RD
Sbjct: 82 ANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD 140
Query: 135 NSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS---------- 184
+++ LWQSFD+PTDTLL +MKLGWD K R L SW++ DDPS
Sbjct: 141 SNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLET 195
Query: 185 ---PDF--------LYKQ------------------FMMEN----KDECVYWYEAYNRPS 211
P+F LY+ +M+ N K+E Y Y
Sbjct: 196 SEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNL 255
Query: 212 IMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEG 271
L LN +G + R W E + W +L+ P C Y CG C + P C C++G
Sbjct: 256 YSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKG 315
Query: 272 FKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAE 328
FK ++ + G C R L C D F L +K PD +++ + L+ CK
Sbjct: 316 FKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKER 375
Query: 329 CLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKLLW 387
CL++C+C A+AN++++ SGC++W +++D R + GQ +Y+R+ A++L +K++
Sbjct: 376 CLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVRLAAAELEDKRIKN 433
Query: 388 ILVI---LVIPVVLLPSFYVFY---RRRRKCQEKETENVETY--QDLLAFDINMNITTRT 439
+I + + ++LL SF +F+ R++++ +T NV+ QD L D+ ++ T
Sbjct: 434 EKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYT 493
Query: 440 NEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVA 499
++ + KS+ LPL L ++ AT NFS KLG+GGFG VYKGRLL+G+E+A
Sbjct: 494 SK--------EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIA 545
Query: 500 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF 559
VKRLS S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI EY+ N SL+ LF
Sbjct: 546 VKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLF 605
Query: 560 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
D T+ LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFG+
Sbjct: 606 DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGM 665
Query: 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679
AR+FG +E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G +
Sbjct: 666 ARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYN 725
Query: 680 MER 682
R
Sbjct: 726 SNR 728
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 529 bits (1363), Expect = e-149, Method: Compositional matrix adjust.
Identities = 308/738 (41%), Positives = 437/738 (59%), Gaps = 81/738 (10%)
Query: 13 LIFLLSMKVSLAADTVTPASFIRDG---EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQI 69
++ + S+AA+T+ +RDG + LVS + FELGFFSPG S R+LGI + I
Sbjct: 14 FLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNI 73
Query: 70 PD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEV---KNPVAQLR 125
D AVVWVANR PISD + VL ISN+GNLVLL+ N T+WS+N+ S N V +
Sbjct: 74 EDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIH 133
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP 185
D GN V+ + T+ +W+SF++PTDT L M++ + + SWRS DPSP
Sbjct: 134 DTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189
Query: 186 ----------------------------------------------DFLYKQFMMENKDE 199
++LY + DE
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDE 249
Query: 200 C--VYWYEAYNRPSIM-TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANT 256
VY+ + PS++ K+ +G WNE KW + S PD C +Y CG
Sbjct: 250 TGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFG 309
Query: 257 ICSLD-QKPMCECLEGFKLESQVN------QPGPIKCERSHSLECKSGDQFIELDEIKAP 309
IC + +C C+ G++ S N + P+KCER+ S+ D+F+ L +K P
Sbjct: 310 ICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISV---GEDEFLTLKSVKLP 366
Query: 310 DFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQ 369
DF ++ + ++ E C+ CL+NCSC AY+ + GC++W DL+D ++ G
Sbjct: 367 DF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQ--FEAGGS 420
Query: 370 SVYLRVPASKLGN--KKLLWILVILVIPVVLLPSFYVFYRR--RRKCQEKETENVETYQD 425
S+++R+ S++G K + ++V +++ V+L+ F + R R+K T
Sbjct: 421 SLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTS 480
Query: 426 LLAFDINMNITTRTNEYGEANGDGKDKSKD-SWLPLFSLASITAATENFSMQCKLGEGGF 484
++ D+ + T + G + + K+ + S LP+FSL +I AT +F + +LG GGF
Sbjct: 481 VVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGF 540
Query: 485 GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544
GPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRLLGCC E EK+L
Sbjct: 541 GPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKML 600
Query: 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604
+ EYMPNKSL+ FLFD TK+ L++W+ R IIEGIA+GLLYLH+ SR RIIHRDLK SN+
Sbjct: 601 VYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNV 660
Query: 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGIL 664
LLD +MNPKISDFG+AR+FGG++ + NT ++VGTYGYMSPEYA++GLFS+KSDV+SFG+L
Sbjct: 661 LLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVL 720
Query: 665 MLETLSSKKNTGLGSMER 682
+LE +S K+NT L S E
Sbjct: 721 LLEIVSGKRNTSLRSSEH 738
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 519 bits (1336), Expect = e-146, Method: Compositional matrix adjust.
Identities = 297/737 (40%), Positives = 422/737 (57%), Gaps = 118/737 (16%)
Query: 1 MEKIPCLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSR 60
ME L++ +F ++ ++ A D + ++DG+ +VS FE+GFFSPG S++R
Sbjct: 1 MEATNVLHLLIISLFS-TILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNR 59
Query: 61 YLGIRFQQIP-DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNV-----S 114
YLGI +++I VVWVANRD P+ D + L +S NG+L L N N IWS++
Sbjct: 60 YLGIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQK 119
Query: 115 SEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYL 174
+ ++NP+ Q+ D GNLV+R+ SG+ + Y+WQS DYP D L MK G +F L R+L
Sbjct: 120 ASLRNPIVQILDTGNLVVRN--SGD-DQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFL 176
Query: 175 SSWRSADDPS-------------------------------------------PDFLYKQ 191
+SWR+ DDPS P+ +Y+
Sbjct: 177 TSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRY 236
Query: 192 FMMENKDECVYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYG 250
+ ++E Y Y+ N PS++T ++LNP+G + R W +N W+ S C +Y
Sbjct: 237 EYVFTEEEVYYTYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYT 295
Query: 251 YCGANTICSLDQKPMCECLEGFKLESQ---VNQPGPIKCERSHSLECKSG-DQFIELDEI 306
CG+ C++++ P C CL+GF ++ V C R L+C G D F+++ ++
Sbjct: 296 LCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKL 355
Query: 307 KAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESS-GCLMWYGDLIDARRPIRN 365
K PD ++ M+L +CK CL+NC+C AY+ ++++ GC++W+GDLID R N
Sbjct: 356 KLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YN 413
Query: 366 FTGQSVYLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQD 425
GQ +Y+ R E ET E+ +
Sbjct: 414 ENGQDLYV-----------------------------------RLASSEIETLQRESSR- 437
Query: 426 LLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFG 485
+++R K + +D LP L +++ AT FS KLG+GGFG
Sbjct: 438 ---------VSSR-----------KQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477
Query: 486 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545
PVYKG L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG CV++ E++LI
Sbjct: 478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537
Query: 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605
EY PNKSL+ F+FD ++R L+W RV II+GIA+G+LYLH+ SR RIIHRDLKASN+L
Sbjct: 538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597
Query: 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
LD DMN KISDFGLAR GGDE + NT ++VGTYGYMSPEY +DG FS+KSDVFSFG+L+
Sbjct: 598 LDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLV 657
Query: 666 LETLSSKKNTGLGSMER 682
LE +S ++N G + E
Sbjct: 658 LEIVSGRRNRGFRNEEH 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 514 bits (1323), Expect = e-144, Method: Compositional matrix adjust.
Identities = 298/720 (41%), Positives = 429/720 (59%), Gaps = 83/720 (11%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVANRDRPIS 84
+T+ + ++DG+ + S +RF GFFS G SK RY+GI + Q+ + +VWVANRD PI+
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 85 DNNAVLTISNNGNLVLLNQTNGT--IWSTNVSSEVKNP--VAQLRDDGNLVIRDNSSGNA 140
D + ++ S GNL + NGT IWST+V ++ P VA+L D GNLV+ D +G +
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 141 TESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDP-SPDFLYK-------QF 192
W+SF++PT+TLL MK G+ ++ ++R ++SWRS DP S + Y+ Q
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 193 MM-----------------------------------ENKDECVYWYEAYNRPSIMTLKL 217
MM N DE Y + + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 218 NPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTIC--SLDQKPMCECLEGFKLE 275
N +G + R WN KW +S P+ C Y +CG N C + +K C CL G++ +
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 276 SQVN---QPGPIKCERSHSLE-CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 331
+ + + C R + C + F +L +K P+ V+++ + L++C+ CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 332 NCSCRAYANSNVKE---SSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL-------- 380
NCSC AYA++ + + GCL W+G+++D R + +GQ YLRV S+L
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVDKSELARWNGNGA 436
Query: 381 -GNKKLLWILVILV-IPVVLLPSFYVFYRRRR-KCQEKETENVETYQDLLAFDINMNITT 437
G K+L+ IL+ L+ + ++LL SF+ + R+RR + Q + +FD+ +
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 438 RTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 497
E DKS+ LPLF L++I AT NF+ Q KLG GGFGPVYKG L NG E
Sbjct: 497 EELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547
Query: 498 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 557
+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCCVE EK+L+ EY+PNKSL+ F
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607
Query: 558 LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617
+F ++ L+W R+ II GI +G+LYLHQ SR RIIHRDLKASN+LLD +M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667
Query: 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677
GLAR+FGG++++G+T ++VGTYGYMSPEYA+DG FSIKSDV+SFG+L+LE ++ K+N+
Sbjct: 668 GLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF 727
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 506 bits (1302), Expect = e-142, Method: Compositional matrix adjust.
Identities = 298/739 (40%), Positives = 437/739 (59%), Gaps = 82/739 (11%)
Query: 7 LNIFCSLIFLL-SMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSR-YLGI 64
L +F +I + ++ + + + T + I + LVS FE+GFF ++ SR YLG+
Sbjct: 16 LLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYLGM 72
Query: 65 RFQQIPD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVS--SEVKNPV 121
++++ D VWVANRD P+S+ L IS N NLVLL+ +N +W TN++ +E V
Sbjct: 73 WYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERSPVV 131
Query: 122 AQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSAD 181
A+L +GN V+RD+S+ +A+E YLWQSFDYPTDTLL +MKLG++ K L R+L+SWRS+D
Sbjct: 132 AELLANGNFVMRDSSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSD 190
Query: 182 DPSP-DFLYK--------------------------------------QFM----MENKD 198
DPS +F YK +M +EN +
Sbjct: 191 DPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNE 250
Query: 199 ECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVP-DQYCGKYGYCGANTI 257
E Y + N L L G+ R W + W+ +S P D C Y CG
Sbjct: 251 EVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAY 310
Query: 258 CSLDQKPMCECLEGF------KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDF 311
C ++ P+C C++GF + + +V G C R L C SGD F + ++K P+
Sbjct: 311 CDVNTSPVCNCIQGFNPRNIQQWDQRVWAGG---CIRRTQLSC-SGDGFTRMKKMKLPET 366
Query: 312 IDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--- 367
++++ + +++CK C+ +C+C A+AN++++ SGC++W L D IRN+
Sbjct: 367 TMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLED----IRNYATDA 422
Query: 368 --GQSVYLRVPASKLGNKKLL---WILVILVIPVVLLPSFYVFYRRRRKCQEKETENVET 422
GQ +Y+R+ A+ + K+ I + + + V+LL + ++R++K + ++
Sbjct: 423 IDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIAN 482
Query: 423 YQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEG 482
Q +N + + E+ G+ K ++ LPL + ++ ATENFS KLG+G
Sbjct: 483 TQRNQNLPMNEMVLSSKREFS-----GEYKFEELELPLIEMETVVKATENFSSCNKLGQG 537
Query: 483 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542
GFG VYKGRLL+G+E+AVKRLS S QG EF NE+ LIA+LQH NLV++LGCC+E EK
Sbjct: 538 GFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEK 597
Query: 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKAS 602
+LI EY+ N SL+ +LF T++ LNW R I G+A+GLLYLHQ SRFRIIHRDLK S
Sbjct: 598 MLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVS 657
Query: 603 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662
NILLDK+M PKISDFG+AR+F DE + NT ++VGTYGYMSPEYA+ G+FS KSDVFSFG
Sbjct: 658 NILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFG 717
Query: 663 ILMLETLSSKKNTGLGSME 681
+++LE +S KKN G +++
Sbjct: 718 VIVLEIVSGKKNRGFYNLD 736
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 497 bits (1280), Expect = e-139, Method: Compositional matrix adjust.
Identities = 298/719 (41%), Positives = 427/719 (59%), Gaps = 77/719 (10%)
Query: 19 MKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVA 77
+ +S+ + T + I + +VS FELGFF S YLGI +++I VWVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 78 NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPV-AQLRDDGNLVIRDNS 136
NRD P+S+ +L ISN NLV+L+ ++ +WSTN++ V++ V A+L D+GN V+R S
Sbjct: 87 NRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLR-GS 144
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS------------ 184
N ++ +LWQSFD+PTDTLL MKLG D K L R+++SW+S+ DPS
Sbjct: 145 KINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLG 204
Query: 185 -PDFL-YKQFM-----------------------------MENKDECVYWYEAYNRPSIM 213
P+F + F+ EN++E Y + + S
Sbjct: 205 LPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHNSYS 264
Query: 214 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 273
L +N G + +W +W+ + +P C YG CG C + P C C++GF+
Sbjct: 265 RLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKGFQ 324
Query: 274 -LESQVNQPGPI--KCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 330
L Q G + +C R L C D+F L +K P +++R+ L++C+ +C
Sbjct: 325 PLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEKCK 383
Query: 331 KNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLW 387
+C+C AYANS+++ SGC++W G+ R IRN+ GQ +++R+ A++ G ++ +
Sbjct: 384 THCNCTAYANSDIRNGGSGCIIWIGEF----RDIRNYAADGQDLFVRLAAAEFGERRTIR 439
Query: 388 ILVILVI---PVVLLPSF--YVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEY 442
+I +I ++L+ SF Y F+++++K + + T Y+D + I N
Sbjct: 440 GKIIGLIIGISLMLVLSFIIYCFWKKKQK-RARATAAPIGYRDRIQELIITN-------- 490
Query: 443 GEANGDGK---DKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVA 499
G G+ + +D LPL ++ ATENFS LG GGFG VYKGRLL+GQE+A
Sbjct: 491 GVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIA 550
Query: 500 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF 559
VKRLS S QG EFKNE+ LIA+LQH NLVRLL CC+ EKILI EY+ N SL+ LF
Sbjct: 551 VKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLF 610
Query: 560 DSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618
++T+ LNWQ R II GIA+GLLYLHQ SRF+IIHRDLKASN+LLDK+M PKISDFG
Sbjct: 611 ETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFG 670
Query: 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677
+AR+F DE + NT+++VGTYGYMSPEYA++G+FS+KSDVFSFG+L+LE +S K+N G
Sbjct: 671 MARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGF 729
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYA0|Y1150_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61500 OS=Arabidopsis thaliana GN=At1g61500 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 300/742 (40%), Positives = 424/742 (57%), Gaps = 121/742 (16%)
Query: 1 MEKIPCLNIFCSLIF-LLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKS 59
M + CL++F +F LLS S T +P S G+ L S+++ +ELGFFSP ++
Sbjct: 2 MTRFACLHLFTMFLFTLLSGSSSAVITTESPLSM---GQTLSSANEVYELGFFSPNNTQD 58
Query: 60 RYLGIRFQQ-IPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVK 118
+Y+GI F+ IP VVWVANR++P++D+ A L IS++G+L+LLN +GT+WS+ V+
Sbjct: 59 QYVGIWFKDTIPRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVTFSSS 118
Query: 119 NPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWR 178
A+L D GNL + DN S E LWQSFD+ DTLL L ++ +R L+SW+
Sbjct: 119 GCRAELSDSGNLKVIDNVS----ERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWK 174
Query: 179 SADDPSP-DFL--------YKQFMMENKDECVYWY----------------EAYNRPSIM 213
S DPSP DFL + F+M + YW E+Y P +
Sbjct: 175 SYTDPSPGDFLGQITPQVPSQGFVM--RGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTL 232
Query: 214 TLKLNPSGFVTR------------------QIWNENSNKWDELFSVPDQYCGKYGYCGAN 255
+N SG++T +++ +N W+ + P + C YG CG
Sbjct: 233 HQDVNGSGYLTYFQRDYKLSRITLTSEGSIKMFRDNGMGWELYYEAPKKLCDFYGACGPF 292
Query: 256 TICSLDQKPMCECLEGFKLES-----QVNQPGPIKCERSHSLEC------KSGDQFIELD 304
+C + PMC+C GF +S + N G C R L+C + D F ++
Sbjct: 293 GLCVMSPSPMCKCFRGFVPKSVEEWKRGNWTG--GCVRHTELDCLGNSTGEDADDFHQIA 350
Query: 305 EIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIR 364
IK PDF + + +N E+C C+ NCSC A+A + GCL+W DL+DA +
Sbjct: 351 NIKPPDFYEFA--SSVNAEECHQRCVHNCSCLAFA---YIKGIGCLVWNQDLMDAVQ--F 403
Query: 365 NFTGQSVYLRVPASKL-GNKKLLWILV-ILVIPVVLLPSFYVFYRRRRKCQEKETENVET 422
+ TG+ + +R+ S+L GNK+ I+ I+ + + ++ F F R C+ + ++
Sbjct: 404 SATGELLSIRLARSELDGNKRKKTIVASIVSLTLFMILGFTAFGVWR--CRVEHIAHI-- 459
Query: 423 YQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSW-----------LPLFSLASITAATE 471
SKD+W L F + +I AT
Sbjct: 460 ------------------------------SKDAWKNDLKPQDVPGLDFFDMHTIQNATN 489
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
NFS+ KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF NE++LI+KLQHRNLVR
Sbjct: 490 NFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVR 549
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
+LGCC+E+ EK+LI E+M NKSL+ FLFDS K+ ++W R II+GIA+GLLYLH SR
Sbjct: 550 VLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQGIARGLLYLHHDSR 609
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
R+IHRDLK SNILLD+ MNPKISDFGLARM+ G E Q NT+++VGT GYMSPEYA G+
Sbjct: 610 LRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTLGYMSPEYAWTGM 669
Query: 652 FSIKSDVFSFGILMLETLSSKK 673
FS KSD++SFG+LMLE +S +K
Sbjct: 670 FSEKSDIYSFGVLMLEIISGEK 691
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 682 | ||||||
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.903 | 0.569 | 0.475 | 1e-175 | |
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.932 | 0.793 | 0.464 | 1e-174 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.944 | 0.770 | 0.474 | 1e-171 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.944 | 0.774 | 0.454 | 1e-170 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.913 | 0.759 | 0.467 | 1e-170 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.961 | 0.798 | 0.463 | 1e-169 | |
| 359493723 | 867 | PREDICTED: G-type lectin S-receptor-like | 0.938 | 0.738 | 0.444 | 1e-169 | |
| 147816068 | 819 | hypothetical protein VITISV_030742 [Viti | 0.938 | 0.781 | 0.442 | 1e-168 | |
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.932 | 0.765 | 0.450 | 1e-168 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.929 | 0.780 | 0.449 | 1e-167 |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 621 bits (1602), Expect = e-175, Method: Compositional matrix adjust.
Identities = 337/709 (47%), Positives = 432/709 (60%), Gaps = 93/709 (13%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
AD++ I D E LVSS Q FELGFFSPG SK+RYLGI ++ P VWVANR+ PI+
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
D+ VLTI NNG LVLLNQ+ IWS N+S +NPVAQL + GNLV+RD S+ ++SY
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSN-ETSKSY 414
Query: 145 LWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS-PDF---------------- 187
+WQSFD P+DT+L MK+GW+ K L+R L+SW+S+DDPS DF
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 188 -------------------------LYKQFMMENKDECVYWYEAYNRPSIMTLKLNPSGF 222
+YK + N DE YE+ N I L LN SGF
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 223 VTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFKLESQVNQP- 281
+ R + + S+ WDEL+S+P + C YG+CGAN IC + + +CECL GF +SQ
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 282 --GPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYA 339
C R L+C+ + F+++ +K PD ID + ++L +CK CL NCSC AYA
Sbjct: 595 FNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAYA 654
Query: 340 NSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLG------NKKLLWILVILV 393
+N S GCLMW GDLID R + +Y+R+ S+LG KKL+ ILVI
Sbjct: 655 YTNPNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVIST 714
Query: 394 IPVVL---LPSFYVFYRRRRKC--QEKETENVETYQDLLAFDINMNITTRTNEYGEANGD 448
+L L ++ F+++R QE + EN+E
Sbjct: 715 FSGILTLGLSFWFRFWKKRTMGTDQESKKENLE--------------------------- 747
Query: 449 GKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 508
LPLF L +I AT NFS K+G GGFG VYKG L G VAVKRLS S
Sbjct: 748 ---------LPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSA 798
Query: 509 QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLN 568
QG++EFKNE +LIAKLQH+NLVRLLGCC++ E+IL+ EYMPNKSL+ F+FD ++ LL
Sbjct: 799 QGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLA 858
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628
W R I+ GIA+GLLYLHQ SRF+IIHRDLK SNILLD ++NPKISDFGLAR+FG +E+
Sbjct: 859 WDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEM 918
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677
+ TK+IVGTYGYMSPEY +DG FSIK DVFSFG+L+LE +S +KN G
Sbjct: 919 ETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGF 967
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1594), Expect = e-174, Method: Compositional matrix adjust.
Identities = 339/730 (46%), Positives = 449/730 (61%), Gaps = 94/730 (12%)
Query: 1 MEKIPCLNIFCSLIFLLSMK-VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKS 59
ME +P IF S +F+ S+ +S +AD +TP ++DG+ L+S SQ FELGFFSPG SK
Sbjct: 1 MESLPFF-IFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKY 59
Query: 60 RYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKN 119
RY+GI +++ P+ VVWVANR+ P++D+ VLTI N GNLVLL+Q IWS+N SS +
Sbjct: 60 RYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAG 119
Query: 120 PVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRS 179
PVAQL D GNLV+RDN S TESY WQSFD P+DTLL MKLGW+ K ERYL +WRS
Sbjct: 120 PVAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179
Query: 180 ADDPSP-DFLYK-----------------------------------------QFMMENK 197
DPSP DF Y+ ++ N+
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239
Query: 198 DECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTI 257
DE Y Y N L LN SG V R + ++ W ++SVP C YG CGAN I
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299
Query: 258 CSLDQKPMCECLEGFK------LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDF 311
C P+CECL+GFK L+ Q N G KCE +L+C+SG+ F++L +K PD
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQ-NFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDL 358
Query: 312 IDVSLNQRMNLEQCKAECLKNCSCRAYANSNVK---ESSGCLMWYGDLIDARRPIRNFTG 368
++ LN+ MNL++C+AEC KNCSC A+A +N+ + SGCLMW+G+LID R + G
Sbjct: 359 LEFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIG 418
Query: 369 QSVYLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLA 428
Q +++RVPAS+L R ++ + +T V + LL
Sbjct: 419 QDIHIRVPASEL-----------------------EMARSSKRKKMLKTALVASMSALLG 455
Query: 429 FDINMNITTRTNEYGEANGDGKDKSKDSW-LPLFSLASITAATENFSMQCKLGEGGFGPV 487
++ G D+ K+ PLF L +I AT NF+ +G GGFG V
Sbjct: 456 IFVS----------------GMDRRKEGMEAPLFDLDTIATATNNFAPDSIIGAGGFGSV 499
Query: 488 YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547
YKG+LL GQE+AVK+LS SGQG++EF+NE++LIAKLQHRNLV LLG C+ + E++LI E
Sbjct: 500 YKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYE 559
Query: 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607
YMPNKSL+ F+FD + LL W+ R II GIA+GLLYLHQ S+ +I+HRDLK SN+LLD
Sbjct: 560 YMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLD 619
Query: 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
++ PKISDFGLAR+ G D + T++++GTYGYM+PEYA+DG FS+KSDVFS G+L+LE
Sbjct: 620 SNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLLLE 679
Query: 668 TLSSKKNTGL 677
+S KKN G
Sbjct: 680 IISGKKNRGF 689
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1567), Expect = e-171, Method: Compositional matrix adjust.
Identities = 344/725 (47%), Positives = 453/725 (62%), Gaps = 81/725 (11%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + IRDG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 18 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GNLVL++ N T+ WS+N ++ + +L D GNLV+RD N
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDEKDVN 137
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP-DFLY--------- 189
+ SYLWQSFDYP+DT+L MKLGWD + L+R LS+W+S DDPS DF +
Sbjct: 138 SG-SYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 190 --------KQF-------------------------MMENKDECVYWYEAYNRPSIMTLK 216
K F ++N +E Y Y N+ I L
Sbjct: 197 LVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVYYTYNLKNKSLITRLV 256
Query: 217 LN-PSGFV-TRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF-- 272
+N +GF+ R WNE S W+ VP YC Y CGA C + Q P+CECLE F
Sbjct: 257 MNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCECLEKFTP 316
Query: 273 -KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 331
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C+++CL+
Sbjct: 317 KSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQ 376
Query: 332 NCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASK------LGNK 383
NCSC AY +++KE SGC +W+GDLID IR F GQ +Y+R+ AS+ L
Sbjct: 377 NCSCMAYTATDIKERSGCAIWFGDLID----IRQFPDGGQEIYIRMNASESSECLSLIKM 432
Query: 384 KLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVET-YQDLLAF---DINMNITTRT 439
++ L I V +LL ++Y+F K TE ++ Y LL + D + ++ +T
Sbjct: 433 EMGIALSIFVACGMLLVAYYIF---------KRTEKLKAHYSFLLVYHVCDSHSLLSEKT 483
Query: 440 NEYGEANGDGKDKS--KDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 497
E N D D +D LPLF +I AT FS+ K+GEGGFGPVYKG L +GQE
Sbjct: 484 GGNREEN-DQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDGQE 542
Query: 498 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 557
+AVK LS SGQGL EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPN+SL+ F
Sbjct: 543 IAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLDSF 602
Query: 558 LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617
+FD T+ +LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISDF
Sbjct: 603 IFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDF 662
Query: 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677
GLARM GGD+ +GNT +++GTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G
Sbjct: 663 GLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGF 722
Query: 678 GSMER 682
+R
Sbjct: 723 YHPDR 727
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1561), Expect = e-170, Method: Compositional matrix adjust.
Identities = 333/733 (45%), Positives = 446/733 (60%), Gaps = 89/733 (12%)
Query: 12 SLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD 71
S++F LS+ S A +++ + DG+ LVSS FELGFFSPG S++RY+GI +++I
Sbjct: 18 SIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76
Query: 72 -AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
VVWVANR+ P++D++ +L ++GNL +N TNGTIWS+N+S NPVAQL D GNL
Sbjct: 77 FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS------ 184
V+R + N E++LWQSFDYP D+ L MK G F L RYL+SW+S DPS
Sbjct: 137 VVRAEND-NDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195
Query: 185 -------------------------------------PDFLYKQFMMENKDECVYWYEAY 207
P+ +Y + N++E Y Y+
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYYKYQIA 255
Query: 208 NRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCE 267
N + + L+P G + R W + + W + C ++ CGA+ +C+++ P C+
Sbjct: 256 NSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPACD 315
Query: 268 CLEGFK---LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQ 324
CL+ F+ LE C R L+C +G+ FI+ IK PD N+ +NLE+
Sbjct: 316 CLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEE 375
Query: 325 CKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL--- 380
C+ CLKNCSC AYAN +V++ SGC++W+GDLID R+ N GQ +Y+R+ AS +
Sbjct: 376 CEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ--YNENGQDIYIRIAASVIDKP 433
Query: 381 ----GNKKLLWILVILVIPVVL-------LPSFYVFYRRRRKCQEKETENVETYQDLLAF 429
G K++ I+VIPV L L F F R+ ++ Q NV T +
Sbjct: 434 VKSRGKKRVR----IIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPE---- 485
Query: 430 DINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYK 489
RT E +++D LPLF LA++T AT FS+ KLG+GGFGPVYK
Sbjct: 486 ------QDRTKE---------SRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYK 530
Query: 490 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549
G L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+LLGCC+E E++LI EYM
Sbjct: 531 GILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYM 590
Query: 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD 609
PNKSL+ F+FD + LL+W R II GIA+GLLYLHQ SR RIIHRDLKASNILLD +
Sbjct: 591 PNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYE 650
Query: 610 MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
MNPKISDFG+AR FGGDE NT +IVGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +
Sbjct: 651 MNPKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 710
Query: 670 SSKKNTGLGSMER 682
S +KN G E
Sbjct: 711 SGRKNRGFRHAEH 723
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1557), Expect = e-170, Method: Compositional matrix adjust.
Identities = 334/714 (46%), Positives = 433/714 (60%), Gaps = 91/714 (12%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + IRDG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 24 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 83
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GN VL++ N T+ WS+N ++ + +L+D GNLV+RD N
Sbjct: 84 NPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQSAMGELQDSGNLVLRDEKDDN 143
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP-DFLYKQFMMENKD 198
+ YLWQSFDYP+DTLL MKLGWD + L+R LS+W+S DDPS DF + + N +
Sbjct: 144 SG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 202
Query: 199 ------------------------------------------ECVYWYEAYNRPSIMTLK 216
E Y Y N+ I +
Sbjct: 203 LVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIV 262
Query: 217 LNPSG-FVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF--- 272
+N + F R WNE + W +VP YC Y CGA C + Q P+C+CLE F
Sbjct: 263 MNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTPR 322
Query: 273 KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKN 332
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C+++CL+N
Sbjct: 323 SPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQN 382
Query: 333 CSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLWI-- 388
CSC AY +N+KE SGC +W+GDLID IR F+ GQ +Y+R+ AS+ K I
Sbjct: 383 CSCMAYTATNIKERSGCAVWFGDLID----IRQFSAAGQEIYIRLNASESRAKAASKIKM 438
Query: 389 -----LVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYG 443
L I V +LL ++Y+F R+ + EN +
Sbjct: 439 TVGSALSIFVACGILLVAYYIFKRKAKHIGGNREENDQI--------------------- 477
Query: 444 EANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL 503
D K +D LPLF +I AT FS KLGEGGFGPVYKG L +GQE+A K L
Sbjct: 478 ----DSGPK-EDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTL 532
Query: 504 SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK 563
S SGQGL EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPNKSL+ F+FD T+
Sbjct: 533 SRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTR 592
Query: 564 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623
+LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISDFGLARMF
Sbjct: 593 GKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMF 652
Query: 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677
GGD+ +GNT ++VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G
Sbjct: 653 GGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGF 706
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1554), Expect = e-169, Method: Compositional matrix adjust.
Identities = 334/721 (46%), Positives = 442/721 (61%), Gaps = 65/721 (9%)
Query: 19 MKVSLAA-DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWV 76
++VS A +T+ P ++DGE L+S+ FELGFFS G S+SRYLGI +++IP VVWV
Sbjct: 2 LRVSAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWV 61
Query: 77 ANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136
NR+ P DN VL ++ G ++L N T G IWS+N S KNPV QL D GNL+++D +
Sbjct: 62 GNREVPSFDNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGN 121
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS------------ 184
GN ++ +WQSFD+P +TLL MKLGW+ L RYL+SW+S DDP+
Sbjct: 122 -GNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180
Query: 185 -------------------------------PDFLYKQFMMENKDECVYWYEAYNRPSIM 213
P+ ++ + NK E Y YE N +
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVS 240
Query: 214 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 273
L ++ G + R W + + W FSVP C Y CGA C+++ P+C CLEGF
Sbjct: 241 RLIVSEKGALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFV 300
Query: 274 LESQVNQPGPI---KCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 330
+S + C R L C +GD F +L +K PD ++ M+L++C+ CL
Sbjct: 301 PKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCL 360
Query: 331 KNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLG-----NK 383
+NCSC AYANS+++ SGCL+W+ LID R+ FT GQ +Y+R+ AS+L K
Sbjct: 361 RNCSCLAYANSDIR-GSGCLLWFDHLIDMRK----FTEGGQDLYIRIAASELAKGKSHGK 415
Query: 384 KLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITT--RTNE 441
++ I+ L+I + + + Y R+RK + + V + +F I+ I +
Sbjct: 416 RVAIIVSCLIIGMGMTALGSLLYTRKRK-RNILGQAVPLVLLVSSFAIHFYIISGLAKET 474
Query: 442 YGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK 501
Y E GD K +D+ L F L +I AT NFS KLGEGGFGPVYKG LL+GQE+AVK
Sbjct: 475 YIENYGDNGAK-EDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVK 533
Query: 502 RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS 561
RLS SGQG KEFKNE++LIA+LQHRNLV+LLGCC+ EK+LI EYMPNKSL+ F+FD
Sbjct: 534 RLSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDK 593
Query: 562 TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621
+ LL+W RII GIA+GLLYLHQ SR RIIHRDLKASNILLD DMNPKISDFGLAR
Sbjct: 594 KRSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLAR 653
Query: 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 681
FG D+ NTK++VGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +S K+N G ++
Sbjct: 654 TFGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLD 713
Query: 682 R 682
Sbjct: 714 H 714
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493723|ref|XP_002280706.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1547), Expect = e-169, Method: Compositional matrix adjust.
Identities = 326/734 (44%), Positives = 445/734 (60%), Gaps = 94/734 (12%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQ- 67
+ + +F L +++S+ DT+T I D E + S+ FELGFFSP SK RYLGIR++
Sbjct: 9 VIFTYVFSL-LRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKK 67
Query: 68 QIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDD 127
++ AVVWVANR+ P++D++ VL +++ G LV+L+ N T+WS+ S +NP AQL D
Sbjct: 68 ELNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDS 127
Query: 128 GNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS--- 184
GNLV+++ + GN E++LWQSFDYP +TLL MKLGW+ L+RYLSSW+SADDPS
Sbjct: 128 GNLVMKNGNDGNP-ENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIGT 186
Query: 185 ----------------------------------------PDFLYKQFMMENKDECVYWY 204
P+ +Y + N+ E + Y
Sbjct: 187 FTYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKEIYFIY 246
Query: 205 EAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKP 264
N + L L P G+ R W + +W + SV + C Y CGAN IC +DQ P
Sbjct: 247 YLVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKIDQSP 306
Query: 265 MCECLEGFKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMN 321
CEC++GF+ Q N C RS L+C+ GD+F++ +K PD N+ MN
Sbjct: 307 KCECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNESMN 366
Query: 322 LEQCKAECLKNCSCRAYANSNVK-ESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASK- 379
L++C + CL+NCSC AY NSN+ E SGCL+W+G+L D R N GQ Y+R+ AS+
Sbjct: 367 LKECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFAEN--GQEFYVRMSASES 424
Query: 380 -------LGNKK------LLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDL 426
+ +KK ++ I + ++ ++L+ ++Y+ + +++ + K
Sbjct: 425 DAFSSTNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKRKG---------- 474
Query: 427 LAFDINMNITTRTNEYGEANGDGKDKSKDSW---LPLFSLASITAATENFSMQCKLGEGG 483
Y E N DG + S+ LPLF LA++ AT NFS KLGEGG
Sbjct: 475 ---------------YMEHNSDGGETSEGQEHLELPLFELATLLNATNNFSSDNKLGEGG 519
Query: 484 FGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543
FGPVYKG L +G+E+AVKRLS S QGLKEFKNE+ IAKLQHRNLV+LLGCC+ EK+
Sbjct: 520 FGPVYKGILEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKM 579
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603
LI EY+PNKSL++F+FD + +L+W R II GIA+GLLYLHQ SR RIIHRDLKA N
Sbjct: 580 LIYEYLPNKSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAEN 639
Query: 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGI 663
+LLD DMNPKISDFG+AR FGG+EL +T ++ GT GYMSPEYA +GL+S KSDV+SFG+
Sbjct: 640 VLLDNDMNPKISDFGIARSFGGNELGASTTRVAGTLGYMSPEYASEGLYSTKSDVYSFGV 699
Query: 664 LMLETLSSKKNTGL 677
L+LE LS K+N G
Sbjct: 700 LVLEILSGKRNRGF 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147816068|emb|CAN61538.1| hypothetical protein VITISV_030742 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1542), Expect = e-168, Method: Compositional matrix adjust.
Identities = 325/734 (44%), Positives = 444/734 (60%), Gaps = 94/734 (12%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQ- 67
+ + +F L +++S+ DT+T I D E + S+ FELGFFSP SK RYLGIR++
Sbjct: 9 VIFTYVFSL-LRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKK 67
Query: 68 QIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDD 127
++ AVVWVANR+ P++D++ VL +++ G LV+L+ N T+WS+ S +NP AQL D
Sbjct: 68 ELNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDS 127
Query: 128 GNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS--- 184
GNLV+++ + GN E++LWQSFDYP +TLL MKLGW+ L+RYLSSW+SADDPS
Sbjct: 128 GNLVMKNGNDGNP-ENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIGT 186
Query: 185 ----------------------------------------PDFLYKQFMMENKDECVYWY 204
P+ +Y + N+ E + Y
Sbjct: 187 FTYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKEIYFIY 246
Query: 205 EAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKP 264
N + L L P G+ R W + +W + SV + C Y CGAN IC +DQ P
Sbjct: 247 YLVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKIDQSP 306
Query: 265 MCECLEGFKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMN 321
CEC++GF+ Q N C RS L+C+ GD+F++ +K PD N+ MN
Sbjct: 307 KCECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNESMN 366
Query: 322 LEQCKAECLKNCSCRAYANSNVK-ESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASK- 379
L++C + CL+NCSC AY NSN+ E SGCL+W+G+L D R N GQ Y+R+ AS+
Sbjct: 367 LKECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFAEN--GQEFYVRMSASES 424
Query: 380 -------LGNKK------LLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDL 426
+ +KK ++ I + ++ ++L+ ++Y+ + +++ + K
Sbjct: 425 DAFSSTNISSKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQLKRKG---------- 474
Query: 427 LAFDINMNITTRTNEYGEANGDGKDKSKDSW---LPLFSLASITAATENFSMQCKLGEGG 483
Y E N DG + S+ LPLF LA++ AT NFS KLGEGG
Sbjct: 475 ---------------YMEHNSDGGETSEGQEHLELPLFELATLLNATNNFSSDNKLGEGG 519
Query: 484 FGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543
FGPVYKG L +G+E+AVKRLS S QGLKEFKNE+ IAKLQHRNLV+LLGCC+ EK+
Sbjct: 520 FGPVYKGILEDGEEIAVKRLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKM 579
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603
LI EY+PNKSL++F+FD + +L+W R II GIA+GLLYLHQ SR RIIHRDLKA N
Sbjct: 580 LIYEYLPNKSLDLFIFDQMRGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAEN 639
Query: 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGI 663
+LLD DMNPKISDFG+AR FGG+EL +T ++ GT GYMSPEYA +GL+S KSDV+SFG+
Sbjct: 640 VLLDNDMNPKISDFGIARSFGGNELXASTTRVAGTLGYMSPEYASEGLYSTKSDVYSFGV 699
Query: 664 LMLETLSSKKNTGL 677
L+LE S K+N G
Sbjct: 700 LVLEIXSGKRNRGF 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1540), Expect = e-168, Method: Compositional matrix adjust.
Identities = 326/723 (45%), Positives = 440/723 (60%), Gaps = 87/723 (12%)
Query: 15 FLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQI-PDAV 73
FLL + + DT+TP IRDG+ LVS+ FELGFFSPG SK RYLGI +Q+I V
Sbjct: 16 FLLISAIRASTDTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRYLGIWYQKISAGTV 75
Query: 74 VWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIR 133
VWVANR+ P++D++ L +++ G L+LLN + IWS+N S +NPV +L D GNLV++
Sbjct: 76 VWVANRETPLNDSSGALIVTDQGILILLNSSKDAIWSSNASRTAQNPVMKLLDSGNLVVK 135
Query: 134 DNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS--------- 184
D + + +E++LWQSFDYP DTLL MK G + L+RYLSSW+S++DP+
Sbjct: 136 DIN--DNSENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKSSNDPAQGEFTFRID 193
Query: 185 ----------------------------------PDFLYKQFMMENKDECVYWYEAYNRP 210
P+ LY + E Y ++ N
Sbjct: 194 PRGNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNMLYTYGFISTATEMYYKFDLINSS 253
Query: 211 SIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLE 270
+ +N SG R W +N W +V C Y CGA C+++++P+C CLE
Sbjct: 254 VASRIVMNSSGAAQRFTWITRTNSWARFSAVLLDQCDDYALCGAYGSCNVNKQPVCACLE 313
Query: 271 GFKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKA 327
GF +S + Q C R L+C GD+F++ +K PD I ++ L++CK
Sbjct: 314 GFIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLPDMIKSWVDTSKGLKECKD 373
Query: 328 ECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLGN---- 382
CLKNCSC AYANS+++ SGCL+W+ +LID R GQ +Y+R+ AS+L N
Sbjct: 374 LCLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTG--GQDLYIRIAASELYNIEKN 431
Query: 383 -----KKLLWILVILVIPVVLLPSFYVFYRRRRKCQEK---ETENVETYQDLLAFDINMN 434
K+L I+ ++ V +L ++ Y RR+K +++ +T +++ Y+D
Sbjct: 432 RSSDKKQLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKTSHLQNYED--------- 482
Query: 435 ITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLN 494
+ +D LP F L++I AT+NFS + KLGEGGFG VYKG L+
Sbjct: 483 --------------EDQRKEDMELPTFDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIE 528
Query: 495 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554
GQEVAVKRLS SGQGL EFKNE++LIAKLQHRNLV+LLGCC+E E+ILI EYMPNKSL
Sbjct: 529 GQEVAVKRLSKNSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSL 588
Query: 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614
+ F+FD + +W+ + I+ GIA+GLLYLHQ SR RIIHRDLKA+N+LLD MNPKI
Sbjct: 589 DYFIFDKKTRNSSDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKI 648
Query: 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674
SDFGLAR FGGD+ + NT +IVGTYGYMSPEYA+DG FS+KSDVFSFG+L+LE +S KKN
Sbjct: 649 SDFGLARTFGGDQTEANTNKIVGTYGYMSPEYAVDGFFSVKSDVFSFGVLVLEIVSGKKN 708
Query: 675 TGL 677
G
Sbjct: 709 RGF 711
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1537), Expect = e-167, Method: Compositional matrix adjust.
Identities = 327/727 (44%), Positives = 427/727 (58%), Gaps = 93/727 (12%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQ 68
IF +F +K+S A D + +RDGE LVS+ FELGFF+P S SRYLG+ +++
Sbjct: 7 IFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK 66
Query: 69 IPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDG 128
P VVWVANR PIS+ L +++ G LVLLN TN +WS+N S+ V+NPVAQL D G
Sbjct: 67 SPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSG 126
Query: 129 NLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP--- 185
NLV+RD + N +++LWQSFDYP DTLL MKLG + L +LSSW+ ++P+P
Sbjct: 127 NLVVRDGND-NKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQF 185
Query: 186 ----------------------------------------DFLYKQFMMENKDECVYWYE 205
D +Y + N++E + +E
Sbjct: 186 TLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVYFKFE 245
Query: 206 AYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPM 265
N L + PSG V W+ +N W + C Y CGAN C + P+
Sbjct: 246 LQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSSPV 305
Query: 266 CECLEGFKLESQV---NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNL 322
C+CL+GF +S +Q C R L+C D F +K PD + +L
Sbjct: 306 CDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSL 365
Query: 323 EQCKAECLKNCSCRAYANSNVK-ESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLG 381
+C+ C++NCSC AYAN + + SGCL W+GDLID RR GQ +Y+R+ AS+ G
Sbjct: 366 VECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEG--GQDIYIRLAASQSG 423
Query: 382 -----------NKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFD 430
+ ++ VIL +++L VF RRRK ++
Sbjct: 424 VTGEKKRKKKTHAGVIGGAVILGSSILILG--IVFCIRRRKHRK---------------- 465
Query: 431 INMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKG 490
N N R E E LP+ L +I AT+NFS KLGEGGFG VYKG
Sbjct: 466 -NGNFEDRKEEEME-------------LPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKG 511
Query: 491 RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550
L+ GQE+AVKRLS SGQGL EFKNE++LIAKLQHRNLV+LLGCC+ + EK+LI EYMP
Sbjct: 512 ELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMP 571
Query: 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610
N+SL+ F+FD T+++ L+W R II+GIA+GLLYLHQ SR RIIHRD+KASNILLD ++
Sbjct: 572 NRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDNEL 631
Query: 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
NPKISDFGLARMFGGD+ + NTK++VGTYGYMSPEYALDG FS+KSDVFSFG+L+LE +S
Sbjct: 632 NPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEIVS 691
Query: 671 SKKNTGL 677
KKN G
Sbjct: 692 GKKNRGF 698
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 682 | ||||||
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.703 | 0.566 | 0.455 | 3.1e-151 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.381 | 0.332 | 0.590 | 3.8e-150 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.316 | 0.268 | 0.648 | 8.2e-134 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.643 | 0.539 | 0.426 | 7.1e-126 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.325 | 0.270 | 0.596 | 4.5e-123 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.620 | 0.524 | 0.437 | 3.2e-121 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.621 | 0.524 | 0.418 | 3.2e-121 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.325 | 0.276 | 0.605 | 8.2e-120 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.524 | 0.421 | 0.486 | 1e-115 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.873 | 0.701 | 0.416 | 1.2e-113 |
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1087 (387.7 bits), Expect = 3.1e-151, Sum P(2) = 3.1e-151
Identities = 234/514 (45%), Positives = 322/514 (62%)
Query: 186 DFLYKQFMMENKDECVYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVP-- 242
D++ F EN + VY Y N+ +I + L L+ +G + R W E + W +L+ P
Sbjct: 236 DYIDNSFT-ENNQQVVYSYRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKD 293
Query: 243 --DQY--CGKYGYCGANTICSLDQKPMCECLEGFKL--ESQVNQPGPIKCERSHSLECKS 296
D Y CG YGYC ANT P+C C++GF+ E + + C R L C
Sbjct: 294 LCDNYKECGNYGYCDANT------SPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDG 347
Query: 297 GDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGD 355
D F+ L +++ PD + S+++ + L++C+ CLK C+C A+AN++++ SGC++W G
Sbjct: 348 RDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGG 407
Query: 356 LIDARRPIRNFT--GQSVYLRVPASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYRRRR 410
L D IRN+ GQ +Y+RV A L +K+ SF +F+ +R
Sbjct: 408 LFD----IRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKR 463
Query: 411 KCQEKETENVET-YQDLL-AFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITA 468
K +K + ++T DL+ + D MN + + + + D + LPL ++
Sbjct: 464 K--QKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLE---LPLMEWKALAM 518
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
AT NFS KLG+GGFG VYKG LL+G+E+AVKRLS S QG EF NE+ LIAKLQH N
Sbjct: 519 ATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHIN 578
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
LVRLLGCCV++GEK+LI EY+ N SL+ LFD T+ LNWQ R II GIA+GLLYLHQ
Sbjct: 579 LVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQ 638
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
SR RIIHRDLKASN+LLDK+M PKISDFG+AR+FG +E + NT+++VGTYGYMSPEYA+
Sbjct: 639 DSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAM 698
Query: 649 DGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 682
DG+FS+KSDVFSFG+L+LE +S K+N G + R
Sbjct: 699 DGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 778 (278.9 bits), Expect = 3.8e-150, Sum P(3) = 3.8e-150
Identities = 154/261 (59%), Positives = 192/261 (73%)
Query: 421 ETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLG 480
E QDL + I T E + K + +D LP L +++ AT FS KLG
Sbjct: 414 ENGQDLYVRLASSEIETLQRESSRVSSR-KQEEEDLELPFLDLDTVSEATSGFSAGNKLG 472
Query: 481 EGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540
+GGFGPVYKG L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG CV++
Sbjct: 473 QGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEE 532
Query: 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600
E++LI EY PNKSL+ F+FD ++R L+W RV II+GIA+G+LYLH+ SR RIIHRDLK
Sbjct: 533 ERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLK 592
Query: 601 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFS 660
ASN+LLD DMN KISDFGLAR GGDE + NT ++VGTYGYMSPEY +DG FS+KSDVFS
Sbjct: 593 ASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFS 652
Query: 661 FGILMLETLSSKKNTGLGSME 681
FG+L+LE +S ++N G + E
Sbjct: 653 FGVLVLEIVSGRRNRGFRNEE 673
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 740 (265.6 bits), Expect = 8.2e-134, Sum P(3) = 8.2e-134
Identities = 140/216 (64%), Positives = 176/216 (81%)
Query: 458 LPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 517
L F + +I AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 518 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 577
++LI+KLQHRNLVR+LGCC+E+ EK+LI E+M NKSL+ FLFDS K+ ++W R II+
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
GIA+GLLYLH SR R+IHRDLK SNILLD+ MNPKISDFGLARM+ G E Q NT+++VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
T GYMSPEYA G+FS KSD++SFG+LMLE +S +K
Sbjct: 656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEK 691
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 903 (322.9 bits), Expect = 7.1e-126, Sum P(2) = 7.1e-126
Identities = 208/488 (42%), Positives = 288/488 (59%)
Query: 204 YEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQK 263
Y R S ++ S + IWN N + W P C Y CG +C
Sbjct: 245 YSLERRNSNLSYTTLTSAGSLKIIWN-NGSGWVTDLEAPVSSCDVYNTCGPFGLCIRSNP 303
Query: 264 PMCECLEGF--KLESQVNQPGPIK-CERSHSLEC----------KSGDQFIELDEIKAPD 310
P CECL+GF K + + N+ C R +L C +GD F + +K PD
Sbjct: 304 PKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIFDIVANVKPPD 363
Query: 311 FID-VSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQ 369
F + +SL +N E C+ CL NCSC A+ S + E GCL+W +L+D + + G+
Sbjct: 364 FYEYLSL---INEEDCQQRCLGNCSCTAF--SYI-EQIGCLVWNRELVDVMQFVAG--GE 415
Query: 370 SVYLRVPASKLG--NKKXXXXXXXXXXXXXXXXSF--YVFYRRRRKCQEKETENVETYQD 425
++ +R+ +S+L N+ F Y ++R + K + +ET QD
Sbjct: 416 TLSIRLASSELAGSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQNDSNPIPLETSQD 475
Query: 426 LLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFG 485
A+ +++ K + F + +I T NFSM+ KLG+GGFG
Sbjct: 476 --AW--------------------REQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFG 513
Query: 486 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545
PVYKG L +G+E+A+KRLS+ SGQGL+EF NE++LI+KLQHRNLVRLLGCC+E EK+LI
Sbjct: 514 PVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLI 573
Query: 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605
E+M NKSLN F+FDSTKK L+W R II+GIA GLLYLH+ S R++HRD+K SNIL
Sbjct: 574 YEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNIL 633
Query: 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
LD++MNPKISDFGLARMF G + Q NT+++VGT GYMSPEYA G+FS KSD+++FG+L+
Sbjct: 634 LDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLL 693
Query: 666 LETLSSKK 673
LE ++ K+
Sbjct: 694 LEIITGKR 701
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 697 (250.4 bits), Expect = 4.5e-123, Sum P(3) = 4.5e-123
Identities = 133/223 (59%), Positives = 175/223 (78%)
Query: 452 KSKD-SWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG 510
+S+D S L F + + AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRL++ S QG
Sbjct: 476 QSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGKEIAVKRLTSSSVQG 535
Query: 511 LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ 570
+EF NE+ LI+KLQHRNL+RLLGCC++ EK+L+ EYM NKSL++F+FD KK ++W
Sbjct: 536 TEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWA 595
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630
R II+GIA+GLLYLH+ S R++HRDLK SNILLD+ MNPKISDFGLAR+F G++ Q
Sbjct: 596 TRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQD 655
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+T +VGT GYMSPEYA G FS KSD++SFG+LMLE ++ K+
Sbjct: 656 STGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKE 698
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 3.2e-121, Sum P(2) = 3.2e-121
Identities = 202/462 (43%), Positives = 276/462 (59%)
Query: 224 TRQI-WNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF--KLESQVNQ 280
T+++ W+ N W F P+ C YG CG +C P C C +GF KL + +
Sbjct: 260 TQELSWH-NGTDWVLNFVAPEHSCDYYGVCGPFGLCVKSVPPKCTCFKGFVPKLIEEWKR 318
Query: 281 PGPIK-CERSHSLEC------KSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNC 333
C R L C K + F + IK PDF + + +N+E+C+ CL NC
Sbjct: 319 GNWTGGCVRRTELYCQGNSTGKYANVFHPVARIKPPDFYEFA--SFVNVEECQKSCLHNC 376
Query: 334 SCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLG-NK-KXXXXXXX 391
SC A+A + GCLMW DL+DA + G+ + +R+ S+LG NK K
Sbjct: 377 SCLAFAYI---DGIGCLMWNQDLMDAVQFSEG--GELLSIRLARSELGGNKRKKAITASI 431
Query: 392 XXXXXXXXXSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKD 451
+F F R + + N +ITT ++ N D K
Sbjct: 432 VSLSLVVIIAFVAFCFWRYRVKH-----------------NADITTDASQVSWRN-DLKP 473
Query: 452 KSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL 511
+ L F + +I AT NFS+ KLG+GGFGPVYKG+L +G+E+AVKRLS+ SGQG
Sbjct: 474 QDVPG-LDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGK 532
Query: 512 KEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQA 571
+EF NE++LI+KLQH+NLVR+LGCC+E EK+LI E+M N SL+ FLFDS K+ ++W
Sbjct: 533 EEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPK 592
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
R+ II+GIA+G+ YLH+ S ++IHRDLK SNILLD+ MNPKISDFGLARM+ G E Q N
Sbjct: 593 RLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDN 652
Query: 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
T+++VGT GYM+PEYA G+FS KSD++SFG+LMLE +S +K
Sbjct: 653 TRRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEK 694
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 3.2e-121, Sum P(2) = 3.2e-121
Identities = 192/459 (41%), Positives = 272/459 (59%)
Query: 226 QIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF---KLESQVNQPG 282
+I+ N W+ F P+ C YG+CG IC + P C+C +GF +E
Sbjct: 262 KIFQHNGMDWELNFEAPENSCDIYGFCGPFGICVMSVPPKCKCFKGFVPKSIEEWKRGNW 321
Query: 283 PIKCERSHSLEC------KSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCR 336
C R L C K+ + F + IK PDF + + ++ E C CL NCSC
Sbjct: 322 TDGCVRHTELHCQGNTNGKTVNGFYHVANIKPPDFYEFA--SFVDAEGCYQICLHNCSCL 379
Query: 337 AYANSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKXXXXXXXXXXXX 396
A+A N GCLMW DL+DA + + G+ + +R+ +S+LG K
Sbjct: 380 AFAYIN---GIGCLMWNQDLMDAVQ--FSAGGEILSIRLASSELGGNKRNKIIVASIVSL 434
Query: 397 XXXXSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKD-KSKD 455
S +V C L + + ++ + ++ D + +D
Sbjct: 435 ----SLFVILAFAAFC-------------FLRYKVKHTVSAKISKIASKEAWNNDLEPQD 477
Query: 456 -SWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF 514
S L F + +I AT+NFS+ KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF
Sbjct: 478 VSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEF 537
Query: 515 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR 574
NE++LI+KLQH+NLVR+LGCC+E E++L+ E++ NKSL+ FLFDS K+ ++W R
Sbjct: 538 MNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFN 597
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
IIEGIA+GL YLH+ S R+IHRDLK SNILLD+ MNPKISDFGLARM+ G E Q NT++
Sbjct: 598 IIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRR 657
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+ GT GYM+PEYA G+FS KSD++SFG+++LE ++ +K
Sbjct: 658 VAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEK 696
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 711 (255.3 bits), Expect = 8.2e-120, Sum P(3) = 8.2e-120
Identities = 135/223 (60%), Positives = 178/223 (79%)
Query: 452 KSKD-SWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG 510
KSK+ L F + +I AT NFS+ KLG+GGFG VYKG+L +G+E+AVK+LS+ SGQG
Sbjct: 468 KSKEVPGLEFFEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQG 527
Query: 511 LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ 570
+EF NE++LI+KLQHRNLVR+LGCC+E EK+LI E+M NKSL+ F+FD+ KK ++W
Sbjct: 528 KEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWP 587
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630
R I++GIA+GLLYLH+ SR ++IHRDLK SNILLD+ MNPKISDFGLARM+ G + Q
Sbjct: 588 KRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQD 647
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
T+++VGT GYMSPEYA G+FS KSD++SFG+L+LE + +K
Sbjct: 648 KTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEK 690
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 865 (309.6 bits), Expect = 1.0e-115, Sum P(3) = 1.0e-115
Identities = 186/382 (48%), Positives = 249/382 (65%)
Query: 311 FIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQS 370
F+ + +R++ C +CL+NCSC AYA++N + +GC +W D + + ++
Sbjct: 353 FVFNEIGRRLSSYDCYVKCLQNCSCVAYASTN-GDGTGCEIWNTDPTNENSASHH--PRT 409
Query: 371 VYLRVPASKLGNKKXXXXXXXXXXXXXXXXSFYVFYRRRRKCQEKETENVETYQDLLAFD 430
+Y+R+ SKL ++ + Y RK + K T V +++
Sbjct: 410 IYIRIKGSKLA---ATWLVVVASLFLIIPVTWLIIYLVLRKFKIKGTNFVSESLKMISSQ 466
Query: 431 ----INMNITT-RTN----------EYG-EANGDGKDKSKDS--WLPLFSLASITAATEN 472
N ++T R E G E GK ++++ L +FS S+ AT+
Sbjct: 467 SCSLTNKRLSTLRVGSTIDQEMLLLELGIERRRRGKRSARNNNNELQIFSFESVAFATDY 526
Query: 473 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
FS KLGEGGFGPVYKGRL++G+EVA+KRLS SGQGL EFKNE MLIAKLQH NLV+L
Sbjct: 527 FSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKL 586
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
LGCCVE+ EK+LI EYMPNKSL+ FLFD +K +L+W+ R RI+EGI QGLLYLH+YSR
Sbjct: 587 LGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRL 646
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
++IHRD+KA NILLD+DMNPKISDFG+AR+FG E + NTK++ GT+GYMSPEY +GLF
Sbjct: 647 KVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLF 706
Query: 653 SIKSDVFSFGILMLETLSSKKN 674
S KSDVFSFG+LMLE + +KN
Sbjct: 707 SAKSDVFSFGVLMLEIICGRKN 728
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 1.2e-113, P = 1.2e-113
Identities = 267/641 (41%), Positives = 372/641 (58%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN----GTIW-STNVSSEVKNPVAQLR 125
D VW N + V + +NGN VL + N G +W S + ++ P +L
Sbjct: 111 DTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLG 170
Query: 126 DDG----NLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSW---R 178
D N IR S + S + SF T+ ++ L W+ ++R+ R W R
Sbjct: 171 WDAKTGFNRFIRSWKSPDDPSSGDF-SFKLETEGF-PEIFL-WNRESRMYRS-GPWNGIR 226
Query: 179 SADDPSPD-FLYKQF-MMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWD 236
+ P F Y F +K+E Y + L ++ SG + R W E + W+
Sbjct: 227 FSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWN 286
Query: 237 ELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFKLES-QV--NQPGPIKCERSHSLE 293
+ + P C +Y CG C + P+C C++GFK + QV + G C R L
Sbjct: 287 QFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLS 346
Query: 294 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMW 352
C GD F+ L ++K PD S+++ + +++C+ +CL++C+C A+AN++++ S SGC+ W
Sbjct: 347 CGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTW 406
Query: 353 YGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYR 407
G+L D IRN+ GQ +Y+R+ A+ L +K+ SF +F+
Sbjct: 407 TGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFL 462
Query: 408 RRRKCQEKETENVETY---QDLLAFDINMN---ITTRTNEYGEANGDGKDKSKDSWLPLF 461
+RK +K + +ET L + D+ MN I++R + E N D D LPL
Sbjct: 463 WKRK--QKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTD------DLELPLM 514
Query: 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLI 521
+ AT NFS KLG+GGFG VYKG+LL+GQE+AVKRLS S QG EFKNE+ LI
Sbjct: 515 EFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLI 574
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
A+LQH NLVRLL CCV+ GEK+LI EY+ N SL+ LFD ++ LNWQ R II GIA+
Sbjct: 575 ARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIAR 634
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GLLYLHQ SRFRIIHRDLKASNILLDK M PKISDFG+AR+FG DE + NT+++VGTYGY
Sbjct: 635 GLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGY 694
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 682
MSPEYA+DG+FS+KSDVFSFG+L+LE +SSK+N G + +R
Sbjct: 695 MSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDR 735
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00027534001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (814 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 682 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-41 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 8e-41 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 9e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-27 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-25 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 3e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-23 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-15 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 3e-53
Identities = 76/205 (37%), Positives = 111/205 (54%), Gaps = 16/205 (7%)
Query: 474 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 527
++ KLGEG FG VYKG+L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+LLG C E+ +++EYM L +L + L+ + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPE 645
IHRDL A N L+ +++ KISDFGL+R D+ + K +M+PE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK---LPIRWMAPE 173
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
+G F+ KSDV+SFG+L+ E +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 4e-53
Identities = 78/205 (38%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 474 SMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 527
++ KLGEG FG VYKG L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+LLG C E+ ++++EYMP L +L + + L+ + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPE 645
S+ IHRDL A N L+ +++ KISDFGL+R D+ K +M+PE
Sbjct: 121 --SK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK---LPIRWMAPE 174
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
+G F+ KSDV+SFG+L+ E +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 3e-52
Identities = 83/205 (40%), Positives = 117/205 (57%), Gaps = 16/205 (7%)
Query: 478 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 532
KLGEG FG VYKG+L EVAVK L S + K+F E ++ KL H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYL 586
LG C E+ L+LEYM L +L F S +K L+ + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTYGYMSPE 645
S+ + +HRDL A N L+ +D+ KISDFGL+R ++ D + T + +M+PE
Sbjct: 122 A--SK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
DG+F+ KSDV+SFG+L+ E +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 6e-51
Identities = 76/207 (36%), Positives = 110/207 (53%), Gaps = 17/207 (8%)
Query: 473 FSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH 526
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
N+VRLLG C + ++ EYMP L FL L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---YMS 643
S+ +HRDL A N L+ +++ KISDFGL+R D+ ++ G +M+
Sbjct: 119 E--SK-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMA 172
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE DG F+ KSDV+SFG+L+ E +
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 6e-51
Identities = 77/193 (39%), Positives = 110/193 (56%), Gaps = 11/193 (5%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
LGEGGFG VY R G++VA+K + + L E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
++ L++EY SL L ++ K L+ +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 597 RDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSI 654
RDLK NILLD D K++DFGL+++ D+ T IVGT YM+PE L G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 655 KSDVFSFGILMLE 667
KSD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 6e-49
Identities = 71/199 (35%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 478 KLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLG G FG VYK + G+ VAVK L ++ + + + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
++ L++EY L +L ++ L+ +I I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS 653
IHRDLK NILLD++ KI+DFGLA+ + VGT YM+PE L G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 654 IKSDVFSFGILMLETLSSK 672
K DV+S G+++ E L+ K
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 69/197 (35%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 530
+ + KLGEG FG VY R G+ VA+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL ++ + L++EY L L + RL +AR + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHSK- 116
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
I+HRDLK NILLD+D + K++DFGLAR E VGT YM+PE L
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 651 LFSIKSDVFSFGILMLE 667
+ D++S G+++ E
Sbjct: 172 GYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 477 CKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 534 GCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
G ++ + L LEY+ SL+ L +L R + I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQ-ILEGLAYLH---S 119
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
I+HRD+K +NIL+D D K++DFG A+ G E T + GT +M+PE
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 652 FSIKSDVFSFGILMLETLSSK 672
+ +D++S G ++E + K
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 8e-41
Identities = 53/115 (46%), Positives = 70/115 (60%), Gaps = 6/115 (5%)
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
VVWVANR P++D++ L + ++GNLVL + +WS+N S + VA L+DDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184
LV+ DNS LWQSFD+PTDTLL K G + R L+SW+S DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-39
Identities = 50/119 (42%), Positives = 69/119 (57%), Gaps = 6/119 (5%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTIS 93
+ G+ LVSS FELGFF Y I ++ VVWVANRD P S ++ LT+
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152
++GNLV+ + + +WS+N + N V L DDGNLV+ D+ ++LWQSFDYP
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQHRN 528
N+ + +G G FG VYKG L G VA+K++S + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYL 586
+V+ +G +ILEY N SL K+ + + + + QGL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLR-----QIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H+ +IHRD+KA+NIL KD K++DFG+A + +VGT +M+PE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
S SD++S G ++E L+
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 79/201 (39%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG G FG V+ G +VAVK L + F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 531 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+L C + E I I+ EYM SL FL K+L V + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKL-RLPQLVDMAAQIAEGMAYLE-- 120
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 646
IHRDL A NIL+ +++ KI+DFGLAR+ DE +G I T +PE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 647 ALDGLFSIKSDVFSFGILMLE 667
A G F+IKSDV+SFGIL+ E
Sbjct: 176 ANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 66/191 (34%), Positives = 105/191 (54%), Gaps = 9/191 (4%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+G+GGFG VYK R G+EVA+K + +S + ++ NE+ ++ K +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+++ E +++E+ SL L ST + L Q + + + +GL YLH IIH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKELLKGLEYLHSN---GIIH 121
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+KA+NILL D K+ DFGL+ +VGT +M+PE + K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 657 DVFSFGILMLE 667
D++S GI +E
Sbjct: 179 DIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 51/120 (42%), Positives = 70/120 (58%), Gaps = 7/120 (5%)
Query: 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLT 91
+ + G+ LVS + FELGFF+ Y I ++ VVWVANRD P+SD+ LT
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSDS-CTLT 59
Query: 92 ISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
+ ++GNLVL + +WS+N + N V L DDGNLVI D+ ++LWQSFDY
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 72/207 (34%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E F+++ KLG G FG V++G N VA+K L + ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRIIEGIAQGL 583
L C +I E M SL FL + L + Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
YL + IHRDL A NIL+ +D+ K++DFGLAR+ D + K+I Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE A G FS KSDV+SFGIL+ E +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 478 KLGEGGFGPVYKGRLLN-----GQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVR 531
+LGEG FG V R G++VAVK L+ + Q +F+ E+ ++ L H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 532 LLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
G C + G + LI+EY+P+ SL +L + ++ + + I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRL-LLFSSQICKGMDYLGSQ 128
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEYA 647
R IHRDL A NIL++ + KISDFGLA++ D + Y +PE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
FS SDV+SFG+ + E +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 77/215 (35%), Positives = 112/215 (52%), Gaps = 29/215 (13%)
Query: 479 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
LGEG FG VYKG L N + VA+K L N + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRIIEG 578
LLG C ++ ++ EY+ + L+ FL D T K L+ + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQI 635
IA G+ YL S +HRDL A N L+ + + KISDFGL+R ++ D +Q +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
V +M PE L G F+ +SD++SFG+++ E S
Sbjct: 190 V---RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 528
+ LG+G G VYK R G+ A+K++ + + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYL 586
+V+ G ++GE ++LEYM SL L K++ V I I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H IIHRD+K SN+L++ KI+DFG++++ + VGT YMSPE
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPER 171
Query: 647 ALDGLFSIKSDVFSFGILMLE 667
+S +D++S G+ +LE
Sbjct: 172 IQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 13/193 (6%)
Query: 478 KLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ E +++EYM SL + R+ Q + + QGL YLH +
Sbjct: 83 SYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQI-AYVCREVLQGLEYLHS---QNV 137
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
IHRD+K+ NILL KD + K++DFG A + + +VGT +M+PE +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 655 KSDVFSFGILMLE 667
K D++S GI+ +E
Sbjct: 196 KVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 15/194 (7%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538
+G+G FG V G GQ+VAVK L + S + F E ++ L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 598
++ EYM SL +L S + ++ ++ + +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 599 LKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY--GYMSPEYALDGLFSIKS 656
L A N+L+ +D+ K+SDFGLA+ + + Q G + +PE + FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 657 DVFSFGILMLETLS 670
DV+SFGIL+ E S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 77/210 (36%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 479 LGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLV 530
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYL 586
+LLG C+ + +I+E M L +L D+ +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 587 HQYSRFRIIHRDLKASNILL-----DKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTYG 640
Q IHRDL A N L+ D D KI DFGLAR ++ D + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE LDG F+ +SDV+SFG+LM E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 479 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VYKG + VA+K L ++ + KE +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLH 587
LG C+ ++ LI + MP L ++ + + LLNW IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSYLE 126
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ R++HRDL A N+L+ + KI+DFGLA++ DE + + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
L +++ KSDV+S+G+ + E ++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 27/203 (13%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
++G+G FG VY R +G+ +K LSN S + ++ NE+ ++ KL H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKR--------LLNW--QARVRIIEGIAQGLL 584
E+G+ +++EY L+ KK +L+W Q + L
Sbjct: 67 SFEEKGKLCIVMEYADGGDLS-QKIKKQKKEGKPFPEEQILDWFVQ--------LCLALK 117
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YLH SR +I+HRD+K NI L + K+ DFG++++ T +VGT Y+SP
Sbjct: 118 YLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSP 172
Query: 645 EYALDGLFSIKSDVFSFGILMLE 667
E + ++ KSD++S G ++ E
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 72/213 (33%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH-R 527
++ + KLGEG FG VY R + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+L ++G L++EY+ SL L +K L+ + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 588 QYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGD----ELQGNTKQIVGTYGYM 642
IIHRD+K NILLD+D K+ DFGLA++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 643 SPEYALDGLF---SIKSDVFSFGILMLETLSSK 672
+PE L S SD++S GI + E L+
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
+ KLG G FG V++G N VAVK L + K+F E ++ KL+H L++L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 535 CCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
C E I I+ E M SL +L R L + + +A G+ YL +
Sbjct: 69 VCT-LEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN--- 123
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDG 650
IHRDL A N+L+ ++ K++DFGLAR+ D + G + +PE AL
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYN 179
Query: 651 LFSIKSDVFSFGILMLE 667
FSIKSDV+SFGIL+ E
Sbjct: 180 RFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 72/204 (35%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 479 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG G FG V KG + +G+E VAVK L G KEF E ++A+L H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
G C + +L++E P L +L L +V A G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-K 114
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARM--FGGDELQGNT--KQIVGTYGYMSPEY 646
F +HRDL A N+LL KISDFG++R G D + T + + Y +PE
Sbjct: 115 HF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APEC 169
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
G FS KSDV+S+G+ + E S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 479 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 531
LGEG FG V+ G + + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFL------------FDSTKKRLLNWQARVRIIEGI 579
G C E I++ EYM + LN FL DS L ++I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAVQI 131
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQIV 636
A G++YL + +HRDL N L+ D+ KI DFG++R ++ D + G+T +
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+M PE + F+ +SDV+SFG+++ E + K
Sbjct: 189 ---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 71/196 (36%), Positives = 106/196 (54%), Gaps = 10/196 (5%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
K+G+G FG VYKG L EVAVK + LK F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
V++ +++E +P SL FL KK L + +++ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSI 654
RDL A N L+ ++ KISDFG++R G + KQI + +PE G ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174
Query: 655 KSDVFSFGILMLETLS 670
+SDV+S+GIL+ ET S
Sbjct: 175 ESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E F + KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V+ G + + +++EY S++ + T K L + I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAA-ILYQTLKGLEYLHSN 118
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+ IHRD+KA NILL+++ K++DFG++ ++GT +M+PE +
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMAPEVIQE 173
Query: 650 GLFSIKSDVFSFGILMLE 667
++ K+D++S GI +E
Sbjct: 174 IGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 72/198 (36%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 479 LGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLL 533
+G G FG V +GRL L G++ VA+K L S + +F E ++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 534 GCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
G V + ++I+ EYM N SL+ FL ++ K V ++ GIA G+ YL S
Sbjct: 72 GV-VTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEM 125
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
+HRDL A NIL++ ++ K+SDFGL+R E TK + +PE F
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 653 SIKSDVFSFGILMLETLS 670
+ SDV+SFGI+M E +S
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 528
+F + K+G+G FG V+K R + + A+K+ LS + + +E +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL---LNWQARVRIIEGIAQGLLY 585
++R +++G+ +++EY N L+ L + L W R I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 646 YALDGLFSIKSDVFSFGILMLE 667
D ++ KSDV++ G+++ E
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 77/204 (37%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E + KLG G FG V+ G +VA+K L Q + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 531 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
RL V E I I+ EYM N SL FL +L + + IA+G+ ++
Sbjct: 65 RLYA--VVTQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE-- 119
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 646
R IHRDL+A+NIL+ + + KI+DFGLAR+ +E +G I T +PE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEA 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
G F+IKSDV+SFGIL+ E ++
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQH 526
+ ++GEG +G VYK R G+ VA+K++ ++ KE E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 527 RNLVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
N+VRL +G ++ EYM + L L DS + + Q + ++ + +GL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIK-CYMKQLLEGLQ 114
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YLH I+HRD+K SNIL++ D K++DFGLAR + T +++ T Y P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 645 EYAL-DGLFSIKSDVFSFGILMLETLSSK 672
E L + + D++S G ++ E K
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
++G G FG V+ G L ++VA+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
E+ L+ E+M + L+ +L ++ + + + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 598 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDGLFSI 654
DL A N L+ ++ K+SDFG+ R D+ +T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 655 KSDVFSFGILMLETLSSKK 673
KSDV+SFG+LM E S K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 479 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 531
+G+G FG V++ R LL + VAVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------------------LNWQAR 572
LLG C L+ EYM LN FL + + L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGN 631
+ I + +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +M PE ++ +SDV+++G+++ E S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 69/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 469 ATENFSMQCKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLI 521
++ ++ LG G FG VY+G R +G +VAVK L + S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIE 577
+K H+N+VRL+G E+ + ++LE M L FL ++ + L + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLAR-MFGGDELQGNTK 633
+A+G YL + IHRD+ A N LL KI+DFG+AR ++ + +
Sbjct: 124 DVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
++ +M PE LDG+F+ K+DV+SFG+L+ E S
Sbjct: 181 AML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 22/209 (10%)
Query: 479 LGEGGFGPVYKGRL----LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LGEG FG V +G+L + +VAVK +L + ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 533 LGCCVEQGEK------ILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGL 583
+G C E ++IL +M + L+ FL S L Q ++ + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDEL-QGNTKQIVGTYGY 641
YL S IHRDL A N +L +DM ++DFGL++ ++ GD QG ++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLS 670
++ E D +++ KSDV++FG+ M E +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 69/197 (35%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538
LG G FG V+ G+ +VA+K + + +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 598
Q ++ EYM N L +L +K L + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 599 LKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPEYALDGLFSIKS 656
L A N L+ +D K+SDFGLAR D+ TK V + PE FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182
Query: 657 DVFSFGILMLETLSSKK 673
DV+SFG+LM E S K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 76/216 (35%), Positives = 114/216 (52%), Gaps = 29/216 (13%)
Query: 478 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 530
+LGE FG VYKG L Q VA+K L +++ L+E FK+E M+ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRIIE 577
LLG ++ +I Y + L+ FL D T K L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQ 634
IA G+ +L S ++H+DL N+L+ +N KISD GL R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +MSPE + G FSI SD++S+G+++ E S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 479 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVR 531
LG G FG V+ + +E V VK L + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLY 585
LLG C E +ILEY L FL + K L+ + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
L S R +HRDL A N L+ K+S L++ E ++ +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKK 673
+ FS KSDV+SFG+LM E + +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 528
E +LGEG G V K RL N + A+K ++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 529 LVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIA 580
+V+ G ++ + +EY SL DS K++ R+ +I E +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+GL YLH +IIHRD+K SNILL + K+ DFG++ G+ + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLE 667
YM+PE +SI SDV+S G+ +LE
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 67/197 (34%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLG 534
LG+G FG V R + G+ A+K L + KE E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ EK+ L+LEY P L F S + R +AR E I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL--FSHLSKEGRFSEERARFYAAE-IVLALEYLHSL---G 113
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
II+RDLK NILLD D + K++DFGLA+ + + T GT Y++PE L +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGKGYG 171
Query: 654 IKSDVFSFGILMLETLS 670
D +S G+L+ E L+
Sbjct: 172 KAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 77/205 (37%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 475 MQCKLGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 528
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 529 LVRLLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+ GCC EQG K LI+EY+P SL +L K LN + + I +G+ YL
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF-GGDELQGNTKQIVGTYGYMSPE 645
H IHRDL A N+LLD D KI DFGLA+ G E + + + E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
+ FS SDV+SFG+ + E L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 474 SMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
LG C + +I E+M +L +L + ++ +N + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY--GYMSPEYALDG 650
IHRDL A N L+ ++ K++DFGL+R+ GD T + + +PE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYN 180
Query: 651 LFSIKSDVFSFGILMLE 667
FSIKSDV++FG+L+ E
Sbjct: 181 KFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 72/194 (37%), Positives = 108/194 (55%), Gaps = 15/194 (7%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
+GEG FG V +G GQ+VAVK + + + Q F E ++ KL H+NLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ G I ++E M +L FL + + L++ ++ +A+G+ YL +++H
Sbjct: 69 LHNGLYI-VMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RDL A NIL+ +D K+SDFGLAR+ G N+K V + +PE FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKKFSSKS 178
Query: 657 DVFSFGILMLETLS 670
DV+S+G+L+ E S
Sbjct: 179 DVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 77/205 (37%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E+ + KLG G FG V+ G +VAVK L + + F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
LV+L E+ I + EYM SL FL D + R L V + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPE 645
R IHRDL+++NIL+ + KI+DFGLAR+ +E QG I T +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
AL G F+IKSDV+SFGIL+ E ++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 77/205 (37%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L E+ I + EYM SL FL K L V + IA G+ Y+
Sbjct: 65 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE--- 119
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEYA 647
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E QG I T +PE A
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 175
Query: 648 LDGLFSIKSDVFSFGILMLETLSSK 672
L G F+IKSDV+SFGIL+ E L++K
Sbjct: 176 LYGRFTIKSDVWSFGILLTE-LTTK 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 39/217 (17%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN-----EMMLIAKLQ 525
+ KLGEG + VYK R G+ VA+K++ + K+ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIEGI 579
H N++ LL + L+ E+M K ++ L + K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYM-LM--------T 111
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG--GDELQGNTKQIVG 637
+GL YLH I+HRDLK +N+L+ D K++DFGLAR FG ++ T Q+V
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV- 164
Query: 638 TYGYMSPEYALDGLFSIKS-----DVFSFGILMLETL 669
T Y +PE LF + D++S G + E L
Sbjct: 165 TRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 26/209 (12%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQG---LKEFKNEMMLIAKLQHRNLVR 531
LG G F Y+ R + G +AVK+++ N S + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LG E L +E+M S++ L + + K+ ++ E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHEN 122
Query: 590 SRFRIIHRDLKASNILLDKD-MNPKISDFGLA-----RMFGGDELQGNTKQIVGTYGYMS 643
+IIHRD+K +N+L+D +I+DFG A + G E QG Q++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSK 672
PE + DV+S G +++E ++K
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+ ++ LGEG FG V K + VAVK L + + + L + +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 578
+ +H+N++ LLG C ++G +++EY + +L FL R E
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 579 ---------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629
+A+G+ +L + IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
T +M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 68/230 (29%), Positives = 112/230 (48%), Gaps = 33/230 (14%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 523
E ++ +LG+G FG VY+G VA+K ++ N S + EF NE ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYM-------------PNKSLNVFLFDSTKKRLLNWQ 570
++VRLLG ++++E M P N L T ++ +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQ 629
A IA G+ YL + +HRDL A N ++ +D+ KI DFG+ R ++ D +
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGL 677
K ++ +M+PE DG+F+ KSDV+SFG+++ E TL+ + GL
Sbjct: 177 KGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 528
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+ V E L++ Y+ SL + S + L+ +++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEY 646
+ IHRD+KA NILL +D + KI+DFG++ GGD + K VGT +M+PE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 647 ALDGL-FSIKSDVFSFGILMLE 667
+ K+D++SFGI +E
Sbjct: 178 MEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 75/206 (36%), Positives = 108/206 (52%), Gaps = 12/206 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL ++ +I EYM SL FL ++L + IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEYA 647
R IHRDL+A+N+L+ + + KI+DFGLAR+ +E +G I T +PE
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAI 176
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKK 673
G F+IKSDV+SFGIL+ E ++ K
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQHRNLVRLLG 534
K+GEG +G VYK R L G+ VA+K++ + E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQYSRFR 593
+G+ L+ E+M +++ ++R L ++ ++ + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH---G 118
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLF 652
I+HRDLK N+L++ + K++DFGLAR FG V T Y +PE L D +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 653 SIKSDVFSFGILMLETLS 670
S D++S G + E LS
Sbjct: 177 STPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 3e-24
Identities = 27/65 (41%), Positives = 43/65 (66%)
Query: 294 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWY 353
C GD F+ L +K PD +++ + L++C+ CL NCSC AYA ++++ SGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWT 60
Query: 354 GDLID 358
G+L+D
Sbjct: 61 GELVD 65
|
Length = 66 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 35/222 (15%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 519
KLGEG FG V+ Q+ VAVK L + S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--------FDSTKKRLLNWQA 571
++++L N+ RLLG C +I+EYM N LN FL + + L++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 628
+ + IA G+ YL +HRDL N L+ K+ KI+DFG++R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
QG +M+ E L G F+ KSDV++FG+ + E L+
Sbjct: 189 QGRA---PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFK-----NEMMLIAKL-QHRNLVR 531
+GEG F V + +E A+K L + Q +KE K E ++ +L H +++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
L ++ +LEY PN L ++ K L+ + I L YLH
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHSK-- 121
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---------------- 635
IIHRDLK NILLDKDM+ KI+DFG A++ + + K
Sbjct: 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 636 --VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
VGT Y+SPE + SD+++ G ++ + L+ K
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
GC + + +EYMP S+ L L R + I +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLH---SN 123
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGYMSPEYALDGL 651
I+HRD+K +NIL D N K+ DFG ++ G K + GT +MSPE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 652 FSIKSDVFSFGILMLETLSSK 672
+ K+DV+S G ++E L+ K
Sbjct: 184 YGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 34/215 (15%)
Query: 479 LGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 534 GCCVEQGEK--ILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLY 585
G C G + L++EY+P SL +L D K L Q I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ-----IVGTYG 640
L R +HRDL NIL++ + KI DFGL ++ D+ ++ I
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF---- 176
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKN 674
+ +PE + FS+ SDV+SFG+++ E + S K+
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVKRLS----NQSGQG-LKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
LG E+ + LE +P SL L + S + ++ R I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH--D 120
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD- 649
R +HRD+K +NIL+D + K++DFG+A+ K G+ +M+PE
Sbjct: 121 R-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 650 GLFSIKSDVFSFGILMLETLSSK 672
G + + +D++S G +LE + K
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLL 533
+LG G G V K G+ +AVK + + K + ++ K +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G G+ + +EYM SL+ L + R+ + +I + +GL YLH + +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL-KEVQGRI-PERILGKIAVAVLKGLTYLH--EKHK 121
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
IIHRD+K SNIL++ K+ DFG++ G + K VGT YM+PE +S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 654 IKSDVFSFGILMLE 667
+KSD++S G+ ++E
Sbjct: 178 VKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 78/207 (37%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 529
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ KL+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V L E+ I + E+M SL FL + K L Q V + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 646
R IHRDL+A+NIL+ ++ KI+DFGLAR+ +E QG I + +PE
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEA 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKK 673
AL G F+IKSDV+SFGIL+ E ++ +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 479 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
LG+G +G VY R L+ Q +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
E G + +E +P SL+ L N Q + + I +GL YLH +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 598 DLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL--FSI 654
D+K N+L++ KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 655 KSDVFSFGILMLETLSSK 672
+D++S G ++E + K
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 30/208 (14%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ----SGQGLKEFKNEMMLIAKLQHRNLV 530
KLGEG +G VYK R G+ VA+K RL N+ L+E L+ +L+H N+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELKHPNIV 61
Query: 531 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA----QGLLY 585
+LL K+ L+ EY + L +L + L+ +I+ I +GL Y
Sbjct: 62 KLLDVIH-TERKLYLVFEYC-DMDLKKYL--DKRPGPLS----PNLIKSIMYQLLRGLAY 113
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
H + RI+HRDLK NIL+++D K++DFGLAR F G L+ T ++V T Y +PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168
Query: 646 YAL-DGLFSIKSDVFSFGILMLETLSSK 672
L +S D++S G + E ++ K
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 24/210 (11%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQG-------LKEFKNEMMLIAKLQHRN 528
+G G FG VY G +G+ +AVK+ L + S L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+ LG ++ + LEY+P S+ L + + ++ L+ + I +GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKGLNYL 122
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ----IVGTYGYM 642
H +R IIHRD+K +NIL+D KISDFG+++ + L T + G+ +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+PE ++ K+D++S G L++E L+ K
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 73/215 (33%), Positives = 116/215 (53%), Gaps = 22/215 (10%)
Query: 479 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQ 588
LG C+ + L+ + MP+ L ++ + + LLNW + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R++HRDL A N+L+ + KI+DFGLAR+ GDE + N +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 649 DGLFSIKSDVFSFGILMLE--TLSSKKNTGLGSME 681
F+ +SDV+S+G+ + E T K G+ + E
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 73/214 (34%), Positives = 111/214 (51%), Gaps = 25/214 (11%)
Query: 478 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVR 531
+LGE FG +YKG L + Q VA+K L + + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLF--------------DSTKKRLLNWQARVRIIE 577
LLG ++ ++ EY+ L+ FL D T K L+ + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIV 636
IA G+ YL S F +H+DL A NIL+ + ++ KISD GL+R ++ D + K ++
Sbjct: 132 QIAAGMEYLS--SHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M PE + G FS SD++SFG+++ E S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLKEFKNEMMLI 521
NF ++ K+G+G F VYK LL+G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIA 580
+L H N+++ L +E E ++LE L+ + K KRL+ + + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
L ++H RI+HRD+K +N+ + K+ D GL R F ++ VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPY 171
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLE 667
YMSPE + ++ KSD++S G L+ E
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-23
Identities = 72/201 (35%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
+LG G FG V G+ +VA+K + S EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL--HQYSRFRII 595
+Q ++ EYM N L +L KR Q + + + + +G+ YL Q+ I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQL-LEMCKDVCEGMAYLESKQF-----I 122
Query: 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDGLF 652
HRDL A N L+D K+SDFGL+R DE + VG+ + PE L F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178
Query: 653 SIKSDVFSFGILMLETLSSKK 673
S KSDV++FG+LM E S K
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 8e-23
Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGCCV 537
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
++ +++E +P FL KK L + V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 598 DLKASNILLDKDMNPKISDFGLARMF-GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
DL A N L+ ++ KISDFG++R G KQI + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 657 DVFSFGILMLETLS 670
DV+S+GIL+ ET S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 9e-23
Identities = 77/223 (34%), Positives = 114/223 (51%), Gaps = 26/223 (11%)
Query: 471 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 521
+ + LGEG FG V K R VAVK L N + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 522 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLL 567
+ +H+N++ LLG C ++G +I+EY +L FL FD TK + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+++ V +A+G+ YL SR R IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
T +M+PE D +++ +SDV+SFGILM E +
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 531 RLLGCCVEQ-GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LLG VE+ G ++ EYM SL +L S + +L ++ + + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+ +HRDL A N+L+ +D K+SDFGL + Q K V + +PE +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 173
Query: 650 GLFSIKSDVFSFGILMLETLS 670
FS KSDV+SFGIL+ E S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 63/204 (30%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 478 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 532
KLG+G FG V +G VAVK L + + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLH 587
G V +++ E P SL L L ++ + IA G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDELQGNTKQIVGTYGYMSPEY 646
R IHRDL A NILL D KI DFGL R ++ + + + + +PE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
FS SDV+ FG+ + E +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 466 ITAATENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQSGQ-GLKEFKNEMM 519
I + + ++ L EG FG ++ G L++ +EV VK + + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS-LNVFL-----FDSTKKRLLNWQARV 573
L+ L H+N++ +L C+E GE +L N L +FL ++ + L+ Q V
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDE--LQG 630
+ IA G+ YLH+ +IH+D+ A N ++D+++ KI+D L+R +F D L
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
N + V +M+ E ++ +S SDV+SFG+L+ E
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 66/195 (33%), Positives = 108/195 (55%), Gaps = 13/195 (6%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 534
K+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
V K+ L+ E++ + L ++ DS+ L+ + + QG+ Y H + R
Sbjct: 66 V-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---R 119
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 652
++HRDLK N+L+D++ K++DFGLAR F G ++ T ++V T Y +PE L +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQY 177
Query: 653 SIKSDVFSFGILMLE 667
S D++S G + E
Sbjct: 178 STPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ + + +LG+G FG VYK + G A K + +S + L++F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V L + + +++E+ +L+ + ++ L Q R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH- 120
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
++IHRDLKA NILL D + K++DFG++ LQ +GT +M+PE
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ-KRDTFIGTPYWMAPEVVA 176
Query: 649 -----DGLFSIKSDVFSFGILMLE 667
D + K+D++S GI ++E
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQ 525
N ++ +LGEG FG V+ N Q+ VAVK L + S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----------FDSTKKRLLNWQARVRI 575
H ++V+ G CVE I++ EYM + LN FL + + L + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNT 632
+ IA G++YL + +HRDL N L+ +++ KI DFG++R ++ D + G+T
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+ +M PE + F+ +SDV+S G+++ E + K
Sbjct: 183 MLPI---RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 9e-22
Identities = 68/227 (29%), Positives = 111/227 (48%), Gaps = 31/227 (13%)
Query: 472 NFSMQCKLGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
N + LGEG FG V K L G+ VAVK L N S L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--------------------- 563
H ++++L G C + G +LI+EY SL FL +S K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 564 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623
+R L + I++G+ YL + +++HRDL A N+L+ + KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
++ + +M+ E D +++ +SDV+SFG+L+ E ++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 475 MQCKLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
++ +LGEG FG V+ LL Q+ VAVK L S ++F+ E L+ LQH++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFL---------FDSTKKRL---LNWQARVRII 576
+VR G C E +++ EYM + LN FL + L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQI 635
IA G++YL + +HRDL N L+ + + KI DFG++R ++ D + + +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+ +M PE L F+ +SD++SFG+++ E + K
Sbjct: 186 LPIR-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 67/205 (32%), Positives = 115/205 (56%), Gaps = 21/205 (10%)
Query: 479 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LGEG FG V +G+L +VAVK +++ + +++F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 534 GCCVEQGEK------ILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLL 584
G C++ E ++IL +M + L+ FL S + L Q V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDEL-QGNTKQIVGTYGYM 642
YL S IHRDL A N +L+++MN ++DFGL+ +++ GD QG ++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE 667
+ E D +++ KSDV+SFG+ M E
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWE 206
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 478 KLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
+G+G FG V K G++L +E+ ++ + Q L +E+ ++ +L+H N+VR
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63
Query: 532 LLGCCV-EQGEKI-LILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLH- 587
+ + + +++EY L + K ++ + + RI+ + L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 588 -QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
++HRDLK +NI LD + N K+ DFGLA++ G D K VGT YMSPE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQ 181
Query: 647 ALDGLFSIKSDVFSFGILMLE 667
+ KSD++S G L+ E
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 21/205 (10%)
Query: 472 NFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 528
+F + KLG+G +G VYK RL + Q A+K L + S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 529 LVR-----LLGCCVEQGEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQG 582
++ L G + +++EY P L+ + K ++L+ Q RI + +G
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
L LH+ +I+HRDLK++NILL + KI D G++++ + K +GT YM
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYM 168
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE 667
+PE +S KSD++S G L+ E
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 22/203 (10%)
Query: 479 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG V+KG + + VA+K + ++SG Q +E + M+ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIAQGLLYLH 587
LG C G + L+ + P SL + +RLLNW + IA+G+ YL
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
++ R++HR+L A NILL D +I+DFG+A + D+ + + +M+ E
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
L G ++ +SDV+S+G+ + E +S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 70/200 (35%), Positives = 106/200 (53%), Gaps = 12/200 (6%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
K+GEG +G VYKGR GQ VA+K RL ++ E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQYSRFR 593
+++ LI E++ + L +L DS K V+ + I QG+L+ H R
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 652
++HRDLK N+L+D K++DFGLAR F G ++ T ++V T Y +PE L +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSPRY 179
Query: 653 SIKSDVFSFGILMLETLSSK 672
S D++S G + E + K
Sbjct: 180 STPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 41/198 (20%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ------GLKEFKNEMMLI 521
++ + KLGEG FG VYK R + G+ VA+K++ + + L+E K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 522 AKLQHRNLVRLLGCCVEQGEKI--------LILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
KL+H N+V L+ VE+ +K ++ YM D LL V
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM----------DHDLSGLLE-NPSV 110
Query: 574 R--------IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625
+ + + +G+ YLH+ I+HRD+KA+NIL+D KI+DFGLAR + G
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 626 DELQGNTKQIVGTYGYMS 643
GT Y +
Sbjct: 168 PPPNPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
+LG G FG V+ G+ +VA+K + N+ ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
+Q ++ E+M N L +L ++ L+ + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 598 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYALDGL 651
DL A N L+ K+SDFG+ R D + + G + PE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDD-------EYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 652 FSIKSDVFSFGILMLETLSSKK 673
+S KSDV+SFG+LM E + K
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 57/175 (32%), Positives = 94/175 (53%), Gaps = 18/175 (10%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG------LKEFKNEMMLIAKLQHRNLV 530
++GEG G V+K + G+ VA+K+++ + +G L+E K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+LL +L++EYMP+ L+ L D + L Q + + + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVK-SYMRMLLKGVAYMHA-- 117
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
I+HRDLK +N+L+ D KI+DFGLAR+F +E + + Q V T Y +PE
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 66/203 (32%), Positives = 111/203 (54%), Gaps = 21/203 (10%)
Query: 479 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G FG V++G L + G++ VA+K L + + ++F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G + ++I EYM N +L+ +L D + + V ++ GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYA 647
+HRDL A NIL++ ++ K+SDFGL+R+ L+ + + T G + +PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
F+ SDV+SFGI+M E +S
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 71/208 (34%), Positives = 110/208 (52%), Gaps = 23/208 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR-----LLNWQARVRIIEGIAQGLLY 585
+L V + +I E+M SL FL + L+++ A+ IA+G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 117
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYM 642
+ Q + IHRDL+A+NIL+ + KI+DFGLAR+ +E +G I T
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---- 170
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLS 670
+PE G F+IKSDV+SFGIL++E ++
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 479 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G FG V +GRL L G+ VA+K L S + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ----ARVRIIEGIAQGLLYLHQY 589
G + ++I E+M N +L+ FL R + Q V ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL------RQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG---TYGYMSPEY 646
S +HRDL A NIL++ ++ K+SDFGL+R D +G + +PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
F+ SDV+S+GI+M E +S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 479 LGEGGFGPV----YKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 532
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 533 LGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL--HQ 588
G C E G LI+E++P+ SL +L K +N + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT-YGYMSPEYA 647
Y +HRDL A N+L++ + KI DFGL + D+ K + + + +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
+ F I SDV+SFG+ + E L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 528
NF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+LL + + L+ E++ ++ L F+ D++ + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ R++HRDLK N+L++ + K++DFGLAR F G ++ T ++V T Y +PE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 649 DG-LFSIKSDVFSFGILMLETLSSK 672
+S D++S G + E ++ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 9e-21
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 25/205 (12%)
Query: 478 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR----NLV 530
+LG G FG V KG ++ Q +VA+K L N++ K ++EMM A++ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
R++G C E +L++E LN FL S KK + V ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPE 645
+HRDL A N+LL KISDFGL++ G D+ + + G + +PE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR----SAGKWPLKWYAPE 168
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
FS +SDV+S+GI M E S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 35/222 (15%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSNQSGQGLK-EFKNEMM 519
KLGEG FG V+ ++ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--------FDSTKKRLLNWQA 571
++++L+ N++RLL C+ +I EYM N LN FL + +++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 628
+ + IA G+ YL S +HRDL N L+ K+ KI+DFG++R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
QG + V +MS E L G F+ SDV++FG+ + E L+
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 530
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+ G ++ + +I+EY S D K L+ I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
IHRD+KA+NILL ++ + K++DFG++ + NT VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQS 173
Query: 651 LFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 174 GYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 479 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 533 LGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQGLLYLHQY 589
GC ++ EK L +EYMP S+ D K L + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGYMSPEYAL 648
I+HRD+K +NIL D N K+ DFG ++ + G + + GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 649 DGLFSIKSDVFSFGILMLETLSSK 672
+ K+DV+S G ++E L+ K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG VY R + + VA+K++S QS + ++ E+ + +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
GC + + L++EY + ++ + KK L + I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEIAA-ICHGALQGLAYLHSHER-- 136
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 650
IHRD+KA NILL + K++DFG A L VGT +M+PE L +G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDEG 189
Query: 651 LFSIKSDVFSFGILMLETLSSKK 673
+ K DV+S GI +E L+ +K
Sbjct: 190 QYDGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSGQGLKE-FKNEMMLIAK 523
N S LG G FG V + L +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
L H N+V LLG C G ++I EY L FL ++ L + + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQIVGTY 639
+ +L + IHRDL A N+LL KI DFGLAR D ++GN + V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 37/217 (17%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVK------RLSNQSGQGLKE----FKNEMMLIAKLQHR 527
+G+G +G VY + G+ +AVK ++ + K+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 528 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIA 580
N+V+ LG E E+ L LEY+P S+ L F+ R Q +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN--TKQIVGT 638
+GL YLH I+HRDLKA N+L+D D KISDFG+++ D++ N + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173
Query: 639 YGYMSPEY-ALDGL-FSIKSDVFSFGILMLETLSSKK 673
+M+PE +S K D++S G ++LE + ++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 479 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G FG V GRL L G+ VA+K L + + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G + +++ EYM N SL+ FL + V ++ GIA G+ YL S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYA 647
+HRDL A NIL++ ++ K+SDFGL+R+ D T T G + +PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIRWTAPEAI 181
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
F+ SDV+S+GI+M E +S
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 72/240 (30%), Positives = 118/240 (49%), Gaps = 43/240 (17%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 519
KLGEG FG V+ ++N Q+ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF-----LFDSTKKR--------- 565
++++L+ N++RLLG CV++ +I EYM N LN F L D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 566 --LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-M 622
+++ + + + IA G+ YL S +HRDL N L+ +++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 623 FGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680
+ GD +QG + V +M+ E L G F+ SDV++FG+ + E L K G +
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 478 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
+LGEG FG V+ N VAVK L + + K+F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQAR-----------VRIIEG 578
G C + I++ EYM + LN FL L++ Q R + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQI 635
IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D + G+T
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+ +M PE + F+ +SDV+SFG+++ E + K
Sbjct: 189 I---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC- 535
+GEG +G VYK R GQ VA+K + +E K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 536 -----CVEQGEKILILEYMPNKSLN--VFLFDSTKKRLL-NWQARVRIIEGIAQGLLYLH 587
+ L++E S+ V KRL W A I+ +GL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYLH 130
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-- 645
+ ++IHRD+K NILL K+ K+ DFG++ D G +GT +M+PE
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAPEVI 185
Query: 646 ---YALDGLFSIKSDVFSFGILMLE 667
D + +SDV+S GI +E
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-20
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 290 HSLECKSG---DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES 346
L C D F++L ++K PD ++LE+C+ CL NCSC AYA +N S
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDNASAITA--ISLEECREACLSNCSCTAYAYNNG--S 56
Query: 347 SGCLMWYGDLIDARRPIRNFTGQSVYLRVP 376
GCL+W G L + R + G ++YLR+
Sbjct: 57 GGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGC 535
++G G FG V+ GRL + VAVK LK +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
C ++ +++E + FL T+ L + ++++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 596 HRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
HRDL A N L+ + KISDFG++R G G KQI + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 654 IKSDVFSFGILMLETLS 670
+SDV+SFGIL+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 70/215 (32%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 479 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VYKG + E VA+K L S + KE +E ++A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQ 588
LG C+ + LI + MP L ++ + + LLNW + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R++HRDL A N+L+ + KI+DFGLA++ G DE + + + +M+ E L
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 649 DGLFSIKSDVFSFGILMLE--TLSSKKNTGLGSME 681
+++ +SDV+S+G+ + E T SK G+ + E
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 478 KLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRLLG 534
K+G G FG VY L+ E+ AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
V + + + +EY +L L R+L+ + +GL YLH + I
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFG------GDELQGNTKQIVGTYGYMSPEYAL 648
+HRD+K +NI LD + K+ DFG A G+E+Q + GT YM+PE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMAPEVIT 176
Query: 649 DGLFSIK---SDVFSFGILMLETLSSKK 673
G +D++S G ++LE + K+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG+GGFG V ++ G+ A K+L + +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ + L++ M L +++ + +A + I GL +LHQ RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---RI 116
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
++RDLK N+LLD N +ISD GLA G K GT GYM+PE ++
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 655 KSDVFSFGILMLETLSSK 672
D F+ G + E ++ +
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 479 LGEGGFGPVYKGRLL--NGQEV--AVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 533
+G+G FG VY G L+ +GQ++ AVK L+ + + +++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 534 GCCV-EQGEKILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQ 588
G C+ +G +++L YM + L F+ T K L+ + +V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG--NTKQIVGTYGYMSPEY 646
+ +HRDL A N +LD+ K++DFGLAR E N +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
F+ KSDV+SFG+L+ E ++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 36/211 (17%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIAK 523
+ + +LG+G FG VY R G+ VA+K++ K+F + E+ + K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 524 LQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVR-IIEGIA 580
L H N+V+L E E + EYM N++ L K + + ++ +R II I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFS-ESVIRSIIYQIL 109
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN---TKQIVG 637
QGL ++H++ F HRDLK N+L+ KI+DFGLAR E++ T V
Sbjct: 110 QGLAHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYT-DYVS 160
Query: 638 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLE 667
T Y +PE L +S D+++ G +M E
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 69/221 (31%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 478 KLGEGGFGPVYKGRLLNGQE---------------VAVKRL-SNQSGQGLKEFKNEMMLI 521
KLGEG FG V+ E VAVK L ++ + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLN-----WQAR 572
++L++ N++RLLG CV +I EYM N LN FL +ST N
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQ 629
+ + IA G+ YL + +HRDL N L+ KI+DFG++R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
G + V +M+ E L G F+ SDV++FG+ + E +
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 28/219 (12%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QH 526
+ Q +GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-------------TKKRLLNWQARV 573
N++ LLG C +G L +EY P+ +L FL S + L+ Q +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+A+G+ YL Q + IHRDL A NIL+ ++ KI+DFGL+R G E+ K
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 179
Query: 634 QIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +G +M+ E +++ SDV+S+G+L+ E +S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 19/197 (9%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
GC + + L++EY + ++ K+ L + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 650
+IHRD+KA NILL + K+ DFG A + VGT +M+PE L +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 651 LFSIKSDVFSFGILMLE 667
+ K DV+S GI +E
Sbjct: 190 QYDGKVDVWSLGITCIE 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 25/202 (12%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
+LG+G FG VYK + G A K + +S + L+++ E+ ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
G+ +++E+ P +++ + + + L Q +V I + + L YLH +IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI------VGTYGYMSPEYAL-- 648
RDLKA N+LL D + K++DFG++ N K + +GT +M+PE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 649 ---DGLFSIKSDVFSFGILMLE 667
D + K+D++S GI ++E
Sbjct: 186 TMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 28/218 (12%)
Query: 473 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH 526
F++ LG+G FG V + +L + Q+VAVK L S ++EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 527 RNLVRLLGCCVEQGEK------ILILEYMPNKSLNVFLFDSTKKRL------LNWQARVR 574
N+++L+G + K ++IL +M + L+ FL S R+ L Q VR
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS---RIGEEPFTLPLQTLVR 117
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDEL-QGNT 632
+ IA G+ YL S IHRDL A N +L+++M ++DFGL++ ++ GD QG
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
++ +++ E D +++ SDV++FG+ M E ++
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGC 535
+G G FG V+ R Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
+E ++++EY P +L + +KR + I+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTL----AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 596 HRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
HRDLK NILLDK M KI DFG++++ + +VGT Y+SPE ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 655 KSDVFSFGILMLETLSSKK 673
KSD+++ G ++ E S K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHR 527
NF ++ K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLN-VFLFDSTKKRLLN----WQARVRIIEGIAQG 582
N+++ L +E E ++LE L+ + + +KRL+ W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
H +SR R++HRD+K +N+ + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE 667
SPE + ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E++ + ++G G +G VYK R + G+ VA+K + + G + + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA-------QG 582
V G + + + +++EY SL ++ T+ L Q IA +G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQ--------IAYVCRETLKG 113
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
L YLH+ IHRD+K +NILL +D + K++DFG++ + + +GT +M
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWM 168
Query: 643 SPEYA---LDGLFSIKSDVFSFGILMLE 667
+PE A G + K D+++ GI +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 478 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSNQSGQGLKEFKNEMMLIAK----LQHRNLV 530
+LG G FG V KG ++ ++ VAVK L N + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
R++G C E +L++E LN FL K + + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEY 646
+HRDL A N+LL KISDFGL++ G DE + + K V Y +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
FS KSDV+SFG+LM E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 473 FSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 528
F+ ++G G FG VY R + EV A+K++S QS + ++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ GC + + L++EY + + L + KK L + I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHS 143
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
++ +IHRD+KA NILL + K++DFG A + VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 649 ---DGLFSIKSDVFSFGILMLETLSSK 672
+G + K DV+S GI +E K
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 19/200 (9%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG-QGLKEFK-NEMMLIAKLQ---HRNLVRL 532
+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L+ H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 533 LGCC-VEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
L C + ++ L+ E++ ++ L +L K L + ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ RI+HRDLK NIL+ D KI+DFGLAR++ + T +V T Y +PE
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVV-TLWYRAPEVL 178
Query: 648 LDGLFSIKSDVFSFGILMLE 667
L ++ D++S G + E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR 527
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 528 NLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
LV L + E + L+++ + L L S K + Q + I E I L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYL 116
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H IIHRD+K NILLD+ + I+DF +A D T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEV 170
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKK 673
+S+ D +S G+ E L K+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 471 ENFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 524
N+ + LG G FG VY GR L ++V S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 525 QHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQ 581
+H +V+ GC + EK L +EYMP S+ D K L R I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYG 640
G+ YLH I+HRD+K +NIL D N K+ DFG ++ + G K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+MSPE + K+DV+S ++E L+ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 8e-19
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 479 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRN 528
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLLNWQARVRI 575
++ LLG C + G +++EY +L +L FD+ K + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-19
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 22/216 (10%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRL----SNQ--SGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+G +G VY G GQ +AVK++ SN + + ++ + E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYS 590
LG C++ + +E++P S++ L R V + + I G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV----GTYGYMSPEY 646
++HRD+K +N++L + K+ DFG AR L G ++ GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 682
+ + KSD++S G + E + K L SM+R
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP--LASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 473 FSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRL--SNQSGQGLKEFK-NEMMLIAKLQH 526
+ ++ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 527 RNLVRLLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGL 583
N+V L+ +E +K L+ +Y + + F KR+ + V+ ++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMF--------GGDELQGN 631
YLH S + ++HRDLK +NIL+ + KI D GLAR+F D
Sbjct: 122 HYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 632 TKQIVGTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
+V T Y +PE L K+ D+++ G + E L+ +
Sbjct: 174 --PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 9e-19
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL-----SNQSGQGLKEFKNEMMLIAKLQ 525
N+ + LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 526 HRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQG 582
H +V+ GC + E+ L +E+MP S+ D K L + I +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGY 641
+ YLH I+HRD+K +NIL D N K+ DFG ++ L G K + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
MSPE + K+D++S G ++E L+ K
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 479 LGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-QHRN 528
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLLNWQARVRI 575
++ LLG C + G +I+EY +L +L +D + + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFGLAR + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++ +SDV+SFG+LM E +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 56/201 (27%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 479 LGEGGFGP--VYK----GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+G FG +Y+ L+ +EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
++ ++ +EY +L + K +L + + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
I+HRD+K NI L K K+ DFG++++ G + T +VGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 653 SIKSDVFSFGILMLETLSSKK 673
+ KSD+++ G ++ E L+ K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 71/227 (31%), Positives = 120/227 (52%), Gaps = 23/227 (10%)
Query: 469 ATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQSGQGLK-EFKNEMMLI 521
A E +M +LG+G FG VY KG + + E VA+K ++ + + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 522 AKLQHRNLVRLLGCCVEQGEKIL-ILEYMPNKSLNVFLF-------DSTKKRLLNWQARV 573
+ ++VRLLG V QG+ L I+E M L +L ++ + + + +
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNT 632
++ IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R ++ D +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGL 677
K ++ +MSPE DG+F+ SDV+SFG+++ E TL+ + G+
Sbjct: 180 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNL 529
NF KLGEG + VYKGR G+ VA+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
VRL + + +L+ EYM +K L ++ + L+ + +G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEYAL 648
R++HRDLK N+L++K K++DFGLAR FG + NT V T Y +P+ L
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPDVLL 173
Query: 649 DG-LFSIKSDVFSFGILMLETLSSK 672
+S D++S G +M E ++ +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 479 LGEGGFGPVYKGRLLNGQE--------VAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRN 528
LGEG FG V + + VAVK L S+ + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRI 575
++ LLG C + G +I+EY +L +L + L+++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV 537
+G G +G VYKGR + ++A ++ + +G +E K E+ ++ K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 538 EQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
++ + L++E+ S+ L +TK L + I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL--- 648
++IHRD+K N+LL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 649 --DGLFSIKSDVFSFGILMLE 667
D + KSD++S GI +E
Sbjct: 188 NPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 479 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VYKG + E VA+K L N S + KE +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQ 588
LG C+ + L+ + MP L ++ ++ + LLNW + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R++HRDL A N+L+ + KI+DFGLAR+ DE + + +M+ E L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
F+ +SDV+S+G+ + E ++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 28/220 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-Q 525
E+ + +GEG FG V + + A+K L + + ++F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQAR 572
H N++ LLG C +G + +EY P +L FL S L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632
++ +A G+ YL S + IHRDL A N+L+ +++ KI+DFGL+R G+E+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173
Query: 633 KQIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
K+ +G +M+ E +++ KSDV+SFG+L+ E +S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 14/210 (6%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+GEG G V R +G++VAVK + + Q + NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ E +++E++ +L D + LN + + E + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+K+ +ILL D K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 657 DVFSFGILMLETLSSK----KNTGLGSMER 682
D++S GI+++E + + ++ + +M+R
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK-NE 517
L ++ S+ + ++ K+G+G G VY + GQEVA+K++ N Q KE NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66
Query: 518 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 577
++++ + +H N+V L + E +++EY+ SL D + ++ +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
Q L +LH ++IHRD+K+ NILL D + K++DFG ++ + +T +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
T +M+PE + K D++S GI+ +E
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHR 527
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL-----NWQARVRIIEGIAQG 582
N+++ +E E ++LE L+ + K++ L W+ V++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
H +SR R++HRD+K +N+ + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE 667
SPE + ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 528
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ R G ++ + +I+EY+ S D K L I+ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 175 QSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 65/204 (31%), Positives = 111/204 (54%), Gaps = 20/204 (9%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 534
K+GEG +G VYK R + + +A+K++ Q +G+ E+ L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG----IAQGLLYLHQYS 590
+ L+ EY+ + L + DS+ ++ R+I+ I +G+ Y H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-DSSP----DFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 591 RFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
R++HRDLK N+L+D+ N K++DFGLAR F G ++ T ++V T Y +PE L
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 650 GL-FSIKSDVFSFGILMLETLSSK 672
+S D++S G + E ++ K
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 479 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 534
LG+GGFG V ++ G+ A K+L+ + + K ++ M+ ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKK-------RLLNWQARVRIIEGIAQGLLYLH 587
+ + L++ M L +++ ++ R + A+ I GL +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISGLEHLH 114
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
Q RII+RDLK N+LLD D N +ISD GLA + Q TK GT G+M+PE
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELL 169
Query: 648 LDGLFSIKSDVFSFGILMLETLSSK 672
+ D F+ G+ + E ++++
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-VAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
GC +++ L++EY + ++ K+ L I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 650
+IHRD+KA NILL + K++DFG A VGT +M+PE L +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 651 LFSIKSDVFSFGILMLETLSSK 672
+ K DV+S GI +E K
Sbjct: 196 QYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG GGFG V ++ + A+K + ++GQ + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
++ +++EY L L D + + AR I + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHNRG--- 113
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
II+RDLK N+LLD + K+ DFG A+ + T GT Y++PE L+ +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 654 IKSDVFSFGILMLETL 669
D +S GIL+ E L
Sbjct: 171 FSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 53/231 (22%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG------------------LKEFKNEMM 519
LGEG +G V K L G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN---KSLN--VFLFDSTKKRLLNWQARVR 574
++ +++H N++ L+ VE L+++ M + K ++ + L +S K +L Q
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ---- 127
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
I GL LH++ +HRDL +NI ++ KI+DFGLAR +G +
Sbjct: 128 ----ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 635 I------------VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSK 672
V T Y +PE + + D++S G + E L+ K
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 473 FSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFK---NEMMLIAKLQHRN 528
F + ++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
LV+LL + L +EY+P L + L AR + E + LH+
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
IHRDLK N L+D + K++DFGL++ G +VG+ YM+PE
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY---ANSVVGSPDYMAPEVLR 171
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
+ D +S G ++ E L
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 478 KLGEGGFGPVYKG--RLLNGQE--VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRL 532
+GEG FG VY+G ++ VAVK N + ++E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+G E I ++E P L +L K L+ + + ++ L YL S+
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE--SK- 126
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
R +HRD+ A N+L+ K+ DFGL+R + +K + +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRF 185
Query: 653 SIKSDVFSFGILMLETLS 670
+ SDV+ FG+ M E L
Sbjct: 186 TSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 15/198 (7%)
Query: 479 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQHRNLVRLLGCC 536
LG G G V K + G +A K + + + K+ E+ ++ + + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSRFRI 594
+ + + +E+M SL D K+ + +I + +GL YL Y+ RI
Sbjct: 73 LNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVVEGLTYL--YNVHRI 125
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
+HRD+K SNIL++ K+ DFG++ G+ + VGT YMSPE G +++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 655 KSDVFSFGILMLETLSSK 672
KSDV+S GI ++E K
Sbjct: 182 KSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 482 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCV 537
G +G V+ + G A+K + + + E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62
Query: 538 EQGEKILIL--EYMPN---KSL--NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
QG+K L L EY+P SL NV D AR+ I E I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDED-------VARIYIAE-IVLALEYLHSNG 113
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLA------RMFGGDELQGNTKQIVGTYGYMSP 644
IIHRDLK NIL+D + + K++DFGL+ R ++ + K+IVGT Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 645 EYALDGLFSIKSDVFSFGILMLETLS 670
E L S D +S G ++ E L
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 57/214 (26%), Positives = 111/214 (51%), Gaps = 10/214 (4%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 518
L ++ SI + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 519 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 578
+++ +L++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+M+PE + K D++S GI+ +E + +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKR-LSNQSGQGLKEFK-NEMMLIAKLQHR 527
+ + +GEG +G V K R G+ VA+K+ ++ + +K+ E+ ++ +L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQG 582
N+V L +G L+ EY+ L + R WQ + Q
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQA 112
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ----IVGT 638
+ Y H IIHRD+K NIL+ + K+ DFG AR L+ V T
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVAT 164
Query: 639 YGYMSPEYAL-DGLFSIKSDVFSFGILMLETLS 670
Y +PE + D + DV++ G +M E L
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 478 KLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLKEFKNEMML--IAKLQHRNLV 530
++GEG +G V+K R L G+ VA+KR+ Q+ G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 531 RLLGCCV-----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
RL C + + L+ E++ ++ L +L D + + + ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH + R++HRDLK NIL+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
L ++ D++S G + E K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-17
Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 10/214 (4%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 518
L S+ S+ + ++ K+G+G G VY + GQEVA+++++ Q + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 519 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 578
+++ + ++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+M+PE + K D++S GI+ +E + +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 8e-17
Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 28/212 (13%)
Query: 479 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QHRNLVRLL 533
+GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIA 580
G C +G L +EY P+ +L FL S L+ Q + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+G+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R G E+ K+ +G
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRLP 174
Query: 641 --YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+ E +++ SDV+S+G+L+ E +S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 473 FSMQCKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIA 522
+ +Q +LG+G FG VY + RL +E+ V L+ N++ Q E L++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLS 57
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIA 580
KL H +V+ +E+ +I EY + L+ L T K L + ++ E
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL----SENQVCEWFI 113
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Q LL +H + RI+HRDLKA NI L ++ KI DFG++R+ G T GT
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLE 667
YMSPE + KSD++S G ++ E
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-17
Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 10/214 (4%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFKNEM 518
L S+ S+ + ++ K+G+G G VY + GQEVA+K+++ Q + NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 519 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 578
+++ + ++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
Q L +LH ++IHRD+K+ NILL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+M+PE + K D++S GI+ +E + +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 65/227 (28%), Positives = 117/227 (51%), Gaps = 23/227 (10%)
Query: 469 ATENFSMQCKLGEGGFGPVYKG---RLLNGQ---EVAVKRLSNQSGQGLK--EFKNEMML 520
+ E ++ +LG+G FG VY+G ++ G+ VAVK + N+S + EF NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASV 62
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------DSTKKRLLNWQARV 573
+ ++VRLLG + ++++E M + L +L ++ + Q +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNT 632
++ IA G+ YL+ + +HRDL A N ++ D KI DFG+ R ++ D +
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGL 677
K ++ M+PE DG+F+ SD++SFG+++ E +L+ + GL
Sbjct: 180 KGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRN 528
+ + K+GEG FG +Y + + E V + + + +KE K E++L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSL-------NVFLFDSTKKRLLNWQARVRIIEGIAQ 581
+V E G +++EY L LF ++ ++L+W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
GL ++H +I+HRD+K+ NI L K+ M K+ DFG+AR T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
Y+SPE + ++ K+D++S G ++ E + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 65/201 (32%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLK-EFKNEMMLIAKLQHRNLVRLLG 534
++GEG +G VY+ R +G+ VA+K++ + G+ E+ L+ L+H N+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 535 CCV-EQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
V + + I L++EY + L D+ Q + ++ + +GL YLH F
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLAS--LLDNMPTPFSESQVKC-LMLQLLRGLQYLH--ENF 128
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
IIHRDLK SN+LL KI+DFGLAR + G + T ++V T Y +PE L
Sbjct: 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPELLLGCTT 185
Query: 653 SIKS-DVFSFGILMLETLSSK 672
+ D+++ G ++ E L+ K
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
K+GEG G V + G++VAVK++ + Q + NE++++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V + + E +++E++ +L D +N + + + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+IHRD+K+ +ILL D K+SDFG + + K +VGT +M+PE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISR 189
Query: 650 GLFSIKSDVFSFGILMLE 667
+ + D++S GI+++E
Sbjct: 190 LPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 31/203 (15%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
++G G G VYK G+ A+K + N ++ E+ ++ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
GE ++LE+M SL + T ++ L AR +I+ GIA YLH R
Sbjct: 141 FDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVAR-QILSGIA----YLH---RR 187
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY------ 646
I+HRD+K SN+L++ N KI+DFG++R+ N+ VGT YMSPE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLN 245
Query: 647 --ALDGLFSIKSDVFSFGILMLE 667
A DG D++S G+ +LE
Sbjct: 246 HGAYDGY---AGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 25/202 (12%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
+LG+G FG VYK + G A K + +S + L+++ E+ ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ +++E+ +++ + + ++ L Q RV + + + L YLH+ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI------VGTYGYMSPEYAL-- 648
RDLKA NIL D + K++DFG++ NT+ I +GT +M+PE +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 649 ---DGLFSIKSDVFSFGILMLE 667
D + K+DV+S GI ++E
Sbjct: 179 TSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 28/215 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIAK 523
+ + ++ EG +G VY+ R G+ VA+K+L + G L+E N ++ K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 524 LQHRNLVRLLGCCVEQG-EKI-LILEYMPN--KSLNVFLFDSTKKRLLNWQARVR-IIEG 578
LQH N+V + V +KI +++EY+ + KSL ++ K+ L Q+ V+ ++
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFL--QSEVKCLMLQ 114
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+ G+ +LH I+HRDLK SN+LL+ KI DFGLAR + G L+ T Q+V T
Sbjct: 115 LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT-QLVVT 169
Query: 639 YGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
Y +PE L +S D++S G + E L+ K
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/195 (27%), Positives = 103/195 (52%), Gaps = 15/195 (7%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH---RNLVRLL 533
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G ++ +I+EY S+ + K + + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 652
+IHRD+KA+NIL+ N K+ DFG+A + + + +T VGT +M+PE +G +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYY 179
Query: 653 SIKSDVFSFGILMLE 667
K+D++S GI + E
Sbjct: 180 DTKADIWSLGITIYE 194
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 64/197 (32%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLG 534
LG G FG V R + A+K LS LK+ NE ++ ++H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKK--RLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ L++EY+P L F +K R AR + + L YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHSLD-- 121
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
I++RDLK N+LLD D KI+DFG A+ ++G T + GT Y++PE L +
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGY 175
Query: 653 SIKSDVFSFGILMLETL 669
D ++ GIL+ E L
Sbjct: 176 GKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 479 LGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G G +G V G++VA+K+LS QS K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 536 CVEQGEKILILEYMPNKSLNVF-------------LFDSTKKRLLNWQARVRIIEGIAQG 582
+ P SL F L + K + L+ ++ I +G
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
L Y+H IIHRDLK SNI +++D KI DFGLAR DE+ G V T Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWYR 182
Query: 643 SPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
+PE L+ + ++ D++S G +M E L+ K
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 48/150 (32%), Positives = 84/150 (56%), Gaps = 9/150 (6%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 534
K+GEG +G V+K + E VA+KR+ + +G+ E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ L+ EY ++ L + FDS + + + + + +GL + H + +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEIVKSFMFQ-LLKGLAFCHSH---NV 120
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFG 624
+HRDLK N+L++K+ K++DFGLAR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQG-----LKEFKNEMMLIAKLQHRNLV 530
K+G+G FG V+K R Q VA+K+ L +G L+E K ++ L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 531 RLLGCCVEQGEK--------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
L+ C + L+ E+ + L L S K ++++ + G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--SNKNVKFTLSEIKKVMKMLLNG 131
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI--VGTYG 640
L Y+H R +I+HRD+KA+NIL+ KD K++DFGLAR F + + V T
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 641 YMSPEYAL-DGLFSIKSDVFSFGILMLE 667
Y PE L + + D++ G +M E
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-16
Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 53/304 (17%)
Query: 376 PASKLGNKKLLWILV---ILVIPVVLLPSF-YVFYRRRRKCQEKETENVETYQDLLAFDI 431
P ++ W + + V+ L +F +VF R R + K EN + +L FD
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD- 676
Query: 432 NMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSM--QCKLGEGGFGPVYK 489
SK S SIT S+ + + G G YK
Sbjct: 677 ---------------------SKVS-------KSITINDILSSLKEENVISRGKKGASYK 708
Query: 490 GRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548
G+ + NG + VK +++ + E + + KLQH N+V+L+G C + LI EY
Sbjct: 709 GKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEY 764
Query: 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 608
+ K+L+ L R L+W+ R +I GIA+ L +LH ++ +L I++D
Sbjct: 765 IEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818
Query: 609 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 668
P + L + D I + Y++PE + KSD++ FG++++E
Sbjct: 819 KDEPHLR-LSLPGLLCTD----TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIEL 871
Query: 669 LSSK 672
L+ K
Sbjct: 872 LTGK 875
|
Length = 968 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQH 526
++ +G G FG V+ R ++ A+K ++ LK+ NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++RL +Q +++EY+P L F + R N E I L YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYL 117
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H I++RDLK NILLDK+ + K++DFG A+ +L+ T + GT Y++PE
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE- 168
Query: 647 ALDGLFSIKS-------DVFSFGILMLETLSSK 672
I+S D ++ GIL+ E L
Sbjct: 169 ------VIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 463 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 522
L+++ F + +G G +G VYKGR + ++A ++ + + +E K E+ ++
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 523 KL-QHRNLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 575
K HRN+ G +++ + L++E+ S+ L +TK L I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYI 126
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
I +GL +LH + ++IHRD+K N+LL ++ K+ DFG++ D G
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTF 181
Query: 636 VGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLE 667
+GT +M+PE D + +SD++S GI +E
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 477 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 532
K+GEG F V K + G+ A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 533 LGCCVEQ--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQY 589
+ ++ G L+ E M +N++ +KR L + RV+ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH-- 117
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL- 648
R I HRD+K NIL+ D K++DFG R G T+ I T Y +PE L
Sbjct: 118 -RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLLT 172
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
DG + K D+++ G + E LS
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQ---HRNLV 530
++G G +G VYK R +G VA+K + +N+ G L + E+ L+ +L+ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 531 RLLGCC----VEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
RL+ C ++ K+ L+ E++ ++ L +L D L + ++ +GL +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH I+HRDLK NIL+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
L ++ D++S G + E K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 477 CKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
K+GEG +G V+K R GQ VA+K+ S K E+ ++ +L+H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ + L+ EY + LN R + +II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLF 652
IHRD+K NIL+ K K+ DFG AR+ G + V T Y +PE + D +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQY 178
Query: 653 SIKSDVFSFGILMLETLSS 671
DV++ G + E L+
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 477 CKLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLL 533
+LG G +G V K R + G +AVKR+ + + Q K ++ + + V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIAQGLLYLH 587
G +G+ + +E M + SL+ F K++ + + +I I + L YLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI-VGTYGYMSPEY 646
S+ +IHRD+K SN+L++++ K+ DFG++ G + K I G YM+PE
Sbjct: 121 --SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPE- 173
Query: 647 ALDGL-----FSIKSDVFSFGILMLE 667
++ + +KSDV+S GI M+E
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 41/213 (19%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMML 520
+ + KLG+G +G V+K + VA+K++ F+N E+M
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 521 IAKL-QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 577
+ +L H N+V+LL + +K L+ EYM V + +L + I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVHKRYIMY 114
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI-- 635
+ + L Y+H S +IHRDLK SNILL+ D K++DFGLAR EL+ N +
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVL 169
Query: 636 ---VGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
V T Y +PE L S ++ G+ M
Sbjct: 170 TDYVATRWYRAPEILL------GSTRYTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 528
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ + G ++ + +I+EY+ S D + L+ I+ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ IHRD+KA+N+LL + K++DFG+A +++ N VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIK 174
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
F + ++GEG +G VYK R G+ VA+K RL N+ E+ ++ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 530 VRLLGCCV----------EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
V L ++G L+ EYM + + + + + ++ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL---ESGLVHFSEDHIKSFMKQL 125
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
+GL Y H+ + +HRD+K SNILL+ K++DFGLAR++ +E + T +++ T
Sbjct: 126 LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181
Query: 640 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSK 672
Y PE L + + DV+S G ++ E + K
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 478 KLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
K+GEG FG G+ +E+ + ++S + + E + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV-----RIIEGIAQGLLYL 586
E G ++++Y L + +N Q V +I++ Q L L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL---------YKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMSPE 645
+I+HRD+K+ NI L KD K+ DFG+AR+ EL + +GT Y+SPE
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPE 171
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 681
+ ++ KSD+++ G ++ E + K G+M+
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-14
Identities = 27/79 (34%), Positives = 36/79 (45%)
Query: 195 ENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGA 254
EN +E Y Y N L L+ G + R W NS W+ +S P C YG CG
Sbjct: 29 ENNEEVYYTYRMTNNSIYSRLTLSSEGSLERFTWIPNSQDWNLFWSAPKDQCDVYGRCGP 88
Query: 255 NTICSLDQKPMCECLEGFK 273
C ++ P C C++GF
Sbjct: 89 YGYCDVNTSPKCNCIKGFV 107
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 528
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ + G ++ + +I+EY+ S D + + +++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 30/205 (14%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 535
+G G FG V K G +AVKR+ S + K ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 536 CVEQGEKILILEYMPNKSLNVF---LFDSTKKRLLNWQARVRIIEGIA----QGLLYLHQ 588
+G+ + +E M + SL+ F +++ K + I+ IA + L YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLKE 125
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI--VGTYGYMSPE- 645
+IIHRD+K SNILLD++ N K+ DFG++ +L + + G YM+PE
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 178
Query: 646 ---YALDGLFSIKSDVFSFGILMLE 667
A DG + ++SDV+S GI + E
Sbjct: 179 IDPSARDG-YDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 51/221 (23%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMMLIAKLQHRN 528
+G G +G V G++VA+K++SN F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLN----VF-LFDSTKKRLLNWQARVRIIEGIAQ-- 581
++ LL IL + N V L ++ +++ ++ + + Q
Sbjct: 61 IIGLL----------DILRPPSPEDFNDVYIVTELMETDLHKVI--KSPQPLTDDHIQYF 108
Query: 582 ------GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-Q 634
GL YLH +IHRDLK SNIL++ + + KI DFGLAR DE + +
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 635 IVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSK 672
V T Y +PE L +I D++S G + E L+ K
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E+F + ++G G +G VYK R +N G+ A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V G + + + + +E+ SL ++ T L+ + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL- 648
+ +HRD+K +NILL + + K++DFG++ K +GT +M+PE A
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAV 180
Query: 649 --DGLFSIKSDVFSFGILMLE 667
G ++ D+++ GI +E
Sbjct: 181 ERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 463 LASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMM 519
++ T + +G G FG V R L GQ VA+K++ + K E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
L+ L+H N++ L + E I + + L+ L R L Q + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQI 117
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-----MFGGDELQGNTKQ 634
+GL Y+H ++HRDLK SNIL++++ + KI DFGLAR M G
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG---------- 164
Query: 635 IVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
V T Y +PE L + ++ D++S G + E L K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 479 LGEGGFGPVYK-------GRLLNGQEVAVKRLS-----NQSGQGLKEFKNEMMLIAK-LQ 525
LG G FG VYK LL +E+ V + + + + + +E+ +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW-QARV-RIIEGIAQGL 583
H N+VR +E ++++ + L F+S K++ + + R+ I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
YLH+ R I+HRDL +NI+L +D I+DFGLA+ + +VGT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSC 181
Query: 644 PEYALDGLFSIKSDVFSFGILMLET 668
PE + + K+DV++FG ++ +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 16/191 (8%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
LG G G VYK LL + +AVK + + + + K+ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ + E+M SL+V+ R + RI + +GL YL +I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---LKILH 118
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+K SN+L++ K+ DFG++ + K VGT YM+PE + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 657 DVFSFGILMLE 667
DV+S GI +E
Sbjct: 175 DVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 479 LGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLK-----EFKNEMMLIAKLQHRNL 529
LG+G FG V+ R + GQ A+K L + LK K E ++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI-IEGIAQGLLYLHQ 588
V+L +G+ LIL+++ L F K ++ + V+ + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
II+RDLK NILLD++ + K++DFGL++ E + GT YM+PE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 171
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
+ +D +SFG+LM E L+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 6e-14
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 27/234 (11%)
Query: 443 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR 502
A+ D D +P A A+ +++ L G G V+ GQ V
Sbjct: 39 DSASES-DDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVVL 96
Query: 503 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST 562
Q G L E ML+ + H +++R+ V ++L P+ S +++ + +
Sbjct: 97 KIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTK 149
Query: 563 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 621
+ R L + I + I +GL YLH RIIHRD+K NI ++ I D G A+
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206
Query: 622 -----MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
F G + GT +PE ++ K+D++S GI++ E L+
Sbjct: 207 PVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ L+L M L ++ + +A E I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
RI++RDLK NILLD + +ISD GLA + G ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 177
Query: 652 FSIKSDVFSFGILMLETLSSK 672
++ D ++ G L+ E ++ +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 479 LGEGGFGPVYKG--RLLNGQE--VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG G FG + +G +L + +E VA+ L + S + + F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G +++ EYM N +L+ FL + L + ++ G+A G+ YL S
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS---------P 644
+H+ L A +L++ D+ KIS F + + Y MS P
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 645 EYALDGLFSIKSDVFSFGILMLETLS 670
E FS SDV+SFGI+M E +S
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 530 VRLLGCCVEQGEKILILEYMPNKSL-NVFLFDSTKKRL-LNWQARVRIIEGIAQGLLYLH 587
V G + + + + +EY SL +++ L + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ +HRD+K +NILL + + K++DFG+A K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 648 L---DGLFSIKSDVFSFGILMLE 667
+G ++ D+++ GI +E
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLH 587
+ L+L M L +++ ++R L + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 646
+ + ++RDLK NILLD + +ISD GLA ++ G+ ++G VGT GYM+PE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEV 172
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+ +++ D + G L+ E + +
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/149 (34%), Positives = 72/149 (48%), Gaps = 9/149 (6%)
Query: 478 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG V G + +V VK L + S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSR 591
G C E +L++E+ P L +L K L+ R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLA 620
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 10/191 (5%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+GEG G V + +G+ VAVK++ + Q + NE++++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ E +++E++ +L D +N + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+K+ +ILL D K+SDFG E+ K +VGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 657 DVFSFGILMLE 667
D++S GI+++E
Sbjct: 198 DIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 478 KLGEGGFGPVYKG---RLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG V G R ++ V VK L + F E+ +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSR 591
G C+E +L+LE+ P L +L + Q V R+ +A GLL+LHQ
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA---- 647
IH DL N L D++ KI D+GLA ++ +++PE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 648 ---LDGLFSIKSDVFSFGILMLE 667
L + KS+++S G+ M E
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 478 KLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+GEG G V G++VAVK++ + Q + NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ E +++E++ +L D +N + + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+K+ +ILL D K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 657 DVFSFGILMLETLSSK 672
D++S GI+++E + +
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQGLKEFK-NEMMLIAKLQHRN-LVRLL 533
K+GEG +G VYK R G+ VA+K+ +G+ E+ L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 534 GCCVEQGEK-------ILILEYMPNKSLNVFLFDSTKK---RLLNWQARVRIIEGIAQGL 583
VE E+ L+ EY+ + L F+ DS + R L + + + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ H++ ++HRDLK N+L+DK KI+D GL R F ++ T +IV T Y
Sbjct: 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYR 178
Query: 643 SPEYALDGL-FSIKSDVFSFGILMLETL 669
+PE L +S D++S G + E
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 479 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G +G V Y RL Q+VAVK+LS QS + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 534 -----GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+E ++ ++ + LN + K + L+ + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLN----NIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
IIHRDLK SN+ +++D +I DFGLAR DE+ G V T Y +PE L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188
Query: 649 DGL-FSIKSDVFSFGILMLETLSSK 672
+ + ++ D++S G +M E L K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL-- 533
+G G +G V G VAVK+LS QS K E+ L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 534 ---GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+E+ + ++ ++ LN + K + L +I I +GL Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
IIHRDLK SN+ +++D KI DFGLAR DE+ G V T Y +PE L+
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNW 192
Query: 651 L-FSIKSDVFSFGILMLETLSSK 672
+ ++ D++S G +M E L+ +
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 636
I GL +LH+ II+RDLK N+LLD + + KI+DFG+ + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
GT Y++PE + D ++ G+L+ E L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAK 523
NF + LG G +G V+ R + G + A+K L Q + + + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 524 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
++ + L + K+ LIL+Y+ L L+ + VR+ IA+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE----SEVRVY--IAEI 114
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+L L + II+RD+K NILLD + + ++DFGL++ F +E + GT YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 643 SPEYAL--DGLFSIKSDVFSFGILMLETLS 670
+PE G D +S G+L E L+
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-13
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 20/191 (10%)
Query: 495 GQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLL--GCCVEQGEKILILEYM 549
G EVA+K L + + + F+ E L A+L H N+V LL G G + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--- 606
P ++L L L R++ + L H I+HRDLK NI++
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 607 DKDMNPKISDFGLARMFGG----DELQGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSF 661
+ K+ DFG+ + G D T +++GT Y +PE + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 662 GILMLETLSSK 672
G++ LE L+ +
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLH 587
+ L+L M L +++ ++R + + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE------ITCGLEDLH 119
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 646
R RI++RDLK NILLD + +ISD GLA + G+ ++G VGT GYM+PE
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEV 172
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+ ++ D + G L+ E + K
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRN 528
++F +LG G G V K + + ++L + + + E+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYL 586
+V G GE + +E+M SL+ L ++ + + +L +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL---GKVSI--AVLRGLAYL 119
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
+ + +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 647 ALDGLFSIKSDVFSFGILMLE 667
+S++SD++S G+ ++E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 527
E ++ ++G G +G V G++VA+K+LS QS K E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 528 NLVRLLGCCVEQG------EKILILEYMPNKSLNV--FLFDSTKKRLLNWQARVRIIEGI 579
N++ LL + L++ YM + K + L +Q +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------M 126
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTR 178
Query: 640 GYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
Y +PE L+ + ++ D++S G +M E L+ K
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 59/183 (32%), Positives = 87/183 (47%), Gaps = 24/183 (13%)
Query: 495 GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GEKILIL 546
GQ VA+K+LS Q+ K E++L+ + H+N++ LL Q + L++
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100
Query: 547 EYMPNKSLNVFLFDSTKKRL--LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604
E M V D +R+ L +Q + G+ +LH IIHRDLK SNI
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNI 149
Query: 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGIL 664
++ D KI DFGLAR G + T +V Y Y +PE L + D++S G +
Sbjct: 150 VVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCI 206
Query: 665 MLE 667
M E
Sbjct: 207 MGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 51/147 (34%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLGEG + VYKGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ L+ EY+ +K L +L D +N + + +GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKV 125
Query: 595 IHRDLKASNILLDKDMNPKISDFGLAR 621
+HRDLK N+L+++ K++DFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKL 524
+ +GEG +G V G +VA+K++S Q L+E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 525 QHRNLVRLLGC----CVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
+H N++ +L E + ++ E M L+ K + L+ + I
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---V 636
+GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR+ D +T + V
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYV 170
Query: 637 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
T Y +PE L+ K+ D++S G ++ E LS++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 38/209 (18%)
Query: 479 LGEGGFGPV----YKGRLLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKLQHRN 528
LG G FG V YK G+ A+K L + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSL------NVFLFDSTKKRLLNWQARVRIIEGIAQG 582
LV L C + ++EY L +VF ++ R + + A V + G
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----SEPRAVFYAACVVL------G 113
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYG 640
L YLH+ +I++RDLK N+LLD + KI+DFGL + M GD T GT
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPE 166
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETL 669
+++PE + ++ D + G+L+ E L
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 527
E + +GEG +G V K + GQ VA+K+ S K E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVF------LFDSTKKRLLNWQARVRIIEGIAQ 581
NLV L+ + L+ E++ + L+ L +S ++ L +Q I+ GI
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQ----ILRGIE- 114
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
+ H ++ IIHRD+K NIL+ + K+ DFG AR V T Y
Sbjct: 115 ---FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWY 166
Query: 642 MSPEYAL-DGLFSIKSDVFSFGILMLETLS 670
+PE + D + D+++ G L+ E L+
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLH 587
+ L++ M L +++ ++ R++++ A+ I G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 646
I++RD+K N+LLD N ++SD GLA + G Q GT GYM+PE
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEI 165
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+ +S D F+ G + E ++ +
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 22/154 (14%)
Query: 477 CKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
KLGEG + VYKGR L GQ VA+K RL ++ G + E L+ L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 534 GCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
+ L+ EY+ + L ++ RL +Q + +GL Y H
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYCH 120
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621
Q R++HRDLK N+L+ + K++DFGLAR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 9/139 (6%)
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V G GE + +E+M SL+ L K + +I + +GL YL +
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 171
Query: 649 DGLFSIKSDVFSFGILMLE 667
++++SD++S G+ ++E
Sbjct: 172 GTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 523
NF + LG G +G V+ R ++G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 524 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
++ + L + K+ LIL+Y+ L F S ++R + ++ E I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE-IVLA 117
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
L +LH + II+RD+K NILLD + + ++DFGL++ F DE++ GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 643 SPEYAL--DGLFSIKSDVFSFGILMLETLS 670
+P+ DG D +S G+LM E L+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 479 LGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLV 530
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 531 RLLGCCVEQGEKILILEYMPNKSL-------NVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L+ G+ LILEY+ L +F+ D+ L I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE----------ISLAL 113
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN--TKQIVGTYGY 641
+LHQ II+RDLK NILLD + K++DFGL + + + T GT Y
Sbjct: 114 EHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLS 670
M+PE + D +S G LM + L+
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 636
IA GL +LH II+RDLK N++LD + + KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
GT Y++PE + D ++FG+L+ E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 468 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK--NEMMLIAKL 524
AAT +++ KLGEG + VYKG +NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 525 QHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIE 577
+H N+V LL + E + + EYM + L ++ RL +Q
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ------- 111
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
+ +GL Y+H I+HRDLK N+L+ K++DFGLAR Q + ++V
Sbjct: 112 -LLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV- 165
Query: 638 TYGYMSPEYALDGL-FSIKSDVFSFGILMLETL 669
T Y P+ L +S D++ G + +E L
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEM 518
+ L S+ T+ + + +G+G +G VYK +G AVK L S +E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 519 MLIAKL-QHRNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQAR 572
++ L H N+V+ G + G+ L+LE S+ + K LL R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 573 VR------IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626
+ I+ G GL +LH RIIHRD+K +NILL + K+ DFG++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 627 ELQGNTKQIVGTYGYMSPEY-----ALDGLFSIKSDVFSFGILMLE 667
L+ NT VGT +M+PE D + + DV+S GI +E
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGC 535
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 536 CVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY-----LHQ 588
+ ++ L+ +Y + ++ F K + V++ G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHY 123
Query: 589 YSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMS 643
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 644 PEYALDGLFSIKS-DVFSFGILMLETLSSK 672
PE L K+ D+++ G + E L+S+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ L+L M L +++ +A E + GL L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RE 121
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
RI++RDLK NILLD + +ISD GLA ++ G+ ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177
Query: 652 FSIKSDVFSFGILMLETL 669
++ D + G L+ E +
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 38/99 (38%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 635
+AQG+ +L + IHRD+ A N+LL KI DFGLAR D ++GN +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674
V +M+PE D +++++SDV+S+GIL+ E S K+
Sbjct: 278 VK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM--LIAKLQHR--NLVRLL 533
+G G G VYK R G +AVK++ + +E K +M + H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW---QARVRIIEGIAQGLLYLHQYS 590
G + + + +E M D KR+ ++ I + L YL +
Sbjct: 81 GYFITDSDVFICMELMST------CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE-- 132
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+ +IHRD+K SNILLD N K+ DFG++ R+ + + T+ G YM+PE +D
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRS-AGCAAYMAPE-RID 187
Query: 650 -----GLFSIKSDVFSFGILMLE 667
+ I++DV+S GI ++E
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
L+ EY+ +K L ++ D +++ + I +GL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLFS 653
+HRDLK N+L+++ K++DFGLAR + + ++V T Y P+ L +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183
Query: 654 IKSDVFSFGILMLETLSSK 672
+ D++ G + E S +
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGC 535
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 536 CVEQGEK--ILILEYMPNKSLNVFLF----DSTKKRLLNWQARVR-IIEGIAQGLLYLHQ 588
+ ++ L+ +Y + ++ F + KK + ++ V+ ++ I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 589 YSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMS 643
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 644 PEYALDGLFSIKS-DVFSFGILMLETLSSK 672
PE L K+ D+++ G + E L+S+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 479 LGEGGFG-PVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
+GEG FG + + + Q+ A+K + +S +++ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 537 VEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
G +++EY L + + +L W + + G+ ++H+
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK-- 119
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
R++HRD+K+ NI L ++ K+ DFG AR+ T VGT Y+ PE +
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176
Query: 652 FSIKSDVFSFGILMLE 667
++ KSD++S G ++ E
Sbjct: 177 YNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 479 LGEGGFGPV--YKGRLLNGQEVAVK-RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G+G +G V + R Q V K L N S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 536 CV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
E G +++ + L L + K L Q ++ IA L YLH+ I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ-IAMALQYLHEK---HI 123
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
+HRDLK N+ L + K+ D G+AR+ +T ++GT YMSPE + ++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 655 KSDVFSFGILMLETLSSK 672
KSDV++ G + E + K
Sbjct: 182 KSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 25/195 (12%)
Query: 495 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------LGCCVEQG 540
+ VAVK++ Q +K E+ +I +L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600
++ EYM NV + L AR+ + + + +GL Y+H + ++HRDLK
Sbjct: 90 SVYIVQEYMETDLANVL----EQGPLSEEHARLFMYQ-LLRGLKYIHSAN---VLHRDLK 141
Query: 601 ASNILLD-KDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMSPEYALDGLFSIKS-D 657
+N+ ++ +D+ KI DFGLAR+ +G + + T Y SP L K+ D
Sbjct: 142 PANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAID 201
Query: 658 VFSFGILMLETLSSK 672
+++ G + E L+ K
Sbjct: 202 MWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 479 LGEGGFGPVYK---GRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G FG V+ R +G+ VA+K++ N Q+ K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 534 GC-------CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
E E ++ E M + + + + + L + +V + + I +GL YL
Sbjct: 66 DILQPPHIDPFE--EIYVVTELMQSDLHKIIV---SPQPLSSDHVKVFLYQ-ILRGLKYL 119
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H I+HRD+K N+L++ + KI DFGLAR+ DE + T+++V Y Y +PE
Sbjct: 120 HSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI 175
Query: 647 ALDGL--FSIKSDVFSFGILMLETLSSK 672
L G ++ D++S G + E L +
Sbjct: 176 -LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVK-----RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+G GGFG VY R + G+ A+K R+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+ +K+ IL+ M L+ L F + R II G+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY----AAEIILGLE------ 111
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H ++RF +++RDLK +NILLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 647 ALDGL-FSIKSDVFSFGILMLETL 669
G+ + +D FS G ++ + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 636
I GL +LH+ II+RDLK N+LLDKD + KI+DFG+ + M G +G
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
GT Y++PE ++ D +SFG+L+ E L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 13/153 (8%)
Query: 517 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVR 574
E+ ++ + +V G GE + +E+M SL+ L + + +++L +V
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVS 109
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
I + +GL YL + + +I+HRD+K SNIL++ K+ DFG++ G +
Sbjct: 110 I--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANS 161
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
VGT YMSPE +S++SD++S G+ ++E
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 495 GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILIL 546
G VAVK+LS Q+ K E++L+ + H+N++ LL Q + L++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606
E M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 106 ELMDANLCQVIHMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 666
D KI DFGLAR + + T +V Y Y +PE L + D++S G +M
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 667 E 667
E
Sbjct: 214 E 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG+G FG V RL +G+ AVK L Q + +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 534 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSR 591
CC + +++ ++E++ L +F K R + +AR R I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALD 649
II+RDLK N+LLD + + K++DFG+ + +F G T GT Y++PE +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEILQE 170
Query: 650 GLFSIKSDVFSFGILMLETLS 670
L+ D ++ G+L+ E L
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGL--KEFKNEMMLIAKLQHRNLVRLL 533
+G+GG G VY + + VA+K++ + S L K F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 534 GCCVEQGEKILILEYMPN------KSL--NVFLFDSTKKRL---LNWQARVRIIEGIAQG 582
C G+ + MP KSL +V+ +S K L + A + I I
Sbjct: 69 SIC-SDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE-----LQGNTK---- 633
+ Y+H S+ ++HRDLK NILL I D+G A +E + + +
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 634 -------QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+IVGT YM+PE L S +D+++ G+++ + L+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 479 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
+G+G FG V R +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 534 GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ EK+ +L+Y+ L F ++ L +AR E +A + YLH +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHSLN-- 116
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
II+RDLK NILLD + ++DFGL + G E + T GT Y++PE +
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 653 SIKSDVFSFGILMLETL 669
D + G ++ E L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 48/147 (32%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ L+ EY+ + L +L D+ + ++ + + + +GL Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRKI 124
Query: 595 IHRDLKASNILLDKDMNPKISDFGLAR 621
+HRDLK N+L+++ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 474 SMQCKLGE----GGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHR 527
+ +G+ + K + VAVK+ L + S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N++ + + E ++ M S L + L A I++ + L Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQ----GNTKQIVGTYGYM 642
IHR +KAS+ILL D +S + M + Q K V ++
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 643 SPEYALDGL--FSIKSDVFSFGI 663
SPE L ++ KSD++S GI
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 479 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+G GGFG VY G++ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+ +K+ IL+ M L+ L F + R II G+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY----ATEIILGLE------ 111
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H ++RF +++RDLK +NILLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 647 ALDGL-FSIKSDVFSFGILMLETL 669
G + +D FS G ++ + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 56/173 (32%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
+G+G FG V + +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 534 GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ +K+ +L+Y+ L F ++ +AR E IA L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
II+RDLK NILLD + ++DFGL + G E T GT Y++PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
+LG+G +G VYK G +A+K RL + + E+ ++ K +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+G + +EYM SL+ + RI + +GL +L + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY------AL 648
IHRD+K +N+L++ + K+ DFG++ G+ + K +G YM+PE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ ++++SDV+S G+ +LE
Sbjct: 181 NPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 523
NF + LG G +G V+ R + G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 524 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQ 581
++ + L + K+ LIL+Y+ + L+ +R + VR G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
L +LH + I++RD+K NILLD + + ++DFGL++ F +E + T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 642 MSPEYALDGLFSIKS-DVFSFGILMLE--------TLSSKKNT 675
M+PE K+ D +S GIL+ E TL ++NT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 33/93 (35%), Positives = 53/93 (56%)
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Q LL +H +IHRD+K++NILL + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
Y++PE +S K+D+FS G+L+ E L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 10/192 (5%)
Query: 479 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSG-QGLKEFK-NEMMLIAKLQHRNLVRLLGC 535
+GEG +G V K R +E VA+K+ + + +KE E+ ++ L+ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
+G+ L+ EY+ L + + + N ++ I Q + +H + I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELL------EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK 655
HRD+K N+L+ + K+ DFG AR + N + V T Y SPE L +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 656 SDVFSFGILMLE 667
D++S G ++ E
Sbjct: 182 VDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 38/95 (40%), Positives = 58/95 (61%), Gaps = 9/95 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 635
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D +G+ +
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +M+PE D +++ +SDV+SFG+L+ E S
Sbjct: 239 L---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 51/147 (34%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ L+ EY+ + L ++ D L ++ + + + +GL Y+HQ R+ I
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQ-LLRGLSYIHQ--RY-I 124
Query: 595 IHRDLKASNILLDKDMNPKISDFGLAR 621
+HRDLK N+L+ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQ--EVAVKRLSNQSGQGLKEFK---NEMMLIAKLQ 525
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLN-----WQARVRIIEGIA 580
H V L G ++ L+LE++ F F KR N + A++ +I
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Q L I++RDLK N+LLDKD K++DFG A++ + T + GT
Sbjct: 148 QSL---------NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPE 193
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETL 669
Y++PE L+ +D ++ GI + E L
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 635
+A+G+ +L + IHRDL A NILL KI DFGLAR D ++GN +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
V +M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 20/185 (10%)
Query: 496 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILILE 547
+ VA+K+LS Q+ K E++L+ + H+N++ LL Q + L++E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607
M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 103 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 668 TLSSK 672
+ K
Sbjct: 211 MVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 27/198 (13%)
Query: 482 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQHRNLVRLLGCC 536
G FG VY + G A+K L + N +++ + + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRL----LNWQARVRIIEGIAQGLLYLHQYSRF 592
+ L++EY+ + K L +W A+ I E + G+ LHQ
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDW-AKQYIAE-VVLGVEDLHQRG-- 117
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
IIHRD+K N+L+D+ + K++DFGL+R G E K+ VGT Y++PE + G+
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGVG 169
Query: 653 SIK-SDVFSFGILMLETL 669
K SD +S G ++ E L
Sbjct: 170 DDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 479 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC 536
+G+G +G V+K NG + AVK L +E + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 537 ----VEQGEKI-LILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYS 590
V+ G+++ L+LE S+ + K+ + I+ GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY---- 646
+ IHRD+K +NILL + K+ DFG++ L+ NT VGT +M+PE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACE 199
Query: 647 -ALDGLFSIKSDVFSFGILMLE 667
LD + + DV+S GI +E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLL 533
LG+G FG V+ L Q A+K L + + M+ L +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 534 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
C + E + ++EY+ L +F S K L +A E I GL +LH
Sbjct: 63 -CTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDLP-RATFYAAE-IICGLQFLHSKG-- 116
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDG 650
I++RDLK NILLD D + KI+DFG+ + M G T GT Y++PE L
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQ 171
Query: 651 LFSIKSDVFSFGILMLETL 669
++ D +SFG+L+ E L
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 38/95 (40%), Positives = 58/95 (61%), Gaps = 9/95 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 635
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D +G+ +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +M+PE D +++ +SDV+SFG+L+ E S
Sbjct: 240 L---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 39/212 (18%)
Query: 479 LGEGGFGPV-YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G G +G V G +VA+K+L QS K E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 536 CVEQGEKILILEYMPNKSLNVF-------------LFDSTKKRLLNWQARVR-IIEGIAQ 581
+ P+ SL+ F L K L+ + R++ ++ + +
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-EDRIQFLVYQMLK 129
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWY 181
Query: 642 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK 672
+PE L+ + ++ D++S G +M E L+ K
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 46/222 (20%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM---------- 519
E+F + +G G FG V R + ++V A+K LS K EM+
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92
Query: 520 ---LIAKLQHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFL--FDSTKKRLLNWQAR 572
++A +V+L Q +K L ++EYMP L + +D +K W AR
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----W-AR 145
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGN 631
E + L +H IHRD+K N+LLDK + K++DFG +M ++ +
Sbjct: 146 FYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 632 TKQIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETL 669
T VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 202 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 479 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSNQSGQGLKEFKNEMMLIAKLQHRN 528
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
LV+L G CV E I++ EY+ L+VFL L+W+ V + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNP-------KISDFGLARMFGGDELQGNTKQIVGTYGY 641
+++H ++ NIL+ + K+SD G+ E + V +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE------ERVERIPW 170
Query: 642 MSPEYALDGLFSIKS--DVFSFGILMLE 667
++PE +G S+ D +SFG +LE
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 20/185 (10%)
Query: 496 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILILE 547
+ VA+K+LS Q+ K E++L+ + H+N++ LL Q + +++E
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607
M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 110 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 668 TLSSK 672
+
Sbjct: 218 MIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 472 NFSMQCKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKL 524
+F M LG G FG V +KG G+ A+K L + +K+ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H +V ++ ++ +LE++ L F R N A+ E +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAE-LVLAFE 132
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YLH II+RDLK N+LLD + K++DFG A+ ++ T + GT Y++P
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 645 EYALDGLFSIKSDVFSFGILMLETL 669
E D ++ G+L+ E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 61/234 (26%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIAKLQHRNLV 530
+G G FG V+ R + +V A+K L NQ + E ++A +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILADADSPWIV 64
Query: 531 RLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG------IAQG 582
+L Q E+ L ++EYMP L +N R + IA+
Sbjct: 65 KLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAEL 110
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA--------RMFGGDELQGNTKQ 634
+L L + IHRD+K NIL+D D + K++DFGL R + ++ +
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 635 -------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
VGT Y++PE + ++ D +S G+++ E L
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
LG+G FG V L EV A+K L + M +L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 534 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSR 591
CC + +++ ++EY+ L +F + R + + R R + L++LH++
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG- 116
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALD 649
+I+RDLK NILLD + + K++DFG+ + + G T GT Y++PE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEILQE 170
Query: 650 GLFSIKSDVFSFGILMLETLSSK 672
+ D ++ G+LM E ++ +
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKLQHRNLVRLLG 534
LG+G FG V R +G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFR 593
+ ++EY+ L F +++R+ + + R R I L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
I++RDLK N++LDKD + KI+DFGL + G K GT Y++PE D +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 654 IKSDVFSFGILMLETLSSK 672
D + G++M E + +
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 26/181 (14%)
Query: 501 KRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE---YMPNK----S 553
KR+ S + + +NE++ + +L H N++++ E+IL E YM +
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248
Query: 554 LNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610
L F++D K R L Q R I++ + + Y+H ++IHRD+K NI L+ D
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLETL 669
+ DFG A F E + VGT SPE A DG I +D++S G+++L+ L
Sbjct: 305 KIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362
Query: 670 S 670
S
Sbjct: 363 S 363
|
Length = 501 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 55/221 (24%)
Query: 478 KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLV 530
+G G +G V +G++VA+K++ + + L+E K ++ +H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67
Query: 531 RLLGCCVEQGEKILILEYMPNKSL--NVFL-FDSTKKRLLNWQARVRIIEG--------- 578
+ IL P + +V++ D + L II
Sbjct: 68 AIR--------DIL----RPPGADFKDVYVVMDLMESDLH------HIIHSDQPLTEEHI 109
Query: 579 ------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQG 630
+ +GL Y+H + +IHRDLK SN+L+++D +I DFG+AR E +
Sbjct: 110 RYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 631 NTKQIVGTYGYMSPE--YALDGLFSIKSDVFSFGILMLETL 669
+ V T Y +PE +L ++ D++S G + E L
Sbjct: 167 FMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIV 636
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F E G + V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 637 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
T Y +PE L K+ DV+S G ++ E L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG V + VA VK L +N S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYLHQY 589
G CVE +L+ EY L +L R LL Q R+ IA G+ ++H++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHKH 118
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ +H DL N L D+ K+ D+G+ + D ++ + V +++PE
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174
Query: 649 ---DGLFSIK----SDVFSFGILMLE 667
GL + + S+V++ G+ + E
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 534
LG+G FG V L G+ AVK L + + M+ ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 535 CCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
C + E + ++E++ L + D K R ++A E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAE-IVCGLQFLHSKG--- 116
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
II+RDLK N++LD+D + KI+DFG+ + +FG GT Y++PE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQGLK 172
Query: 652 FSIKSDVFSFGILMLETL 669
++ D +SFG+L+ E L
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+A+G+ +L + +HRDL A N+LL + KI DFGLAR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D L++ SDV+S+GIL+ E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 21/187 (11%)
Query: 506 QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR 565
++ G K E+ ++ + HR ++ L+ K + MP ++F + +
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSG 180
Query: 566 LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625
L + + I + + L YLH IIHRD+K NI LD+ N + DFG A
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 626 DELQGNTKQIVGTYGYM---SPEY-ALDGLFSIKSDVFSFGILMLE------TLSSKKNT 675
+T Q G G + SPE ALD + K+D++S G+++ E TL K+
Sbjct: 238 HP---DTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293
Query: 676 GLGSMER 682
S R
Sbjct: 294 SSSSQLR 300
|
Length = 392 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-08
Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 295 KSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK-NCSCRAYANSNVKESSGCLMWY 353
KS D F+ L K P F + ++ +LE+C ++CL NCSCR++ +N + GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNG--TKGCLLWS 57
Query: 354 -GDLIDARRPIRNFTGQSVYLRV 375
L DAR + G +Y ++
Sbjct: 58 ESSLGDAR--LFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
+G+G FG V R ++ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ +L+Y+ L F ++ L +AR E IA L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
I++RDLK NILLD + ++DFGL + E G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 654 IKSDVFSFGILMLETL 669
D + G ++ E L
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
IA GL +LH II+RDLK N++LD + + KI+DFG+ + D + TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
Y++PE + D ++FG+L+ E L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 9/130 (6%)
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFRIIHRDLKAS 602
++EY L F +++R+ + + R R I L YLH S +++RDLK
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLE 125
Query: 603 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662
N++LDKD + KI+DFGL + G + K GT Y++PE D + D + G
Sbjct: 126 NLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 663 ILMLETLSSK 672
++M E + +
Sbjct: 184 VVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL-NWQARVRIIEGIAQGLLYLH 587
LV L C L++EY+ L +F ++R L AR E I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPE 645
+ II+RDLK N+LLD D + K++D+G+ + + GD T GT Y++PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPE 166
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
+ D ++ G+LM E ++ +
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H LV L C + ++EY+ L + +++L AR E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 111
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 643
LH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIA 164
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSK 672
PE + D ++ G+LM E ++ +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
I L YLH +++RDLK N++LDKD + KI+DFGL + G K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
Y++PE D + D + G++M E +
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF------KNEMMLIAKLQHRNLVR 531
+G+G FG VY+ R + + + A+K LS + KE +N ++ + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
L + L+ +YM L F + R +A+ I E + L +LH+Y
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKYD- 116
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
I++RDLK NILLD + + DFGL++ D NT GT Y++PE LD
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEK 172
Query: 652 -FSIKSDVFSFGILMLE 667
++ D +S G+L+ E
Sbjct: 173 GYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 29/146 (19%), Positives = 58/146 (39%), Gaps = 13/146 (8%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCC 536
L G VY ++ +K ++ +E + ++ + + V ++L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
G L++E++ ++L+ ++ + + I E +A+ L LHQ + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 597 RDLKASNILLDKDMNPKISDFGLARM 622
DL NIL+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 10/130 (7%)
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFRIIHRDLKAS 602
++EY L F +++R+ + R R I L YLH +++RD+K
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD---VVYRDIKLE 124
Query: 603 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662
N++LDKD + KI+DFGL + D K GT Y++PE D + D + G
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 663 ILMLETLSSK 672
++M E + +
Sbjct: 183 VVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 479 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
+G+G FG V R L+G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ +L+++ L F ++ +AR E IA L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---IN 116
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
I++RDLK NILLD + ++DFGL + G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 654 IKSDVFSFGILMLETL 669
D + G ++ E L
Sbjct: 175 NTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 636
I+ GL +LH+ II+RDLK N++LD + + KI+DFG+ + M G T+
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
GT Y++PE + D +++G+L+ E L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 68/240 (28%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 450 KDKSKDSWLPLFS-----LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL 503
K+K+ D++L + + + E++ + +G G FG V R + Q+V A+K L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 504 SN-----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNV 556
S +S F E ++A +V+L C Q +K L ++EYMP L
Sbjct: 77 SKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVN 132
Query: 557 FL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614
+ +D +K + A V +L L +IHRD+K N+LLDK + K+
Sbjct: 133 LMSNYDVPEKWAKFYTAEV---------VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKL 183
Query: 615 SDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY----ALDGLFSIKSDVFSFGILMLETL 669
+DFG +M ++ +T VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 184 ADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+ +GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR E + V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171
Query: 639 YGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSK 672
Y +PE L + +I DV+S G + E L K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
A+ L L +F +I+RDLK NILLD + + DFGL ++ D+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
Y++PE L ++ D ++ G+L+ E L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 51/217 (23%)
Query: 479 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRNLVRLLGC- 535
+G G FG VY+ ++ E VA+K++ ++KN E++++ L H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 536 ---CVEQGEKIL----ILEYMP-------------NKSLNVFLFDSTKKRLLNWQARVRI 575
C ++ EK + ++E++P N +L +FL +L ++Q
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLAR-MFGGDELQGNTK 633
+ + L Y+H S+F I HRDLK N+L+D + + K+ DFG A+ + G Q +
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVS 229
Query: 634 QIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETL 669
I + Y +PE L ++ D++S G ++ E +
Sbjct: 230 YICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 479 LGEGGFGPVYKG--------RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
LG+G F ++KG L+ EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
G CV E I++ EY+ SL+ +L K L+N ++ + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 591 RFRIIHRDLKASNILL-----DKDMNP---KISDFGLA 620
+ H ++ A N+LL K NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H LV L C + ++E++ L + +++L AR E I+ L +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNF 111
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 643
LH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIA 164
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSK 672
PE + D ++ G+LM E ++ +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 2/156 (1%)
Query: 515 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR 574
++E+ +A H +V+ + +LI+EY LN + K+ L + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
++ Q +L L + +++HRDLK++NI L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
GT Y++PE +S K+D++S G+++ E L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 43/196 (21%), Positives = 91/196 (46%), Gaps = 22/196 (11%)
Query: 487 VYKGRLLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK- 542
+YKG N +EV ++ + +NE+ + ++ N++++ G ++ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 543 ---ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 599
LILEY L L K++ L+++ ++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNL 149
Query: 600 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS---IKS 656
+ + L+ ++ KI GL ++ L + V Y S + D +FS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203
Query: 657 DVFSFGILMLETLSSK 672
D++S G+++ E + K
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+A G+ +L + +HRDL A N+L+ + KI DFGLAR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE + L++ SDV+SFGIL+ E +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 525
++F + +G G FG V ++ + + + ++ N+ + LK F+ E ++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK-WEMLKRAETACFREERNVLVNGD 59
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
+ + L ++ L+++Y L + L + RL AR I A+ +L
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYI----AEMVLA 114
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVGTYGYMSP 644
+H + +HRD+K N+LLD + + +++DFG +M +Q + VGT Y+SP
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VGTPDYISP 172
Query: 645 EY--ALD---GLFSIKSDVFSFGILMLETL 669
E A++ G + + D +S G+ M E L
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM---------FGG----DELQ 629
L YLH Y I+HRDLK N+L+ + K++DFGL+++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
KQ+ GT Y++PE L + D ++ GI++ E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVG 637
+A+ +L + + +HRD+K N+LLDK+ + +++DFG R+ +Q N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 638 TYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETL 669
T Y+SPE A++ G + + D +S G+ M E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA-----KLQHRNLVRL 532
K+G G FG V+ + QE + S +GLKE + ++I +L+H+N+VR
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 533 LGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQY 589
+ + + + L ++E+ L+ + K + A V I + L Y H
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 590 ----SRFRIIHRDLKASNILLD-------------KDMN----PKISDFGLARMFGGDEL 628
+ R++HRDLK NI L ++N KI DFGL++ G +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---I 194
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSI--KSDVFSFGILMLETLSSK 672
+ VGT Y SPE L S KSD+++ G ++ E S K
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 37/97 (38%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTY 639
+ L Y+H + F HRDLK NIL + D KI DFGLAR F V T
Sbjct: 114 RALKYIHTANVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 640 GYMSPEYALDGLFSIKS----DVFSFGILMLETLSSK 672
Y +PE L G F K D++S G + E L+ K
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 29/237 (12%)
Query: 450 KDKSKDSWLPLFS-----LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL 503
K+K+ D++L + + + E++ + +G G FG V R + ++V A+K L
Sbjct: 17 KNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 76
Query: 504 SN-----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 558
S +S F E ++A +V+L + +++EYMP L +
Sbjct: 77 SKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 134
Query: 559 --FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616
+D +K + A V +L L IHRD+K N+LLDK + K++D
Sbjct: 135 SNYDVPEKWARFYTAEV---------VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEY----ALDGLFSIKSDVFSFGILMLETL 669
FG + + VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 186 FGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 36/138 (26%), Positives = 67/138 (48%), Gaps = 24/138 (17%)
Query: 544 LILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
L++EY P L L FD + +A+ +L +H + +HR
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------LAELVLAIHSVHQMGYVHR 126
Query: 598 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY--ALDG----L 651
D+K N+L+D+ + K++DFG A +++ N+K VGT Y++PE ++G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 652 FSIKSDVFSFGILMLETL 669
+ ++ D +S G++ E +
Sbjct: 186 YGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 525
E+F + +G G FG V +L N +V ++ N+ + LK F+ E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETACFREERDVLVNGD 59
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
++ + L ++ L+++Y L + L + RL AR + A+ ++
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYL----AEMVIA 114
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVGTYGYMSP 644
+ + +HRD+K NIL+D + + +++DFG ++ +Q + VGT Y+SP
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISP 172
Query: 645 EY--ALD---GLFSIKSDVFSFGILMLETL 669
E A++ G + + D +S G+ M E L
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 8/151 (5%)
Query: 517 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
E ++ + H ++++L G LIL P +++ + + K+ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636
+ + + YLH+ RIIHRD+KA NI ++ + + DFG A F D
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
GT +PE + D++S GI++ E
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 60/263 (22%), Positives = 98/263 (37%), Gaps = 85/263 (32%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH 526
E+F +G+G FG V RL+ G+ A+K L K+EM +L H
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAH 47
Query: 527 ----RNL---------VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
R++ V L + LI+E++P L L + +
Sbjct: 48 VKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFS 99
Query: 574 RIIEG--IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA----------- 620
+ +A+ +L + + IHRD+K NIL+D+ + K+SDFGL+
Sbjct: 100 EDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
Query: 621 --RMFGGDELQ------------------GNTKQI--------------VGTYGYMSPEY 646
++ G + + QI VGT Y++PE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 647 ALDGLFSIKSDVFSFGILMLETL 669
L + + D +S G +M E L
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKLQHRNLVRLL 533
LG+G G V+ RL G+ A+K L + + K E ++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ L+++Y P L L K L AR E + L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG--- 123
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARM---------------------------FGGD 626
I++RDLK NILL + + +SDF L++ +
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 627 ELQGNTKQIVGTYGYMSPEY-ALDG-LFSIKSDVFSFGILMLETL 669
E + VGT Y++PE + DG ++ D ++ GIL+ E L
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 15/122 (12%)
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLL 584
+ N ++L +LI++Y+ + L FD KK L+ +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
LH++ IIH D+K N+L D+ + + D+GL ++ G GT Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 644 PE 645
PE
Sbjct: 175 PE 176
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 32/167 (19%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E F + + G FG VY GR N + AVK + + N+ M+ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57
Query: 530 VRL--------LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRI 575
+ L L ++ + L++EY+ + L FD + V+
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKY 109
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622
I +A L YLH++ IIHRDLK N+L+ + + K++DFGL+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 40/160 (25%)
Query: 479 LGEGGFGPVYKGRL----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNL- 529
+G G FG V RL G A+K+L K+EM+ ++ H R++
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLR----------KSEMLEKEQVAHVRAERDIL 55
Query: 530 --------VRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
V+L Q E LI+EY+P + L K + R I E I
Sbjct: 56 AEADNPWVVKLY--YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI 111
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
L + + IHRD+K N+LLD + K+SDFGL
Sbjct: 112 ----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIAKLQHRNLV 530
+G G FG V R ++ + A+K L NQ+ K E ++A+ + +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH----VKAERDILAEADNEWVV 64
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+L ++ +++Y+P + L ++ L AR I E + + +H
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL----ARFYIAE-LTCAIESVH- 118
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623
+ IHRD+K NIL+D+D + K++DFGL F
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 475 MQCKLGEG--GFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+Q ++G G VY R G V V+ L N + + LK +NE++L +H N+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQ 588
+ +I +M S N L + + +A + I+ G +GL YLHQ
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS--EALIGNILFGALRGLNYLHQ 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-----QGNTKQIVGTY---- 639
IHR++KAS+IL IS GL + G L G ++V +
Sbjct: 120 NG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 640 ----GYMSPEYALDGL--FSIKSDVFSFGILMLE 667
++SPE L +++KSD++S GI E
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603
LI+E++P + L KK L + I A+ +L + + IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLTEEETQFYI---AETVLAIDSIHQLGFIHRDIKPDN 131
Query: 604 ILLDKDMNPKISDFGLARMF-----------------------------GGDELQGNTKQ 634
+LLD + K+SDFGL + + N +Q
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 635 I----VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
+ VGT Y++PE + ++ D +S G++M E L
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603
LI+E++P + L KK L+ +A I + +HQ IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDN 131
Query: 604 ILLDKDMNPKISDFGLARMF-----------------------------GGDELQGNTKQ 634
+LLD + K+SDFGL + + N +Q
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 635 I----VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
+ VGT Y++PE + ++ D +S G++M E L
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 59/242 (24%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG G FG V ++ + A+K L + + + K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 535 CCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
++ +++Y+P + L + + L + IA+ L + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY--------IAELTLAIESVHKM 120
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFG---------------------------- 624
IHRD+K NIL+D D + K++DFGL F
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 625 -----GDEL----QGNTKQ--------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
GD L Q TKQ +VGT Y++PE L ++ D +S G+++ E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 668 TL 669
L
Sbjct: 241 ML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 52/240 (21%), Positives = 96/240 (40%), Gaps = 55/240 (22%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG G FG V R ++ + + A+K L + + K E ++A+ + +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
++ +++Y+P + L R+ + + IA+ + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI-----RMGIFPEDLARFY-IAELTCAVESVHKMGF 122
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMF----------GGDELQGNT------------ 632
IHRD+K NIL+D+D + K++DFGL F GD ++ ++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 633 -----------------------KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
+VGT Y++PE L ++ D +S G+++ E L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
L++++ H +L + G CV E I++ E++ + L+V L + + W ++ + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNP--KISDFGLARMFGGDELQGNT 632
A L YL + ++H ++ A NILL + +P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 633 KQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 667
++I +++PE G S +D +SFG +LE
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 14/157 (8%)
Query: 516 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 575
+E L+ +L H ++ LL V G L+L P +++ + + R L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 576 IEGIAQGLL----YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
+ +A+ LL Y+H IIHRD+K N+L++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 668
I GT +PE ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 479 LGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKL-QHRNLV 530
LG G FG V + G+ N VAVK L + +E +E+ +++ L QH+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFL 558
LLG C G ++I EY L FL
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 29/161 (18%)
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
++ ++ H+++V L G CV E I++ E++ L++F+ + W+ +V + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV--AKQL 114
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILL-----DKDMNP--KISDFG-----LARMFGGDE 627
A L YL ++H ++ NILL D + P K+SD G L+R
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------ 165
Query: 628 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLE 667
++ V +++PE D SI +D +SFG + E
Sbjct: 166 -----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 682 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.98 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.98 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.53 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.51 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.41 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.59 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.34 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.2 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.19 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.08 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.06 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.02 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.97 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.91 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.88 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.86 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.61 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.3 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.28 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.21 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.07 | |
| PLN02236 | 344 | choline kinase | 97.02 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.93 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.75 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.69 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.66 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.62 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.38 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.26 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.11 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.0 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=378.60 Aligned_cols=219 Identities=48% Similarity=0.818 Sum_probs=195.4
Q ss_pred CCCccchhHHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 005705 457 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536 (682)
Q Consensus 457 ~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~ 536 (682)
....|++.++..+|++|...+.||+|+||.||+|.+.+++.||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998765443156699999999999999999999999
Q ss_pred EecC-eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEe
Q 005705 537 VEQG-EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (682)
Q Consensus 537 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 615 (682)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+...++||||||||+|||||++.++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999775544 89999999999999999999999988889999999999999999999999
Q ss_pred eeccccccCCCccccccccc-cccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 616 DFGLARMFGGDELQGNTKQI-VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+..
T Consensus 220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 999996643211 111112 7999999999999999999999999999999999999988864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=359.59 Aligned_cols=202 Identities=30% Similarity=0.535 Sum_probs=182.1
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..+|.+.+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888899999999999999985 4789999998665 5566778899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC------CCeEEeeeccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD------MNPKISDFGLA 620 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kL~DFGla 620 (682)
||+.+|+|..|+. +.+.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999994 3447999999999999999999999998 9999999999999865 45899999999
Q ss_pred cccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
+.+.... .....+|++-|||||++....|+.|+|+||+|+|||||++|+.||.-.+.
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9986433 34567999999999999999999999999999999999999999986543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.11 Aligned_cols=204 Identities=29% Similarity=0.437 Sum_probs=183.5
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|+++++||+|+||+||.++..+ ++.+|+|.+++.. ....+..++|..+|.+++||+||+++-.|++...+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 46789999999999999999998754 8899999997753 2345678899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|+||+.||.|..+| ++.+.+++..+.-++..|+.||.|||+++ ||||||||+|||||++|+++|+|||+++..-
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998 45667999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
.. ...+..++||+.|||||++.+..|+.++|.||||+++|||++|.+||...+.
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 22 2345568999999999999999999999999999999999999999987763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=347.71 Aligned_cols=204 Identities=38% Similarity=0.611 Sum_probs=177.9
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-eEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E 547 (682)
+.+.+.+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ...+|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 44555677999999999999985555599999976432 22669999999999999999999999999887 7999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeeccccccCCC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGD 626 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~ 626 (682)
||++|+|..+++.. .+..+++..+++++.|||+||.|||++++ ||||||||+|||++.+. ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999764 46789999999999999999999999874 99999999999999997 9999999999876432
Q ss_pred ccccccccccccccccCccccc--CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYAL--DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ...+...||..|||||++. ...|+.|+|||||||+||||+||+.||+..+
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 1 2233368999999999999 5699999999999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.00 Aligned_cols=202 Identities=30% Similarity=0.461 Sum_probs=186.1
Q ss_pred cCcccccccccCCceeEEEEEE-cCCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..|...+.||+|||+.+|+++. ..|+.||+|++.+. .+...+...+|+++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999998 77999999999763 4556788999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
|.+++++|.+++. +++.+++.+++.++.||+.||.|||+++ |||||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999983 5678999999999999999999999998 999999999999999999999999999988654
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
.. +..+.+|||.|+|||++....++..+||||+|||||-||.|++||+..++
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v 223 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV 223 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence 32 34468999999999999999999999999999999999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=329.43 Aligned_cols=198 Identities=30% Similarity=0.419 Sum_probs=178.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-eEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E 547 (682)
.+++.++.||+|+.|+|||++++ +++.+|+|.+... .+...+++.+|++++++.+||+||+++|.|..+. +..++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34566789999999999999986 4788999999543 4566789999999999999999999999999998 5999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||.+|+|+.++.. .+.+++..+.+|+.++++||.|||+ ++ ||||||||+|||++..|++||||||.++.+.+.
T Consensus 159 YMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999843 3569999999999999999999996 55 999999999999999999999999999987543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+...
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 345679999999999999999999999999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=321.27 Aligned_cols=208 Identities=27% Similarity=0.443 Sum_probs=180.6
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCeeeEEE-EEEecCe-EEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLG-CCVEQGE-KIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~HpnIv~l~~-~~~~~~~-~~l 544 (682)
..+|+++++||+|+||.|||+.. .+|..+|.|.++- .+.+..++...|+.+|++|+|||||++++ -+.++.+ .++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35689999999999999999975 6799999998863 24556778999999999999999999998 4455555 889
Q ss_pred EEEecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 545 ILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYS-RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
|||++..|+|..++... ..++.++++.+++++.|++.||.++|.+- +..|+||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999998653 34567999999999999999999999832 22499999999999999999999999999999
Q ss_pred cCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ......+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.-++
T Consensus 178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 86543 23455799999999999999999999999999999999999999997653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=331.24 Aligned_cols=202 Identities=28% Similarity=0.429 Sum_probs=174.5
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChh-------hHHHHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~-------~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~ 540 (682)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++++... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 356788999999999999999976 56999999999764321 1233579999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC---CCeEEeee
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDF 617 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DF 617 (682)
..||||||++||+|.+++. ..+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999883 4455777788889999999999999999 9999999999999766 67999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCCCC---CccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF---SIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|+|+..+. ...+...+|||.|.|||++..... ..|.|+||+||+||-+|+|.+||+...
T Consensus 324 GlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 324 GLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred chhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 99998753 235667899999999999976553 457899999999999999999998654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=312.37 Aligned_cols=199 Identities=30% Similarity=0.422 Sum_probs=181.5
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||.|+||.|.+++.+. |.-+|+|++++..- .+.+...+|..+|+.+.||+++++.+.+.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 4678999999999999999998864 77899999987543 3455678999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||++||.|..+++ +.+.++++.++.++.||+.||+|||+.+ |++|||||+|||||++|.+||+|||.|+...
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 99999999999994 4456999999999999999999999998 9999999999999999999999999999864
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..+...+|||.|+|||++..+.|+.++|.|||||++|||+.|.+||..++
T Consensus 196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 34667899999999999999999999999999999999999999998765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.69 Aligned_cols=206 Identities=37% Similarity=0.557 Sum_probs=181.7
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..+.+.+.+.||+|.||.||.|++.....||+|.++... ...++|.+|+++|++|+|+|||+++++|..+..++|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 345567789999999999999999888899999997652 3457899999999999999999999999998899999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
|+.|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+.+
T Consensus 283 m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999965 34567999999999999999999999998 99999999999999999999999999996655444
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGSM 680 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~~ 680 (682)
.. .....-+..|.|||.+....|+.|+|||||||+||||+| |+.|+.-.+.
T Consensus 359 ~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 359 TA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred ee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 32 223345789999999999999999999999999999999 9999876553
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=351.74 Aligned_cols=209 Identities=34% Similarity=0.510 Sum_probs=183.9
Q ss_pred hhcCcccccccccCCceeEEEEEEcC------CceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
...+.+..+.||+|+||.||+|+... ...||||.++..... ..++|++|+++|+.++|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 34566777899999999999997642 457999999887555 78899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhcc-------c----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC
Q 005705 542 KILILEYMPNKSLNVFLFDST-------K----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 610 (682)
.+||+|||..|+|.+||.... . ..+|+..+.+.||.|||.||+||-++. +|||||.++|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999995321 1 234899999999999999999999987 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 005705 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGSM 680 (682)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~~ 680 (682)
.|||+|||+++.....++........-+++|||||.+..++||.++|||||||+|||+++ |+.|+.--+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 999999999998877666554444566899999999999999999999999999999999 9999865443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.30 Aligned_cols=205 Identities=30% Similarity=0.439 Sum_probs=180.6
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 543 (682)
...+|..++.||+|+|++|++|+.. .++.+|||++.+. .+.-.+-...|-.+|.+| .||.|++|+-.|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4568999999999999999999764 5889999999764 222334567788899999 8999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+|+||.++|+|.++|. +.+.+++...+.++.||+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999994 4567999999999999999999999998 999999999999999999999999999998
Q ss_pred CCCccc---------cc--cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQ---------GN--TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...... .. ...++||..|.+||++.....+..+|+|+||||||+|+.|++||.-.+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 543221 11 145899999999999999999999999999999999999999998765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=307.55 Aligned_cols=201 Identities=26% Similarity=0.372 Sum_probs=175.6
Q ss_pred cCcccccccccCCceeEEEEEEcC-CceEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
+.|+.+.++|+|+||.|||+++++ |+.||||++....+ ...+-.++|+++|++++|||+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888899999999999999865 89999999966533 334456899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|++..-|+++-. ....++.+.+.+++.|+++|+.|+|+++ +|||||||+|||++.++.+||||||+|+.+...
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 999887776642 2345889999999999999999999998 999999999999999999999999999998642
Q ss_pred cccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....+..+.|..|.|||.+.+ ..|....||||+||++.||++|.+.|.-.+
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 123445688999999999987 789999999999999999999999987654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=321.44 Aligned_cols=207 Identities=26% Similarity=0.379 Sum_probs=181.2
Q ss_pred hhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
...++|+++++||+|+||.||+++.+ +|..+|+|++++.. ....+..+.|-.+|....+|.||+++-.|++...+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35688999999999999999999875 58899999998753 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
|||||++||++..+| .+...|++..+..++.+++-|++.||+.| +|||||||+|+|||..|++||+||||+.-+
T Consensus 218 LiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999998 46678999999999999999999999998 999999999999999999999999998644
Q ss_pred CC----------------------Ccccc-----c------------------cccccccccccCcccccCCCCCccccH
Q 005705 624 GG----------------------DELQG-----N------------------TKQIVGTYGYMSPEYALDGLFSIKSDV 658 (682)
Q Consensus 624 ~~----------------------~~~~~-----~------------------~~~~~gt~~y~aPE~~~~~~~s~k~DV 658 (682)
.. .+... . ....+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 00000 0 012489999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC
Q 005705 659 FSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 659 wSlGvil~elltG~~pf~~~~~ 680 (682)
||||||+||||.|-+||..++.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp 393 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETP 393 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999987753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=325.34 Aligned_cols=198 Identities=31% Similarity=0.470 Sum_probs=178.8
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+. .+...+.+.+|++++++++||||+.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999764 5788999999664 44567889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+.+ +|..+|. ....++++.+..|+.+++.||.|||+.. |+|||+||+|||++.++.+|++|||+|+-+....
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 9999994 4456999999999999999999999997 9999999999999999999999999999875432
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
...+.+.|||.|||||...+.+|+..+|.|||||||||+.+|++||--
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 234567999999999999999999999999999999999999999954
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=317.94 Aligned_cols=204 Identities=28% Similarity=0.409 Sum_probs=175.3
Q ss_pred hhhcCcccccccccCCceeEEEEEE-cCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 542 (682)
...+.|+.+++||+|.||.||||++ .+|+.||+|++.-. .+....-..+|+.||++|.||||++|.+...+. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3456789999999999999999986 56899999988543 344556678999999999999999999999877 689
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
|||+|||+. +|.-++.. ..-.+++.++..++.||+.||+|+|.++ |+|||||..|||||.+|.+||+|||||++
T Consensus 194 YlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence 999999987 66666632 2335999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+....... .+..+-|..|.|||.+.+. .|+.+.|+||.||||.||+.|++.|--.
T Consensus 268 y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 268 YTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred ccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 86654333 4455779999999999875 6999999999999999999999988643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.54 Aligned_cols=209 Identities=31% Similarity=0.471 Sum_probs=182.6
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
+.+...+.++||+|-||.|.+++...+..||||+++... .....+|..|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 456678889999999999999999888999999998754 3456899999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
||++|+|..|+..+... .+......+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++-+...+
T Consensus 616 YmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999655332 2455667789999999999999998 9999999999999999999999999999765555
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGLGSME 681 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~pf~~~~~e 681 (682)
+..-....+-+++|||||.+..++++.++|||+||+.|||+++ ..+||+.-+.|
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 4444444567899999999999999999999999999999876 78888765544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.88 Aligned_cols=203 Identities=28% Similarity=0.458 Sum_probs=178.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc----Ch-hhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~-~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 541 (682)
...+|.+.+.||+|+||.|++|++. ++..||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999764 5899999977553 11 23456778999999999 9999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC-CCeEEeeeccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLA 620 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla 620 (682)
.++||||+.+|+|.+++.. ...+.+.++..++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 456888999999999999999999998 9999999999999999 99999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCC-CC-ccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS-IKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+
T Consensus 169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 98731 123455679999999999999988 86 77999999999999999999999755
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.03 Aligned_cols=206 Identities=25% Similarity=0.392 Sum_probs=182.6
Q ss_pred HhhhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCe
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE 541 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 541 (682)
...-++|.++++||+|+||+|++++.+. ++.+|||.+++.. .+..+..+.|..++.... ||.|++++.+++..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3456789999999999999999998864 7789999998753 455677888998888885 9999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.+.||||+.||++..+ .....+++..+.-++..|+-||.|||+++ ||+||||.+|||||.+|++||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999995433 34567999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 681 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~e 681 (682)
.--. ....+.+++|||.|||||++.+..|+.++|.|||||+|||||.|..||.-++.|
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 7432 234577899999999999999999999999999999999999999999977654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.14 Aligned_cols=203 Identities=31% Similarity=0.473 Sum_probs=172.9
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC--eEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 546 (682)
..++...+.||+|+||.||++...+ |...|||..........+.+.+|+.+|.+++|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778999999999999998855 8999999987654333778999999999999999999999855444 688999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeEEeeeccccccCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGG 625 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~ 625 (682)
||+++|+|.+++..... .+++..+..++.||++||+|||+++ ||||||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999954332 6999999999999999999999998 999999999999999 79999999999987753
Q ss_pred -CccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 626 -DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 626 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
...........||+.|||||++... ....++|||||||++.||+||++||..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 1112234457899999999999863 334599999999999999999999975
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=307.59 Aligned_cols=198 Identities=33% Similarity=0.542 Sum_probs=169.8
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhc--CCCCeeeEEEEEEecC----eEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL--QHRNLVRLLGCCVEQG----EKIL 544 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l--~HpnIv~l~~~~~~~~----~~~l 544 (682)
+...+.++||+|.||.||||++ +++.||||++.. +..+.|++|-.|.+.. +|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4456678999999999999999 459999999974 4456788887777664 7999999999877655 8899
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY------SRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
|+||.+.|+|.++| +...++|....+|+..+++||+|||+. .+++|+|||||.+||||.+++.+.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 456799999999999999999999963 45789999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCC-CC-----ccccHHHHHHHHHHHHcCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS-----IKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~k~DVwSlGvil~elltG~~pf~ 676 (682)
+|..+............+||.+|||||++.+.. +. .+.||||+|.+||||++...-+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 999987666556666689999999999997754 22 35899999999999999877664
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.95 Aligned_cols=211 Identities=33% Similarity=0.538 Sum_probs=181.8
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~ 540 (682)
..+.....+.+.+.+.||+|.||+||+|++.. .||||.+.-. .++..++|++|+..+++-+|.||+-+.|+|....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 35555666778888999999999999998843 6999998543 4567899999999999999999999999998887
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
. .+|..+++|.+|+.+++..+ ..++..+.+.|++||++||.|||.++ |||||||..||+|.+++.|||.|||++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 6 99999999999999997544 45888899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGSME 681 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~pf~~~~~e 681 (682)
..-....-........|...|||||++.. .+|+..+||||||+++|||++|..||...+.|
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d 599 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD 599 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence 76543322333445678889999999863 57899999999999999999999999966554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.19 Aligned_cols=201 Identities=30% Similarity=0.467 Sum_probs=181.2
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
...|...++||+|+-|.||.++. .+++.||||++........+-+.+|+.+|+..+|+|||++++.+...++.++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 35677778999999999999965 46889999999776655667789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
|++|+|.+.+ ....+++.++..|++++++||+|||.++ |||||||.+|||++.++.+||+|||++..+....
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~- 423 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ- 423 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc-
Confidence 9999999988 4445999999999999999999999998 9999999999999999999999999998875543
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+|||.|||||++....|..|.||||||++++||+-|.+||=.++
T Consensus 424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~ 473 (550)
T KOG0578|consen 424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN 473 (550)
T ss_pred -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC
Confidence 24566899999999999999999999999999999999999999997544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=284.41 Aligned_cols=201 Identities=31% Similarity=0.459 Sum_probs=173.6
Q ss_pred cCcccccccccCCceeEEEEEE-cCCceEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|..+++||+|.||.||+|++ .+|+.||||+++.... .......+|++.|+.++|+||+.+++++-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999987 4689999999865422 223456899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
||+. +|...+.+ +...+...++..++.++++|++|+|++. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 78888854 3457999999999999999999999998 9999999999999999999999999999986544
Q ss_pred cccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. ....+-|..|.|||.+.+. .|+...||||.|||+.||+-|.+-|.-.+
T Consensus 156 ~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 156 RI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred cc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 22 2223678999999998775 58999999999999999999998876544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.49 Aligned_cols=201 Identities=30% Similarity=0.434 Sum_probs=175.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHH--HHHHHHHHHhcC-CCCeeeEEEEEEecC-eEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKE--FKNEMMLIAKLQ-HRNLVRLLGCCVEQG-EKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~--f~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~~ 543 (682)
.-++|.+.++||.|.||.||+|+.. ++..||||++++.-.. +++ =.+|++.|++|+ ||||+++.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3568999999999999999999864 5889999999875433 333 368999999998 999999999999888 999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+|||||+. +|.+++.++ ++.+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999965 788888654 678999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... ...+..+.|..|.|||++.. ..|+.+.||||+|||++|+.+-++.|--.+
T Consensus 161 ~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 161 RSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred ccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 543 34456788999999999865 668999999999999999999999986543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=317.92 Aligned_cols=199 Identities=28% Similarity=0.433 Sum_probs=179.3
Q ss_pred CcccccccccCCceeEEEEEE-cCCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
-|++++.||.|+.|.|-+|++ .+|+.+|||++.+. .......+.+|+.+|+.+.|||++++++++.+..++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 477889999999999999988 46999999999765 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++|.|.+++ .+++.+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.+....
T Consensus 93 yv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 93 YVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred ecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 99999999998 46678999999999999999999999998 999999999999999999999999999874332
Q ss_pred cccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+|+|.|.|||++.+.+| ..++||||.|||||.||||+.||+.++
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 33456799999999999999998 578999999999999999999999765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.30 Aligned_cols=204 Identities=31% Similarity=0.472 Sum_probs=178.1
Q ss_pred hcCcccccccccCCceeEEEEEEcC----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.....|.++||.|.||.|++|+++- ...||||.++.. .+....+|+.|+.||.++.||||++|.|+.......++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3456778999999999999998853 347999999875 56678899999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|.|||++|+|+.||.... +.+.+.++..++++||.||.||.+.+ +|||||.++|||++.+..+|++|||+++.+.
T Consensus 708 iTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999996543 55899999999999999999999998 9999999999999999999999999999886
Q ss_pred CCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 625 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 625 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.+... ..+....-+.+|.|||.+....++.++|||||||+|||.++ |.+||=..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 54411 11222233789999999999999999999999999999998 88887443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.95 Aligned_cols=203 Identities=25% Similarity=0.351 Sum_probs=175.7
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+++.. +++.||||++++.. ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 48899999996532 234467889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999843 356899999999999999999999998 999999999999999999999999999765321
Q ss_pred cc---------------------------------ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCC
Q 005705 627 EL---------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673 (682)
Q Consensus 627 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~ 673 (682)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 000123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 005705 674 NTGLGS 679 (682)
Q Consensus 674 pf~~~~ 679 (682)
||...+
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.27 Aligned_cols=208 Identities=36% Similarity=0.585 Sum_probs=181.9
Q ss_pred hcCcccccccccCCceeEEEEEEcC--Cc----eEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~--g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.++.++.+.||+|+||.||+|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566778899999999999998753 43 4999999765 566788999999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 543 ILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
++++|||++|+|..||.+.. ....+...+++.++.|||+|+.|||+++ +|||||..+|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997542 1346889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGSM 680 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~~ 680 (682)
+|+.+.+.++........-+..|||||.+....|+.|+|||||||+|||++| |..||...+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 9997765555444333455789999999999999999999999999999999 9999986543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=310.43 Aligned_cols=208 Identities=30% Similarity=0.439 Sum_probs=172.9
Q ss_pred hhcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~ 540 (682)
..++|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4578999999999999999999742 35689999997543 33456799999999999 8999999999887644
Q ss_pred -eEEEEEEecCCCChhHHhhhccc--------------------------------------------------------
Q 005705 541 -EKILILEYMPNKSLNVFLFDSTK-------------------------------------------------------- 563 (682)
Q Consensus 541 -~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 563 (682)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999854211
Q ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccccccccc
Q 005705 564 ---KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640 (682)
Q Consensus 564 ---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 640 (682)
...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999998 99999999999999999999999999986543222222223356788
Q ss_pred ccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 641 YMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 641 y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
|+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.11 Aligned_cols=198 Identities=26% Similarity=0.340 Sum_probs=175.2
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999843 346889999999999999999999998 999999999999999999999999999865322
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=282.16 Aligned_cols=203 Identities=31% Similarity=0.426 Sum_probs=181.2
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|++.+.||+|.||.||.|+.+ ++..||+|++.+.. .+...++.+|+++-..|+||||+++++++.++...||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578999999999999999999875 46789999996542 2345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
++||.++|+|...|... ....+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||-+....
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999998542 3456888999999999999999999988 9999999999999999999999999987532
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+||..|++||+..+..++.+.|+|++|++.||++.|.+||+..+
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 344566899999999999999999999999999999999999999998765
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.84 Aligned_cols=202 Identities=24% Similarity=0.352 Sum_probs=173.7
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.|++++.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999874 57899999996532 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999843 345889999999999999999999998 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------ccccccccccccccCcccccCCCCCccccHHHHH
Q 005705 628 L---------------------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662 (682)
Q Consensus 628 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlG 662 (682)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001234799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 005705 663 ILMLETLSSKKNTGLGS 679 (682)
Q Consensus 663 vil~elltG~~pf~~~~ 679 (682)
|++|||++|+.||...+
T Consensus 236 ~il~elltG~~Pf~~~~ 252 (381)
T cd05626 236 VILFEMLVGQPPFLAPT 252 (381)
T ss_pred hHHHHHHhCCCCCcCCC
Confidence 99999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.64 Aligned_cols=206 Identities=31% Similarity=0.506 Sum_probs=169.3
Q ss_pred CCCCCccchhHHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHH--hcCCCCeeeE
Q 005705 455 DSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA--KLQHRNLVRL 532 (682)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~--~l~HpnIv~l 532 (682)
.+.+|.+-...+ .+...+.+.||+|.||.||+|++ .|..||||++...++.. +.+|.++.+ .|+|+||+.+
T Consensus 198 GSGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgF 270 (513)
T KOG2052|consen 198 GSGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGF 270 (513)
T ss_pred CCCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhh
Confidence 355777655555 46788899999999999999988 68899999998766543 444555544 5699999999
Q ss_pred EEEEEecC----eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCcEeccCCCCC
Q 005705 533 LGCCVEQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-----YSRFRIIHRDLKASN 603 (682)
Q Consensus 533 ~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-----~~~~~iiH~Dlkp~N 603 (682)
++.-..+. +++||.+|.+.|||.+|| ....++....++++..+|.||+|||- ++++.|.|||||++|
T Consensus 271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 99876543 789999999999999999 34679999999999999999999994 688899999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCC--ccccccccccccccccCcccccCCC----C-C-ccccHHHHHHHHHHHHcC
Q 005705 604 ILLDKDMNPKISDFGLARMFGGD--ELQGNTKQIVGTYGYMSPEYALDGL----F-S-IKSDVFSFGILMLETLSS 671 (682)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-s-~k~DVwSlGvil~elltG 671 (682)
||+.+++.+.|+|+|||..+... +.....+..+||.+|||||++.... | + ..+||||||.++||+...
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 99999999999999999887543 2333456679999999999886532 2 2 359999999999998753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.49 Aligned_cols=203 Identities=26% Similarity=0.344 Sum_probs=174.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|.+.++||+|+||.||+++.. +++.||||++... .....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999874 5889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999843 346889999999999999999999998 999999999999999999999999999643210
Q ss_pred cc------------cc---------------------------------ccccccccccccCcccccCCCCCccccHHHH
Q 005705 627 EL------------QG---------------------------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSF 661 (682)
Q Consensus 627 ~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSl 661 (682)
.. .. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00 0012468999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 005705 662 GILMLETLSSKKNTGLGS 679 (682)
Q Consensus 662 Gvil~elltG~~pf~~~~ 679 (682)
||++|||++|++||...+
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN 252 (377)
T ss_pred chhhhhhhcCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=288.70 Aligned_cols=203 Identities=29% Similarity=0.395 Sum_probs=172.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 543 (682)
..++|+.++.|++|.||.||+|+++ +++.||+|+++-..+. ..-.-.+|+.+|.+++|||||.+-.+..-. +..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3568999999999999999999885 5788999999643211 122357899999999999999999887643 5799
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||++. +|...+... .+.+...++.-++.|+++|++|||... |+||||||+|+|++..|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999976 788887543 356888999999999999999999997 999999999999999999999999999988
Q ss_pred CCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.. ....+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++.|.-.+
T Consensus 228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 654 2345566789999999999875 58999999999999999999999997654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=295.85 Aligned_cols=205 Identities=27% Similarity=0.390 Sum_probs=178.6
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..+.|++.++||.|..++||+|+. +.+..||||++.-.. ....+.+.+|+..|..++||||++++..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457899999999999999999976 457899999996432 234789999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
.||.+|++.++++..-.. .+++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999664433 4999999999999999999999998 999999999999999999999999987766432
Q ss_pred c-cc-cccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 627 E-LQ-GNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 627 ~-~~-~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
. .. .......||+.|||||++.. ..|+.|+||||||+...||.+|..||..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 2 11 12256799999999999654 4589999999999999999999999975
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=314.91 Aligned_cols=203 Identities=25% Similarity=0.367 Sum_probs=175.4
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999885 58899999996532 234566889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999843 346899999999999999999999998 999999999999999999999999998765321
Q ss_pred cccc------------------------------------ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc
Q 005705 627 ELQG------------------------------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670 (682)
Q Consensus 627 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 670 (682)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 005705 671 SKKNTGLGS 679 (682)
Q Consensus 671 G~~pf~~~~ 679 (682)
|+.||...+
T Consensus 235 G~~Pf~~~~ 243 (364)
T cd05599 235 GYPPFCSDN 243 (364)
T ss_pred CCCCCCCCC
Confidence 999997643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.79 Aligned_cols=198 Identities=25% Similarity=0.405 Sum_probs=176.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999886 48899999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999984 3346889999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 2334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=316.23 Aligned_cols=202 Identities=25% Similarity=0.371 Sum_probs=173.4
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.|+++++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999874 57889999986532 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998843 346889999999999999999999998 9999999999999999999999999975432100
Q ss_pred c---------------------------------------------ccccccccccccccCcccccCCCCCccccHHHHH
Q 005705 628 L---------------------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662 (682)
Q Consensus 628 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlG 662 (682)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001234789999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 005705 663 ILMLETLSSKKNTGLGS 679 (682)
Q Consensus 663 vil~elltG~~pf~~~~ 679 (682)
|+||||++|++||...+
T Consensus 236 vil~elltG~~Pf~~~~ 252 (382)
T cd05625 236 VILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=309.17 Aligned_cols=199 Identities=24% Similarity=0.350 Sum_probs=176.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467999999999999999999885 57899999986532 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999998843 346889999999999999999999998 99999999999999999999999999987533
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 2 223578999999999999999999999999999999999999997554
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=310.20 Aligned_cols=200 Identities=27% Similarity=0.373 Sum_probs=175.9
Q ss_pred hhcCcccccccccCCceeEEEEEEcC--CceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|++.+.||+|+||.||+|++.. +..||+|.+... .....+.+.+|+.++..++||||+++++++.+++..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34679999999999999999998644 368999998643 2234567889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999843 346899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .....||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 321 234578999999999999889999999999999999999999997654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.12 Aligned_cols=202 Identities=24% Similarity=0.448 Sum_probs=183.0
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..+|++.+.||+|.||.|-++.. ..|+.||||.+++. +++..-.+.+|++||..|+||||+.++.+|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999965 67999999998764 455667789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||..+|.|.+|+ ...+.|++.+.+.+++||..|+.|+|.+. ++|||||.+|||||+++++||+|||++.++..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 45567999999999999999999999987 99999999999999999999999999998765
Q ss_pred CccccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
.. ....++|+|-|.+||++.+.+| .+..|-|||||+||-|+.|..||+--+.
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh 258 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH 258 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH
Confidence 43 4566899999999999999998 4779999999999999999999986543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.04 Aligned_cols=201 Identities=28% Similarity=0.395 Sum_probs=174.2
Q ss_pred CcccccccccCCceeEEEEEE-cCCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.|++.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999987 468999999986432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|..++... ....+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998887542 2345899999999999999999999998 9999999999999999999999999998753221
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 1234578999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=315.42 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=174.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.+|++.++||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999875 48899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999843 346889999999999999999999998 999999999999999999999999998533110
Q ss_pred c-----------------------------------------cccccccccccccccCcccccCCCCCccccHHHHHHHH
Q 005705 627 E-----------------------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665 (682)
Q Consensus 627 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil 665 (682)
. .........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001234799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 005705 666 LETLSSKKNTGLGS 679 (682)
Q Consensus 666 ~elltG~~pf~~~~ 679 (682)
|||++|+.||...+
T Consensus 235 yell~G~~Pf~~~~ 248 (376)
T cd05598 235 YEMLVGQPPFLADT 248 (376)
T ss_pred eehhhCCCCCCCCC
Confidence 99999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.34 Aligned_cols=187 Identities=33% Similarity=0.504 Sum_probs=167.5
Q ss_pred ccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCC
Q 005705 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 553 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 553 (682)
..++-||.|+-|.||+|++ .++.||||+++... ..+++-|++|+||||+.+.|+|.....+++||||+..|.
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3457899999999999998 56899999986433 347889999999999999999999999999999999999
Q ss_pred hhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccc
Q 005705 554 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633 (682)
Q Consensus 554 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 633 (682)
|.+.| ..++.+.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++.+... . ..-
T Consensus 199 L~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--S-TkM 269 (904)
T KOG4721|consen 199 LYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--S-TKM 269 (904)
T ss_pred HHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--h-hhh
Confidence 99999 34567888999999999999999999997 999999999999999999999999999886432 1 223
Q ss_pred cccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 634 ~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.++||..|||||++...+.+.|+|||||||+|||||||..||..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 47999999999999999999999999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=297.58 Aligned_cols=204 Identities=27% Similarity=0.415 Sum_probs=170.3
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh--------------hhHHHHHHHHHHHHhcCCCCeeeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------QGLKEFKNEMMLIAKLQHRNLVRLL 533 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--------------~~~~~f~~E~~~l~~l~HpnIv~l~ 533 (682)
..++|++++.||+|.||.|-+|+.. +++.||||++.+..- ...+...+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999874 588999999965321 1245788999999999999999999
Q ss_pred EEEEec--CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 534 GCCVEQ--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 534 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
++..+. +..|||+||+..|.+...- .....+.+.+++++++++..||+|||.++ ||||||||.|+||+++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 998754 5789999999988875432 33333999999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCC---ccccccccccccccccCcccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 612 PKISDFGLARMFGGD---ELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 612 ~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+||+|||.+..+... .........+|||.|+|||.+.+.. .+.+.||||+||+||.|+.|+.||--+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999999999876221 1122334479999999999987732 256789999999999999999999754
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.21 Aligned_cols=205 Identities=24% Similarity=0.309 Sum_probs=175.8
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
....++|++.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999885 4788999998642 222345688999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999998843 34789999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+..... .......||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 643221 1223457999999999987543 7889999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.44 Aligned_cols=195 Identities=27% Similarity=0.338 Sum_probs=170.1
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++.+++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 58899999987532 234567889999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (682)
+|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 9988884 3456899999999999999999999998 999999999999999999999999998753221 1223
Q ss_pred ccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 34579999999999999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.53 Aligned_cols=195 Identities=26% Similarity=0.342 Sum_probs=169.7
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
+.||+|+||.||+++.. +|+.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999874 5889999998753 2234567788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (682)
+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9988874 3346899999999999999999999998 9999999999999999999999999987542221 122
Q ss_pred ccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 34578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=286.62 Aligned_cols=205 Identities=29% Similarity=0.413 Sum_probs=173.2
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChh--hHHHHHHHHHHHHhcCCCC-eeeEEEEEEecC-----
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQG----- 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~Hpn-Iv~l~~~~~~~~----- 540 (682)
...|..+++||+|.||+||+|+.+ +|+.||+|+++-..++ ......+|+.+|++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 455777789999999999999874 5889999998654332 3345688999999999999 999999998877
Q ss_pred -eEEEEEEecCCCChhHHhhhcccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 541 -EKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 541 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
..++|+||++. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+|||+++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78899999854 888888554322 45777899999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
+|+.+.-.. ...+..++|..|.|||++.+. .|+...||||+|||+.||+++++.|..++.
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 999654221 224456889999999999887 789999999999999999999999977653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=303.58 Aligned_cols=195 Identities=27% Similarity=0.338 Sum_probs=170.0
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
+.||+|+||.||+++.. +++.||||++.+. .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 5889999999753 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (682)
+|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99888743 346899999999999999999999998 9999999999999999999999999987542211 122
Q ss_pred ccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 34578999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.77 Aligned_cols=203 Identities=25% Similarity=0.365 Sum_probs=175.2
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999875 5889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999984 3356899999999999999999999998 999999999999999999999999998754221
Q ss_pred cc---------------------------------ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCC
Q 005705 627 EL---------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673 (682)
Q Consensus 627 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~ 673 (682)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 000123479999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 005705 674 NTGLGS 679 (682)
Q Consensus 674 pf~~~~ 679 (682)
||...+
T Consensus 235 Pf~~~~ 240 (360)
T cd05627 235 PFCSET 240 (360)
T ss_pred CCCCCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=300.44 Aligned_cols=193 Identities=24% Similarity=0.332 Sum_probs=169.0
Q ss_pred cccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
||+|+||.||+++.. +++.||+|.+... .......+.+|+.++.+++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999885 4788999998643 234456788999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccc
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (682)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 998843 346899999999999999999999998 9999999999999999999999999998643221 12334
Q ss_pred ccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.31 Aligned_cols=203 Identities=34% Similarity=0.488 Sum_probs=173.8
Q ss_pred hcCcccccccccCCceeEEEEEEcC--C--ce-EEEEEecc---cChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN--G--QE-VAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~--g--~~-vAVK~l~~---~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
-++..+.++||+|+||.||+|++.. + .. ||||..+. .......+|++|+++|++++|||||+++|++..+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455666899999999999998753 2 23 89999875 346678899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
+++|||++.||+|+++|.... ..++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999995432 25999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.-. .+........-+..|+|||.+....|+.++|||||||++||+++ |..||...+
T Consensus 311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 643 11111112245789999999999999999999999999999999 888987543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.42 Aligned_cols=207 Identities=24% Similarity=0.304 Sum_probs=177.0
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~ 540 (682)
.+....++|++.+.||+|+||.||++++. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34455689999999999999999999885 4788999998642 2233456789999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++||||+++++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999998843 34788899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.+..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 87643221 1223457999999999987543 7899999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.98 Aligned_cols=203 Identities=26% Similarity=0.326 Sum_probs=174.5
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|++.++||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4578999999999999999999875 5789999998642 22334567899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 34788899999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCC----CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 3221 122345799999999998653 37899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.74 Aligned_cols=200 Identities=26% Similarity=0.355 Sum_probs=171.7
Q ss_pred CcccccccccCCceeEEEEEEcC-CceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCC-CeeeEEEEEEecCeEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~ 546 (682)
+|++.+.||+|+||.||+|+..+ ++.||||++... .....+.+..|+.++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47889999999999999998754 678999998753 234456788899999999765 5888999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 345889999999999999999999998 999999999999999999999999998753211
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1 12334578999999999999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.68 Aligned_cols=205 Identities=31% Similarity=0.504 Sum_probs=171.8
Q ss_pred hcCcccccccccCCceeEEEEEEcC-----------------CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeee
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 531 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-----------------g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~ 531 (682)
.++|++.++||+|+||.||++.+.+ +..||+|.+... ......+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578899999999999999997532 336999998764 3345668999999999999999999
Q ss_pred EEEEEEecCeEEEEEEecCCCChhHHhhhcc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 005705 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDST----------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595 (682)
Q Consensus 532 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ii 595 (682)
+++++.+.+..++||||+++++|.+++.... ....+++.++++++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885321 1134788899999999999999999998 99
Q ss_pred eccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc--CCC
Q 005705 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKK 673 (682)
Q Consensus 596 H~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~ 673 (682)
||||||+|||++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987643332222233455789999999988899999999999999999987 556
Q ss_pred CCCC
Q 005705 674 NTGL 677 (682)
Q Consensus 674 pf~~ 677 (682)
||..
T Consensus 241 p~~~ 244 (304)
T cd05096 241 PYGE 244 (304)
T ss_pred CCCc
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.26 Aligned_cols=203 Identities=26% Similarity=0.404 Sum_probs=177.8
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|.+.+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999885 58899999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999988 999999999999999999999999999876432
Q ss_pred c---------------------------cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 E---------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .........||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=300.25 Aligned_cols=195 Identities=30% Similarity=0.412 Sum_probs=168.7
Q ss_pred cccccCCceeEEEEEEc----CCceEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 477 CKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++||+|+||.||+++.. .++.||||.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999763 47889999986532 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++. +...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999998884 3346788899999999999999999998 9999999999999999999999999987542221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 12234578999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.53 Aligned_cols=200 Identities=26% Similarity=0.370 Sum_probs=176.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.+.||+|+||.||+++.. ++..+|+|.+... .+...+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999885 5788999998654 33455779999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999843 345889999999999999999999864 3999999999999999999999999999765322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 223357899999999999999999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.29 Aligned_cols=200 Identities=27% Similarity=0.359 Sum_probs=171.5
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
+|.+.+.||+|+||.||+|+.. +++.||||.+.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999875 46799999987532 23345567788888877 5899999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988743 345889999999999999999999998 999999999999999999999999999754321
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 1 12334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=297.99 Aligned_cols=204 Identities=26% Similarity=0.396 Sum_probs=181.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..|...+.||+|+||.||||.+. .++.||+|++.-. .+...+++++|+.+|.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45677789999999999999874 5889999999653 445678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+.+|++.+.+ +....+++..+.-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999998 34455688888899999999999999998 99999999999999999999999999988765433
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 682 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~e~ 682 (682)
....++||+.|||||++....|+.|+||||||++++||.+|.+|+..-...|
T Consensus 167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr 218 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR 218 (467)
T ss_pred --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence 3367899999999999999999999999999999999999999998765443
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=312.54 Aligned_cols=205 Identities=20% Similarity=0.255 Sum_probs=177.8
Q ss_pred CcccccccccCCceeEEEEEEc-C-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999764 3 5788999876555555667889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 550 PNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 550 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
++|+|.+++... .....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988543 23446889999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 222344579999999999999999999999999999999999999997543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.58 Aligned_cols=202 Identities=24% Similarity=0.362 Sum_probs=174.1
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|++.+.||+|+||.||++++. +++.||||++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999985 4788999998653 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2346899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
........|++.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 112234578999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=301.19 Aligned_cols=203 Identities=23% Similarity=0.314 Sum_probs=174.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|.+.+.||+|+||.||+++.. +++.||+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 4788999998652 2233456889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 346889999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 21 12233578999999998875 467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.03 Aligned_cols=200 Identities=28% Similarity=0.393 Sum_probs=171.3
Q ss_pred CcccccccccCCceeEEEEEEc----CCceEEEEEeccc----ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~----~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 542 (682)
+|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|+.++.++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999763 5789999998643 223356688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998843 345899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 533221 122345789999999998865 4789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.82 Aligned_cols=198 Identities=26% Similarity=0.401 Sum_probs=169.3
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHH---HhcCCCCeeeEEEEEEecCeEEEE
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLI---AKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
|++.+.||+|+||.||+++.. +++.||||.++... ....+.+.+|+.++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999875 58899999997532 23345666676655 466799999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|..++. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 346899999999999999999999998 99999999999999999999999999875422
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 1 122334678999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.11 Aligned_cols=203 Identities=25% Similarity=0.341 Sum_probs=173.7
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+++.. +++.||+|.+.+. .....+.|.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999875 4889999998642 2234566889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998432 345889999999999999999999998 999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 21 11223468999999999863 457889999999999999999999997644
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.68 Aligned_cols=201 Identities=27% Similarity=0.384 Sum_probs=171.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999875 57899999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 88888743 2345789999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+++.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11233467899999998865 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=301.01 Aligned_cols=195 Identities=26% Similarity=0.332 Sum_probs=168.8
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
+.||+|+||.||+++.. +++.||+|.+... ......++.+|++++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 5889999999753 2234567788999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
+|..++. +...+++.++..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9988873 33468999999999999999999997 56 9999999999999999999999999987542211 12
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 234578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=296.42 Aligned_cols=195 Identities=28% Similarity=0.382 Sum_probs=166.1
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 47789999987532 23345566677777654 899999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999988843 345899999999999999999999998 9999999999999999999999999997643222 22
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.63 Aligned_cols=195 Identities=25% Similarity=0.359 Sum_probs=168.5
Q ss_pred cccccCCceeEEEEEEcC-CceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
++||+|+||.||+|+... ++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998754 789999998753 233456678899988876 799999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999888743 345889999999999999999999998 9999999999999999999999999987543221 12
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 234578999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=299.67 Aligned_cols=204 Identities=28% Similarity=0.443 Sum_probs=182.7
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe-EEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE-KILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~ 546 (682)
++|..++++|+|+||.++..+++ +++.+++|.+.- ..+...+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999875 477899998743 344555678999999999999999999999999988 89999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
+|++||+|.+.+.... +..++++++..++.||+.|+.|||+.. |+|||||+.||+++.++.+||.|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986543 567999999999999999999999776 999999999999999999999999999998765
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
. ......+||+.||.||.+.+.+|+.|+|||||||++|||++-+++|.-.++
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 4 234567999999999999999999999999999999999999999987765
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.59 Aligned_cols=203 Identities=24% Similarity=0.325 Sum_probs=173.1
Q ss_pred cCcccccccccCCceeEEEEEEcC-CceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.++||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478899999999999999998854 678999998642 2223455889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 345899999999999999999999998 999999999999999999999999999765322
Q ss_pred ccccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 11 1223357899999999886 3468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.17 Aligned_cols=197 Identities=27% Similarity=0.379 Sum_probs=172.5
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC-C-----CCeeeEEEEEEecCeEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H-----pnIv~l~~~~~~~~~~~l 544 (682)
+|++.+.||+|.||+|.||.+. +++.||||++++.. ....+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999764 58999999998764 34566688999999997 4 479999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC--CeEEeeeccccc
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM--NPKISDFGLARM 622 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kL~DFGla~~ 622 (682)
|+|.++ .+|.++|+.. +...++...++.|+.||+.||..||+.+ |||+|||||||||.+.. .+||+|||.+..
T Consensus 266 VfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999884 5899999654 4456999999999999999999999998 99999999999997544 699999999987
Q ss_pred cCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....- ...+.+..|.|||++.+.+|+.+.||||||||++||++|.+.|.-++
T Consensus 341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 54322 24578899999999999999999999999999999999988887654
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=293.48 Aligned_cols=200 Identities=28% Similarity=0.370 Sum_probs=169.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999885 588999999865432 233567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 567666643 2345889999999999999999999998 9999999999999999999999999987543221
Q ss_pred cccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12233567899999998865 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.26 Aligned_cols=195 Identities=26% Similarity=0.395 Sum_probs=168.4
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||+++.. +++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 4789999998653 233456678888888877 699999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988743 346899999999999999999999998 9999999999999999999999999987542211 12
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.22 Aligned_cols=208 Identities=32% Similarity=0.466 Sum_probs=173.5
Q ss_pred hhcCcccccccccCCceeEEEEEEc------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~ 540 (682)
..++|++.+.||+|+||.||+++.. ++..||||.++.. .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4568999999999999999998742 2357999999754 333456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhcc----------------------------------------------------------
Q 005705 541 EKILILEYMPNKSLNVFLFDST---------------------------------------------------------- 562 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 562 (682)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999885321
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccc
Q 005705 563 ---------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633 (682)
Q Consensus 563 ---------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 633 (682)
....+++.++++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1124788899999999999999999998 9999999999999999999999999998653322111112
Q ss_pred cccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 634 ~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
...++..|||||++.+..++.++|||||||++|||++ |+.||....
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 2345678999999999999999999999999999997 999996543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=301.78 Aligned_cols=203 Identities=23% Similarity=0.390 Sum_probs=175.4
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|.+.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999875 58899999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 246899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCccccc------CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 211 223347899999999986 4567899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.85 Aligned_cols=200 Identities=25% Similarity=0.370 Sum_probs=171.1
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 546 (682)
+|+..+.||+|+||.||+++.. +++.||||++.+. .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999875 5889999998753 2234566788999998885 577888999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999998884 3346899999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1 12234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=296.82 Aligned_cols=193 Identities=23% Similarity=0.373 Sum_probs=168.1
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
++||+|+||.||++++. +++.||||++++. .....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 5789999999753 233456688999999998 699999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence 99988874 3356899999999999999999999998 999999999999999999999999998753211 112
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 3345789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=312.17 Aligned_cols=210 Identities=22% Similarity=0.326 Sum_probs=178.8
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC---
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--- 540 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~--- 540 (682)
....++|.+.+.||+|+||.||+++.. +++.||||++... .......+.+|+..+..++|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345679999999999999999999864 6899999998643 3445667899999999999999999988765432
Q ss_pred -----eEEEEEEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 541 -----EKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 541 -----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3679999999999999986432 3356899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999987654322223344679999999999999999999999999999999999999997654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=282.12 Aligned_cols=209 Identities=25% Similarity=0.328 Sum_probs=180.2
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..+.|++++.||.|.-|+||++++.+ +...|+|++.+.. .+...+.+.|-+||+.+.||.++.|+..++.+...+|
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34678889999999999999999865 5789999997653 3345567789999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
+|||++||+|...++. +..+.+++..++.++.+++-||+|||-.| ||.|||||+||||-++|++-|.||.|+....
T Consensus 155 ~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999988744 45567999999999999999999999998 9999999999999999999999999876541
Q ss_pred CC----------------------------------c--------------------cccccccccccccccCcccccCC
Q 005705 625 GD----------------------------------E--------------------LQGNTKQIVGTYGYMSPEYALDG 650 (682)
Q Consensus 625 ~~----------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~ 650 (682)
.. . .......++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 0 00112235899999999999999
Q ss_pred CCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 005705 651 LFSIKSDVFSFGILMLETLSSKKNTGLGSME 681 (682)
Q Consensus 651 ~~s~k~DVwSlGvil~elltG~~pf~~~~~e 681 (682)
.++.++|.|+|||+|||||.|+.||.-.+.+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~ 341 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK 341 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCch
Confidence 9999999999999999999999999877654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=295.40 Aligned_cols=201 Identities=26% Similarity=0.373 Sum_probs=175.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.++||+|+||.||++++. ++..+|+|.+... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999886 5788999988654 33445679999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.. +|+|+||||+|||+++++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999843 345889999999999999999999753 3999999999999999999999999998765321
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1233468999999999999899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.85 Aligned_cols=192 Identities=24% Similarity=0.387 Sum_probs=166.8
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||+++.. +++.+|+|++++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4789999998753 233456678899888877 799999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 99988874 3346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 234578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=288.66 Aligned_cols=191 Identities=21% Similarity=0.348 Sum_probs=165.9
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChh---hHHHHHHHHHHHHhcCCCCeeeEEEEEEe----cCeEEEEEEec
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILILEYM 549 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~ 549 (682)
..|++|++|.||+|+. +|+.||||+++..... ..+.|.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 7899999999764322 25778899999999999999999999877 34678999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
++|+|.+++.. ...+++...++++.|++.||+|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999843 34688999999999999999999985 5 8899999999999999999999999998653321
Q ss_pred ccccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 23467899999999976 678999999999999999999999998654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.07 Aligned_cols=212 Identities=27% Similarity=0.378 Sum_probs=179.4
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEcCC-ceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEE-EEEec--
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLG-CCVEQ-- 539 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~-~~~~~-- 539 (682)
.+.....++++.+.|.+|||+.||.|++..+ .++|+|++-..++...+..++|+.+|++|+ |+|||.+++ .....
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3455667899999999999999999998765 999999998778889999999999999997 999999999 33221
Q ss_pred ----CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEe
Q 005705 540 ----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (682)
Q Consensus 540 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 615 (682)
-+.+|+|||+++|.|-+++..+...+ |++.++++|+.|+++|+++||... ++|||||||-|||||+.+++.|||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeC
Confidence 26789999999999999996554444 999999999999999999999985 579999999999999999999999
Q ss_pred eeccccccCCCcccc-cc------ccccccccccCcccc---cCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 616 DFGLARMFGGDELQG-NT------KQIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 616 DFGla~~~~~~~~~~-~~------~~~~gt~~y~aPE~~---~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
|||.|.......... .. -...-|+.|+|||++ .+..+++|+|||+|||+||-|+....||+..
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 999986532211000 00 012458999999987 5788999999999999999999999999976
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=275.64 Aligned_cols=205 Identities=27% Similarity=0.399 Sum_probs=177.2
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..+.|++-+.||+|.|+.|++..+ .+|+.+|+|++.. ......+++.+|+.|-+.|+||||+++...+.+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 357789999999999999999966 4688999988743 2345778999999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEEeeeccccc
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLARM 622 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGla~~ 622 (682)
+|+|.|++|-.=+- .+...++..+-..++||+++|+|.|..+ |||||+||+|++|.+ .--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999865542 2245778888999999999999999998 999999999999954 34599999999998
Q ss_pred cCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 682 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~e~ 682 (682)
++.. .......|||+|||||++...+|+..+|||+.|||||-||.|.+||-.++.+|
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 8632 22345689999999999999999999999999999999999999998876654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.92 Aligned_cols=206 Identities=31% Similarity=0.416 Sum_probs=172.9
Q ss_pred hcCcccccccccCCceeEEEEEE------cCCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 541 (682)
.++|++.++||+|+||.||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999964 235689999996532 33456789999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccc----------------------------------------------------------
Q 005705 542 KILILEYMPNKSLNVFLFDSTK---------------------------------------------------------- 563 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 563 (682)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998854211
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 564 --------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 564 --------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788999999999999999999988 999999999999999999999999999876432211
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 11222345678999999999999999999999999999998 89998654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=282.43 Aligned_cols=204 Identities=29% Similarity=0.436 Sum_probs=174.6
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecc--cChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----cC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-----QG 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~-----~~ 540 (682)
....|...+.||+|+||.|..+... +|+.||||++.+ ......++-.+|+++|+.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666789999999999999874 589999999874 244456788999999999999999999998865 24
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..|+|+|+| ..+|...+ ..++.++...+..++.||++||.|+|+.+ |+||||||.|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 789999999 56888888 33445999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+...........+..+.|..|.|||++. ...|+.+.||||.||||.||++|++.|...+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 9875442334456678899999999875 4679999999999999999999999997654
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.58 Aligned_cols=195 Identities=26% Similarity=0.330 Sum_probs=165.8
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||+++.. +|+.+|+|++.... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999874 58899999986532 223345555554 46778999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 99988873 3456899999999999999999999998 999999999999999999999999998753221 122
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=296.24 Aligned_cols=201 Identities=25% Similarity=0.360 Sum_probs=168.2
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-----eEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 543 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 543 (682)
+|++.++||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999875 5889999998643 2234467889999999999999999999886432 479
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||++ ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 58888773 3345899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-ccccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDEL-QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 32211 111234578999999999876 678999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=294.55 Aligned_cols=193 Identities=26% Similarity=0.404 Sum_probs=167.7
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4788999999753 223456688999999888 699999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 99988874 3346899999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 2345789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=285.20 Aligned_cols=197 Identities=29% Similarity=0.421 Sum_probs=161.8
Q ss_pred CcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-----eEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKILI 545 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV 545 (682)
.|.-.+++|.|+||.||+|...+ ++.||||+.-.... --.+|+++|+++.|||||+++-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999998854 68999998743322 1146899999999999999999887543 23489
Q ss_pred EEecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC-CCeEEeeecccccc
Q 005705 546 LEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMF 623 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla~~~ 623 (682)
|||||. +|...+... ..+..++...+.-+..||++||+|||+.+ |+||||||+|+|+|.+ +.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 677777532 23456888888889999999999999987 9999999999999976 89999999999988
Q ss_pred CCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...+.. ....-|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.-++
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 654321 233557899999998875 59999999999999999999999997654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=300.98 Aligned_cols=193 Identities=22% Similarity=0.283 Sum_probs=167.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..+|++.+.||+|+||.||++.+. +++.||+|... ...+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 468999999999999999999874 57899999753 24568899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+. ++|..++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 85 678777733 345889999999999999999999998 9999999999999999999999999997543211
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
........||+.|+|||++.+..++.++|||||||++|||++|+.||-
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 122334579999999999999999999999999999999999997763
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=292.50 Aligned_cols=195 Identities=27% Similarity=0.380 Sum_probs=166.7
Q ss_pred cccccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||+|++.+ ++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 7889999987542 23345567778888764 899999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999998843 345889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=286.25 Aligned_cols=195 Identities=29% Similarity=0.431 Sum_probs=169.2
Q ss_pred cccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
||+|+||+||+++.. +++.+|+|.+.... ....+.+..|+.++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 58899999986532 22346678899999999999999999999999999999999999999
Q ss_pred hHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccc
Q 005705 555 NVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633 (682)
Q Consensus 555 ~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 633 (682)
..++... .....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+.... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 8887542 23456899999999999999999999998 9999999999999999999999999998654322 1223
Q ss_pred cccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 634 ~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=294.53 Aligned_cols=202 Identities=28% Similarity=0.416 Sum_probs=181.9
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChh---hHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~ 543 (682)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45679999999999999999998865 999999999765432 4568999999999998 999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC----CCeEEeeecc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKISDFGL 619 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGl 619 (682)
+|||++.||.|.+.+... .+++.++..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999988554 2999999999999999999999998 9999999999999643 4799999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...+.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 998765 3346678999999999999999999999999999999999999999988764
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=294.87 Aligned_cols=195 Identities=27% Similarity=0.331 Sum_probs=165.4
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||+|+.. +++.||+|++.... .....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999885 58899999986532 122344555544 56789999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999988843 446889999999999999999999998 999999999999999999999999998753221 122
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=293.13 Aligned_cols=195 Identities=27% Similarity=0.375 Sum_probs=167.0
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
++||+|+||.||++++. +++.||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999885 57899999997532 23445667788888765 899999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 999988843 345889999999999999999999998 999999999999999999999999998753211 112
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=294.21 Aligned_cols=195 Identities=27% Similarity=0.340 Sum_probs=164.9
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHH-HHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEM-MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
++||+|+||.||+++.. +++.||+|++.+.. .....++..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999885 57899999986532 12234455555 467889999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|...+. +...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 99988873 3346888999999999999999999988 9999999999999999999999999987532211 22
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 334578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=294.02 Aligned_cols=195 Identities=27% Similarity=0.337 Sum_probs=163.9
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHH-HHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEM-MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||++++. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999875 46789999986532 12223444444 456788999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++.. ...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 999998843 345788888999999999999999998 999999999999999999999999999754221 122
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 334579999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=286.10 Aligned_cols=201 Identities=29% Similarity=0.404 Sum_probs=174.0
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
+|++.++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999874 58899999986532 2233567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887542 2346899999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||...+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1223478999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=286.54 Aligned_cols=201 Identities=28% Similarity=0.445 Sum_probs=166.8
Q ss_pred cCcccccccccCCceeEEEEEEc--CCceEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEe-----
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVE----- 538 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l---~HpnIv~l~~~~~~----- 538 (682)
++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999873 46789999886432 22334566777777666 69999999999852
Q ss_pred cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
....++||||++ ++|..++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 5888887542 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||...+
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99875432 22334578999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=315.32 Aligned_cols=205 Identities=25% Similarity=0.344 Sum_probs=174.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.+|++.++||+|+||.||+|++. +++.||||++... .+...++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47899999999999999999875 4889999998653 2234567999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 547 EYMPNKSLNVFLFDST--------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
||+++++|.+++.... ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234567788999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc----------------ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 619 LARMFGGDEL----------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 619 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9987621110 00112347999999999999999999999999999999999999999654
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.90 Aligned_cols=195 Identities=31% Similarity=0.380 Sum_probs=169.6
Q ss_pred cccccCCceeEEEEEE----cCCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 477 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
+.||+|+||.||+++. .+++.+|+|++.... ......+.+|++++.+++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999975 357899999997532 2234567889999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|.+++. +...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999999884 3346899999999999999999999998 9999999999999999999999999998653321 1
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 2334578999999999999899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.18 Aligned_cols=204 Identities=27% Similarity=0.407 Sum_probs=172.8
Q ss_pred hcCcccccccccCCceeEEEEEEc----CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457899999999999999999763 35689999997653 3345679999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++... ...+++.+++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998542 346899999999999999999999998 9999999999999999999999999876542
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.... .......++..|+|||.+.+..++.++|||||||++||+++ |++||...+
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 2111 11112345678999999999999999999999999999875 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=285.90 Aligned_cols=207 Identities=31% Similarity=0.506 Sum_probs=176.7
Q ss_pred hcCcccccccccCCceeEEEEEEcC------CceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.++|.+.+.||+|+||.||+|+..+ ++.||||.++..... ..+.|.+|++++.+++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568889999999999999998643 478999999765443 567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 543 ILILEYMPNKSLNVFLFDST-----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
++||||+++++|.+++.... ....+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999985421 2345889999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999986543322222223345788999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.02 Aligned_cols=204 Identities=31% Similarity=0.491 Sum_probs=171.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCc----eEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
..+|++.+.||+|+||.||+|++. ++. .||||.++... ....+++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356899999999999999999864 333 48999987543 34567899999999999999999999998765 567
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999998543 345889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.............++..|+|||.+.+..++.++||||||+++|||++ |++||+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 54322222222344678999999999999999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.56 Aligned_cols=197 Identities=28% Similarity=0.441 Sum_probs=167.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|+..++||+|+||.||++++. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 356777899999999999999875 58899999986543 3445779999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|... ....+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 153 ~~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999998543 23567788899999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccccccccccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11234578999999998743 23456899999999999999999999743
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.70 Aligned_cols=195 Identities=26% Similarity=0.354 Sum_probs=168.3
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||++++. +++.||||++++. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 4789999999753 233456678899999888 699999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999888743 346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 234578999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.32 Aligned_cols=208 Identities=30% Similarity=0.423 Sum_probs=174.2
Q ss_pred hhhcCcccccccccCCceeEEEEEEcC------CceEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEec
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ 539 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~ 539 (682)
...++|++.++||+|+||.||+|+... +..||||++.... ....+.|.+|++++.++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 346789999999999999999997632 3469999996543 334567999999999996 99999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccc--------------------------------------------------------
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTK-------------------------------------------------------- 563 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 563 (682)
...++||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999998854210
Q ss_pred -------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 564 -------------------------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 564 -------------------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
...+++.+++.++.||++||+|||+.+ |+|+||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 124788889999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
+.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 9999999999999987643222222223456788999999999999999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=279.63 Aligned_cols=200 Identities=28% Similarity=0.463 Sum_probs=180.8
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
+-|.++++||+|+||.|||+.++ .|+.+|||.+.- +...+++..|+.+|.+.+.|++|+++|.+.....+++||||+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34788899999999999999875 489999999864 346789999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
..|+..+++. .+++++.+.++..+++..++||+|||... -||||||+.||||+.+|.+||+|||.|..+.. ..
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TM 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TM 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hH
Confidence 9999999985 35678999999999999999999999986 89999999999999999999999999987643 33
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...+...|||.|||||++..-.|+.++||||||+...||.-|++||+.-.
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 45567899999999999999999999999999999999999999997543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=284.50 Aligned_cols=205 Identities=34% Similarity=0.533 Sum_probs=174.9
Q ss_pred cCcccccccccCCceeEEEEEEcC------CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....+|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998643 2579999986543 344567999999999999999999999999888999
Q ss_pred EEEEecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC
Q 005705 544 LILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 610 (682)
++|||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854321 145889999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999986543332222334466789999999998899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=299.89 Aligned_cols=201 Identities=29% Similarity=0.435 Sum_probs=175.9
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC------eEEE
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKIL 544 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l 544 (682)
+...+.||+|+||.||+|+++ .|+.||||.+.+. .....+...+|+++|++++|||||++++.-.... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445578999999999999964 6999999999764 2345677889999999999999999999865443 5689
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC--CC--CeEEeeeccc
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DM--NPKISDFGLA 620 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~--~~kL~DFGla 620 (682)
||||+.+|+|...|..+++...|++.+.+.++..+..||.|||+++ |+||||||.||++-. +| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888889999999999999999999999988 999999999999943 23 4799999999
Q ss_pred cccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.+.... ......||..|++||+..+ +.|+..+|.|||||++||+.||..||...-
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9886543 5567899999999999985 888999999999999999999999998643
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=283.82 Aligned_cols=207 Identities=31% Similarity=0.504 Sum_probs=177.1
Q ss_pred hcCcccccccccCCceeEEEEEEc------CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467899999999999999999752 24568999998766666778999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeE
Q 005705 544 LILEYMPNKSLNVFLFDST----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 613 (682)
+||||+++++|.+++.... +...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999985322 2235899999999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |++||...+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999986643322222223345778999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=282.54 Aligned_cols=204 Identities=33% Similarity=0.490 Sum_probs=173.5
Q ss_pred cCcccccccccCCceeEEEEEE-----cCCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
++|++.++||+|+||.||+|.. ..+..+|+|.+.... .....+|.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5678889999999999999975 245789999997533 3445789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC
Q 005705 545 ILEYMPNKSLNVFLFDST--------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 610 (682)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ |+|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1235888999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 005705 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 677 (682)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~ 677 (682)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999987643332222333455778999999988889999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=282.97 Aligned_cols=208 Identities=29% Similarity=0.465 Sum_probs=174.1
Q ss_pred hhcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
..++|++.+.||+|+||.||+|.+. .+..||||.+.... .....+|.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 24679999986432 2345678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 542 KILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
.++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854221 234678899999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999986543322222222345778999999999899999999999999999999 788886543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=277.38 Aligned_cols=202 Identities=31% Similarity=0.455 Sum_probs=174.1
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
++|++.+.||+|+||.||+++..++..+|+|.+.... ...++|.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688889999999999999998888899999886432 335678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999988542 235889999999999999999999998 999999999999999999999999999865432221
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 1122345678999999998899999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=294.30 Aligned_cols=197 Identities=22% Similarity=0.320 Sum_probs=171.2
Q ss_pred hcCcccccccccCCceeEEEEEEc---CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..+|++.+.||+|+||.||++... .+..||+|.+... ..+.+|+.++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999753 3568999988643 23568999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
|++. ++|.+++ .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 5777777 23456899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 3333334567999999999999999999999999999999999999999654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=278.42 Aligned_cols=203 Identities=34% Similarity=0.492 Sum_probs=176.0
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46799999999999999999998888899999986533 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998543 2345888999999999999999999987 999999999999999999999999999876432211
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 1122345678999999988889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=276.91 Aligned_cols=205 Identities=33% Similarity=0.471 Sum_probs=176.0
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346789999999999999999998778899999987543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.... ...+++.++..++.|++.|+.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999985432 346899999999999999999999998 99999999999999999999999999987653221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
........+..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 159 -EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred -cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 11112233468999999999999999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.41 Aligned_cols=201 Identities=31% Similarity=0.442 Sum_probs=175.8
Q ss_pred ccccccccCCceeEEEEEE-cCCc----eEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 474 SMQCKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~-~~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
...++||+|+||+||||.+ ++|+ +||+|++... ..+..+++.+|+.+|.++.||||++++++|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457999999999999976 3443 7899998654 4456789999999999999999999999998765 889999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
||+.|.|.++++.+ +..+..+..+.+..|||+||.|||++. ++||||.++|||+.+-.++||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999653 345888999999999999999999987 9999999999999999999999999999987766
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGSM 680 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~~ 680 (682)
.........-.+.|||-|.+....|+.++|||||||.+||++| |.+|+.-.+.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 5555555566789999999999999999999999999999999 9999876543
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=281.95 Aligned_cols=206 Identities=31% Similarity=0.491 Sum_probs=176.9
Q ss_pred cCcccccccccCCceeEEEEEEc------CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999753 345689999877666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 545 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985422 1235899999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999986543322222233456789999999999999999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=278.27 Aligned_cols=193 Identities=28% Similarity=0.414 Sum_probs=165.9
Q ss_pred cccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
||+|+||.||+++.. +|+.+|+|.+.... ......+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 58999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccc
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (682)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8887543 2345889999999999999999999998 9999999999999999999999999998764321 1223
Q ss_pred ccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 46889999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=293.71 Aligned_cols=200 Identities=28% Similarity=0.385 Sum_probs=169.2
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-----eEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 543 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 543 (682)
+|++.++||+|+||.||+++.. +++.||||++... .....+++.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999874 6889999998653 2234567899999999999999999999998776 789
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46777663 3456899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 43221 122334678999999998774 57999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=285.04 Aligned_cols=201 Identities=27% Similarity=0.398 Sum_probs=170.2
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|.+.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999875 57789999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 985 77777643 2345889999999999999999999998 9999999999999999999999999997643222
Q ss_pred ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+++.|+|||++.+ ..++.++||||||+++|||++|++||...+
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223467899999998865 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=277.87 Aligned_cols=206 Identities=33% Similarity=0.523 Sum_probs=180.7
Q ss_pred hhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++..+|++.++||+|+||.||+|...+++.+|+|.+.........++.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567999999999999999999998899999999987665567789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++... ....+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999998653 3356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 11 113345678999999998899999999999999999998 899997644
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=298.97 Aligned_cols=200 Identities=22% Similarity=0.385 Sum_probs=163.8
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--------
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-------- 539 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-------- 539 (682)
..++|.+.++||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3568999999999999999999875 57899999885432 2345799999999999999999887432
Q ss_pred CeEEEEEEecCCCChhHHhhh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeee
Q 005705 540 GEKILILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDF 617 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DF 617 (682)
...++||||+++ +|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999986 56665533 234456899999999999999999999998 99999999999999665 6999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||+||||++|++||...+
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998764322 22235789999999988764 68999999999999999999999997543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=277.10 Aligned_cols=205 Identities=33% Similarity=0.491 Sum_probs=174.7
Q ss_pred hcCcccccccccCCceeEEEEEEcC----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|++.+.||+|+||.||+|++.. ...||||.++.. ......+|.+|+.++.+++||||+++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999998743 357999998754 33445679999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
+|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998542 236899999999999999999999987 9999999999999999999999999998875
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 2222112222345678999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=278.88 Aligned_cols=201 Identities=39% Similarity=0.589 Sum_probs=168.5
Q ss_pred ccccccccCCceeEEEEEEc-----CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 474 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+.+++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35679999999999999886 2568999999654 33457899999999999999999999999998888999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++|+|.++|... ....+++.++..|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999654 2356899999999999999999999997 9999999999999999999999999998763322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.............|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2222333456789999999999999999999999999999999 78888653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=289.78 Aligned_cols=199 Identities=29% Similarity=0.340 Sum_probs=168.5
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-----
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----- 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~----- 540 (682)
..++|++.+.||+|+||.||+++.. +++.||||.+... ......++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999874 5889999998643 3344567889999999999999999999986543
Q ss_pred -eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecc
Q 005705 541 -EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (682)
Q Consensus 541 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 619 (682)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 478999999764 544442 23788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9764322 12234578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=277.07 Aligned_cols=193 Identities=28% Similarity=0.416 Sum_probs=170.2
Q ss_pred cCcccccccccCCceeEEEEEE-cCCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.++||+|+||.||+|++ .+++.||+|.+... .....+++.+|+.++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4678889999999999999986 46889999998654 334456799999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997553 3678889999999999999999998 999999999999999999999999999865322
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 22335789999999999999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=278.10 Aligned_cols=206 Identities=30% Similarity=0.493 Sum_probs=175.5
Q ss_pred hcCcccccccccCCceeEEEEEEc------CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++|++.++||+|+||.||+++.. ++..+|+|.+........+.|.+|++++.+++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999642 35689999988776667788999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 544 LILEYMPNKSLNVFLFDSTK------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
++|||+++++|.+++..... ...+++..++.++.||+.|++|||+.+ |+|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999854321 135889999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |++||...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 99999999976543222122222345678999999999999999999999999999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=275.86 Aligned_cols=200 Identities=27% Similarity=0.433 Sum_probs=173.2
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++.+..+...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999987 46789999999765545566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998843 346899999999999999999999987 9999999999999999999999999998763221
Q ss_pred ccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 1123346888999999874 34578899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=287.96 Aligned_cols=205 Identities=31% Similarity=0.474 Sum_probs=171.1
Q ss_pred hcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec-C
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ-G 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~-~ 540 (682)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457999999999999999999642 24689999986532 33456788899999999 899999999988654 5
Q ss_pred eEEEEEEecCCCChhHHhhhccc---------------------------------------------------------
Q 005705 541 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 563 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 563 (682)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998853211
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccccccccccc
Q 005705 564 -KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642 (682)
Q Consensus 564 -~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 642 (682)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999988 9999999999999999999999999998764332222223345677899
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 005705 643 SPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 677 (682)
Q Consensus 643 aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~ 677 (682)
|||++.+..++.++|||||||+||||++ |+.||..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=275.48 Aligned_cols=202 Identities=33% Similarity=0.477 Sum_probs=173.5
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
++|.+.+.||+|+||.||+++..++..+|+|.+.... ...++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688889999999999999988777789999987543 234679999999999999999999999998889999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|.+++... ...+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999998542 236899999999999999999999998 999999999999999999999999998865433211
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 1112345678999999988889999999999999999999 999987543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-33 Score=264.26 Aligned_cols=199 Identities=29% Similarity=0.416 Sum_probs=172.6
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-----Ch---hhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SG---QGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-----~~---~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~ 538 (682)
..++|.-.+.||+|..++|.++.++ +|++.|+|++... .+ .-.++-..|+.+|+++ -||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 4567888889999999999988764 5889999988432 11 2244567899999999 59999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
+.-.++|+|.|+.|.|.++| ...-.+++++..+|++|+.+|++|||..+ ||||||||+|||++++.++||.|||
T Consensus 95 ~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 99999999999999999999 45567999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccC------CCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
+|..+...+ .....+|||+|+|||.+.- ..|+...|+||+|||||-||.|.+||=
T Consensus 169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 999875433 4566899999999998853 347788999999999999999999983
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=277.81 Aligned_cols=199 Identities=30% Similarity=0.405 Sum_probs=172.0
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
|++.+.||+|+||.||++... +++.+|||.+.... ......+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999875 58899999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|..++... ....+++.++..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999888542 2345899999999999999999999987 9999999999999999999999999987653221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 122347899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=280.28 Aligned_cols=201 Identities=25% Similarity=0.374 Sum_probs=177.2
Q ss_pred cCcccccccccCCceeEEEEEE-cCCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.-|.+.+.||+|.|..|-++++ .+|..||||++.+.. ......+.+|+.-|+.++|||||+++++...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3478889999999999999976 589999999997653 3345578899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-CCCCeEEeeeccccccCCC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~~~ 626 (682)
.-.+|+|.+||-.+.. .+++....+++.||+.|+.|+|+.. +|||||||+||.+- +-|-+||.|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999976554 4899999999999999999999998 99999999999874 5688999999999877543
Q ss_pred ccccccccccccccccCcccccCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.+....+|+..|.|||++.+..|+ ++.||||||||||.|++|++||..-+
T Consensus 173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 345667999999999999999996 56899999999999999999997644
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=279.84 Aligned_cols=201 Identities=26% Similarity=0.431 Sum_probs=176.8
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..+|++.+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|+.+++.+.||||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999864 5889999998766555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 999999998832 35789999999999999999999998 9999999999999999999999999987653322
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+++.|+|||.+.+..++.++|||||||++|||++|++||...+
T Consensus 171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223468899999999998889999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=277.68 Aligned_cols=208 Identities=32% Similarity=0.495 Sum_probs=173.7
Q ss_pred hhcCcccccccccCCceeEEEEEEcC------CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
..++|.+.+.||+|++|.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35679999999999999999998753 5678999886443 3345679999999999999999999999999889
Q ss_pred EEEEEEecCCCChhHHhhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC---CeEE
Q 005705 542 KILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKI 614 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL 614 (682)
.++||||+++++|.+++..... ...+++.++++++.||+.||+|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999854321 235899999999999999999999998 99999999999998754 5999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999987643322222222334568999999999999999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=273.46 Aligned_cols=202 Identities=31% Similarity=0.454 Sum_probs=173.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
++|.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999874 58899999886432 1234578999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 345889999999999999999999998 9999999999999999999999999997654
Q ss_pred CCcccc-ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 321111 112346788999999999999999999999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=277.22 Aligned_cols=199 Identities=28% Similarity=0.388 Sum_probs=172.3
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|+.++.+++|+||+++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999874 58899999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999887542 2346899999999999999999999998 9999999999999999999999999987653221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 123347899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=279.10 Aligned_cols=205 Identities=34% Similarity=0.492 Sum_probs=172.9
Q ss_pred cCcccccccccCCceeEEEEEEcC------CceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.+|.+.++||+|+||.||+|...+ ++.||||+++.... ...+.|.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 457788999999999999998643 46899999975433 33567899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC
Q 005705 544 LILEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 610 (682)
+++||+++++|..++... .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998421 11235888999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999887643322222233456789999999988889999999999999999998 88888653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=280.80 Aligned_cols=199 Identities=26% Similarity=0.354 Sum_probs=173.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.+.||+|+||.||++++. ++..+|+|.+... ......++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999875 4778999988654 334456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.. ...+++..+..++.|+++||+|||+.. +++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999999843 356889999999999999999999742 3999999999999999999999999998765321
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 123357889999999998888999999999999999999999998644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=279.67 Aligned_cols=207 Identities=28% Similarity=0.461 Sum_probs=173.0
Q ss_pred hhcCcccccccccCCceeEEEEEEcC------CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
..++|++.++||+|+||.||+|...+ +..||+|.+.... .....++.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999997542 4579999886443 2334568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 542 KILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
.++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999854221 234677888999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999986543322222222345678999999999999999999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=275.37 Aligned_cols=203 Identities=30% Similarity=0.478 Sum_probs=169.7
Q ss_pred cccccccccCCceeEEEEEEcC----CceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe-----
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 541 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 541 (682)
|.+.+.||+|+||.||+|.+.. +..||||+++.. ......++.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998743 367999998753 23445789999999999999999999998876554
Q ss_pred -EEEEEEecCCCChhHHhhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeee
Q 005705 542 -KILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (682)
Q Consensus 542 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 617 (682)
.++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 2346899999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99987644332222222345678999999988999999999999999999999 88988654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=271.47 Aligned_cols=202 Identities=30% Similarity=0.455 Sum_probs=176.8
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.+.||+|++|.||++... +++.|++|.+... .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 5889999988643 344567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998643 2456899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+++.|+|||++.+..++.++|+||||+++|||++|+.||...+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1233467889999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=289.92 Aligned_cols=193 Identities=27% Similarity=0.366 Sum_probs=162.2
Q ss_pred cccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
||+|+||.||+|+.. +++.||||++.... ......+..|..++.+. +||||++++..+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 58899999986532 12234455666777665 699999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99988874 3456899999999999999999999998 9999999999999999999999999987542221 22
Q ss_pred cccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 3345799999999998764 48999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=276.95 Aligned_cols=202 Identities=30% Similarity=0.437 Sum_probs=169.4
Q ss_pred cCcccccccccCCceeEEEEEEc-CCc----eEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
++|++.+.||+|+||.||+|+.. +++ .+++|.+.... .....++..|+.+++++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999874 344 47888875443 234567888999999999999999999875 446788
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
++||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 346899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 3322222334467789999999998899999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=273.67 Aligned_cols=202 Identities=33% Similarity=0.464 Sum_probs=172.4
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
.+|++.+.||+|+||.||+++..++..+|+|.+.... ....+|.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4578889999999999999998777789999986432 234578899999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998543 236899999999999999999999998 9999999999999999999999999998654322111
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 111233457999999999999999999999999999999 899997543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=295.58 Aligned_cols=194 Identities=24% Similarity=0.316 Sum_probs=166.9
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..+|.+.+.||+|+||.||++.+.. ++.||||... ...+.+|+.+|++++||||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999998854 7889999642 23467899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+. ++|..++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 678777743 2346899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf 675 (682)
........||+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223457999999999999999999999999999999999987654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=277.62 Aligned_cols=207 Identities=27% Similarity=0.414 Sum_probs=176.2
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-cCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 541 (682)
..++|++.+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46789999999999999999998765 678999998754 33456778999999999999999999998876 467
Q ss_pred EEEEEEecCCCChhHHhhhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEee
Q 005705 542 KILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 616 (682)
.++++||+++++|..++...... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998553322 56899999999999999999999987 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
||+++.+...+.........++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 999987644332222223345678999999999999999999999999999999 99999754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=271.71 Aligned_cols=197 Identities=30% Similarity=0.449 Sum_probs=166.8
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
+.||+|+||.||+|++. +++.+|+|.+... .......|.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 6889999988654 334567799999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccc
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (682)
.+++.. ....+++.+++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999843 2345889999999999999999999998 99999999999999999999999999876532211111111
Q ss_pred ccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 123457999999999899999999999999999998 99998644
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=277.19 Aligned_cols=207 Identities=29% Similarity=0.457 Sum_probs=176.3
Q ss_pred hcCcccccccccCCceeEEEEEEcC------CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678999999999999999998643 3689999986543 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEe
Q 005705 543 ILILEYMPNKSLNVFLFDST-------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 615 (682)
++||||+++++|..++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999985422 1234788999999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999987644332222333456789999999988889999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=281.91 Aligned_cols=207 Identities=30% Similarity=0.488 Sum_probs=173.6
Q ss_pred hcCcccccccccCCceeEEEEEEcC--------CceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~ 539 (682)
.++|.+.+.||+|+||.||+++... ...+|+|.++.. ......++.+|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999997532 346999999754 234566788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
+..++||||+++++|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999864321 235889999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||...+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999976543221122222234578999999999999999999999999999998 889986544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=275.16 Aligned_cols=200 Identities=26% Similarity=0.448 Sum_probs=174.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|.+.++||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 457899999999999999999874 5889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.. ...+++.+++.++.|++.|++|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999998843 346899999999999999999999998 9999999999999999999999999987654221
Q ss_pred ccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 2223457899999999874 45688999999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=277.20 Aligned_cols=202 Identities=29% Similarity=0.486 Sum_probs=175.5
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.+.|++.++||+|+||.||+|++.. ++.+|+|.+........+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3678999999999999999998854 889999999877777788899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|..++... ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 9999998887432 345899999999999999999999987 999999999999999999999999998754221
Q ss_pred ccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
........++..|+|||.+. ...++.++|||||||++|||++|++||...
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 11223356788999999884 345788999999999999999999999654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=281.77 Aligned_cols=198 Identities=26% Similarity=0.422 Sum_probs=160.9
Q ss_pred ccccccCCceeEEEEEEc---CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--cCeEEEEEEecC
Q 005705 476 QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILILEYMP 550 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ 550 (682)
.++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 45789999986542 23457889999999999999999998864 346789999986
Q ss_pred CCChhHHhhhcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE----cCCCCeEEeeeccc
Q 005705 551 NKSLNVFLFDST------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLA 620 (682)
Q Consensus 551 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DFGla 620 (682)
+ +|..++.... +...+++..+..++.||+.||+|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7777664211 2235889999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCCcc-ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.+..... ........+|+.|+|||++.+ ..++.++||||+||++|||++|++||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643221 112334578999999999877 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=278.76 Aligned_cols=201 Identities=26% Similarity=0.416 Sum_probs=177.4
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46899999999999999999987 46899999999765555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++. ...+++.++..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999883 245789999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223467889999999999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=273.39 Aligned_cols=203 Identities=26% Similarity=0.443 Sum_probs=175.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.++||+|+||.||+|+.. +++.||||.++.. .......+.+|+.++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999875 6889999987542 2344567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 547 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
||+++++|..++.... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875322 3345889999999999999999999998 99999999999999999999999999887643
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||..+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 221 122346788999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=278.07 Aligned_cols=205 Identities=31% Similarity=0.491 Sum_probs=171.9
Q ss_pred CcccccccccCCceeEEEEEEcC------CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
+|++.+.||+|+||.||+|.... ...+|+|.+.... ....+++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999997632 3578999886543 3345779999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCC
Q 005705 545 ILEYMPNKSLNVFLFDST---------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 603 (682)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235889999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999986533222112223345678999999988899999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=273.72 Aligned_cols=202 Identities=31% Similarity=0.519 Sum_probs=167.0
Q ss_pred cccccccccCCceeEEEEEEcCCc---eEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec------Ce
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLNGQ---EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GE 541 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~g~---~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 541 (682)
|.+.++||+|+||.||+|+..+.. .+|+|.++.. .....+.+.+|+.++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999875432 5899988653 344567899999999999999999999987532 24
Q ss_pred EEEEEEecCCCChhHHhhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 542 KILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
.+++|||+++++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 2345899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 677 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~ 677 (682)
+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9987643322111222345778999999999999999999999999999999 8899864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=276.96 Aligned_cols=203 Identities=27% Similarity=0.434 Sum_probs=176.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|++.+.||+|+||.||+++.. ++..+|+|.+........+.|.+|+.++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 567999999999999999999875 5789999999776666778899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|..++... ...+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999988542 346899999999999999999999998 9999999999999999999999999987653221
Q ss_pred ccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+++.|+|||.+. ...++.++||||||+++|||++|+.||...+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 1223356889999999875 3457889999999999999999999997543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=275.02 Aligned_cols=200 Identities=28% Similarity=0.453 Sum_probs=173.5
Q ss_pred CcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
.|++.+.||+|+||.||+++... +..+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 46788999999999999998854 77889999977666677889999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|..++.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999888743 2346899999999999999999999998 9999999999999999999999999987653221 1
Q ss_pred ccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......++..|+|||++. +..++.++|||||||++|||++|++||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 223356889999999874 445788999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=274.79 Aligned_cols=199 Identities=27% Similarity=0.373 Sum_probs=162.3
Q ss_pred cccccCCceeEEEEEEcC---CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 477 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
+.||+|+||.||+|+..+ ...+|+|.+.... ......|.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997644 3468888876442 334567899999999999999999999999999999999999999
Q ss_pred ChhHHhhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 553 SLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 553 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+|.+++..... ....++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865332 233567888999999999999999998 9999999999999999999999999987543222111
Q ss_pred ccccccccccccCccccc-------CCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYAL-------DGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~-------~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
......++..|+|||++. ...++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 122334567899999864 3456889999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=273.96 Aligned_cols=200 Identities=29% Similarity=0.377 Sum_probs=164.5
Q ss_pred cccccCCceeEEEEEEcC---CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 477 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
+.||+|+||.||+|+..+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 4579999886543 234457899999999999999999999999988999999999999
Q ss_pred ChhHHhhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 553 SLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 553 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+|.+++..... ....++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864322 234677788899999999999999998 9999999999999999999999999997643332222
Q ss_pred ccccccccccccCcccccCC-------CCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDG-------LFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 22334577899999988642 35789999999999999996 999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=279.81 Aligned_cols=209 Identities=30% Similarity=0.488 Sum_probs=176.5
Q ss_pred hhhcCcccccccccCCceeEEEEEEcC------CceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~ 539 (682)
...++|++.+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.++.++ +||||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345678999999999999999998642 357999998753 334456789999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 540 GEKILILEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
+..+++|||+++++|..++... .....+++..++.++.|++.||+|||+.+ |+|+||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998532 22356899999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||...+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 9999999999999987654332222222345678999999998999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=273.95 Aligned_cols=198 Identities=34% Similarity=0.542 Sum_probs=173.4
Q ss_pred cccccccccCCceeEEEEEEcC-CceEEEEEecccChhhH--HHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~--~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
|++.+.||+|+||+||+++... ++.+|+|.+........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999865 56899999977654332 23456999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++. ....+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999985 4456899999999999999999999998 99999999999999999999999999976411 12
Q ss_pred cccccccccccccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......++..|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2344567899999999998 888999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=275.84 Aligned_cols=203 Identities=31% Similarity=0.461 Sum_probs=170.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCc----eEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++|++.++||+|+||.||+|++. +++ .||+|.++.. .....+++.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 467888999999999999999853 444 4899998654 334567789999999999999999999998754 577
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+++||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998542 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 43222111222344678999999999999999999999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=273.45 Aligned_cols=204 Identities=31% Similarity=0.481 Sum_probs=174.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..+|++.++||+|+||.||+|... .++.||+|.+... ....+++.+|+.++.+++||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345888899999999999999875 4789999998754 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998542 2346899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
. ......++..|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1 1112234668999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=272.50 Aligned_cols=202 Identities=30% Similarity=0.430 Sum_probs=171.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 542 (682)
++|++.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999875 4889999987532 123456789999999999999999999988764 467
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
+++|||+++++|.+++.. ...+++..+++++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998843 235788999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 542211 11223346888999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=272.33 Aligned_cols=202 Identities=33% Similarity=0.514 Sum_probs=171.8
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.++|++.++||+|+||.||+|++.++..||+|.++... ...++|.+|+.++.+++||||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 45699999999999999999988777789999997533 23467899999999999999999999874 45678999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++... ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998543 2345789999999999999999999988 999999999999999999999999999866433211
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 1122345678999999988899999999999999999999 88888654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=277.71 Aligned_cols=203 Identities=31% Similarity=0.478 Sum_probs=169.7
Q ss_pred cCcccccccccCCceeEEEEEEcC-C--ceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN-G--QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~-g--~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 545 (682)
++|++.+.||+|+||.||+|+..+ + ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998754 3 25788888753 334567799999999999 799999999999999999999
Q ss_pred EEecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCe
Q 005705 546 LEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 612 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 612 (682)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1135889999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 613 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 613 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |+.||...+
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999998643211 11111233567999999998899999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=276.45 Aligned_cols=198 Identities=30% Similarity=0.426 Sum_probs=175.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999875 58899999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 356899999999999999999999988 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||...+
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 233468899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=279.11 Aligned_cols=207 Identities=30% Similarity=0.457 Sum_probs=172.1
Q ss_pred hcCcccccccccCCceeEEEEEEcC---------------CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLL 533 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~---------------g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~ 533 (682)
.++|++.+.||+|+||.||+++..+ ...||+|.++.. .......|.+|++++.+++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578999999999999999987632 125899998754 334456799999999999999999999
Q ss_pred EEEEecCeEEEEEEecCCCChhHHhhhccc---------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCE
Q 005705 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTK---------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (682)
Q Consensus 534 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 604 (682)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999854221 124788999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCC
Q 005705 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGLGS 679 (682)
Q Consensus 605 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~pf~~~~ 679 (682)
+++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ +..||...+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999976543222222223345678999999998899999999999999999998 667776543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=277.47 Aligned_cols=201 Identities=26% Similarity=0.433 Sum_probs=177.3
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++......++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35799999999999999999986 46889999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|..++. ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999883 235899999999999999999999998 99999999999999999999999999886543221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223467889999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=287.88 Aligned_cols=208 Identities=29% Similarity=0.438 Sum_probs=173.4
Q ss_pred hhhcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEec
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ 539 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~ 539 (682)
...++|.+.++||+|+||.||+|++. .+..||||+++... ....+.+++|+.+|.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34567888999999999999999863 24689999997542 333457899999999997 99999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc---------------------------------------------------------
Q 005705 540 GEKILILEYMPNKSLNVFLFDST--------------------------------------------------------- 562 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 562 (682)
+..++||||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999985421
Q ss_pred --------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCE
Q 005705 563 --------------------------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (682)
Q Consensus 563 --------------------------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 604 (682)
....+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 1124678888999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 605 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
|+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999986532221111222356789999999998889999999999999999998 89998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=268.72 Aligned_cols=205 Identities=28% Similarity=0.358 Sum_probs=180.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
-++|..+++||+|.||.|-+++-+ .++.+|+|++++... +....-..|-++|...+||.+..+--.++..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 468899999999999999999764 588999999987533 2334456788999999999999998889999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||..||.|.-+| .+.+.+++...+.+-..|+.||.|||+++ ||.||||.+|.|||++|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 9999999998877 45667899988999999999999999998 9999999999999999999999999998632
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSMER 682 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~e~ 682 (682)
.....+..++|||.|+|||++....|..+.|.|.+||++|||++|+.||-..+.|+
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k 375 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK 375 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH
Confidence 23455678999999999999999999999999999999999999999998776653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=286.85 Aligned_cols=198 Identities=29% Similarity=0.345 Sum_probs=168.3
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec------
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 539 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------ 539 (682)
..++|.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999874 5889999998653 233456788999999999999999999988643
Q ss_pred CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecc
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 619 (682)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 246899999976 5555542 24788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865332 1223457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=279.26 Aligned_cols=208 Identities=30% Similarity=0.496 Sum_probs=175.1
Q ss_pred hhcCcccccccccCCceeEEEEEEc--------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~ 538 (682)
..++|.+.+.||+|+||.||+++.. ++..||+|.+... .....+++.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4567889999999999999999742 2457999998653 234567899999999999 89999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEE
Q 005705 539 QGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIL 605 (682)
....++||||+++++|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999986432 1235788999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999987644332222333455678999999998899999999999999999998 788886443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=287.10 Aligned_cols=198 Identities=28% Similarity=0.339 Sum_probs=168.4
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec------
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 539 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------ 539 (682)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999874 5789999998653 233456788999999999999999999987543
Q ss_pred CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecc
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 619 (682)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 5666552 23788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 98653321 223457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=274.29 Aligned_cols=201 Identities=32% Similarity=0.455 Sum_probs=170.9
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.+.||+|++|.||+|+.. +++.||||.++... ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 58899999986432 23356788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
++ ++|.+++........+++.++..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 588888755444467899999999999999999999998 9999999999999999999999999997653221
Q ss_pred ccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......+++.|+|||.+.+. .++.++||||||+++|||++|++||...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 112233568899999988654 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=261.04 Aligned_cols=212 Identities=24% Similarity=0.259 Sum_probs=177.8
Q ss_pred HHhhhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC----
Q 005705 466 ITAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG---- 540 (682)
Q Consensus 466 ~~~~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~---- 540 (682)
+....++|.+.+.||+|||+-||+++. .+++.+|+|++.-...+..+..++|+..-++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 345678999999999999999999985 568899999987666677888999999999999999999998875433
Q ss_pred -eEEEEEEecCCCChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 541 -EKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 541 -~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
+.|++++|...|+|.+.+..... +..+++.+++.|+.+|++||++||+..+ +++||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEecc
Confidence 58999999999999998865444 4479999999999999999999999864 69999999999999999999999999
Q ss_pred cccccCCCccc-------cccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 619 LARMFGGDELQ-------GNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 619 la~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.+....-.-.. ..-....-|..|.|||.+. +..+++|+|||||||+||+|+.|..||+..
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 98765211000 0011235588999999885 456789999999999999999999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=271.23 Aligned_cols=201 Identities=28% Similarity=0.446 Sum_probs=173.3
Q ss_pred CcccccccccCCceeEEEEEEcCCceEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~------~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
+|.+.+.||+|+||.||+|...+++.+|||.+.... ....+.+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988889999999886432 22345689999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 245789999999999999999999988 99999999999999999999999999876532
Q ss_pred Cc----cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 626 DE----LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 626 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.. .........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence 11 111223356889999999999988999999999999999999999999653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=275.51 Aligned_cols=199 Identities=29% Similarity=0.443 Sum_probs=164.5
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEec-----C
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQ-----G 540 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l---~HpnIv~l~~~~~~~-----~ 540 (682)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999875 58899999886532 22234456677777665 699999999988642 3
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..+++|||+++ +|..++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 787777432 2345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+...... ......++..|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 8764321 223356789999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.73 Aligned_cols=198 Identities=30% Similarity=0.398 Sum_probs=168.3
Q ss_pred hhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-----
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ----- 539 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~----- 539 (682)
...++|.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999874 57899999986532 23446678999999999999999999987543
Q ss_pred -CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 540 -GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 540 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
...++++|++ +++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3568999987 778887763 345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99865322 233578999999999877 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=275.67 Aligned_cols=206 Identities=31% Similarity=0.465 Sum_probs=174.6
Q ss_pred hcCcccccccccCCceeEEEEEEcC-----------------CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeee
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 531 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-----------------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~ 531 (682)
.++|++.++||+|+||.||++++.+ +..||+|.+.... ....+++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999997643 2458999987543 345678999999999999999999
Q ss_pred EEEEEEecCeEEEEEEecCCCChhHHhhhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCC
Q 005705 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDST--------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (682)
Q Consensus 532 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 603 (682)
+++++..++..+++|||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1236899999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCC
Q 005705 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGLG 678 (682)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~pf~~~ 678 (682)
|+++.++.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ +..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999986543332222333456788999999988889999999999999999998 77777643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=269.42 Aligned_cols=203 Identities=28% Similarity=0.456 Sum_probs=176.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999886 6899999988642 2334678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 547 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 547 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
||+++++|..++... .....+++.++..++.|+++||+|||+.+ |+|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988543 23456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 221 122346788999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=282.13 Aligned_cols=203 Identities=31% Similarity=0.466 Sum_probs=177.3
Q ss_pred HhhhcCcccccccccCCceeEEEEEEcC---C--ceEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLLN---G--QEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~~---g--~~vAVK~l~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~ 540 (682)
+...+...+.++||+|-||.||+|...+ | -.||||..+. ..++..+.|+.|+.+|+++.||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3345566677899999999999997632 3 3689999987 4566788999999999999999999999999875
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++|||..+.|.|.+||.. ++..++...+..++.||+.||+|||+.. +|||||..+|||+....-+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 68999999999999999954 4456899999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTG 676 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~ 676 (682)
+.+..+.+.... ...-++.|||||.+.-.+++.++|||-|||.+||+++ |.+||-
T Consensus 539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 998766544333 4456889999999999999999999999999999998 999985
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=276.82 Aligned_cols=206 Identities=30% Similarity=0.465 Sum_probs=171.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-----------------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeee
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 531 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-----------------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~ 531 (682)
.++|++.++||+|+||.||+++.. +...+|+|.+... .....++|.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998542 2346899999754 3345678999999999999999999
Q ss_pred EEEEEEecCeEEEEEEecCCCChhHHhhhccc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCC
Q 005705 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (682)
Q Consensus 532 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 603 (682)
+++++...+..++||||+++++|.+++..... ...+++.++..++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999854221 134778899999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCC
Q 005705 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGLG 678 (682)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt--G~~pf~~~ 678 (682)
||++.++.++|+|||+++.+.............++..|+|||...+..++.++|||||||++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999986543222111222344678999999888889999999999999999998 77888643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=275.57 Aligned_cols=201 Identities=25% Similarity=0.424 Sum_probs=172.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.+.||+|+||.||+++.. +++.+|+|.++.. .+.....+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999885 6889999988653 334457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
+++++|..++........+++..+..++.||+.||.|||+. + |+|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999885543344789999999999999999999974 5 999999999999999999999999998765322
Q ss_pred cccccccccccccccCcccccCC------CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 12234678899999988544 3578999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=305.69 Aligned_cols=207 Identities=26% Similarity=0.384 Sum_probs=171.3
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 543 (682)
..++|+++++||+|+||.||++++.. +..+|+|.+... .......|..|+.++.+++||||+++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 45689999999999999999998754 678899988643 334567799999999999999999999988653 4689
Q ss_pred EEEEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCcEeccCCCCCEEEcCC---------
Q 005705 544 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSR----FRIIHRDLKASNILLDKD--------- 609 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~----~~iiH~Dlkp~NILl~~~--------- 609 (682)
+||||+++++|..+|.... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999985422 23569999999999999999999998541 249999999999999642
Q ss_pred --------CCeEEeeeccccccCCCccccccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 610 --------MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 610 --------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998764322 2234578999999999864 45889999999999999999999999654
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=269.81 Aligned_cols=202 Identities=35% Similarity=0.521 Sum_probs=172.2
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.++|++.++||+|+||.||++...++..+|+|.++.... ..+.|.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457889999999999999999988888999999875432 3467999999999999999999999875 45688999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++... ....+++.++..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998542 2345899999999999999999999998 999999999999999999999999999876432211
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 1122345678999999988889999999999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=278.51 Aligned_cols=206 Identities=33% Similarity=0.500 Sum_probs=172.9
Q ss_pred hcCcccccccccCCceeEEEEEEc--------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~ 539 (682)
.++|.+.++||+|+||.||+++.. ....+|+|.++.. ......++.+|+.++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 467889999999999999999752 2457899998754 334567789999999999 699999999999998
Q ss_pred CeEEEEEEecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 540 GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
+..+++|||+++++|..++.... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 89999999999999999985432 1245889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999987643222222222234568999999999999999999999999999999 88888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=265.11 Aligned_cols=195 Identities=27% Similarity=0.375 Sum_probs=168.9
Q ss_pred cccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 477 CKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
+.||+|+++.|--+.. .+|.++|||++.+.....+.+..+|++++.+.+ |+||++++++|+++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 5899999999998864 679999999999988888899999999999996 99999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC---eEEeeeccccccCCC-----
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMFGGD----- 626 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFGla~~~~~~----- 626 (682)
..+|. +...+++.++.++..+|+.||.+||.++ |.||||||+|||..+... +||+||.++.-+...
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 98884 4456899999999999999999999998 999999999999976554 899999987654211
Q ss_pred ccccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.........+|+..|||||+.. ...|+.+.|.||||||||-||+|-+||.-
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 1122334568999999999863 24578999999999999999999999964
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=277.09 Aligned_cols=206 Identities=31% Similarity=0.446 Sum_probs=173.8
Q ss_pred hhcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~ 540 (682)
..++|.+.+.||+|+||.||++... .+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467999999999999999999742 24579999987543 34456799999999999 7999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..+++|||+++++|.+++... ....+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999998542 2234899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
+.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 86543221111222345778999999999999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=278.14 Aligned_cols=197 Identities=27% Similarity=0.430 Sum_probs=160.1
Q ss_pred cccccCCceeEEEEEEcC---CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--cCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~ 551 (682)
++||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998753 5689999986542 23467889999999999999999998854 4577899999875
Q ss_pred CChhHHhhhc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE----cCCCCeEEeeecccc
Q 005705 552 KSLNVFLFDS------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 621 (682)
Q Consensus 552 gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DFGla~ 621 (682)
+|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 12235889999999999999999999998 9999999999999 566789999999998
Q ss_pred ccCCCccc-cccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.+...... .......+|+.|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76433211 12234578999999999876 457999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=276.04 Aligned_cols=201 Identities=29% Similarity=0.410 Sum_probs=177.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.+.|..-++||+|+||.|+-++.. +|+-+|.|.+.+. ..+.....++|..+|.+++.+.||.+--.++..+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456777789999999999999764 5889999988553 223445578899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
+..|.||+|.-+|++... +.++++.++.++.+|+-||++||++. ||.|||||+|||||+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999998876443 67999999999999999999999998 99999999999999999999999999998754
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.+ .....+||.+|||||++.+..|+...|.|||||+||||+.|+.||..
T Consensus 340 g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 340 GK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 33 23344899999999999999999999999999999999999999964
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=271.52 Aligned_cols=203 Identities=30% Similarity=0.492 Sum_probs=171.1
Q ss_pred cCcccccccccCCceeEEEEEEcC-C---ceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~-g---~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..|++.+.||+|+||.||+|++.. + ..||||.+... ......+|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998753 3 36999998754 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998542 346899999999999999999999998 99999999999999999999999999876543
Q ss_pred Ccccccccc-c--cccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 626 DELQGNTKQ-I--VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 626 ~~~~~~~~~-~--~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
......... . ..+..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 221111111 1 12457999999999999999999999999999987 99998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=268.29 Aligned_cols=200 Identities=29% Similarity=0.446 Sum_probs=176.7
Q ss_pred cCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
++|++.+.||+|+||.||+|+..+ ++.+++|.+..... .+++.+|+.++++++||||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578999999999999999998865 78999999875433 678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 99999999843 2356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......++..|+|||.+.+..++.++||||||+++|||++|++||...+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 12233457889999999999999999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=268.89 Aligned_cols=202 Identities=27% Similarity=0.445 Sum_probs=177.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|++.+.||+|+||.||+++.. +++.+|+|.+........+.+.+|+.++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467899999999999999999875 4778999999776656678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ...+++.++..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999987432 246899999999999999999999988 9999999999999999999999999987654321
Q ss_pred ccccccccccccccCcccccCC---CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......++..|+|||.+.+. .++.++||||||+++|||++|++||...
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 112334678899999998777 8899999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=282.45 Aligned_cols=193 Identities=25% Similarity=0.332 Sum_probs=164.3
Q ss_pred hhhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
....+|++.+.||+|+||.||+|+... ++.||+|..... ....|+.++++++||||+++++++.+....++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 345689999999999999999998754 678999985432 2356899999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
|++. ++|..++.. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9985 577777743 3346899999999999999999999998 999999999999999999999999999753221
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf 675 (682)
.......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223457899999999999999999999999999999999855544
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=271.18 Aligned_cols=204 Identities=26% Similarity=0.446 Sum_probs=175.9
Q ss_pred cCcccccccccCCceeEEEEEE-cCCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+++. .+++.+|||.+... .....+++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999986 47889999987643 2334568899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 547 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 547 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
||+++++|.+++... .....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 23456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... ......++..|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 221 1223468889999999999899999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=270.91 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=175.5
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.+.||.|++|.||+|+.. +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999875 58899999986543 34556789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999843 26899999999999999999999988 9999999999999999999999999998765332
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 2233456788999999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=269.19 Aligned_cols=203 Identities=35% Similarity=0.494 Sum_probs=173.8
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..++|++.++||+|+||.||+|...+++.||+|.+.... ...++|.+|+.++++++||||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 356789999999999999999998889999999987543 33568899999999999999999999864 4578999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999988543 2346899999999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
. ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1122345678999999998899999999999999999999 99999644
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=267.93 Aligned_cols=200 Identities=40% Similarity=0.576 Sum_probs=173.7
Q ss_pred cccccCCceeEEEEEEcC----CceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||++.... +..+|+|.++..... ..+++.+|+..+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 778999999765433 367899999999999999999999999999999999999999
Q ss_pred CChhHHhhhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 552 KSLNVFLFDSTK------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 552 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
++|.+++..... ...+++.++..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865321 367999999999999999999999988 99999999999999999999999999987754
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
...........++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 332222334567889999999988899999999999999999999 699997653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=276.92 Aligned_cols=202 Identities=28% Similarity=0.391 Sum_probs=170.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357899999999999999999875 57899999986432 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|++ ++|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 5888877432 345889999999999999999999998 9999999999999999999999999997643221
Q ss_pred cccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+++.|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234568899999988654 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=280.74 Aligned_cols=196 Identities=28% Similarity=0.464 Sum_probs=171.7
Q ss_pred ccccccCCceeEEEEEE-cCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 476 QCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
.++||.|-||+||-|++ ++|+.||||++.+. ......++.+|++||.+++||.||.+-..|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 37899999999999987 46999999999763 3345578999999999999999999999999999999999999776
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC---CeEEeeeccccccCCCccc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~~~~~~~~ 629 (682)
.|.-+|. ..++.+++..-..++.||+.||.|||.++ |+|+||||+||||.+.. .+||+|||.|+.++...+
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 6665553 34456888888889999999999999998 99999999999997543 699999999999865443
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....+|||.|+|||++.++.|+..-|+||.|||+|--|+|.-||..+.
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 345799999999999999999999999999999999999999998764
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=277.52 Aligned_cols=204 Identities=32% Similarity=0.487 Sum_probs=170.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCc--eEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~--~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|++.+.||+|+||.||+|++. ++. .+|+|.++.. .....+++.+|+.++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888999999999999999874 343 4688877653 334567889999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 545 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
||||+++++|..++.... ....+++.+++.++.||+.|++|||+.+ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999985432 1235889999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+||+|||+++..... ........+..|+|||.+.+..++.++|||||||++|||+| |..||...+
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 999999998643211 11112234668999999988889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=268.82 Aligned_cols=204 Identities=36% Similarity=0.530 Sum_probs=176.2
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..++|++.++||+|+||.||++.+.+++.+|||.+.... ...+++.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457899999999999999999998888899999987543 3457899999999999999999999999988899999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ....+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998542 2346899999999999999999999998 99999999999999999999999999987643211
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
. .......+..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1112234568999999998899999999999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=269.53 Aligned_cols=201 Identities=32% Similarity=0.522 Sum_probs=172.1
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccCh---------hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---------~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++.+++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999874 578999998864322 123578899999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.+++|||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 346889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc----cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 622 MFGGDELQ----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 622 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 76422111 1112346788999999999989999999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=271.85 Aligned_cols=200 Identities=29% Similarity=0.392 Sum_probs=171.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999886 58899999886432 2334668899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|++++.|..++. ....+++.+++.++.|++.+|+|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887763 2345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1 1223457889999999876 56789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=271.34 Aligned_cols=202 Identities=29% Similarity=0.483 Sum_probs=171.2
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec------C
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ------G 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~------~ 540 (682)
+...|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888999999999999999875 47889999986543 3456788999999998 699999999998753 3
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..+++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999998542 3346889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8653221 2233457889999999986 34688899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=271.99 Aligned_cols=201 Identities=30% Similarity=0.516 Sum_probs=169.8
Q ss_pred cCcccccccccCCceeEEEEEEc-----CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 543 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 543 (682)
++|++.+.||+|+||.||++... ++..||+|.+........+.|.+|++++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888999999999999999742 4779999999877666778899999999999999999999987543 4678
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 245899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccc-ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 624 GGDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 624 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 4322111 1111233456999999998899999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=293.92 Aligned_cols=202 Identities=24% Similarity=0.324 Sum_probs=165.0
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCC------CCeeeEEEEEE
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH------RNLVRLLGCCV 537 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H------pnIv~l~~~~~ 537 (682)
.+....++|++.++||+|+||.||+|++. .++.||||+++... ....++..|+.++.+++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999875 47789999996532 234456677877777755 45888998887
Q ss_pred ec-CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCC-----
Q 005705 538 EQ-GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDM----- 610 (682)
Q Consensus 538 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~----- 610 (682)
.+ ...++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 65 4678889887 6678777743 34689999999999999999999974 6 99999999999998765
Q ss_pred -----------CeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 611 -----------NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 611 -----------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886432 12334689999999999999999999999999999999999999997543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=269.29 Aligned_cols=205 Identities=30% Similarity=0.446 Sum_probs=172.1
Q ss_pred hhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.+++++.....||+|+||.||+|++. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34555555678999999999999865 47789999987766666778999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeEEeeeccccccCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGG 625 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~ 625 (682)
||+++++|..++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999864322212378888999999999999999988 999999999999986 67999999999876533
Q ss_pred CccccccccccccccccCcccccCCC--CCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.. .......+++.|+|||++.+.. ++.++||||||+++|||++|++||..
T Consensus 162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 22 1122345789999999986543 78899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=266.11 Aligned_cols=202 Identities=25% Similarity=0.412 Sum_probs=176.2
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|+..+.||+|+||.||.++.. +++.+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788999999999999999764 5889999987643 345567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.... ...+++.++..++.|++++|+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999985432 356899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 2234568899999999988889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=304.11 Aligned_cols=209 Identities=26% Similarity=0.326 Sum_probs=182.0
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEcC-CceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~ 538 (682)
...+....++|.++++||+|+||.|..++++. ++.+|+|++.+. ......-|.+|-.+|..-..+=|+.++-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34556667899999999999999999999864 778899999762 23345678999999999899999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
+..+|+|||||+||+|-.++.. ...+++..+..++..|.-||+-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999843 336999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccccc----C-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYAL----D-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.+-.+..+. .......+|||.|++||++. + +.|...+|.||+||++||||.|..||=-+
T Consensus 221 sClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 221 SCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred hHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 998876443 23445679999999999984 3 56899999999999999999999999543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=283.30 Aligned_cols=206 Identities=30% Similarity=0.474 Sum_probs=179.7
Q ss_pred HHhhhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 466 ITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 466 ~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.+....+..+..+||.|-||.||.|.++. .-.||||.++... -..++|+.|+.+|+.++|||+|+|+|+|..+..+|+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 34445667788999999999999998865 5689999997543 457899999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|.|||.+|+|.+||.+- .+..++.-.++.++.||..||+||..++ +|||||..+|+|+.++..+|++|||+++++.
T Consensus 341 iTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999653 3345777888999999999999999998 9999999999999999999999999999987
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 677 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~ 677 (682)
.+.+.. .....-++.|.|||.+.-..++.|+|||+|||+||||.| |..||.-
T Consensus 417 gDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 417 GDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred CCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 765432 222334789999999999999999999999999999999 8888754
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=281.38 Aligned_cols=206 Identities=30% Similarity=0.461 Sum_probs=169.8
Q ss_pred hcCcccccccccCCceeEEEEEE------cCCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec-C
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ-G 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~-~ 540 (682)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999974 346789999997543 33456788999999999 689999999988654 4
Q ss_pred eEEEEEEecCCCChhHHhhhccc---------------------------------------------------------
Q 005705 541 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 563 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 563 (682)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998853210
Q ss_pred -------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccccc
Q 005705 564 -------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636 (682)
Q Consensus 564 -------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 636 (682)
...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788889999999999999999998 9999999999999999999999999998753322111222234
Q ss_pred ccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 637 gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 5678999999999999999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=268.84 Aligned_cols=202 Identities=30% Similarity=0.440 Sum_probs=170.8
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 542 (682)
.+|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999875 58899999885431 23456789999999999999999999988753 567
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++++||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998843 345889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCc-cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDE-LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+.... .........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 53211 111122346788999999999988999999999999999999999999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=271.36 Aligned_cols=204 Identities=31% Similarity=0.481 Sum_probs=171.9
Q ss_pred hcCcccccccccCCceeEEEEEEcC-Cc----eEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~----~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
..+|.+.+.||+|+||.||+|...+ +. .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3568888999999999999998643 33 58999886553 3455789999999999999999999999887 7889
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999998542 335899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.............++..|+|||.+....++.++|+||||+++||+++ |+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 43222111122234568999999988899999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=266.64 Aligned_cols=195 Identities=32% Similarity=0.475 Sum_probs=163.0
Q ss_pred ccccCCceeEEEEEEc---CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCC
Q 005705 478 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 553 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 553 (682)
.||+|+||.||+|.+. ++..||+|.+.... ....++|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 35579999987653 334567999999999999999999999875 457899999999999
Q ss_pred hhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc-cc
Q 005705 554 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NT 632 (682)
Q Consensus 554 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~ 632 (682)
|.+++.. ....+++.++++++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||+++.+....... ..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998853 2346899999999999999999999998 9999999999999999999999999998654322111 11
Q ss_pred ccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
....++..|+|||.+....++.++||||||+++|||++ |++||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 12233578999999988889999999999999999996 99999643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=274.73 Aligned_cols=205 Identities=29% Similarity=0.480 Sum_probs=173.0
Q ss_pred hcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....++|.+|+.+++++.||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999864 36789999987543 34457799999999999999999999999999899
Q ss_pred EEEEEecCCCChhHHhhhcc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCC
Q 005705 543 ILILEYMPNKSLNVFLFDST-------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 603 (682)
+++|||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234788999999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 005705 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 677 (682)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~ 677 (682)
|+++.++.++|+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999876543322222222344678999999998999999999999999999998 8888753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=270.45 Aligned_cols=205 Identities=31% Similarity=0.477 Sum_probs=172.5
Q ss_pred hcCcccccccccCCceeEEEEEEcC----CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..+|++.+.||+|+||.||+|++.. +..+|+|.++... ....+.|.+|+.++.+++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3578889999999999999998642 3379999986532 3446789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999998542 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc-ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 322111 1112233568999999998899999999999999999987 999986543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=267.15 Aligned_cols=202 Identities=25% Similarity=0.397 Sum_probs=175.2
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
+|++.++||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++||||+++++.+..++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999875 5889999988543 3345677889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 999998887432 3445889999999999999999999998 9999999999999999999999999997654321
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+++.|+|||++.+..++.++|+||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 11223568889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=271.92 Aligned_cols=199 Identities=35% Similarity=0.472 Sum_probs=167.1
Q ss_pred cccccccccCCceeEEEEEE-----cCCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEEE
Q 005705 473 FSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 544 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 544 (682)
|++.+.||+|+||.||++.. .+++.||+|.+.... ......|.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999988653 357789999987543 33567789999999999999999999988654 35789
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
+|||+++++|.+++.. ..+++.+++.++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccc-cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 3221111 12234566799999998888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=284.91 Aligned_cols=193 Identities=35% Similarity=0.514 Sum_probs=168.6
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.|+-++.||.|+||.||.+++. +...||||++.- .....++++..|+..|.+++|||++.+-|+|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4666789999999999999874 567899999863 334457889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+-| +-.+++.-. ++++.+.++..|..+.++||+|||+++ .||||||+.||||++.|.|||+|||.|....
T Consensus 107 YClG-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 107 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred HHhc-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 9955 555665332 356889999999999999999999998 9999999999999999999999999997653
Q ss_pred cccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
..+.++|||.|||||++. .+.|+-|+||||||+...||--.++|.-
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 345679999999999985 5779999999999999999999999853
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=268.70 Aligned_cols=191 Identities=24% Similarity=0.369 Sum_probs=161.8
Q ss_pred cccccCCceeEEEEEEcC-------------CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 477 CKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-------------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
+.||+|+||.||+|+..+ ...||+|.+..........|.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2258999987665556678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC-------eEEee
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-------PKISD 616 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kL~D 616 (682)
+||||+++++|+.++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988743 2345899999999999999999999998 999999999999987664 89999
Q ss_pred eccccccCCCccccccccccccccccCccccc-CCCCCccccHHHHHHHHHHHH-cCCCCCCCC
Q 005705 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETL-SSKKNTGLG 678 (682)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~ell-tG~~pf~~~ 678 (682)
||++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+...
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 999875422 12245788999999886 567899999999999999998 588887643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=316.17 Aligned_cols=191 Identities=27% Similarity=0.478 Sum_probs=162.7
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
...+...+.||+|+||.||+|+. .++..||||++...... ..+|++++++++||||+++++++.+++..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577778999999999999987 46889999998654322 23468899999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++|+|.+++. .++|.++.+|+.||++||+|||.....+|+||||||+||+++.++.+++. |+.+.....
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999983 27899999999999999999996644569999999999999999888876 666544321
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.....+++.|+|||++.+..++.|+|||||||++|||+||++||..
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1123678999999999999999999999999999999999999854
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=264.91 Aligned_cols=196 Identities=31% Similarity=0.439 Sum_probs=167.9
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCChh
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 555 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 555 (682)
++||+|+||.||+|...+++.+|+|.+..... .....|.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 37999999999999988889999999876533 33457899999999999999999999999999999999999999999
Q ss_pred HHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccc
Q 005705 556 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635 (682)
Q Consensus 556 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 635 (682)
+++... ...+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988432 345889999999999999999999988 999999999999999999999999998764332211 11122
Q ss_pred cccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 636 ~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.++..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 34568999999998889999999999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.17 Aligned_cols=206 Identities=28% Similarity=0.429 Sum_probs=177.8
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+.+++.++|+||+++++.+..+...++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999864 57889999986532 33567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++........+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433356899999999999999999999988 99999999999999999999999999987654322
Q ss_pred cc--ccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QG--NTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. ......++..|+|||.+... .++.++|+||||+++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 11 22334688999999998776 78999999999999999999999997544
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=266.80 Aligned_cols=194 Identities=33% Similarity=0.474 Sum_probs=163.8
Q ss_pred ccccCCceeEEEEEEc---CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 478 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
+||+|+||.||+|.+. ++..+|+|+++... ....+++.+|+.++++++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999653 47789999986543 345678999999999999999999999875 45678999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc-cc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ-GN 631 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~ 631 (682)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...... ..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 346899999999999999999999998 999999999999999999999999999876433211 11
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122234678999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.16 Aligned_cols=203 Identities=24% Similarity=0.324 Sum_probs=172.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+++.. .++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999875 47899999986543 234567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 346899999999999999999999987 999999999999999999999999998742110
Q ss_pred c-------------cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 E-------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .........++..|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0 0001112457889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=267.00 Aligned_cols=197 Identities=31% Similarity=0.425 Sum_probs=169.1
Q ss_pred cccccCCceeEEEEEEcC--C--ceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~--g--~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
++||+|++|.||+|.+.+ + ..||||.+..... ...++|.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998743 2 3689999987655 567789999999999999999999999988 889999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc-c
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ-G 630 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 630 (682)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865332 46899999999999999999999998 999999999999999999999999999876432211 1
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1123456789999999998999999999999999999999 99998643
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=279.13 Aligned_cols=207 Identities=30% Similarity=0.486 Sum_probs=173.2
Q ss_pred hcCcccccccccCCceeEEEEEEcC--------CceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~ 539 (682)
..+|.+.+.||+|+||.||+++... ...||+|.+... .....+++.+|++++.++ +||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3568999999999999999997521 236899988754 334567899999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 540 GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
+..+++|||+++++|.+++.... ....+++.+++.++.|+++||+|||+.+ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999985422 2235888999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999987643222222222344568999999999999999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=281.50 Aligned_cols=202 Identities=25% Similarity=0.413 Sum_probs=179.3
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
....|.+.+.||+|.|+.|.++++. ++..||||.+++.. ....+.+.+|+++|..++|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567999999999999999999874 58999999997653 33446689999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||..+|.+.+++..+ ..+.+..+..++.|+.+|++|+|+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999543 44666888899999999999999998 99999999999999999999999999998752
Q ss_pred CccccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+..+
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 334556799999999999999887 578999999999999999999999654
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=266.38 Aligned_cols=198 Identities=31% Similarity=0.451 Sum_probs=173.0
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999886 68899999886532 23567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
+||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 345889999999999999999999998 99999999999999999999999999887543
Q ss_pred CccccccccccccccccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.. ......++..|+|||.+.... ++.++|+||||+++|||++|++||...
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 22 223456888999999987776 899999999999999999999999654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.66 Aligned_cols=205 Identities=32% Similarity=0.497 Sum_probs=172.3
Q ss_pred hcCcccccccccCCceeEEEEEEcC-C---ceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g---~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|+..+.||+|+||.||+|++.. + ..+|+|.++.. .....+++.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578888999999999999998753 3 36999998654 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|..++... ...+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998542 346899999999999999999999998 9999999999999999999999999998664
Q ss_pred CCccccc-cccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
....... ......+..|+|||++....++.++||||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 3221111 111223457999999988889999999999999999997 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.21 Aligned_cols=200 Identities=21% Similarity=0.271 Sum_probs=165.8
Q ss_pred cccccccC--CceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 475 MQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 475 i~~~LG~G--~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
++++||+| +|++||+++.. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999874 6889999998654 2334566788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc-
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL- 628 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~- 628 (682)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+++.||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 235889999999999999999999998 99999999999999999999999986544321110
Q ss_pred ----ccccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 ----QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 011122356778999999876 45899999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=275.20 Aligned_cols=200 Identities=26% Similarity=0.409 Sum_probs=173.5
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
+.|.....||+|+||.||++... ++..||||.+........+.+.+|+.++.+++||||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34444568999999999999874 57899999987665566678999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++. ...+++.++..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 9999999873 235889999999999999999999998 9999999999999999999999999987653322
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12233568899999999998899999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=274.45 Aligned_cols=205 Identities=26% Similarity=0.334 Sum_probs=175.5
Q ss_pred cCcccccccccCCceeEEEEEEcC-CceEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|++++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999998864 88999999875432 24567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 3356899999999999999999999998 999999999999999999999999998765321
Q ss_pred cc---------------------------ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 EL---------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. ........|+..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 001123467889999999999899999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=264.56 Aligned_cols=198 Identities=33% Similarity=0.471 Sum_probs=169.2
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCChh
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 555 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 555 (682)
++||+|+||.||++.+.+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred HHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccc
Q 005705 556 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635 (682)
Q Consensus 556 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 635 (682)
+++... ...+++..++.++.|++.+++|||+.+ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998542 235789999999999999999999998 999999999999999999999999999865422211111122
Q ss_pred cccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 636 ~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
..+..|+|||.+.+..++.++|+||||+++|||++ |..||...+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 33567999999988899999999999999999999 899986544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=286.50 Aligned_cols=192 Identities=32% Similarity=0.539 Sum_probs=171.9
Q ss_pred ccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCChhH
Q 005705 478 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 556 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 556 (682)
+||+|.||+||-|++.+ ...+|||.+..+.....+-+.+|+.+-++|+|.|||+++|.+.+++..-+.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999865 55789999988777777889999999999999999999999999999999999999999999
Q ss_pred HhhhccccCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeEEeeeccccccCCCccccccc
Q 005705 557 FLFDSTKKRLL--NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTK 633 (682)
Q Consensus 557 ~l~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~ 633 (682)
+|.. +-+++ ++..+-.+.+||++||.|||+.. |||||||-+|||++. .|.+||.|||-++.+.+ ....+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 9843 34556 78888999999999999999998 999999999999974 68999999999998865 345567
Q ss_pred cccccccccCcccccCC--CCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 634 QIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 634 ~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
.+.||..|||||++..+ .|..++|||||||.+.||-||++||-
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 78999999999999754 48899999999999999999999994
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.07 Aligned_cols=211 Identities=26% Similarity=0.366 Sum_probs=175.1
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE---
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV--- 537 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~--- 537 (682)
+..+....++|++.+.||+|+||.||+++.. +++.+|+|.+.... ....++.+|+.++.++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 4455667889999999999999999999874 47899999886532 2245688899999999 6999999999884
Q ss_pred --ecCeEEEEEEecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 538 --EQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 538 --~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 334689999999999999887532 23356889999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+|||+++....... ......|++.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99999986543221 223346899999999875 3457889999999999999999999987543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.61 Aligned_cols=202 Identities=28% Similarity=0.467 Sum_probs=173.0
Q ss_pred CcccccccccCCceeEEEEEE-cCCceEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~------~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
+|+..+.||+|++|.||+++. .+++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 458899999986432 2245788999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeecccccc
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMF 623 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~ 623 (682)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 346889999999999999999999998 99999999999998776 5999999999876
Q ss_pred CCCccc--cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...... .......++..|+|||.+.+..++.++||||||++++||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 432111 11223467889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=274.47 Aligned_cols=197 Identities=29% Similarity=0.439 Sum_probs=171.3
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334458999999999999874 5889999998665545567789999999999999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++. ...+++.+++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+.... ..
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 173 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK 173 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence 99998873 245889999999999999999999998 9999999999999999999999999987653322 11
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 23356889999999999889999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.16 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=174.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.++||+|+||+||+++.. +++.+|+|++... .....+.+.+|++++..++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357888999999999999999875 5889999987653 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|..++.. .+.+++..+..++.|++.+|.|||+.. +++|+||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999988743 346899999999999999999999742 2999999999999999999999999998754221
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 1223578999999999988899999999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=263.07 Aligned_cols=206 Identities=27% Similarity=0.381 Sum_probs=170.0
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-----CceEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEEEEe-cC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QG 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~~~~~~-~~ 540 (682)
....|+....||+|.||.||||.-.+ ...+|+|.++..... ......+|+.+++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34678999999999999999995432 237899999764221 23456789999999999999999999877 77
Q ss_pred eEEEEEEecCCCChhHHhhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC----CCeEE
Q 005705 541 EKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKI 614 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kL 614 (682)
..+|++||.+. +|.++++- ..+.+.++...+..|+.||+.|+.|||+.- |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999987 67677642 334467999999999999999999999986 9999999999999876 89999
Q ss_pred eeeccccccCCCcc-ccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 615 SDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 615 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+|||+++.+...-. .......+-|..|.|||.+.+. .|+.+.||||+|||+.||||-++.|.-.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999999865321 1133456779999999999875 5899999999999999999999988654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=272.70 Aligned_cols=201 Identities=26% Similarity=0.364 Sum_probs=171.7
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999885 48899999886532 2235678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|..+... ...+++.++..++.||++||+|||+.+ |+|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887632 234899999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......++..|+|||++.+ ..++.++||||||+++|||++|++||...+
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 12233467889999998875 457889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=265.29 Aligned_cols=202 Identities=34% Similarity=0.515 Sum_probs=171.2
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.++|.+.++||+|++|.||++...++..+|+|.+.... ...+.+.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688899999999999999998777789999886543 34567899999999999999999999875 45678999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999998543 2345889999999999999999999988 999999999999999999999999999876432211
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122345678999999998899999999999999999999 89998653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=267.65 Aligned_cols=199 Identities=26% Similarity=0.431 Sum_probs=173.9
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..|+..+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.+++++.||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999875 5789999998654 244567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++. ...+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999883 245889999999999999999999987 99999999999999999999999999977643221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122346788999999999888999999999999999999999999744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=265.34 Aligned_cols=199 Identities=32% Similarity=0.510 Sum_probs=174.0
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.++|++.+.||+|+||.||++.. .++.||+|.+..... ..+++.+|+.++.+++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788899999999999999987 478999999976543 5678999999999999999999999999889999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 9999999985432 236899999999999999999999998 9999999999999999999999999998763221
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.....+..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 12234568999999988889999999999999999997 999987654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=263.57 Aligned_cols=202 Identities=28% Similarity=0.413 Sum_probs=173.1
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-cCeEEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKILILE 547 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 547 (682)
+|++.+.||+|++|.||+++.. +++.+|+|.+... .....+.+.+|+.++++++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999875 4778999998643 23445678999999999999999999988764 446789999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++... ....+++.++..++.|++.|+++||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988542 3346899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+++.|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 12234568899999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=270.97 Aligned_cols=199 Identities=28% Similarity=0.429 Sum_probs=173.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35777889999999999999874 47889999986442 34567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++. ...+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999998873 345889999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 1122346788999999999989999999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=270.42 Aligned_cols=200 Identities=32% Similarity=0.530 Sum_probs=169.4
Q ss_pred cCcccccccccCCceeEEEEEE-----cCCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 542 (682)
+.|++.+.||+|+||.||+++. .++..||+|.++... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 247789999987543 44557899999999999999999999998775 568
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998432 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 005705 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675 (682)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf 675 (682)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 6432211 1122345677899999999888999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=265.33 Aligned_cols=202 Identities=31% Similarity=0.444 Sum_probs=171.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 542 (682)
.+|.+.+.||+|+||.||+|++. +++.||+|.+... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999874 5889999987432 234456889999999999999999999998764 457
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 235789999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... ........++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 532111 11122346889999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=264.92 Aligned_cols=204 Identities=32% Similarity=0.463 Sum_probs=174.2
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..++|.+.++||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++++++|+||+++++++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 356889999999999999999988778889999887543 345788999999999999999999999887 778999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999998543 2345788999999999999999999987 99999999999999999999999999976543221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.......++..|+|||++....++.++|+||||+++||+++ |+.||...+
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 158 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred -ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 11222345678999999998889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=267.99 Aligned_cols=203 Identities=27% Similarity=0.401 Sum_probs=171.1
Q ss_pred hcCcccccccccCCceeEEEEEEcC----CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|.+.++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568888999999999999998643 2468999887654 4556789999999999999999999998875 46789
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998542 235899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 432211 122344568999999988889999999999999999996 999996543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=284.77 Aligned_cols=202 Identities=26% Similarity=0.437 Sum_probs=178.1
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.+.+.|+..||.|+||.||++..++ +-..|.|.+....+...++|+-|+.||+...||+||++++.|..++.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 4567888899999999999998865 445678999888888999999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+.||-.+.++.. -.+.|.+.++.-++.|++.||.|||++. |||||||+.|||++.+|.++|+|||.+..... .
T Consensus 111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 999999998754 3457999999999999999999999998 99999999999999999999999999865422 2
Q ss_pred ccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......+.|||.|||||++. ..+|+.++||||||+.|.||.-+.+|-..-
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 22345679999999999864 578999999999999999999999997543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=270.03 Aligned_cols=202 Identities=29% Similarity=0.351 Sum_probs=168.4
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999874 588999999865432 23346788999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+. ++|..++... ...+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5666665332 245788889999999999999999998 999999999999999999999999998764322
Q ss_pred ccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
. .......+++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 1 112234568899999998764 5788999999999999999999999643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=268.42 Aligned_cols=190 Identities=25% Similarity=0.355 Sum_probs=159.6
Q ss_pred ccccCCceeEEEEEEcC-------------------------CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeE
Q 005705 478 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~~~-------------------------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l 532 (682)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13589999876555556788999999999999999999
Q ss_pred EEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC--
Q 005705 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-- 610 (682)
Q Consensus 533 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-- 610 (682)
++++.++...++||||+++++|..++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998843 2346889999999999999999999987 99999999999997644
Q ss_pred -----CeEEeeeccccccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHH-cCCCCCCCC
Q 005705 611 -----NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETL-SSKKNTGLG 678 (682)
Q Consensus 611 -----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~ell-tG~~pf~~~ 678 (682)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3899999988643211 12356788999998865 56899999999999999995 799998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=264.69 Aligned_cols=198 Identities=32% Similarity=0.496 Sum_probs=169.1
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-ecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~ 548 (682)
.++|.+.+.||+|+||.||++.. .+..+|+|.++... ..+.|.+|+.++++++|+|++++++++. +++..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35788899999999999999976 47889999986532 3567899999999999999999999765 44578999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999998543 2345889999999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 12244568999999998899999999999999999997 999987543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=265.74 Aligned_cols=196 Identities=33% Similarity=0.495 Sum_probs=163.8
Q ss_pred cccccCCceeEEEEEEcC-Cc--eEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||+|++.+ +. .+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998754 33 5788988753 344567889999999999 799999999999999999999999999
Q ss_pred CChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 552 KSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 552 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
++|.+++.... ....+++.++..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985422 1235789999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
++..... .........+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9864221 111111233567999999988899999999999999999997 99999644
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=264.77 Aligned_cols=202 Identities=30% Similarity=0.495 Sum_probs=172.9
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
.+|++.+.||+|+||.||++...+++.+|+|.+.... ....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4678889999999999999988778899999986543 234678999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|.+++... ...++++.+..++.|++.+++|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999988432 245789999999999999999999998 9999999999999999999999999987653322111
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 112234678999999998889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=267.96 Aligned_cols=200 Identities=29% Similarity=0.428 Sum_probs=172.6
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999874 58899999987543 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+ +++|.+++.... ..+++.+++.++.||+++|+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999885432 56899999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......++..|+|||.+.+. .++.++||||+|++++||++|++||...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 122345788999999988654 4689999999999999999998888643
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=267.63 Aligned_cols=203 Identities=32% Similarity=0.442 Sum_probs=173.3
Q ss_pred cCcccccccccCCceeEEEEEEc------CCceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
++|++.+.||+|+||.||+|+.. +.+.+++|.+...... ..+++.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67889999999999999999864 2457999998765443 5678999999999999999999999999988999
Q ss_pred EEEEecCCCChhHHhhhcccc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeee
Q 005705 544 LILEYMPNKSLNVFLFDSTKK------RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 617 (682)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998543321 25899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 005705 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 677 (682)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~ 677 (682)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99875432221 12233456778999999988888999999999999999999 8888854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=266.35 Aligned_cols=200 Identities=29% Similarity=0.424 Sum_probs=170.0
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC----------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----------~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~ 540 (682)
+|.+.+.||+|+||.||+|... +++.+|+|.++... ....+.+.+|+.++.+++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4777889999999999999764 58899999875321 112356889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998433 46899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCC--CCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
+...............++..|+|||.+.... ++.++|+||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 8654322122233456788999999987654 78999999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.89 Aligned_cols=199 Identities=37% Similarity=0.543 Sum_probs=167.6
Q ss_pred cccccCCceeEEEEEEcC-------CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 477 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+.||+|+||.||+|+..+ +..+|+|.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2578999886543 34567899999999999999999999999998999999999
Q ss_pred cCCCChhHHhhhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-----CeEEeeecc
Q 005705 549 MPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-----NPKISDFGL 619 (682)
Q Consensus 549 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kL~DFGl 619 (682)
+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2234788999999999999999999987 99999999999999877 899999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 986643322222223345788999999999999999999999999999998 99998643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=267.81 Aligned_cols=200 Identities=29% Similarity=0.378 Sum_probs=176.4
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999885 48899999986532 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|..++.. ...+++.++..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999843 247899999999999999999999998 9999999999999999999999999988764322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 22335678899999999988899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=273.41 Aligned_cols=204 Identities=26% Similarity=0.393 Sum_probs=169.4
Q ss_pred CcccccccccCCceeEEEEEEcC---CceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 543 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 543 (682)
+|.+.++||+|+||.||+|+... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998754 7899999997633 34456788999999999999999999999988 7899
Q ss_pred EEEEecCCCChhHHhhhcc-c-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC----CCCeEEeee
Q 005705 544 LILEYMPNKSLNVFLFDST-K-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK----DMNPKISDF 617 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kL~DF 617 (682)
+||||+++ +|..++.... . ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 5555553222 2 236899999999999999999999998 999999999999999 899999999
Q ss_pred ccccccCCCcc-ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 618 GLARMFGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 618 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|++..+..... ........++..|+|||.+.+ ..++.++||||||++++||++|++||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987643221 112234567889999998766 457899999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=265.99 Aligned_cols=199 Identities=23% Similarity=0.353 Sum_probs=160.3
Q ss_pred cccccCCceeEEEEEEcCCc---eEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 477 CKLGEGGFGPVYKGRLLNGQ---EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~---~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
++||+|+||.||+++..++. .+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999765433 45677765432 344678999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 553 SLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 553 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
+|.+++..... ...+++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999864322 234677788899999999999999987 99999999999999999999999999864322221122
Q ss_pred cccccccccccCcccccC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 234567889999998743 345789999999999999997 57787543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=272.22 Aligned_cols=203 Identities=33% Similarity=0.515 Sum_probs=168.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCc----eEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++|++.+.||+|+||.||+|.+. ++. .+|+|.+.... .....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999864 343 57899886543 23345789999999999999999999998754 567
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998532 335889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 43322222223345778999999999999999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=270.03 Aligned_cols=201 Identities=27% Similarity=0.433 Sum_probs=176.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|.+.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++.+......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468999999999999999999864 5789999998755545567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999832 35789999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+++.|+|||.+.+..++.++||||||+++||+++|+.||...+
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2233468889999999988889999999999999999999999997553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=269.39 Aligned_cols=201 Identities=28% Similarity=0.389 Sum_probs=169.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.+.||+|++|.||+|+.. +++.||||.+..... .....+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367899999999999999999875 578999999865322 223457789999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++ +|..++... ...+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9985 888887542 236889999999999999999999998 9999999999999999999999999987543211
Q ss_pred cccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
. ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1122346789999998875 45889999999999999999999999644
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=275.11 Aligned_cols=205 Identities=28% Similarity=0.370 Sum_probs=174.7
Q ss_pred HHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEec--ccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeE
Q 005705 466 ITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 466 ~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~--~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 542 (682)
+......|+++++||.||-+.||++...+.+.+|+|++. ..+.+..+.|.+|+..|.+|+ |.+|+++++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 455677899999999999999999998888889988764 356677889999999999996 99999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
||||||= ..+|..+|.... ..++.-.+..+..||+.++.++|+++ |||.||||.|+|+- .|.+||+|||+|.-
T Consensus 436 YmvmE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 9999984 558999985432 22332377889999999999999998 99999999999995 46999999999998
Q ss_pred cCCCccccccccccccccccCcccccCCC-----------CCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGL-----------FSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
+..+...-.....+||+.||+||.+.... .++++||||||||||+|+.|++||+.
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 87766555555679999999999885432 46789999999999999999999974
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=266.47 Aligned_cols=199 Identities=26% Similarity=0.463 Sum_probs=172.5
Q ss_pred CcccccccccCCceeEEEEEE-cCCceEEEEEeccc-ChhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEecCeEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.|++.+.||+|+||.||+|.+ .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999987 46889999998654 3345677889999999997 999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998732 36899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 12233468889999998865 457899999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=264.33 Aligned_cols=189 Identities=28% Similarity=0.454 Sum_probs=161.2
Q ss_pred cccccCCceeEEEEEEcCCc-----------eEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 477 CKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~-----------~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999886533 5788887654433 6789999999999999999999999988 778999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-------CeEEeeec
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-------NPKISDFG 618 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kL~DFG 618 (682)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999985432 26899999999999999999999988 99999999999999887 79999999
Q ss_pred cccccCCCccccccccccccccccCcccccCC--CCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9986532 1223566789999998876 78999999999999999999 57777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=263.29 Aligned_cols=201 Identities=30% Similarity=0.418 Sum_probs=177.8
Q ss_pred cCcccccccccCCceeEEEEEEcC-CceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.+.||+|++|.||+++... ++.||||++..... ...+++.+|+..+.+++||||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998864 89999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
+++++|.+++... ..+++..++.++.|+++|++|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998533 568999999999999999999999 87 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. .....++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 21 123467889999999999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=267.53 Aligned_cols=211 Identities=29% Similarity=0.378 Sum_probs=175.0
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec-
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ- 539 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~- 539 (682)
..++..+.++|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3455566889999999999999999999874 58899999986532 2345678899999999 799999999998754
Q ss_pred ----CeEEEEEEecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 540 ----GEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 540 ----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
...++||||+++++|.+++... .....+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 3589999999999999987532 23456899999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|++||...+
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 99999886543221 11234678899999987543 36889999999999999999999987543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=261.75 Aligned_cols=195 Identities=36% Similarity=0.507 Sum_probs=163.6
Q ss_pred cccccCCceeEEEEEEcC----CceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999876543 34567999999999999999999999875 4568999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc-
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG- 630 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~- 630 (682)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998542 36899999999999999999999998 9999999999999999999999999998764322111
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
......++..|+|||.+.+..++.++||||||+++|||++ |++||+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 1111233568999999998999999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=262.96 Aligned_cols=201 Identities=31% Similarity=0.485 Sum_probs=174.4
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|.+.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999875 688999999876543 3678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999843 345788999999999999999999998 99999999999999999999999999987643322
Q ss_pred cc-c-cccccccccccCcccccCCC---CCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QG-N-TKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~-~-~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.. . .....++..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 11 1 12346788999999998766 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=266.47 Aligned_cols=202 Identities=30% Similarity=0.460 Sum_probs=171.8
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
+|++.++||+|++|.||+|+.. +++.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999985 588999999875432 23566788999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++ +|.+++........+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 85 78888755444456899999999999999999999998 9999999999999999999999999997653321
Q ss_pred cccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......++..|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234568899999988654 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=282.10 Aligned_cols=193 Identities=32% Similarity=0.473 Sum_probs=165.2
Q ss_pred ccccccCCceeEEEEEEc-CCceEEEEEec----ccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC--eEEEEEEe
Q 005705 476 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILILEY 548 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~----~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E~ 548 (682)
..+||+|+|-+||||.+. +|.+||=-.++ .+.+...++|..|+.+|+.|+||||++++..+.+.. ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 358999999999999874 47677632221 235566799999999999999999999999998765 47899999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-CCCCeEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~~~~ 627 (682)
+..|+|..|+.+ .+.++.+.+..+++||++||.|||++. +||||||||-+||+|+ ..|.|||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999854 345888999999999999999999997 5799999999999997 4689999999999987543
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.....+|||.|||||+.. ..|+..+||||||+.|+||.|+..||.-
T Consensus 200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 234479999999999765 8999999999999999999999999863
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=265.46 Aligned_cols=199 Identities=29% Similarity=0.416 Sum_probs=174.9
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.+.||+|++|.||++.+. +++.+|+|++.... ....+++.+|++++++++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999886 58899999987653 34567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
+++++|.+++.... ..+++..+..++.|+++||+|||+ .+ ++|+||||+||++++++.++|+|||.+..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568899999999999999999999 76 9999999999999999999999999987653221
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11256788999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=267.29 Aligned_cols=201 Identities=27% Similarity=0.384 Sum_probs=173.1
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|++.+.||+|+||.||+|.+. +++.||+|.++.. .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999886 4789999988653 23345789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|++++.+..+.. +...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877766652 2345899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
. .......++..|+|||++.+. .++.++||||||+++|||++|++||...
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 122335678899999999888 8899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=260.42 Aligned_cols=201 Identities=37% Similarity=0.572 Sum_probs=171.6
Q ss_pred cccccccccCCceeEEEEEEcC-----CceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
+++.+.||+|+||.||+++..+ +..||+|.+...... ..+.+.+|+.++.+++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998754 378999999765433 5678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854221 12899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
...... ...+++.|+|||.+.+..++.++||||||++++||++ |++||...
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 221111 2336789999999988889999999999999999998 88888643
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=265.65 Aligned_cols=200 Identities=28% Similarity=0.418 Sum_probs=165.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMML-IAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|++.+.||+|+||.||++++. +|+.||+|+++... .....++..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999875 58999999986542 2233455556655 566689999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 548 YMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 548 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|++ ++|..++... .....+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6787776432 2335689999999999999999999987 5 99999999999999999999999999986532
Q ss_pred CccccccccccccccccCcccccC----CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 21 1123467889999998865 4568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=263.94 Aligned_cols=203 Identities=30% Similarity=0.473 Sum_probs=167.7
Q ss_pred cccccccccCCceeEEEEEEc----CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------ 540 (682)
|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999763 3678999998653 3345678899999999999999999999886532
Q ss_pred eEEEEEEecCCCChhHHhhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeee
Q 005705 541 EKILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 617 (682)
..++++||+++++|..++.... ....+++..+++++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998874321 2235788999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
|+++...............+++.|++||.+....++.++||||||+++|||++ |++||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 99987643322222223345678999999999999999999999999999999 89998644
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=265.16 Aligned_cols=202 Identities=29% Similarity=0.404 Sum_probs=173.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 546 (682)
++|+..+.||.|++|.||++.+. +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999885 57899999987543 24567799999999999999999999988654 4689999
Q ss_pred EecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 547 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 547 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
||+++++|.+++... .....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 23456889999999999999999999998 99999999999999999999999999876532
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 21 123457889999999999999999999999999999999999998663
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=260.62 Aligned_cols=202 Identities=25% Similarity=0.420 Sum_probs=174.2
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.+.||+|+||.||+++.. +++.+|+|.+... .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999874 5789999998643 334456889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ....+++.+++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988532 2335789999999999999999999987 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+++.|+|||++.+..++.++|+||||++++||++|+.||...+
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 1223467889999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=266.28 Aligned_cols=200 Identities=29% Similarity=0.396 Sum_probs=169.9
Q ss_pred CcccccccccCCceeEEEEEE----cCCceEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 542 (682)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 368899999986532 22346788999999999 599999999999998899
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... .......|+..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 543221 122235688999999998753 4678999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=263.83 Aligned_cols=202 Identities=27% Similarity=0.443 Sum_probs=172.0
Q ss_pred CcccccccccCCceeEEEEEEcC--CceEEEEEeccc----------ChhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCVE 538 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~----------~~~~~~~f~~E~~~l~~-l~HpnIv~l~~~~~~ 538 (682)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998865 678999987532 22345567888888875 799999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhh-ccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcCCCCeEEee
Q 005705 539 QGEKILILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISD 616 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~D 616 (682)
++..+++|||+++++|.+++.. ......+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 2234568999999999999999999996 44 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|++||...+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 99998754332 2334578899999999998889999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=261.59 Aligned_cols=196 Identities=30% Similarity=0.483 Sum_probs=160.7
Q ss_pred cccccCCceeEEEEEEcC----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-ecCeEEEEEEecC
Q 005705 477 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQGEKILILEYMP 550 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ 550 (682)
+.||+|+||.||+|++.+ ...+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 357999998643 3345678899999999999999999999876 4556889999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc-
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ- 629 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~- 629 (682)
+++|..++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998542 234677888999999999999999987 999999999999999999999999999765332111
Q ss_pred -cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcC-CCCCCC
Q 005705 630 -GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTGL 677 (682)
Q Consensus 630 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG-~~pf~~ 677 (682)
.......++..|+|||.+.+..++.++||||||+++|||++| .+||..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 111223457789999999888999999999999999999995 566653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=268.57 Aligned_cols=197 Identities=27% Similarity=0.417 Sum_probs=166.2
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.+.||+|+||.||+|+.. +|+.+|+|+++... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999885 58899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++ +|..++... ...+++..++.++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 677766432 345899999999999999999999998 9999999999999999999999999998654321
Q ss_pred ccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 112234678899999988764 47899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=260.11 Aligned_cols=201 Identities=27% Similarity=0.431 Sum_probs=173.6
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.+.||+|+||.||++... +++.+|||.+... .....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999874 5789999998643 334567899999999999999999999999989999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 627 (682)
+++++|.+++... ....+++..+..++.|++++|+|||+++ |+|+||+|+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998542 2345899999999999999999999998 99999999999998654 58999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 1223467889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=268.05 Aligned_cols=200 Identities=30% Similarity=0.411 Sum_probs=169.5
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccChh-----hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
+|++.+.||+|+||.||+|... +++.||||.+...... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999875 5889999998654322 345678899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999984322 36899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. .......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...+
T Consensus 155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 155 PN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred CC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 22 11222356788999998854 567899999999999999999988876433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=262.37 Aligned_cols=199 Identities=27% Similarity=0.434 Sum_probs=172.8
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+-|++.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.++.+++||||+++++++..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34777889999999999999864 57899999886432 34456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|..++. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999883 245889999999999999999999988 99999999999999999999999999876643221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......++..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 122346788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=264.22 Aligned_cols=209 Identities=28% Similarity=0.461 Sum_probs=173.4
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE-- 538 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~-- 538 (682)
+.++..+...|++.+.||+|+||.||+|++. +++.+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3444456678999999999999999999874 57899999886543 3446788999999999 69999999999853
Q ss_pred ----cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 539 ----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 539 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
....+++|||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 35789999999999999988542 2345888889999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9999987653211 1223356889999999876 356888999999999999999999999543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=263.62 Aligned_cols=203 Identities=30% Similarity=0.445 Sum_probs=177.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
..+.|+..+.||+|++|.||++.+. +++.+++|.+..... ..+.+.+|+.++++++|+|++++++++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4677888899999999999999886 588999999976544 56788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999985432 36999999999999999999999987 9999999999999999999999999987654321
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1223457889999999998889999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=265.62 Aligned_cols=201 Identities=30% Similarity=0.441 Sum_probs=169.8
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.+.||+|++|.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 58899999886432 23346789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+. ++|..++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 5788887442 2356899999999999999999999988 9999999999999999999999999987653221
Q ss_pred ccccccccccccccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1122235678999999887644 6889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=264.88 Aligned_cols=203 Identities=32% Similarity=0.470 Sum_probs=171.8
Q ss_pred cCcccccccccCCceeEEEEEEc-----CCceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEe--cCeE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEK 542 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 542 (682)
+.|.+.+.||+|+||.||+++.. .+..+|||.+...... ..+.|.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999863 3678999999765443 56789999999999999999999999877 5578
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998542 235899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcc-ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 653211 11111234456799999998889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=262.87 Aligned_cols=191 Identities=29% Similarity=0.390 Sum_probs=158.0
Q ss_pred ccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHH---hcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIA---KLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~---~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
.||+|+||.||++... +++.+|+|.+.+.. ......+.+|..++. ..+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58899999886532 112233444544333 3479999999999999899999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|..++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988843 346899999999999999999999998 9999999999999999999999999987653221
Q ss_pred ccccccccccccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....|+..|+|||.+. +..++.++||||+||++|||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 22346899999999886 456899999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=261.18 Aligned_cols=196 Identities=34% Similarity=0.514 Sum_probs=167.9
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
++|++.+.||+|+||.||++.. +++.+|+|.++... ..+.+.+|+.++.+++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999975 67889999986532 346789999999999999999999998654 5789999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999985432 345889999999999999999999987 999999999999999999999999998764321
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 112234568999999998899999999999999999998 999987554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=279.04 Aligned_cols=201 Identities=32% Similarity=0.448 Sum_probs=173.3
Q ss_pred cCcccccccccCCceeEEEEEEcC--Cc--eEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~--g~--~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
+...+.++||+|.||.|++|.+.. |+ .||||.++..... ...+|++|+.+|.+|+|||+++|+|+..+ ...+||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 344566899999999999998753 44 6899999775443 68899999999999999999999999887 678899
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
+|..+.|+|.+.|.+ ..+..+....+..++.|||.||.||..+. +|||||..+|+||-....+||+||||.+-+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999977 55667888889999999999999999998 99999999999999999999999999998865
Q ss_pred Ccccc-ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCC
Q 005705 626 DELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTG 676 (682)
Q Consensus 626 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~ 676 (682)
.+... ......-+..|.|||.+....|+.++|||+|||.+|||+| |..||-
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 43222 2222334678999999999999999999999999999999 888874
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=263.50 Aligned_cols=197 Identities=26% Similarity=0.406 Sum_probs=171.6
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 5789999998655555567789999999999999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++....... ..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PR 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--cc
Confidence 999998843 45889999999999999999999998 9999999999999999999999999887653321 11
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 22346889999999999888999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=255.47 Aligned_cols=199 Identities=33% Similarity=0.520 Sum_probs=176.9
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
.|++.+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|||++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3777899999999999999885 588999999977655567889999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|.+++.... ..+++..+..++.|++++|++||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985432 46899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23456888999999998888999999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=259.94 Aligned_cols=192 Identities=28% Similarity=0.416 Sum_probs=168.7
Q ss_pred cccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
||.|++|.||+++... ++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999998854 8899999986532 23456799999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccc
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (682)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 345899999999999999999999987 9999999999999999999999999998764322 2233
Q ss_pred ccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..+++.|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 467889999999988889999999999999999999999997655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=265.12 Aligned_cols=205 Identities=26% Similarity=0.365 Sum_probs=173.7
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 543 (682)
...+|..+.+||+|+||.|.+++-+. .+.+|||++++.. .+..+--+.|-++|+.. +-|.+++++.+++.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34568888999999999999997654 5679999998642 22334446677777766 4688999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
.||||+.+|+|--++ +.-+.+.+..+..++..||-||-+||+++ ||.||||..|||||.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999997666 34455778888999999999999999999 999999999999999999999999999863
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 681 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~e 681 (682)
--. ...+..++|||.|+|||++.-.+|...+|.||+||+||||+.|++||+-++.+
T Consensus 501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 211 23456789999999999999999999999999999999999999999987653
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=262.37 Aligned_cols=194 Identities=29% Similarity=0.422 Sum_probs=166.8
Q ss_pred cccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
||+|+||+||++... +++.+|+|.+.... ......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999764 58899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccc
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (682)
.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 99885432 246899999999999999999999998 999999999999999999999999998765431 11223
Q ss_pred ccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..++..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 467889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=263.46 Aligned_cols=190 Identities=26% Similarity=0.414 Sum_probs=160.9
Q ss_pred cccccCCceeEEEEEEcC--------CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 477 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+.||+|+||.||+|.... ...+|+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997632 235888888765555667899999999999999999999999998899999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC--------eEEeeeccc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--------PKISDFGLA 620 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kL~DFGla 620 (682)
+++++|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998542 235899999999999999999999998 999999999999987765 699999998
Q ss_pred cccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCC-CCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK-KNTGL 677 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~-~pf~~ 677 (682)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 75432 223467889999999986 45799999999999999999984 66543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=262.09 Aligned_cols=204 Identities=30% Similarity=0.450 Sum_probs=172.6
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecC------
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG------ 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~------ 540 (682)
+.++|++.+.||+|++|.||+|+.. +++.+++|.+..... ..+++.+|+.+++++ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999885 578899999875443 346799999999999 6999999999997654
Q ss_pred eEEEEEEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecc
Q 005705 541 EKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 619 (682)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999885422 2456899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+....... .......++..|+|||.+.. ..++.++||||||++||||++|++||...
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 87653321 22233568889999998753 34678999999999999999999999743
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=264.48 Aligned_cols=200 Identities=30% Similarity=0.405 Sum_probs=169.1
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILI 545 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 545 (682)
++|++.+.||+|+||.||+|+.. +++.+|+|.++... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999885 47899999986432 22334677899999999999999999998877 789999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++ +|..++... ...+++.+++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 888887432 236899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.. .......+++.|+|||.+.+. .++.++|+||||+++|||++|++||...
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 112234578899999988754 4689999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=259.09 Aligned_cols=206 Identities=28% Similarity=0.438 Sum_probs=173.0
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--cCeEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILIL 546 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 546 (682)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+++.+|+.++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 5789999998643 33456778999999999999999999998764 34678999
Q ss_pred EecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 547 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 547 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
||+++++|..++... .....+++..++.++.||++||+|||..+ ..+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998543 22456899999999999999999999332 223999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 43321 1233468899999999999889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=264.27 Aligned_cols=202 Identities=27% Similarity=0.362 Sum_probs=167.2
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCe-----
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE----- 541 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~----- 541 (682)
++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999875 58899999876532 223467888999999995 6999999999887665
Q ss_pred EEEEEEecCCCChhHHhhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeEEeeec
Q 005705 542 KILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFG 618 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFG 618 (682)
.++||||+++ +|..++..... ...+++..++.++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78887754322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred cccccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 998653321 11122356788999998865 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=259.26 Aligned_cols=198 Identities=24% Similarity=0.344 Sum_probs=164.1
Q ss_pred HHHhhhcCccccccc--ccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecC
Q 005705 465 SITAATENFSMQCKL--GEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (682)
Q Consensus 465 ~~~~~~~~y~i~~~L--G~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~ 540 (682)
+.....++|++.+.+ |+|+||.||+++.. ++..+|+|.+........ |+.....+ +||||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445677777776 99999999999874 578899999865322111 22222222 6999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeecc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGL 619 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGl 619 (682)
..++||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999843 237899999999999999999999998 99999999999999988 999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 8765322 22367889999999999999999999999999999999999997543
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=255.79 Aligned_cols=202 Identities=30% Similarity=0.439 Sum_probs=177.0
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILIL 546 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 546 (682)
+|.+.+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999886 58899999986654 24577899999999999999999999999988 8899999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++... ..+++.++..++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998543 37899999999999999999999987 999999999999999999999999999876544
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..........++..|+|||.+.+...+.++||||||++++||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32111334568889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=264.15 Aligned_cols=197 Identities=33% Similarity=0.480 Sum_probs=167.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.+.|++.+.||+|+||.||+|+.. +++.||+|.+... .....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999875 5889999988643 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 466666532 2345899999999999999999999988 99999999999999999999999999876432
Q ss_pred CccccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
. ....+++.|+|||++. ...++.++||||||+++|||++|++||...
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 1 2346788999999874 456889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=302.83 Aligned_cols=206 Identities=31% Similarity=0.437 Sum_probs=175.8
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
+-++.....||.|.||.||-|... +|.-.|||.+..+. ........+|+.++..++|||+|+++|+-.+.+..++-|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 345566679999999999999864 58889999876543 344567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|.+.+. .++..++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+.+.
T Consensus 1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999983 3445667777778999999999999999 999999999999999999999999999988654
Q ss_pred --ccccccccccccccccCcccccCCC---CCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 005705 627 --ELQGNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGLGSME 681 (682)
Q Consensus 627 --~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltG~~pf~~~~~e 681 (682)
+.........||+-|||||++.+.. ...++|||||||+..||+||++||.--+.|
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 2334455679999999999997644 677899999999999999999999765543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=270.96 Aligned_cols=199 Identities=29% Similarity=0.355 Sum_probs=169.1
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec------
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 539 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------ 539 (682)
..++|++.+.||+|+||.||+++.. +++.||+|.+... ......++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999875 6889999998643 334456778899999999999999999988643
Q ss_pred CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecc
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 619 (682)
...++||||+.+ +|...+.. .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 256999999965 77776632 2888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 98754322 1223467889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=260.02 Aligned_cols=191 Identities=30% Similarity=0.396 Sum_probs=158.5
Q ss_pred ccccCCceeEEEEEEc-CCceEEEEEecccCh---hhHHHHHHHHH---HHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMM---LIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~---~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
.||+|+||.||+++.. +++.||+|.+..... .....+..|.. .+....||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 478999998865321 11222344433 3444579999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|..++. ....+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998874 3346999999999999999999999988 9999999999999999999999999987653221
Q ss_pred ccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 2234789999999998754 6899999999999999999999999755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=260.43 Aligned_cols=195 Identities=28% Similarity=0.393 Sum_probs=168.7
Q ss_pred cccCCceeEEEEEEcC-CceEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
||+|+||.||+++..+ ++.+|+|.+..... ...+.+.+|+.++.+++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999865433 4567789999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc------
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL------ 628 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~------ 628 (682)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998542 36899999999999999999999998 99999999999999999999999999876432211
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
........++..|+|||.+.....+.++||||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 012233467889999999988889999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=270.36 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=167.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-----eE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~ 542 (682)
+++|++.++||+|+||.||+|+.. +++.||||.+... ......++.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 5889999998643 2334567889999999999999999999876543 57
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++++||+++ +|..++ ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 776666 2346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 543221 112233568899999998754 56899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=262.81 Aligned_cols=194 Identities=26% Similarity=0.406 Sum_probs=169.9
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCChh
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 555 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 555 (682)
.+||+|+||.||++... +++.||||.+..........+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 68899999986655556677999999999999999999999999999999999999999999
Q ss_pred HHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccc
Q 005705 556 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635 (682)
Q Consensus 556 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 635 (682)
+++. ...+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++....... ......
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 8873 235789999999999999999999998 9999999999999999999999999987653321 112334
Q ss_pred cccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 636 ~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.++..|+|||.+.+..++.++|+||+|+++|||++|+.||...+
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 67889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=283.64 Aligned_cols=200 Identities=24% Similarity=0.366 Sum_probs=159.0
Q ss_pred hhcCcccccccccCCceeEEEEEEcC--CceEEEE------------------EecccChhhHHHHHHHHHHHHhcCCCC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVK------------------RLSNQSGQGLKEFKNEMMLIAKLQHRN 528 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~--g~~vAVK------------------~l~~~~~~~~~~f~~E~~~l~~l~Hpn 528 (682)
..++|+++++||+|+||.||++.... +...+.| .+. ........+.+|+.+|.+++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987532 2222222 111 11233556889999999999999
Q ss_pred eeeEEEEEEecCeEEEEEEecCCCChhHHhhhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 529 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
|+++++++...+..++|+|++.. +|..++..... .......++..++.||+.||+|||+++ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999854 66666543211 122345677889999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCC
Q 005705 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674 (682)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p 674 (682)
+.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||+||||++|+.+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999987643221 122345799999999999999999999999999999999998754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=263.50 Aligned_cols=205 Identities=31% Similarity=0.426 Sum_probs=171.7
Q ss_pred cCcccccccccCCceeEEEEEE-cCCceEEEEEeccc-------ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-ecCe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQGE 541 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~-------~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 541 (682)
++|-++.+||+|+|+.|||+-+ ...+-||||+-.-. .+.-.+...+|..|-+.|.||-||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5688889999999999999965 45788999976422 1122344678999999999999999999996 4457
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEEeeec
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFG 618 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFG 618 (682)
++-|+||++|.+|+-+|. ..+.+++++++.|+.||+.||.||.+.. ++|||-||||.||||-. -|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999994 4457999999999999999999999885 67999999999999965 4679999999
Q ss_pred cccccCCCccc-----cccccccccccccCcccccC----CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQ-----GNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++.+..+.+. ..+....||..|++||.+.- ..++.|+||||+|||+|.+|.|++||+.+-
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 99998765432 23456789999999998753 347899999999999999999999999753
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=261.46 Aligned_cols=201 Identities=29% Similarity=0.412 Sum_probs=166.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 58899999886432 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeEEeeeccccccCCC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGD 626 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~ 626 (682)
|+++ +|..++... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 677766332 2234678888999999999999999987 999999999999985 557999999999765322
Q ss_pred ccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
. .......+++.|+|||.+.+ ..++.++||||||+++|||+||++||...
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 11223456889999998866 45789999999999999999999999754
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=264.93 Aligned_cols=202 Identities=30% Similarity=0.426 Sum_probs=167.9
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 543 (682)
..++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++.+++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3568999999999999999999875 58899999986432 22234567899999999999999999998765 4689
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++ +|.+++... ...+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999975 787777432 256899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.... .......++..|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4322 11222345788999998865 56789999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=262.87 Aligned_cols=202 Identities=20% Similarity=0.235 Sum_probs=153.7
Q ss_pred hcCcccccccccCCceeEEEEEEcCC----ceEEEEEecccChhhH-----------HHHHHHHHHHHhcCCCCeeeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVRLLG 534 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g----~~vAVK~l~~~~~~~~-----------~~f~~E~~~l~~l~HpnIv~l~~ 534 (682)
.++|.+.++||+|+||.||+|+..++ ..+|+|.......... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999987543 4566665432221110 11223344556678999999999
Q ss_pred EEEecC----eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC
Q 005705 535 CCVEQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (682)
Q Consensus 535 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 610 (682)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876543 34677777643 55555422 223578888999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCcc-----ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 611 NPKISDFGLARMFGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 611 ~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.++|+|||+++.+..... ........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999987632211 11122347999999999999999999999999999999999999999765
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=260.92 Aligned_cols=199 Identities=30% Similarity=0.446 Sum_probs=167.9
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
|++.+.||.|++|.||+|... +|..||+|++.... ....+.+.+|+.++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999874 68999999986432 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
+ ++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 5 68988874322 236899999999999999999999987 9999999999999999999999999997653221
Q ss_pred cccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......++..|+|||++.+. .++.++||||||+++|||++|++||...
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 111223568899999988664 5789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=253.42 Aligned_cols=198 Identities=33% Similarity=0.466 Sum_probs=174.5
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.+.||+|++|.||+++.. +++.+|+|.+..... ...+.+.+|++++.+++|||++++++++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999875 578999999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ..+++..+..++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998432 56899999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 12334678899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=256.09 Aligned_cols=191 Identities=26% Similarity=0.333 Sum_probs=161.4
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccCh---hhHHHHHHHHHHH-HhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLI-AKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.||+|+||.||+|... +++.||||.+..... .....+..|..++ ...+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999874 588999999865422 2223344554443 455899999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
++|..++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999843 346899999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...+
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 223467889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=263.49 Aligned_cols=205 Identities=28% Similarity=0.419 Sum_probs=167.4
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-----
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----- 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~----- 540 (682)
..++|++.++||+|+||.||+++.. +++.||||.+.... ......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999875 58899999885432 223345678999999999999999999987654
Q ss_pred ---eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeee
Q 005705 541 ---EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (682)
Q Consensus 541 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 617 (682)
..++||||+.+ +|...+.. ....+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 35999999975 67776633 2235899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccc--cccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 618 GLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 618 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999876432211 112234678899999988664 47889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=259.40 Aligned_cols=200 Identities=30% Similarity=0.445 Sum_probs=169.4
Q ss_pred cccccccccCCceeEEEEEEcC-CceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEEEEEE
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILILE 547 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 547 (682)
|++.++||+|++|.||+|+..+ ++.+|+|++.... ....+.+.+|+.++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678899999999999998764 7899999997652 33456788999999999999999999999888 78999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++ +|..++... ...+++.+++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 788877432 246899999999999999999999988 9999999999999999999999999998764432
Q ss_pred cccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11223456788999998765 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=267.27 Aligned_cols=201 Identities=30% Similarity=0.436 Sum_probs=168.2
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec--CeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ--GEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~--~~~~ 543 (682)
.++|++.+.||+|+||.||+|.+. +++.+|||++... .......+.+|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 568999999999999999999875 5789999988542 233456678899999999 999999999998654 3679
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 488888732 26889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCccc---cccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 624 GGDELQ---GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 624 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 433211 12233568899999998765 55789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-31 Score=271.27 Aligned_cols=201 Identities=24% Similarity=0.320 Sum_probs=178.6
Q ss_pred hcCcccccccccCCceeEEEEEEcCCc-eEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~-~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..+++++..||-|+||.|-+++..... ..|+|++++. ...+.+....|-.+|...+.|.||+++..+.++...|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 456677789999999999999875433 4888888664 334556678899999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
||-+-||.|..+|. .++.++......++..+++|++|||+++ ||.|||||+|.||+.+|-+||+|||+|+.+..
T Consensus 499 mEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999994 4556888888899999999999999998 99999999999999999999999999999854
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...+..++|||.|.|||++.++.++.++|.||||+++||||+|++||+-.+
T Consensus 573 ---g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 573 ---GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred ---CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 346778999999999999999999999999999999999999999998654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=256.53 Aligned_cols=202 Identities=27% Similarity=0.443 Sum_probs=172.8
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999875 4789999998643 223456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC-eEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kL~DFGla~~~~~~~ 627 (682)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2335799999999999999999999988 999999999999998864 6999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ......|++.|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1 1223468889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=260.69 Aligned_cols=203 Identities=30% Similarity=0.445 Sum_probs=176.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 545 (682)
++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999875 6889999998653 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 346999999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccc------------------cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQ------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... .......++..|+|||++.+..++.++||||||++++|+++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 3211 22234567899999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=235.47 Aligned_cols=208 Identities=28% Similarity=0.368 Sum_probs=170.9
Q ss_pred HHhhhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeE
Q 005705 466 ITAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 466 ~~~~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 542 (682)
+....+...-+..||+|++|.|-+-++ .+|+..|+|++.... .+..++..+|+.+..+. .+|.+|+++|...++...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344556666678999999999999887 568999999997643 34456777888877665 689999999999999999
Q ss_pred EEEEEecCCCChhHHhhh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 543 ILILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
++.||.|. .+|+.+-.+ -.++..+++..+-+|+..+.+||.|||++- .+||||+||+|||++.+|++|+||||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999984 477766432 235567999999999999999999999865 69999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccC----CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.+.+.- ..+...|-..|||||.+.. ..|+.|+||||||+.+.||-+++.||+.+-
T Consensus 198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 764332 1122467789999998753 468999999999999999999999998763
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=261.43 Aligned_cols=204 Identities=29% Similarity=0.425 Sum_probs=168.8
Q ss_pred hhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC----
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG---- 540 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~---- 540 (682)
...++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999885 47899999986432 233456788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 541 ------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 541 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
..++|+||+++ +|..++.. ....+++.++..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 56666532 2346899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+|||++..+..... .......++..|+|||.+.+ ..++.++|||||||++|||++|++||...
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999987643221 11122345778999998765 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=260.11 Aligned_cols=201 Identities=28% Similarity=0.390 Sum_probs=165.7
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|...++||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999875 47899999986532 344567899999999996 9999999999999889999999
Q ss_pred ecCCCChhHHhhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 548 YMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 548 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|++. +|..+... ......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 44443211 12235689999999999999999999975 5 9999999999999999999999999997654
Q ss_pred CCccccccccccccccccCcccccCC---CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
... ......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 321 11233678899999998776 6899999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=252.48 Aligned_cols=203 Identities=25% Similarity=0.435 Sum_probs=177.4
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|.+.+.||+|+||.||++... +++.+|+|++.... ....+++.+|++++++++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999875 58899999987543 25567889999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
+++++|.+++.... ....+++.++..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999885432 2367899999999999999999999997 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......|++.|+|||.+.+..++.++||||+|+++++|++|+.||...+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 12233468889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=256.75 Aligned_cols=196 Identities=27% Similarity=0.378 Sum_probs=162.7
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEec--CeEEEEEE
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ--GEKILILE 547 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E 547 (682)
|++.++||+|+||.||+|+.. +++.+|+|+++... ........+|+.++.++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999874 58899999987542 222234457888899885 99999999999987 88999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++ +|.+++.. ....+++.++..++.|++.||+|||+.+ ++|+||+|+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 77777643 2346899999999999999999999998 999999999999999 999999999998764322
Q ss_pred cccccccccccccccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......++..|+|||.+. +..++.++|||||||++|||++|++||...
T Consensus 154 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 154 ---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred ---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 112345788999999764 456788999999999999999999999654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=265.31 Aligned_cols=203 Identities=31% Similarity=0.396 Sum_probs=169.5
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEE-cCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~ 539 (682)
..++....++|.+.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345566789999999999999999999986 46889999998653 223356788999999999999999999988643
Q ss_pred ------CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeE
Q 005705 540 ------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (682)
Q Consensus 540 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 613 (682)
...+++++++ +++|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2467777775 778888763 235899999999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
|+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999876432 1223467889999998866 56889999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=260.09 Aligned_cols=196 Identities=33% Similarity=0.492 Sum_probs=166.7
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
+.|...+.||+|+||.||+++.. ++..+|+|.+... ......++.+|+.++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778889999999999999874 5789999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++ +|.+++... ...+++.++..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 676666432 345899999999999999999999998 99999999999999999999999999875432
Q ss_pred ccccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....++..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 22346788999999874 456889999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=254.97 Aligned_cols=202 Identities=31% Similarity=0.470 Sum_probs=175.6
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|++.++||+|+||.||+++.. +++.+|+|.+... ......++.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999764 5789999998653 234456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999885422 2356899999999999999999999998 999999999999999999999999999876443
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...+.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12234678899999999999999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=258.62 Aligned_cols=200 Identities=29% Similarity=0.402 Sum_probs=169.4
Q ss_pred CcccccccccCCceeEEEEEEc----CCceEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 542 (682)
+|++.+.||+|++|.||+++.. +++.||||.++... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999753 46789999986432 23446788999999999 599999999999988899
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|..++.. ...+++..+..++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 345889999999999999999999987 99999999999999999999999999877
Q ss_pred cCCCccccccccccccccccCcccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+..... .......++..|+|||.+.+.. .+.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 543221 1122346789999999987665 788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=266.29 Aligned_cols=202 Identities=23% Similarity=0.372 Sum_probs=168.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----cCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~----~~~~ 542 (682)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999875 58899999987542 2345678889999999999999999988753 3467
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888873 3345899999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCccc--cccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDELQ--GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 5432211 11223478899999998865 45889999999999999999999999543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=264.27 Aligned_cols=199 Identities=28% Similarity=0.395 Sum_probs=168.5
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC---
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--- 540 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~--- 540 (682)
....++|++.+.||+|+||.||++... ++..||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335678999999999999999999864 6889999998543 2334567889999999999999999999987543
Q ss_pred ---eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeee
Q 005705 541 ---EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (682)
Q Consensus 541 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 617 (682)
..++||||+ +++|..++. ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 458999998 678888773 245899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
|++...... .....+++.|+|||.+.+ ..++.++|+||||+++|||++|+.||...
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999865321 223467889999999876 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=265.03 Aligned_cols=200 Identities=26% Similarity=0.393 Sum_probs=167.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-----Ce
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 541 (682)
.++|.+.+.||+|+||.||+++.. +++.||||.+... .......+.+|+.++..++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999874 5889999998653 233456778899999999999999999987644 24
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++|+||+. ++|..++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 67877773 3356899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 754321 11233467889999998865 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=243.83 Aligned_cols=203 Identities=25% Similarity=0.387 Sum_probs=168.2
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++.+.+..||.|..|+|++.+.. .|..+|||.+.+. ..+..++++..+.++.+-+ .|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 44566678999999999999875 4889999999764 4456678888888887776 8999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
.|.- .++.++.. ..+++++..+-++...+++||.||.++. +|||||+||+|||+|+.|++||||||++-.+-...
T Consensus 172 lMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 8843 45555533 3456888888899999999999998765 69999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGSME 681 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~pf~~~~~e 681 (682)
..+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||..-+.|
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td 300 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD 300 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc
Confidence 2334578899999999864 46899999999999999999999999875543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=247.93 Aligned_cols=201 Identities=24% Similarity=0.399 Sum_probs=175.5
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|.++++||+|+|..|..++++ +.+.+|+|++++. ..+.++-.+.|-.+..+. +||.+|.++.+++.+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4578999999999999999999885 4778999998764 333455566777777776 6999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+|.||+++|+|--++ ++.+.++++.++.+...|.-||.|||+++ ||.||||..|||+|.+|++||.|+|+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999986555 55667999999999999999999999999 999999999999999999999999999863
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
-. ....+..++|||.|+|||++.+..|....|.|+|||+++||+.|+.||++
T Consensus 402 l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 LG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 22 22346678999999999999999999999999999999999999999975
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=261.31 Aligned_cols=199 Identities=30% Similarity=0.423 Sum_probs=168.2
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-cCeE
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEK 542 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 542 (682)
...+++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345788999999999999999999865 6889999988542 22345678899999999999999999999875 4578
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++++||+ +++|..++. ...+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 558887773 335788888899999999999999998 99999999999999999999999999875
Q ss_pred cCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 422 1223466889999998765 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=254.44 Aligned_cols=199 Identities=31% Similarity=0.471 Sum_probs=166.4
Q ss_pred cccccccccCCceeEEEEEEcC-CceEEEEEecccCh--hhHHHHHHHHHHHHhc---CCCCeeeEEEEEEecCe-----
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQGE----- 541 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l---~HpnIv~l~~~~~~~~~----- 541 (682)
|++.+.||+|+||.||+|+... ++.+|+|++..... .....+.+|+.++.++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999864 88999999964322 2234566788777666 59999999999988776
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.+++|||+.+ +|.+++.... ...+++.+++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7888774422 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.+.... ......++..|+|||.+.+..++.++||||||+++|||++|++||...+
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 156 IYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 764322 1223357889999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.58 Aligned_cols=200 Identities=23% Similarity=0.222 Sum_probs=165.1
Q ss_pred ccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
.+.+.+|.|+++.|++++. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 4455666666666666655 6899999998654 345567899999999999999999999999999999999999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc---
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--- 628 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~--- 628 (682)
++|.+++.... ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||.+..+.....
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999985432 245889999999999999999999998 99999999999999999999999998875532111
Q ss_pred --ccccccccccccccCcccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 --QGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 --~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
........++..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1112234567889999998763 5889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=261.75 Aligned_cols=203 Identities=27% Similarity=0.374 Sum_probs=166.6
Q ss_pred hcCccc-ccccccCCceeEEEEEEc-CCceEEEEEecccChhh--------------HHHHHHHHHHHHhcCCCCeeeEE
Q 005705 470 TENFSM-QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLL 533 (682)
Q Consensus 470 ~~~y~i-~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~--------------~~~f~~E~~~l~~l~HpnIv~l~ 533 (682)
.++|.. .+.||+|+||.||+|+.. +++.||||.++...... ...+.+|+.++.+++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 467999999999999875 58899999886432111 12578899999999999999999
Q ss_pred EEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeE
Q 005705 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (682)
Q Consensus 534 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 613 (682)
+++..++..++||||++ ++|.+++. ....+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 58888873 3345899999999999999999999988 99999999999999999999
Q ss_pred EeeeccccccCCCcc------------ccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 614 ISDFGLARMFGGDEL------------QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 614 L~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|+|||+++....... ........++..|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987641110 1111223567889999998764 46899999999999999999999997553
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=255.83 Aligned_cols=199 Identities=32% Similarity=0.459 Sum_probs=170.2
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
|++.+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999875 588999999865432 34567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++ +|.+++... ...+++.++..++.|+++||+|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 76 787777432 246899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......++..|+|||.+.+. .++.++|+||||+++|||++|++||...+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234577899999998776 78999999999999999999999996544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=263.20 Aligned_cols=196 Identities=30% Similarity=0.430 Sum_probs=165.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------ 540 (682)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999874 5889999998653 2233456889999999999999999999986542
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999864 666554 235889999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 76432 1223467889999999876 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=260.21 Aligned_cols=203 Identities=30% Similarity=0.455 Sum_probs=165.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------ 540 (682)
.++|++.++||+|+||.||+|+.. +++.+|||++.... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999875 57899999885432 222346788999999999999999999875433
Q ss_pred --eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 541 --EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 541 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
..++|+||+.. +|...+.. ....+++.++..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999875 56555532 2346999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc---------cccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 619 LARMFGGDELQ---------GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 619 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
++......... .......+++.|+|||.+.+. .++.++||||||+++|||++|++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 99865432211 111234668889999987654 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=257.23 Aligned_cols=199 Identities=26% Similarity=0.400 Sum_probs=165.5
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.++|++.+.||+|+||.||+|+..+ ++.||||.++... .....++..|+.++.+.. ||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678889999999999999999865 8899999986542 234456677887777775 999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
||+++ +|..++... ...+++..+..++.||++||+|||+. + |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 666665332 23689999999999999999999974 5 99999999999999999999999999976543
Q ss_pred CccccccccccccccccCcccccCCC----CCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 221 12235778999999987654 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=256.31 Aligned_cols=194 Identities=33% Similarity=0.480 Sum_probs=164.8
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
|...++||+|+||.||+|+.. +++.|++|.+... .....+.+.+|+.++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666678999999999999874 5789999998643 223456788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+.+ +|.+++.. ....+++.+++.++.||+.+++|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 964 66666533 2346899999999999999999999998 9999999999999999999999999986432
Q ss_pred ccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......|+..|+|||++. ...++.++||||||+++|||++|++||...
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122356888999999874 456888999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=249.74 Aligned_cols=214 Identities=26% Similarity=0.369 Sum_probs=186.2
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEc------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~ 535 (682)
..++.....+++....+-+|.||.||+|.+. +.+.|-||.++.. ++-+...+..|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4556666778888899999999999999653 3456888888654 44467789999999999999999999999
Q ss_pred EEec-CeEEEEEEecCCCChhHHhh-----hccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC
Q 005705 536 CVEQ-GEKILILEYMPNKSLNVFLF-----DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD 609 (682)
Q Consensus 536 ~~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 609 (682)
+.++ ...++++.++.-|+|..||. +....+.+...+...++.|++.|++|||+++ +||.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9765 46788999999999999997 5555677888999999999999999999998 9999999999999999
Q ss_pred CCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 610 MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 610 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.++||+|=.+++.+.+.++.........+..||+||.+....|+.++|||||||+||||+| |+.|+..-+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 9999999999999888777666666677889999999999999999999999999999999 999986543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=227.30 Aligned_cols=200 Identities=26% Similarity=0.388 Sum_probs=166.8
Q ss_pred CcccccccccCCceeEEEEEEcC-CceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+|...++||+|.||+||||+..+ ++.||+|+++-. ++.......+|+-+|+.++|.|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45666899999999999998754 778999988543 333345678999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+.. +|..+.. .-++.++.+.+..++.|+++||.+.|+++ +.|||+||+|.|++.+|++||+|||+++-++-..
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 954 6777753 23456899999999999999999999998 9999999999999999999999999999775432
Q ss_pred ccccccccccccccCcccccCCC-CCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
......+-|..|.+|.++.+.. |+...|+||-|||+.|+-. |++.|.-.+
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 1223346688999999998764 8999999999999999987 666665444
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=262.75 Aligned_cols=201 Identities=30% Similarity=0.421 Sum_probs=171.7
Q ss_pred CcccccccccCCceeEEEEEEcC-CceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-----eEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 543 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 543 (682)
+|.+.+.||+|++|.||+|+... ++.+|||.+.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57888999999999999998754 8899999987643 345578999999999999999999999988765 789
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
++|||+++ +|..++. +...+++..+..++.||++||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 7888773 3347999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-ccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... ........++..|+|||.+.+. .++.++|+||||+++|||++|++||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 44321 0122334678899999999887 78999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=259.58 Aligned_cols=199 Identities=25% Similarity=0.293 Sum_probs=163.0
Q ss_pred ccccccC--CceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 476 QCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 476 ~~~LG~G--~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
.+.||+| +||+||++++. +++.||||++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 89999999874 6899999998643 33445788999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc-
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ- 629 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~- 629 (682)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999885432 235889999999999999999999987 999999999999999999999999865433211100
Q ss_pred ----cccccccccccccCcccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 630 ----GNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 630 ----~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 001112345679999998764 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=261.26 Aligned_cols=206 Identities=23% Similarity=0.368 Sum_probs=174.7
Q ss_pred hhhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
....-|..++.||-|+||.|-+++..| ...+|+|.|++.+ .......+.|-.||+....+=||+|+--|++++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 334568888999999999999996544 5678999997754 234456788999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||++||++-.+|. +.+.+.+..++.++.++.-|+++.|..| +|||||||+|||||.+|++||.||||+.-+
T Consensus 706 FVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999988873 4567888888999999999999999998 999999999999999999999999998654
Q ss_pred CC---------Cc---------------cc----------------cccccccccccccCcccccCCCCCccccHHHHHH
Q 005705 624 GG---------DE---------------LQ----------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGI 663 (682)
Q Consensus 624 ~~---------~~---------------~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGv 663 (682)
.- .+ .. ......+||+.|+|||++....|+.-+|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 10 00 00 0011248999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 005705 664 LMLETLSSKKNTGLGS 679 (682)
Q Consensus 664 il~elltG~~pf~~~~ 679 (682)
|||||+.|++||--++
T Consensus 860 il~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADT 875 (1034)
T ss_pred HHHHHhhCCCCccCCC
Confidence 9999999999997554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-31 Score=250.27 Aligned_cols=202 Identities=29% Similarity=0.368 Sum_probs=164.3
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+.+-+..||.|+||+|+|-.++ .|+..|||+++... ....++++.|.....+- +.||||+++|.+..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444578999999999999875 58999999997653 35567788887766555 689999999999999999999999
Q ss_pred cCCCChhHHhh--hccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 549 MPNKSLNVFLF--DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 549 ~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
|. .+|+.+-. -..++..+++..+-+|..-..+||.||-..- .|||||+||+||||+..|.+||||||++-.+...
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 94 46655431 1223456889988899999999999998754 5999999999999999999999999998766432
Q ss_pred ccccccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ..+.-.|-..|||||.+.. ..|+.++||||||+.|||+.||+-|+..++
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 1 2233478889999999853 458999999999999999999999997654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=259.91 Aligned_cols=201 Identities=29% Similarity=0.390 Sum_probs=164.8
Q ss_pred CcccccccccCCceeEEEEEEcC---CceEEEEEecccC--hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec----Ce
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ----GE 541 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~----~~ 541 (682)
+|++.+.||+|+||.||+++... +..+|+|++.... ....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47888999999999999998753 6789999986532 22356788999999999 599999999876432 35
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++++||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 58888873 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDEL--QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.+..... ........|+..|+|||.+.+ ..++.++||||||+++|||++|++||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 6643211 111233578999999998765 568999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=281.21 Aligned_cols=199 Identities=34% Similarity=0.501 Sum_probs=160.3
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-----
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ----- 539 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~----- 539 (682)
.+...+|+.++.||+||||.|||++.+ ||+.+|||++... +......+.+|++.|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456778999999999999999999875 8999999998654 445567789999999999999999886522110
Q ss_pred --------------------------------------------------------------------------------
Q 005705 540 -------------------------------------------------------------------------------- 539 (682)
Q Consensus 540 -------------------------------------------------------------------------------- 539 (682)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHH
Q 005705 540 ----------------------------------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585 (682)
Q Consensus 540 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~y 585 (682)
...|+=|||++...|+.++....... .....++++++|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 01356688888888888774322211 467788999999999999
Q ss_pred HHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC----C------------CccccccccccccccccCcccccC
Q 005705 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG----G------------DELQGNTKQIVGTYGYMSPEYALD 649 (682)
Q Consensus 586 LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~ 649 (682)
+|+++ ||||||||.||+++++..|||+|||+|.... . .......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99998 9999999999999999999999999998831 0 011113345799999999999876
Q ss_pred CC---CCccccHHHHHHHHHHHHc
Q 005705 650 GL---FSIKSDVFSFGILMLETLS 670 (682)
Q Consensus 650 ~~---~s~k~DVwSlGvil~ellt 670 (682)
.. |+.|+|+|||||||+||+.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc
Confidence 54 9999999999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=263.20 Aligned_cols=201 Identities=26% Similarity=0.369 Sum_probs=166.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec---------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--------- 539 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--------- 539 (682)
..+|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999875 5889999998766656677899999999999999999999776543
Q ss_pred -----CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeE
Q 005705 540 -----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPK 613 (682)
Q Consensus 540 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~k 613 (682)
...++||||++ ++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 48887773 235889999999999999999999998 999999999999974 56789
Q ss_pred EeeeccccccCCCccc-cccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 614 ISDFGLARMFGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 614 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
|+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999865332111 11122357889999998754 56888999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=224.55 Aligned_cols=110 Identities=47% Similarity=0.784 Sum_probs=82.6
Q ss_pred CCeEEEecCCCCCCcCC--CceEEEecCCcEEEecCCCCeEEEE-eccCCc-CCceEEEecCCceEEecCCCCCCCccce
Q 005705 70 PDAVVWVANRDRPISDN--NAVLTISNNGNLVLLNQTNGTIWST-NVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYL 145 (682)
Q Consensus 70 ~~~~vW~an~~~p~~~~--~~~l~~~~~g~lvl~~~~~~~~w~s-~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~ 145 (682)
++||||+|||+.|+... ..+|.|+.||||||++..++++|+| ++.+.+ ....|+|+|+|||||++. .+.+|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-----~~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-----SGNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-----TSEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-----cceEE
Confidence 46999999999999543 4889999999999999999999999 666555 678999999999999996 45899
Q ss_pred eeecCCCcccccccCccccccccCcceeEEEeecCCCCC
Q 005705 146 WQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184 (682)
Q Consensus 146 WqsFd~Ptdtllp~~~l~~~~~~~~~~~l~s~~~~~dps 184 (682)
||||||||||+||+|+|+.+..++.+..++||++..|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988887778899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=253.29 Aligned_cols=199 Identities=33% Similarity=0.447 Sum_probs=170.4
Q ss_pred cccccccccCCceeEEEEEEcC-CceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
|++.+.||+|++|.||+|+..+ ++.+|+|.+.... ....+.+..|+.++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999998864 8899999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999885432 46899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......++..|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 12233557789999998776 78999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=244.27 Aligned_cols=197 Identities=24% Similarity=0.313 Sum_probs=164.9
Q ss_pred hhcCcccc-cccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----cCe
Q 005705 469 ATENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGE 541 (682)
Q Consensus 469 ~~~~y~i~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~----~~~ 541 (682)
.+++|++. ++||-|-.|.|..+.++ +++.+|+|++... ....+|+++--.. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35677765 58999999999999775 5889999998643 3346777766555 59999999998853 346
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEEeeec
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFG 618 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFG 618 (682)
+.+|||.|+||.|...+.++ ....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999999888543 4456999999999999999999999998 999999999999964 4569999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
+|+.-.. .......+-||.|.|||++....|+...|+||+||++|-||+|-+||=.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 9987432 3344556889999999999999999999999999999999999999943
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=252.52 Aligned_cols=198 Identities=30% Similarity=0.398 Sum_probs=166.7
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEecccCh-hhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEEEec
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
|.+.+.||+|++|.||+|+.. +++.||||++..... .......+|+..+.+++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999985 478899999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
+++|.+++.... ...+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 788888874432 346899999999999999999999988 9999999999999999999999999998654321
Q ss_pred cccccccccccccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......++..|+|||++. ...++.++|+||||++++||++|++||...
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 122346788999999875 455789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=246.61 Aligned_cols=193 Identities=31% Similarity=0.425 Sum_probs=168.7
Q ss_pred cccCCceeEEEEEEc-CCceEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
||+|+||.||++... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999865432 3456889999999999999999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccc
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (682)
.+++.. ...+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 999843 336899999999999999999999987 9999999999999999999999999998764321 12334
Q ss_pred ccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||...+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 567889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=279.01 Aligned_cols=146 Identities=29% Similarity=0.434 Sum_probs=131.1
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|.+.++||+|+||.||+|++. +++.||||+++... ......+.+|+.++..++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999886 58899999986532 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
|||+++++|..++.. ...+++..++.|+.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999843 345889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=254.79 Aligned_cols=195 Identities=34% Similarity=0.507 Sum_probs=165.5
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
+.|...+.||+|+||.||+|+.. ++..+|+|.+... .....+++.+|+.+++.++|||++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777789999999999999875 4778999988632 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+. ++|...+... ...+++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 9997 5777666432 345889999999999999999999987 99999999999999999999999999876532
Q ss_pred ccccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.....+++.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 22346788999999874 35678899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=278.53 Aligned_cols=208 Identities=34% Similarity=0.496 Sum_probs=175.1
Q ss_pred HhhhcCcccccccccCCceeEEEEEEcC--------CceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 536 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~ 536 (682)
+...++..+.+.||+|.||.|++|.... ...||||.++.. .....+.+..|+++|..+ +||||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 4445666777899999999999997531 357999999764 335678899999999999 699999999999
Q ss_pred EecCeEEEEEEecCCCChhHHhhhcc-----------cc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCC
Q 005705 537 VEQGEKILILEYMPNKSLNVFLFDST-----------KK--RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (682)
Q Consensus 537 ~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~N 603 (682)
.+++..++|+||++.|+|..+|.... .. ..++..+++.++.|||.||+||++.. +|||||..+|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999996544 00 23889999999999999999999997 9999999999
Q ss_pred EEEcCCCCeEEeeeccccccCCCcccc-ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 005705 604 ILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGL 677 (682)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~ 677 (682)
||+.++..+||+|||+|+......... ......-+..|||||.+....|+.|+|||||||+||||+| |..|+.-
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999765443322 1111113567999999999999999999999999999999 8999864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=248.14 Aligned_cols=201 Identities=29% Similarity=0.397 Sum_probs=166.5
Q ss_pred CcccccccccCCceeEEEEEEcC-CceEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~-----~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998754 444556655431 222344577899999999999999999999988899999
Q ss_pred EEecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 546 LEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|||+++++|..++... .....+++.+++.++.|+++||+|||+.+ ++|+||+|+||+++. +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 23456899999999999999999999988 999999999999975 569999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3221 122346788999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=259.86 Aligned_cols=198 Identities=30% Similarity=0.424 Sum_probs=168.0
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe----
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE---- 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 541 (682)
..++|++.+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999885 4789999998643 22344667889999999999999999988766554
Q ss_pred --EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecc
Q 005705 542 --KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (682)
Q Consensus 542 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 619 (682)
.++|+||+ +++|.+++.. ..+++.++..++.|+++||+|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888732 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865322 233467889999998865 467899999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=242.81 Aligned_cols=180 Identities=22% Similarity=0.174 Sum_probs=153.9
Q ss_pred CCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCChhHHhhh
Q 005705 482 GGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD 560 (682)
Q Consensus 482 G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 560 (682)
|.+|.||++++. +++.+|+|++.... .+.+|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999874 57899999997543 234455566667799999999999999999999999999999998843
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccccccccc
Q 005705 561 STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640 (682)
Q Consensus 561 ~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 640 (682)
...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 235899999999999999999999988 999999999999999999999999988765322 122345678
Q ss_pred ccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 641 y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
|+|||.+.+..++.++||||+|+++|||++|+.|+..
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=261.21 Aligned_cols=204 Identities=23% Similarity=0.330 Sum_probs=154.4
Q ss_pred hhcCcccccccccCCceeEEEEEE-----------------cCCceEEEEEecccChhhHHHH--------------HHH
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSNQSGQGLKEF--------------KNE 517 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-----------------~~g~~vAVK~l~~~~~~~~~~f--------------~~E 517 (682)
..++|++.++||+|+||.||+|.+ ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356799999865433223333 447
Q ss_pred HHHHHhcCCCCe-----eeEEEEEEe--------cCeEEEEEEecCCCChhHHhhhccc---------------------
Q 005705 518 MMLIAKLQHRNL-----VRLLGCCVE--------QGEKILILEYMPNKSLNVFLFDSTK--------------------- 563 (682)
Q Consensus 518 ~~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 563 (682)
+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 667777653 3568999999999999998853211
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccC
Q 005705 564 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643 (682)
Q Consensus 564 ~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 643 (682)
...+++..+..++.|++++|+|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567788999999999999999988 99999999999999999999999999976533211 11122344789999
Q ss_pred cccccCCC--------------------C--CccccHHHHHHHHHHHHcCCC-CCC
Q 005705 644 PEYALDGL--------------------F--SIKSDVFSFGILMLETLSSKK-NTG 676 (682)
Q Consensus 644 PE~~~~~~--------------------~--s~k~DVwSlGvil~elltG~~-pf~ 676 (682)
||.+.... + ..+.||||+||+++||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 99875432 1 134799999999999999875 664
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=257.06 Aligned_cols=196 Identities=25% Similarity=0.363 Sum_probs=168.8
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccCh---h-----hHHHHHHHHHHHHhcC---CCCeeeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---Q-----GLKEFKNEMMLIAKLQ---HRNLVRLLGCCV 537 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~---~-----~~~~f~~E~~~l~~l~---HpnIv~l~~~~~ 537 (682)
..+|...+.+|+|+||.|+.+.++. ...|+||.+.+... . ..-..-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3568999999999999999998864 56899998865321 1 1122457999999997 999999999999
Q ss_pred ecCeEEEEEEecC-CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEee
Q 005705 538 EQGEKILILEYMP-NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (682)
Q Consensus 538 ~~~~~~lV~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 616 (682)
+++.+||+||-.. +-+|.+++ ..++.+++.++..|+.|++-|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 9999999999874 55788887 45667999999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcccccCCCCC-ccccHHHHHHHHHHHHcCCCCC
Q 005705 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNT 675 (682)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltG~~pf 675 (682)
||.|..... .....++||..|.|||++.+..|- ..-|||+||++||-++....||
T Consensus 714 fgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 714 FGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999987543 345668999999999999999884 5589999999999999998887
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=261.84 Aligned_cols=209 Identities=26% Similarity=0.437 Sum_probs=179.8
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE-- 538 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~-- 538 (682)
+..+...++.|++.+.||+|.+|.||+++. ++++.+|+|++.... +..+++..|..+|+.+ .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 444455678899999999999999999986 468899999986543 3446778899999988 59999999999974
Q ss_pred ---cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEe
Q 005705 539 ---QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (682)
Q Consensus 539 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 615 (682)
+++++|||||+.+|+..+++..-. ...+.|..+..|+..++.||.+||... +||||||=.|||++.++.|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 458999999999999999987654 678999999999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
|||++..+.. ........+||+.|||||++.. ..|+.++|+||||++..||--|.+|+-..
T Consensus 166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 9999987643 3345566799999999999864 34788999999999999999999998653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-27 Score=232.10 Aligned_cols=199 Identities=34% Similarity=0.481 Sum_probs=172.9
Q ss_pred cccccccccCCceeEEEEEEcC-CceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|+..+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999865 889999999766544 67889999999999999999999999999899999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+..+.... ..
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AA 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cc
Confidence 9999999853221 1789999999999999999999997 9999999999999999999999999998764332 01
Q ss_pred ccccccccccccCcccc-cCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678899999998 677788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=256.10 Aligned_cols=194 Identities=24% Similarity=0.344 Sum_probs=164.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++.|.+...+|.|+|+.|-++.+. +++..+||++.+... +-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 678899899999999999999774 578899999976632 234566555555 79999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE-cCCCCeEEeeeccccccCCC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL-DKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kL~DFGla~~~~~~ 626 (682)
.+.++-|.+.+.. .+.. ..++..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~---~~~~-~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KPEF-CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---cchh-HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999887766632 2222 3777889999999999999998 9999999999999 69999999999999876543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....+-|..|.|||++....|+.++|+||||++|||||+|+.||....
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 223466889999999999999999999999999999999999998654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=224.14 Aligned_cols=197 Identities=23% Similarity=0.410 Sum_probs=167.6
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecC--eEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG--EKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~~l 544 (682)
..++|++.+++|+|.++.||.|.. .+.+.++||+++.. ..+.+.+|+++|..|. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999975 56789999999753 3467899999999997 999999999987653 5679
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC-CCeEEeeecccccc
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMF 623 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla~~~ 623 (682)
|+||+.+.+...+- +.++..++..++.++++||.|+|+.| |+|||+||.|+++|.. ..++|+|+|+|.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876554 45778889999999999999999999 9999999999999965 46999999999988
Q ss_pred CCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
.+.. ..+..+.+..|.-||.+.. ..|+..-|+|||||+|.+|+..+.||-.+..
T Consensus 184 Hp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 184 HPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred CCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 6543 2233466778899998876 4588999999999999999999999977653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-29 Score=234.51 Aligned_cols=204 Identities=28% Similarity=0.472 Sum_probs=163.9
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEe--cccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--------c
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--------Q 539 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l--~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~--------~ 539 (682)
..|+...+||+|.||.||+|+.. +++.||+|+. .+..+..-....+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666779999999999999875 4778898865 22222223445789999999999999999988753 2
Q ss_pred CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecc
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 619 (682)
...++||++++. +|.-+|.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 358999999976 67777733 3345889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcc--ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 620 ARMFGGDEL--QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 620 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
++.+...+. ....+..+-|..|.+||.+.+ ..|+.+.|||.-|||+.||+|+.+-+.-++.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 987744322 122233456899999998876 5689999999999999999999998876543
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=205.06 Aligned_cols=115 Identities=43% Similarity=0.724 Sum_probs=101.9
Q ss_pred CccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCCCCeEEEE
Q 005705 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (682)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~w~s 111 (682)
++|.+|++|+|+++.|++|||.+......|++|||...+.++||.|||+.|. ...+.|.|+.||+|||+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 5788999999999999999999876545999999987667899999999984 447899999999999999999999999
Q ss_pred eccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCCC
Q 005705 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (682)
Q Consensus 112 ~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~P 152 (682)
++.+.....+|+|+|||||||++.. +.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 9876445678899999999999873 47899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=238.87 Aligned_cols=198 Identities=24% Similarity=0.292 Sum_probs=167.0
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCC--CC----eeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RN----LVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--pn----Iv~l~~~~~~~~~~ 542 (682)
+.+|.+...+|+|.||.|-++.+.. +..||||+++.-. .-.++-+-|+++|.++.+ |+ +|.+.+++...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 7899999999999999999997644 6889999997543 345566789999999942 33 77888889999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC--------------
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------------- 608 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------------- 608 (682)
++|+|.+ |-++.+++.. ....+++..+++.|+.|+++++++||+.. ++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999987 5589999854 23456889999999999999999999998 999999999999831
Q ss_pred ------CCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 609 ------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 609 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+..++|+|||.|...... ...++.|..|.|||++.+..++.++||||+||||+|+.+|...|-..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 335899999999874322 25678999999999999999999999999999999999999877543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-28 Score=235.59 Aligned_cols=195 Identities=28% Similarity=0.402 Sum_probs=161.3
Q ss_pred ccccccccCCceeEEEEEE-cCCceEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-----eEEEE
Q 005705 474 SMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKILI 545 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV 545 (682)
+-.+.||-|+||.||.+.+ .+|+.||+|++..... ...+++.+|+++|.-++|.|++..++..+-.. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3346899999999999987 4699999999865432 34577889999999999999998887765432 56778
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
.|.|.. +|..++ ...+.++...+.-++.||++||.|||+.+ |.||||||.|.|++++..+||+|||+|+....
T Consensus 136 TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 887744 677766 34456888888889999999999999998 99999999999999999999999999998765
Q ss_pred CccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
++. ...+..+-|..|.|||++++. +|+.+.||||.|||+.||+..+..|-
T Consensus 209 d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 209 RDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 443 344556778999999999875 58999999999999999998887664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=258.67 Aligned_cols=200 Identities=23% Similarity=0.287 Sum_probs=142.1
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-----CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEE------EE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------CV 537 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~------~~ 537 (682)
..++|++.++||+|+||.||+|++.+ +..||||++...... +.+.+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 689999998643221 111221 1122222222222111 24
Q ss_pred ecCeEEEEEEecCCCChhHHhhhccc-----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCC
Q 005705 538 EQGEKILILEYMPNKSLNVFLFDSTK-----------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (682)
Q Consensus 538 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlk 600 (682)
.+...++||||+++++|.+++..... ........+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 55688999999999999998853211 011223446689999999999999998 9999999
Q ss_pred CCCEEEcC-CCCeEEeeeccccccCCCccccccccccccccccCcccccCC----------------------CCCcccc
Q 005705 601 ASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG----------------------LFSIKSD 657 (682)
Q Consensus 601 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~D 657 (682)
|+|||++. ++.+||+|||+|+.+.... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5799999999998654321 1223446789999999965422 2345679
Q ss_pred HHHHHHHHHHHHcCCCCCC
Q 005705 658 VFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 658 VwSlGvil~elltG~~pf~ 676 (682)
||||||+||||+++..+++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999776654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=229.21 Aligned_cols=186 Identities=34% Similarity=0.472 Sum_probs=164.9
Q ss_pred CceeEEEEEEcC-CceEEEEEecccChhh-HHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCChhHHhhh
Q 005705 483 GFGPVYKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD 560 (682)
Q Consensus 483 ~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~-~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 560 (682)
+||.||+|+..+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8899999997665444 78899999999999999999999999999999999999999999999843
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccccccccccc
Q 005705 561 STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640 (682)
Q Consensus 561 ~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 640 (682)
. ..+++..+..++.++++++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 2 22889999999999999999999997 9999999999999999999999999998764432 2334567889
Q ss_pred ccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 641 y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
|++||.+.+..++.++||||||++++||++|+.||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=253.66 Aligned_cols=199 Identities=31% Similarity=0.436 Sum_probs=162.5
Q ss_pred CcccccccccCCcee-EEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEec
Q 005705 472 NFSMQCKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~-Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
-|.-.+.+|.|+-|+ ||+|.. +|++||||++-. ...+...+|+..|+.- .|||||++++.-.+++..|+..|.+
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355557889999985 789977 788999999854 3344567899999988 5999999999988999999999999
Q ss_pred CCCChhHHhhhcccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---C--CCeEEeeecccccc
Q 005705 550 PNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---D--MNPKISDFGLARMF 623 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~--~~~kL~DFGla~~~ 623 (682)
.. +|++++...... ........+.+..|+++||++||+.+ ||||||||+||||+. + .+++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 54 899998653111 11111445678899999999999987 999999999999976 2 57999999999998
Q ss_pred CCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcC-CCCCCCC
Q 005705 624 GGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTGLG 678 (682)
Q Consensus 624 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG-~~pf~~~ 678 (682)
...... .......||.+|+|||++....-+.++||+||||++|+.++| ++||+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 654332 235667899999999999998888999999999999999995 9999854
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=194.08 Aligned_cols=113 Identities=45% Similarity=0.772 Sum_probs=100.0
Q ss_pred CccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCCCCeEEEE
Q 005705 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (682)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~w~s 111 (682)
+.|..|++|+|+++.|++|||.+.. ...+++|||+..+.++||+|||+.|+.. ++.|.|+.||+|||++.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~-q~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIM-QNDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCC-CCCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 5788899999999999999998864 4789999998766789999999999876 5899999999999999999999999
Q ss_pred eccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCC
Q 005705 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (682)
Q Consensus 112 ~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~ 151 (682)
++.......+++|+|||||||++.. +.++||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 9874445678999999999999873 4799999997
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=222.56 Aligned_cols=131 Identities=27% Similarity=0.363 Sum_probs=108.4
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC-----C---CCeeeEEEEEEec--
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----H---RNLVRLLGCCVEQ-- 539 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----H---pnIv~l~~~~~~~-- 539 (682)
.+|.++++||-|.|++||++.+. ..+.||+|+.+... .-.+.-+.|+++|++++ | .+||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 58999999999999999999874 46789999986542 33456788999999984 3 3599999999754
Q ss_pred --CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 540 --GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 540 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
.+++||+|++ |.+|..+|.. ...+.++...+.+|++||+.||.|||.++ +|||.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4789999998 4466666543 23456999999999999999999999987 79999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=230.11 Aligned_cols=204 Identities=24% Similarity=0.284 Sum_probs=173.4
Q ss_pred HhhhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCC------CCeeeEEEEEEec
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH------RNLVRLLGCCVEQ 539 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H------pnIv~l~~~~~~~ 539 (682)
+....+|.+....|+|-|++|.+|.+.. |+.||||++.+.. .-.+.=+.|+++|++|+. -|.++++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3345689999999999999999998754 7899999998653 233455789999999963 4789999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeec
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFG 618 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFG 618 (682)
++++||+|-+ ..+|.+.|....+.-.|....+..++.|+.-||..|-..+ |+|.||||.|||+++.. .+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999987 4589999987777777999999999999999999999887 99999999999998764 58999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.|......+. +...-+..|.|||++.+.+|+...|+||.||.||||.||+..|.-.+
T Consensus 583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 9987654432 22334568999999999999999999999999999999999997654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-23 Score=202.77 Aligned_cols=183 Identities=40% Similarity=0.659 Sum_probs=158.7
Q ss_pred cccCCceeEEEEEEcC-CceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCChhH
Q 005705 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 556 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 556 (682)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 889999999765432 45789999999999999999999999999899999999999999999
Q ss_pred HhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeEEeeeccccccCCCccccccccc
Q 005705 557 FLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQI 635 (682)
Q Consensus 557 ~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~ 635 (682)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 45889999999999999999999998 999999999999999 89999999999987643321 12334
Q ss_pred cccccccCcccccCC-CCCccccHHHHHHHHHHH
Q 005705 636 VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLET 668 (682)
Q Consensus 636 ~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~el 668 (682)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 577899999998877 888999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=212.15 Aligned_cols=194 Identities=30% Similarity=0.350 Sum_probs=160.7
Q ss_pred cCcccccccccCCceeEEEEEE-cCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec------Ce
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GE 541 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 541 (682)
.+|.-++.+|.|.- .|-.+-+ -.+++||+|.+... .....++..+|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46666778888887 4554433 35889999987543 233456778999999999999999999998643 36
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.|+|||+|.. +|...+. -.++...+..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 7899999954 7777764 23778889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
..... -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+..|.-
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 75432 245567889999999999998899999999999999999999988763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-24 Score=206.56 Aligned_cols=195 Identities=21% Similarity=0.360 Sum_probs=155.2
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEE-EEecCeEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC-CVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~-~~~~~~~~lV~ 546 (682)
.+.|.+.+.||+|.||.+-+++++. .+.+++|.+.... ...++|.+|..---.| .|.||+.-+++ ++..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4679999999999999999999865 6688999886543 3467888887655555 58999987765 45566788999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc--CCCCeEEeeeccccccC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFG 624 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kL~DFGla~~~~ 624 (682)
||++.|+|.+-+ ....+.+.-..+++.|++.|+.|||+++ +||||||.+||||- +..++||+|||+....+
T Consensus 102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999998776 3345778888899999999999999998 99999999999993 44589999999987653
Q ss_pred CCccccccccccccccccCcccccCC---C--CCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDG---L--FSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~--~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
..- ....-+..|-+||..... . ..+.+|||.||+++|.+|||+.||-.
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 221 112235578999976432 2 35678999999999999999999964
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=218.00 Aligned_cols=168 Identities=20% Similarity=0.220 Sum_probs=131.2
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc--CCceEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~-----~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~ 539 (682)
....++|.+.+.||+|+||+||+|++. +++.+|||++... .....+.|.+|+++|.+++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999875 4677899987533 22345679999999999999999853322 2
Q ss_pred CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC-CCCCEEEcCCCCeEEeeec
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL-KASNILLDKDMNPKISDFG 618 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kL~DFG 618 (682)
+..++||||+++++|.... . .. ...++.|++++|+|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996321 1 11 1467889999999999998 999999 9999999999999999999
Q ss_pred cccccCCCccccc------cccccccccccCcccccCC
Q 005705 619 LARMFGGDELQGN------TKQIVGTYGYMSPEYALDG 650 (682)
Q Consensus 619 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 650 (682)
+|+.+........ .....++..|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9998754321111 1356778899999988654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-25 Score=232.36 Aligned_cols=200 Identities=27% Similarity=0.445 Sum_probs=175.9
Q ss_pred hhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
...++|++...+|.|.+|.|||+++. .++..|||.++-......+-+++|+.+++..+||||+.+++-+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 34678999999999999999999875 58889999998777777788899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+.+|+|+++- ....++++.++....+..++||+|||+.+ =+|||||=.|||+++.+.+|++|||.+..+...
T Consensus 92 EycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 999999998875 34567999999999999999999999998 799999999999999999999999998876432
Q ss_pred ccccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNT 675 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf 675 (682)
-.+...+.||+.|||||+.. ...|..++|||++|+...|+---++|-
T Consensus 166 --i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 166 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred --hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 23455689999999999863 456899999999999999987766653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=214.96 Aligned_cols=203 Identities=25% Similarity=0.416 Sum_probs=168.2
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc----CCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCe
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE 541 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 541 (682)
....+.|..+++||+|.|++||++.+. ..+.||+|.+...+ ...++.+|+++|..+. +.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 334567889999999999999999764 35689999986543 3467899999999995 8999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeEEeeeccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLA 620 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla 620 (682)
..+|+||++.....++.. .++..++..+++.+++||+++|..| ||||||||.|+|.+. .++-.|+|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 999999999999888873 3678899999999999999999998 999999999999984 567899999999
Q ss_pred cccCCCc-------------cc-----------------------------cccccccccccccCcccccCC-CCCcccc
Q 005705 621 RMFGGDE-------------LQ-----------------------------GNTKQIVGTYGYMSPEYALDG-LFSIKSD 657 (682)
Q Consensus 621 ~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~D 657 (682)
....... .. .......||++|.|||++... ..+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 8321100 00 001124799999999998765 4688999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCC
Q 005705 658 VFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 658 VwSlGvil~elltG~~pf~~~~~ 680 (682)
|||.|||+.-+++++.||-....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred eeeccceeehhhccccccccCcc
Confidence 99999999999999999976554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=206.20 Aligned_cols=203 Identities=25% Similarity=0.295 Sum_probs=166.3
Q ss_pred CcccccccccCCceeEEEEEEcCC--ceEEEEEecccChhhHHHHHHHHHHHHhcCC----CCeeeEEEEE-EecCeEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLNG--QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNLVRLLGCC-VEQGEKIL 544 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~g--~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H----pnIv~l~~~~-~~~~~~~l 544 (682)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999987553 4789998765433333378889999999873 5888888888 46778899
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC-----CCeEEeeecc
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-----MNPKISDFGL 619 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kL~DFGl 619 (682)
||+.+ |.+|.++..... .+.++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99875 779988764433 567999999999999999999999998 9999999999999865 4599999999
Q ss_pred cc--ccCCCcc----cc-c-cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 AR--MFGGDEL----QG-N-TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++ .+..... .. . .....||.+|.+++.+.+...+.+.|+||++.++.|++.|..||...+
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 99 3322111 11 1 234569999999999999999999999999999999999999996544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=190.40 Aligned_cols=201 Identities=22% Similarity=0.320 Sum_probs=168.0
Q ss_pred hhhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 545 (682)
...-+|.+.++||+|+||.++.|+. .+++.||||.-...++. .++..|....+.|. .++|...+-+..++....||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 3467899999999999999999975 57999999987554332 45666777777774 68999998888888888999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC-----CCeEEeeeccc
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-----MNPKISDFGLA 620 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kL~DFGla 620 (682)
+|.+ |-+|.++..- -.+.++.++++.+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|
T Consensus 103 idLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9987 6788877521 3456899999999999999999999998 9999999999999743 35899999999
Q ss_pred cccCCCccc-----cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 621 RMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 621 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
+.+...... .......||.+||+=..+.+...+.+.|+-|||-++++.|.|..||-
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQ 237 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 237 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccc
Confidence 998654332 22345689999999999999999999999999999999999999985
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=183.96 Aligned_cols=200 Identities=22% Similarity=0.316 Sum_probs=165.5
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~ 546 (682)
...+|.++++||.|+||.+|.|.. .+|.+||||.-++.... .++.-|.++...|+| ..|.++.-+..+.....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 356899999999999999999976 56999999997654332 456778888899975 67888888888888999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC---CCeEEeeecccccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMF 623 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DFGla~~~ 623 (682)
|.+ +-+|.+++.-- .+.++-.+++-++.|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|||+|+.+
T Consensus 91 dLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 987 67887776321 234788899999999999999999998 9999999999999754 45899999999988
Q ss_pred CCCcc-----ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 624 GGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 624 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
..... ........||.+|.+-..+.+...+.+.|+-|+|.+|.+...|..||-
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 54321 123345689999999888888888999999999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-20 Score=194.96 Aligned_cols=202 Identities=36% Similarity=0.518 Sum_probs=171.1
Q ss_pred cccccccccCCceeEEEEEEcCCceEEEEEecccChh---hHHHHHHHHHHHHhcCCC-CeeeEEEEEEecCeEEEEEEe
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E~ 548 (682)
|.+.+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++.+++......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677789999999999999876 78999998764332 467899999999999988 799999999777778999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 627 (682)
+.++++..++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966633211136889999999999999999999998 99999999999999988 79999999998664433
Q ss_pred ccc----ccccccccccccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQG----NTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 2456789999999999987 578899999999999999999999977654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=230.71 Aligned_cols=148 Identities=19% Similarity=0.217 Sum_probs=111.8
Q ss_pred cCC-CCeeeEEEEE-------EecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 005705 524 LQH-RNLVRLLGCC-------VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595 (682)
Q Consensus 524 l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ii 595 (682)
++| +||+++++.+ .+....++++|++ +++|.++|... ...+++.+++.++.||++||+|||+++ |+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 445 5777777766 2334567788887 55999998532 345999999999999999999999998 99
Q ss_pred eccCCCCCEEEcCC-------------------CCeEEeeeccccccCCCc--------------ccccccccccccccc
Q 005705 596 HRDLKASNILLDKD-------------------MNPKISDFGLARMFGGDE--------------LQGNTKQIVGTYGYM 642 (682)
Q Consensus 596 H~Dlkp~NILl~~~-------------------~~~kL~DFGla~~~~~~~--------------~~~~~~~~~gt~~y~ 642 (682)
||||||+||||+.. +.+||+|||+++...... .........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 445566666665321100 000011235788999
Q ss_pred CcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 643 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 643 aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
|||++.+..++.++|||||||+||||++|.+|+..
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999999999999999999999999999998763
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.4e-21 Score=186.76 Aligned_cols=170 Identities=16% Similarity=0.188 Sum_probs=133.2
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhh---HHH------HHHHHHHHHhcCCCCeeeEEEEEEec-
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---LKE------FKNEMMLIAKLQHRNLVRLLGCCVEQ- 539 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~---~~~------f~~E~~~l~~l~HpnIv~l~~~~~~~- 539 (682)
..+|.+.++||.|+||.||+... +++.+|||.+++..... ... |.+|+..+.++.||+|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999755 67789999997543222 222 68999999999999999998886543
Q ss_pred -------CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCe
Q 005705 540 -------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 612 (682)
Q Consensus 540 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 612 (682)
+..+++|||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||+++.++ +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35789999999999977741 222 24568999999999998 99999999999999988 9
Q ss_pred EEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHH
Q 005705 613 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669 (682)
Q Consensus 613 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ell 669 (682)
+|+|||........... ...+....|..++|+|+||+.+....
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988654211100 11345566778999999999887643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=182.81 Aligned_cols=139 Identities=18% Similarity=0.174 Sum_probs=108.5
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccChh--h-------HHH-----------------HHHHHHHHHhcCCCCe
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G-------LKE-----------------FKNEMMLIAKLQHRNL 529 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~--~-------~~~-----------------f~~E~~~l~~l~HpnI 529 (682)
...||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998653211 0 112 2359999999988776
Q ss_pred eeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEeccCCCCCEEEcC
Q 005705 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL-HQYSRFRIIHRDLKASNILLDK 608 (682)
Q Consensus 530 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~iiH~Dlkp~NILl~~ 608 (682)
.....+.. ...++||||++++++..... ....++..++..++.|++.+|++| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 23489999999987765432 234688999999999999999999 6777 99999999999998
Q ss_pred CCCeEEeeecccccc
Q 005705 609 DMNPKISDFGLARMF 623 (682)
Q Consensus 609 ~~~~kL~DFGla~~~ 623 (682)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=164.22 Aligned_cols=84 Identities=36% Similarity=0.860 Sum_probs=79.8
Q ss_pred eecccceEEEEEEeeCCCeeeEEEECCCCcEEEEEEeCCCCceEEEeeccCCCCcCCcCCCCCccccCCCCCcccccCCC
Q 005705 193 MMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF 272 (682)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~w~~~~~~W~~~~~~~~~~C~~~g~CG~~g~C~~~~~~~C~C~~Gf 272 (682)
++.+.++.+|+|...+.+.++|++||++|+++++.|++..+.|...|++|.++||+|+.||+||+|+.+..+.|.||+||
T Consensus 27 fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~Cd~y~~CG~~g~C~~~~~~~C~Cl~GF 106 (110)
T PF00954_consen 27 FVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQCDVYGFCGPNGICNSNNSPKCSCLPGF 106 (110)
T ss_pred EEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCCCCccccCCccEeCCCCCCceECCCCc
Confidence 35788899999999999999999999999999999999999999999999999999999999999998888999999999
Q ss_pred eeCC
Q 005705 273 KLES 276 (682)
Q Consensus 273 ~~~~ 276 (682)
+|++
T Consensus 107 ~P~n 110 (110)
T PF00954_consen 107 EPKN 110 (110)
T ss_pred CCCc
Confidence 9975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=176.56 Aligned_cols=140 Identities=21% Similarity=0.240 Sum_probs=111.3
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccChh--------------------------hHHHHHHHHHHHHhcCCCCe
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------------------------GLKEFKNEMMLIAKLQHRNL 529 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~--------------------------~~~~f~~E~~~l~~l~HpnI 529 (682)
...||+|+||.||+|++.+|+.||||+++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754211 01224678999999999987
Q ss_pred eeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcC
Q 005705 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDK 608 (682)
Q Consensus 530 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~ 608 (682)
.....+... ..++||||++++++..... ....++..+...++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 3489999999886543321 22357788999999999999999999 87 99999999999999
Q ss_pred CCCeEEeeeccccccC
Q 005705 609 DMNPKISDFGLARMFG 624 (682)
Q Consensus 609 ~~~~kL~DFGla~~~~ 624 (682)
++.++|+|||++..+.
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=167.38 Aligned_cols=187 Identities=18% Similarity=0.135 Sum_probs=139.8
Q ss_pred cccccccCCceeEEEEEEcCCceEEEEEecccCh----hhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEEEec
Q 005705 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG----QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 475 i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~----~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
+...|++|+||+||.+.. ++.+++.+.+..... .....|.+|+++|+++. |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997765 677888777754322 11235889999999995 5889999886 3569999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC-CCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL-KASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+|.+|...+. . ....++.|++++|+++|+++ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999865431 0 11357789999999999998 999999 79999999999999999999986543221
Q ss_pred -----c-cc-----cccccccccccCcccccCC-CCC-ccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 -----Q-GN-----TKQIVGTYGYMSPEYALDG-LFS-IKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 -----~-~~-----~~~~~gt~~y~aPE~~~~~-~~s-~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .. ..-...++.|++|+...-. ..+ .+.+.++.|.-+|+++|++.++-.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 00 0012357888888855322 333 56799999999999999998865443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.3e-19 Score=170.37 Aligned_cols=107 Identities=26% Similarity=0.216 Sum_probs=93.5
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (682)
|+|.+++.. .+..+++.+++.++.||++||+|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 688888853 2456999999999999999999999875 999999999999999 9999865332
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...|++.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 126789999999999999999999999999999999999999654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-19 Score=172.54 Aligned_cols=197 Identities=24% Similarity=0.386 Sum_probs=156.0
Q ss_pred cccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecC
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
..+..+|.+...|..|+|+++ |..+++|++.-+ +....++|.+|.-.|+-+.||||+.+++.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344568999999999999994 556777777433 34445789999999999999999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
.|+|...|++. ..-..+..++.+++.+||+|++|||+..+. |.---|..+.|++|++.+++|. .+-+++ ..
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltaris-mad~kf------sf 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARIS-MADTKF------SF 341 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhhee-ccccee------ee
Confidence 99999999653 334578889999999999999999998732 3344689999999999987764 111111 11
Q ss_pred ccccccccccccCcccccCCCCC---ccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFS---IKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s---~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.......|.||+||.+..++-+ .++|+|||.++||||-|...||...+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 12223457899999999877643 46899999999999999999998654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.9e-19 Score=200.39 Aligned_cols=201 Identities=21% Similarity=0.246 Sum_probs=163.4
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEecCe
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGE 541 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~~~~~~~~~ 541 (682)
+.....+.|.|.+.||+|+||+||+|...+|+.||+|.-+....- +|.--.+++.+|+ -+-|+++..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 445567889999999999999999999988999999997654321 2222233444444 2445566666666778
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-------CCCeEE
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------DMNPKI 614 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kL 614 (682)
-+||+||.+.|+|.+++. ..+.+++.....++.|+++.+++||..+ |||+||||+|.||.. ..-++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999984 5567999999999999999999999998 999999999999943 335999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p 674 (682)
+|||.+-.+..-.........++|-.+-.+|+..+..++..+|.|.|+.+++-||.|+..
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999776543333456667889999999999999999999999999999999999753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.8e-18 Score=165.39 Aligned_cols=136 Identities=23% Similarity=0.347 Sum_probs=106.0
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhc-----CCCCeeeEEEEEEecC---eEE-EEE
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-----QHRNLVRLLGCCVEQG---EKI-LIL 546 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~~~-lV~ 546 (682)
.+.||+|+||.||. +++....+||++........+++.+|+.++.++ .||||+++++++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46899999999996 544344479988765444567899999999999 5799999999998764 333 789
Q ss_pred Ee--cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEeccCCCCCEEEcC----CCCeEEee-ec
Q 005705 547 EY--MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL-LYLHQYSRFRIIHRDLKASNILLDK----DMNPKISD-FG 618 (682)
Q Consensus 547 E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kL~D-FG 618 (682)
|| .++++|.+++.+ ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+| ||
T Consensus 85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 557999999943 235554 35677888777 9999998 999999999999974 33799999 55
Q ss_pred cccc
Q 005705 619 LARM 622 (682)
Q Consensus 619 la~~ 622 (682)
....
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 4443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-19 Score=192.38 Aligned_cols=186 Identities=28% Similarity=0.368 Sum_probs=156.1
Q ss_pred ccccCCceeEEEEEE----cCCceEEEEEecccChhh--HHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEEEecC
Q 005705 478 KLGEGGFGPVYKGRL----LNGQEVAVKRLSNQSGQG--LKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~~~~--~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 550 (682)
.+|+|.||.|++++. +.+..+|+|.+++..... ......|..++...+ ||.++++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998743 346778999886643221 125567888888897 9999999999999999999999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccc
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+|.|...+ .......+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 99987776 33445677777788888999999999998 99999999999999999999999999987533221
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.+||..|||||++. .+..++|.||||++++||+||..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999888 677889999999999999999999976
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.7e-19 Score=199.16 Aligned_cols=200 Identities=24% Similarity=0.326 Sum_probs=158.0
Q ss_pred cccccccCCceeEEEEEEc-CCceEEEEEec----c-cChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 475 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----N-QSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 475 i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~----~-~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
..+.+|.|++|.|+..... .....+.|... . .... ....+..|+-+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3468999999988777543 23333333322 1 1111 12226678888888999999888877777666666699
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++ +|..++. ....+...++..++.|++.|++|||+.+ |.|||+||+|+++..++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9988873 3346888899999999999999999999 9999999999999999999999999998775433
Q ss_pred cc--cccccccccccccCcccccCCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCCCC
Q 005705 628 LQ--GNTKQIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSSKKNTGLGSME 681 (682)
Q Consensus 628 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~k-~DVwSlGvil~elltG~~pf~~~~~e 681 (682)
.. ......+|+..|+|||++.+..|.++ .||||.|+++..|++|+.||.....+
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 32 44566899999999999999999765 89999999999999999999876544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=163.99 Aligned_cols=150 Identities=17% Similarity=0.164 Sum_probs=115.2
Q ss_pred HHHhhhcCcccccccccCCceeEEEEE--EcCCceEEEEEecccChh------------------------hHHHHHHHH
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQ------------------------GLKEFKNEM 518 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~--~~~g~~vAVK~l~~~~~~------------------------~~~~f~~E~ 518 (682)
.+......|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 333444568899999999999999998 467999999988643210 112357899
Q ss_pred HHHHhcCCC--CeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 005705 519 MLIAKLQHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596 (682)
Q Consensus 519 ~~l~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH 596 (682)
..+.++.+. .+.++++. ...++||||+++.+|..... ....+...+...++.||+.++.+||+.+ .|+|
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH 172 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVH 172 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence 999999753 33444432 24589999999988866542 2234566677899999999999999986 4999
Q ss_pred ccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 597 RDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 597 ~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
+||||+||+++ ++.++|+|||.+....
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999 8899999999998654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.1e-17 Score=159.48 Aligned_cols=135 Identities=20% Similarity=0.286 Sum_probs=113.9
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--------~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
+.||+|++|.||+|.. .+..+++|....... .....+.+|+.++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 778899998654221 1124578899999999999988777777777888999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999987431 12 77899999999999999998 99999999999999 789999999998753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.5e-18 Score=192.70 Aligned_cols=199 Identities=20% Similarity=0.213 Sum_probs=153.7
Q ss_pred CcccccccccCCceeEEEEEEcCCceEEEEEecccCh-hhHHHHHHHHHH--HHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMML--IAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~--l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++...+.||.+.|=.|.++++++|. |+||++-++.+ ...+.|++++.- ...++|||.+++.-.-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677789999999999999998887 99999976653 344445443333 4555899999988776666667788888
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC--
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD-- 626 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~-- 626 (682)
..+ +|.+.+ ..++.+...+..-|+.|++.||..+|..+ |+|+|||.+||||+.-.-+.|+||...+...-.
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 755 676666 45566888888899999999999999998 999999999999999999999999877654221
Q ss_pred ---ccccccccccccccccCcccccCC----------C-CCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 627 ---ELQGNTKQIVGTYGYMSPEYALDG----------L-FSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 627 ---~~~~~~~~~~gt~~y~aPE~~~~~----------~-~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
++.........-..|+|||.+... . .+++-||||+||+++||++ |++||+..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 111122223445689999987542 2 5678999999999999999 79999753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.1e-17 Score=166.07 Aligned_cols=202 Identities=21% Similarity=0.305 Sum_probs=133.8
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEeccc---ChhhHHHHHHHHHHHHhcCC----------CCeeeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH----------RNLVRLLGC 535 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H----------pnIv~l~~~ 535 (682)
...+...+.||.|+++.||.+++.+ ++++|||++.-. .....+++++|......+.+ -.++-.++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 3456677899999999999999865 889999987432 23457788888766666433 122222222
Q ss_pred EE---------ec---C-----eEEEEEEecCCCChhHHhh---hccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 005705 536 CV---------EQ---G-----EKILILEYMPNKSLNVFLF---DSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594 (682)
Q Consensus 536 ~~---------~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 594 (682)
.. .. . ..+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||+++ +
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---L 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence 21 11 1 235677766 557777753 2221 123445566778899999999999999 9
Q ss_pred EeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccC--------CCCCccccHHHHHHHHH
Q 005705 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILML 666 (682)
Q Consensus 595 iH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwSlGvil~ 666 (682)
+|+||+|+|++++++|.++|.||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999999999887764322111 234578999997643 24788999999999999
Q ss_pred HHHcCCCCCCCCCC
Q 005705 667 ETLSSKKNTGLGSM 680 (682)
Q Consensus 667 elltG~~pf~~~~~ 680 (682)
.|++|+.||+..+.
T Consensus 242 ~lWC~~lPf~~~~~ 255 (288)
T PF14531_consen 242 SLWCGRLPFGLSSP 255 (288)
T ss_dssp HHHHSS-STCCCGG
T ss_pred HHHHccCCCCCCCc
Confidence 99999999997654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=155.85 Aligned_cols=144 Identities=19% Similarity=0.206 Sum_probs=112.5
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChh----------------------hHHHHHHHHHHHH
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ----------------------GLKEFKNEMMLIA 522 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~----------------------~~~~f~~E~~~l~ 522 (682)
.+......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444458888999999999999999888999999986542200 1123677899999
Q ss_pred hcCCCC--eeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCC
Q 005705 523 KLQHRN--LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (682)
Q Consensus 523 ~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlk 600 (682)
++.|++ +.+.++ ....++||||+++++|..... ......++.+++.++.++|+.+ |+|+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 444443 245689999999999876541 0334678899999999999987 9999999
Q ss_pred CCCEEEcCCCCeEEeeeccccccC
Q 005705 601 ASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-16 Score=154.94 Aligned_cols=131 Identities=23% Similarity=0.359 Sum_probs=107.3
Q ss_pred ccccCCceeEEEEEEcCCceEEEEEecccC---h-----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQS---G-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~---~-----~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.||+|+||.||+|.. ++..+++|...... + ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999865321 1 12356789999999999887665555556667789999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
++++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988873211 078999999999999998 99999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-17 Score=128.81 Aligned_cols=66 Identities=50% Similarity=1.105 Sum_probs=59.0
Q ss_pred cCCCCeeEEeccccCCCccchhcccccChHHHHHHhhcCCceEeEeeccccCCcceeecccccccc
Q 005705 294 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDA 359 (682)
Q Consensus 294 C~~~~~f~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~C~~w~~~l~~~ 359 (682)
|+.+|+|++|++|++|++....+..++++++|++.|++||||+||+|.++.++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 556799999999999999776666779999999999999999999998776779999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-16 Score=177.53 Aligned_cols=138 Identities=21% Similarity=0.326 Sum_probs=112.5
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEe-ccc-C------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL-SNQ-S------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l-~~~-~------~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
...|...+.||+|+||.||+|...+. .+++|+. .+. . ....+++.+|++++.+++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999987544 4444432 211 1 1123568899999999999999988888777778
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+++++|.+++. ....++.|++++|.+||+.+ ++||||||+|||+ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998873 34678999999999999998 9999999999999 67899999999998
Q ss_pred cc
Q 005705 622 MF 623 (682)
Q Consensus 622 ~~ 623 (682)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=139.67 Aligned_cols=135 Identities=21% Similarity=0.245 Sum_probs=114.4
Q ss_pred cccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 475 i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| +++.+++.+...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999998854 7899999866443 5678999999999976 58999998888778899999999988
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
.+..+ +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76433 4566678899999999999986444599999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4e-15 Score=144.40 Aligned_cols=137 Identities=20% Similarity=0.257 Sum_probs=98.7
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccChh--hHHH----------------------HHHHHHHHHhcCCCC--e
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLKE----------------------FKNEMMLIAKLQHRN--L 529 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~--~~~~----------------------f~~E~~~l~~l~Hpn--I 529 (682)
.+.||+|+||.||+|.+.+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 1111 135666666665433 4
Q ss_pred eeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcC
Q 005705 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDK 608 (682)
Q Consensus 530 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~ 608 (682)
.+.+++ ...++||||++++.+......... . ..+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 245899999999543221111000 1 15678899999999999999 76 99999999999999
Q ss_pred CCCeEEeeeccccccC
Q 005705 609 DMNPKISDFGLARMFG 624 (682)
Q Consensus 609 ~~~~kL~DFGla~~~~ 624 (682)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-14 Score=143.88 Aligned_cols=135 Identities=23% Similarity=0.279 Sum_probs=104.7
Q ss_pred cccc-cCCceeEEEEEEcCCceEEEEEecccC-------------hhhHHHHHHHHHHHHhcCCCCe--eeEEEEEEecC
Q 005705 477 CKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLLGCCVEQG 540 (682)
Q Consensus 477 ~~LG-~G~fG~Vyk~~~~~g~~vAVK~l~~~~-------------~~~~~~f~~E~~~l~~l~HpnI--v~l~~~~~~~~ 540 (682)
..|| .|+.|+||+++. ++..++||++.... ......+.+|+.++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 888999999877 47789999885311 1223567889999999998775 67777654332
Q ss_pred ----eEEEEEEecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEe
Q 005705 541 ----EKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (682)
Q Consensus 541 ----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 615 (682)
..++|||++++ .+|.+++.. ..++.. .+.||+.++.+||+.+ |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 22599999997 689888732 234443 3568999999999998 9999999999999998999999
Q ss_pred eecccccc
Q 005705 616 DFGLARMF 623 (682)
Q Consensus 616 DFGla~~~ 623 (682)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-15 Score=169.30 Aligned_cols=169 Identities=27% Similarity=0.347 Sum_probs=123.3
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..+|..++.|..|++|.||..+++. .+..|+|+-+... - .++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-i----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-I----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch-h----hhc---cccccCCccee------------------
Confidence 3578899999999999999998864 5678885533211 0 000 22222334333
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC---
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG--- 625 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~--- 625 (682)
|+-...+. .-+.++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++..-.
T Consensus 136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 22222231 11233322 378899999998 99999999999999999999999999876411
Q ss_pred ----------CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 005705 626 ----------DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSME 681 (682)
Q Consensus 626 ----------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~e 681 (682)
...+....+.+||+.|+|||++....|...+|.|++|+|+||.+-|+.||.-++-|
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 01122334679999999999999999999999999999999999999999887544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-15 Score=159.07 Aligned_cols=124 Identities=31% Similarity=0.440 Sum_probs=109.2
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++.|+++...+|.++|.........++...+.++.|++.+++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 467899999999999999766666678888999999999999999 55 999999999999999999999999998
Q ss_pred cccCCCc----cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc
Q 005705 621 RMFGGDE----LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670 (682)
Q Consensus 621 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 670 (682)
....... .....+...||..||+||.+.+..|+.|+||||||+||+|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7664433 2234556789999999999999999999999999999999997
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.6e-14 Score=153.82 Aligned_cols=154 Identities=32% Similarity=0.481 Sum_probs=127.4
Q ss_pred HHhcCCCCeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-EeccC
Q 005705 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI-IHRDL 599 (682)
Q Consensus 521 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i-iH~Dl 599 (682)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.-...++++|++||+|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 3568899999999999999999999999999999999965 3445888889999999999999999875 4 99999
Q ss_pred CCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCC-------CCccccHHHHHHHHHHHHcCC
Q 005705 600 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSSK 672 (682)
Q Consensus 600 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~k~DVwSlGvil~elltG~ 672 (682)
++.|++++....+||.|||+.................-..-|.|||.+.+.. .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987764211111111122345799999887642 467799999999999999999
Q ss_pred CCCCCCC
Q 005705 673 KNTGLGS 679 (682)
Q Consensus 673 ~pf~~~~ 679 (682)
.||....
T Consensus 156 ~~~~~~~ 162 (484)
T KOG1023|consen 156 GPFDLRN 162 (484)
T ss_pred Ccccccc
Confidence 9998754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-13 Score=139.37 Aligned_cols=144 Identities=24% Similarity=0.366 Sum_probs=105.5
Q ss_pred CCCCeeeEEEEEEec---------------------------CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHH
Q 005705 525 QHRNLVRLLGCCVEQ---------------------------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 577 (682)
Q Consensus 525 ~HpnIv~l~~~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 577 (682)
+|||||++.++|.++ ...|+||.-.+ .+|.+++.. +..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 599999998877542 25678877653 478888843 2355666777899
Q ss_pred HHHHHHHHHHhcCCCCcEeccCCCCCEEEc--CCC--CeEEeeeccccccCC--C--ccccccccccccccccCcccccC
Q 005705 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDM--NPKISDFGLARMFGG--D--ELQGNTKQIVGTYGYMSPEYALD 649 (682)
Q Consensus 578 qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~~kL~DFGla~~~~~--~--~~~~~~~~~~gt~~y~aPE~~~~ 649 (682)
|+++|+.|||+++ |.|||+|.+|||+. +++ .+.|+|||.+---.. - .+....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999994 333 378999997632111 1 11111122356778899998764
Q ss_pred CC-----C-CccccHHHHHHHHHHHHcCCCCCC
Q 005705 650 GL-----F-SIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 650 ~~-----~-s~k~DVwSlGvil~elltG~~pf~ 676 (682)
.+ . -.|+|.|+.|.+.||+++...||=
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY 458 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY 458 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence 32 1 258999999999999999998884
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.1e-13 Score=147.68 Aligned_cols=141 Identities=23% Similarity=0.278 Sum_probs=101.8
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChhhH----------------------------------------HHHHH
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL----------------------------------------KEFKN 516 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~----------------------------------------~~f~~ 516 (682)
+.||.|++|+||+|++.+|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999865321110 02455
Q ss_pred HHHHHHhcC----CCCeeeEEEEE-EecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 005705 517 EMMLIAKLQ----HRNLVRLLGCC-VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ-GLLYLHQYS 590 (682)
Q Consensus 517 E~~~l~~l~----HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~L~yLH~~~ 590 (682)
|+..+.+++ |.+-+.+-.++ ...+..+|||||++|++|.++...... .. .+..++.++++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666652 33333333333 234567999999999999887643211 12 23456666666 468889887
Q ss_pred CCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 591 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
++|+|+||.||+++.++.++++|||++..+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-14 Score=163.43 Aligned_cols=207 Identities=25% Similarity=0.327 Sum_probs=165.9
Q ss_pred hcCcccccccccCCceeEEEEEEcC--CceEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 544 (682)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456777889999999998886633 4456777665432 334455566777777776 9999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEeccCCCCCEEEcCCC-CeEEeeeccccc
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH-QYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARM 622 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~ 622 (682)
+.||..++++...+... .....+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999987776311 1113555666789999999999999 777 99999999999999999 999999999998
Q ss_pred cCC-Cccccccccccc-cccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 623 FGG-DELQGNTKQIVG-TYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 623 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 866 444444556688 9999999999885 446779999999999999999999987654
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=3e-13 Score=109.90 Aligned_cols=72 Identities=21% Similarity=0.359 Sum_probs=60.5
Q ss_pred cCCCCeeEEeccccCCCccchhcccccChHHHHHHhhc---CCceEeEeeccccCCcceeeccccc-ccccCcccCCCCc
Q 005705 294 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK---NCSCRAYANSNVKESSGCLMWYGDL-IDARRPIRNFTGQ 369 (682)
Q Consensus 294 C~~~~~f~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~~ 369 (682)
|.....|+++.++++|++.. ++++||++.|++ ||||+||+|.+. +++|++|++++ ++.+... ..+.
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~--~~g~ 74 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEF--SHGF 74 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhcc--CCCc
Confidence 34557899999999998754 689999999999 999999999753 36899999999 9988765 4578
Q ss_pred eEEEee
Q 005705 370 SVYLRV 375 (682)
Q Consensus 370 ~~ylrv 375 (682)
++|+|.
T Consensus 75 ~Ly~r~ 80 (80)
T cd00129 75 DLYENK 80 (80)
T ss_pred eeEeEC
Confidence 899973
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.6e-12 Score=108.37 Aligned_cols=80 Identities=41% Similarity=0.850 Sum_probs=64.3
Q ss_pred CcccCCC---CeeEEeccccCCCccchhcccccChHHHHHHhhcCCceEeEeeccccCCcceeecccccccccCcccCCC
Q 005705 291 SLECKSG---DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT 367 (682)
Q Consensus 291 ~l~C~~~---~~f~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~C~~w~~~l~~~~~~~~~~~ 367 (682)
+++|..+ +.|+++.++++|++.... ..+++++|++.|++||+|+||+|.+ ++++|++|.+.+.+.+... ..
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~~~~~~~~~--~~ 75 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN--GSGGCLLWNGLLNNLRSLS--SG 75 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC--CCCeEEEEeceecceEeec--CC
Confidence 3456544 689999999999885543 6789999999999999999999974 4689999999998876543 33
Q ss_pred CceEEEeec
Q 005705 368 GQSVYLRVP 376 (682)
Q Consensus 368 ~~~~ylrv~ 376 (682)
+.++|||++
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 568999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=9e-12 Score=137.79 Aligned_cols=145 Identities=19% Similarity=0.251 Sum_probs=97.9
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChh------------------------------hH----H--
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ------------------------------GL----K-- 512 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~------------------------------~~----~-- 512 (682)
...|+. +.||.|++|+||+|++++ |+.||||+.++.... .. +
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 799999999999999987 999999999754211 00 1
Q ss_pred ----HHHHHHHHHHhcC----CCCeeeEEEEEEe-cCeEEEEEEecCCCChhHHhhhcccc---CCCCHHHHHHHHHHHH
Q 005705 513 ----EFKNEMMLIAKLQ----HRNLVRLLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKK---RLLNWQARVRIIEGIA 580 (682)
Q Consensus 513 ----~f~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qi~ 580 (682)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++......+ ..+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 2445555555553 4444444444433 55788999999999997753211111 112233333333333
Q ss_pred HHHHHHHhcCCCCcEeccCCCCCEEEcCCC----CeEEeeeccccccCC
Q 005705 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFGLARMFGG 625 (682)
Q Consensus 581 ~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFGla~~~~~ 625 (682)
+..+ ++|+|+||.||+++.++ +++++|||++..+..
T Consensus 277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3455 99999999999999888 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.9e-12 Score=119.06 Aligned_cols=130 Identities=23% Similarity=0.200 Sum_probs=97.5
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCee-eEEEEEEecCeEEEEEEecCCCChh
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNKSLN 555 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gsL~ 555 (682)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+.++..+.+.+++ +++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 57899999999999874 77899999765432 223567899999998765554 44443 233458999999998875
Q ss_pred HHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 556 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 556 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
... . ....++.+++++|+.||+.+ +..++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 320 0 11245678999999999986 22369999999999999 67899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=2e-10 Score=110.79 Aligned_cols=136 Identities=15% Similarity=0.129 Sum_probs=99.0
Q ss_pred cccccCCceeEEEEEEcC-------CceEEEEEecccC----------------------hhhHHHHH----HHHHHHHh
Q 005705 477 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS----------------------GQGLKEFK----NEMMLIAK 523 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-------g~~vAVK~l~~~~----------------------~~~~~~f~----~E~~~l~~ 523 (682)
..||.|--+.||.|...+ +..+|||+.+... ....+.+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999997643 4799999764210 01122333 89999999
Q ss_pred cCC--CCeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEeccCC
Q 005705 524 LQH--RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL-HQYSRFRIIHRDLK 600 (682)
Q Consensus 524 l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~iiH~Dlk 600 (682)
+.. -++.+++++ ...++||||+.+..+..-.. +...++..+...+..+++.+|..| |+.+ |||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 953 456666654 46789999998754422111 112345566778889999999999 7777 9999999
Q ss_pred CCCEEEcCCCCeEEeeecccccc
Q 005705 601 ASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~~ 623 (682)
+.|||++ ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999988764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.8e-10 Score=112.33 Aligned_cols=142 Identities=18% Similarity=0.267 Sum_probs=110.2
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccCh-hhHHHHHHHHHHHHhcCC--CCeeeEEEEEEecC---eEEEEEEecC
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQG---EKILILEYMP 550 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H--pnIv~l~~~~~~~~---~~~lV~E~~~ 550 (682)
+.|+.|..+.||+++..+|+.+++|....... ....++..|++++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778999999765332 245678999999999976 44567777765532 5689999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS---------------------------------------- 590 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------- 590 (682)
+.++...+.. ..++..++..++.+++++|+.||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988665421 34677778888888999888888531
Q ss_pred -------------CCCcEeccCCCCCEEEcC--CCCeEEeeeccccc
Q 005705 591 -------------RFRIIHRDLKASNILLDK--DMNPKISDFGLARM 622 (682)
Q Consensus 591 -------------~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~ 622 (682)
+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.7e-10 Score=123.02 Aligned_cols=167 Identities=19% Similarity=0.241 Sum_probs=128.4
Q ss_pred EEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHH
Q 005705 491 RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ 570 (682)
Q Consensus 491 ~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 570 (682)
+..++.+|.|...+.......+...+-++.|+.++||||++++.....++..|+|+|-+ ..|..++.+ +...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHH
Confidence 34468889999887766544566788899999999999999999999999999999986 456666632 2355
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCC
Q 005705 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650 (682)
Q Consensus 571 ~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 650 (682)
.+.-.+.||+.||.+||+.+ .++|++|.-..|+++..|+.||++|.++....+... ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 66677899999999999776 599999999999999999999999998865433221 11111222356677755433
Q ss_pred CCCccccHHHHHHHHHHHHcC
Q 005705 651 LFSIKSDVFSFGILMLETLSS 671 (682)
Q Consensus 651 ~~s~k~DVwSlGvil~elltG 671 (682)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 3 346999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-09 Score=101.08 Aligned_cols=144 Identities=24% Similarity=0.315 Sum_probs=107.2
Q ss_pred cccccccCCceeEEEEEEcCCceEEEE-Eeccc--Ch-----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 475 MQCKLGEGGFGPVYKGRLLNGQEVAVK-RLSNQ--SG-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 475 i~~~LG~G~fG~Vyk~~~~~g~~vAVK-~l~~~--~~-----~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
....|-||+-+.|+++.. .|+.++|| ++.+. .+ -...+.++|+++|.+++--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 346899999999999987 67777777 44332 11 13456789999999997656555555566666778999
Q ss_pred EecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC---CeEEeeeccccc
Q 005705 547 EYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARM 622 (682)
Q Consensus 547 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~ 622 (682)
||+++ .++.+++......... .+....++.+|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4778887654333222 2333678899999999999998 99999999999997655 358999999875
Q ss_pred c
Q 005705 623 F 623 (682)
Q Consensus 623 ~ 623 (682)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-10 Score=125.59 Aligned_cols=201 Identities=26% Similarity=0.358 Sum_probs=156.1
Q ss_pred cCccccccccc--CCceeEEEEEE---cCCceEEEEEecc--cChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeE
Q 005705 471 ENFSMQCKLGE--GGFGPVYKGRL---LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 471 ~~y~i~~~LG~--G~fG~Vyk~~~---~~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 542 (682)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+. ..+.....=.+|+...++++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666788999 99999999976 3577899997433 22233333345666666664 99999988888888888
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEeccCCCCCEEEcCC-CCeEEeee
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ----GLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDF 617 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DF 617 (682)
++-+|... .+|..+... ....++...++.+..+..+ ||.++|... |+|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 88888864 677777643 3334777888888888888 999999998 9999999999999999 89999999
Q ss_pred ccccccCCCcccccc---ccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 618 GLARMFGGDELQGNT---KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 618 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
|+...+......... ....|...|++|| +....++.++|+|++|.+..|...+..+...+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChh-hhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 999988665432211 2236788999999 45567788999999999999999988777655
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.4e-09 Score=99.69 Aligned_cols=132 Identities=22% Similarity=0.338 Sum_probs=102.1
Q ss_pred cccccCCceeEEEEEEcCCceEEEEE-eccc--Chh-----hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQ--SGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~-l~~~--~~~-----~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..+.+|+-+.+|.+... |.++++|. +++. .+. ...+-.+|+.++.+++--.|.-..-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999664 44566763 3221 111 234567899999999866666556666778888999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+++..|.+.+... ...++..+-..+.-||..+ |+|+||.++||++..+. +.++||||+..-
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888432 2457778888899999998 99999999999998765 999999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.6e-10 Score=128.09 Aligned_cols=209 Identities=20% Similarity=0.244 Sum_probs=148.3
Q ss_pred hhhcCcccccccccCCceeEEEEEEcC-CceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
...+.+.+.+-+-.|.++.++.++-.. |...+.|..... .....+....+-.++-..+||-+++..--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345778888899999999999875432 333333332211 1112233333433333345566665554444556788
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
|+++|..+++|...|+.. ...+..-....+..+.++++|||... +.|+|++|.|++...+++.++.||+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999998887432 24555555666777889999999986 899999999999999999999999844332
Q ss_pred CC-------------------------Cccc----cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCC
Q 005705 624 GG-------------------------DELQ----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674 (682)
Q Consensus 624 ~~-------------------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p 674 (682)
.. .... .......+|+.|.+||...+......+|.|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0000 112235789999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 005705 675 TGLGSMER 682 (682)
Q Consensus 675 f~~~~~e~ 682 (682)
|.-.+.+|
T Consensus 1035 ~na~tpq~ 1042 (1205)
T KOG0606|consen 1035 FNAETPQQ 1042 (1205)
T ss_pred CCCcchhh
Confidence 98876553
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.3e-09 Score=108.70 Aligned_cols=153 Identities=25% Similarity=0.314 Sum_probs=115.6
Q ss_pred HHHhcCCCCeeeEEEEEEec-----CeEEEEEEecCCCChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005705 520 LIAKLQHRNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593 (682)
Q Consensus 520 ~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 593 (682)
-|-.+-|.|||+++.|+.+. .+..++.|||+.|+|..+|.+..+ ...+......+++.||+.||.|||+.. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 44456799999999988654 356889999999999999976443 345778888899999999999999986 56
Q ss_pred cEeccCCCCCEEEcCCCCeEEeeeccccccC---CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc
Q 005705 594 IIHRDLKASNILLDKDMNPKISDFGLARMFG---GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670 (682)
Q Consensus 594 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 670 (682)
|+|+++..+-|++..++-+|+.-- -..... ............+-++|.|||.=.....+.++|||+||+...||--
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999988887421 111111 0111122233456789999997766677889999999999999977
Q ss_pred CCCC
Q 005705 671 SKKN 674 (682)
Q Consensus 671 G~~p 674 (682)
+..-
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 6543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.7e-08 Score=98.48 Aligned_cols=133 Identities=17% Similarity=0.151 Sum_probs=97.1
Q ss_pred eeEEEEEEcCCceEEEEEecccChh-----------hHHHHHHHHHHHHhcCCCC--eeeEEEEEEe-----cCeEEEEE
Q 005705 485 GPVYKGRLLNGQEVAVKRLSNQSGQ-----------GLKEFKNEMMLIAKLQHRN--LVRLLGCCVE-----QGEKILIL 546 (682)
Q Consensus 485 G~Vyk~~~~~g~~vAVK~l~~~~~~-----------~~~~f~~E~~~l~~l~Hpn--Iv~l~~~~~~-----~~~~~lV~ 546 (682)
..|++.+. +|+.+.||+....... ....+.+|...+.++...+ ..+++++... ....++|+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34667655 6778999977433211 1124778999998885333 3455555543 23578999
Q ss_pred EecCCC-ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-------CCCeEEeeec
Q 005705 547 EYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------DMNPKISDFG 618 (682)
Q Consensus 547 E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kL~DFG 618 (682)
|++++. +|.+++.... ....+......++.+++..+.-||..+ |+|+|++++|||++. +..+.|+||+
T Consensus 115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999986 8988874321 234556777889999999999999998 999999999999975 4679999999
Q ss_pred cccc
Q 005705 619 LARM 622 (682)
Q Consensus 619 la~~ 622 (682)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.6e-08 Score=95.80 Aligned_cols=125 Identities=26% Similarity=0.298 Sum_probs=82.6
Q ss_pred eEEEEEEcCCceEEEEEecccC-------------h-------------hhHHHHHHHHHHHHhcCCC--CeeeEEEEEE
Q 005705 486 PVYKGRLLNGQEVAVKRLSNQS-------------G-------------QGLKEFKNEMMLIAKLQHR--NLVRLLGCCV 537 (682)
Q Consensus 486 ~Vyk~~~~~g~~vAVK~l~~~~-------------~-------------~~~~~f~~E~~~l~~l~Hp--nIv~l~~~~~ 537 (682)
.||.|...+|..+|||+.+... . ......++|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999899999999874311 0 0123467899999999765 45666644
Q ss_pred ecCeEEEEEEecC--CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 538 EQGEKILILEYMP--NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY-LHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 538 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
....+||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999999 65665443211 1123445677778885555 56776 9999999999999988 9999
Q ss_pred eeecccccc
Q 005705 615 SDFGLARMF 623 (682)
Q Consensus 615 ~DFGla~~~ 623 (682)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.2e-09 Score=116.09 Aligned_cols=198 Identities=22% Similarity=0.252 Sum_probs=149.8
Q ss_pred hhcCcccccccccCCceeEEEEEE--cCCceEEEEEecccChhhHHHH--HHHHHHHHhc-CCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKEF--KNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~--~~g~~vAVK~l~~~~~~~~~~f--~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 543 (682)
...+|..+..||.|.|+.|++... .++..+++|.+.+......++. ..|+.+...+ .|.+++++...+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456788889999999999998854 3577899998866543322222 3455555555 5888998888777777888
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC-CCeEEeeeccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARM 622 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla~~ 622 (682)
+=-||++++++...+ .....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 889999999887665 23345788888999999999999999887 9999999999999886 7889999999864
Q ss_pred cCCCcccccccccccccccc--CcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYM--SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
+.-. ........+++ +|+......+..++|++|||.-+.|.+++.+.-+.
T Consensus 417 ~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~ 468 (524)
T KOG0601|consen 417 LAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES 468 (524)
T ss_pred ccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc
Confidence 3111 11122333444 45555567788999999999999999998765543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2e-07 Score=98.91 Aligned_cols=169 Identities=20% Similarity=0.290 Sum_probs=127.6
Q ss_pred ceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEE----ecCeEEEEEEecCC-CChhHH
Q 005705 484 FGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV----EQGEKILILEYMPN-KSLNVF 557 (682)
Q Consensus 484 fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~ 557 (682)
-.+.||+.. .||..+++|+++....+.......-++.++++.|+|+|++.+++. .+...++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356888865 579999999995543333333345678899999999999999886 34478899999986 567766
Q ss_pred hhhc------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 558 LFDS------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 558 l~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
-+.. ..+...++..++.++.|+..||.++|+.| +.-+-|.|++||++.+.+++|..-|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5432 12345888999999999999999999998 88899999999999988888887776655432
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p 674 (682)
+.. |-+.+ -.+-|.=.||.+++.|-||...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 2357999999999999999654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.7e-07 Score=92.62 Aligned_cols=136 Identities=21% Similarity=0.222 Sum_probs=98.2
Q ss_pred CcccccccccCCceeEEEEEEcCCceEEEEEecccC----------------------hhhHHHHHHHHHHHHhcCCC--
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------------GQGLKEFKNEMMLIAKLQHR-- 527 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----------------------~~~~~~f~~E~~~l~~l~Hp-- 527 (682)
=..+..+||-|--+.||.|..+.|.++|||.-+... .-.....++|.++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 355678999999999999999999999999543211 01233457899999999654
Q ss_pred CeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc
Q 005705 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (682)
Q Consensus 528 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~ 607 (682)
.+.+.++. +...+||||+++-.|...- ++.+..-.++..|+.-+.-+-..| |||+|+.+=||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 56666653 4668999999997764332 122233334444555554444555 99999999999999
Q ss_pred CCCCeEEeeeccccc
Q 005705 608 KDMNPKISDFGLARM 622 (682)
Q Consensus 608 ~~~~~kL~DFGla~~ 622 (682)
++|.+.++||-.+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.5e-07 Score=102.01 Aligned_cols=145 Identities=17% Similarity=0.229 Sum_probs=97.7
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChh------------------------------hHH--------
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ------------------------------GLK-------- 512 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~------------------------------~~~-------- 512 (682)
..|+. +.|+.++-|+||+|++++|+.||||+.++.-.. ..+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 44543 589999999999999999999999988643211 011
Q ss_pred --HHHHHHHHHHhcC-----CCCeeeEEEEE-EecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHH-H
Q 005705 513 --EFKNEMMLIAKLQ-----HRNLVRLLGCC-VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG-L 583 (682)
Q Consensus 513 --~f~~E~~~l~~l~-----HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~-L 583 (682)
+|.+|+.-+.+++ .|++ ++=.++ .-.+..+|+|||++|-.+.++..... ...+.+.+ +..++++ +
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~i---a~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKEL---AELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHH---HHHHHHHHH
Confidence 2445666666653 2333 333333 33567899999999999988853322 33553333 3333332 2
Q ss_pred HHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 584 ~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
..+-..+ ++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2222344 99999999999999999999999999987754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.6e-07 Score=93.84 Aligned_cols=193 Identities=14% Similarity=0.149 Sum_probs=128.5
Q ss_pred ccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEE------EEecC-eEEEE
Q 005705 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC------CVEQG-EKILI 545 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~------~~~~~-~~~lV 545 (682)
...+.||+|+-+.+|-.- .-...+.|+.+...+....+.. ..|.+. .||-+-.=+.+ .-+++ ..-++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345789999999999542 2223456777665444333322 233333 45543321111 01122 24567
Q ss_pred EEecCCCC-hhHHhh---hccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 546 LEYMPNKS-LNVFLF---DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 546 ~E~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
|..+++.. ...+.. ..+.....+|.-+++.++.++.+.+.||..| .+-+|+.++|+|+++++.+.|+|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776653 222322 1223345889999999999999999999998 8899999999999999999999966544
Q ss_pred ccCCCccccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcC-CCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSS-KKNTGL 677 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG-~~pf~~ 677 (682)
...+. ......+|.+.|.+||.-. +..-+...|-|.|||+++++|.| ++||+-
T Consensus 166 i~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 INANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 43211 1223357889999999643 33346778999999999999996 999974
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.57 E-value=6.1e-07 Score=79.07 Aligned_cols=100 Identities=25% Similarity=0.404 Sum_probs=69.0
Q ss_pred CeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEec-CCCCCCcCCCceEEEecCCcEEEecCCCCeEEEEeccCC
Q 005705 38 EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVA-NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSE 116 (682)
Q Consensus 38 ~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~ 116 (682)
+.+.+.+|.+.|-|..+|+ |.|.- . ..+++|.. +...... ..+.+.|+.||||||+|..+.++|+|.. .
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~-~-~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLYD-S-NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEEE-T-TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred cccccccccccceECCCCe-----EEEEc-C-CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence 4566655899999988875 44442 2 35779999 5444433 3688999999999999999999999942 3
Q ss_pred cCCceEEEec--CCceEEecCCCCCCCccceeeecCCCc
Q 005705 117 VKNPVAQLRD--DGNLVIRDNSSGNATESYLWQSFDYPT 153 (682)
Q Consensus 117 ~~~~~~~l~d--~gnlvl~~~~~~~~~~~~~WqsFd~Pt 153 (682)
...+.+..++ +||++ +.. ...+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~-----~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKN-----DSLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EES-----TSSEEEESS----
T ss_pred CccEEEeccCcccCCCc-ccc-----ceEEeECCCCCCC
Confidence 4567778888 99999 654 2357898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=6.8e-07 Score=88.03 Aligned_cols=107 Identities=24% Similarity=0.268 Sum_probs=84.4
Q ss_pred HHHHHHHHHHHHhcCC--CCeeeEEEEEEecC----eEEEEEEecCCC-ChhHHhhhccccCCCCHHHHHHHHHHHHHHH
Q 005705 511 LKEFKNEMMLIAKLQH--RNLVRLLGCCVEQG----EKILILEYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583 (682)
Q Consensus 511 ~~~f~~E~~~l~~l~H--pnIv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L 583 (682)
.....+|...+.++.. -...+.+++..... ..++|+|++++. +|.+++..... ++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3457788888888853 34556666665532 458999999984 79998843222 56677788999999999
Q ss_pred HHHHhcCCCCcEeccCCCCCEEEcCCC---CeEEeeecccccc
Q 005705 584 LYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMF 623 (682)
Q Consensus 584 ~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~~ 623 (682)
+-||+.+ |+|+|++|.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.8e-06 Score=83.64 Aligned_cols=139 Identities=16% Similarity=0.174 Sum_probs=103.3
Q ss_pred cccCCceeEEEEEEcCCceEEEEEeccc------ChhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEec----CeEEEEE
Q 005705 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQ------SGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQ----GEKILIL 546 (682)
Q Consensus 479 LG~G~fG~Vyk~~~~~g~~vAVK~l~~~------~~~~~~~f~~E~~~l~~l~H--pnIv~l~~~~~~~----~~~~lV~ 546 (682)
-|+||.+-|++-.+ +|+.+-+|+-.+. -+.....|.+|...|.++.. -.+.+.+...... -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46688899999776 4457889987532 14466789999999999953 3344544222221 1457999
Q ss_pred EecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC--eEEeeeccccc
Q 005705 547 EYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLARM 622 (682)
Q Consensus 547 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kL~DFGla~~ 622 (682)
|-+++ .+|.+++.+.. ....+...+..++.++++.++-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 58888874322 234677788899999999999999998 999999999999986667 99999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.9e-06 Score=82.45 Aligned_cols=140 Identities=16% Similarity=0.177 Sum_probs=85.6
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEecCeEEEEEEecCCCC-
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCVEQGEKILILEYMPNKS- 553 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs- 553 (682)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+.+....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 35567889886533 2345688999999886433 4667777777777789999999963
Q ss_pred hhHHhh--------------h-----ccc-cCCCCHHHHH-HHHHHH----------HH-HHHHHHhc-CCCCcEeccCC
Q 005705 554 LNVFLF--------------D-----STK-KRLLNWQARV-RIIEGI----------AQ-GLLYLHQY-SRFRIIHRDLK 600 (682)
Q Consensus 554 L~~~l~--------------~-----~~~-~~~l~~~~~~-~i~~qi----------~~-~L~yLH~~-~~~~iiH~Dlk 600 (682)
+...+. . +.- .......... .+..++ .+ ..++|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 000 0011111100 110000 01 11222211 12347899999
Q ss_pred CCCEEEcCCCCeEEeeeccccc
Q 005705 601 ASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~ 622 (682)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.9e-06 Score=79.48 Aligned_cols=137 Identities=17% Similarity=0.206 Sum_probs=92.4
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHH---------HHHHHHHHhcCC---CCeeeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF---------KNEMMLIAKLQH---RNLVRLLGCCV 537 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f---------~~E~~~l~~l~H---pnIv~l~~~~~ 537 (682)
..+|.+.+++-......|.+-.. +|+.+++|..+.......+.| .+++..+.+++. -.+..++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46788878887777777777665 678999998876543322222 234444444432 22333333322
Q ss_pred -----ecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCe
Q 005705 538 -----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 612 (682)
Q Consensus 538 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 612 (682)
.....+++|||++|..|.++.. +++ .++..+.+++.-||+.| +.|+|.+|.|++++.+ .+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 2235678999999998866531 222 24566778899999998 9999999999999865 49
Q ss_pred EEeeeccccc
Q 005705 613 KISDFGLARM 622 (682)
Q Consensus 613 kL~DFGla~~ 622 (682)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.3e-06 Score=71.24 Aligned_cols=72 Identities=38% Similarity=0.761 Sum_probs=52.9
Q ss_pred CeeEEeccccCCCccchhcccccChHHHHHHhhc-CCceEeEeeccccCCcceeecc-cccccccCcccCCCCceEEEe
Q 005705 298 DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK-NCSCRAYANSNVKESSGCLMWY-GDLIDARRPIRNFTGQSVYLR 374 (682)
Q Consensus 298 ~~f~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~~~~C~~w~-~~l~~~~~~~~~~~~~~~ylr 374 (682)
..|.++.++.+++..... ....++++|++.|++ +|+|.||.|.. .+++|.+|. +.+.+..... ..+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~~~~--~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDARLFP--SGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccceecc--cCCceeEEe
Confidence 569999999998664432 346799999999999 99999999975 568999999 6666554222 234445543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=8.3e-06 Score=89.80 Aligned_cols=140 Identities=20% Similarity=0.237 Sum_probs=92.2
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChhh-------------------------------H------HHHHHHHH
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------------------L------KEFKNEMM 519 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~-------------------------------~------~~f~~E~~ 519 (682)
+.|+..+.|+||+|++++|+.||||+-++.-... . -+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999876532110 0 02455555
Q ss_pred HHHhc----CCCC---eeeEEEEEE-ecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHH-HhcC
Q 005705 520 LIAKL----QHRN---LVRLLGCCV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL-HQYS 590 (682)
Q Consensus 520 ~l~~l----~Hpn---Iv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~ 590 (682)
-..+. +|-+ -|.+=.++. -...++|+||||+|..+.+.-.-. +..++...+ +..+.++...+ -..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i---~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHDI---LNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 55444 3545 122223332 235789999999999877664322 223555543 33344432222 2233
Q ss_pred CCCcEeccCCCCCEEEcC----CCCeEEeeeccccccC
Q 005705 591 RFRIIHRDLKASNILLDK----DMNPKISDFGLARMFG 624 (682)
Q Consensus 591 ~~~iiH~Dlkp~NILl~~----~~~~kL~DFGla~~~~ 624 (682)
++|+|-+|.||++.. +.++.+.|||+...+.
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 6789999999988764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.7e-05 Score=79.29 Aligned_cols=144 Identities=22% Similarity=0.227 Sum_probs=84.9
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCC--CeeeEEEEEEe---cCeEEEEEEecC
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGCCVE---QGEKILILEYMP 550 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~~~~~~---~~~~~lV~E~~~ 550 (682)
++.|+.|..+.||+....+ +.+++|..... .....+.+|+.++..+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999998866 69999997654 4556778888888888533 35566664432 235689999999
Q ss_pred CCChhH----------------Hh---hhc-cccCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005705 551 NKSLNV----------------FL---FDS-TKKRLLNWQA---------RVRI------------IEGIAQ-GLLYLHQ 588 (682)
Q Consensus 551 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~qi~~-~L~yLH~ 588 (682)
+..+.. .+ +.. .......... .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 11 011 0000001000 0000 111222 2333332
Q ss_pred ----cCCCCcEeccCCCCCEEEc-CCCCeEEeeeccccc
Q 005705 589 ----YSRFRIIHRDLKASNILLD-KDMNPKISDFGLARM 622 (682)
Q Consensus 589 ----~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~ 622 (682)
..+..++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1334599999999999999 566668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.9e-06 Score=76.20 Aligned_cols=55 Identities=31% Similarity=0.584 Sum_probs=44.1
Q ss_pred eEEEecCCcEEEecCC-CCeEEEEeccCCc-CCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 89 VLTISNNGNLVLLNQT-NGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 89 ~l~~~~~g~lvl~~~~-~~~~w~s~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
.+.++.||+||+++.. +.++|++++.... ....+.|+++|||||++.. +.++|+|
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S 79 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSS 79 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEe
Confidence 4667789999999865 5899999986543 3367899999999999863 4679998
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.9e-05 Score=79.99 Aligned_cols=141 Identities=14% Similarity=0.132 Sum_probs=85.4
Q ss_pred ccccCCc-eeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEEEecCCCChh
Q 005705 478 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLN 555 (682)
Q Consensus 478 ~LG~G~f-G~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 555 (682)
.|-.|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444444 788998764 4788889876543 345677888888884 444667777776666789999999998876
Q ss_pred HHhh-------------------hccc-cCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 005705 556 VFLF-------------------DSTK-KRLLNW--QARVRIIE--------------------GIAQGLLYLHQ----Y 589 (682)
Q Consensus 556 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------qi~~~L~yLH~----~ 589 (682)
.... .... ...... ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4320 0000 001110 00000000 01111222211 1
Q ss_pred CCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 590 ~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999987789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.9e-06 Score=74.41 Aligned_cols=55 Identities=31% Similarity=0.533 Sum_probs=43.6
Q ss_pred eEEEec-CCcEEEecCC-CCeEEEEeccCC-cCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 89 VLTISN-NGNLVLLNQT-NGTIWSTNVSSE-VKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 89 ~l~~~~-~g~lvl~~~~-~~~~w~s~~~~~-~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
.+.++. ||+||+++.. +.++|++|+... .....+.|+++|||||++.+ +.++|+|
T Consensus 23 ~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S 80 (116)
T cd00028 23 KLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSS 80 (116)
T ss_pred cCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEe
Confidence 355676 9999999865 589999998653 34567899999999999863 3679987
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.5e-05 Score=77.00 Aligned_cols=105 Identities=22% Similarity=0.239 Sum_probs=83.3
Q ss_pred HHHHHHHHhcCC-CCeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005705 515 KNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593 (682)
Q Consensus 515 ~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 593 (682)
.+|..++..+++ +++.+++|.| ..+++.||...+++...-..-..-...+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888976 6999999998 34788999987765422000011224789999999999999999999865556
Q ss_pred cEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 594 IIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 594 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+...|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=5e-05 Score=74.72 Aligned_cols=152 Identities=19% Similarity=0.237 Sum_probs=99.5
Q ss_pred chhHHHhhhcCccccc---ccccCCceeEEEEEEcCCceEEEEEecccChhh-------------------HHH-----H
Q 005705 462 SLASITAATENFSMQC---KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------LKE-----F 514 (682)
Q Consensus 462 ~~~~~~~~~~~y~i~~---~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~-------------------~~~-----f 514 (682)
+...+....++..+.. .|+.|--+.||+|...++..+|||+++...... .++ -
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3444444444444433 567788889999988889999999986432111 011 2
Q ss_pred HHHHHHHHhcC--CCCeeeEEEEEEecCeEEEEEEecCCCChh-HHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005705 515 KNEMMLIAKLQ--HRNLVRLLGCCVEQGEKILILEYMPNKSLN-VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591 (682)
Q Consensus 515 ~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~ 591 (682)
..|..-|.++. +-.+.+.+.+. ...|||||+....+- -.| +...+...+...+..++++.+.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 45777777764 33444444442 457999999765211 011 1122333356777888888888877633
Q ss_pred CCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 592 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
.+||+||..=|||+. ++.+.|+||+.|....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8899999999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.3e-07 Score=96.20 Aligned_cols=188 Identities=16% Similarity=0.114 Sum_probs=133.1
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~ 548 (682)
+.-+....-+++++.++++|.+....+....+.+... ....-++++|.+++||| .++.++-+..+...++++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3444445678899999999986543333334444322 34456888999999999 77777777777788899999
Q ss_pred cCCC--ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 549 MPNK--SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 549 ~~~g--sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
...+ +..+.. ...-.+..-+...+.+.-++++++||+.. =+|+| ||+..+ +..+..||+.+..+...
T Consensus 316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 8776 221111 11112333444556666778899999864 48888 777765 68999999998876543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
. ..+...+++.++|||+..+..+..+.|+|++++-..++--|-+|-.
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2 3455688999999999999999999999999987777766766643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.0001 Score=87.76 Aligned_cols=79 Identities=18% Similarity=0.397 Sum_probs=58.0
Q ss_pred ccccccCCceeEEEEEEcCC---ceEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCe--eeEEEEEEec---CeEEEE
Q 005705 476 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLLGCCVEQ---GEKILI 545 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g---~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnI--v~l~~~~~~~---~~~~lV 545 (682)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877554 467888764432 123456889999999995 6654 7788877664 457899
Q ss_pred EEecCCCCh
Q 005705 546 LEYMPNKSL 554 (682)
Q Consensus 546 ~E~~~~gsL 554 (682)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.6e-06 Score=95.52 Aligned_cols=98 Identities=23% Similarity=0.456 Sum_probs=76.3
Q ss_pred HHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC-cc-----ccc-cccccccccccCcccccCC
Q 005705 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD-EL-----QGN-TKQIVGTYGYMSPEYALDG 650 (682)
Q Consensus 578 qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~-~~-----~~~-~~~~~gt~~y~aPE~~~~~ 650 (682)
+++.|+.|+|... ++||++|.|++|.++.++..||+.|+.+....+. ++ ... ..-......|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4559999999876 6999999999999999999999999988765431 11 111 1112335689999999998
Q ss_pred CCCccccHHHHHHHHHHHH-cCCCCCCC
Q 005705 651 LFSIKSDVFSFGILMLETL-SSKKNTGL 677 (682)
Q Consensus 651 ~~s~k~DVwSlGvil~ell-tG~~pf~~ 677 (682)
..+.++|++|+|+++|-+. .|+.-++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhc
Confidence 8899999999999999998 45554443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=70.37 Aligned_cols=133 Identities=18% Similarity=0.258 Sum_probs=93.7
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccC----------------hhhHHHHHHHHHHHHhcC------CCCeeeEE
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLL 533 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----------------~~~~~~f~~E~~~l~~l~------HpnIv~l~ 533 (682)
...||+|+.-.||. +++.....||+..... ....+++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999995 6667778889886544 123456677777666665 78899999
Q ss_pred EEEEecCeEEEEEEecCC--C----ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc
Q 005705 534 GCCVEQGEKILILEYMPN--K----SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (682)
Q Consensus 534 ~~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~ 607 (682)
|....+-..-+|+|.+.+ | +|.+++ +...++. ...+. +-+-..||-+.. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999998888899998853 2 466676 3334555 33333 334455666665 99999999999996
Q ss_pred CCC----CeEEee-ecccc
Q 005705 608 KDM----NPKISD-FGLAR 621 (682)
Q Consensus 608 ~~~----~~kL~D-FGla~ 621 (682)
... .+.|+| ||-..
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 432 577887 45443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00019 Score=74.87 Aligned_cols=77 Identities=13% Similarity=0.120 Sum_probs=57.1
Q ss_pred cccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCC---CCeeeEEEEEEec---CeEEEEEEe
Q 005705 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGCCVEQ---GEKILILEY 548 (682)
Q Consensus 475 i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H---pnIv~l~~~~~~~---~~~~lV~E~ 548 (682)
-.+.||+|..+.||+....++ .+.+|..+.. .....|..|+..|+.+.. ..+.++++++..+ +..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 346899999999999876555 4677775431 123578899999998853 3677888877543 568999999
Q ss_pred cCCCCh
Q 005705 549 MPNKSL 554 (682)
Q Consensus 549 ~~~gsL 554 (682)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.0001 Score=68.63 Aligned_cols=129 Identities=20% Similarity=0.275 Sum_probs=89.6
Q ss_pred ccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeee-EEEEEEecCeEEEEEEecCCC
Q 005705 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR-LLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lV~E~~~~g 552 (682)
...+.|++|.+|.||++.. .|..+|+|.-+. +.....+..|+++|..++-.++.+ ++.|. .-++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 4457899999999999988 455889998654 345678999999999998776654 34332 234559999998
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCC-CCCEEEcCCCCeEEeeeccccc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK-ASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlk-p~NILl~~~~~~kL~DFGla~~ 622 (682)
.|.+.-.. .+.+++. .+++.---|...+ |-|+.|. |..++|-.+..+.|+||..|..
T Consensus 98 ~L~~~~~~------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIG------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhc------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88766421 1222333 3444434445555 8888886 5656666666999999999974
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0001 Score=74.23 Aligned_cols=73 Identities=12% Similarity=0.177 Sum_probs=46.0
Q ss_pred cccccCCce-eEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCC---CeeeEEEEEEec---CeEEEEEEec
Q 005705 477 CKLGEGGFG-PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCVEQ---GEKILILEYM 549 (682)
Q Consensus 477 ~~LG~G~fG-~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hp---nIv~l~~~~~~~---~~~~lV~E~~ 549 (682)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|++++..+... .+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457767766 48875 245778876542 2345788999999888532 234444433322 1347899999
Q ss_pred CCCChh
Q 005705 550 PNKSLN 555 (682)
Q Consensus 550 ~~gsL~ 555 (682)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00025 Score=71.29 Aligned_cols=141 Identities=18% Similarity=0.235 Sum_probs=81.8
Q ss_pred cccccCCceeEEEEEEcC--CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCee-eEEEEEEecCeEEEEEEecCCCC
Q 005705 477 CKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNKS 553 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gs 553 (682)
+.|..|-...+|+....+ ++.+++|+........ -.-.+|+.++..+...+++ +++... + ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~-~---~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATF-Q---NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEe-C---CcEEEEeeCCCc
Confidence 567888888999987654 6789999876433221 2235788888888544443 343332 2 247999999877
Q ss_pred hhHH-------h----------hhcccc--------CCCC-HHHHHHHHHH----------------------HHHHHHH
Q 005705 554 LNVF-------L----------FDSTKK--------RLLN-WQARVRIIEG----------------------IAQGLLY 585 (682)
Q Consensus 554 L~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~q----------------------i~~~L~y 585 (682)
+... + +..... .... +..+..+... +.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 1 110000 0111 1222222111 1111111
Q ss_pred ----HHhc-CCCCcEeccCCCCCEEEcC-CCCeEEeeeccccc
Q 005705 586 ----LHQY-SRFRIIHRDLKASNILLDK-DMNPKISDFGLARM 622 (682)
Q Consensus 586 ----LH~~-~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~ 622 (682)
+... .+..++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 2235899999999999998 57899999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0003 Score=71.74 Aligned_cols=139 Identities=14% Similarity=0.107 Sum_probs=79.5
Q ss_pred ccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCee-eEEEEEEecCeEEEEEEecCCCChhH
Q 005705 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNKSLNV 556 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gsL~~ 556 (682)
.+..|-...+|+... +++.+++|..........-...+|..+++.+....++ +++... . ..+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 456677888998873 5678889986543322112357788888888644333 333332 2 368999999876542
Q ss_pred H--------------h---hhcc-ccCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCcEeccCCCCC
Q 005705 557 F--------------L---FDST-KKRLLNWQA-RVRIIEGI---------AQGLLYLHQY-----SRFRIIHRDLKASN 603 (682)
Q Consensus 557 ~--------------l---~~~~-~~~~l~~~~-~~~i~~qi---------~~~L~yLH~~-----~~~~iiH~Dlkp~N 603 (682)
- + +... ....++... +..+..++ .+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1 1110 111122211 11211111 1112222111 12348999999999
Q ss_pred EEEcCCCCeEEeeeccccc
Q 005705 604 ILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 604 ILl~~~~~~kL~DFGla~~ 622 (682)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00078 Score=72.46 Aligned_cols=75 Identities=13% Similarity=0.194 Sum_probs=54.2
Q ss_pred cccccCCceeEEEEEEcCC-ceEEEEEeccc-----C--hhhHHHHHHHHHHHHhcC-C--CCeeeEEEEEEecCeEEEE
Q 005705 477 CKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-----S--GQGLKEFKNEMMLIAKLQ-H--RNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~~-----~--~~~~~~f~~E~~~l~~l~-H--pnIv~l~~~~~~~~~~~lV 545 (682)
+.||.|.+..||++...+| +.++||.-... . +-..+++..|.+.|..+. + .++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 58999985421 1 224567778888888863 2 346666665 44557899
Q ss_pred EEecCCCC
Q 005705 546 LEYMPNKS 553 (682)
Q Consensus 546 ~E~~~~gs 553 (682)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00078 Score=64.97 Aligned_cols=125 Identities=24% Similarity=0.399 Sum_probs=89.7
Q ss_pred cCcccccccccCCc-eeEEEEEEcCCceEEEEEecc---cC-----------h-------hhHHHHHHHHHHHHhcC---
Q 005705 471 ENFSMQCKLGEGGF-GPVYKGRLLNGQEVAVKRLSN---QS-----------G-------QGLKEFKNEMMLIAKLQ--- 525 (682)
Q Consensus 471 ~~y~i~~~LG~G~f-G~Vyk~~~~~g~~vAVK~l~~---~~-----------~-------~~~~~f~~E~~~l~~l~--- 525 (682)
.+++.++.||.|.- |.|||++. +|+.+|+|.++. .. + ...+-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 99999998 678999999421 00 0 11235788988888885
Q ss_pred CCCe--eeEEEEEEecC------------------eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHH
Q 005705 526 HRNL--VRLLGCCVEQG------------------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585 (682)
Q Consensus 526 HpnI--v~l~~~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~y 585 (682)
+.++ |+.+|+..-.. ...+|.||++... .+. .+-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 3456 89999874220 2346777765532 122 2234567788888
Q ss_pred HHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 586 LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99888 999999999986 3589999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0048 Score=65.09 Aligned_cols=142 Identities=19% Similarity=0.218 Sum_probs=76.6
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCC--CeeeEEE------EEEecCeEEEEEEe
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLG------CCVEQGEKILILEY 548 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~~------~~~~~~~~~lV~E~ 548 (682)
+.|..|....+|+.+..+| .+++|+..... .+....|+.++..|... .+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4567777789999876555 78899876222 23333455555555321 1333332 12234567899999
Q ss_pred cCCCChhH-----------Hh---hhccc--------cCCCCH-HHHHH------------HH-HHHHHHHHHHHhc---
Q 005705 549 MPNKSLNV-----------FL---FDSTK--------KRLLNW-QARVR------------II-EGIAQGLLYLHQY--- 589 (682)
Q Consensus 549 ~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~------------i~-~qi~~~L~yLH~~--- 589 (682)
++|..+.. .+ +.... ...+.+ ..... .+ ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875311 11 11000 001111 11111 11 1111122333211
Q ss_pred -CCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 590 -SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 590 -~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
-+..+||+|++|.||+++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 133599999999999999766668999998854
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0016 Score=68.22 Aligned_cols=142 Identities=26% Similarity=0.318 Sum_probs=83.4
Q ss_pred cccccCCceeEEEEEEcC-------CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCee-eEEEEEEecCeEEEEEEe
Q 005705 477 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEY 548 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~ 548 (682)
+.|..|-...+|+....+ ++.+++|+...... ...+..+|.+++..+....+. ++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 456667777899887654 47899999765432 223457788888888543333 4444442 2 358999
Q ss_pred cCCCChhHHh-----------------hhccccC------CCC--HHHHHH--------------------------HHH
Q 005705 549 MPNKSLNVFL-----------------FDSTKKR------LLN--WQARVR--------------------------IIE 577 (682)
Q Consensus 549 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 577 (682)
++|..+.... +...... ..+ +..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764310 1100000 000 111111 111
Q ss_pred HHHHHHHHHHh------cCCCCcEeccCCCCCEEEcCC----CCeEEeeecccccc
Q 005705 578 GIAQGLLYLHQ------YSRFRIIHRDLKASNILLDKD----MNPKISDFGLARMF 623 (682)
Q Consensus 578 qi~~~L~yLH~------~~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~~ 623 (682)
.+...++.|.. ..+..++|+|+.|.|||++++ +.++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22223334432 134468999999999999985 88999999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0065 Score=63.31 Aligned_cols=143 Identities=18% Similarity=0.185 Sum_probs=85.4
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEE------EEecCeEEEEEE
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CVEQGEKILILE 547 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lV~E 547 (682)
.+.|..|....+|+.... +..+++|+.... ...+...|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 457778887899998764 457889987652 2355667888888775332 4444331 123456689999
Q ss_pred ecCCCChhH----Hh----------hhccc--------cCCCCHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 005705 548 YMPNKSLNV----FL----------FDSTK--------KRLLNWQARV----------RIIEGIAQGLLYLHQY----SR 591 (682)
Q Consensus 548 ~~~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~qi~~~L~yLH~~----~~ 591 (682)
|++|..+.. .. +.... .....|.... .....+..++.++.+. -+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 11 10000 0011111110 0111233344444431 12
Q ss_pred CCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 592 FRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 592 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0053 Score=63.84 Aligned_cols=127 Identities=20% Similarity=0.283 Sum_probs=79.3
Q ss_pred eEEEEEEcCCceEEEEEecc--cChhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEecC--eEEEEEEecCCCChhHHhh
Q 005705 486 PVYKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQG--EKILILEYMPNKSLNVFLF 559 (682)
Q Consensus 486 ~Vyk~~~~~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~H--pnIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~ 559 (682)
.+|.... ++++++++ ... ..........+|..+|+.+.- .-+.+.+++|.++. ..+.||+|.+|..+...+.
T Consensus 40 ~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 3444433 37788888 331 222344556778888888743 34455677776665 6799999999864322221
Q ss_pred hccccCCCCHHHHHHHH-HHHHHHHHHHHhc-------------------------------------------------
Q 005705 560 DSTKKRLLNWQARVRII-EGIAQGLLYLHQY------------------------------------------------- 589 (682)
Q Consensus 560 ~~~~~~~l~~~~~~~i~-~qi~~~L~yLH~~------------------------------------------------- 589 (682)
.. ... .+++ ..+++.|+-||+.
T Consensus 118 ~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 118 PE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred cc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 00 000 1112 2444555555531
Q ss_pred ------CCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 590 ------SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 590 ------~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++..++|+|+++.||+++.++.+-|.||+++..
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 224589999999999999999999999999875
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0052 Score=65.48 Aligned_cols=142 Identities=18% Similarity=0.246 Sum_probs=83.0
Q ss_pred cccccCCceeEEEEEEcC-----CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCee-eEEEEEEecCeEEEEEEecC
Q 005705 477 CKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMP 550 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~ 550 (682)
+.|-.|-.-.+|+....+ ++.+++|+.........++ .+|..++..+...++. ++++.+. .+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEeeC
Confidence 355557778899887532 3678999886654433333 6788888888654443 4455442 22 5899998
Q ss_pred CCChhHH-------h----------hhcc-c--cCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 005705 551 NKSLNVF-------L----------FDST-K--KRLLNWQARVRIIEGI-----------------AQGLLYL----HQ- 588 (682)
Q Consensus 551 ~gsL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~qi-----------------~~~L~yL----H~- 588 (682)
+.+|..- + +... . .....+.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 0 1100 0 0112233333333221 1112222 11
Q ss_pred cCCCCcEeccCCCCCEEEcC-CCCeEEeeecccccc
Q 005705 589 YSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMF 623 (682)
Q Consensus 589 ~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~ 623 (682)
..+..++|+|+++.|||+++ ++.+.|+||..+..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 12235899999999999986 468999999988753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.018 Score=60.36 Aligned_cols=144 Identities=20% Similarity=0.228 Sum_probs=81.9
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCC--CeeeEEEE------EEecCeEEEEEE
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGC------CVEQGEKILILE 547 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~~~------~~~~~~~~lV~E 547 (682)
.+.++.|....+|+.+..++ .+++|+.+... ..++...|++++..|... .+.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789999876444 67788875432 123445666777776422 23344331 122456789999
Q ss_pred ecCCCChhH-----------Hh---hhcccc---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005705 548 YMPNKSLNV-----------FL---FDSTKK---------RLLNWQARV------------RIIEGIAQGLLYLHQ---- 588 (682)
Q Consensus 548 ~~~~gsL~~-----------~l---~~~~~~---------~~l~~~~~~------------~i~~qi~~~L~yLH~---- 588 (682)
|++|..+.. .+ +..... ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865321 11 110000 001111100 011123344555542
Q ss_pred cCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 589 ~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
.-+..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1234599999999999999888778999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0079 Score=61.99 Aligned_cols=30 Identities=30% Similarity=0.581 Sum_probs=25.7
Q ss_pred CcEeccCCCCCEEEcCCCC-eEEeeeccccc
Q 005705 593 RIIHRDLKASNILLDKDMN-PKISDFGLARM 622 (682)
Q Consensus 593 ~iiH~Dlkp~NILl~~~~~-~kL~DFGla~~ 622 (682)
.++|+|++|.|||++++++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0017 Score=66.28 Aligned_cols=135 Identities=14% Similarity=0.161 Sum_probs=93.6
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEeccc-----------------Ch-h----hHHHHHHHHHHHHhcCC--
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-----------------SG-Q----GLKEFKNEMMLIAKLQH-- 526 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~-----------------~~-~----~~~~f~~E~~~l~~l~H-- 526 (682)
.-+.+.++||-|.-+.+|.+-..+|++.++|.-+-. .. . ..-...+|.+.|+.|..
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 346788999999999999999988999999843210 00 0 11234678888888853
Q ss_pred CCeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 527 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
-.+.+.+++ +..++|||++.+-.|...- ...+..+ +...+...+--|..+| +||+|+.-=||++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 234445443 4668999999988875442 1223333 3333444455666677 9999999999999
Q ss_pred cCCCCeEEeeecccc
Q 005705 607 DKDMNPKISDFGLAR 621 (682)
Q Consensus 607 ~~~~~~kL~DFGla~ 621 (682)
++++.++++||-...
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999997543
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0019 Score=51.85 Aligned_cols=49 Identities=18% Similarity=0.349 Sum_probs=35.3
Q ss_pred ccccCCCccchhcccccChHHHHHHhhcCCceEeEeeccccCCcceeecccc
Q 005705 304 DEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGD 355 (682)
Q Consensus 304 ~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~C~~w~~~ 355 (682)
.++.++.+..... ...+.++|++.|+.+|+|.||.|.. +.+.|+++...
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~--~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT--KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC--CCCeEEcccCC
Confidence 3444444332222 3568999999999999999999973 45789998765
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.014 Score=60.37 Aligned_cols=74 Identities=18% Similarity=0.226 Sum_probs=48.8
Q ss_pred cccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 475 i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
-.+.|+.|....+|+.. .+++.+.||.-.. .....|..|+.-|+.|. --.+.+++++...++..+|||||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34678989999999987 5788999998762 33456888888888884 34577888888777777999999987
Q ss_pred C
Q 005705 552 K 552 (682)
Q Consensus 552 g 552 (682)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.016 Score=60.37 Aligned_cols=142 Identities=18% Similarity=0.195 Sum_probs=97.2
Q ss_pred ccccccccCCceeEEEEEEcCCceEEEEEecccC----------------------hhhHHH----HHHHHHHHHhcCCC
Q 005705 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------------GQGLKE----FKNEMMLIAKLQHR 527 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----------------------~~~~~~----f~~E~~~l~~l~Hp 527 (682)
.+...|..|--+.||.+.-.+|..+|||+++..- ...++. ...|+.-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3446889999999999999999999999875310 001111 24577778887644
Q ss_pred CeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc
Q 005705 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (682)
Q Consensus 528 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~ 607 (682)
.|.-.--... ...+|||+|+...... ....+...++...+..+-.|++.-|.-|-+.+ ++||.||.-=|+|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY- 298 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-
Confidence 4321111111 1357999999643211 11123345777788888899999999998877 59999999999998
Q ss_pred CCCCeEEeeecccccc
Q 005705 608 KDMNPKISDFGLARMF 623 (682)
Q Consensus 608 ~~~~~kL~DFGla~~~ 623 (682)
.+|.+.|+|-+.+...
T Consensus 299 hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEH 314 (520)
T ss_pred ECCEEEEEEccccccC
Confidence 5678999999887654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.026 Score=59.62 Aligned_cols=79 Identities=14% Similarity=0.166 Sum_probs=50.1
Q ss_pred ccccCCceeEEEEEEcCC-ceEEEEEeccc-------ChhhHHHHHHHHHHHHhcC--CCC-eeeEEEEEEecCeEEEEE
Q 005705 478 KLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQ--HRN-LVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~~-------~~~~~~~f~~E~~~l~~l~--Hpn-Iv~l~~~~~~~~~~~lV~ 546 (682)
.||.|....||++..++| +.|+||.-... -+-..++..-|...|.... -|. +.+++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 589999999999998654 68999965321 1233455556777776653 354 344443 3455667999
Q ss_pred EecCCC-ChhHHh
Q 005705 547 EYMPNK-SLNVFL 558 (682)
Q Consensus 547 E~~~~g-sL~~~l 558 (682)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.046 Score=58.83 Aligned_cols=73 Identities=10% Similarity=0.059 Sum_probs=49.5
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEeccc----C---hhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEecCeEEEE
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----S---GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~----~---~~~~~~f~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV 545 (682)
.+.||.|.--.||+... +++.++||+-... . +....+-..|+..|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999876 4567999976521 1 123344444566666553 246777887766 446788
Q ss_pred EEecCC
Q 005705 546 LEYMPN 551 (682)
Q Consensus 546 ~E~~~~ 551 (682)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.00075 Score=80.64 Aligned_cols=160 Identities=11% Similarity=-0.028 Sum_probs=114.4
Q ss_pred HHHHHHHHHhcCCCCeeeEEEEEE--ecCeEEEEEEecCCCChhHHhhhcccc-CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 005705 514 FKNEMMLIAKLQHRNLVRLLGCCV--EQGEKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYS 590 (682)
Q Consensus 514 f~~E~~~l~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ 590 (682)
...|...++..+|+++.....-.. +..+-+.+++|+..|.+...+....++ +.++..-+.....+......-.|++.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445555666778998877655433 234567889999999999887554433 33444333333333355555555443
Q ss_pred C--CCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHH
Q 005705 591 R--FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 668 (682)
Q Consensus 591 ~--~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~el 668 (682)
. ..-+|+++|+-|.+|..+.++|+.++|+.+..... ........+++.|++|+....-.++.|+|+|..|+.+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2 34799999999999999999999999999843221 2233445778899999998888999999999999999999
Q ss_pred HcCCCCC
Q 005705 669 LSSKKNT 675 (682)
Q Consensus 669 ltG~~pf 675 (682)
..|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.033 Score=59.07 Aligned_cols=142 Identities=17% Similarity=0.246 Sum_probs=80.6
Q ss_pred cccccCCceeEEEEEEcC----CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCee-eEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~ 551 (682)
+.|..|-.-.+|+....+ +..+++|+.......... -.+|..++..+..-++. ++++++ ..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcC
Confidence 455557777889886543 237899988665433222 36788888888655553 455544 222 58999987
Q ss_pred CChhHH-------h----------hhcc---ccCCCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 005705 552 KSLNVF-------L----------FDST---KKRLLNWQARVRIIEGI----------------------AQGLLYLH-- 587 (682)
Q Consensus 552 gsL~~~-------l----------~~~~---~~~~l~~~~~~~i~~qi----------------------~~~L~yLH-- 587 (682)
..|..- + +... ......+..+.++..++ .+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 1100 00011233333332221 11111111
Q ss_pred --h-cCCCCcEeccCCCCCEEEcC-CCCeEEeeecccccc
Q 005705 588 --Q-YSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMF 623 (682)
Q Consensus 588 --~-~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~ 623 (682)
. ..+.-+.|.|+.+.|||+++ ++.++++||..|..-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 1 11224799999999999975 578999999988653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.019 Score=67.76 Aligned_cols=157 Identities=19% Similarity=0.190 Sum_probs=111.0
Q ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE----EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH
Q 005705 512 KEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587 (682)
Q Consensus 512 ~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH 587 (682)
....-|...+.++.|+|++.++.+-.++...- +..|++...++...+ .....++....+.+..++..||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHH
Confidence 34456778888899999999999887654332 345667777776666 33456888999999999999999999
Q ss_pred hcCCCCcEeccCCCC---CEEEcCCCCeEEe--eeccccccCCCccccccccccccccccCcccccCCCCCcc--ccHHH
Q 005705 588 QYSRFRIIHRDLKAS---NILLDKDMNPKIS--DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK--SDVFS 660 (682)
Q Consensus 588 ~~~~~~iiH~Dlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k--~DVwS 660 (682)
+.. ..|.-+... +--.+.++.+.+. ||+..+.+..... ......+..+.+||......+..+ .|+|.
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHH
Confidence 885 555544444 4444556667776 8888877643321 112234567888888776666544 79999
Q ss_pred HHHHHHHHHcCCCCCCC
Q 005705 661 FGILMLETLSSKKNTGL 677 (682)
Q Consensus 661 lGvil~elltG~~pf~~ 677 (682)
+|..+..+..|..+-..
T Consensus 378 lgll~~~~~~~~~i~~~ 394 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEK 394 (1351)
T ss_pred HHHHHhhhhhcCccccc
Confidence 99999999998776543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.01 Score=58.56 Aligned_cols=30 Identities=40% Similarity=0.567 Sum_probs=21.5
Q ss_pred CcEeccCCCCCEEE-cCCCCeEEeeeccccc
Q 005705 593 RIIHRDLKASNILL-DKDMNPKISDFGLARM 622 (682)
Q Consensus 593 ~iiH~Dlkp~NILl-~~~~~~kL~DFGla~~ 622 (682)
.+.|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47999999999999 8899999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 682 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-111
Identities = 89/228 (39%), Positives = 125/228 (54%), Gaps = 15/228 (6%)
Query: 458 LPLFSLASITAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSN----QS 507
FS + T NF + K+GEGGFG VYKG + N VAVK+L+ +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 508 GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL 567
+ ++F E+ ++AK QH NLV LLG + + L+ YMPN SL L L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+W R +I +G A G+ +LH+ IHRD+K++NILLD+ KISDFGLAR
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675
T +IVGT YM+PE L G + KSD++SFG+++LE ++
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-108
Identities = 92/221 (41%), Positives = 138/221 (62%), Gaps = 3/221 (1%)
Query: 457 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFK 515
L FSL + A++NFS + LG GGFG VYKGRL +G VAVKRL + QG + +F+
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 516 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-LNWQARVR 574
E+ +I+ HRNL+RL G C+ E++L+ YM N S+ L + + + L+W R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
I G A+GL YLH + +IIHRD+KA+NILLD++ + DFGLA++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA- 194
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675
+ GT G+++PEY G S K+DVF +G+++LE ++ ++
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-100
Identities = 86/215 (40%), Positives = 134/215 (62%), Gaps = 4/215 (1%)
Query: 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 520
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-LNWQARVRIIEGI 579
++ +H +LV L+G C E+ E ILI +YM N +L L+ S + ++W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
A+GL YLH + IIHRD+K+ NILLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674
GY+ PEY + G + KSDV+SFG+++ E L ++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 7e-81
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 22/232 (9%)
Query: 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 520
++ + + G FG V+K +L + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 521 IAKLQHRNLVRLLGCCVE----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
+ ++H N+++ +G + LI + SL+ FL K +++W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 577 EGIAQGLLYLHQ-------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629
E +A+GL YLH+ + I HRD+K+ N+LL ++ I+DFGLA F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 630 GNTKQIVGTYGYMSPEYALDGL-----FSIKSDVFSFGILMLETLSSKKNTG 676
G+T VGT YM+PE + ++ D+++ G+++ E S
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 9e-69
Identities = 64/244 (26%), Positives = 107/244 (43%), Gaps = 32/244 (13%)
Query: 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 520
+ + + +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 521 IAKLQHRNLVRLLGCCVE-----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 575
+ ++H N+ R + + E +L++EY PN SL +L +W + R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 576 IEGIAQGLLYLHQ------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG---- 625
+ +GL YLH + + I HRDL + N+L+ D ISDFGL+ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 626 --DELQGNTKQIVGTYGYMSPEYALDGLFSI--------KSDVFSFGILMLETLSSKKNT 675
E VGT YM+PE L+G ++ + D+++ G++ E +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 676 GLGS 679
G
Sbjct: 236 FPGE 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-64
Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 6/204 (2%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 528
+ +++ K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V +G + ++ EY+ SL L S + L+ + R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
I+HR+LK+ N+L+DK K+ DFGL+R+ L +K GT +M+PE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212
Query: 649 DGLFSIKSDVFSFGILMLETLSSK 672
D + KSDV+SFG+++ E + +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQ 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-60
Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRL----SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G GGFG VY+ G EVAVK Q ++ + E L A L+H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G C+++ L++E+ LN L + + V IA+G+ YLH +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 594 IIHRDLKASNILLDKDMNP--------KISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
IIHRDLK+SNIL+ + + KI+DFGLAR + G Y +M+PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
+FS SDV+S+G+L+ E L+ +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-60
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ ++ +G G FG V K + ++VA+K++ ++S K F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C+ L++EY SL L + + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 591 RFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+IHRDLK N+LL KI DFG A ++Q + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 650 GLFSIKSDVFSFGILMLETLSSKK 673
+S K DVFS+GI++ E ++ +K
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK 201
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-60
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
LG+G FG K G+ + +K L + + F E+ ++ L+H N+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ I EY+ +L + W RV + IA G+ YLH IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQ------------GNTKQIVGTYGYMSP 644
RDL + N L+ ++ N ++DFGLAR+ ++ Q +VG +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 645 EYALDGLFSIKSDVFSFGILMLETLSSKK 673
E + K DVFSFGI++ E +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 8e-59
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 528
++ ++G G FG VYKG+ +G +VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
++ +G I + ++ SL L + + + I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA 138
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE--- 645
S IIHRDLK++NI L +D KI DFGLA +Q+ G+ +M+PE
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
+S +SDV++FGI++ E ++ +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-58
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 528
+ + KL E G ++KGR G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 529 LVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++ +LG C I +MP SL L + T + + V+ +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H I L + ++++D+DM +IS + F + + +++PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178
Query: 647 ALDG----LFSIKSDVFSFGILMLETLSSK 672
AL +D++SF +L+ E ++ +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-58
Identities = 59/218 (27%), Positives = 113/218 (51%), Gaps = 25/218 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-------LKEFKNEMMLIA 522
+ ++G+GGFG V+KGRL+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
L H N+V+L G +++E++P L L D K + W ++R++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARMFGGDELQGNTKQIVG 637
+ Y+ I+HRDL++ NI L + K++DFGL++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 638 TYGYMSPE--YALDGLFSIKSDVFSFGILMLETLSSKK 673
+ +M+PE A + ++ K+D +SF +++ L+ +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-55
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G+G FG VY GR +G EVA++ + + + LK FK E+M + +H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
C+ +I ++L + D K +L+ +I + I +G+ YLH I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---VGTYGYMSPE------- 645
H+DLK+ N+ D + I+DFGL + G + ++ G +++PE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 646 --YALDGLFSIKSDVFSFGILMLETLSSK 672
FS SDVF+ G + E + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-54
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 27/226 (11%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHR 527
+ ++ +G+G +G V++G G+ VAVK S++ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 528 NLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
N++ + + LI Y SL +L + L+ + +RI+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 584 LYLHQYSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIV 636
+LH I HRDLK+ NIL+ K+ I+D GLA M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 637 GTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSSKKNTG 676
GT YM+PE + D+++FG+++ E + G
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-52
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRN 528
+ M ++G+G +G V+ G+ G++VAVK + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 529 LVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
++ + ++ LI +Y N SL +L K L+ ++ +++ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 585 YLHQYSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVG 637
+LH I HRDLK+ NIL+ K+ I+D GLA F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 638 TYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLS 670
T YM PE LD I +D++SFG+++ E
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRNLVRL 532
+Q +G+G FG V++G+ G+EVAVK S++ + + E + L+H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101
Query: 533 LGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ + L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 589 YSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGY 641
I HRDLK+ NIL+ K+ I+D GLA D + VGT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 642 MSPEYALDGL-------FSIKSDVFSFGILMLETLS 670
M+PE LD ++D+++ G++ E
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-49
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 528
E+ + ++G G FG V+ GRL + VAVK +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+VRL+G C ++ +++E + FL T+ L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEY 646
IHRDL A N L+ + KISDFG++R G +Q+ + +PE
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
G +S +SDV+SFGIL+ ET S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-48
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
LGEG FG V G+ VAVK L ++ Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 525 QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
H ++++ GCC + G L++EY+P SL +L + + + + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGT 638
+ YLH ++ IHRDL A N+LLD D KI DFGLA+ ++ + V
Sbjct: 147 MAYLH--AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-- 201
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +PE + F SDV+SFG+ + E L+
Sbjct: 202 -FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-48
Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 27/215 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 525
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 526 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 579
H N+V+ G C G + LI+EY+P SL +L +LL + + I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 154
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQI 635
+G+ YL ++ R IHRDL NIL++ + KI DFGL ++ D+ ++ +
Sbjct: 155 CKGMEYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ + +PE + FS+ SDV+SFG+++ E +
Sbjct: 212 I---FWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 27/215 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 525
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 526 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 579
H N+V+ G C G + LI+EY+P SL +L +LL + + I
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 123
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQI 635
+G+ YL ++ R IHRDL NIL++ + KI DFGL ++ D+ ++ +
Sbjct: 124 CKGMEYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ + +PE + FS+ SDV+SFG+++ E +
Sbjct: 181 I---FWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 525
+ +LG+G FG V R G VAVK+L + ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 526 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 579
+V+ G G + L++EY+P+ L FL RLL + + I
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
+G+ YL SR R +HRDL A NIL++ + + KI+DFGLA++ D+ +V
Sbjct: 137 CKGMEYLG--SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREP 189
Query: 640 G-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
G + +PE D +FS +SDV+SFG+++ E +
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-47
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
LGEG FG V R G++VAVK L G + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 525 QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEG 578
H N+V+ G C E G LI+E++P+ SL +L + K+ L +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------Q 134
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQ 634
I +G+ YL + +HRDL A N+L++ + KI DFGL + D+ ++ +
Sbjct: 135 ICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
V + +PE + F I SDV+SFG+ + E L+
Sbjct: 192 PV---FWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-47
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C+EQ L+ E+M + L+ +L T++ L + + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
+IHRDL A N L+ ++ K+SDFG+ R D+ TK V + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
+S KSDV+SFG+LM E S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-47
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRLSNQSGQGLKEFKNEMMLIAKL 524
+ ++ +LGEG FG V+ N VAVK L + + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQA 571
QH ++V+ G C + I++ EYM + LN FL K L
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 628
+ I IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
G+T + +M PE + F+ +SDV+SFG+++ E +
Sbjct: 192 GGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-47
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 531 RLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LLG VE+ + I EYM SL +L S + +L ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMS 643
+HRDL A N+L+ +D K+SDFGL + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 182
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE + FS KSDV+SFGIL+ E S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 38/219 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 580
+ ++ RLLG C+ ++ I + MP L ++ + + LLNW IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+G+ YL R++HRDL A N+L+ + KI+DFGLA++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 641 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS 670
M+ E L +++ +SDV+S+G+ + E ++
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E ++ +LG G FG V G+ +VAVK + + EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+ G C ++ ++ EY+ N L +L + + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
+ IHRDL A N L+D+D+ K+SDFG+ R D+ TK V + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFH 178
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
+S KSDV++FGILM E S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKEFKNEMMLIAKL 524
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL------------FDSTKKRLLNWQAR 572
QH+++VR G C E +++ EYM + LN FL + L
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQ 629
+ + +A G++YL + +HRDL N L+ + + KI DFG++R ++ D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
G T + +M PE L F+ +SDV+SFG+++ E +
Sbjct: 218 GRTMLPI---RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
++ + +LG G FG V G+ +VA+K + + EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C +Q +I EYM N L +L + Q + + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
+ +HRDL A N L++ K+SDFGL+R DE +K V + PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
FS KSD+++FG+LM E S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-46
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 531 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LLG VE+ + ++ EYM SL +L S + +L ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+HRDL A N+L+ +D K+SDFGL + Q K V + +PE +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360
Query: 650 GLFSIKSDVFSFGILMLETLS 670
FS KSDV+SFGIL+ E S
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 76/223 (34%), Positives = 110/223 (49%), Gaps = 29/223 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+LGE FG VYKG L Q VA+K L G +EF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQ 570
LQH N+V LLG + +I Y + L+ FL D T K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--E 627
V ++ IA G+ YL S ++H+DL N+L+ +N KISD GL R ++ D +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
L GN+ + +M+PE + G FSI SD++S+G+++ E S
Sbjct: 186 LLGNSLLPI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-46
Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+ +M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V+LLG C + +I E+M +L +L + ++ ++ + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYA 647
+ IHRDL A N L+ ++ K++DFGL+R+ GD K + + +PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
FSIKSDV++FG+L+ E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL ++ I I EYM N SL FL + L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
IHRDL+A+NIL+ ++ KI+DFGLAR+ +E + K + + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAIN 183
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
++ +G G G V GRL VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N++RL G +++ EYM N SL+ FL T V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY---- 641
L S +HRDL A N+L+D ++ K+SDFGL+R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 642 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 670
+PE FS SDV+SFG++M E L+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKL 524
LG G FG V+KG + E V +K + ++SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 580
H ++VRLLG C ++ + +Y+P SL + + LLNW IA
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIA 125
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+G+ YL ++HR+L A N+LL +++DFG+A + D+ KQ++ +
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEA 177
Query: 641 -----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+ E G ++ +SDV+S+G+ + E ++
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-45
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG G FG V+ +VAVK + ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L ++ I I E+M SL FL + + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
+ IHRDL+A+NIL+ + KI+DFGLAR+ +E + K + + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAIN 358
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
G F+IKSDV+SFGIL++E ++
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-45
Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 23/217 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL--SNQSGQGLKEFKNEMMLIAKL 524
+ LGEG FG V +G L VAVK + N S + ++EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 525 QHRNLVRLLGCCVEQG-----EKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRII 576
H N++RLLG C+E + ++IL +M L+ +L S T + + Q ++ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 633
IA G+ YL S +HRDL A N +L DM ++DFGL++ ++ GD K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
V +++ E D +++ KSDV++FG+ M E +
Sbjct: 211 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-45
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H N++RL G + ++I EYM N +L+ FL K + V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---- 640
YL + +HRDL A NIL++ ++ K+SDFGL+R+ D T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 641 --YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +PE F+ SDV+SFGI+M E ++
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 523
E +M +LG+G FG VY+G + VA+K + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------FDSTKKRLLNWQARVRII 576
++VRLLG + ++I+E M L +L ++ + +++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 633
IA G+ YL + + +HRDL A N ++ +D KI DFG+ R ++ D G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
V +MSPE DG+F+ SDV+SFG+++ E +
Sbjct: 202 LPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 34/223 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKL-Q 525
+ Q +GEG FG V K R+ A+KR+ S ++F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQAR 572
H N++ LLG C +G L +EY P+ +L FL ++ L+ Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632
+ +A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 633 KQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
G +M+ E +++ SDV+S+G+L+ E +S
Sbjct: 200 M------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
+G+G FG VY G ++ + A+K L Q ++ F E +L+ L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 526 HRNLVRLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H N++ L+G + + L YM + L F+ +R + + +A+G+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGME 138
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---- 640
YL + + +HRDL A N +LD+ K++DFGLAR E + +
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ---HRHARLPV 192
Query: 641 -YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ + E F+ KSDV+SFG+L+ E L+
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-44
Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 7/201 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+ +M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V+LLG C + +I E+M +L +L ++ ++ + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+ IHR+L A N L+ ++ K++DFGL+R+ GD + + +PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 650 GLFSIKSDVFSFGILMLETLS 670
FSIKSDV++FG+L+ E +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 524
+ F++ LG+G FG V + +L +VAVK L + ++EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 525 QHRNLVRLLGCCVEQGEKI------LILEYMPNKSLNVFLFDS---TKKRLLNWQARVRI 575
H ++ +L+G + K +IL +M + L+ FL S L Q VR
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNT 632
+ IA G+ YL S IHRDL A N +L +DM ++DFGL+R ++ GD +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
K V +++ E D L+++ SDV++FG+ M E ++
Sbjct: 200 KLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 521
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 522 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-- 578
+ +H+N++ LLG C + G +I+EY +L +L + R+ E
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 579 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 626
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFGLAR + D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 627 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ T G +M+PE D +++ +SDV+SFG+LM E +
Sbjct: 212 YYKKTTN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 68/234 (29%), Positives = 111/234 (47%), Gaps = 43/234 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+N + LGEG FG V K + VAVK L N S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL---------------------FDST 562
+ H ++++L G C + G +LI+EY SL FL D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 563 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 621
+R L + I+QG+ YL + +++HRDL A NIL+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 622 MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
++ D ++ G +M+ E D +++ +SDV+SFG+L+ E ++
Sbjct: 200 VYEEDSYVKRSQ------GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
N +GEG FG V++ R VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL---------------------FDST 562
+ N+V+LLG C L+ EYM LN FL S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 563 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 621
L+ ++ I +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 622 MFGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
++ D + GN + +M PE ++ +SDV+++G+++ E S
Sbjct: 224 IYSADYYKADGNDAIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-44
Identities = 71/297 (23%), Positives = 131/297 (44%), Gaps = 50/297 (16%)
Query: 404 VFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSW-LPLFS 462
+ RR+ + + ++ + L+ ++ T T + + + W P
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS-EYELPEDPKWEFPR-- 80
Query: 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKE 513
+ ++ LGEG FG V + VAVK L + + + L +
Sbjct: 81 --------DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132
Query: 514 FKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------F 559
+EM ++ + +H+N++ LLG C + G +I+EY +L +L
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 560 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
+ + + ++ V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFGL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 620 AR-MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
AR + D + T G +M+PE D +++ +SDV+SFG+LM E +
Sbjct: 250 ARDINNIDYYKKTTN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLNWQARVRIIEGI 579
H+N+VR +G ++ + +++E M L FL ++ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 633
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
V +M PE ++G+F+ K+D +SFG+L+ E S
Sbjct: 207 LPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+ + LG G FG V + + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 524 L-QHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG--- 578
+ H N+V LLG C + G + +I+E+ +L+ +L + + A + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 579 ----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDE 627
+A+G+ +L + + IHRDL A NILL + KI DFGLAR ++ +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 628 LQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 204 YVRKGD------ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 5e-44
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 478 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 533 LGCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
LG C+ L +L YM + L F+ + + + +A+G+ YL +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPE 645
+ +HRDL A N +LD+ K++DFGLAR D + G +M+ E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
F+ KSDV+SFG+L+ E ++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-44
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 475 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 531 RLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
RL+G C Q E +++ +E L+ FL K+ + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMS 643
+HRDL A N+LL KISDFGL++ G D+ + +
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYA 181
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE FS +SDV+S+G+ M E LS
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-44
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 38/219 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 580
+ ++ RLLG C+ ++ I + MP L ++ + + LLNW IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+G+ YL R++HRDL A N+L+ + KI+DFGLA++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 641 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS 670
M+ E L +++ +SDV+S+G+ + E ++
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLNWQARVRIIEGI 579
H+N+VR +G ++ + ++LE M L FL ++ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 633
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
V +M PE ++G+F+ K+D +SFG+L+ E S
Sbjct: 248 LPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
N S+ +G G FG V GRL + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N++RL G + +++ EYM N SL+ FL V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY---- 641
L S +HRDL A NIL++ ++ K+SDFGL R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----------EAAYTTR 208
Query: 642 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 670
SPE F+ SDV+S+GI++ E +S
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H ++V+L+G E I I+E L FL +K L+ + + ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 643
L R +HRD+ A N+L+ + K+ DFGL+R K + +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE F+ SDV+ FG+ M E L
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 38/229 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 523
S LG G FG V + + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 578
L H N+V LLG C G ++I EY L FL + + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 579 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 626
+A+G+ +L + IHRDL A NILL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 627 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE + +++ +SDV+S+GI + E S
Sbjct: 200 NYVVKGN------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 478 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 533 LGCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
LG C+ L +L YM + L F+ + + + +A+G+ +L +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPEY 646
+ +HRDL A N +LD+ K++DFGLAR E T +M+ E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN---KTGAKLPVKWMALES 267
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
F+ KSDV+SFG+L+ E ++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 38/222 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 522
E+ LG+G F ++KG L+ EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
KL H++LV G CV E IL+ E++ SL+ +L K +N ++ + + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNP--------KISDFGLARMFGGDELQGNTKQ 634
+ +L +IH ++ A NILL ++ + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 635 IVGTYGY-----MSPEYALDG-LFSIKSDVFSFGILMLETLS 670
+ PE + ++ +D +SFG + E S
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 478 KLGEGGFGPVYKGRLLNG---QEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+LG G FG V KG + VAVK L E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
+G C + E L++E LN +L + R + + + ++ ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEYA 647
+HRDL A N+LL KISDFGL++ DE Q + K V + +PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPECI 192
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
FS KSDV+SFG+LM E S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAK 523
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L HRNL+RL G + K+ + E P SL L + R +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGM 134
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YG 640
YL R IHRDL A N+LL KI DFGL R ++ ++ +
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +PE FS SD + FG+ + E +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-43
Identities = 70/200 (35%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 651 LFSIKSDVFSFGILMLETLS 670
F+IKSDV+SFGIL+ E +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
E+ + LGEG FG VY+G N + VAVK + + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H ++V+L+G E+ I I+E P L +L K L V I + + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 643
L +HRD+ NIL+ K+ DFGL+R ++ T+ + +MS
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMS 182
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE F+ SDV+ F + M E LS
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-43
Identities = 70/200 (35%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 651 LFSIKSDVFSFGILMLETLS 670
F+IKSDV+SFGIL+ E +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 66/229 (28%), Positives = 108/229 (47%), Gaps = 38/229 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SNQSGQGLKEFKNEMMLI 521
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 522 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-- 578
+ +H+N++ LLG C + G +I+EY +L +L L E
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 579 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 626
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 627 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ T G +M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 246 YYKKTTN------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 523
N LG G FG V + + VAVK L S + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTKKRLLNWQA 571
L QH N+V LLG C G ++I EY L FL + + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQG 630
+ +AQG+ +L + IHRD+ A N+LL KI DFGLAR +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 631 NTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++++SDV+S+GIL+ E S
Sbjct: 223 KGN------ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-42
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+F +G GGFG V+K + ++G+ +KR+ + ++ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 530 VRLLGCCVEQGEKI----------------LILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
V GC + +E+ +L ++ ++L A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL- 125
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+ E I +G+ Y+H ++I+RDLK SNI L KI DFGL D G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+ GT YMSPE + + D+++ G+++ E L
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-41
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 475 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL+G C + + ++E L+ FL K+ + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEY 646
+HR+L A N+LL KISDFGL++ G D+ + K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
FS +SDV+S+G+ M E LS
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 528
+F LG GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 529 LVRLLGCCVEQGEKI------------LILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
+VR +E+ + ++ ++L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ-- 634
IA+ + +LH ++HRDLK SNI D K+ DFGL DE +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 635 --------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
VGT YMSPE +S K D+FS G+++ E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 63/234 (26%), Positives = 91/234 (38%), Gaps = 43/234 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 523
EN LG G FG V + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 578
L H N+V LLG C G LI EY L +L +K +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 579 ----------------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 621
+A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 622 MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +M+PE +G+++IKSDV+S+GIL+ E S
Sbjct: 222 IMSDSNYVVRGN------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-40
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H ++V+L+G E I I+E L FL +K L+ + + ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 643
L R +HRD+ A N+L+ + K+ DFGL+R K + +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE F+ SDV+ FG+ M E L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 535 CCVEQGEK----ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+ +L+ E M + +L +L + +++ + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 591 RFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
IIHRDLK NI + + KI D GLA + K ++GT +M+PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204
Query: 650 GLFSIKSDVFSFGILMLETLSSK 672
+ DV++FG+ MLE +S+
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 23/223 (10%)
Query: 465 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIA 522
S++ +S+ ++G GG V++ Q A+K L Q L ++NE+ +
Sbjct: 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 523 KLQHRNL--VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 580
KLQ + +RL + +++E N LN +L KK + W+ + + +
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERK-SYWKNML 137
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+ + +HQ+ I+H DLK +N L+ K+ DFG+A D VGT
Sbjct: 138 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 641 YMSPE-----------YALDGLFSIKSDVFSFGILMLETLSSK 672
YM PE S KSDV+S G ++ K
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 52/200 (26%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 527
E + K+GEG FG + +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+ E G ++++Y L + ++ K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+I+HRD+K+ NI L KD ++ DFG+AR+ +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 648 LDGLFSIKSDVFSFGILMLE 667
+ ++ KSD+++ G ++ E
Sbjct: 198 ENKPYNNKSDIWALGCVLYE 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+F LG+G FG V K R L+ + A+K++ + + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 529 LVRLLGCCVEQGEKI-------------LILEYMPNKSLNVFLFD--STKKRLLNWQARV 573
+VR +E+ + + +EY N +L +D ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF---------- 623
R+ I + L Y+H IIHRDLK NI +D+ N KI DFGLA+
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 624 --GGDELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 667
N +GT Y++ E G ++ K D++S GI+ E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 528
+S+ ++G GG V++ Q A+K L Q L ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 529 L--VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+RL + +++E N LN +L KK + W+ + + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 124
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE- 645
HQ+ I+H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 646 ----------YALDGLFSIKSDVFSFGILMLETLSSK 672
S KSDV+S G ++ K
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-39
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLL 533
++G GG V++ Q A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ +++E N LN +L KK + W+ + + + + + +HQ+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTIHQH---G 175
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-------- 645
I+H DLK +N L+ D K+ DFG+A D VG YM PE
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 646 ---YALDGLFSIKSDVFSFGILMLETLSSK 672
S KSDV+S G ++ K
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII-EGIAQGLLYLHQYSRFRIIH 596
E G + +E +P SL+ L S L + + + + I +GL YLH +I+H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 597 RDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE---YALDGLF 652
RD+K N+L++ KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG-Y 202
Query: 653 SIKSDVFSFGILMLETLSSK 672
+D++S G ++E + K
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQH 526
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV-RIIEGIAQGLLY 585
N+++ +E E ++LE L+ + K++ L + V + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
+H R++HRD+K +N+ + K+ D GL R F ++ +VGT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
+ ++ KSD++S G L+ E + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-38
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 10/205 (4%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 527
E++ + +G G +G K R +G+ + K + + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 528 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARV-RIIEGIAQGLL 584
N+VR +++ L ++EY L + TK+R + V R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 585 YLHQ--YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
H+ ++HRDLK +N+ LD N K+ DFGLAR+ D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE 667
SPE ++ KSD++S G L+ E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYE 208
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 14/207 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKL-QH 526
++F +LG G +G V+K R +G+ AVK + + E+ K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
VRL E G L E SL ++ L Q + + L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRD-TLLALAHL 173
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H ++H D+K +NI L K+ DFGL G + G YM+PE
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE- 226
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKK 673
L G + +DVFS G+ +LE + +
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQHRNLVRLLG 534
LG+GGF ++ + A K + +E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
E + + ++LE +SL +K L +AR + I G YLH+ R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLHRN---R 135
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++PE S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193
Query: 654 IKSDVFSFGILM 665
+ DV+S G +M
Sbjct: 194 FEVDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 526
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
+++V G E + + ++LE +SL +K L +AR + I G Y
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQY 156
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH+ R+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++PE
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPE 211
Query: 646 YALDGLFSIKSDVFSFGILM 665
S + DV+S G +M
Sbjct: 212 VLSKKGHSFEVDVWSIGCIM 231
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 27/220 (12%)
Query: 466 ITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 524
+ +++ KLGEGGF V L +G A+KR+ Q +E + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 525 QHRNLVRLLGCCVEQGEK----ILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEG 578
H N++RL+ C+ + L+L + +L + L Q ++ G
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLG 142
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-----MFGGDELQGNTK 633
I +GL +H HRDLK +NILL + P + D G + G +
Sbjct: 143 ICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 634 QI--VGTYGYMSPE------YALDGLFSIKSDVFSFGILM 665
T Y +PE + + ++DV+S G ++
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVL 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 533
KLG GG VY + +VA+K + + LK F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
E L++EY+ +L+ ++ L+ + I G+ + H R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
I+HRD+K NIL+D + KI DFG+A+ L T ++GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATD 190
Query: 654 IKSDVFSFGILMLETL 669
+D++S GI++ E L
Sbjct: 191 ECTDIYSIGIVLYEML 206
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ Q ++G G FG V++ + G + AVK++ + + E++ A L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPR 111
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLH 587
+V L G E + +E + SL + + L + R G +GL YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP-EDRALYYLGQALEGLEYLH 167
Query: 588 QYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQ---IVGTYGYMS 643
RI+H D+KA N+LL D + + DFG A D L + I GT +M+
Sbjct: 168 TR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSK 672
PE + K D++S +ML L+
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V L + E +++EY+ SL D + ++ + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
++IHRD+K+ NILL D + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ K D++S GI+ +E
Sbjct: 190 RKAYGPKVDIWSLGIMAIE 208
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 465 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLI 521
S+ ++ +LG G +G V K R + +GQ +AVKR+ + + Q K ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RI 575
+ V G +G+ + +E M + SL+ F K++++ + +I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
I + L +LH S+ +IHRD+K SN+L++ K+ DFG++ D++ +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-- 169
Query: 636 VGTYGYMSPE----YALDGLFSIKSDVFSFGILMLE 667
G YM+PE +S+KSD++S GI M+E
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 526
E+F + LG+G F VY+ + G EVA+K + ++ G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
+++ L E + L+LE N +N +L + K +AR + I G+LY
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEAR-HFMHQIITGMLY 127
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH I+HRDL SN+LL ++MN KI+DFGLA + T + GT Y+SPE
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPE 182
Query: 646 YALDGLFSIKSDVFSFGILMLETL 669
A ++SDV+S G + L
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLL 206
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
K+GEG G V R +G++VAVK + + Q + NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V + + E +++E++ +L D + LN + + E + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+IHRD+K+ +ILL D K+SDFG D + + +VGT +M+PE
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 649 DGLFSIKSDVFSFGILMLE 667
L++ + D++S GI+++E
Sbjct: 215 RSLYATEVDIWSLGIMVIE 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 47/223 (21%), Positives = 85/223 (38%), Gaps = 34/223 (15%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKL-Q 525
T F K+G G FG V+K L+G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLL 584
H ++VR E ++ EY SL + ++ + +A ++ + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLARMFGG 625
Y+H ++H D+K SNI + + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 626 DELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 667
+ + G +++ E + K+D+F+ + ++
Sbjct: 185 ----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 56/204 (27%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E + + +LG+G FG VYK + G A K + +S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+LLG G+ +++E+ P +++ + + L Q +V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE--- 645
RIIHRDLKA N+L+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 646 --YALDGLFSIKSDVFSFGILMLE 667
D + K+D++S GI ++E
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 11/226 (4%)
Query: 444 EANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKR 502
E D + + + ++F +LG G G V+K +G +A K
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 503 LS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS 561
+ + E+ ++ + +V G GE + +E+M SL+ L
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--- 122
Query: 562 TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621
K + Q ++ + +GL YL + +I+HRD+K SNIL++ K+ DFG++
Sbjct: 123 KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
+ N+ VGT YMSPE +S++SD++S G+ ++E
Sbjct: 181 QL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 525
E+F + LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N++RL G + LILEY P ++ L + + I +A L Y
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSY 124
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPE 177
Query: 646 YALDGLFSIKSDVFSFGILMLETL 669
+ K D++S G+L E L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-33
Identities = 40/200 (20%), Positives = 79/200 (39%), Gaps = 24/200 (12%)
Query: 478 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLG 534
+ GG G +Y +NG+ V +K L + + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 535 CCVEQGEKI-----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+++EY+ +SL + L + + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+++ DLK NI+L ++ K+ D G + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251
Query: 650 GLFSIKSDVFSFGILMLETL 669
G ++ +D+++ G +
Sbjct: 252 GP-TVATDIYTVGRTLAALT 270
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 527
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
+ + G ++ + +I+EY+ S D + L+ I+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ IHRD+KA+N+LL + K++DFG+A +++ NT VGT +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 648 LDGLFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 192 KQSAYDSKADIWSLGITAIE 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+ G + + +++EY S++ + K L + I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R IHRD+KA NILL+ + + K++DFG+A + NT ++GT +M+PE
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ ++ +D++S GI +E
Sbjct: 199 EIGYNCVADIWSLGITAIE 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 533
LG GG V+ R L + ++VAVK L + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 534 --GCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
G + +++EY+ +L + + + + + +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYMSPEYAL 648
+ IIHRD+K +NI++ K+ DFG+AR T ++GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 649 DGLFSIKSDVFSFGILMLETL 669
+SDV+S G ++ E L
Sbjct: 193 GDSVDARSDVYSLGCVLYEVL 213
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 528
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 529 LVRLLGC--CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+L K+LI+E+ P SL L + + L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 587 HQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ I+HR++K NI+ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 643 SPE--------YALDGLFSIKSDVFSFGILMLETLS 670
P+ + D++S G+ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 11/196 (5%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 533
+G GG G VY+ + + VA+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G+ + + + L L ++ L V I+ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
HRD+K NIL+ D + DFG+A ++L VGT YM+PE + +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHAT 213
Query: 654 IKSDVFSFGILMLETL 669
++D+++ ++ E L
Sbjct: 214 YRADIYALTCVLYECL 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLIAKLQHR 527
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIAQ 581
+V+ G +G+ + +E M + S + F K + +I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
L +L +IIHRD+K SNILLD+ N K+ DFG++ + G Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191
Query: 642 MSPE----YALDGLFSIKSDVFSFGILMLE 667
M+PE A + ++SDV+S GI + E
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 20/233 (8%)
Query: 443 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK 501
G + GK + A + ++G G G V+K R G +AVK
Sbjct: 1 GSSGSSGKQTGYLT----IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 502 RL-SNQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF 559
++ + + + K ++ +++ +V+ G + + + +E M +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE---KL 113
Query: 560 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
+ + + ++ I + L YL + +IHRD+K SNILLD+ K+ DFG+
Sbjct: 114 KKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 620 ARMFGGDELQGNTKQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLE 667
+ D+ + G YM+PE + I++DV+S GI ++E
Sbjct: 172 SGRL-VDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 528
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 529 LVRLLGC--CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+L K+LI+E+ P SL L + + L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 587 HQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ I+HR++K NI+ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 643 SPE--------YALDGLFSIKSDVFSFGILM 665
P+ + D++S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-32
Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLV 530
+F + LG G G + + + ++VAVKR+ + E+ +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 531 RLLGCCVEQGEKI--LILEYMPNKSLNVFLFD---STKKRLLNWQARVRIIEGIAQGLLY 585
R C E+ + + +E L + L + +++ GL +
Sbjct: 82 RYF--CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 586 LHQYSRFRIIHRDLKASNILL-----DKDMNPKISDFGLARMFGGDEL-QGNTKQIVGTY 639
LH I+HRDLK NIL+ + ISDFGL + + GT
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 640 GYMSPEY---ALDGLFSIKSDVFSFGILMLETLS 670
G+++PE + D+FS G + +S
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 535
L EGGF VY+ + + +G+E A+KRL + + + E+ + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 536 CVEQGEK-------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
E+ L+L + L FL + L+ ++I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI----------VGT 638
+ IIHRDLK N+LL K+ DFG A + Q T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 639 YGYMSPE-YALDGLFSI--KSDVFSFGILMLE 667
Y +PE L F I K D+++ G ++
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------NQSGQGLKE 513
++ + L +G F + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 514 FKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL------NVFLFDSTKKRLL 567
FKNE+ +I +++ + G E +I EYM N S+ L + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+ II+ + Y+H + I HRD+K SNIL+DK+ K+SDFG + +
Sbjct: 150 IQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 628 LQGNTKQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLETL 669
++G GTY +M PE + +G K D++S GI +
Sbjct: 207 IKG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMF 246
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 1e-30
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 529
+ M+ +LG GGFG V + G++VA+K+ + +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 530 VRLL------GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
V +L +EY L +L L ++ I+ L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 584 LYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
YLH+ RIIHRDLK NI+L + + KI D G A+ EL + VGT
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQ 188
Query: 641 YMSPEYALDGLFSIKSDVFSFGILM 665
Y++PE +++ D +SFG L
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 525
++F + LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGL 583
H N++R+ ++ L+LE+ P L + R ++ +E +A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADAL 127
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
Y H ++IHRD+K N+L+ KI+DFG + T + GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLP 180
Query: 644 PEYALDGLFSIKSDVFSFGILMLETL 669
PE K D++ G+L E L
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 16/218 (7%)
Query: 462 SLASITAATENFSMQCKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKN 516
++S + + +G+G V R G+ V V+R L S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 517 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
E+ + H N+V + E ++ +M S L + +N A I+
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYIL 134
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT---- 632
+G+ + L Y+H +HR +KAS+IL+ D +S +
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 633 -KQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLE 667
K V ++SPE L + KSD++S GI E
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 461 FSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMM 519
L+++ F + +G G +G VYKGR + GQ A+K + + +G +E K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 520 LIAKL-QHRNLVRLLGCCVEQGEKI------LILEYMPNKSLNVFLFDSTKKRLLNWQAR 572
++ K HRN+ G +++ L++E+ S+ + ++ L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632
I I +GL +LHQ ++IHRD+K N+LL ++ K+ DFG++ + NT
Sbjct: 133 Y-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 633 KQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLE 667
+GT +M+PE D + KSD++S GI +E
Sbjct: 189 --FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRN 528
+++ +Q +G G V ++VA+KR++ + Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE--GIA------ 580
+V V + E L+++ + S+ D K + + + +++ IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 581 -QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL-ARMFGGDELQGNTKQ--IV 636
+GL YLH + IHRD+KA NILL +D + +I+DFG+ A + G ++ N + V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 637 GTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 667
GT +M+PE + K+D++SFGI +E
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 525
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N ++ GC + + L++EY + + L + KK L + + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH + +IHRD+KA NILL + K+ DFG A N+ VGT +M+PE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPE 220
Query: 646 ---YALDGLFSIKSDVFSFGILMLE 667
+G + K DV+S GI +E
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 34/190 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 521
ENF K+GEG +G VYK R L G+ VA+K++ L E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 575
+L H N+V+LL + + L+ E++ + + + +Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+ QGL + H + R++HRDLK N+L++ + K++DFGLAR F G ++ T ++
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164
Query: 636 VGTYGYMSPE 645
V T Y +PE
Sbjct: 165 V-TLWYRAPE 173
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 34/189 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 522
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRII 576
+L H N+V L+ + L+ E+M L DS K L +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL-YQ------ 127
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636
+ +G+ + HQ+ RI+HRDLK N+L++ D K++DFGLAR F G ++ T ++V
Sbjct: 128 --LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
Query: 637 GTYGYMSPE 645
T Y +P+
Sbjct: 182 -TLWYRAPD 189
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 40/224 (17%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCC 536
LG G G V G+ VAVKR+ E+ +L H N++R C
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76
Query: 537 VEQGEK--ILILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
E ++ + LE N +L + D K + ++ IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSL 134
Query: 590 SRFRIIHRDLKASNILLD-------------KDMNPKISDFGLARMFGGDE--LQGNTKQ 634
+IIHRDLK NIL+ +++ ISDFGL + + + N
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 635 IVGTYGYMSPEYALDGLFSI-------KSDVFSFGILMLETLSS 671
GT G+ +PE + D+FS G + LS
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 521
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 575
+L+H+N+VRL + L+ E+ S N L K L +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL-FQ----- 109
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+ +GL + H ++HRDLK N+L++++ K+++FGLAR F G ++ + ++
Sbjct: 110 ---LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEV 162
Query: 636 VGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKK 673
V T Y P+ L+S D++S G + E ++ +
Sbjct: 163 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 33/228 (14%), Positives = 65/228 (28%), Gaps = 24/228 (10%)
Query: 465 SITAATENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEM 518
++ + LGEG F VY+ N Q+ +K + M
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 519 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN---VFLFDSTKKRLLNWQARVRI 575
+ ++ + Q +L+ E +L ++ +K +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILL-----------DKDMNPKISDFGLARMFG 624
+ + + +H IIH D+K N +L D + D G +
Sbjct: 179 MR-MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
T G+ E + ++ + D F + L
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 25/246 (10%), Positives = 57/246 (23%), Gaps = 43/246 (17%)
Query: 459 PLFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEF 514
+ ++ + L G V+ R + ++ A+K + S L+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 515 KNEMMLIAKLQHRNLVRLLGCC-VEQGEKILILEYMPN-----------KSLNVFL---- 558
A+L + + + ++ P N L
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 559 -------------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605
F + A + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226
Query: 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGI 663
+ D + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 664 LMLETL 669
+
Sbjct: 282 SIYRVW 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 6e-29
Identities = 32/230 (13%), Positives = 68/230 (29%), Gaps = 43/230 (18%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQH-------- 526
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 527 --------RNLVRLLGCC-----VEQGEKILILEY---MPNKSLNVFLF------DSTKK 564
+LV+ + +L P N+ F S+
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 565 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624
+ L AR+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 625 GDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETL 669
G + + L + D ++ G+ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
E +++ C LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLL 584
N+++L + ++ E L FD +KR A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
Y+H+++ I+HRDLK NILL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189
Query: 642 MSPEYALDGLFSIKSDVFSFGILM 665
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-29
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
E +++ C LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 584
N+++L + ++ E L FD +KR A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
Y+H++ I+HRDLK NILL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189
Query: 642 MSPEYALDGLFSIKSDVFSFGILM 665
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 34/189 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 522
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRII 576
+L+H N+V+L + +L+ E++ L T K L Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-LQ------ 108
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636
+ G+ Y H R++HRDLK N+L++++ KI+DFGLAR F G ++ T +IV
Sbjct: 109 --LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
Query: 637 GTYGYMSPE 645
T Y +P+
Sbjct: 163 -TLWYRAPD 170
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-29
Identities = 62/192 (32%), Positives = 93/192 (48%), Gaps = 36/192 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN--------EMM 519
+ + LGEG F VYK R Q VA+K +L ++S E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIK 64
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARV 573
L+ +L H N++ LL + L+ ++M K ++ L S K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LM--- 120
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
QGL YLHQ+ I+HRDLK +N+LLD++ K++DFGLA+ F G + T
Sbjct: 121 -----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171
Query: 634 QIVGTYGYMSPE 645
Q+V T Y +PE
Sbjct: 172 QVV-TRWYRAPE 182
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
+E + KLG G +G V R + E A+K + ++ S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 584
N+++L ++ L++E L FD + + A II+ + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
YLH+++ I+HRDLK N+LL +KD KI DFGL+ +F + K+ +GT Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204
Query: 642 MSPEYALDGLFSIKSDVFSFGILM 665
++PE L + K DV+S G+++
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 33/194 (17%)
Query: 468 AATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLI 521
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYM----------PNKSLNVFLFDSTKKRLLNWQA 571
+L+H N+VRL + + L+ E+M + + WQ
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
+ QGL + H+ +I+HRDLK N+L++K K+ DFGLAR F G +
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165
Query: 632 TKQIVGTYGYMSPE 645
+ ++V T Y +P+
Sbjct: 166 SSEVV-TLWYRAPD 178
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ ++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYL 586
++RL + + L++E LF+ K+ A RI++ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 587 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
H+ + HRDLK N L D K+ DFGLA F ++ + VGT Y+S
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176
Query: 644 PEYALDGLFSIKSDVFSFGILM 665
P+ L+GL+ + D +S G++M
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 534 G-CCVEQGEKI-LILEYMPNKSLNVFLFDS-TKKRLLNWQAR---VRIIEGIAQGLLYLH 587
E+ +K+ +++EY + DS +KR QA ++I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
I+H+D+K N+LL KIS G+A + G+ + PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 648 L-----DGLFSIKSDVFSFGI 663
G K D++S G+
Sbjct: 184 NGLDTFSGF---KVDIWSAGV 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHR 527
+ F + KLG G FG V+ +G E +K ++ ++S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW------QARVRIIEGIAQ 581
N++++ + +++E L + +++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVA-ELMKQMMN 135
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
L Y H ++H+DLK NIL KI DFGLA +F DE GT
Sbjct: 136 ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILM 665
YM+PE + K D++S G++M
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQ 525
++ + Q LG+G FG V + + GQE AVK +S + + E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGL 583
H N+++L ++G L+ E L FD ++KR A RII + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 584 LYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Y+H+ I+HRDLK N+LL KD N +I DFGL+ F + K +GT
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAY 193
Query: 641 YMSPEYALDGLFSIKSDVFSFGILM 665
Y++PE L G + K DV+S G+++
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 30/187 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLIAKL 524
E + KLGEG + VYKG+ L VA+K + + +G ++E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIEG 578
+H N+V L + L+ EY+ + K L +Q
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-FQ-------- 108
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+ +GL Y H+ +++HRDLK N+L+++ K++DFGLAR + ++V T
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-T 163
Query: 639 YGYMSPE 645
Y P+
Sbjct: 164 LWYRPPD 170
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 17/189 (8%)
Query: 504 SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK 563
S + ++ + +N V L + + ++ ++L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 564 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623
+ I IA+ + +LH ++HRDLK SNI D K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 624 GGDELQGNTKQI----------VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
DE + VGT YMSPE +S K D+FS G+++ E L
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE-LLYSF 273
Query: 674 NTGLGSMER 682
+T MER
Sbjct: 274 STQ---MER 279
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ + + +LG G FG V++ G+ K ++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
L+ L ++ E +LILE++ LFD + + ++ + + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 587 HQYSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
H++ I+H D+K NI+ K + KI DFGLA DE K T + +P
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E +D+++ G+L
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 34/237 (14%), Positives = 71/237 (29%), Gaps = 54/237 (22%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ--------- 525
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 526 ----------------HRNLVRLLGCC-VEQGEKILILEYMPNKSLNVF---LFD-STKK 564
+ ++R+ L +L F L S+
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 565 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624
+ L AR+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 625 GDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLS 670
G + G+ PE L + D ++ G+++
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
S LG G FG V+K G ++A K + + + +E KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+L + + +L++EY+ LFD + L + ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 589 YSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
I+H DLK NIL ++D KI DFGLAR + E K GT +++PE
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259
Query: 647 ALDGLFSIKSDVFSFGILM 665
S +D++S G++
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 35/190 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 521
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 575
+L+H NLV LL + L+ EY + + + K + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQ----- 110
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
Q + + H++ IHRD+K NIL+ K K+ DFG AR+ ++
Sbjct: 111 ---TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEV 163
Query: 636 VGTYGYMSPE 645
T Y SPE
Sbjct: 164 A-TRWYRSPE 172
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 59/194 (30%), Positives = 84/194 (43%), Gaps = 39/194 (20%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 521
+ + KLGEG +G VYK + + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPN--KSL---NVFLFDSTKKRLLNWQARVRII 576
+LQHRN++ L LI EY N K N + K L +Q
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL-YQ------ 140
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-----KISDFGLARMFGGDELQGN 631
+ G+ + H R +HRDLK N+LL KI DFGLAR F G ++
Sbjct: 141 --LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 632 TKQIVGTYGYMSPE 645
T +I+ T Y PE
Sbjct: 195 THEII-TLWYRPPE 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 29/198 (14%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 537 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV---RIIEGIAQGLLYLHQYSR 591
E + L LEY L FD + A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 645
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 646 YALDGLFSIKSDVFSFGI 663
+ DV+S GI
Sbjct: 184 F--HAE---PVDVWSCGI 196
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 25/211 (11%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 523
+ + + +G+G F V + GQ+ AVK + ++ G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ------ARVRIIE 577
L+H ++V LL G ++ E+M L KR A +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVAS-HYMR 137
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQ 634
I + L Y H IIHRD+K +LL + K+ FG+A G
Sbjct: 138 QILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
VGT +M+PE + DV+ G+++
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------NQSGQGLKEFK 515
E++ KLG G +G V + E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 516 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV 573
NE+ L+ L H N+++L ++ L+ E+ L F+ + + A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQG 630
I++ I G+ YLH+++ I+HRD+K NILL + +N KI DFGL+ F D
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
+ +GT Y++PE L ++ K DV+S G++M
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G+G F V R +L G+EVA+K + + L++ E+ ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 536 CVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+E + + LI+EY + FD R+ +AR I + Y H +
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QK 133
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------Y 646
RI+HRDLKA N+LLD DMN KI+DFG + F G Y +PE Y
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKY 190
Query: 647 ALDGLFSIKSDVFSFGILM 665
DG + DV+S G+++
Sbjct: 191 --DGP---EVDVWSLGVIL 204
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQH 526
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 527 RNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
V+L Q ++ L L Y N L + R E I L
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAE-IVSALE 144
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YLH IIHRDLK NILL++DM+ +I+DFG A++ + Q VGT Y+SP
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 645 EYALDGLFSIKSDVFSFGILMLETLS 670
E + SD+++ G ++ + ++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLIAK 523
E + +GEG +G V K R G+ VA+K S+ K K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIE 577
L+H NLV LL C ++ L+ E++ + + L ++ L +Q
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-FQ------- 132
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
I G+ + H + IIHRD+K NIL+ + K+ DFG AR + ++
Sbjct: 133 -IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA- 186
Query: 638 TYGYMSPE 645
T Y +PE
Sbjct: 187 TRWYRAPE 194
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+++ + +LG G FG V++ G A K + + + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
LV L + E ++I E+M LF+ + + ++ V + + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 587 HQYSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
H+ + +H DLK NI+ K N K+ DFGL + + K GT + +P
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E A +D++S G+L
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 29/198 (14%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 537 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV---RIIEGIAQGLLYLHQYSR 591
E + L LEY L FD + A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 645
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 646 YALDGLFSIKSDVFSFGI 663
+ DV+S GI
Sbjct: 184 F--HAE---PVDVWSCGI 196
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 453 SKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RL 503
++D+ LP S EN+ + LG G V + +E AVK
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 504 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD- 560
S + Q L+E E+ ++ K+ H N+++L L+ + M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY 114
Query: 561 -STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
+ K L + R +I+ + + + LH+ I+HRDLK NILLD DMN K++DFG
Sbjct: 115 LTEKVTLSEKETR-KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 620 ARMFGGDELQGNTKQIVGTYGYMSPE 645
+ E +++ GT Y++PE
Sbjct: 171 SCQLDPGEK---LREVCGTPSYLAPE 193
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLL 584
N+VRL E+ L+ + + L F+ ++ A I+ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173
Query: 642 MSPE 645
+SPE
Sbjct: 174 LSPE 177
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 522
+ + + +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 581
++ H N++ L + + +LILE + LFD +K L+ + I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
G+ YLH I H DLK NI+L + K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILM 665
T +++PE +++D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 522
+ + + +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 581
++ H N++ L + + +LILE + LFD +K L+ + I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL-DKDMNP---KISDFGLARMFGGDELQGNTKQIVG 637
G+ YLH I H DLK NI+L DK++ K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILM 665
T +++PE +++D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 522
+++ M +LG G F V K R G+E A K RLS+ +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 581
+++H N++ L + + +LILE + LFD +K L + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILD 119
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
G+ YLH RI H DLK NI+L + K+ DFG+A K I G
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILM 665
T +++PE +++D++S G++
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ F LG G F V+ + L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
+V L L+++ + LFD + A +I+ + + YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDAS-LVIQQVLSAVKYL 122
Query: 587 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
H+ I+HRDLK N+L +++ I+DFGL++M + GT GY++
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVA 175
Query: 644 PEYALDGLFSIKSDVFSFGILM 665
PE +S D +S G++
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 48/249 (19%), Positives = 86/249 (34%), Gaps = 60/249 (24%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 523
+ + ++ +G+G +G V A+K ++ + + ++ K E+ L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV---------- 573
L H N+ RL ++ L++E L D + + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 574 -------------------------------RIIEGIAQGLLYLHQYSRFRIIHRDLKAS 602
I+ I L YLH I HRD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 603 NILL--DKDMNPKISDFGLARMFGGDELQGNT--KQIVGTYGYMSPE--YALDGLFSIKS 656
N L +K K+ DFGL++ F GT +++PE + + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 657 DVFSFGILM 665
D +S G+L+
Sbjct: 258 DAWSAGVLL 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE---FKNEMML 520
+ + M LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEG 578
+ KL H ++++ + + ++LE M L FD KRL +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQI 635
+ + YLH+ IIHRDLK N+LL ++D KI+DFG +++ G L + +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176
Query: 636 VGTYGYMSPE 645
GT Y++PE
Sbjct: 177 CGTPTYLAPE 186
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-------RLSNQSGQGLKE-FKNEMML 520
+ + + +G G V + G E AVK RLS + + ++E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 521 IAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIE 577
+ ++ H +++ L+ L+ + M L FD + K L + R I+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
+ + + +LH I+HRDLK NILLD +M ++SDFG + E +++ G
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261
Query: 638 TYGYMSPE 645
T GY++PE
Sbjct: 262 TPGYLAPE 269
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 48/198 (24%)
Query: 477 CKLGEGGFGPVYKGR---LLNGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNL 529
CK+G G +G VYK + + ++ A+K++ S E+ L+ +L+H N+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80
Query: 530 VRLLGCCVEQGEKI--LILEYM--------------PNKSLNVFLFDSTKKRLLNWQARV 573
+ L + ++ L+ +Y V L K LL +Q
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQ--- 136
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMFG--GDE 627
I G+ YLH ++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 137 -----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 628 LQGNTKQIVGTYGYMSPE 645
L +V T+ Y +PE
Sbjct: 189 LADLDPVVV-TFWYRAPE 205
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 45/201 (22%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E + + LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
++ L E ++I E++ +F+ +T LN + V + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 587 HQYSRFRIIHRDLKASNILL--DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
H ++ I H D++ NI+ + KI +FG AR + + + Y +P
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E + S +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 23/186 (12%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRN 528
++ +G G FG V++ +L+ EVA+K++ K FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 529 LVRLLGCCVEQGEKI------LILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIA 580
+V L G+K L+LEY+P +++ + K+ + ++ + + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQ-LL 151
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTY 639
+ L Y+H I HRD+K N+LLD K+ DFG A++ + N I Y
Sbjct: 152 RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY 206
Query: 640 GYMSPE 645
Y +PE
Sbjct: 207 -YRAPE 211
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------NQSGQGLKEFKNEMML 520
+ + M LG G G V ++VA++ +S + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEG 578
+ KL H ++++ + + ++LE M L FD KRL +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQI 635
+ + YLH+ IIHRDLK N+LL ++D KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 636 VGTYGYMSPE 645
GT Y++PE
Sbjct: 302 CGTPTYLAPE 311
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 522
+ + +LG G F V K R G + A K R + +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 581
++QH N++ L + + ILILE + LFD +K L + ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILN 125
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
G+ YLH I H DLK NI+L KI DFGLA K I G
Sbjct: 126 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILM 665
T +++PE +++D++S G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 43/200 (21%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKE-FKN----EMMLIA 522
+ K+G+G FG V+K R GQ+VA+K + N+ KE F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-----KEGFPITALREIKILQ 71
Query: 523 KLQHRNLVRLLGCCVEQGEKI--------LILEYMPN------KSLNVFLFDSTKKRLLN 568
L+H N+V L+ C + L+ ++ + ++ V S KR++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM- 130
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG---G 625
+ GL Y+H+ +I+HRD+KA+N+L+ +D K++DFGLAR F
Sbjct: 131 QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 626 DELQGNTKQIVGTYGYMSPE 645
+ T ++V T Y PE
Sbjct: 180 SQPNRYTNRVV-TLWYRPPE 198
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RLSNQSGQGLKEFKNEMMLIA 522
+S LG G FG V+ +EV VK L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
+++H N++++L QG L++E + L++F F RL A I +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVSA 142
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ YL IIHRD+K NI++ +D K+ DFG A +L GT Y
Sbjct: 143 VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYC 196
Query: 643 SPE------YALDGLFSIKSDVFSFGILM 665
+PE Y G + +++S G+ +
Sbjct: 197 APEVLMGNPY--RGP---ELEMWSLGVTL 220
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 49/221 (22%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------NQSGQGLKEFKNEMML 520
+G+G +G V + A+K LS + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 521 ------IA---KLQHRNLVRLLGCCVEQGEK---ILILEYMPNKSLNVFLFD-STKKRLL 567
IA KL H N+V+L+ ++ + ++ E + + + T K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF-GGD 626
QAR + + +G+ YLH +IIHRD+K SN+L+ +D + KI+DFG++ F G D
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 627 ELQGNTKQIVGTYGYMSPEYALDGLFSI----KSDVFSFGI 663
L NT VGT +M+PE +L I DV++ G+
Sbjct: 192 ALLSNT---VGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 584
N+VRL E+ L+ + + LF+ ++ A I+ I + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 142
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 196
Query: 642 MSPEYALDGLFSIKSDVFSFGILM 665
+SPE +S D+++ G+++
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 50/177 (28%), Positives = 76/177 (42%), Gaps = 33/177 (18%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLI 521
AT + ++G G +G VYK R +G VA+K R+ N G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 522 AKLQ---HRNLVRLLGCCVEQGEKI-----LILEYMPN------KSLNVFLFDSTKKRLL 567
+L+ H N+VRL+ C L+ E++ + + L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624
Q +GL +LH I+HRDLK NIL+ K++DFGLAR++
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 33/174 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIA 522
+ + ++GEG +G V+K R G+ VA+KR+ + + G ++E + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69
Query: 523 KLQHRNLVRLLGCCV----EQGEKI-LILEYMPN--KSL-----NVFLFDSTKKRLLNWQ 570
+H N+VRL C ++ K+ L+ E++ + + T K ++ +Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM-FQ 128
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624
+ +GL +LH + R++HRDLK NIL+ K++DFGLAR++
Sbjct: 129 --------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG G FG V G L G +VAVK L+ Q S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
+ +++EY+ L FD R+ +AR R+ + I + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---R 129
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 645
++HRDLK N+LLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 186
Query: 646 YALDGLFSIKSDVFSFGILM 665
Y G + D++S G+++
Sbjct: 187 Y--AGP---EVDIWSCGVIL 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 58/187 (31%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 527
+++ +G G FG VY+ +L +G+ VA+K++ K FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 528 NLVRLLGCCVEQGEKI------LILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGI 579
N+VRL GEK L+L+Y+P +++ + K+ L ++ + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQ-L 165
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGT 638
+ L Y+H F I HRD+K N+LLD D K+ DFG A+ E N I
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 220
Query: 639 YGYMSPE 645
Y Y +PE
Sbjct: 221 Y-YRAPE 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 50/178 (28%), Positives = 72/178 (40%), Gaps = 18/178 (10%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC 536
LGEG V L+ QE AVK + Q G E+ ++ + Q HRN++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 537 VEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
E+ L+ E M S+ K+R N +++ +A L +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133
Query: 596 HRDLKASNILL---DKDMNPKISDFGLARMF-----GGDELQGNTKQIVGTYGYMSPE 645
HRDLK NIL ++ KI DF L G+ YM+PE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 30/209 (14%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKL 524
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 525 QHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIA 580
++RLL +LILE LFD + + L AR +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELAR-SFFWQVL 159
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTY 639
+ + + H ++HRD+K NIL+D + K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212
Query: 640 GYMSPEYAL----DGLFSIKSDVFSFGIL 664
Y PE+ G + V+S GIL
Sbjct: 213 VYSPPEWIRYHRYHGR---SAAVWSLGIL 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 18/192 (9%)
Query: 463 LASITAA--TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNE 517
+A+IT TE + + +LG+G F V + +L GQE A + S + ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 518 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRII 576
+ L+H N+VRL E+G LI + + L F+ + + I
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCI 116
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTK 633
+ I + +L+ HQ ++HR+LK N+LL K K++DFGLA G+ Q
Sbjct: 117 QQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWF 171
Query: 634 QIVGTYGYMSPE 645
GT GY+SPE
Sbjct: 172 GFAGTPGYLSPE 183
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 22/199 (11%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS----------NQSGQGLKEFKNEMMLIAKLQHR 527
LG+GGFG V+ G L + +VA+K + + S E + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
++RLL Q +L+LE P + ++F + + K L +R + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 588 QYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
++HRD+K NIL+D K+ DFG + + GT Y PE+
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEW 209
Query: 647 ALDGLFS-IKSDVFSFGIL 664
+ + + V+S GIL
Sbjct: 210 ISRHQYHALPATVWSLGIL 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR-NLVRLL 533
+LG G F V + GQE A K + + E +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW---QARVRIIEGIAQGLLYLHQYS 590
E ILILEY + F L +R+I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150
Query: 591 RFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
I+H DLK NILL + KI DFG++R G ++I+GT Y++PE
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205
Query: 648 LDGLFSIKSDVFSFGILM 665
+ +D+++ GI+
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 30/200 (15%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
+ I +++EY+ L FD RL ++R R+ + I G+ Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESR-RLFQQILSGVDYCH---R 134
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 645
++HRDLK N+LLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 191
Query: 646 YALDGLFSIKSDVFSFGILM 665
Y G + D++S G+++
Sbjct: 192 Y--AGP---EVDIWSSGVIL 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 31/200 (15%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLLG 534
LGEG FG V Q+VA+K +S Q + + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
+ I +++EY + LFD KKR+ + R R + I + Y H R
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---R 126
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 645
+I+HRDLK N+LLD ++N KI+DFGL+ + K G+ Y +PE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKL 183
Query: 646 YALDGLFSIKSDVFSFGILM 665
Y G + DV+S GI++
Sbjct: 184 Y--AGP---EVDVWSCGIVL 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLH 587
++ L + ++ E M L D +++ + + ++ I + + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 588 QYSRFRIIHRDLKASNILL-DKDMNP---KISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
++HRDLK SNIL D+ NP +I DFG A+ + G T +++
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFVA 188
Query: 644 PE 645
PE
Sbjct: 189 PE 190
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 40/198 (20%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKL 524
+ F ++ G+G FG V G+ G VA+K++ F+N M +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76
Query: 525 QHRNLVRLLGCCVEQGEK-------ILILEYMP---------NKSLNVFLFDSTKKRLLN 568
H N+V+L GE+ +++EY+P V K L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL- 135
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDE 627
+Q + + + LH S + HRD+K N+L+++ K+ DFG A+ E
Sbjct: 136 FQ--------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 628 LQGNTKQIVGTYGYMSPE 645
N I Y Y +PE
Sbjct: 187 P--NVAYICSRY-YRAPE 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
++ F ++ +LG G VY+ + + A+K L + K + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
+++L E L+LE + L FD K A ++ I + + YL
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA-DAVKQILEAVAYL 164
Query: 587 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
H+ I+HRDLK N+L D KI+DFGL+++ L K + GT GY +
Sbjct: 165 HEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCA 218
Query: 644 PEYALDGLFSIKSDVFSFGILM 665
PE + + D++S GI+
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 30/201 (14%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 535
LG G G V + GQ+ A+K L + + + E+ + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 536 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 587
+I+E M L F ++R +A I+ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 588 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
++ I HRD+K N+L +KD K++DFG A+ + L + T Y++P
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAP 198
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E + D++S G++M
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 18/194 (9%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 535
LGEG F K + Q AVK +S + + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+Q L++E + L F+ KK+ + I+ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---V 127
Query: 595 IHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
+HRDLK N+L + ++ KI DFG AR+ D K T Y +PE
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNG 185
Query: 652 FSIKSDVFSFGILM 665
+ D++S G+++
Sbjct: 186 YDESCDLWSLGVIL 199
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 6e-22
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
R +V L E + + L+L M L ++ + +A E I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH R RI++RDLK NILLD + +ISD GLA + K VGT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355
Query: 646 YALDGLFSIKSDVFSFGILMLETL 669
+ ++ D ++ G L+ E +
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMI 379
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 522
+FS+ +G GGFG VY R + ++ A+K L L E + + L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 523 KLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
+V + +K+ IL+ M L S R E I
Sbjct: 248 TGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAAE-IIL 303
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GL ++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GY
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGY 356
Query: 642 MSPEYALDGLFSIKS-DVFSFGILMLETL 669
M+PE G+ S D FS G ++ + L
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 30/197 (15%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
+G G FG R L + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 537 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ +I+EY L ++ R +AR + + G+ Y H +I
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEAR-FFFQQLLSGVSYCH---SMQI 137
Query: 595 IHRDLKASNILLDKD--MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------Y 646
HRDLK N LLD KI DFG ++ K VGT Y++PE Y
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEY 194
Query: 647 ALDGLFSIKSDVFSFGI 663
DG +DV+S G+
Sbjct: 195 --DGK---IADVWSCGV 206
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRI-IEGIAQGLL 584
R +V L E + L++ M + +++ + + R I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
+LHQ II+RDLK N+LLD D N +ISD GLA + TK GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAP 358
Query: 645 EYALDGLFSIKSDVFSFGILMLETL 669
E L + D F+ G+ + E +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 42/201 (20%), Positives = 80/201 (39%), Gaps = 29/201 (14%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 535
LG G G V + ++ A+K L + + + E+ L + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 536 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 587
+++E + L F + R +A I++ I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178
Query: 588 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
+ I HRD+K N+L + K++DFG A+ + T Y++P
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP 232
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E + D++S G++M
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 23/197 (11%), Positives = 58/197 (29%), Gaps = 43/197 (21%)
Query: 478 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRL 532
G ++ L ++VA+ + Q L+E + + ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
L + +++ E++ SL A +R ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
+ S + + D + ++ M
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------- 179
Query: 653 SIKSDVFSFGILMLETL 669
+ + D+ G + L
Sbjct: 180 NPQDDIRGIGASLYALL 196
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 41/199 (20%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ + ++ +G G +G V + L + VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 520 LIAKLQHRNLVRLLGCCV----EQGEKI-LILEYMPN------KSLNVFLFDSTKKRLLN 568
++ +L H ++V++L + E+ +++ ++LE + ++ V+L + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628
+ + G+ Y+H S I+HRDLK +N L+++D + K+ DFGLAR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 629 QGNTKQIVGTYGYMSPEYA 647
+ I M+
Sbjct: 212 GNSQLPISPREDDMNLVTF 230
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 16/240 (6%)
Query: 436 TTRTNEYGEANGDGKDKSKDSWLPLFSLASITAAT-ENFSMQCKLGEGGFGPVYKGRL-L 493
+ E+ + K+K+ +L + S A + F LG G FG V +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 494 NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550
+G A+K L Q LK+ NE ++ + LV+L + +++EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610
+ F R AR + I YLH +I+RDLK N+L+D+
Sbjct: 125 GGEM--FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQG 178
Query: 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+++DFG A+ ++G T + GT ++PE L ++ D ++ G+L+ E +
Sbjct: 179 YIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 17/209 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 526
E+F + +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
+ + L + + L+++Y L + L + RL AR + E + +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
+HQ +HRD+K NIL+D + + +++DFG D + VGT Y+SPE
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE 246
Query: 646 YALDGLFSIKS-----DVFSFGILMLETL 669
D +S G+ M E L
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 51/247 (20%), Positives = 103/247 (41%), Gaps = 57/247 (23%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 527
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 528 NLVRLLGCCVEQGEKI--------------------------------------LILEYM 549
N+++L+ G++ +I+EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 550 PNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607
P +L+ L F + + + + I + + + + ++H I HRD+K N+L++
Sbjct: 121 P-DTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 608 -KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILM 665
KD K+ DFG A+ + + I + Y +PE L ++ D++S G +
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 666 LETLSSK 672
E + K
Sbjct: 233 GELILGK 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 19/211 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 526
++F + +G G F V ++ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
R + +L + + L++EY L + L +R+ AR + E I +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
+H+ +HRD+K NILLD+ + +++DFG D + VGT Y+SPE
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE 233
Query: 646 -------YALDGLFSIKSDVFSFGILMLETL 669
G + + D ++ G+ E
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 520 LIAKLQHRNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQ 570
L+ + H+N++ LL +E+ + + +++E M + + + L LL +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630
+ G+ +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 136 --------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 182
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
V T Y +PE L + D++S G +M E +
Sbjct: 183 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 526
++F + LG G FG V+ R + A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++R+ G + + +I++Y+ L F +R N A+ E + L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYL 122
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H II+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
++ D +SFGIL+ E L+
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 53/226 (23%), Positives = 84/226 (37%), Gaps = 38/226 (16%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE--FKN---------EM 518
+++Q + G +G V G G VA+KR+ N G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 519 MLIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMPN------KSLNVFLFDSTKKRLL 567
L+ H N++ L K+ L+ E M + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+ I GL LH+ ++HRDL NILL + + I DF LAR D
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
N V Y +PE + F+ D++S G +M E + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR 527
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 528 NLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
N++ L + + L+ E++ N + L ++ R + E I + L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDY 145
Query: 586 LHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
H S I+HRD+K N+++D + ++ D+GLA Q ++ Y + P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGP 199
Query: 645 EYALDGLFSIKS-DVFSFGILMLETLSSKK 673
E +D S D++S G ++ + K+
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 7e-18
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 520 LIAKLQHRNLVRLL------GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
L+ + H+N++ LL E + L++E M L + L + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSY 168
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+ + + G+ +LH S IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 169 LLYQ-MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MT 221
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
V T Y +PE L + D++S G +M E + K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 60/275 (21%), Positives = 95/275 (34%), Gaps = 81/275 (29%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-----------LKE 513
+ + LG G FG V + + VAVK L + L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 514 F----------------KNEMMLIAKL-QHRNLVRLLGCCVEQGE--KILILEYMPNKSL 554
+M+I + + NL L + K + K
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 555 NVFLFDSTKKRL------------------------------------LNWQARVRIIEG 578
+ K+RL L + +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQI 635
+A+G+ +L + + IHRDL A NILL + KI DFGLAR D +G+ +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 526
E++ + +G G FG V R + ++V A+K LS + F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+L + +++EYMP L + + + AR E + L +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALDAI 184
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE- 645
H IHRD+K N+LLDK + K++DFG + + VGT Y+SPE
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEV 240
Query: 646 ---YALDGLFSIKSDVFSFGILMLETL 669
DG + + D +S G+ + E L
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEML 267
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKN---EMMLIAKLQH 526
++F + +G+G FG V + + +++ A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 527 RNLVRLLGCCVEQ-GEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
LV L Q E + ++++ + L ++ I E + L
Sbjct: 75 PFLVNLWYSF--QDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICE-LVMALD 129
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YL RIIHRD+K NILLD+ + I+DF +A M + + GT YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183
Query: 645 EYALDGLFSIKS---DVFSFGILMLETL 669
E + S D +S G+ E L
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 526
+ + +G G +G V +G++VA+K+LS QS K E++L+ +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 527 RNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQARVRIIE 577
N++ LL + L++ +M K + + + + L+ +Q
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ------- 134
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
+ +GL Y+H ++HRDLK N+ +++D KI DFGLAR + V
Sbjct: 135 -MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVV 185
Query: 638 TYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
T Y +PE L ++ D++S G +M E L+ K
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 9e-17
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 526
F LG+G FG V + A+K L + E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
L L + +++ ++EY L F S ++ +AR E I L Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDY 263
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 643
LH S +++RDLK N++LDKD + KI+DFGL + + G K GT Y++
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTFCGTPEYLA 317
Query: 644 PEYALDGLFSIKSDVFSFGILMLETL 669
PE D + D + G++M E +
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 42/202 (20%), Positives = 82/202 (40%), Gaps = 41/202 (20%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+N+ ++ +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKI-----LILEYMPN------KSLNVFLFDSTKKRLLN 568
++ +L+ ++RL + ++LE + K+ +FL + K +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628
+ + G ++H IIHRDLK +N LL++D + K+ DFGLAR ++
Sbjct: 136 YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 629 QGNTKQIVGTYGYMSPEYALDG 650
+ L
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKK 206
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
++ +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 520 LIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQA 571
++ + +H N++ + +EQ + + ++ + M K L + +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
I +GL Y+H S ++HRDLK SN+LL+ + KI DFGLAR+ D
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 632 T-KQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
+ V T Y +PE L+ ++ D++S G ++ E LS++
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 78.4 bits (192), Expect = 8e-16
Identities = 34/199 (17%), Positives = 60/199 (30%), Gaps = 46/199 (23%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL--------SNQSGQGLKEFKNEMML 520
TE K+GEG FG V++ + VA+K + + + +E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 521 IAKLQ---------HRNLVRLLGCCVEQGE--KILILEYM----PNKSLNVFL------- 558
+L + L QG +L+ + S N
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 559 -------------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605
+ + +L + I+ + L R HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 606 LDKDMNPKISDFGLARMFG 624
L K K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ LG GG G V+ + VA+K++ Q +K E+ +I +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 529 LVRLL--------------GCCVEQGEKILILEYMP---NKSLNVFLFDSTKKRLLNWQA 571
+V++ G E ++ EYM L RL +Q
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ- 128
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQG 630
+ +GL Y+H + ++HRDLK +N+ ++ +D+ KI DFGLAR+
Sbjct: 129 -------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 631 NT-KQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSK 672
+ + T Y SP L ++ D+++ G + E L+ K
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQ 525
E+F + LG+G FG V+ + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H L + C + E + ++EY+ L + + +A E I GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 642
+LH I++RDLK NILLDKD + KI+DFG+ + M G T GT Y+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDYI 185
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETL 669
+PE L ++ D +SFG+L+ E L
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 526
+F LG+G FG V R A+K L + E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
L L + +++ ++EY L F S ++ +AR E I L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 643
LH +++RD+K N++LDKD + KI+DFGL + + G K GT Y++
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLA 173
Query: 644 PEYALDGLFSIKSDVFSFGILMLETL 669
PE D + D + G++M E +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 1e-15
Identities = 71/399 (17%), Positives = 136/399 (34%), Gaps = 23/399 (5%)
Query: 283 PIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSN 342
P C H+ +D + + N ++ S
Sbjct: 149 PSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSE 208
Query: 343 VKESSGCLM---WYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKLLWILVILVIPVVLL 399
K+ + + R ++ + ++ + L
Sbjct: 209 SKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQ 268
Query: 400 PSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLP 459
+ + + +E E NV + + + + G+ ++K+ ++
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328
Query: 460 LFSLASITAAT-ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNE 517
+ + +F+ LG+G FG V E+ AVK L + +
Sbjct: 329 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388
Query: 518 MM----LIAKLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQAR 572
M+ L + L +L C + +++ ++EY+ L R A
Sbjct: 389 MVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAV 445
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQG 630
E IA GL +L II+RDLK N++LD + + KI+DFG+ + ++ G
Sbjct: 446 FYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---- 497
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
TK GT Y++PE + D ++FG+L+ E L
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 525
+F +G+G FG V R + AVK L ++ KE K+ M L+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H LV L + +K+ +L+Y+ L F ++ L +AR E IA L
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALG 153
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 642
YLH + I++RDLK NILLD + ++DFGL + + T GT Y+
Sbjct: 154 YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEYL 206
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETL 669
+PE + D + G ++ E L
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 525
++F + +G G + V RL + A+K + + ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H LV L C + ++ ++EY+ L +++L AR E I+ L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALN 124
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 642
YLH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y+
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYI 177
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLS 670
+PE + D ++ G+LM E ++
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 525
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
L +L C + +++ ++EY+ L R A E IA GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAE-IAIGLF 135
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 642
+L II+RDLK N++LD + + KI+DFG+ + ++ G TK GT Y+
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYI 188
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETL 669
+PE + D ++FG+L+ E L
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 19/259 (7%)
Query: 420 VETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKL 479
+ Y D ++ T G +++ + AS + ++F + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60
Query: 480 GEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLLG 534
G G + V RL + A++ + + ++ H LV L
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH- 119
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
C + ++ ++EY+ L +++L AR E I+ L YLH+
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNYLHE---RG 173
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++PE
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGED 229
Query: 652 FSIKSDVFSFGILMLETLS 670
+ D ++ G+LM E ++
Sbjct: 230 YGFSVDWWALGVLMFEMMA 248
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 526
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 527 RNLVRLL-----GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 580
N++ LL ++ L++ +M L + K L ++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQML 138
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+GL Y+H IIHRDLK N+ +++D KI DFGLAR + V T
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRW 190
Query: 641 YMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
Y +PE L+ ++ D++S G +M E ++ K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLKEF---------KNE 517
F + LG+G FG V+ + ++G + A+K L K K E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76
Query: 518 MMLIAKLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
++ ++ H +V+L + K+ LIL+++ L F S + + +
Sbjct: 77 RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 133
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQ 634
E +A L +LH II+RDLK NILLD++ + K++DFGL++ + +
Sbjct: 134 E-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AYS 185
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
GT YM+PE + +D +SFG+LM E L
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 35/156 (22%), Positives = 64/156 (41%), Gaps = 26/156 (16%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC 535
LG G G V + ++ A+K L + + + E+ L + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 536 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 587
+++E + L F + R +A I++ I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134
Query: 588 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLA 620
+ I HRD+K N+L + K++DFG A
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQS-GQGLKEF---KNEMMLIA 522
E F + LG+GG+G V++ R + G A+K L + K+ K E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 523 KLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
+++H +V L+ + G K+ LILEY+ L F+ + + A + E I+
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISM 132
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTY 639
L +LHQ II+RDLK NI+L+ + K++DFGL + + G T GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGTI 185
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETL 669
YM+PE + + D +S G LM + L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 525
+NF LG+G FG V R+ ++ AVK L + + M L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H L +L CC + +++ ++E++ L +R +AR E I L+
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAE-IISALM 138
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA--RMFGGDELQGNTKQIVGTYGYM 642
+LH II+RDLK N+LLD + + K++DFG+ + G T GT Y+
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYI 191
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETL 669
+PE + L+ D ++ G+L+ E L
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 43/223 (19%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
E + +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 520 LIAKLQHRNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQ 570
L+ ++H N++ LL +E+ + L+ M N + + L +Q
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630
I +GL Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTAD 184
Query: 631 NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
V T Y +PE L+ ++ D++S G +M E L+ +
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 40/195 (20%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ +F ++ LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 520 LIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQA 571
++ +H N++ + E ++ +I E M ++ ++ + + +Q
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ- 120
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
+ + LH + +IHRDLK SN+L++ + + K+ DFGLAR+ DE +
Sbjct: 121 -------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAAD 168
Query: 632 TKQIVGTYGYMSPEY 646
+ G M E+
Sbjct: 169 NSEPTGQQSGMV-EF 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 34/198 (17%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ + KLG+G +G V+K G+ VAVK++ + F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 520 LIAKLQ-HRNLVRLLGCCV-EQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQARV 573
++ +L H N+V LL + + L+ +YM + + + + K+ + +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--- 117
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+ + + YLH S ++HRD+K SNILL+ + + K++DFGL+R F N
Sbjct: 118 -----LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 634 QIVGTYGYMSPEYALDGL 651
+ + + L
Sbjct: 170 PLSINENTENFDDDQPIL 187
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-13
Identities = 20/126 (15%), Positives = 42/126 (33%), Gaps = 19/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ +T + G+ L + VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNLVLYD--------HSTSVWASNTGIL-GK 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ ++GN V+ + ++W+++ N V L++DGN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 146 WQSFDY 151
W + Y
Sbjct: 103 WSTGTY 108
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLKEF-----------K 515
ENF + LG G +G V+ R ++G + A+K L K +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTR 106
Query: 516 NEMMLIAKLQHRN-LVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
E ++ ++ LV L + K+ LIL+Y+ L F S ++R + ++
Sbjct: 107 TERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQI 163
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+ E I L +LH+ II+RD+K NILLD + + ++DFGL++ F DE +
Sbjct: 164 YVGE-IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AY 218
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDV--FSFGILMLETL 669
GT YM+P+ G V +S G+LM E L
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 9e-13
Identities = 27/123 (21%), Positives = 47/123 (38%), Gaps = 19/123 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
++++ + + G L + L G VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNFVLYDSGK--------PVWASNTGGL--G 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ LT+ NNGNLV+ +Q+N IW T + + + V L+ D N+VI +
Sbjct: 51 SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 146 WQS 148
W +
Sbjct: 103 WAT 105
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFK-------NEMMLIAKLQH 526
KLG G F V+ + ++N VA+K + E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 527 RNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
++++LL +G ++ E + ++L + + + + +I + + G
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNP------KISDFGLARMFGGDELQGNTKQIV 636
L Y+H R IIH D+K N+L++ +P KI+D G A + + +
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY----TNSI 196
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
T Y SPE L + +D++S L+ E
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 40/194 (20%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
NF + K+G G FG + G+ L + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRIIEGIAQGL 583
++ ++LE + SL LFD + + Q + +E
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPK-----ISDFGLARMFGGDELQGNTKQ---- 634
Y+H + +I+RD+K N L+ + N I DF LA+ + + TK+
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDPETKKHIPY 171
Query: 635 -----IVGTYGYMS 643
+ GT YMS
Sbjct: 172 REHKSLTGTARYMS 185
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 41/185 (22%), Positives = 79/185 (42%), Gaps = 22/185 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RN 528
+ + K+G G FG +Y G + G+EVA+K ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ + C E ++++E + SL LF+ ++ + + + + + + + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRK-FSLKTVLLLADQMISRIEYIHS 123
Query: 589 YSRFRIIHRDLKASNILLDKDMNPK---ISDFGLARMFGGDELQGNT-------KQIVGT 638
+ IHRD+K N L+ I DFGLA+ + + + + K + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRENKNLTGT 178
Query: 639 YGYMS 643
Y S
Sbjct: 179 ARYAS 183
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-11
Identities = 27/124 (21%), Positives = 51/124 (41%), Gaps = 18/124 (14%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
+D + + G L + + L + + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK-- 48
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
+ VL + N+GNLV+ + + IW++N + + N L+ D N+VI D +S NA
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD-NSNNA---- 102
Query: 145 LWQS 148
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-06
Identities = 18/69 (26%), Positives = 36/69 (52%), Gaps = 1/69 (1%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+++ + I N+ NLVL + N +W++ + + V ++++DGNLVI S
Sbjct: 16 LAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWAS 74
Query: 143 SYLWQSFDY 151
+ Q+ +Y
Sbjct: 75 NTNRQNGNY 83
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 32/201 (15%), Positives = 77/201 (38%), Gaps = 34/201 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR---------LLNGQEVAVKRLSNQSGQGLKEFK------ 515
+ ++ G +Y+ Q+ ++K L + G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 516 -----NEMMLIAKLQHRNLVRLLGCCVEQGE-KILILEYMPNKSLNVFLFDSTKKRLLNW 569
N+ + + +G V Q + + L+L + +SL D + K +L+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSE 158
Query: 570 QARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMF--GG 625
++ +++ + L +LH+ +H ++ A NI +D + ++ + +G A + G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 626 DEL---QGNTKQIVGTYGYMS 643
+ +G+ G ++S
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS 236
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 40/187 (21%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 527
++ + ++GEG FG +++G LLN Q+VA+K +S Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
+ + E +L+++ + SL L D ++ + + + + + +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLCGRKF-SVKTVAMAAKQMLARVQSIH 123
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPK-----ISDFGLARMFGGDELQGN------TKQIV 636
+ S +++RD+K N L+ + + + DFG+ + + D + K +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLS 179
Query: 637 GTYGYMS 643
GT YMS
Sbjct: 180 GTARYMS 186
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 527
+ + +G+G FG V K + + VA+K + N+ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 528 -----NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQ 581
+V L + + L+ E + S N++ L +T R ++ + + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTY 639
LL+L IIH DLK NILL KI DFG + G + Q + +
Sbjct: 169 ALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIY----QYIQSR 222
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLE 667
Y SPE L + + D++S G +++E
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-11
Identities = 21/123 (17%), Positives = 39/123 (31%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + L + + L + +W +N DR
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNLVKYQ--------NGRQIWASNTDR--RG 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ LT+ ++GNLV+ + N +W + + L+ DG VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 146 WQS 148
W
Sbjct: 103 WSL 105
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-11
Identities = 18/76 (23%), Positives = 33/76 (43%), Gaps = 10/76 (13%)
Query: 73 VVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+W N N + +G LV++ N T+W + V+ + + V L+ D N+VI
Sbjct: 50 PIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 133 RDNSSGNATESYLWQS 148
++ LW +
Sbjct: 108 YGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 4e-08
Identities = 19/77 (24%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 73 VVWVANRDRPISDNNA-VLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLV 131
++ + + + + NLVL + N IW+TN A L+ DG LV
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLV 74
Query: 132 IRDNSSGNATESYLWQS 148
+ N + +WQS
Sbjct: 75 VITNEN-----VTVWQS 86
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 7e-11
Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + GE L ++ R+ + +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNLVLYDVDK--------PIWATNTGGL--D 49
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
L++ ++GNLV+ + N IW++N E N V L+ D N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 146 WQS 148
W +
Sbjct: 102 WAT 104
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 39/201 (19%), Positives = 77/201 (38%), Gaps = 48/201 (23%)
Query: 478 KLGEGGFGPVYKGRLLNGQ------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
+G+GGFG +Y + + + VK + +G E K Q + +R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 532 LL-------------GCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRL-------LNW 569
G + G+ +I++ L ++++ KR L+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKRFSRKTVLQLSL 159
Query: 570 QARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMFGGDE 627
+ + I+E Y+H++ +H D+KASN+LL+ ++ D+GLA + +
Sbjct: 160 RI-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 628 L-----QGNTKQIVGTYGYMS 643
+ + GT + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLV-RLL 533
K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
VE +L+++ + SL LF+ ++ L+ + + + + + + ++H S
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 594 IIHRDLKASNILLDKDMNPK---ISDFGLARMFGGDELQG------NTKQIVGTYGYMS 643
+HRD+K N L+ I DFGLA+ + D K + GT Y S
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTARYAS 181
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-10
Identities = 20/112 (17%), Positives = 40/112 (35%), Gaps = 13/112 (11%)
Query: 21 VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRD 80
+ + + + +L + + +L W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN---------LVLYGGKYGWQSNTH 50
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+ + L +++ G L++ + TIWS+ SS+ V L+DDG VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-07
Identities = 16/71 (22%), Positives = 28/71 (39%), Gaps = 7/71 (9%)
Query: 78 NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSS 137
D ++ N L + + NLVL W +N ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 138 GNATESYLWQS 148
+W S
Sbjct: 74 KT-----IWSS 79
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR------N 528
+G+G FG V K Q VA+K + N+ Q +E + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
++ +L + + E + S+N++ L K + + + I Q L LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 588 QYSRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
+ RIIH DLK NILL + K+ DFG + + + + + Y +PE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TYIQSRFYRAPE 269
Query: 646 YALDGLFSIKSDVFSFGILMLE 667
L + + D++S G ++ E
Sbjct: 270 VILGARYGMPIDMWSLGCILAE 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 39/203 (19%), Positives = 73/203 (35%), Gaps = 55/203 (27%)
Query: 478 KLGEGGFGPVYKG-RLLNGQEVA---VKRLSNQSGQGLKEFKNEMML-----IAKLQHRN 528
K+G GGFG +Y ++ A VK ++G E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 529 LVRLLG----------CCVEQGEKILILEYMPNKSLNVFLFDSTKK-----------RLL 567
+ LG + + +++E + L + R+L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKSTVLQLGIRML 161
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMFGG 625
+ ++E Y+H+ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 162 D------VLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 626 DEL-----QGNTKQIVGTYGYMS 643
+ + K GT + S
Sbjct: 206 NGNHKQYQENPRKGHNGTIEFTS 228
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-09
Identities = 22/126 (17%), Positives = 41/126 (32%), Gaps = 23/126 (18%)
Query: 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRP 82
L + + + L + F+L W +N
Sbjct: 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCNLVLYNGN-----------WQSNTAN- 46
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+ + LT+++ G LV+ N T+W + S N A + DG LV+ S
Sbjct: 47 -NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99
Query: 143 SYLWQS 148
+++
Sbjct: 100 --VFKI 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 9e-09
Identities = 11/76 (14%), Positives = 31/76 (40%), Gaps = 10/76 (13%)
Query: 73 VVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+VW + + + + ++G L + + T++ +N + + V L+ +G V+
Sbjct: 46 IVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
Query: 133 RDNSSGNATESYLWQS 148
+ +W +
Sbjct: 104 YGPA--------VWST 111
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 7e-07
Identities = 13/67 (19%), Positives = 27/67 (40%), Gaps = 6/67 (8%)
Query: 83 ISDNNAVLTISNNGNLVL-LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNAT 141
++ + L + ++ NLVL +W + S ++ +L G L I D+
Sbjct: 21 LATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNT-- 78
Query: 142 ESYLWQS 148
++ S
Sbjct: 79 ---VFVS 82
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 2e-08
Identities = 18/79 (22%), Positives = 27/79 (34%), Gaps = 10/79 (12%)
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
D VW N + NG + +L N +W++ S V L+ D N
Sbjct: 167 RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 130 LVIRDNSSGNATESYLWQS 148
L I + LW +
Sbjct: 225 LAIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 5e-05
Identities = 26/156 (16%), Positives = 41/156 (26%), Gaps = 11/156 (7%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
D VW +N + ++G LV+L N WS+ + N V L+ D +
Sbjct: 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPDFLYK 190
I LW S +++ + S
Sbjct: 101 TIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPY 152
Query: 191 QFMMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQ 226
+ ME V + S T Q
Sbjct: 153 RLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQ 188
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 6e-05
Identities = 17/89 (19%), Positives = 37/89 (41%), Gaps = 6/89 (6%)
Query: 66 FQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLR 125
Q D + + + + L++ + NLVL + + +WSTN + + A L+
Sbjct: 130 STQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVLQ 188
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTD 154
+G + + N + +W S + +
Sbjct: 189 PNGRMDVLTNQN-----IAVWTSGNSRSA 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 3e-07
Identities = 77/580 (13%), Positives = 149/580 (25%), Gaps = 184/580 (31%)
Query: 154 DTLLQDMKLGWDF----KNRLERYLSSWRSADDPSPDFLYKQFMMENKDECVYW--YEAY 207
D + ++L W + +++++ + FL E + + Y
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKFVEE---VLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 208 NRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSV-PDQY---CGKYGYCG----ANTICS 259
++ V+R + L + P + G G G A +C
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQA--LLELRPAKNVLIDGVLG-SGKTWVALDVCL 172
Query: 260 LDQKPMCECLEGFKLESQVNQPGPI------KCERSHSLECKSGDQFIELDEIKAPDF-- 311
K C I C ++ ++D P++
Sbjct: 173 -SYKVQC------------KMDFKIFWLNLKNCNSPETVLEMLQKLLYQID----PNWTS 215
Query: 312 -IDVSLNQRMNLEQCKAECLKNCSCRAYANS-----NVKESS-------GCLMWYGDLID 358
D S N ++ + +AE + + Y N NV+ + C + L+
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI----LLT 271
Query: 359 AR-RPIRNFTGQSVYLRVPASKLGN-------KKLL--WI----------------LVIL 392
R + + +F + + K LL ++ +
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 393 VIPVVL--LPSFYVFYRR---------RRKC--QEKETENVETYQDLLAFDINMNITTRT 439
+I + + + ++ + E + + L F + +I T
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391
Query: 440 NEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVA 499
L L I + + +K L+ Q
Sbjct: 392 ------------------LSLIWFDVIKSDVMVVVNKL----------HKYSLVEKQP-- 421
Query: 500 VKRLSNQSGQGLKEFKNEMMLIA---KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 556
KE + I K++ N L + ++ Y K+
Sbjct: 422 ------------KESTISIPSIYLELKVKLENEYAL--------HRSIVDHYNIPKT--- 458
Query: 557 FLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-----SRFRIIHRDLKASNILLDKD-M 610
FDS Y + + R + LD +
Sbjct: 459 --FDSDDLIPPYLDQ-------------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 611 NPKISDFGLARMFGGDELQGNTKQIVGTY-GYMS---PEY 646
KI A G L NT Q + Y Y+ P+Y
Sbjct: 504 EQKIRHDSTAWNASGSIL--NTLQQLKFYKPYICDNDPKY 541
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 4e-04
Identities = 54/328 (16%), Positives = 99/328 (30%), Gaps = 85/328 (25%)
Query: 355 DLIDARRPIRNFTGQSV--YLRVPASKLGNKKLLWIL-------VILVIPVVLLPSFYVF 405
D+ D + I + + + + + G +L W L V + VL + Y F
Sbjct: 37 DVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKF 93
Query: 406 ----YRRRRKCQEKETENVETYQDLLAFD----INMNITTRTNEYGEANGDGKDKSKDSW 457
+ ++ T +D L D N++ R Y K + +
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPY--------LKLRQA- 143
Query: 458 LPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 517
L L +N + G G G K VA+ + Q +FK
Sbjct: 144 --LLELRP----AKNVLID---GVLGSG---K------TWVALDVCLSYKVQCKMDFK-- 183
Query: 518 MMLIAKLQHRNLVRLLGCCVEQGEKILILE-----YMPNKSLNVFLFDSTKKRLLNWQAR 572
I L L C + +L+ PN + + K R+ + QA
Sbjct: 184 ---IFWLN-------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI----SDFGLARMFGGDEL 628
+R LL Y ++ +++ + +++ KI + D L
Sbjct: 234 LRR-------LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT-----DFL 281
Query: 629 QGNTKQ---IVGTYGYMSPEYALDGLFS 653
T + ++P+ L
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVK-SLLL 308
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 8e-04
Identities = 48/314 (15%), Positives = 98/314 (31%), Gaps = 96/314 (30%)
Query: 52 FSPGKSK---SRYLGIRFQQIPD----------AVVWVANRDRPI-SDN---------NA 88
+P + K +YL R Q +P +++ + RD DN
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357
Query: 89 VLTISNNG-----------NLVLLN-------QTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
++ S N L + IW + S+V V +L L
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS-L 416
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRL-----ERY-LSSWRSADDPS 184
V + + ++ ++K+ + + L + Y + +DD
Sbjct: 417 VEKQ-----------PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
Query: 185 PDFLYKQFMMENKDECVYWYEAY--------NRPSIMTLKLNPSGFVTRQIWNENSNKWD 236
P +L D+ Y + + R ++ + F+ ++I ++++ W+
Sbjct: 466 PPYL---------DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTA-WN 515
Query: 237 ELFSVPD--QYCGKY-GYCGANTICSLDQKPMCECLEGFKLESQVNQPGPIKCERSHSLE 293
S+ + Q Y Y IC D P E L + + + + +
Sbjct: 516 ASGSILNTLQQLKFYKPY-----IC--DNDPKYERLVN-AILDFLPKIEE------NLIC 561
Query: 294 CKSGD--QFIELDE 305
K D + + E
Sbjct: 562 SKYTDLLRIALMAE 575
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.6 bits (122), Expect = 3e-07
Identities = 13/69 (18%), Positives = 26/69 (37%), Gaps = 8/69 (11%)
Query: 84 SDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATES 143
+GNLV+ N +W ++ + V +L+ +G++ I D
Sbjct: 193 GKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDEKP------ 245
Query: 144 YLWQSFDYP 152
+W F +
Sbjct: 246 -VWARFGFQ 253
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.7 bits (104), Expect = 4e-05
Identities = 33/157 (21%), Positives = 57/157 (36%), Gaps = 20/157 (12%)
Query: 22 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDR 81
+ + + G+ L+S +QRF+L G L I+ A VWVAN +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62
Query: 82 PIS------DNNAVLTISNNGNLVLLNQTNGTIW-----STNVSSEVKNPVAQLRDDGNL 130
P S + A L L + + +W + + + L+DDGN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 131 VIRDNSSG-NATESYLWQSFDYPTDTLLQDMKLGWDF 166
V+ D+ + N T + + L +L
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGV 159
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.8 bits (94), Expect = 9e-04
Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 9/88 (10%)
Query: 75 WVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRD 134
+ + L +GNLV W+ + A + DGNLV+
Sbjct: 153 SELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGK-GAVRAVFQGDGNLVVYG 211
Query: 135 NSSGNATESYLWQS--FDYPTDTL-LQD 159
+ + LW S + + L LQ
Sbjct: 212 AGN-----AVLWHSHTGGHASAVLRLQA 234
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 5e-07
Identities = 14/66 (21%), Positives = 25/66 (37%), Gaps = 6/66 (9%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+S +A + + NLVL N + +N + +L + G L I +S
Sbjct: 17 LSYESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTP-- 72
Query: 143 SYLWQS 148
+W
Sbjct: 73 --VWVY 76
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-05
Identities = 14/81 (17%), Positives = 33/81 (40%), Gaps = 13/81 (16%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGT---IWSTNVSSEVKNPVAQLRDD 127
+A + +N + L ++N G L + + + T ++ +V++ N A L D
Sbjct: 37 EAGGFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94
Query: 128 GNLVIRDNSSGNATESYLWQS 148
++ I + +W +
Sbjct: 95 QHVTIYGPA--------IWST 107
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 45/226 (19%), Positives = 75/226 (33%), Gaps = 46/226 (20%)
Query: 473 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 527
+ + LGEG FG V + +VA+K + N E ++ K++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76
Query: 528 ------NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIA 580
V + G + E + N F + + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLAR 621
L +LH ++ H DLK NIL +++DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
F + IV T Y PE L+ ++ DV+S G ++ E
Sbjct: 190 TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 49/252 (19%), Positives = 88/252 (34%), Gaps = 72/252 (28%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRN 528
KLG G F V+ + + VA+K + + + +E+ L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 529 LVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
+V+LL G ++ E + L ++ S + L + +II+ + QGL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLD 160
Query: 585 YLHQYSRFRIIHRDLKASNILL-------------------------------------- 606
YLH ++ RIIH D+K NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 607 -----------DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK 655
+ + KI+D G A + + T Y S E + ++
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSLEVLIGSGYNTP 273
Query: 656 SDVFSFGILMLE 667
+D++S + E
Sbjct: 274 ADIWSTACMAFE 285
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 50/230 (21%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 527
F + K+G+G FG V + + N + AVK + N E ++ K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 528 ----NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQG 582
N+V+ G + LI E + +++ + + + I +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------------KISDF 617
L YL + + H DLK NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
G A F D I+ T Y +PE L+ + + SD++SFG ++ E
Sbjct: 207 GCA-TFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 48/227 (21%), Positives = 81/227 (35%), Gaps = 48/227 (21%)
Query: 473 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 527
+ + LGEG FG V + G+ VAVK + N E + ++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ----VLEHLNTT 71
Query: 528 ------NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIA 580
V++L G ++ E + L+ + ++ I
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLAR 621
+ + +LH ++ H DLK NIL + K+ DFG A
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 667
+ + +V T Y +PE L L +S DV+S G +++E
Sbjct: 185 TYDDEHH----STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIE 226
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} Length = 369 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 11/92 (11%), Positives = 28/92 (30%), Gaps = 2/92 (2%)
Query: 76 VANRDRPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRD 134
+ + + + + +G +V ++ +G + W N +S V + +G +
Sbjct: 163 ASLPEDDVDYKMSHFVSNGDGLVVTVDSESGDVLWIQNYASPVVA-FYVWQREGLRKVMH 221
Query: 135 NSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166
+ T YL +
Sbjct: 222 INVAVETLRYLTFMSGEVGRITKWKYPFPKET 253
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 682 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.98 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.98 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.98 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.87 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.86 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.84 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.84 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.83 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.79 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.75 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.39 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.39 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.36 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.29 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.12 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.12 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.03 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.87 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.61 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.63 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.27 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.22 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.98 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.74 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.59 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.92 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.13 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.12 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.65 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.87 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 88.57 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.39 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 84.4 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.03 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.02 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 81.67 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=395.48 Aligned_cols=207 Identities=31% Similarity=0.499 Sum_probs=182.7
Q ss_pred hcCcccccccccCCceeEEEEEEc------CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++|.+.++||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++++|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467899999999999999999864 36789999998877777889999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeE
Q 005705 544 LILEYMPNKSLNVFLFDST----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 613 (682)
+||||+++|+|.++|.... ....+++.++++|+.||++||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999996432 2356999999999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
|+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...+
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999987654433333344579999999999999999999999999999999999 999997644
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=392.32 Aligned_cols=204 Identities=28% Similarity=0.416 Sum_probs=184.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.++||+|+||+||+|++. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999875 5889999999753 234567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999943 456999999999999999999999998 99999999999999999999999999998765
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..........+||+.|||||++.+..|+.++|||||||+||||++|++||...+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 444445566799999999999999999999999999999999999999997654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=394.90 Aligned_cols=207 Identities=30% Similarity=0.491 Sum_probs=175.6
Q ss_pred hcCcccccccccCCceeEEEEEEc------CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467888999999999999999864 47789999998877777889999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 544 LILEYMPNKSLNVFLFDST------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
+||||+++|+|.+++.... ....+++.+++.|+.||++||+|||+++ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999996532 2346999999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 99999999997755443334445689999999999999999999999999999999999 999997543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=393.27 Aligned_cols=203 Identities=27% Similarity=0.431 Sum_probs=175.8
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|+++++||+|+||.||+|++. +|+.||||++... .....+.|.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999875 5899999999654 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++|+|.++|... +...+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999998542 3456899999999999999999999998 999999999999999999999999999876422
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||...+
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 122345689999999999999999999999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=392.52 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=181.8
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356999999999999999999985 5899999999766555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999999843 45999999999999999999999998 9999999999999999999999999999875432
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+||+.|||||++.+..|+.++|||||||+||||++|++||...+
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 23445799999999999999999999999999999999999999997543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=388.68 Aligned_cols=206 Identities=34% Similarity=0.502 Sum_probs=179.9
Q ss_pred cCcccccccccCCceeEEEEEEc------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++++.++||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999863 4678999999754 3345688999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC
Q 005705 544 LILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 610 (682)
+||||+++|+|.++|.... ....+++.++++|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996432 1346999999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.+||+|||+|+.+...+.........||+.|||||++.+..|+.++|||||||+||||+| |++||...+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 999999999987754443344455689999999999999999999999999999999999 899997543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=383.96 Aligned_cols=203 Identities=30% Similarity=0.479 Sum_probs=170.9
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..+++++.++||+|+||+||+|++. ..||||+++.. ..+..++|.+|+.+|++++|||||++++++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 4567889999999999999999864 36999998643 44567889999999999999999999998865 5689999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|.++|... ...+++.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999998543 346999999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.........+||+.|||||++.+ ..|+.++|||||||+||||+||++||...+
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 33334456789999999999864 468999999999999999999999997543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=394.16 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=182.1
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999985 5899999999766555667799999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999999843 35999999999999999999999998 9999999999999999999999999998775432
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+||+.|||||++.+..|+.++|||||||+||||++|++||...+
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 23455799999999999999999999999999999999999999997543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=371.71 Aligned_cols=197 Identities=30% Similarity=0.459 Sum_probs=170.3
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----cCeEEEE
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILI 545 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 545 (682)
|++.++||+|+||.||+|++. +++.||||++... .....++|.+|+.+|++++|||||++++++.+ +...++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366778999999999999885 4889999998653 34456789999999999999999999999875 3457999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-CCCCeEEeeeccccccC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFG 624 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~ 624 (682)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||++++ +||||||||+||||+ .++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999953 4569999999999999999999998752 599999999999998 47899999999998643
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.. .....+||+.|||||++.+ .|+.++|||||||+||||+||++||...
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 22 2345689999999998865 6999999999999999999999999643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=381.94 Aligned_cols=200 Identities=27% Similarity=0.302 Sum_probs=173.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.+.|++.++||+|+||.||+|++. +|+.||||+++.... +.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888999999999999999985 589999999975422 24799999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeeccccccCCCc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 627 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 627 (682)
+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999953 356999999999999999999999998 99999999999999887 69999999999875432
Q ss_pred ccc---ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 628 LQG---NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 628 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
... .....+||+.|||||++.+..|+.++|||||||+||||++|++||...+.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 211 22346899999999999999999999999999999999999999976543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=382.00 Aligned_cols=201 Identities=28% Similarity=0.371 Sum_probs=171.4
Q ss_pred cCcccccccccCCceeEEEEEEc----CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
++|++++.||+|+||+||+|+.. .++.||||++++.. .....++.+|+.+|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 36789999996532 2234568899999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999943 456999999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... ......+||+.|||||++.+..|+.++|||||||+||||+||++||...+
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 322 23345689999999999999999999999999999999999999997654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=368.91 Aligned_cols=199 Identities=28% Similarity=0.475 Sum_probs=163.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||+||+|++. +++.||||++++. .....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999874 5899999999653 2334678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6789888843 456999999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .....+||+.|||||++.+..+ +.++|||||||+||||++|+.||...+
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 2 2345689999999999998886 579999999999999999999997654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=380.06 Aligned_cols=215 Identities=29% Similarity=0.437 Sum_probs=184.8
Q ss_pred chhHHHhhhcCcccccccccCCceeEEEEEEcC------CceEEEEEecccC-hhhHHHHHHHHHHHHhcCC-CCeeeEE
Q 005705 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQH-RNLVRLL 533 (682)
Q Consensus 462 ~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H-pnIv~l~ 533 (682)
.....+...++|++.++||+|+||.||+|++.. ++.||||++.... ....++|.+|+.+|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 334455667899999999999999999998743 3579999997643 3456789999999999965 9999999
Q ss_pred EEEEec-CeEEEEEEecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC
Q 005705 534 GCCVEQ-GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 599 (682)
Q Consensus 534 ~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dl 599 (682)
++|.+. +..++||||+++|+|.++|..... ...+++.+++.++.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 568999999999999999965322 345899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 600 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 600 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
||+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998755443334455689999999999999999999999999999999998 99999764
Q ss_pred C
Q 005705 679 S 679 (682)
Q Consensus 679 ~ 679 (682)
+
T Consensus 292 ~ 292 (353)
T 4ase_A 292 K 292 (353)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=370.18 Aligned_cols=202 Identities=27% Similarity=0.386 Sum_probs=165.8
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC----eEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~ 546 (682)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688899999999999999988 6899999999754322 223455777778899999999999998764 579999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
||+++|+|.+++.. ..+++.++++++.|+++||+|||++. ..+||||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999943 45899999999999999999999861 2349999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccccccccCcccccCC------CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 622 MFGGDEL--QGNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 622 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
....... .......+||+.|||||++.+. .++.|+|||||||+||||+||++||...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 7643321 1223346899999999998765 3678999999999999999999887643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=364.86 Aligned_cols=200 Identities=29% Similarity=0.440 Sum_probs=163.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe-------
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE------- 541 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~------- 541 (682)
++|++++.||+|+||+||+|++. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999875 58899999986543 3456789999999999999999999999876543
Q ss_pred -----EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEee
Q 005705 542 -----KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (682)
Q Consensus 542 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 616 (682)
.++||||+++|+|.+++.........++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999965544445677888999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCccc----------cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 617 FGLARMFGGDELQ----------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 617 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
||+|+.+...... ......+||+.|||||++.+..|+.++|||||||+||||++ ||.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 9999887543211 12234589999999999999999999999999999999997 664
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=362.96 Aligned_cols=203 Identities=25% Similarity=0.392 Sum_probs=173.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------cC
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QG 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~------~~ 540 (682)
.++|+++++||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 368999999999999999999884 68999999997542 3445678999999999999999999998764 35
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..|+||||++ |+|..++. +.+.+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67888883 4467999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCc--cccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDE--LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||...+
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 8764322 12234457999999999998875 46999999999999999999999997543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=357.48 Aligned_cols=201 Identities=24% Similarity=0.367 Sum_probs=172.2
Q ss_pred hhhcCcccccccccCCceeEEEEEEc----CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 542 (682)
...++|++.++||+|+||+||+|+.+ .++.||||.+.... ...++.+|+++|.++ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999864 36789999986543 345788999999998 699999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC-CCeEEeeecccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLAR 621 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla~ 621 (682)
++||||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999882 4899999999999999999999998 9999999999999877 799999999998
Q ss_pred ccCCCccc--------------------------cccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCC
Q 005705 622 MFGGDELQ--------------------------GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKN 674 (682)
Q Consensus 622 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~p 674 (682)
........ ......+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432110 112345799999999999876 489999999999999999999999
Q ss_pred CCCCC
Q 005705 675 TGLGS 679 (682)
Q Consensus 675 f~~~~ 679 (682)
|..++
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=375.36 Aligned_cols=199 Identities=28% Similarity=0.379 Sum_probs=173.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhh---HHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQG---LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~---~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
-++|++.++||+|+||.||+|+.. +|+.||||++.+.. ... ..+...++.++..++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999885 58999999996431 112 22334456777788999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
|+||||++||+|..+|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999943 456999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+... .....+||+.|||||++.+ ..|+.++|||||||+||||++|++||...
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6433 2345699999999999974 57999999999999999999999999654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=370.49 Aligned_cols=202 Identities=24% Similarity=0.378 Sum_probs=181.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999885 5899999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC--CCeEEeeeccccccCCC
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--MNPKISDFGLARMFGGD 626 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kL~DFGla~~~~~~ 626 (682)
+++|+|.+++.. +...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999998843 3346899999999999999999999998 9999999999999854 89999999999987543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .....+||+.|||||++.+..|+.++|||||||+||||++|++||...+
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2 2345689999999999999999999999999999999999999997543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.12 Aligned_cols=214 Identities=40% Similarity=0.696 Sum_probs=188.7
Q ss_pred chhHHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 462 ~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
.+.++....++|++.+.||+|+||.||+|++.+++.||||++........+++.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34445567889999999999999999999988899999999987766778899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
.++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999854322 235899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+...............||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 8754333222334457899999999999999999999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.84 Aligned_cols=211 Identities=23% Similarity=0.315 Sum_probs=181.8
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~ 538 (682)
+..+....++|++.++||+|+||.||+|++.. ++.||||++++.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34455567899999999999999999999865 7889999996532 1223348899999999999999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
++..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999542 356999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|++||...+
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 9987643322 2233468999999999987 5678999999999999999999999997654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=320.70 Aligned_cols=202 Identities=26% Similarity=0.425 Sum_probs=181.3
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
..++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 356899999999999999999986 4688999999976655667789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++.. ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999843 35899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22344689999999999999999999999999999999999999997543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=326.93 Aligned_cols=202 Identities=26% Similarity=0.339 Sum_probs=179.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999885 5889999999753 234567789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999998843 356899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 21 23345689999999999999999999999999999999999999997654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=325.17 Aligned_cols=201 Identities=28% Similarity=0.447 Sum_probs=179.4
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..+|++.+.||+|+||.||+|++ .+|+.||||++... .....+++.+|+.++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999998 56899999998654 3445678899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999854 345899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .....+||+.|+|||++.+..+. .++|||||||++|||++|+.||...+
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 2 33456899999999999988875 78999999999999999999997654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.85 Aligned_cols=212 Identities=29% Similarity=0.423 Sum_probs=186.2
Q ss_pred CccchhHHHhhhcC----------cccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCC
Q 005705 459 PLFSLASITAATEN----------FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR 527 (682)
Q Consensus 459 ~~~~~~~~~~~~~~----------y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hp 527 (682)
+.++.+++..+++. |...++||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666776666553 777789999999999999986 6899999999776666778899999999999999
Q ss_pred CeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc
Q 005705 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (682)
Q Consensus 528 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~ 607 (682)
||+++++++...+..++||||+++++|.+++. ...+++.++..++.||++||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999983 345899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 608 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999998764332 12344679999999999999999999999999999999999999997543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.38 Aligned_cols=203 Identities=26% Similarity=0.397 Sum_probs=174.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|++.++||+|+||.||++++. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999885 4889999999753 234556788999999998 6999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999843 356999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .......+||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 322 123345689999999999999999999999999999999999999997654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=328.47 Aligned_cols=209 Identities=30% Similarity=0.493 Sum_probs=181.9
Q ss_pred hhcCcccccccccCCceeEEEEEEc--------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~ 538 (682)
..++|++.+.||+|+||.||+|++. ++..||||+++.. .....+++.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3578999999999999999999863 3457999999764 344567899999999999 89999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEE
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIL 605 (682)
.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999865321 235899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 005705 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGSM 680 (682)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~~ 680 (682)
++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999987755433333444567889999999999999999999999999999999 9999976543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.82 Aligned_cols=208 Identities=24% Similarity=0.302 Sum_probs=180.1
Q ss_pred hHHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec
Q 005705 464 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (682)
Q Consensus 464 ~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~ 539 (682)
..+....++|++.++||+|+||.||++++. +++.||||++++.. ....+.+.+|+.++..++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344556789999999999999999999986 47899999996521 12234588999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecc
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 619 (682)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999843 35899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++.+..... ......+||+.|+|||++.+.. ++.++|||||||+||||++|++||...+
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 987654321 1233568999999999998765 7899999999999999999999997654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.68 Aligned_cols=204 Identities=28% Similarity=0.461 Sum_probs=180.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|++.++||+|+||.||++++. +++.||+|.+........+.|.+|+.++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467999999999999999999885 5889999999877777788999999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998542 346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cc------------ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QG------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 11 111457999999999999999999999999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=330.96 Aligned_cols=201 Identities=23% Similarity=0.385 Sum_probs=176.1
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|++.++||+|+||.||++++. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3578999999999999999999986 47889999997542 23345688899999887 8999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999998843 356999999999999999999999998 999999999999999999999999999863
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
... .......+||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 222 1234456899999999999999999999999999999999999999963
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=320.44 Aligned_cols=199 Identities=29% Similarity=0.417 Sum_probs=178.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||+|+||.||+++.. +++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999885 58899999997532 23467788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999853 346899999999999999999999998 99999999999999999999999999987542
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2334689999999999999999999999999999999999999997543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.64 Aligned_cols=205 Identities=26% Similarity=0.389 Sum_probs=178.9
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCe
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 541 (682)
....++|++.+.||+|+||.||+|++. +++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999985 58899999997542 33456788899999887 89999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 643221 22445689999999999999999999999999999999999999997654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.30 Aligned_cols=203 Identities=28% Similarity=0.451 Sum_probs=174.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||+|+||.||++++. +++.||+|.+... .....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 568999999999999999999875 5889999998542 334567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 122334579999999999999999999999999999999999999997653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.15 Aligned_cols=206 Identities=17% Similarity=0.162 Sum_probs=177.6
Q ss_pred HHhhhcCcccccccccCCceeEEEEE------EcCCceEEEEEecccChhhHHHHHHHHHHHHhcC---CCCeeeEEEEE
Q 005705 466 ITAATENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCC 536 (682)
Q Consensus 466 ~~~~~~~y~i~~~LG~G~fG~Vyk~~------~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~~~~ 536 (682)
+....++|.+.++||+|+||.||+|. ..+++.||||+++... ..++..|+.++.+++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34456889999999999999999994 3468899999997543 456778888888887 99999999999
Q ss_pred EecCeEEEEEEecCCCChhHHhhhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC------
Q 005705 537 VEQGEKILILEYMPNKSLNVFLFDST--KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK------ 608 (682)
Q Consensus 537 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~------ 608 (682)
...+..++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+++ |+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 99999999999999999999996422 3456999999999999999999999998 999999999999998
Q ss_pred -----CCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 609 -----DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 609 -----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999765422222334456899999999999999999999999999999999999999854
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=333.10 Aligned_cols=211 Identities=22% Similarity=0.313 Sum_probs=181.9
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~ 538 (682)
+.+.....++|++.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.+++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4445556789999999999999999999985 58999999996532 2233458899999999999999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999998542 236899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccccc-------CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYAL-------DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++.+..... ......+||+.|+|||++. ...++.++|||||||++|||++|++||...+
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 9987644321 1223458999999999987 4578999999999999999999999997654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.40 Aligned_cols=200 Identities=24% Similarity=0.392 Sum_probs=177.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|++.+.||+|+||.||++++. +++.||||++.+. .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999985 4889999999754 234466788999999988 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999843 346899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 221 233456899999999999999999999999999999999999999964
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.91 Aligned_cols=218 Identities=42% Similarity=0.707 Sum_probs=189.1
Q ss_pred CCccchhHHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 005705 458 LPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCC 536 (682)
Q Consensus 458 ~~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~~~~ 536 (682)
+..++..++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++.+++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999975432 2234689999999999999999999999
Q ss_pred EecCeEEEEEEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEe
Q 005705 537 VEQGEKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (682)
Q Consensus 537 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 615 (682)
...+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||++...+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999986543 33459999999999999999999999922229999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|++||.
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999987643322 22334569999999999999999999999999999999999999995
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.24 Aligned_cols=201 Identities=28% Similarity=0.388 Sum_probs=178.8
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.+.|++.+.||+|+||.||+++.. +|+.||||.+..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 567999999999999999999885 588999999965432 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC----CeEEeeec
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 618 (682)
++||||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999984 3456999999999999999999999998 99999999999998877 79999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 998764422 2344679999999999999999999999999999999999999997543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=321.57 Aligned_cols=205 Identities=30% Similarity=0.401 Sum_probs=177.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999886 68899999986443 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999883 3446999999999999999999999998 9999999999999999999999999998764333
Q ss_pred cccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||...+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 3333445689999999999988775 7789999999999999999999976543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=324.86 Aligned_cols=201 Identities=25% Similarity=0.387 Sum_probs=177.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 478999999999999999999875 47889999986532 33467889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...+
T Consensus 168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 2 23345689999999999864 458999999999999999999999997543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.05 Aligned_cols=203 Identities=26% Similarity=0.347 Sum_probs=178.7
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|++.+.||+|+||.||+++... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999999864 789999999754 224567788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++|+|..++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999843 345899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 3221 23445689999999999999999999999999999999999999997654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.80 Aligned_cols=198 Identities=20% Similarity=0.244 Sum_probs=153.1
Q ss_pred cccccccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCC----CceEEEecCC
Q 005705 21 VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDN----NAVLTISNNG 96 (682)
Q Consensus 21 ~~~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~----~~~l~~~~~g 96 (682)
++++.|+|.+|++|++|++|+|++|.|+||||+++ ++|+ |+ ..+ +||+|||++|+.++ +++|+|+.||
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 46788999999999999999999999999999543 6777 66 345 99999999999885 7899999999
Q ss_pred cEEE--ecCCCCeEEEEeccCC-----cCCceEEEecCCceEEecCCCCCCCccceeeecCCCcccccccCccccccccC
Q 005705 97 NLVL--LNQTNGTIWSTNVSSE-----VKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNR 169 (682)
Q Consensus 97 ~lvl--~~~~~~~~w~s~~~~~-----~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~Ptdtllp~~~l~~~~~~~ 169 (682)
+||| .|++|.+||+|+++.. ..+++|+|+|+|||||++ +.+|||| ||||||||||+||.+..+|
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--ccccccccccccccccccC
Confidence 9999 7888999999997652 346789999999999997 2689999 9999999999999888877
Q ss_pred cceeEEEeecCCCCCCc-ccc---c--c-ceecc------------------------------cceEEEEEEeeCCCee
Q 005705 170 LERYLSSWRSADDPSPD-FLY---K--Q-FMMEN------------------------------KDECVYWYEAYNRPSI 212 (682)
Q Consensus 170 ~~~~l~s~~~~~dps~g-~~~---~--~-~~~~~------------------------------~~~~~~~~~~~~~~~~ 212 (682)
.. | ++..||++| |.+ + + ++..+ .....+|++.......
T Consensus 153 ~~--L---~S~~dps~G~fsl~l~~dGnlvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS~t~~~~~ 227 (276)
T 3m7h_A 153 SE--L---VQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHAS 227 (276)
T ss_dssp EE--E---CTTCEEEETTEEEEECTTSCEEEECTTSSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEECSCTTCTT
T ss_pred cc--c---ccCCCCCCceEEEeecCCceEEEEeCCCeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEecCCCCCC
Confidence 55 3 677889888 431 0 0 11111 0111223332222334
Q ss_pred eEEEECCCCcEEEEEEeCCCCceEEEeeccC
Q 005705 213 MTLKLNPSGFVTRQIWNENSNKWDELFSVPD 243 (682)
Q Consensus 213 ~~~~l~~~G~l~~~~w~~~~~~W~~~~~~~~ 243 (682)
+|++|+.||++++|.| ...|..++..|+
T Consensus 228 ~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 228 AVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp CEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred EEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 7999999999999998 245766666554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.66 Aligned_cols=199 Identities=24% Similarity=0.319 Sum_probs=178.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999985 58899999996532 23467889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999854 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .....||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 2 234689999999999999999999999999999999999999997653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.81 Aligned_cols=202 Identities=29% Similarity=0.390 Sum_probs=168.7
Q ss_pred hcCcccccccccCCceeEEEEEE----cCCceEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
.++|++.+.||+|+||.||+++. .+++.||||++++.. ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 56899999999999999999987 468899999997542 2345668899999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999843 346899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 643221 12334579999999999999999999999999999999999999997654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=312.75 Aligned_cols=218 Identities=40% Similarity=0.602 Sum_probs=189.7
Q ss_pred CCCccchhHHHhhhcCcccc------cccccCCceeEEEEEEcCCceEEEEEeccc----ChhhHHHHHHHHHHHHhcCC
Q 005705 457 WLPLFSLASITAATENFSMQ------CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH 526 (682)
Q Consensus 457 ~~~~~~~~~~~~~~~~y~i~------~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~----~~~~~~~f~~E~~~l~~l~H 526 (682)
..+.|++.++...+++|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568888999999888776 8899999999999987 6889999998653 23456789999999999999
Q ss_pred CCeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 527 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999876555567999999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|++||...+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 9999999999999987654322222344578999999998765 58899999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=316.93 Aligned_cols=210 Identities=31% Similarity=0.517 Sum_probs=173.9
Q ss_pred HHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 466 ITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 466 ~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
+....++|++.+.||+|+||.||+|+. +++.||||++.... ....++|.+|+.++++++||||+++++++.+.+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 344567899999999999999999987 68899999986543 345678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++........+++..++.++.||+.||+|||++++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999654434459999999999999999999998852 4999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 12334578999999999999999999999999999999999999997643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.90 Aligned_cols=202 Identities=29% Similarity=0.458 Sum_probs=174.3
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC----eEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~l 544 (682)
..++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.+.. ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4578999999999999999999874 7899999997543 33455677999999999999999999998754 3699
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY----------SRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
||||+++++|.+++.. ..+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 9999999999999843 3489999999999999999999998 7 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999877554433334456899999999998863 45678999999999999999999997543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=314.36 Aligned_cols=201 Identities=28% Similarity=0.394 Sum_probs=178.2
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.+.|.+.+.||+|+||.||+++.. +++.||||.+..... ...+++.+|+.++.+++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999885 588999999865422 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC----CeEEeeec
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 618 (682)
++||||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999984 3456999999999999999999999998 99999999999999887 79999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 998764322 2334579999999999999999999999999999999999999996543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=319.84 Aligned_cols=202 Identities=26% Similarity=0.405 Sum_probs=178.1
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..++|++.+.||+|+||.||++++. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999885 5889999999654 334567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC---CeEEeeeccccc
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARM 622 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~ 622 (682)
|||+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999998884 3456899999999999999999999998 99999999999998654 599999999987
Q ss_pred cCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... ......||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 65322 2234679999999999999999999999999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=313.99 Aligned_cols=201 Identities=22% Similarity=0.313 Sum_probs=178.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|++.+.||+|+||.||++++. +++.+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999885 47899999987543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC--CCCeEEeeeccccccCCC
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGD 626 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~ 626 (682)
+++++|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999843 2346899999999999999999999998 999999999999987 789999999999876533
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ......||+.|+|||++.+..++.++||||||+++|||++|++||...+
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 2 2344678999999999999889999999999999999999999997654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.02 Aligned_cols=203 Identities=29% Similarity=0.397 Sum_probs=174.1
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..++|++.++||+|+||.||+|++.+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 357899999999999999999999889999999986532 233577899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++ +|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 77777643 3345899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 2 22334578999999999876 568999999999999999999999997544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=319.02 Aligned_cols=204 Identities=25% Similarity=0.340 Sum_probs=177.2
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.+.|++.+.||+|+||.||++++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999875 58899999985421 224678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC---eEEeeecc
Q 005705 544 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGL 619 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFGl 619 (682)
+||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 3345899999999999999999999998 999999999999987655 99999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 98765432 1233457999999999999999999999999999999999999999653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=314.75 Aligned_cols=203 Identities=28% Similarity=0.417 Sum_probs=174.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------- 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------- 540 (682)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999986 6899999999653 3345678999999999999999999999986653
Q ss_pred --------------------------------------------------eEEEEEEecCCCChhHHhhhccccCCCCHH
Q 005705 541 --------------------------------------------------EKILILEYMPNKSLNVFLFDSTKKRLLNWQ 570 (682)
Q Consensus 541 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 570 (682)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999766555667888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc----------ccccccccccc
Q 005705 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ----------GNTKQIVGTYG 640 (682)
Q Consensus 571 ~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~ 640 (682)
.++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999887543211 12234579999
Q ss_pred ccCcccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 005705 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675 (682)
Q Consensus 641 y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf 675 (682)
|+|||++.+..++.++||||||+++|||++|..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999998775
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.45 Aligned_cols=216 Identities=29% Similarity=0.445 Sum_probs=183.6
Q ss_pred cchhHHHhhhcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeE
Q 005705 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRL 532 (682)
Q Consensus 461 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l 532 (682)
+.........++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445566677899999999999999999999742 35789999997643 34457899999999999 79999999
Q ss_pred EEEEEecCe-EEEEEEecCCCChhHHhhhccc------------------------------------------------
Q 005705 533 LGCCVEQGE-KILILEYMPNKSLNVFLFDSTK------------------------------------------------ 563 (682)
Q Consensus 533 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 563 (682)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999965432
Q ss_pred ---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 564 ---------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 564 ---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999998 99999999999999999999999999987644333
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 333445678899999999999999999999999999999998 999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=313.48 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=177.4
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC--eEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV 545 (682)
.++|++.++||+|+||.||+|++.. ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999998864 8899999997543 345678899999999999999999999998765 77999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE----cCCCCeEEeeecccc
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 621 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DFGla~ 621 (682)
|||+++++|.+++........+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555556999999999999999999999998 9999999999999 778889999999998
Q ss_pred ccCCCccccccccccccccccCccccc--------CCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYAL--------DGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 765432 223457899999999886 57889999999999999999999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.36 Aligned_cols=203 Identities=26% Similarity=0.314 Sum_probs=169.0
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMML-IAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|++.+.||+|+||.||+++.. +++.||||++++.. ......+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3568999999999999999999986 47889999996543 2234556677776 56789999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999843 346899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .......+||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 322 123445689999999999999999999999999999999999999997543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.99 Aligned_cols=205 Identities=27% Similarity=0.398 Sum_probs=170.1
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe---
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE--- 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 541 (682)
..++|++.+.||+|+||.||++++ .+++.||||++... .......+.+|+.++.+++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999997 46889999999754 33445689999999999999999999999876543
Q ss_pred -EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 542 -KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 542 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
.++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999853 346899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc-ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87643321 122334578999999999999999999999999999999999999997654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.58 Aligned_cols=206 Identities=30% Similarity=0.432 Sum_probs=178.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..++|++.+.||+|+||.||+|++. +++.||||.++... ....++|.+|+.++++++||||+++++++.+++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4578999999999999999999986 68899999987543 344567899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999998542 345899999999999999999999998 999999999999999999999999999875433
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22222222345788999999998999999999999999999998 999997543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=316.14 Aligned_cols=201 Identities=27% Similarity=0.436 Sum_probs=176.0
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..+|.+.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999997 468899999986532 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+ +|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788888743 346999999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
.. .....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||...+.
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 32 2344579999999999988876 7899999999999999999999976543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.55 Aligned_cols=200 Identities=24% Similarity=0.362 Sum_probs=169.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh--------------------------hhHHHHHHHHHHHH
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------------------QGLKEFKNEMMLIA 522 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--------------------------~~~~~f~~E~~~l~ 522 (682)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+++.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999874 588999999865321 12356899999999
Q ss_pred hcCCCCeeeEEEEEEe--cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCC
Q 005705 523 KLQHRNLVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (682)
Q Consensus 523 ~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlk 600 (682)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++.++..++.||++||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 56789999999999998765 3456999999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCC---CCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 601 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
|+|||++.++.+||+|||+++.+.... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999998765432 1233457999999999987765 47889999999999999999999975
Q ss_pred C
Q 005705 678 G 678 (682)
Q Consensus 678 ~ 678 (682)
.
T Consensus 243 ~ 243 (298)
T 2zv2_A 243 E 243 (298)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.21 Aligned_cols=202 Identities=24% Similarity=0.335 Sum_probs=179.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999885 5889999999776655667899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC--CCCeEEeeeccccccCCC
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGD 626 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~ 626 (682)
+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||+++.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 2346899999999999999999999998 999999999999974 467999999999876543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 2 2234578999999999999999999999999999999999999997643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=314.43 Aligned_cols=204 Identities=30% Similarity=0.462 Sum_probs=175.1
Q ss_pred hcCcccccccccCCceeEEEEEEc----CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|++.+.||+|+||.||+|++. .+..||||+++.. .....+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 568999999999999999999884 3446999999764 44556789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998532 346999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 625 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 625 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 43211 12223456778999999999999999999999999999999 99999654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=305.20 Aligned_cols=204 Identities=31% Similarity=0.490 Sum_probs=179.7
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..++|++.+.||+|+||.||+|++.+++.||+|++.... ...+++.+|+.++.+++||||+++++++.+++..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 356899999999999999999999889999999997643 2346799999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999854 3346899999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 162 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred -ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 12233466788999999999999999999999999999999 999997654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.52 Aligned_cols=203 Identities=26% Similarity=0.390 Sum_probs=177.0
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4678999999999999999999874 68899999986543 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc---CCCCeEEeeeccccc
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARM 622 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kL~DFGla~~ 622 (682)
|||+++|+|.+.+.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998853 346999999999999999999999998 99999999999998 467899999999987
Q ss_pred cCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... .......||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 65432 22234689999999999999999999999999999999999999996543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=317.57 Aligned_cols=212 Identities=29% Similarity=0.454 Sum_probs=182.0
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEcC------CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~ 537 (682)
.+....++|++.+.||+|+||.||+|++.+ ++.||||+++.. .....+.|.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344567899999999999999999998853 478999999764 3445678999999999999999999999999
Q ss_pred ecCeEEEEEEecCCCChhHHhhhccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEe
Q 005705 538 EQGEKILILEYMPNKSLNVFLFDSTK---------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596 (682)
Q Consensus 538 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH 596 (682)
+.+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 99999999999999999999865321 256999999999999999999999998 999
Q ss_pred ccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCC
Q 005705 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNT 675 (682)
Q Consensus 597 ~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf 675 (682)
|||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999987644332233344577899999999999999999999999999999999 99999
Q ss_pred CCCC
Q 005705 676 GLGS 679 (682)
Q Consensus 676 ~~~~ 679 (682)
...+
T Consensus 278 ~~~~ 281 (343)
T 1luf_A 278 YGMA 281 (343)
T ss_dssp TTSC
T ss_pred CCCC
Confidence 7543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.71 Aligned_cols=202 Identities=23% Similarity=0.265 Sum_probs=176.7
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 57899999999999999999987 4688999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC-----eEEeeeccccc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISDFGLARM 622 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kL~DFGla~~ 622 (682)
|+ +++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998543 356999999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCcccc-----ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQG-----NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 64432211 1245689999999999999999999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.29 Aligned_cols=210 Identities=32% Similarity=0.474 Sum_probs=182.1
Q ss_pred hhhcCcccccccccCCceeEEEEEEc------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~ 540 (682)
...++|.+.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 34678999999999999999999862 3478999999754 3455678999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC
Q 005705 541 EKILILEYMPNKSLNVFLFDSTK---------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 599 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dl 599 (682)
..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999965332 234899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 600 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 600 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654433333344567889999999999999999999999999999999 99999765
Q ss_pred CC
Q 005705 679 SM 680 (682)
Q Consensus 679 ~~ 680 (682)
+.
T Consensus 257 ~~ 258 (314)
T 2ivs_A 257 PP 258 (314)
T ss_dssp CG
T ss_pred CH
Confidence 43
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.47 Aligned_cols=207 Identities=32% Similarity=0.484 Sum_probs=177.7
Q ss_pred hcCcccccccccCCceeEEEEEEc------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.++|++.++||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468999999999999999999853 4668999999654 345566799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC---CeEEe
Q 005705 543 ILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKIS 615 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~ 615 (682)
++||||+++++|.+++.... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996532 2245899999999999999999999998 99999999999999555 59999
Q ss_pred eeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999986533222223344577899999999999999999999999999999998 999997654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.40 Aligned_cols=209 Identities=30% Similarity=0.475 Sum_probs=182.3
Q ss_pred hhhcCcccccccccCCceeEEEEEEc--------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV 537 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~ 537 (682)
...++|.+.++||+|+||.||+|+.. .+..||||++... .....+++.+|+.++.++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34678999999999999999999863 2357999999764 344567899999999999 8999999999999
Q ss_pred ecCeEEEEEEecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCE
Q 005705 538 EQGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (682)
Q Consensus 538 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 604 (682)
+++..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999965331 245999999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 605 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999987755433334445577899999999999999999999999999999999 999997543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.03 Aligned_cols=200 Identities=26% Similarity=0.388 Sum_probs=171.0
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999999779999999986543 23357788999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++ +|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 88888743 2346899999999999999999999998 9999999999999999999999999998764321
Q ss_pred ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......||+.|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12234578999999999876 45899999999999999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.95 Aligned_cols=205 Identities=28% Similarity=0.427 Sum_probs=181.2
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|.+.+.||+|+||.||++++. +|+.||||++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999985 58999999996532 23457789999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 546 LEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|||+++|+|..++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999986533 2446999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 332 12334589999999999999999999999999999999999999997653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.31 Aligned_cols=198 Identities=25% Similarity=0.388 Sum_probs=170.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|++.++||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999885 5889999998643 23345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|++++ |...+.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99864 4444432 2356999999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||-
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 2233457899999999998766 7999999999999999999888863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=317.18 Aligned_cols=207 Identities=21% Similarity=0.276 Sum_probs=179.2
Q ss_pred hhcCcccccccccC--CceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G--~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
...+|++.++||+| +||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999986 5899999999654 2445677899999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998543 2345899999999999999999999998 999999999999999999999999998654
Q ss_pred CCCc-----cccccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDE-----LQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2211 1112233478999999999987 679999999999999999999999997644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=330.83 Aligned_cols=202 Identities=26% Similarity=0.327 Sum_probs=168.2
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999874 5889999999753 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|||+++++|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999998843 3468999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 221 22345689999999999999999999999999999999999999997654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=320.20 Aligned_cols=205 Identities=32% Similarity=0.491 Sum_probs=166.0
Q ss_pred hhcCcccccccccCCceeEEEEEEc----CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|++.+.||+|+||.||+|++. ++..||||+++.. .....++|.+|+.++.+++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999875 4678999999764 3455678999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999853 2346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 624 GGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 624 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
...... .......+++.|+|||++.+..++.++||||||+++|||++ |++||...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 443211 11222345778999999999999999999999999999998 99999654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.01 Aligned_cols=204 Identities=31% Similarity=0.449 Sum_probs=179.6
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..++|++.+.||+|+||.||+++..++..||||++.... ...+++.+|+.++.+++||||+++++++.++...++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 457899999999999999999999888899999997543 2357799999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999998543 345899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 1 2233456778999999999899999999999999999999 999997543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.74 Aligned_cols=210 Identities=29% Similarity=0.466 Sum_probs=163.5
Q ss_pred HhhhcCcccccccccCCceeEEEEEEcCCc----eEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~----~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~ 540 (682)
....++|++.+.||+|+||.||+|++.... .||||+++.. .....+++.+|+.++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 345678999999999999999999875432 7999999754 3455788999999999999999999999998776
Q ss_pred eE------EEEEEecCCCChhHHhhhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 541 EK------ILILEYMPNKSLNVFLFDSTK---KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 541 ~~------~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
.. ++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 899999999999999854322 225899999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 99999999987654433333334566889999999999999999999999999999999 999997644
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=330.66 Aligned_cols=204 Identities=28% Similarity=0.395 Sum_probs=180.4
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|++.+.||+|+||.||++++. +|+.||||++... .......+.+|+.+|.+++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999885 5899999999653 22345678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++|+|..++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.
T Consensus 262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999998543 2345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .....+||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 332 2334589999999999999999999999999999999999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.02 Aligned_cols=198 Identities=29% Similarity=0.404 Sum_probs=170.3
Q ss_pred ccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 474 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
...+.||+|+||.||+|+.. +++.||+|+++.......+++.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33578999999999999874 58899999998766667788999999999999999999999999999999999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE--cCCCCeEEeeeccccccCCCcccc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--DKDMNPKISDFGLARMFGGDELQG 630 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~ 630 (682)
+|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 999888542 345899999999999999999999998 9999999999999 567889999999998765432
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2233579999999999999999999999999999999999999997543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.91 Aligned_cols=203 Identities=31% Similarity=0.515 Sum_probs=173.2
Q ss_pred hcCcccccccccCCceeEEEEEE-----cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 542 (682)
.++|++.++||+|+||.||+++. .+++.||||++........++|.+|+.++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 57899999999999999999984 35789999999877777778999999999999999999999998654 458
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 6433211 122334577889999999999999999999999999999999998864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=301.15 Aligned_cols=201 Identities=24% Similarity=0.390 Sum_probs=178.2
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
..++|++.+.||+|+||.||+|+... +..+|+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35679999999999999999998854 67899999977655667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE---cCCCCeEEeeeccccccC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFG 624 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~~ 624 (682)
|+++++|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998843 345899999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... ......||+.|+|||++.+. ++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 432 23345789999999988654 8999999999999999999999997643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=308.21 Aligned_cols=204 Identities=30% Similarity=0.426 Sum_probs=161.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999875 58899999986543 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 548 YMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988885432 2245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 12234578999999999876 468999999999999999999999997543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.78 Aligned_cols=204 Identities=31% Similarity=0.488 Sum_probs=169.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCc----eEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++|++.++||+|+||.||+|++. +++ +||+|.+... .....++|.+|+.++++++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 467999999999999999999864 344 4688888543 335567899999999999999999999999875 478
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+|+||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998543 346899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 55443333344567889999999999999999999999999999999 999998654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.72 Aligned_cols=209 Identities=31% Similarity=0.455 Sum_probs=177.4
Q ss_pred hhhcCcccccccccCCceeEEEEEEc------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~ 539 (682)
...++|.+.+.||+|+||.||+|++. ++..||||++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 35678999999999999999999862 3568999999754 233457899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTK--------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 599 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dl 599 (682)
+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 999999999999999999965322 134899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 600 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 600 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
||+|||++.++.+||+|||++..+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987644332222334567889999999999999999999999999999998 99999765
Q ss_pred C
Q 005705 679 S 679 (682)
Q Consensus 679 ~ 679 (682)
+
T Consensus 279 ~ 279 (344)
T 1rjb_A 279 P 279 (344)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.20 Aligned_cols=200 Identities=26% Similarity=0.385 Sum_probs=161.8
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999986 47889999997543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEEeeeccccccC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLARMFG 624 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGla~~~~ 624 (682)
|+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999984 3456899999999999999999999998 999999999999975 8899999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 322 2334578999999999999999999999999999999999999996543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.48 Aligned_cols=201 Identities=25% Similarity=0.333 Sum_probs=166.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
..++|++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4578999999999999999999986 68899999996543 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC--eEEeeeccccccCC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLARMFGG 625 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kL~DFGla~~~~~ 625 (682)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999843 345999999999999999999999998 999999999999987765 99999999975322
Q ss_pred CccccccccccccccccCcccccCCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...+
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 1 22334579999999999988888766 899999999999999999997643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=316.43 Aligned_cols=202 Identities=28% Similarity=0.374 Sum_probs=169.9
Q ss_pred hhhcCcccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEecCeEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~ 543 (682)
...++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++.++...+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 346789999999999999999999988999999998643 34456789999999999976 99999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||| +.+++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+
T Consensus 86 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 568899999853 356899999999999999999999998 99999999999997 578999999999877
Q ss_pred CCCccccccccccccccccCcccccC-----------CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 54433333345689999999999865 6789999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=303.53 Aligned_cols=205 Identities=30% Similarity=0.452 Sum_probs=177.2
Q ss_pred hhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
...++|++.+.||+|+||.||++++.++..||||++.... ...+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3467899999999999999999999888899999997643 234779999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++... ...+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999998542 345999999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 1 12233456788999999998999999999999999999998 999997543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=323.75 Aligned_cols=201 Identities=27% Similarity=0.468 Sum_probs=178.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..+|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999985 68999999996532 23456899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 32 2334589999999999988776 689999999999999999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=315.90 Aligned_cols=203 Identities=29% Similarity=0.442 Sum_probs=164.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecC--eE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG--EK 542 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~ 542 (682)
..++|++.+.||+|+||.||+|.+. +++.||||++... .....+++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4678999999999999999999874 5889999998643 3445677889999999997 999999999997654 68
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 588888843 46899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCc-------------------cccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDE-------------------LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 63211 1112334589999999999986 678999999999999999999999997543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=306.45 Aligned_cols=209 Identities=30% Similarity=0.409 Sum_probs=181.1
Q ss_pred hhhcCcccccccccCCceeEEEEEE------cCCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEec
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~ 539 (682)
...++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3467899999999999999999985 246789999997543 34567899999999999 999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCE
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTK---------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 604 (682)
+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999865332 225899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 605 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999987754433222334567889999999999999999999999999999999 999997654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=310.74 Aligned_cols=208 Identities=30% Similarity=0.497 Sum_probs=179.6
Q ss_pred hhcCcccccccccCCceeEEEEEEc--------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~ 538 (682)
..++|++.+.||+|+||.||+|++. ++..||||++... .....+++.+|+.++.++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4678999999999999999999873 4678999999754 344567899999999999 89999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEE
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIL 605 (682)
.+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965321 234899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999987754433333344567889999999999999999999999999999999 999997543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.14 Aligned_cols=211 Identities=30% Similarity=0.449 Sum_probs=180.4
Q ss_pred HHhhhcCcccccccccCCceeEEEEEEcC-C-----ceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 005705 466 ITAATENFSMQCKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV 537 (682)
Q Consensus 466 ~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g-----~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~ 537 (682)
.....++|.+.+.||+|+||.||+|+... + ..||+|.+.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456889999999999999999998743 2 479999997643 34567899999999999 8999999999999
Q ss_pred ecCeEEEEEEecCCCChhHHhhhccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 538 EQGEKILILEYMPNKSLNVFLFDSTK-----------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 538 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 99999999999999999999864321 345899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999987643322222334567889999999999999999999999999999999 999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=312.24 Aligned_cols=209 Identities=27% Similarity=0.326 Sum_probs=181.1
Q ss_pred ccchhHHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC-----CCCeeeEE
Q 005705 460 LFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HRNLVRLL 533 (682)
Q Consensus 460 ~~~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----HpnIv~l~ 533 (682)
.+++.......++|.+.++||+|+||.||+|++. +++.||||++... ....+.+..|+.++.+++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3455555566789999999999999999999884 5889999999743 344567788999999997 99999999
Q ss_pred EEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-----
Q 005705 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK----- 608 (682)
Q Consensus 534 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~----- 608 (682)
+++...+..++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999999999 99999998543 2335899999999999999999999998 999999999999975
Q ss_pred --------------------CCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHH
Q 005705 609 --------------------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 668 (682)
Q Consensus 609 --------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~el 668 (682)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999864322 2345789999999999999999999999999999999
Q ss_pred HcCCCCCCCCC
Q 005705 669 LSSKKNTGLGS 679 (682)
Q Consensus 669 ltG~~pf~~~~ 679 (682)
++|+.||...+
T Consensus 253 l~g~~pf~~~~ 263 (360)
T 3llt_A 253 YTGSLLFRTHE 263 (360)
T ss_dssp HHSSCSCCCSS
T ss_pred HHCCCCCCCCc
Confidence 99999997543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=299.75 Aligned_cols=204 Identities=30% Similarity=0.410 Sum_probs=178.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999885 5889999998643 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999883 3356899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.........|++.|+|||++.+..+ +.++||||||+++|||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 2223345678999999999987765 778999999999999999999997654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=300.26 Aligned_cols=206 Identities=30% Similarity=0.495 Sum_probs=159.9
Q ss_pred hhhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
...++|++.+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 3456899999999999999999987 468899999996432 233578999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++.. ....+++.+++.++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 88 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 99999999999999853 2356899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 163 KMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp C------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred cCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 4322 122335789999999999999999999999999999999999999987653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.58 Aligned_cols=212 Identities=29% Similarity=0.446 Sum_probs=181.7
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~ 537 (682)
+.....++|++.+.||+|+||.||+|++. +++.||||.+.... .....++.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34456789999999999999999999764 36789999997543 345567999999999999999999999999
Q ss_pred ecCeEEEEEEecCCCChhHHhhhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC
Q 005705 538 EQGEKILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (682)
Q Consensus 538 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 610 (682)
+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 99999999999999999999854221 245789999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 999999999987644332223334567889999999999999999999999999999999 899997543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=326.11 Aligned_cols=205 Identities=32% Similarity=0.458 Sum_probs=178.5
Q ss_pred HhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
....++|.+.+.||+|+||.||+|++.++..||||+++... ...++|.+|+.+|++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 44567899999999999999999999888999999997643 45788999999999999999999999986 56789999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999998542 2235889999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
... ......+|+.|+|||++....++.++|||||||+||||++ |+.||...
T Consensus 338 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 338 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp HHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 211 1223456789999999998999999999999999999999 99999754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.16 Aligned_cols=204 Identities=28% Similarity=0.428 Sum_probs=172.3
Q ss_pred hcCcccccccccCCceeEEEEEEcC-Cce----EEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQE----VAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~----vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++|++.+.||+|+||.||+|++.. ++. ||+|.+.... ....+++.+|+.++.+++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4679999999999999999998743 443 7888875432 334466789999999999999999999886 55789
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998542 346889999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 55443333445678889999999999999999999999999999999 999998654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=320.66 Aligned_cols=200 Identities=31% Similarity=0.478 Sum_probs=174.3
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC-eEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E 547 (682)
..++|++.+.||+|+||.||+|+. .++.||||+++... ..++|.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 457899999999999999999987 47899999997643 4578999999999999999999999987765 7899999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999643 2334799999999999999999999998 999999999999999999999999999864321
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGSM 680 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~~ 680 (682)
.....+++.|+|||.+.+..++.++||||||++||||++ |+.||...+.
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 122356889999999999999999999999999999999 9999976543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.33 Aligned_cols=210 Identities=23% Similarity=0.275 Sum_probs=173.9
Q ss_pred HHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec
Q 005705 466 ITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (682)
Q Consensus 466 ~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-----~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~ 539 (682)
+....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4556788999999999999999999874 5788999998643 334567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhHHhhhcc-------------------------------------ccCCCCHHHHHHHHHHHHHH
Q 005705 540 GEKILILEYMPNKSLNVFLFDST-------------------------------------KKRLLNWQARVRIIEGIAQG 582 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~~ 582 (682)
+..++||||+++++|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01224677888999999999
Q ss_pred HHHHHhcCCCCcEeccCCCCCEEEcCCC--CeEEeeeccccccCCCcc--ccccccccccccccCcccccC--CCCCccc
Q 005705 583 LLYLHQYSRFRIIHRDLKASNILLDKDM--NPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPEYALD--GLFSIKS 656 (682)
Q Consensus 583 L~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~k~ 656 (682)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999987532211 112344678999999999875 6789999
Q ss_pred cHHHHHHHHHHHHcCCCCCCCC
Q 005705 657 DVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 657 DVwSlGvil~elltG~~pf~~~ 678 (682)
||||||+++|||++|+.||...
T Consensus 258 DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=337.25 Aligned_cols=203 Identities=26% Similarity=0.347 Sum_probs=178.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999885 4788999999753 233456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++|+|..++.. ...+++.+++.++.||+.||+|||+++ ||||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999854 346999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|++||...+
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 3222 23445789999999999999999999999999999999999999997654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=299.53 Aligned_cols=201 Identities=34% Similarity=0.530 Sum_probs=166.2
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||+|+||.||+|++ .++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999987 48899999986532 23457899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC--------CCCeEEeee
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--------DMNPKISDF 617 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~~kL~DF 617 (682)
|||+++++|.+++. ...+++..++.++.|+++||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 446899999999999999999999987556899999999999986 678999999
Q ss_pred ccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998654322 223578999999999999999999999999999999999999997543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=306.14 Aligned_cols=201 Identities=28% Similarity=0.392 Sum_probs=178.2
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.++|++.+.||+|+||.||+++.. +++.||||.+..... ...+++.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999885 588999999865432 1467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC----CeEEeeec
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 618 (682)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999843 356899999999999999999999998 99999999999999888 79999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 998764322 2234578999999999999999999999999999999999999997543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.47 Aligned_cols=192 Identities=25% Similarity=0.332 Sum_probs=151.3
Q ss_pred cccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
+.||+|+||.||++++. +++.||||++... ....+.+|+.++.++. ||||+++++++.++...++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999885 5889999999653 3467789999999997 99999999999999999999999999999
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC---CeEEeeeccccccCCCccccc
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMFGGDELQGN 631 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~ 631 (682)
.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 165 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP 165 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence 999854 356999999999999999999999998 99999999999998765 79999999998754322 22
Q ss_pred cccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 334578999999999999999999999999999999999999997643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=316.41 Aligned_cols=202 Identities=27% Similarity=0.361 Sum_probs=170.6
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcC--CCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~l 544 (682)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++ ||||+++++++..++..++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34679999999999999999999888999999998643 3455678999999999996 5999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||| +.+++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 134 v~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 578899999854 346889999999999999999999998 99999999999995 5799999999998765
Q ss_pred CCccccccccccccccccCcccccC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
............||+.|+|||++.+ ..++.++|||||||+||||++|++||...
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 4332223345689999999999865 46889999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.32 Aligned_cols=201 Identities=30% Similarity=0.365 Sum_probs=171.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999985 48899999886543 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999998873 3356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......||+.|+|||++.+ ..++.++||||||+++|||++|++||...+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12234578999999999876 668999999999999999999999997643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.23 Aligned_cols=203 Identities=30% Similarity=0.450 Sum_probs=169.6
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccC-----hhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEec
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQ 539 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l---~HpnIv~l~~~~~~~ 539 (682)
..++|++.++||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999987 468899999986422 11234566777777666 499999999999876
Q ss_pred C-----eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 540 G-----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 540 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
. ..++||||+. ++|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 5999988543 2234899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999876432 22345688999999999999999999999999999999999999997543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=305.36 Aligned_cols=204 Identities=26% Similarity=0.352 Sum_probs=171.3
Q ss_pred hcCcccc-cccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEE
Q 005705 470 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.+.|.+. +.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 78999999999999864 6889999999776666678899999999995 7999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC---eEEeeecccccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMF 623 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFGla~~~ 623 (682)
||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999854 346899999999999999999999998 999999999999998776 999999999865
Q ss_pred CCCcc-----ccccccccccccccCcccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDEL-----QGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|++||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 32211 111223468999999999875 558899999999999999999999997653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.39 Aligned_cols=203 Identities=28% Similarity=0.387 Sum_probs=174.4
Q ss_pred hcCcccccccccCCceeEEEEEE----cCCceEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecC
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~ 540 (682)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999987 368899999986532 23445678899999999 6999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++||||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999854 346899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.+..... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 87643221 22334679999999999985 347899999999999999999999997543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.91 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=177.2
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999875 4889999998653 3445678899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC---eEEeeecccccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMF 623 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFGla~~~ 623 (682)
||+++++|.+.+.. ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888843 346899999999999999999999998 999999999999986655 999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 4322 2234578999999999999999999999999999999999999996543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=326.20 Aligned_cols=205 Identities=30% Similarity=0.478 Sum_probs=180.3
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
..++|++.++||+|+||.||+|++.. +..||||+++... ...++|.+|+.+|++++||||+++++++.+....++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 45779999999999999999999865 8899999997643 346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999643 2346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.. ......+++.|+|||++.+..++.++|||||||+||||++ |+.||...+
T Consensus 373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 21 2233456789999999999999999999999999999999 999997654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.16 Aligned_cols=197 Identities=27% Similarity=0.313 Sum_probs=165.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.++||+|+||+||+|++. +++.||||++... ......++..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999986 6899999998653 233344556666666665 899999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+ +++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 66888887543 346999999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22 2334568999999998876 78999999999999999999976654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=312.16 Aligned_cols=203 Identities=20% Similarity=0.282 Sum_probs=169.2
Q ss_pred hhcCcccccccccCCceeEEEEEEcC------CceEEEEEecccChhhH-----------HHHHHHHHHHHhcCCCCeee
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVR 531 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~~~~-----------~~f~~E~~~l~~l~HpnIv~ 531 (682)
..++|++.++||+|+||.||+|++.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998864 47899999876542211 12445666778889999999
Q ss_pred EEEEEEec----CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc
Q 005705 532 LLGCCVEQ----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (682)
Q Consensus 532 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~ 607 (682)
+++++... ...++||||+ +++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998765 4579999999 9999999854 2356999999999999999999999998 99999999999999
Q ss_pred --CCCCeEEeeeccccccCCCccc-----cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 608 --KDMNPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 608 --~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8899999999999876432211 112334699999999999999999999999999999999999999984
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=322.74 Aligned_cols=198 Identities=29% Similarity=0.346 Sum_probs=166.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec------C
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------~ 540 (682)
.++|++.++||+|+||.||+|++. +++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999875 5889999999754 344567889999999999999999999999654 3
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++||||++++ |...+. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999875 555542 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+..... .......||+.|+|||++.+..++.++|||||||+||||++|++||...+
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 876432 22345689999999999999999999999999999999999999997543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.63 Aligned_cols=203 Identities=26% Similarity=0.369 Sum_probs=179.0
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|.+.+.||+|+||.||++++.+ ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 35689999999999999999999864 788999998653 23456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998743 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 12334578999999999999999999999999999999999999997653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=298.94 Aligned_cols=201 Identities=30% Similarity=0.430 Sum_probs=174.4
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|++.+.||+|+||.||+|++.. ++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45789999999999999999998754 6789999986532 2335678999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999999843 345899999999999999999999998 9999999999999999999999999986543
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 22 2234578999999999999999999999999999999999999998654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=305.45 Aligned_cols=215 Identities=29% Similarity=0.440 Sum_probs=182.2
Q ss_pred chhHHHhhhcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEE
Q 005705 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLL 533 (682)
Q Consensus 462 ~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~ 533 (682)
.........++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34455556789999999999999999999752 46789999997643 34557899999999999 799999999
Q ss_pred EEEEecC-eEEEEEEecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC
Q 005705 534 GCCVEQG-EKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 599 (682)
Q Consensus 534 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dl 599 (682)
+++...+ ..++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9988755 48999999999999999965332 223889999999999999999999998 999999
Q ss_pred CCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 600 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 600 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
||+||+++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654333233344577889999999999999999999999999999998 99999765
Q ss_pred C
Q 005705 679 S 679 (682)
Q Consensus 679 ~ 679 (682)
+
T Consensus 255 ~ 255 (316)
T 2xir_A 255 K 255 (316)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=309.94 Aligned_cols=200 Identities=24% Similarity=0.379 Sum_probs=175.1
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~ 539 (682)
..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999874 58899999986542 11344678899999999999999999999999
Q ss_pred CeEEEEEEecCCC-ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 540 GEKILILEYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 540 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
+..++||||+..| +|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999884 3346999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 998765432 2334579999999999988877 7899999999999999999999964
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=303.61 Aligned_cols=199 Identities=29% Similarity=0.454 Sum_probs=166.6
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.++|++.+.||+|+||.||+++. .++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 46789999999999999999987 4789999999643 34578999999999999999999999876 3578999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC-eEEeeeccccccCCCcc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDEL 628 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kL~DFGla~~~~~~~~ 628 (682)
++++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999966544456889999999999999999999932223999999999999998887 799999999765322
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 22346899999999999999999999999999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.73 Aligned_cols=197 Identities=34% Similarity=0.490 Sum_probs=172.2
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.+.|++.+.||+|+||.||+|+. .+++.||||++... .....+++.+|+.++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999987 46889999998643 233456799999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||++ |+|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 577777643 2356899999999999999999999998 99999999999999999999999999986532
Q ss_pred CccccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....||+.|+|||++. ...++.++|||||||++|||++|++||...
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23357899999999984 567899999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.90 Aligned_cols=198 Identities=31% Similarity=0.423 Sum_probs=166.3
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEec----CeE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQ----GEK 542 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~--l~HpnIv~l~~~~~~~----~~~ 542 (682)
..++|++.+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999987 7899999999654 33556667777666 7999999999987653 457
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
++||||+++++|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999983 346899999999999999999999 766 999999999999999999999
Q ss_pred eeeccccccCCCccc--cccccccccccccCcccccCC------CCCccccHHHHHHHHHHHHcC----------CCCCC
Q 005705 615 SDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSS----------KKNTG 676 (682)
Q Consensus 615 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwSlGvil~elltG----------~~pf~ 676 (682)
+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999876433211 112334799999999999876 455799999999999999999 88875
Q ss_pred C
Q 005705 677 L 677 (682)
Q Consensus 677 ~ 677 (682)
.
T Consensus 235 ~ 235 (301)
T 3q4u_A 235 D 235 (301)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.72 Aligned_cols=202 Identities=21% Similarity=0.297 Sum_probs=176.2
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 56899999999999999999987 568899999986543 234678899999999 79999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC-----eEEeeeccccc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISDFGLARM 622 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kL~DFGla~~ 622 (682)
|+ +++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998543 345999999999999999999999998 999999999999987776 99999999987
Q ss_pred cCCCccc-----cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 7543221 12345679999999999999999999999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.87 Aligned_cols=201 Identities=27% Similarity=0.407 Sum_probs=174.8
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.++|++.+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999986 588999999865321 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC----CeEEeeec
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 618 (682)
++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999843 346899999999999999999999998 99999999999998877 89999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 998764322 2234578999999999999999999999999999999999999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.12 Aligned_cols=203 Identities=26% Similarity=0.369 Sum_probs=179.6
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-CceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|.+.+.||+|+||.||++++.+ ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35789999999999999999998854 778999998653 33456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++.. ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998843 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 322 12334578999999999999999999999999999999999999997653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.10 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=168.1
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-----Ce
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 541 (682)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+++.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 578999999999999999999875 4789999999753 334567899999999999999999999999766 57
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||++ ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 59998884 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--------------------cccccccccccccCcccc-cCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 622 MFGGDELQ--------------------GNTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 622 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76432211 123556899999999986 56679999999999999999998665554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=297.03 Aligned_cols=204 Identities=31% Similarity=0.478 Sum_probs=179.1
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..++|++.+.||+|+||.||+++..+++.||+|++..... ..+++.+|+.++.+++||||+++++++.+++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3468999999999999999999998889999999976432 347899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 9999999998542 346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.......+++.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 160 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred -cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 12233466789999999998999999999999999999999 899997643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.78 Aligned_cols=203 Identities=23% Similarity=0.298 Sum_probs=167.4
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|++.+.||+|+||.||++++. +++.||||++.... ....+.+.+|+.++.+++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999985 58899999997542 3345789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999853 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 3321 1223457899999999999999999999999999999999999999754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=301.11 Aligned_cols=204 Identities=26% Similarity=0.369 Sum_probs=164.7
Q ss_pred hhcCcccccccccCCceeEEEEEEcC----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|++.+.||+|+||.||+|++.. +..||+|.+... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45789999999999999999998743 457999998764 3445678999999999999999999999974 56788
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998542 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |++||...+
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 44321 12233456789999999999999999999999999999997 999997543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=317.06 Aligned_cols=203 Identities=26% Similarity=0.386 Sum_probs=176.6
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC--eEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV 545 (682)
.++|.+.++||+|+||.||+|++.. ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4689999999999999999998864 8899999997543 344678899999999999999999999998765 67999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE----cCCCCeEEeeecccc
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 621 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL~DFGla~ 621 (682)
|||+++++|.+++........+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999966555555999999999999999999999998 9999999999999 777889999999998
Q ss_pred ccCCCccccccccccccccccCcccccC--------CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 764432 2234579999999998865 56788999999999999999999999643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.54 Aligned_cols=212 Identities=29% Similarity=0.470 Sum_probs=168.9
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEcC----CceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~ 538 (682)
.+....++|.+.+.||+|+||.||+|+... +..||||+++.. .....+.+.+|+.++.+++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 334456889999999999999999997743 457999998654 34456789999999999999999999999987
Q ss_pred cC-----eEEEEEEecCCCChhHHhhhc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC
Q 005705 539 QG-----EKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (682)
Q Consensus 539 ~~-----~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 610 (682)
.. ..++||||+++++|.+++... .....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 55 349999999999999998532 23456999999999999999999999998 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 999999999987654332233344567889999999999999999999999999999999 999997654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.64 Aligned_cols=204 Identities=33% Similarity=0.512 Sum_probs=172.4
Q ss_pred hhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
...++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3567899999999999999999999888889999997643 345789999999999999999999999876 67899999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++|+|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999532 2345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
. .......+++.|+|||.+.+..++.++||||||++||||++ |+.||...
T Consensus 335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 1 11223456789999999999999999999999999999999 99999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.81 Aligned_cols=202 Identities=24% Similarity=0.365 Sum_probs=164.5
Q ss_pred hhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~ 538 (682)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999875 47899999986532 122335889999999999999999999975
Q ss_pred cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC---CeEEe
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKIS 615 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~ 615 (682)
.+..++||||+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 456899999999999988873 3456999999999999999999999998 99999999999997544 59999
Q ss_pred eeccccccCCCccccccccccccccccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 999998764322 2344689999999999853 668889999999999999999999997543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.25 Aligned_cols=194 Identities=25% Similarity=0.404 Sum_probs=154.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-----Ce
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 541 (682)
.++|++.++||+|+||.||+|++. +++.||||++... .....+++.+|+.+|.+++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999875 5889999998653 334567899999999999999999999998543 46
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999974 68888873 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-------------------------ccccccccccccccCcccc-cCCCCCccccHHHHHHHHHHHHc
Q 005705 622 MFGGDEL-------------------------QGNTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLS 670 (682)
Q Consensus 622 ~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwSlGvil~ellt 670 (682)
....... .......+||+.|+|||++ ....++.++|||||||+||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 7642211 0123445789999999986 56679999999999999999999
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.82 Aligned_cols=197 Identities=26% Similarity=0.421 Sum_probs=172.8
Q ss_pred hcCcccccccccCCceeEEEEEEcC-C-------ceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g-------~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
.++|++.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999998753 3 4699999987766778899999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC--------eE
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--------PK 613 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~k 613 (682)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999543 334899999999999999999999998 999999999999998887 99
Q ss_pred EeeeccccccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcC-CCCCCC
Q 005705 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSS-KKNTGL 677 (682)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG-~~pf~~ 677 (682)
|+|||++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++| .+|+..
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 999999976432 223467899999999987 7789999999999999999995 455543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=297.97 Aligned_cols=203 Identities=25% Similarity=0.400 Sum_probs=172.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|.+.++||+|+||.||+++.. ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999875 58899999986543 3456889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE---cCCCCeEEeeecccccc
Q 005705 548 YMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMF 623 (682)
Q Consensus 548 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~ 623 (682)
|+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988543 23456999999999999999999999998 9999999999999 45678999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||...+
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 4322 233457899999999875 568999999999999999999999997543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.28 Aligned_cols=199 Identities=24% Similarity=0.380 Sum_probs=174.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|.+.+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999885 6889999999765544556789999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE---cCCCCeEEeeeccccccCC
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~~~ 625 (682)
+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998843 346899999999999999999999998 9999999999999 7889999999999976432
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2 233457899999999999999999999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.74 Aligned_cols=206 Identities=30% Similarity=0.477 Sum_probs=181.4
Q ss_pred hhhcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
...++|++.+.||+|+||.||+|++.. +..||+|.+.... ...+++.+|+.++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 456789999999999999999999865 7899999997543 45678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999998543 3356899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22 22333467889999999999999999999999999999999 999997654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.98 Aligned_cols=200 Identities=26% Similarity=0.374 Sum_probs=176.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.+.||+|+||.||++++. +++.||+|++... .....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999885 5889999998754 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 9999999999853 34589999999999999999999986 7 99999999999999999999999999976522
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12334578999999999999999999999999999999999999997643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.94 Aligned_cols=202 Identities=28% Similarity=0.406 Sum_probs=171.5
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.++|++.+.||+|+||.||+++... ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4689999999999999999999854 8899999985543 334567889999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988863 3345899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. .......||+.|+|||++.+. .++.++||||||+++|||++|++||...+
T Consensus 178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 122345789999999998875 78999999999999999999999997654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=308.84 Aligned_cols=198 Identities=22% Similarity=0.356 Sum_probs=171.1
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..++|++.+.||+|+||.||++++. +++.||||++..... .+.+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999885 588999999975432 235688888888 7999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC----CCeEEeeeccccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKISDFGLARM 622 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~ 622 (682)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+..+ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998843 356999999999999999999999998 9999999999998543 3499999999987
Q ss_pred cCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+.... .......||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 64332 2233457899999999998888999999999999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=296.36 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=178.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999874 58899999986543 3457889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++. ...+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999983 346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 1233457899999999999999999999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=296.33 Aligned_cols=200 Identities=27% Similarity=0.400 Sum_probs=177.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999885 47789999986432 23456799999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999854 245899999999999999999999998 99999999999999999999999999976543
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 2 2234578999999999999999999999999999999999999997643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=310.38 Aligned_cols=198 Identities=21% Similarity=0.291 Sum_probs=162.6
Q ss_pred hcCcccc-cccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEe----cCeE
Q 005705 470 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCVE----QGEK 542 (682)
Q Consensus 470 ~~~y~i~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~-l~HpnIv~l~~~~~~----~~~~ 542 (682)
.++|.+. ++||+|+||.||++++. +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 68999999999999885 5889999999642 456778888754 489999999999875 5578
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEEeeecc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 619 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGl 619 (682)
++||||+++|+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999998542 2346999999999999999999999998 999999999999997 78899999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 9875432 12345688999999999999999999999999999999999999997543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.11 Aligned_cols=204 Identities=28% Similarity=0.386 Sum_probs=165.7
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
....++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344578999999999999999999874 68899999996543 233567889999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-----CCCCeEEeeec
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-----KDMNPKISDFG 618 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-----~~~~~kL~DFG 618 (682)
+||||+++ +|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 89888843 345899999999999999999999998 99999999999994 45569999999
Q ss_pred cccccCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++.+.... .......||+.|+|||++.+. .++.++|||||||++|||++|++||...+
T Consensus 183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 998764322 223345789999999999874 48999999999999999999999997543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.05 Aligned_cols=202 Identities=32% Similarity=0.493 Sum_probs=162.1
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..++|++.++||+|+||.||+|+.. ..||||+++.. .....+.|.+|+.++++++||||++++++. .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4678999999999999999999763 36999998653 345567899999999999999999999965 556789999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999843 3356899999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
..........||+.|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 3233344567899999999986 667889999999999999999999999754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.07 Aligned_cols=204 Identities=31% Similarity=0.489 Sum_probs=167.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCce----EEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQE----VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~----vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+++.+|+.++.+++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999874 3443 577777543 3456788999999999999999999999998764 78
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+|+||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 54433333344567889999999999999999999999999999999 999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=305.60 Aligned_cols=205 Identities=22% Similarity=0.375 Sum_probs=177.9
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--------hhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLLG 534 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~~l~~l-~HpnIv~l~~ 534 (682)
......++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445678999999999999999999985 68999999986532 12245788999999999 7999999999
Q ss_pred EEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 535 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
++...+..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999853 346899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccC------CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 9999998765332 2334689999999998863 35889999999999999999999999654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.56 Aligned_cols=197 Identities=27% Similarity=0.394 Sum_probs=167.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------ 540 (682)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999884 5899999998543 3344678899999999999999999999997653
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899998843 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 176 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 87532 2334578999999999887 679999999999999999999999997543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=306.23 Aligned_cols=201 Identities=27% Similarity=0.407 Sum_probs=166.1
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999985 6889999998654322 122456799999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 4888887542 346899999999999999999999998 9999999999999999999999999998654321
Q ss_pred ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......||+.|+|||++.+ ..++.++||||||+++|||++|++||...+
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22234578999999999876 568999999999999999999999997654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=294.76 Aligned_cols=203 Identities=35% Similarity=0.496 Sum_probs=176.3
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..++|++.+.||+|+||.||+|+..+++.||||.+.... ...+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 457899999999999999999998888899999997543 34678999999999999999999999876 4568999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++++|.+++... ....+++.+++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999998432 2236899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
. ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 1 2233456789999999998899999999999999999999 99999754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=295.85 Aligned_cols=204 Identities=29% Similarity=0.467 Sum_probs=175.3
Q ss_pred hcCccccc-ccccCCceeEEEEEEc---CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~-~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|.+.+ .||+|+||.||+|... ++..||||+++.. .....+++.+|+.++.+++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45677776 9999999999999763 5778999999764 344577899999999999999999999998 5567899
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999853 3346899999999999999999999998 9999999999999999999999999998774
Q ss_pred CCcc-ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 3322 112233456889999999998899999999999999999998 999997654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.30 Aligned_cols=202 Identities=31% Similarity=0.512 Sum_probs=173.1
Q ss_pred hcCcccccccccCCceeEEEEEE-----cCCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--Ce
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~ 541 (682)
.+.|++.+.||+|+||.||++++ .+++.||||++... .....+.+.+|+.++.+++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45689999999999999999984 35889999999754 334567899999999999999999999999876 56
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+++++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999998543 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 622 MFGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 622 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 77543221 22334567888999999999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=303.58 Aligned_cols=204 Identities=27% Similarity=0.441 Sum_probs=172.2
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------- 539 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------- 539 (682)
.++|++.++||+|+||.||+|++ .+++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999998 468899999985532 23356788999999999999999999999873
Q ss_pred -CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 540 -GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 540 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
+..++||||+++ +|...+.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 66666633 2345999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCc--cccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDE--LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++.+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998764321 1122344578999999999876 558999999999999999999999997643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.17 Aligned_cols=203 Identities=29% Similarity=0.445 Sum_probs=177.7
Q ss_pred hcCcccccccccCCceeEEEEEE-----cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--ecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV--EQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~--~~~~~ 542 (682)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 357899999998877777788999999999999999999999987 44568
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998543 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 623 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 623 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
...... ........+|+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 643321 1122334678889999999999999999999999999999999999854
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=293.98 Aligned_cols=200 Identities=23% Similarity=0.328 Sum_probs=172.5
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3578999999999999999999886 6899999998753 234567788999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC--------------
Q 005705 545 ILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-------------- 609 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-------------- 609 (682)
||||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999864322 256899999999999999999999998 9999999999999844
Q ss_pred -----CCeEEeeeccccccCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 610 -----MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 610 -----~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|||++|++++..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999998764322 23589999999999776 567899999999999999999987653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=302.77 Aligned_cols=208 Identities=31% Similarity=0.482 Sum_probs=173.6
Q ss_pred hhcCcccccccccCCceeEEEEEE------cCCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
..++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++.+++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 357899999999999999999984 24678999999654 34556789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEE
Q 005705 542 KILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKI 614 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL 614 (682)
.++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999965332 245899999999999999999999998 999999999999984 446999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 99999986543332233334577899999999999999999999999999999998 999997653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.30 Aligned_cols=201 Identities=20% Similarity=0.265 Sum_probs=166.1
Q ss_pred hcCcccccccccCCceeEEEEEEc----CCceEEEEEecccChh-----------hHHHHHHHHHHHHhcCCCCeeeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQ-----------GLKEFKNEMMLIAKLQHRNLVRLLG 534 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~~-----------~~~~f~~E~~~l~~l~HpnIv~l~~ 534 (682)
.++|.+.+.||+|+||.||+|+.. ++..+|||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999985 5678999998654321 1234678889999999999999999
Q ss_pred EEEe----cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC
Q 005705 535 CCVE----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (682)
Q Consensus 535 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 610 (682)
++.. ....++||||+ +++|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 9999999843 237999999999999999999999998 99999999999999887
Q ss_pred --CeEEeeeccccccCCCcc-----ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 611 --NPKISDFGLARMFGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 611 --~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.+||+|||+++.+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999987643211 1112445799999999999999999999999999999999999999954
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=293.24 Aligned_cols=202 Identities=29% Similarity=0.563 Sum_probs=171.4
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChh-------hHHHHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-------~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~ 540 (682)
..++|++.+.||+|+||.||+|++. +++.||||++...... ..+++.+|+.++.+++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3578999999999999999999884 6889999998643221 1267899999999999999999999986554
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC-----eEEe
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKIS 615 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kL~ 615 (682)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||++++ +|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999888754 33469999999999999999999999852 4999999999999988776 9999
Q ss_pred eeccccccCCCccccccccccccccccCcccc--cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYA--LDGLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
|||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||...+.
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 9999975432 23446789999999998 455678999999999999999999999976543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.48 Aligned_cols=201 Identities=16% Similarity=0.236 Sum_probs=164.9
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEecc---cChhhHHHHHHHH---HHHHhcCCCCeeeEE-------E
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN---QSGQGLKEFKNEM---MLIAKLQHRNLVRLL-------G 534 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~---~~~~~~~~f~~E~---~~l~~l~HpnIv~l~-------~ 534 (682)
..++|++.+.||+|+||.||+|++ .+++.||||++.. ......+.|.+|+ +++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999987 4689999999863 2344568899999 555566899999998 6
Q ss_pred EEEecCe-----------------EEEEEEecCCCChhHHhhhccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005705 535 CCVEQGE-----------------KILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593 (682)
Q Consensus 535 ~~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 593 (682)
++...+. .++||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6665532 78999999 6899999854321 122445888899999999999999998
Q ss_pred cEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCC-----------CCCccccHHHHH
Q 005705 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----------LFSIKSDVFSFG 662 (682)
Q Consensus 594 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DVwSlG 662 (682)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999986432 2334567 999999999887 899999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 005705 663 ILMLETLSSKKNTGLGS 679 (682)
Q Consensus 663 vil~elltG~~pf~~~~ 679 (682)
|+||||++|+.||...+
T Consensus 301 ~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 301 LVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHHHSSCCC----
T ss_pred HHHHHHHHCCCCCcccc
Confidence 99999999999997654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=295.53 Aligned_cols=202 Identities=31% Similarity=0.463 Sum_probs=172.5
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
++|.....||+|+||.||+|++. +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555568999999999999874 57899999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeEEeeeccccccCCCcc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~ 628 (682)
++++|.+++........+++..+..++.||+.||+|||+.+ |+|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999966544456789999999999999999999998 999999999999987 8999999999998764322
Q ss_pred ccccccccccccccCcccccCCC--CCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 1223457899999999987654 78999999999999999999999964
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.05 Aligned_cols=207 Identities=25% Similarity=0.316 Sum_probs=174.7
Q ss_pred HhhhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----cCe
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGE 541 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~----~~~ 541 (682)
....++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34567899999999999999999988 5689999999977666777889999999999999999999999873 347
Q ss_pred EEEEEEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 542 KILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
.++||||+++++|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 789999999999999985422 3456999999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCccc-------cccccccccccccCcccccCCC---CCccccHHHHHHHHHHHHcCCCCCC
Q 005705 621 RMFGGDELQ-------GNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 621 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
......... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 765321110 0112346799999999987654 6899999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=292.76 Aligned_cols=201 Identities=26% Similarity=0.440 Sum_probs=169.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999986 68999999986532 23467899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999854 245899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||...+
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 32 1234578999999999988765 689999999999999999999997543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=296.72 Aligned_cols=204 Identities=26% Similarity=0.443 Sum_probs=166.8
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999987 46889999998752 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 546 LEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999985422 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 322 1223457899999999999999999999999999999999999999654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=318.04 Aligned_cols=201 Identities=30% Similarity=0.473 Sum_probs=174.3
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..++|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999885 6889999998643 233567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc---CCCCeEEeeeccccc
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARM 622 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kL~DFGla~~ 622 (682)
|||+++++|.+.+.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988843 346899999999999999999999998 99999999999995 456799999999987
Q ss_pred cCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|++||...+
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 64332 2334579999999998876 58999999999999999999999996543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=319.60 Aligned_cols=201 Identities=30% Similarity=0.458 Sum_probs=177.0
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
..++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3567999999999999999999885 68899999986432 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE---cCCCCeEEeeecccc
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLAR 621 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~ 621 (682)
||||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999988843 346899999999999999999999998 9999999999999 567899999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.+.... ......||+.|+|||++.+ .++.++|||||||++|||++|++||...+
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 764332 2344579999999998876 68999999999999999999999997643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=300.13 Aligned_cols=212 Identities=26% Similarity=0.381 Sum_probs=178.7
Q ss_pred cchhHHHhhhcCcccc-cccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCCeeeEEEE
Q 005705 461 FSLASITAATENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 535 (682)
Q Consensus 461 ~~~~~~~~~~~~y~i~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~-HpnIv~l~~~ 535 (682)
..+.......+.|.+. ++||+|+||.||+|+.. +++.||||++.... .....++.+|+.++.+++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344555566778887 89999999999999885 58899999987542 334678999999999995 6999999999
Q ss_pred EEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCe
Q 005705 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNP 612 (682)
Q Consensus 536 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~ 612 (682)
+.+.+..++||||+++++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999988432 3356999999999999999999999998 999999999999998 7899
Q ss_pred EEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 613 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 613 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998764322 2234579999999999999999999999999999999999999996543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=301.16 Aligned_cols=205 Identities=32% Similarity=0.469 Sum_probs=169.8
Q ss_pred hhcCcccccccccCCceeEEEEEEcC-----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
..++|.+.+.||+|+||.||+|+... +..||||+++.. ......++.+|+.++.+++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 35678889999999999999998753 235999999754 334566799999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999854 2346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 6433211 11223356788999999999999999999999999999999 99999653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=297.64 Aligned_cols=204 Identities=26% Similarity=0.464 Sum_probs=172.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
..++|++.+.||+|+||.||+|++. +++.||+|.+........+++.+|+.++.+++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3578999999999999999999986 488999999987766678899999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|..++... ...+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999988542 345899999999999999999999998 999999999999999999999999987643211
Q ss_pred cccccccccccccccCcccc-----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYA-----LDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
........||+.|+|||++ .+..++.++||||||+++|||++|+.||...+
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 1112335789999999988 46778999999999999999999999997643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=297.68 Aligned_cols=202 Identities=27% Similarity=0.390 Sum_probs=167.3
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-----------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV----------- 537 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~----------- 537 (682)
.++|++.+.||+|+||.||+|+... ++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999864 8899999998777777888999999999999999999999873
Q ss_pred ---ecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-CCCCeE
Q 005705 538 ---EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPK 613 (682)
Q Consensus 538 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~k 613 (682)
+....++||||++ ++|.+++. ...+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 59999883 346899999999999999999999998 99999999999997 567999
Q ss_pred EeeeccccccCCCcc-ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 614 ISDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 614 L~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|+|||+++....... ........+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 999999987643211 122334567899999998865 678999999999999999999999997653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.31 Aligned_cols=213 Identities=24% Similarity=0.326 Sum_probs=164.1
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe----
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE---- 538 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~---- 538 (682)
.+.....+|++.++||+|+||.||++++. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 33445678999999999999999999975 68899999997766667788999999999996 9999999999953
Q ss_pred ----cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 539 ----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 539 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
....++||||+. |+|.+++........+++.+++.++.||+.||+|||++++ +|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEB
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEE
Confidence 335789999996 6898888654555679999999999999999999998752 4999999999999999999999
Q ss_pred eeeccccccCCCccc----------cccccccccccccCcccc---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 615 SDFGLARMFGGDELQ----------GNTKQIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+|||+++........ .......||+.|+|||++ .+..++.++||||||+++|||++|+.||...+
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999876432211 111234689999999998 56778999999999999999999999997654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=305.35 Aligned_cols=208 Identities=28% Similarity=0.367 Sum_probs=170.6
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccC-----------hhhHHHHHHHHHHHHhcCCCCeee
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-----------GQGLKEFKNEMMLIAKLQHRNLVR 531 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-----------~~~~~~f~~E~~~l~~l~HpnIv~ 531 (682)
..++....++|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456677789999999999999999999998889999999985432 123478999999999999999999
Q ss_pred EEEEEEec-----CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE
Q 005705 532 LLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (682)
Q Consensus 532 l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl 606 (682)
+++++... ...++||||++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99998543 35799999998 577777743 3446999999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999998643322 2334578999999999877 678999999999999999999999997653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=293.48 Aligned_cols=203 Identities=30% Similarity=0.410 Sum_probs=171.8
Q ss_pred hhcCcccccccccCCceeEEEEEEcC----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
..++|++.+.||+|+||.||+|+..+ +..||||.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 46789999999999999999998643 235999999764 34456789999999999999999999999765 4568
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998542 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 44321 12233466889999999998999999999999999999998 99999654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=317.39 Aligned_cols=200 Identities=28% Similarity=0.423 Sum_probs=170.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.+.|++.++||+|+||.||+|+.. ++..||||++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999985 57899999986542 334578899999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC---CCeEEeeecccccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMF 623 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DFGla~~~ 623 (682)
||+++++|.+.+.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888843 346899999999999999999999998 9999999999999764 45999999999876
Q ss_pred CCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... ......||+.|+|||++. ..++.++|||||||++|||++|++||...+
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5332 234457999999999876 569999999999999999999999997543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=307.91 Aligned_cols=204 Identities=29% Similarity=0.471 Sum_probs=163.1
Q ss_pred cCcccccccccCCceeEEEEEEcC--C--ceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-cCeEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKIL 544 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~--g--~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~l 544 (682)
..|.+.++||+|+||.||+|++.+ + ..||||.++.. .....++|.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457788999999999999998743 2 36899998654 33556889999999999999999999998764 457899
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++++|.+++.. ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999853 3345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc--cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 33211 12233467889999999999999999999999999999999 788886544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=324.37 Aligned_cols=204 Identities=33% Similarity=0.512 Sum_probs=177.4
Q ss_pred hhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
...++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3467899999999999999999999888899999997643 345789999999999999999999999876 67899999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++... ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999532 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
. .......++..|+|||++....++.++|||||||+||||++ |+.||...
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11223456789999999999999999999999999999999 99999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.17 Aligned_cols=201 Identities=29% Similarity=0.435 Sum_probs=173.4
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh-------------hhHHHHHHHHHHHHhcCCCCeeeEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------------QGLKEFKNEMMLIAKLQHRNLVRLLG 534 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-------------~~~~~f~~E~~~l~~l~HpnIv~l~~ 534 (682)
..++|.+.++||+|+||.||+|+.. +++.||||++..... ...+++.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999985 478999999865321 34577999999999999999999999
Q ss_pred EEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC---C
Q 005705 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---N 611 (682)
Q Consensus 535 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~ 611 (682)
++.+....++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998843 346999999999999999999999998 99999999999998776 6
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+||+|||+++.+.... ......||+.|+|||++. ..++.++|||||||++|||++|++||...+
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998765432 234457999999999876 468999999999999999999999997654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=309.09 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=168.2
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe------EE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE------KI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~------~~ 543 (682)
..+|.+.++||+|+||.||+|++..+..+|+|++..... ...+|+.+++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457999999999999999999998877899998854322 12369999999999999999999976543 78
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-CCCCeEEeeeccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARM 622 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~ 622 (682)
+||||++++.+............+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988665554433334567999999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||...+
T Consensus 192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 64332 22345789999999998765 58999999999999999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.11 Aligned_cols=197 Identities=31% Similarity=0.413 Sum_probs=155.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec------C
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------~ 540 (682)
.++|++.+.||+|+||.||+|++. +|+.||||++... .....+++.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 578999999999999999999874 5889999999653 334567889999999999999999999998754 4
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++|+|++ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999998 689988873 246999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 180 RHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 86532 2334578999999999887 678999999999999999999999997543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=304.11 Aligned_cols=204 Identities=30% Similarity=0.420 Sum_probs=168.1
Q ss_pred hhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChh-----hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
...++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999885 4889999998643211 23468899999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+++ +|..++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 78887743 3346888999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.+.... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||...+
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 764322 223345789999999998764 58999999999999999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=298.04 Aligned_cols=199 Identities=31% Similarity=0.453 Sum_probs=171.9
Q ss_pred CcccccccccCCceeEEEEEEc-----CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 543 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 543 (682)
.|++.++||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3489999999999999988642 57899999997643 34567899999999999999999999999874 5789
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++.. ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 112 lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999843 34899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 624 GGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 624 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
...... .......+|+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 543211 123345678889999999999999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.91 Aligned_cols=198 Identities=28% Similarity=0.340 Sum_probs=163.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------ 540 (682)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 5889999998653 3345677899999999999999999999997654
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 68999999975 6777763 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8754321 2334578999999999999999999999999999999999999997543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=291.13 Aligned_cols=199 Identities=23% Similarity=0.377 Sum_probs=172.3
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec--CeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 545 (682)
.++|++.+.||+|+||.||+|++ +++.||||++... .....++|.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46799999999999999999998 4889999999754 344567899999999999999999999999877 678999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++... ....+++.+++.++.||++||+|||+++ .+|+||||||+||+++.++.++|.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 9999999999999542 2336899999999999999999999875 249999999999999999999999999875432
Q ss_pred CccccccccccccccccCcccccCCCCCc---cccHHHHHHHHHHHHcCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSI---KSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||...
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 22346899999999998766554 799999999999999999999754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=293.37 Aligned_cols=197 Identities=28% Similarity=0.469 Sum_probs=172.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe---------
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--------- 538 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~--------- 538 (682)
...+|++.+.||+|+||.||+|++. +++.||||++.... +.+.+|++++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999986 68999999997543 356789999999999999999998864
Q ss_pred -------cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 539 -------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 539 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
....++||||+++++|.+++... ....+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34579999999999999998543 2356899999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9999999998765432 2233578999999999999999999999999999999999998863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=293.36 Aligned_cols=208 Identities=28% Similarity=0.433 Sum_probs=174.8
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--cCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 544 (682)
.++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999885 5889999998653 34456789999999999999999999998864 567899
Q ss_pred EEEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 545 ILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSR--FRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~--~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+. .+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986532 23459999999999999999999999861 239999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 764322 11233578999999999999999999999999999999999999997643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.59 Aligned_cols=201 Identities=29% Similarity=0.458 Sum_probs=172.9
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
..++|++.+.||+|+||.||+|+.. +++.||||.+.... ..+++.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999885 48899999997543 34678999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++.. ....+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999853 2356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 1233457899999999999999999999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=291.92 Aligned_cols=201 Identities=26% Similarity=0.363 Sum_probs=175.9
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---------hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCV 537 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---------~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~ 537 (682)
..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999885 58899999986432 123567889999999996 999999999999
Q ss_pred ecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeee
Q 005705 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (682)
Q Consensus 538 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF 617 (682)
..+..++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999853 346899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccc------CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
|++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 9998764322 233457899999999885 456889999999999999999999999654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=294.71 Aligned_cols=205 Identities=29% Similarity=0.456 Sum_probs=171.2
Q ss_pred hcCcccccccccCCceeEEEEEEcC----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-cCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~ 543 (682)
..+|++.++||+|+||.||+|++.+ ...||+|.+... .....+++.+|+.++++++||||+++++++.+ ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578999999999999999998643 236899998764 33456789999999999999999999998654 55789
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999853 3356899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc--cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 624 GGDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 543211 12234567889999999999999999999999999999999 666665543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=310.67 Aligned_cols=199 Identities=28% Similarity=0.407 Sum_probs=164.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC------eE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------~~ 542 (682)
..+|++.+.||+|+||.||+|++. +++.||||++..... .+.+|+++|++++||||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346999999999999999999985 589999999865322 2347999999999999999999986422 36
Q ss_pred EEEEEecCCCChhHHhhh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC-CCeEEeeeccc
Q 005705 543 ILILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLA 620 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kL~DFGla 620 (682)
++||||+++ +|...+.. ......+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999986 55555432 233467999999999999999999999998 9999999999999965 56899999999
Q ss_pred cccCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.+.... ......||+.|+|||++.+. .++.++|||||||+||||++|++||...+
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 8764322 22345789999999998765 78999999999999999999999997643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=290.15 Aligned_cols=200 Identities=30% Similarity=0.436 Sum_probs=171.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----cCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~----~~~~ 542 (682)
.+.|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 456888899999999999999875 4778999998653 34456789999999999999999999999875 3458
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-CCCCeEEeeecccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLAR 621 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~ 621 (682)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ .+|+|+||||+|||++ .++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999843 356899999999999999999999875 2499999999999998 78999999999997
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
..... ......||+.|+|||++. ..++.++||||||+++|||++|+.||...
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 65332 233457899999999876 45899999999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=296.59 Aligned_cols=194 Identities=23% Similarity=0.388 Sum_probs=171.0
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe--cCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE--QGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~~lV 545 (682)
.++|++.++||+|+||.||+|++ .+++.||||+++.. ..+.+.+|+.++.+++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46899999999999999999987 46889999999753 3467899999999997 9999999999987 5678999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeeccccccC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFG 624 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~ 624 (682)
|||+++++|..++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998872 3889999999999999999999998 99999999999999776 89999999998764
Q ss_pred CCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 332 2334578999999999877 67899999999999999999999999544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=298.22 Aligned_cols=201 Identities=24% Similarity=0.370 Sum_probs=169.2
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~ 539 (682)
..++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3568999999999999999999875 47899999986532 12234688999999999999999999998765
Q ss_pred CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC---eEEee
Q 005705 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISD 616 (682)
Q Consensus 540 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~D 616 (682)
. .++||||+++++|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999884 3456899999999999999999999998 999999999999987664 99999
Q ss_pred eccccccCCCccccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99998764322 223457899999999874 5678999999999999999999999997644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=298.89 Aligned_cols=211 Identities=28% Similarity=0.472 Sum_probs=172.3
Q ss_pred cchhHHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 005705 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (682)
Q Consensus 461 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~ 538 (682)
+.+..+....++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 334445556789999999999999999999884 68899999986543 3457889999999999 79999999999987
Q ss_pred ------cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCe
Q 005705 539 ------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 612 (682)
Q Consensus 539 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 612 (682)
....++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 45789999999999999998643 2356899999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 613 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 613 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
||+|||++....... .......|++.|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998764321 1223457899999999987 567899999999999999999999999654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=295.67 Aligned_cols=204 Identities=31% Similarity=0.448 Sum_probs=172.2
Q ss_pred hhcCccccc-ccccCCceeEEEEEEc---CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 469 ATENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 469 ~~~~y~i~~-~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
..++|.+.+ .||+|+||.||+|... .++.||||+++... ....+++.+|+.++.+++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 456788888 9999999999999653 36789999997543 33467899999999999999999999998 56678
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++.. ...+++.+++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999854 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 6443221 11223356789999999998889999999999999999999 999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.01 Aligned_cols=200 Identities=23% Similarity=0.288 Sum_probs=173.4
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhc------CCCCeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL------QHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l------~HpnIv~l~~~~~~~~~ 541 (682)
...+|++.++||+|+||.||+|++. +++.||||++... ....+++.+|+.++..+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3567999999999999999999875 4889999999753 33456778888888887 56799999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC--eEEeeecc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGL 619 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kL~DFGl 619 (682)
.++||||+. ++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 5888887543 2345899999999999999999999998 999999999999999887 99999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+..... ......||+.|+|||++.+..++.++|||||||+||||++|++||...+
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 976432 2234578999999999999999999999999999999999999997654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.93 Aligned_cols=205 Identities=23% Similarity=0.312 Sum_probs=171.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--ecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCV--EQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~--~~~~~ 542 (682)
.++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999874 57899999997542 345678999999999999999999999984 44578
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||++++ |.+++... ....+++.++..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 66666432 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 65433233334457899999999987654 4789999999999999999999998654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=299.26 Aligned_cols=204 Identities=32% Similarity=0.485 Sum_probs=171.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCce--EEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQE--VAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~--vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|++.+.||+|+||.||+|++. ++.. +|||.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367999999999999999999875 4554 499988653 334556799999999999 89999999999999999999
Q ss_pred EEEecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 545 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
||||+++++|.+++.... ....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999985432 2346999999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999975321 112233466889999999999999999999999999999998 999997543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=298.79 Aligned_cols=209 Identities=26% Similarity=0.399 Sum_probs=159.4
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999864 68899999986542 3446778999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecc
Q 005705 545 ILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl 619 (682)
||||+++++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998531 12356899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcc---ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 620 ARMFGGDEL---QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 620 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 987643211 111234578999999999875 56899999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.58 Aligned_cols=202 Identities=26% Similarity=0.381 Sum_probs=172.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-----CeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 542 (682)
.++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 568999999999999999999875 57889999997543 34457899999999999999999999999755 368
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++ +|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999999984 88888743 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 6432211 12344589999999998654 558999999999999999999999997654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=302.47 Aligned_cols=202 Identities=27% Similarity=0.408 Sum_probs=177.0
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChh-----------------hHHHHHHHHHHHHhcCCCCeeeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-----------------GLKEFKNEMMLIAKLQHRNLVRL 532 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~-----------------~~~~f~~E~~~l~~l~HpnIv~l 532 (682)
.++|.+.+.||+|+||.||+|+. +++.||||++...... ..+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 8999999998643211 12789999999999999999999
Q ss_pred EEEEEecCeEEEEEEecCCCChhHH------hhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEE
Q 005705 533 LGCCVEQGEKILILEYMPNKSLNVF------LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNIL 605 (682)
Q Consensus 533 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NIL 605 (682)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||+|||+ .+ |+|+||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 422 124679999999999999999999999 87 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCC-CCCc-cccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSI-KSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||...+.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999876432 23445789999999999887 6666 99999999999999999999986543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=323.79 Aligned_cols=204 Identities=29% Similarity=0.460 Sum_probs=169.9
Q ss_pred hcCccccc-ccccCCceeEEEEEEc---CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~-~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.+++.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 44555555 8999999999999874 45679999997643 3467889999999999999999999999876 56899
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++|+|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 413 v~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999853 3456999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
..... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 32211 11222345689999999999999999999999999999998 999997654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=307.38 Aligned_cols=198 Identities=13% Similarity=0.151 Sum_probs=155.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhc--CCCCeeeEE-------EEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL--QHRNLVRLL-------GCC 536 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l--~HpnIv~l~-------~~~ 536 (682)
..+|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999975 68899999997643 23456778885555555 699988755 455
Q ss_pred EecC-----------------eEEEEEEecCCCChhHHhhhccccCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 005705 537 VEQG-----------------EKILILEYMPNKSLNVFLFDSTKKRLLNWQAR------VRIIEGIAQGLLYLHQYSRFR 593 (682)
Q Consensus 537 ~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~~~~ 593 (682)
...+ ..++||||++ ++|.+++.... ..+.+..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 4332 3799999999 89999996532 23455555 778899999999999998
Q ss_pred cEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcC
Q 005705 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSS 671 (682)
Q Consensus 594 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG 671 (682)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999875321 213466799999999987 7799999999999999999999
Q ss_pred CCCCCCC
Q 005705 672 KKNTGLG 678 (682)
Q Consensus 672 ~~pf~~~ 678 (682)
+.||...
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.86 Aligned_cols=195 Identities=29% Similarity=0.437 Sum_probs=161.9
Q ss_pred HhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhc--CCCCeeeEEEEEEec----C
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL--QHRNLVRLLGCCVEQ----G 540 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l--~HpnIv~l~~~~~~~----~ 540 (682)
....++|++.++||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999874 8999999986432 23445555555554 899999999999887 6
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCcEeccCCCCCEEEcCCCCe
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY--------SRFRIIHRDLKASNILLDKDMNP 612 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~~~~iiH~Dlkp~NILl~~~~~~ 612 (682)
..++||||+++++|.+++.. ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 88999999999999999843 3589999999999999999999988 6 9999999999999999999
Q ss_pred EEeeeccccccCCCcccc--ccccccccccccCcccccCCCCCcc------ccHHHHHHHHHHHHcCC
Q 005705 613 KISDFGLARMFGGDELQG--NTKQIVGTYGYMSPEYALDGLFSIK------SDVFSFGILMLETLSSK 672 (682)
Q Consensus 613 kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------~DVwSlGvil~elltG~ 672 (682)
||+|||+++.+....... ......||+.|+|||++.+.....+ +|||||||++|||++|+
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 999999998764332211 1224579999999999988776665 99999999999999993
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.94 Aligned_cols=202 Identities=29% Similarity=0.410 Sum_probs=170.8
Q ss_pred cCcccccccccCCceeEEEEEEcC-C---ceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE-EE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK-IL 544 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~-g---~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~-~l 544 (682)
-.|.+.++||+|+||.||+|++.+ + ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356677899999999999998643 2 269999997643 34567899999999999999999999999876655 89
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+.+++|.+++.. ....+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999854 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc--ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCC-CCC
Q 005705 625 GDEL--QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN-TGL 677 (682)
Q Consensus 625 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~p-f~~ 677 (682)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++|+.| |..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence 4321 1223345778999999999999999999999999999999995554 443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.63 Aligned_cols=208 Identities=22% Similarity=0.307 Sum_probs=162.2
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe--
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE-- 541 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 541 (682)
......++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 44566789999999999999999999985 58899999985432 334566788889999999999999999976443
Q ss_pred -----EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCcEeccCCCCCEEEcC-CCCeE
Q 005705 542 -----KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--QYSRFRIIHRDLKASNILLDK-DMNPK 613 (682)
Q Consensus 542 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~~~~iiH~Dlkp~NILl~~-~~~~k 613 (682)
.++||||++++.+..+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987543333322344567899999999999999999999 777 999999999999997 89999
Q ss_pred EeeeccccccCCCccccccccccccccccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|+|||+++.+.... ......||+.|+|||++.+.. ++.++|||||||++|||++|++||...+
T Consensus 173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999998765332 223457899999999987654 8999999999999999999999997654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.00 Aligned_cols=203 Identities=23% Similarity=0.321 Sum_probs=168.8
Q ss_pred hhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEE-EecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-VEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~ 546 (682)
..++|++.+.||+|+||.||+|++ .+++.||||++..... .+++.+|+.++.+++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999987 5688999998754322 24578899999999988877666655 5667889999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE---cCCCCeEEeeecccccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMF 623 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~ 623 (682)
||+ +++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 345999999999999999999999998 9999999999999 78899999999999876
Q ss_pred CCCccc-----cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 543221 12234688999999999999999999999999999999999999997643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=299.86 Aligned_cols=203 Identities=31% Similarity=0.529 Sum_probs=175.7
Q ss_pred hcCcccccccccCCceeEEEEEE-----cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC--eE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~--~~ 542 (682)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999984 358899999998777677789999999999999999999999987654 67
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998543 245899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 6543211 112234567789999999998999999999999999999999998763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=289.90 Aligned_cols=201 Identities=23% Similarity=0.324 Sum_probs=171.8
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEE-EecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-VEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~E 547 (682)
.++|++.+.||+|+||.||+|++ .+++.||||++..... .+++.+|+.++.+++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999987 5689999999865432 24688999999999988866666555 56677899999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE---cCCCCeEEeeeccccccC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFG 624 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~~ 624 (682)
|+ +++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998532 346999999999999999999999998 9999999999999 488899999999998765
Q ss_pred CCccc-----cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 43221 1124467999999999999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=293.16 Aligned_cols=202 Identities=27% Similarity=0.372 Sum_probs=160.1
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4578999999999999999999884 68899999997542 22334455666668888999999999999999999999
Q ss_pred EEecCCCChhHHhhh-ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 546 LEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
|||+++ +|.+++.. ......+++..++.++.||+.||+|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 88777643 22345799999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccc----cCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||..
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 4322 22334789999999996 566789999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=298.28 Aligned_cols=210 Identities=27% Similarity=0.356 Sum_probs=172.9
Q ss_pred cchhHHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcC--CCCeeeEEEEE
Q 005705 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCC 536 (682)
Q Consensus 461 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~--HpnIv~l~~~~ 536 (682)
+.+..+....++|++.+.||+|+||.||+++..+++.||||++... .....+.+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4455556677899999999999999999999888999999998643 3445678999999999997 59999999999
Q ss_pred EecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEee
Q 005705 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (682)
Q Consensus 537 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 616 (682)
..++..++||| +.+++|.+++.. ...+++.+++.++.||++||+|||+++ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 678899999853 346899999999999999999999998 999999999999965 8999999
Q ss_pred eccccccCCCccccccccccccccccCcccccC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
||+++.+.............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 999987654332222334578999999999875 46888999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.42 Aligned_cols=203 Identities=26% Similarity=0.425 Sum_probs=155.5
Q ss_pred cCccc-ccccccCCceeEEEEEEc---CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--cCeEEE
Q 005705 471 ENFSM-QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 544 (682)
Q Consensus 471 ~~y~i-~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 544 (682)
+.|++ .++||+|+||.||+|++. +++.||||++.... ....+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 458999999999999975 47889999997543 23568899999999999999999999965 568899
Q ss_pred EEEecCCCChhHHhhhcc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE----cCCCCeEE
Q 005705 545 ILEYMPNKSLNVFLFDST------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKI 614 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kL 614 (682)
||||+++ +|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 7777664221 2235999999999999999999999998 9999999999999 77889999
Q ss_pred eeeccccccCCCcc-ccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 615 SDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||+||||++|++||...+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987643211 1223446889999999999874 58999999999999999999999996543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=304.51 Aligned_cols=200 Identities=19% Similarity=0.227 Sum_probs=171.5
Q ss_pred hcCcccccccccCCceeEEEEEEcC---------CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeee---------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR--------- 531 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~---------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~--------- 531 (682)
.++|.+.+.||+|+||.||+|+... ++.||||.+... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999998864 789999998654 46789999999999999887
Q ss_pred ------EEEEEEe-cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCE
Q 005705 532 ------LLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (682)
Q Consensus 532 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 604 (682)
+++++.. +...++||||+ +++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 99999999643 2356999999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEeeeccccccCCCccc-----cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 605 LLDKDM--NPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 605 Ll~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876432211 112345889999999999999999999999999999999999999976
Q ss_pred CC
Q 005705 678 GS 679 (682)
Q Consensus 678 ~~ 679 (682)
.+
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 43
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.03 Aligned_cols=201 Identities=24% Similarity=0.356 Sum_probs=167.0
Q ss_pred hhhcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-------
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------- 539 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------- 539 (682)
...++|++.+.||+|+||.||+|++ .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999987 4689999999865422 234799999999999999999998543
Q ss_pred -------------------------------CeEEEEEEecCCCChhHHhhhc-cccCCCCHHHHHHHHHHHHHHHHHHH
Q 005705 540 -------------------------------GEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLH 587 (682)
Q Consensus 540 -------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH 587 (682)
...++||||+++ +|.+.+... .....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 237899999984 777776432 33457999999999999999999999
Q ss_pred hcCCCCcEeccCCCCCEEEc-CCCCeEEeeeccccccCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHH
Q 005705 588 QYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILM 665 (682)
Q Consensus 588 ~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil 665 (682)
+.+ |+||||||+|||++ .++.+||+|||+++.+.... ......+|+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 99999999999998 68899999999998764332 22345789999999998775 489999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 005705 666 LETLSSKKNTGLGS 679 (682)
Q Consensus 666 ~elltG~~pf~~~~ 679 (682)
|||++|++||...+
T Consensus 233 ~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 233 GELILGKPLFSGET 246 (383)
T ss_dssp HHHHHSSCSSCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=292.67 Aligned_cols=199 Identities=32% Similarity=0.489 Sum_probs=166.7
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-CeEEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILE 547 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E 547 (682)
..++|++.+.||+|+||.||+++. +++.||||+++... ..+.+.+|+.++.+++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 357899999999999999999987 58899999997543 457899999999999999999999997654 47899999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+++++|.+++... ....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999998542 2234889999999999999999999998 999999999999999999999999999865322
Q ss_pred cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 223367889999999999999999999999999999998 999997654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=299.66 Aligned_cols=198 Identities=31% Similarity=0.507 Sum_probs=160.5
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHH--HHhcCCCCeeeEEEEEEec-----Ce
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML--IAKLQHRNLVRLLGCCVEQ-----GE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~--l~~l~HpnIv~l~~~~~~~-----~~ 541 (682)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|..+ +..++||||+++++.+... ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 357899999999999999999977 78999999996533 2344444444 4558999999999866432 25
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCcEeccCCCCCEEEcCCCCe
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY---------SRFRIIHRDLKASNILLDKDMNP 612 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~~~~iiH~Dlkp~NILl~~~~~~ 612 (682)
.++||||+++++|.+++.. ...++..+..++.||++||+|||+. + |+||||||+|||++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 6899999999999999843 3358899999999999999999998 6 9999999999999999999
Q ss_pred EEeeeccccccCCCcc------ccccccccccccccCcccccC-------CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 613 KISDFGLARMFGGDEL------QGNTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 613 kL~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||-.
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 9999999987643221 112234579999999999987 4567789999999999999999776643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.31 Aligned_cols=199 Identities=24% Similarity=0.298 Sum_probs=170.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC--------CCCeeeEEEEEE---
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRNLVRLLGCCV--- 537 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~--------HpnIv~l~~~~~--- 537 (682)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999874 5789999999753 345678899999999995 788999999987
Q ss_pred -ecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCC-----
Q 005705 538 -EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDM----- 610 (682)
Q Consensus 538 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~----- 610 (682)
.....++||||+ +++|.+.+... ....+++.+++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 455789999999 55555555332 234699999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------CeEEeeeccccccCCCccccccccccccccccCccc
Q 005705 611 --------------------------------------------NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646 (682)
Q Consensus 611 --------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 646 (682)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999875422 334578999999999
Q ss_pred ccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 647 ~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.+..++.++|||||||+||||++|+.||...+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=298.53 Aligned_cols=202 Identities=25% Similarity=0.383 Sum_probs=171.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-----CeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 542 (682)
.++|.+.+.||+|+||.||+|++. +++.||||++... ......++.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 578999999999999999999885 5889999999654 334566789999999999999999999988754 578
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 589888743 46899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc--------ccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDELQG--------NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+....... ......||+.|+|||++.+ ..++.++||||||+++|||++|++||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 64321111 1223578999999998764 778999999999999999999999997643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=322.82 Aligned_cols=196 Identities=32% Similarity=0.448 Sum_probs=165.2
Q ss_pred cccccCCceeEEEEEEc---CCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+.+|.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999663 35789999997643 3456889999999999999999999999864 568899999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc-cc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-QG 630 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~ 630 (682)
++|.+++.. ...+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999943 356899999999999999999999998 99999999999999999999999999987754321 12
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...+
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2233456789999999999999999999999999999998 999997654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=293.25 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=173.3
Q ss_pred hcCcccccccccCCceeEEEEEE--cCCceEEEEEecccChhhHHHHHHHHHHHHhcCCC------CeeeEEEEEEecCe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR------NLVRLLGCCVEQGE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~--~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hp------nIv~l~~~~~~~~~ 541 (682)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++.+++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 35889999999753 34567789999999998765 49999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-------------
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK------------- 608 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~------------- 608 (682)
.++||||+ +++|.+++... ....+++.++..++.||++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88999988543 2246889999999999999999999998 999999999999987
Q ss_pred ------CCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 609 ------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 609 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 66899999999986432 2234578999999999999999999999999999999999999997653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.50 Aligned_cols=205 Identities=29% Similarity=0.397 Sum_probs=165.8
Q ss_pred hhcCcccccccccCCceeEEEEEEcC--Cc--eEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~--g~--~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
..++|++.+.||+|+||.||+|++.. ++ .||||+++.. .....+++.+|+.++.+++||||+++++++..+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 35689999999999999999998632 33 6899998653 3345678999999999999999999999987664
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+++++|.+++... ...+++.++..++.||++||+|||+++ |+|+||||+||+++.++.+||+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 88999999999999998543 245899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 622 MFGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
........ .......+|..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 76543221 12233467889999999998889999999999999999999 999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=293.56 Aligned_cols=204 Identities=28% Similarity=0.435 Sum_probs=171.4
Q ss_pred hhhcCcccccccccCCceeEEEEEE--cCCceEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCeeeEEEEEE---
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCV--- 537 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~--~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l---~HpnIv~l~~~~~--- 537 (682)
...++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3467899999999999999999998 357899999986432 12223566777777666 8999999999987
Q ss_pred --ecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEe
Q 005705 538 --EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (682)
Q Consensus 538 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 615 (682)
.....++||||++ ++|.+++.... ...+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 59999885432 345899999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|++||...+
T Consensus 163 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 163 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999875422 12334578999999999999999999999999999999999999997543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=299.62 Aligned_cols=196 Identities=28% Similarity=0.417 Sum_probs=168.1
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE----
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK---- 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~---- 542 (682)
.++|.+.+.||+|+||.||+|++. +++.||||++... .....+++.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 578999999999999999999875 5889999999753 334467889999999999999999999999877654
Q ss_pred --EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 543 --ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 543 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
++||||+. ++|..++. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 57877762 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 192 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 86532 2334578999999999887 778999999999999999999999997643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=294.46 Aligned_cols=201 Identities=27% Similarity=0.397 Sum_probs=170.6
Q ss_pred HhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEecC----
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQG---- 540 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~--l~HpnIv~l~~~~~~~~---- 540 (682)
....++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34467899999999999999999988 5899999999653 34667888888888 78999999999998776
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCcEeccCCCCCEEEcCCCCe
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNILLDKDMNP 612 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~ 612 (682)
..++||||+++++|.+++.. ..+++.+++.++.||+.||+||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999843 35899999999999999999999 666 9999999999999999999
Q ss_pred EEeeeccccccCCCccc--cccccccccccccCcccccCCC------CCccccHHHHHHHHHHHHcC----------CCC
Q 005705 613 KISDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSS----------KKN 674 (682)
Q Consensus 613 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~k~DVwSlGvil~elltG----------~~p 674 (682)
||+|||++......... .......||+.|+|||++.+.. ++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876433211 1233457899999999987763 34789999999999999999 677
Q ss_pred CCCC
Q 005705 675 TGLG 678 (682)
Q Consensus 675 f~~~ 678 (682)
|...
T Consensus 267 ~~~~ 270 (342)
T 1b6c_B 267 YYDL 270 (342)
T ss_dssp TTTT
T ss_pred cccc
Confidence 7543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=286.31 Aligned_cols=201 Identities=29% Similarity=0.460 Sum_probs=174.6
Q ss_pred hhhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
...++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999985 6889999998653 23456789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC---CCeEEeeecccc
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLAR 621 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~DFGla~ 621 (682)
||||+++++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+|+||||+||+++.+ ..+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888743 345899999999999999999999998 9999999999999764 469999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
...... ......+++.|+|||.+.+. ++.++||||||+++|||++|+.||...
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 764322 22334689999999988654 899999999999999999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.01 Aligned_cols=202 Identities=23% Similarity=0.324 Sum_probs=172.3
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.++||+|+||.||+|++ .+++.||||++..... .+++.+|++++..++| +++..+..++.+....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 57899999999999999999987 4688999998765432 2457889999999987 556666677778888999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE---cCCCCeEEeeeccccccC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFG 624 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kL~DFGla~~~~ 624 (682)
|+ +++|.+++... ...+++.+++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 346999999999999999999999998 9999999999999 688999999999998875
Q ss_pred CCccc-----cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 43221 12235689999999999999999999999999999999999999997643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=294.94 Aligned_cols=196 Identities=28% Similarity=0.416 Sum_probs=167.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe-----
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 541 (682)
.++|.+.+.||+|+||.||+|++. +|+.||||++... .....+++.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999875 5889999999653 33446788999999999999999999999987653
Q ss_pred -EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 542 -KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 542 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
.++||||++ ++|.+++. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58877762 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 174 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 174 RHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 86532 1234578999999999877 678999999999999999999999997543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.39 Aligned_cols=195 Identities=30% Similarity=0.480 Sum_probs=162.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE---------- 538 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~---------- 538 (682)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 567999999999999999999974 6889999999643 3456789999999999999999999998865
Q ss_pred ---cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEe
Q 005705 539 ---QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (682)
Q Consensus 539 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~ 615 (682)
....++||||+++++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34678999999999999999542 345788999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCcc------------ccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHc
Q 005705 616 DFGLARMFGGDEL------------QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLS 670 (682)
Q Consensus 616 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~ellt 670 (682)
|||++........ ........|++.|+|||++.+. .++.++||||||+++|||++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999987643210 1122345789999999998865 68999999999999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=295.38 Aligned_cols=202 Identities=25% Similarity=0.345 Sum_probs=171.6
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC-CC-----CeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR-----NLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-Hp-----nIv~l~~~~~~~~~ 541 (682)
..++|++.+.||+|+||.||+|++. +++.||||+++.. .....++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999875 5789999999753 344567888999998885 55 49999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc--CCCCeEEeeecc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGL 619 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kL~DFGl 619 (682)
.++||||+++ +|.+++.... ...+++..+..++.||+.||+|||.+. .+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999965 9999885432 245899999999999999999999531 1399999999999995 477899999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876432 234578999999999999999999999999999999999999998643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.06 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=152.9
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..++|++.+.||+|+||.||+|+.. +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3578999999999999999999985 68899999997643 334455666665 67778999999999999999999999
Q ss_pred EEecCCCChhHHhhh--ccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 546 LEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
|||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999986 77777642 12245789999999999999999999998 7 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccc----cCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 623 FGGDELQGNTKQIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred ccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 64322 12234789999999998 4667899999999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=315.50 Aligned_cols=206 Identities=26% Similarity=0.362 Sum_probs=173.0
Q ss_pred HHhhhcCcccccccccCCceeEEEEEEcC----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC
Q 005705 466 ITAATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (682)
Q Consensus 466 ~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~ 540 (682)
.....++|++.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34456789999999999999999998743 457999998754 3445678999999999999999999999985 45
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++||||+++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 689999999999999998542 345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
+....... .......+|+.|+|||++.+..++.++||||||+++|||++ |++||...
T Consensus 539 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 539 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 87644322 12233466789999999999999999999999999999997 99999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=290.16 Aligned_cols=199 Identities=25% Similarity=0.344 Sum_probs=170.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CC-ceEEEEEecccChhhHHHHHHHHHHHHhcCCCC------eeeEEEEEEecCe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCVEQGE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g-~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~ 541 (682)
.++|++.+.||+|+||.||+|+.. ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999874 34 68999999753 345577889999999997765 9999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEE---------------
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--------------- 606 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl--------------- 606 (682)
.++||||+ +++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55666666432 2346899999999999999999999998 9999999999999
Q ss_pred ----cCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 607 ----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 607 ----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5678999999999986432 2234578999999999999999999999999999999999999997643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=295.40 Aligned_cols=199 Identities=23% Similarity=0.364 Sum_probs=169.0
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCCeeeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCV 537 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----------HpnIv~l~~~~~ 537 (682)
.++|++.+.||+|+||.||+|++ .+++.||||++... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999987 46889999999743 334567889999999886 899999999998
Q ss_pred ecC----eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEc-----
Q 005705 538 EQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLD----- 607 (682)
Q Consensus 538 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~----- 607 (682)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 788999999 889999985432 34589999999999999999999998 7 99999999999994
Q ss_pred -CCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 608 -KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 608 -~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4447999999999875422 233578999999999999999999999999999999999999998654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-33 Score=292.65 Aligned_cols=207 Identities=28% Similarity=0.432 Sum_probs=170.3
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
......++|++.+.||+|+||.||+|+..+ .+|+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 334456889999999999999999998743 5999998653 233446688999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||++..
T Consensus 105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999843 2346899999999999999999999998 99999999999998 67999999999876
Q ss_pred cCCCc---cccccccccccccccCcccccC---------CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDE---LQGNTKQIVGTYGYMSPEYALD---------GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... .........|++.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 53211 1122234568999999999864 457889999999999999999999997654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-33 Score=290.81 Aligned_cols=200 Identities=24% Similarity=0.372 Sum_probs=172.3
Q ss_pred hhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh------hhHHHHHHHHHHHHhcC--CCCeeeEEEEEEe
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVE 538 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~--HpnIv~l~~~~~~ 538 (682)
...++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++.+++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34678999999999999999999874 588999999865421 12345778999999996 5999999999999
Q ss_pred cCeEEEEEEecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-CCCCeEEee
Q 005705 539 QGEKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISD 616 (682)
Q Consensus 539 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~D 616 (682)
.+..++|||++.+ ++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 899999853 356899999999999999999999998 99999999999999 788999999
Q ss_pred eccccccCCCccccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCC
Q 005705 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99998765322 234578999999999887665 6789999999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-33 Score=299.68 Aligned_cols=192 Identities=19% Similarity=0.223 Sum_probs=163.3
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccC--------hhhHHHHHHHHHHHHhcC---------CCCeee
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQ---------HRNLVR 531 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--------~~~~~~f~~E~~~l~~l~---------HpnIv~ 531 (682)
..++|++.++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356899999999999999999988 78999999996542 234578899999999886 888888
Q ss_pred EEEEEE------------------------------ecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHH
Q 005705 532 LLGCCV------------------------------EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581 (682)
Q Consensus 532 l~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~ 581 (682)
+.+++. ..+..++||||+++|++.+.+. +..+++.++..++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHH
Confidence 887653 2678999999999997666652 246899999999999999
Q ss_pred HHHHHH-hcCCCCcEeccCCCCCEEEcCCC--------------------CeEEeeeccccccCCCcccccccccccccc
Q 005705 582 GLLYLH-QYSRFRIIHRDLKASNILLDKDM--------------------NPKISDFGLARMFGGDELQGNTKQIVGTYG 640 (682)
Q Consensus 582 ~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 640 (682)
||+||| +.+ |+||||||+|||++.++ .+||+|||+|+.... ....||+.
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDV 242 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCC
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeec
Confidence 999999 888 99999999999999887 899999999987542 23479999
Q ss_pred ccCcccccCCCCCccccHHHHHHH-HHHHHcCCCCCC
Q 005705 641 YMSPEYALDGLFSIKSDVFSFGIL-MLETLSSKKNTG 676 (682)
Q Consensus 641 y~aPE~~~~~~~s~k~DVwSlGvi-l~elltG~~pf~ 676 (682)
|+|||++.+.. +.++|||||+++ .+++++|..||.
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 99999998777 899999998776 888999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=300.07 Aligned_cols=201 Identities=27% Similarity=0.336 Sum_probs=158.0
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEEEec
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345667899999999998776778999999998643 345678999999987 8999999999999999999999999
Q ss_pred CCCChhHHhhhccccC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC-------------CCe
Q 005705 550 PNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-------------MNP 612 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~ 612 (682)
. ++|.+++....... ...+..++.++.||+.||+|||+++ |+||||||+|||++.+ ..+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999985432211 1233456789999999999999998 9999999999999754 489
Q ss_pred EEeeeccccccCCCccc--cccccccccccccCcccccC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 613 KISDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 613 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999987543211 12234579999999999876 668999999999999999999 99999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-33 Score=289.93 Aligned_cols=201 Identities=25% Similarity=0.407 Sum_probs=164.5
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChh------hHHHHHHHHHHHHhc----CCCCeeeEEEE
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ------GLKEFKNEMMLIAKL----QHRNLVRLLGC 535 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~------~~~~f~~E~~~l~~l----~HpnIv~l~~~ 535 (682)
....++|++.+.||+|+||.||+|++. +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344678999999999999999999874 5889999999654321 233466799999999 89999999999
Q ss_pred EEecCeEEEEEEe-cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-CCCCeE
Q 005705 536 CVEQGEKILILEY-MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPK 613 (682)
Q Consensus 536 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~k 613 (682)
+...+..++|||+ +.+++|.+++.. ...+++.+++.++.||++||+|||+.+ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9998999999999 789999999854 345899999999999999999999998 99999999999999 889999
Q ss_pred EeeeccccccCCCccccccccccccccccCcccccCCCCC-ccccHHHHHHHHHHHHcCCCCCCC
Q 005705 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwSlGvil~elltG~~pf~~ 677 (682)
|+|||++....... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||..
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99999998765432 2345789999999998877664 589999999999999999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=288.62 Aligned_cols=199 Identities=22% Similarity=0.280 Sum_probs=147.0
Q ss_pred hhcCccccc-ccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----cCeE
Q 005705 469 ATENFSMQC-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 542 (682)
Q Consensus 469 ~~~~y~i~~-~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~----~~~~ 542 (682)
..++|.+.+ .||+|+||.||+|++. +++.||||++.... ....+....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357889855 6999999999999886 58999999986532 222233344567799999999999876 4458
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEEeeecc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 619 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGl 619 (682)
++||||+++++|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999998543 2346999999999999999999999998 999999999999986 44599999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++..... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9875432 2234578999999999988899999999999999999999999996543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=310.87 Aligned_cols=202 Identities=29% Similarity=0.420 Sum_probs=174.9
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------cCe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QGE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~------~~~ 541 (682)
..+|++.++||+|+||.||+|.+. +++.||||++... .....+++.+|+.++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999874 5889999998754 44556789999999999999999999998765 567
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC---eEEeeec
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFG 618 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kL~DFG 618 (682)
.++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555556899999999999999999999998 999999999999997765 9999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 998764332 22345789999999999999999999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=298.76 Aligned_cols=202 Identities=23% Similarity=0.354 Sum_probs=160.8
Q ss_pred hhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
....+|.+.++||+|+||+|+.....+++.||||++..... ..+.+|+.+|+++ +||||+++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34567999999999999997665566899999999965332 2356899999999 7999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-----CCCeEEeeecccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLAR 621 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kL~DFGla~ 621 (682)
||++ ++|.+++.... ..+.+.+++.++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9997 59999885432 23445566789999999999999998 999999999999953 3368899999998
Q ss_pred ccCCCcc-ccccccccccccccCccccc---CCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 005705 622 MFGGDEL-QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLS-SKKNTGLG 678 (682)
Q Consensus 622 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwSlGvil~ellt-G~~pf~~~ 678 (682)
.+..... ........||+.|+|||++. ...++.++|||||||++|||++ |++||+..
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 7643221 12234467999999999987 4567889999999999999999 99999654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=315.75 Aligned_cols=192 Identities=21% Similarity=0.343 Sum_probs=167.0
Q ss_pred hcCcccccccccCCceeEEEEEEc--CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe-----
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 541 (682)
.++|++.+.||+|+||.||++++. +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999985 5889999998653 34456788999999999999999999999987765
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+++++|.+++.. .+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887622 6899999999999999999999998 9999999999999986 99999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
..... ....||+.|+|||++.+.. +.++|||||||+||||++|.+||..
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 76432 3457999999999887654 8899999999999999999998764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-32 Score=282.84 Aligned_cols=200 Identities=23% Similarity=0.378 Sum_probs=152.5
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3578999999999999999999985 688999999965432 2234455566678888999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
|||+ ++.+..+... ....+++..+..++.||++||+|||+. + |+|+||||+||+++.++.+||+|||++..+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4455554422 235689999999999999999999985 7 9999999999999999999999999997654
Q ss_pred CCccccccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
... ......|++.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 322 223457899999999984 56688999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-31 Score=270.74 Aligned_cols=173 Identities=12% Similarity=0.101 Sum_probs=152.4
Q ss_pred hcCcccccccccCCceeEEEEEEcC-CceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
..+|++.+.||+|+||.||+|++.. ++.||||++.... ....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4679999999999999999999854 8999999997542 34457899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++.. . ....++.+++.||+.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 2 356678899999999999999998 9999999999999999999997443
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|++| ++.++||||||+++|||++|+.||...+
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3333 6889999999999999999999998654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-31 Score=285.80 Aligned_cols=201 Identities=16% Similarity=0.238 Sum_probs=155.9
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCC-CCe---------ee---
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQH-RNL---------VR--- 531 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H-pnI---------v~--- 531 (682)
....|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.|.+|+.++..++| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4456888899999999999999964 58999999987432 2336789999999999987 221 11
Q ss_pred ---------EEEEEEe-----cCeEEEEEEecCCCChhHHhhh----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005705 532 ---------LLGCCVE-----QGEKILILEYMPNKSLNVFLFD----STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593 (682)
Q Consensus 532 ---------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 593 (682)
+..+... ....+++|+. .+++|.+++.. ......+++..++.++.||++||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 1234566665 46889888741 223445788899999999999999999998
Q ss_pred cEeccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccc----------cCCCCCccccHHHHHH
Q 005705 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA----------LDGLFSIKSDVFSFGI 663 (682)
Q Consensus 594 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DVwSlGv 663 (682)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999865322 334577 999999999 5566889999999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 005705 664 LMLETLSSKKNTGLGS 679 (682)
Q Consensus 664 il~elltG~~pf~~~~ 679 (682)
++|||++|+.||...+
T Consensus 306 il~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDA 321 (413)
T ss_dssp HHHHHHHSSCCCCTTG
T ss_pred HHHHHHHCCCCCCCcc
Confidence 9999999999997654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=263.81 Aligned_cols=176 Identities=22% Similarity=0.320 Sum_probs=151.1
Q ss_pred hcCcccc-cccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHH-HhcCCCCeeeEEEEEEe----cCeE
Q 005705 470 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLI-AKLQHRNLVRLLGCCVE----QGEK 542 (682)
Q Consensus 470 ~~~y~i~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l-~~l~HpnIv~l~~~~~~----~~~~ 542 (682)
.++|.+. +.||+|+||.||++... +++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567776 78999999999999874 5889999998642 4567888888 55689999999999987 6678
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEEeeecc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 619 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGl 619 (682)
++||||+++++|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998653 2346999999999999999999999998 999999999999998 78899999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+.... +..++.++||||||+++|||++|+.||...
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 86532 244677999999999999999999999654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=254.51 Aligned_cols=138 Identities=18% Similarity=0.247 Sum_probs=110.3
Q ss_pred cccccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEec
Q 005705 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (682)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 102 (682)
++.|+|.+|++|.+|++| ++|.|+|||+.+++ +.+|. .+++||+|||+.| .++.|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~---~~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEEEE---CCEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 567999999999999999 59999999998765 34444 3799999999988 47899999999999999
Q ss_pred CCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCCCcccc-cccCcccccc-ccCc-----ceeEE
Q 005705 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTL-LQDMKLGWDF-KNRL-----ERYLS 175 (682)
Q Consensus 103 ~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~Ptdtl-lp~~~l~~~~-~~~~-----~~~l~ 175 (682)
++|.+||+|++......+.|+|+|+|||||++. ++||||||||||+ ||+| |.+. .+|+ ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~--------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS--------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC--------CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 999999999987555567899999999999952 6999999998766 4443 3333 2332 34555
Q ss_pred EeecCCCCCCc
Q 005705 176 SWRSADDPSPD 186 (682)
Q Consensus 176 s~~~~~dps~g 186 (682)
+..||++|
T Consensus 143 ---s~~d~s~G 150 (236)
T 1dlp_A 143 ---ATQSLQLS 150 (236)
T ss_dssp ---SSCCCBCS
T ss_pred ---cCcEeecC
Confidence 36777777
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-29 Score=282.85 Aligned_cols=184 Identities=16% Similarity=0.162 Sum_probs=131.1
Q ss_pred ccccCCceeEEEEEE-cCCceEEEEEeccc----------ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEEE
Q 005705 478 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 478 ~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----------~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 545 (682)
..+.|++|.+..++. .-|+.+|||.+.+. .+...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 567777777776643 45899999998643 123457799999999999 799999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||++|++|.++|. +...++.. +|+.||+.||+|||+++ ||||||||+|||+++++++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999994 33456654 48899999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~ 673 (682)
.. ......+||+.|||||++.+. +..++|+||+|++++++.++..
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 32 234457899999999988764 5678999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-26 Score=255.45 Aligned_cols=186 Identities=18% Similarity=0.185 Sum_probs=147.7
Q ss_pred ccccccccCCceeEEEEEEcCCceEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--------~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
...++||+|+||.||+++. .++.+++|+...... ...++|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3356899999999999944 678899998643221 1245689999999999999999776666777888999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 4689999999999999998 999999999999999 999999999998754
Q ss_pred Ccccc-----ccccccccccccCcccccC--CCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 626 DELQG-----NTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 626 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
..... ......||+.|||||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32111 1235689999999999987 668888999999999999998888774
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=180.33 Aligned_cols=105 Identities=16% Similarity=0.359 Sum_probs=94.2
Q ss_pred cccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCC
Q 005705 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (682)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (682)
.|+|.+||.|.+||+|.| |.|.|.|+.+|+ +.++. ..++||+|||+.|... .+.|+|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCC
Confidence 378999999999999988 789999999887 77776 5689999999999866 689999999999999999
Q ss_pred CCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
+.+||+|++.+....+.|+|+||||||||+. .||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 9999999987766778899999999999974 49998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=209.67 Aligned_cols=166 Identities=17% Similarity=0.137 Sum_probs=130.4
Q ss_pred hhHHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccCh------------------hhHHHHHHHHHHHHhc
Q 005705 463 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKL 524 (682)
Q Consensus 463 ~~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~------------------~~~~~f~~E~~~l~~l 524 (682)
+..+......|.+.+.||+|+||.||+|+..+|+.||||.++.... .....+.+|+.++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344555667888899999999999999997799999999964321 1356789999999999
Q ss_pred CCCCeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCE
Q 005705 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (682)
Q Consensus 525 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 604 (682)
+| +++.+++.. +..++||||+++++|.+ +.. .....++.||+.||+|||+.+ |+||||||+||
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 94 555554433 45699999999999987 411 224479999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccC----------CCCCccccHHHH
Q 005705 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD----------GLFSIKSDVFSF 661 (682)
Q Consensus 605 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~s~k~DVwSl 661 (682)
|++ ++.+||+|||+++. +..++|||++.+ ..+...+|+|.+
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999 99999999999864 235788998754 445667787764
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.1e-22 Score=171.90 Aligned_cols=110 Identities=25% Similarity=0.432 Sum_probs=96.3
Q ss_pred cccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCC
Q 005705 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (682)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (682)
+|+|.+||+|.+|++|+ ++|.|.|+|+.+|+ + ++|+ .+++||.+|++.|. .++.|.|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECCC
Confidence 48999999999999999 99999999998875 3 5665 47999999998763 3688999999999999999
Q ss_pred CCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCCCc
Q 005705 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPT 153 (682)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~Pt 153 (682)
+.++|+|++....+...++|+|+|||||++. ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 9999999987666677899999999999963 5999999983
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=173.37 Aligned_cols=108 Identities=19% Similarity=0.372 Sum_probs=95.3
Q ss_pred cccccccCCCccCCCCeEe--eCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEE
Q 005705 23 LAADTVTPASFIRDGEKLV--SSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVL 100 (682)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl 100 (682)
++.|+|.+|++|.+|++|+ |++|.|+|+|+.+|+ + +||++ +++||+|||+.| +.++.|+|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 5679999999999999999 999999999999875 2 57765 799999999876 3368999999999999
Q ss_pred ecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 101 LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 101 ~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
+|.++.++|+|++....+...++|+|+|||||++. ++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~--------~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc--------cEeCC
Confidence 99999999999987665677899999999999972 59998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.6e-21 Score=167.32 Aligned_cols=110 Identities=21% Similarity=0.383 Sum_probs=94.6
Q ss_pred cccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCC
Q 005705 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (682)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (682)
.|+|.+||+|.+|++|+ +|.|+|+|+.+|+ +. +|+ ..++||+||++.|. .++.|.|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCCC--CceEEEECCCCcEEEECCC
Confidence 58999999999999998 7999999988775 33 354 47999999999884 3689999999999999999
Q ss_pred CCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCCCcc
Q 005705 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTD 154 (682)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~Ptd 154 (682)
+.++|+|++....+...++|+|+|||||++. ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 9999999987555677899999999999953 59999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.84 E-value=8.5e-21 Score=166.27 Aligned_cols=110 Identities=23% Similarity=0.460 Sum_probs=93.9
Q ss_pred cccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCC
Q 005705 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (682)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (682)
+|+|.+||+|.+|++| ++|.|.|+|+.+|+ + ++|++ +++||+||++.+ ..++.|.|+.||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 58999999999885 3 35654 789999999753 336889999999999999 8
Q ss_pred CCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCCC
Q 005705 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (682)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~P 152 (682)
+.++|+|++....+...++|+++|||||++. .+.++||||+|.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~-----~~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECC-----CCceEEECCCcc
Confidence 8999999987666678899999999999974 236899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-20 Score=161.65 Aligned_cols=105 Identities=26% Similarity=0.439 Sum_probs=89.5
Q ss_pred cccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCC
Q 005705 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (682)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (682)
.++|.|||.|.+|+.|+ +|.|.|+|+.+|+ +.+ |.. .++||.+|++.+ +.++.|.|+.||||||+|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 37899999999999996 7999999998875 444 443 689999999876 33689999999999999999
Q ss_pred CCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeec
Q 005705 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (682)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsF 149 (682)
+.++|+|++.+.....+|+|+||||||||++ ++|||=
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s~ 105 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWATG 105 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeCC
Confidence 9999999987655567899999999999974 499983
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.79 E-value=2e-19 Score=156.52 Aligned_cols=106 Identities=20% Similarity=0.345 Sum_probs=88.7
Q ss_pred ccccccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEe
Q 005705 22 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLL 101 (682)
Q Consensus 22 ~~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~ 101 (682)
.+|.|+|.+||.|.+|+.|+| |.|.|.|..+|+ +.+ |.. ++||.+|++.. ..++.|.|+.||||||+
T Consensus 3 ~~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CCBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred ccccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 368899999999999999998 458888877775 555 433 58999999763 33579999999999999
Q ss_pred cCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 102 NQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 102 ~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
|.++.++|+|++.+..+.++|+|+||||||||++ .+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 9999999999986555567899999999999973 49997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.78 E-value=9.3e-19 Score=153.16 Aligned_cols=108 Identities=14% Similarity=0.285 Sum_probs=91.6
Q ss_pred cccccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEec
Q 005705 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (682)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 102 (682)
.+.|+|.+||.|.+|+.|. +|.|.|.|..+|+ +.++... ..++||.+|+..+. .++.|.|+.||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~--~g~~~L~~q~dGN-----LvL~~~~-~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLA--TRDYSLVMRDDCN-----LVLTKGS-KTNIVWESGTSGRG--QHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEETT-TTEEEEECCCTTSC--SSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeE--cCCEEEEEcCCCE-----EEEEECC-CCEEEEECCcccCC--cCEEEEEeCCCcEEEEC
Confidence 4679999999999999996 4889999988886 7775421 47899999998653 36899999999999999
Q ss_pred CCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 103 ~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
.++.++|+|++.+..+.++|+|+||||||||+. .+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~~--------~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYGP--------AVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEecC--------CEecC
Confidence 999999999987655567899999999999973 49997
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.9e-19 Score=178.63 Aligned_cols=139 Identities=16% Similarity=0.188 Sum_probs=108.0
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCce--EEEEEecccChh------------------------hHHHHHHHHHHHH
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQE--VAVKRLSNQSGQ------------------------GLKEFKNEMMLIA 522 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~--vAVK~l~~~~~~------------------------~~~~f~~E~~~l~ 522 (682)
..-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 33467889999999999999988 67888 999987543111 1236889999999
Q ss_pred hcCCCCe--eeEEEEEEecCeEEEEEEecCC-C----ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCc
Q 005705 523 KLQHRNL--VRLLGCCVEQGEKILILEYMPN-K----SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH-QYSRFRI 594 (682)
Q Consensus 523 ~l~HpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~i 594 (682)
+++|+++ ..++.. ...++||||+.+ | +|.++... .++.++..++.||+.+|.||| +.+ |
T Consensus 126 ~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred HHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 9988764 334432 356899999942 4 66665422 224466789999999999999 887 9
Q ss_pred EeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 595 IHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 595 iH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999865
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.8e-18 Score=148.12 Aligned_cols=103 Identities=21% Similarity=0.380 Sum_probs=86.9
Q ss_pred cccccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEec
Q 005705 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (682)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 102 (682)
+|.|+|.|||.|.+|+.| .+|.|.|.|..+|+ +.+ |.. +|.+|+..+ ..++.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 478999999999999999 57999999988875 444 322 699998765 236899999999999999
Q ss_pred CCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 103 ~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
.++.++|+|++.+....+.|+|+||||||||+. .+|+|
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~~--------~~W~s 103 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP--------SVFKI 103 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEECS--------EEEEE
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEec--------CEECC
Confidence 999999999987654567899999999999973 49998
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.65 E-value=3.8e-16 Score=135.99 Aligned_cols=103 Identities=17% Similarity=0.267 Sum_probs=84.1
Q ss_pred cccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCC
Q 005705 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (682)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (682)
.|+|.+||.|.+|+.| .+|.|.|.|..+|+ +.+ |.. .. ||.+|+..+. .++.|.|+.||||||++.+
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~~--~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGRG--VDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTSC--SSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccCC--cCEEEEEcCCCcEEEEeCC
Confidence 4899999999999999 47899999988876 555 332 23 9999998762 3589999999999999988
Q ss_pred CC-eEEEEeccC--CcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 105 NG-TIWSTNVSS--EVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 105 ~~-~~w~s~~~~--~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
+. ++|+|++.. .....+++|++|||||||+. .+|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~~--------~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGP--------AIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEECS--------EEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEecc--------CEEcc
Confidence 76 599999642 23467899999999999973 49998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=6.5e-17 Score=170.98 Aligned_cols=146 Identities=13% Similarity=0.145 Sum_probs=104.6
Q ss_pred hHHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccCh--------------hhHH--------HHHHHHHHH
Q 005705 464 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------------QGLK--------EFKNEMMLI 521 (682)
Q Consensus 464 ~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--------------~~~~--------~f~~E~~~l 521 (682)
..+.....-|++.++||+|+||.||+|...+|+.||||+++.... .... ....|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 333444445999999999999999999998999999998753210 0011 123566777
Q ss_pred HhcCCCCeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCC
Q 005705 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKA 601 (682)
Q Consensus 522 ~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp 601 (682)
.++.+.++.-..-+... ..+|||||+++.+|..+.. ......++.||+.+|.+||+.+ ||||||||
T Consensus 168 ~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 77755443221111112 3479999999988865431 1234568899999999999998 99999999
Q ss_pred CCEEEcCCCC----------eEEeeecccccc
Q 005705 602 SNILLDKDMN----------PKISDFGLARMF 623 (682)
Q Consensus 602 ~NILl~~~~~----------~kL~DFGla~~~ 623 (682)
.|||+++++. +.|+||+.+...
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999988763 899999987654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.39 E-value=2.8e-12 Score=112.84 Aligned_cols=59 Identities=32% Similarity=0.418 Sum_probs=50.1
Q ss_pred CceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCC
Q 005705 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (682)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~ 151 (682)
..+|.|+.||||||++. +.+||++++........++|+|+|||||++. .+.++||||..
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~-----~~~~lW~S~~~ 89 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-----ENVTVWQSPVA 89 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECSCC
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC-----CCcEEEcCCCC
Confidence 45699999999999997 8999999987655567899999999999986 34789999943
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-12 Score=133.09 Aligned_cols=114 Identities=24% Similarity=0.443 Sum_probs=88.3
Q ss_pred cccccccCCCc----cCCCCeEeeC----CCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEec
Q 005705 23 LAADTVTPASF----IRDGEKLVSS----SQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISN 94 (682)
Q Consensus 23 ~~~~~l~~g~~----l~~~~~l~s~----~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~ 94 (682)
..+|||.||+. |..|+.|.|+ .|.|.|.|...| + +.+| .+ ..+++|.+++..+- .+.|.|+.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dG---n--lvLy-~~-~~~~yW~Sgt~~~~---~~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDG---N--LVAY-GP-NGAATWNAGTQGKG---AVRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTS---C--EEEE-CT-TSSEEEECCCTTTT---CCEEEECT
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCc---e--EEEE-eC-CCeEEEECCCCCCc---cEEEEEcC
Confidence 56799999999 8889998654 355666664433 3 3333 22 36899999998762 37899999
Q ss_pred CCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCC-Ccc
Q 005705 95 NGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY-PTD 154 (682)
Q Consensus 95 ~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~-Ptd 154 (682)
||+||++|.++.++|+|++.+. ...+|+|++|||||||+. .++|||||| |+.
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGFQPTY 256 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSCCTTS
T ss_pred CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCccCCc
Confidence 9999999998899999997654 357899999999999974 469999998 544
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.7e-12 Score=113.27 Aligned_cols=64 Identities=28% Similarity=0.563 Sum_probs=52.1
Q ss_pred CCcCCCceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCCC
Q 005705 82 PISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (682)
Q Consensus 82 p~~~~~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~P 152 (682)
|+.+...+|.|+.||||||++. +.+||++++.+......|+|+++|||||++ ++ .++||||+.|
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~-----~~~W~S~~~~ 78 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GS-----RAIWASNTNR 78 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TT-----EEEEECCCCC
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CC-----EEEEECCccC
Confidence 3334467899999999999987 789999998755456789999999999998 32 6899999543
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=9.7e-13 Score=114.28 Aligned_cols=60 Identities=27% Similarity=0.464 Sum_probs=51.2
Q ss_pred CceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCCC
Q 005705 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (682)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~P 152 (682)
..+|.|+.||||||++ .+.+||++++.+......++|+++|||||++.+ +.++||||..|
T Consensus 21 ~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~t~~ 80 (110)
T 3a0c_A 21 SYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTKTNG 80 (110)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCCC
T ss_pred CEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecCCCC
Confidence 6789999999999999 589999999876555678999999999999863 47899999544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=4.5e-12 Score=128.34 Aligned_cols=146 Identities=16% Similarity=0.111 Sum_probs=115.0
Q ss_pred hhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEE
Q 005705 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 468 ~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 546 (682)
.....|.+...++.|+.+.||++.. +++.+++|+...........+.+|+.+++.+. |..+.++++++...+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446788888999999999999975 46899999987532223346889999999985 677889999998888999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 590 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------ 590 (682)
||++|.+|.+.+. +......++.+++++|+.||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999977631 11223468889999999999821
Q ss_pred --------------------CCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 591 --------------------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 591 --------------------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
+..++|+|++|.|||++.+..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766677999998754
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.29 E-value=6.8e-12 Score=109.40 Aligned_cols=63 Identities=21% Similarity=0.372 Sum_probs=52.1
Q ss_pred CCCcCCCceEEEecCCcEEEecC-CCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 81 RPISDNNAVLTISNNGNLVLLNQ-TNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 81 ~p~~~~~~~l~~~~~g~lvl~~~-~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
.|+.+....|.|+.||||||++. .+.++|++++.+......++|+++|||||++.+ +.++|||
T Consensus 19 ~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-----~~~iW~S 82 (113)
T 3mez_B 19 AQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-----LNTVFVS 82 (113)
T ss_dssp CEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEEC
T ss_pred CEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-----CCEEEEC
Confidence 34445567899999999999998 489999999876555678999999999999863 3679998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.1e-11 Score=108.70 Aligned_cols=60 Identities=33% Similarity=0.466 Sum_probs=51.2
Q ss_pred CceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCCC
Q 005705 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (682)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~P 152 (682)
...|.|+.||||||++ .+.++|++++.+...+..++|+++|||||++.+ +.++|||||+|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~~ 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACWG 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCCC
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCCC
Confidence 5679999999999998 588999999875545678999999999999863 46899999983
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=4.1e-11 Score=120.71 Aligned_cols=140 Identities=17% Similarity=0.185 Sum_probs=104.1
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~ 546 (682)
....+.+....+.|..+.||++...+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34456664444566679999998777888999997653 2245788999999886544 556888888777889999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 590 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------ 590 (682)
||++|.+|. . .. .+ ...++.++++.|+.||+..
T Consensus 95 e~i~G~~l~--~-~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--S-SH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--T-SC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--c-Cc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999884 2 10 11 1256778888888888753
Q ss_pred -------------------CCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 591 -------------------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 591 -------------------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
+..++|+|++|.|||++.+..+.|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998876677999999865
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=2e-10 Score=99.38 Aligned_cols=57 Identities=28% Similarity=0.492 Sum_probs=48.4
Q ss_pred CceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeec
Q 005705 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (682)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsF 149 (682)
...|.|+.||||||++. +.++|++++.+......++|+++|||||++.+ +.++|||.
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-----~~~~W~S~ 76 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-----NNPIWASN 76 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-----SCEEEECC
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-----CCEEEECC
Confidence 56799999999999987 78999999876545678999999999999863 36899984
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-10 Score=100.74 Aligned_cols=56 Identities=27% Similarity=0.462 Sum_probs=47.3
Q ss_pred CceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeec
Q 005705 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (682)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsF 149 (682)
+..|.|+.||||||++. .++|++++.+......++|+++|||||++.+ +.++|||-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-----~~~iW~S~ 80 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-----FKTIWSSR 80 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-----CCEEEECC
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-----CCEEEEcC
Confidence 57799999999999986 5999999876555578999999999999863 36899984
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.03 E-value=4.3e-10 Score=97.21 Aligned_cols=58 Identities=29% Similarity=0.538 Sum_probs=47.0
Q ss_pred CCcCCCceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 82 PISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 82 p~~~~~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
|+.+....|.|+.||||||+++ +|+|++.+......++|+++|||||++.+ +.++|+|
T Consensus 17 ~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-----~~~vWss 74 (109)
T 3r0e_A 17 HLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-----GSTVWKS 74 (109)
T ss_dssp EEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEEC
T ss_pred EeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-----CCEEEcC
Confidence 4444467899999999999984 79999876555678999999999999863 3678976
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.02 E-value=2.8e-10 Score=98.76 Aligned_cols=59 Identities=22% Similarity=0.339 Sum_probs=48.6
Q ss_pred CCCceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeec
Q 005705 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (682)
Q Consensus 85 ~~~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsF 149 (682)
+....|.|+.||||||++.++ +|++++.+......++|+++|||||++.++ +.++|||.
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~ 77 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYP 77 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEES
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEec
Confidence 336789999999999999876 999998765556789999999999998642 23599996
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.9e-09 Score=114.27 Aligned_cols=142 Identities=15% Similarity=0.249 Sum_probs=107.0
Q ss_pred cccccccCCceeEEEEEEcCCceEEEEEec--ccC-hhhHHHHHHHHHHHHhcC--CCCeeeEEEEEEec---CeEEEEE
Q 005705 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQS-GQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQ---GEKILIL 546 (682)
Q Consensus 475 i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~--~~~-~~~~~~f~~E~~~l~~l~--HpnIv~l~~~~~~~---~~~~lV~ 546 (682)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3568999999999998774 4678899876 322 123456788999999997 45678888888766 3578999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 590 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------ 590 (682)
||+++..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774321 123678888899999999999999731
Q ss_pred -------------------CCCcEeccCCCCCEEEcCCCC--eEEeeeccccc
Q 005705 591 -------------------RFRIIHRDLKASNILLDKDMN--PKISDFGLARM 622 (682)
Q Consensus 591 -------------------~~~iiH~Dlkp~NILl~~~~~--~kL~DFGla~~ 622 (682)
+..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=7.9e-10 Score=114.46 Aligned_cols=186 Identities=18% Similarity=0.197 Sum_probs=122.3
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCC--eeeEEEEEEecC---eEEEEEEecC
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN--LVRLLGCCVEQG---EKILILEYMP 550 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E~~~ 550 (682)
+.++.|....||+.. ..+++|..... .....+.+|+.+|+.+. +.. +.+++....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 468999999999863 57899986533 34577899999999884 333 344544433332 3478999999
Q ss_pred CCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005705 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS---------------------------------------- 590 (682)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------- 590 (682)
|.+|..... ..++..++..++.++++.++.||+..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 998865432 23677788888999999999998621
Q ss_pred ---------------CCCcEeccCCCCCEEEcC--CCCeEEeeeccccccCCCcccccccc------------ccccccc
Q 005705 591 ---------------RFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGDELQGNTKQ------------IVGTYGY 641 (682)
Q Consensus 591 ---------------~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~------------~~gt~~y 641 (682)
+..++|+|++|.||+++. +..+.|+||+.+..-........... .....+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 134799999999999998 55689999998865322100000000 0000011
Q ss_pred cC-cccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q 005705 642 MS-PEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675 (682)
Q Consensus 642 ~a-PE~~~~~~~s~k~DVwSlGvil~elltG~~pf 675 (682)
.. |+.... .....+.|+++.++|++.+|+++|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 221111 112258999999999999998765
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.87 E-value=3.1e-09 Score=91.06 Aligned_cols=56 Identities=30% Similarity=0.512 Sum_probs=46.1
Q ss_pred CceEEEecCCcEEEecCCCCeEEEEeccCCc-CCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
.-+|.|+.||||||++. +.+||++++.... ....+.|++||||||++.+ ++++|+|
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-----~~~vWss 76 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-----GRSLWAS 76 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-----CCEEEEC
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC-----cEEEEEe
Confidence 35699999999999984 6899999986543 3567899999999999874 4789987
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.61 E-value=8.8e-08 Score=95.05 Aligned_cols=106 Identities=20% Similarity=0.290 Sum_probs=78.3
Q ss_pred cccccccCCC-------ccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecC
Q 005705 23 LAADTVTPAS-------FIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNN 95 (682)
Q Consensus 23 ~~~~~l~~g~-------~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~ 95 (682)
+..|+|.+|+ .|..++.+. .|.|.|.|.+.|+ +-+|.. ..++|.++..... .++.++|+.+
T Consensus 123 ~g~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG~-----LvL~~~---~~~~W~s~~~~~~--~~~~~~L~~~ 190 (236)
T 1dlp_A 123 NGNSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFDR---DDRVWSTNTAGKG--TGCRAVLQPN 190 (236)
T ss_dssp CCCEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEEBT---TBCCSCCCCCSSC--SSCEEEEETT
T ss_pred ccceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCCc-----EEEEcC---CEeEEeCCCcCCC--CceEEEECCC
Confidence 4568889998 565565553 6899999877652 445432 3578988764332 3578999999
Q ss_pred CcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 96 GNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 96 g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
|+|++++.++.++|.+.+....+...++|.++|||+++.. .+|+|
T Consensus 191 Gnl~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~~--------~~W~s 235 (236)
T 1dlp_A 191 GRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 235 (236)
T ss_dssp TEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred CcEEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEeCC--------CCccC
Confidence 9999999888899999876544567889999999999953 48986
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.3e-06 Score=88.35 Aligned_cols=135 Identities=22% Similarity=0.209 Sum_probs=96.4
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCC---CeeeEEEEEE-ecCeEEEEEEecCCC
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCV-EQGEKILILEYMPNK 552 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~~g 552 (682)
+.++.|....||+. ++.+++|+.. .......+..|+.+|..+.+. .+.+.+.+.. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46788888899987 5788999853 234457889999999999752 3556666664 345678999999999
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------------ 590 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------------ 590 (682)
.|..... ..++..+...++.++++.|+.||+..
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8876321 12345555566666666666666432
Q ss_pred ---------------CCCcEeccCCCCCEEEcC---CCC-eEEeeeccccc
Q 005705 591 ---------------RFRIIHRDLKASNILLDK---DMN-PKISDFGLARM 622 (682)
Q Consensus 591 ---------------~~~iiH~Dlkp~NILl~~---~~~-~kL~DFGla~~ 622 (682)
+..++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999987 455 58999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.4e-06 Score=85.17 Aligned_cols=135 Identities=19% Similarity=0.189 Sum_probs=98.6
Q ss_pred ccccCCce-eEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 478 KLGEGGFG-PVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 478 ~LG~G~fG-~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
.+..|..+ .||+.... ++..+++|+-... ...++.+|...|+.+. +-.+.+++.++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44445544 68987664 4668999986533 3456888999998884 44477888888888999999999999988
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-------------------------------------------- 590 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------------- 590 (682)
.+..... ......+..++++.|+.||...
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7765221 1223456677777777777531
Q ss_pred -----------CCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 591 -----------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 591 -----------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
+..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999999887778999998865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=1.3e-06 Score=92.19 Aligned_cols=80 Identities=8% Similarity=0.016 Sum_probs=55.8
Q ss_pred cccc-ccCCceeEEEEEEc-------CCceEEEEEecccC---hhhHHHHHHHHHHHHhcC-C--CCeeeEEEEEEec--
Q 005705 476 QCKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQ-H--RNLVRLLGCCVEQ-- 539 (682)
Q Consensus 476 ~~~L-G~G~fG~Vyk~~~~-------~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~-H--pnIv~l~~~~~~~-- 539 (682)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88989999998764 26788999865432 101245677888888874 2 3567788776654
Q ss_pred -CeEEEEEEecCCCChh
Q 005705 540 -GEKILILEYMPNKSLN 555 (682)
Q Consensus 540 -~~~~lV~E~~~~gsL~ 555 (682)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=3.5e-05 Score=80.27 Aligned_cols=141 Identities=15% Similarity=0.152 Sum_probs=79.9
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcC-----CCCeeeEE-E--EEEecCeEEEEEEe
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HRNLVRLL-G--CCVEQGEKILILEY 548 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----HpnIv~l~-~--~~~~~~~~~lV~E~ 548 (682)
+.|+.|..+.||+....+| .+++|+.... . .++..|+.++..+. .|.++... + +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987544 5899998752 1 33344555555442 24444310 0 12345678999999
Q ss_pred cCCCChh-----------HH---hhhccc-c----------CCCCHHHH-------------------------------
Q 005705 549 MPNKSLN-----------VF---LFDSTK-K----------RLLNWQAR------------------------------- 572 (682)
Q Consensus 549 ~~~gsL~-----------~~---l~~~~~-~----------~~l~~~~~------------------------------- 572 (682)
++|..+. .. ++.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 01 111000 0 01122211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 573 VRIIEGIAQGLLYLHQ----------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 573 ~~i~~qi~~~L~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
..+..++.+++++|++ ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112224445666663 1234599999999999998888999999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=2.5e-05 Score=83.55 Aligned_cols=75 Identities=9% Similarity=0.156 Sum_probs=49.9
Q ss_pred ccccccCCceeEEEEEEc-CCceEEEEEecccCh-------hhHHHHHHHHHHHHhcCC--CC-eeeEEEEEEecCeEEE
Q 005705 476 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------QGLKEFKNEMMLIAKLQH--RN-LVRLLGCCVEQGEKIL 544 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-------~~~~~f~~E~~~l~~l~H--pn-Iv~l~~~~~~~~~~~l 544 (682)
.+.||.|..+.||++... +++.++||....... ...+++..|..++..+.+ |. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 467899998653211 123456788888888742 33 3455543 4455689
Q ss_pred EEEecCCC
Q 005705 545 ILEYMPNK 552 (682)
Q Consensus 545 V~E~~~~g 552 (682)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.89 E-value=4.4e-05 Score=77.82 Aligned_cols=80 Identities=16% Similarity=0.259 Sum_probs=59.6
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCC---CCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H---pnIv~l~~~~~~~~~~~lV~E 547 (682)
....-.+.+|.|..+.||+.+..+|+.++||+...........|..|+..|+.|.. -.+.+++++ . ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 45566678999999999999999999999999765544444568899999998842 234455543 2 3478999
Q ss_pred ecCCCCh
Q 005705 548 YMPNKSL 554 (682)
Q Consensus 548 ~~~~gsL 554 (682)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00035 Score=71.89 Aligned_cols=138 Identities=22% Similarity=0.134 Sum_probs=92.0
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEecCeEEEEEEecCCC
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILILEYMPNK 552 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~g 552 (682)
.+.|+.|....+|+... +++.+++|+.... ....|..|+..|+.|. ...+.+++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46799999999999875 5678899987543 3567888999988884 356888888888778899999999988
Q ss_pred Chh--------HH---hhhccc-c------------------CCCCHHHHH---HHHH----------------HHHHH-
Q 005705 553 SLN--------VF---LFDSTK-K------------------RLLNWQARV---RIIE----------------GIAQG- 582 (682)
Q Consensus 553 sL~--------~~---l~~~~~-~------------------~~l~~~~~~---~i~~----------------qi~~~- 582 (682)
.+. .. |+.... . -.-+|.... ++.. +++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 642 11 121111 0 012444321 1111 11111
Q ss_pred HHHHHh-cCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 583 LLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 583 L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
...|.. ..++.++|+|+.+.|++++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223322 2345699999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00023 Score=76.67 Aligned_cols=73 Identities=11% Similarity=0.151 Sum_probs=45.9
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEeccc----C---h--hhHHHHHHHHHHHHh-cCCCCeeeEEEEEEecCeEEEE
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----S---G--QGLKEFKNEMMLIAK-LQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~----~---~--~~~~~f~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~lV 545 (682)
.+.||.|....||++.. +++.++||..... . + .....+..|+..+.. .....+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46799999999999964 5678999943211 0 0 123344455444332 2234566666654 5667899
Q ss_pred EEec-CC
Q 005705 546 LEYM-PN 551 (682)
Q Consensus 546 ~E~~-~~ 551 (682)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0006 Score=69.75 Aligned_cols=71 Identities=8% Similarity=0.163 Sum_probs=44.8
Q ss_pred ccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEecCeEEEEEEec-CCCC
Q 005705 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYM-PNKS 553 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~~gs 553 (682)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+...++ .+++.+ +.+..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 468888999999998 678999886542221 123467777777643233 345543 344457899999 6655
Q ss_pred h
Q 005705 554 L 554 (682)
Q Consensus 554 L 554 (682)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0017 Score=66.84 Aligned_cols=158 Identities=14% Similarity=0.143 Sum_probs=84.9
Q ss_pred chhHHHhhhcCccc-----ccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEE
Q 005705 462 SLASITAATENFSM-----QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLG 534 (682)
Q Consensus 462 ~~~~~~~~~~~y~i-----~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~~ 534 (682)
+...+....+.|.+ .+.|+.|....+|+....++ .+++|...... ..+++..|+.++..+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444543 34677788889999987555 78899886521 1234556777776663212 223331
Q ss_pred E------EEecCeEEEEEEecCCCChhH----H----------hhhcccc------CCC---CHHHHHH-----------
Q 005705 535 C------CVEQGEKILILEYMPNKSLNV----F----------LFDSTKK------RLL---NWQARVR----------- 574 (682)
Q Consensus 535 ~------~~~~~~~~lV~E~~~~gsL~~----~----------l~~~~~~------~~l---~~~~~~~----------- 574 (682)
. ....+..+++|+|++|..+.. . ++..... ... .|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 123456789999999865321 0 1110000 001 1221100
Q ss_pred -HHHHHHHHHHHHHhc----CCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 575 -IIEGIAQGLLYLHQY----SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 575 -i~~qi~~~L~yLH~~----~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
+...+.+.++.+++. .+..++|+|+++.|||++.+..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001134445555532 123589999999999999876668999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0019 Score=67.02 Aligned_cols=141 Identities=13% Similarity=0.136 Sum_probs=71.5
Q ss_pred cccccCCcee-EEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEecCeEEEEEEecCCCC
Q 005705 477 CKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNKS 553 (682)
Q Consensus 477 ~~LG~G~fG~-Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gs 553 (682)
+.|+.|.... +|+....+++.+++|....... .++..|+.++..+.. -.+.+++.+..+. .+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 3565554443 6677654467788876543321 233455666666532 2345666653333 378999998766
Q ss_pred hhHHhhhcc---------------------c--cCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 005705 554 LNVFLFDST---------------------K--KRLLNWQARV-------R-------------IIEGIAQGLLYLH--- 587 (682)
Q Consensus 554 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~qi~~~L~yLH--- 587 (682)
+.+.+.... . ....+..... . ....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654331100 0 0111111100 0 0011112222221
Q ss_pred hcCCCCcEeccCCCCCEEEcCC----CCeEEeeeccccc
Q 005705 588 QYSRFRIIHRDLKASNILLDKD----MNPKISDFGLARM 622 (682)
Q Consensus 588 ~~~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~ 622 (682)
...+..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999875 6799999998865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00074 Score=72.86 Aligned_cols=72 Identities=22% Similarity=0.342 Sum_probs=49.0
Q ss_pred cccccCCceeEEEEEEcC--------CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEecCeEEEEEE
Q 005705 477 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILE 547 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E 547 (682)
+.|+.|....+|+....+ ++.+++|+..... ..+.+..|..++..+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 578888889999998753 4789999884421 12455678888888853333 45666543 2 38999
Q ss_pred ecCCCCh
Q 005705 548 YMPNKSL 554 (682)
Q Consensus 548 ~~~~gsL 554 (682)
|+++..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0015 Score=69.04 Aligned_cols=141 Identities=20% Similarity=0.263 Sum_probs=83.0
Q ss_pred cccccCCceeEEEEEEcC--------CceEEEEEecccChhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEecCeEEEEEE
Q 005705 477 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~E 547 (682)
+.|..|-...+|+....+ ++.+++|+..... .......+|..+++.+...+ ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 467778888899987642 4689999864322 23456678999988885222 3456655432 28999
Q ss_pred ecCCCChhHH--------------h---hhc--cccCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 005705 548 YMPNKSLNVF--------------L---FDS--TKKRLLN--WQARVRIIEGIAQ-------------------GLLYL- 586 (682)
Q Consensus 548 ~~~~gsL~~~--------------l---~~~--~~~~~l~--~~~~~~i~~qi~~-------------------~L~yL- 586 (682)
|++|..|..- | +.. ...+... +.++.++..++.. .++.|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 0 110 0111122 4555555544422 22333
Q ss_pred ---Hhc-CCCCcEeccCCCCCEEEcCC----CCeEEeeeccccc
Q 005705 587 ---HQY-SRFRIIHRDLKASNILLDKD----MNPKISDFGLARM 622 (682)
Q Consensus 587 ---H~~-~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~ 622 (682)
... .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 22458999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0041 Score=64.15 Aligned_cols=142 Identities=14% Similarity=0.144 Sum_probs=81.1
Q ss_pred cccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCC--CCeeeEEEE-----EEecCeEEEEEEec
Q 005705 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGC-----CVEQGEKILILEYM 549 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~~~-----~~~~~~~~lV~E~~ 549 (682)
+.|+ |....||+....+|+.+++|...... .....+..|..++..+.. -.+.+++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 77788999877677789999986331 133566678887777742 123444432 12345668899999
Q ss_pred CCCChh-----HH---------hhhcc------ccCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 005705 550 PNKSLN-----VF---------LFDST------KKRLLNWQAR----VRI---------------IEGIAQGLLYLHQY- 589 (682)
Q Consensus 550 ~~gsL~-----~~---------l~~~~------~~~~l~~~~~----~~i---------------~~qi~~~L~yLH~~- 589 (682)
+|..+. .. ++... .....++... ..+ ...+.+.++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 886532 11 11100 0111222111 001 11111222333221
Q ss_pred ---CCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 590 ---SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 590 ---~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 233589999999999999 4 899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0031 Score=68.39 Aligned_cols=73 Identities=12% Similarity=0.114 Sum_probs=47.9
Q ss_pred cccccCCceeEEEEEEcC-CceEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEecCeEEEEEEecCCCCh
Q 005705 477 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
+.|+.|-...+|+....+ +..+++|+.........+ -.+|..++..|...++ .++++.+ .+ .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 578888889999998755 478889987543322211 2578888888865554 4566655 22 259999997654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0022 Score=67.53 Aligned_cols=73 Identities=12% Similarity=0.090 Sum_probs=43.9
Q ss_pred cccccCCceeEEEEEEcC---------CceEEEEEecccChhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEecCeEEEEE
Q 005705 477 CKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~---------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~ 546 (682)
+.|+.|..-.+|+....+ ++.+++|+........ .+...|..++..+...+ ..++++.. . .++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567888888999998754 2678888875433221 12356777777775333 34555443 2 36899
Q ss_pred EecCCCCh
Q 005705 547 EYMPNKSL 554 (682)
Q Consensus 547 E~~~~gsL 554 (682)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0095 Score=61.92 Aligned_cols=31 Identities=23% Similarity=0.444 Sum_probs=27.6
Q ss_pred CCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 592 FRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 592 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.056 Score=57.79 Aligned_cols=141 Identities=15% Similarity=0.184 Sum_probs=83.8
Q ss_pred ccccccCCceeEEEEEEcC--------CceEEEEEecccChhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEecCeEEEEE
Q 005705 476 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~ 546 (682)
.+.|..|-...+|+....+ ++.+++|+......... +-.+|..+++.+...+ ..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3577778888999998753 57899998755432221 2356788887774222 34455432 2 37899
Q ss_pred EecCCCChhH-------H-------h---hh--c-----c---ccCCCCHHHHHHHHHHHH-------------------
Q 005705 547 EYMPNKSLNV-------F-------L---FD--S-----T---KKRLLNWQARVRIIEGIA------------------- 580 (682)
Q Consensus 547 E~~~~gsL~~-------~-------l---~~--~-----~---~~~~l~~~~~~~i~~qi~------------------- 580 (682)
||+++..|.. . | +. . . ...+..+.++.++..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876421 0 0 10 0 0 111122444444443321
Q ss_pred HHHHHHHh---------------------cCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 581 QGLLYLHQ---------------------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 581 ~~L~yLH~---------------------~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
..++.|.+ ..+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22233321 11235899999999999 8888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.13 E-value=0.2 Score=53.06 Aligned_cols=29 Identities=28% Similarity=0.438 Sum_probs=25.1
Q ss_pred cEeccCCCCCEEE------cCCCCeEEeeeccccc
Q 005705 594 IIHRDLKASNILL------DKDMNPKISDFGLARM 622 (682)
Q Consensus 594 iiH~Dlkp~NILl------~~~~~~kL~DFGla~~ 622 (682)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.12 E-value=0.35 Score=46.19 Aligned_cols=98 Identities=15% Similarity=0.070 Sum_probs=63.7
Q ss_pred ChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcccccc
Q 005705 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632 (682)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (682)
+|.++|.. .+.++++++++.++.|.+.+|.-+-... .+ ..+=+-|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 78888843 5678999999999999999987762211 01 1223347899999999988764 1110
Q ss_pred ccccccccccCcccccCCCCCccccHHHHHHHHHHHHc
Q 005705 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670 (682)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt 670 (682)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123567888653 445678889999999998775
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.65 E-value=0.21 Score=34.20 Aligned_cols=24 Identities=29% Similarity=0.373 Sum_probs=10.0
Q ss_pred hhhHHHHHHHHHHHHhhhheehhh
Q 005705 387 WILVILVIPVVLLPSFYVFYRRRR 410 (682)
Q Consensus 387 ~i~~~~~i~vvl~~~~~~~~rr~r 410 (682)
.+++++++++++.+++++++||||
T Consensus 16 ~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 16 SAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhheehhh
Confidence 334443333333344444555443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.87 E-value=0.26 Score=33.86 Aligned_cols=16 Identities=31% Similarity=0.461 Sum_probs=7.2
Q ss_pred HHHHHHhhhheehhhc
Q 005705 396 VVLLPSFYVFYRRRRK 411 (682)
Q Consensus 396 vvl~~~~~~~~rr~rk 411 (682)
+++++++++++|||++
T Consensus 25 ~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 25 LVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHTTTC
T ss_pred HHHHHHHHHHhhhhHh
Confidence 3344444455555443
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=88.57 E-value=2 Score=42.48 Aligned_cols=66 Identities=12% Similarity=0.287 Sum_probs=42.1
Q ss_pred CCeEEEecCCCCC--CcC----CCceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecC
Q 005705 70 PDAVVWVANRDRP--ISD----NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDN 135 (682)
Q Consensus 70 ~~~~vW~an~~~p--~~~----~~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~ 135 (682)
..+++|...+..+ +.+ +++.+-++.++.+..+|++|..+|.-.+........+..+.+||+++-+.
T Consensus 24 tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 24 TKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp TTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred CCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 5678888876542 111 23344445555566678889999998864222233567788999988764
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.39 E-value=0.28 Score=33.69 Aligned_cols=15 Identities=27% Similarity=0.483 Sum_probs=6.5
Q ss_pred HHHHHhhhheehhhc
Q 005705 397 VLLPSFYVFYRRRRK 411 (682)
Q Consensus 397 vl~~~~~~~~rr~rk 411 (682)
++++++++++||||+
T Consensus 25 ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 25 IVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHTTCS
T ss_pred HHHHHHHHHhhhhhh
Confidence 333344445555433
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=84.40 E-value=0.83 Score=36.10 Aligned_cols=36 Identities=25% Similarity=0.534 Sum_probs=30.0
Q ss_pred cccChHHHHHHhhcCCceEeEeeccccCCcceeecccc
Q 005705 318 QRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGD 355 (682)
Q Consensus 318 ~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~C~~w~~~ 355 (682)
...++++|++.|+.+=.|.||.|.. ....|++..+.
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~--~s~~CflKs~~ 63 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNV--KSGLCYPKRGK 63 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEET--TTTEEEEEESS
T ss_pred cCCCHHHHHHHhhccCCCCeEEecc--CCCceEcccCC
Confidence 3468999999999999999999963 45789988754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.03 E-value=0.2 Score=54.20 Aligned_cols=61 Identities=11% Similarity=0.106 Sum_probs=18.7
Q ss_pred ccccccccCCceeEEEEEEcC-CceEEE------EEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 005705 474 SMQCKLGEGGFGPVYKGRLLN-GQEVAV------KRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537 (682)
Q Consensus 474 ~i~~~LG~G~fG~Vyk~~~~~-g~~vAV------K~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~ 537 (682)
.+.+.|| ||.||+|.+.. ..+||| |..+.. ..+....|.+|..++..++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456777 99999998854 368888 766542 2234457888999999999999999988765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.02 E-value=2.4 Score=40.24 Aligned_cols=84 Identities=10% Similarity=0.031 Sum_probs=59.2
Q ss_pred CCCCeeeEEEEEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCE
Q 005705 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (682)
Q Consensus 525 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 604 (682)
.||++++. .+-.+++...+.++-- .....+- .-+.++...+++++.+|+....+++. -+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 68988876 4555555555554443 3222221 12347888999999999998866653 47888999999
Q ss_pred EEcCCCCeEEeeeccc
Q 005705 605 LLDKDMNPKISDFGLA 620 (682)
Q Consensus 605 Ll~~~~~~kL~DFGla 620 (682)
+++.++.++++=.|+-
T Consensus 111 ~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp EECTTSCEEESCCEET
T ss_pred EEcCCCCEEEEEccCc
Confidence 9999999999877764
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=81.67 E-value=8.1 Score=38.02 Aligned_cols=44 Identities=9% Similarity=0.132 Sum_probs=30.7
Q ss_pred EEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCC
Q 005705 91 TISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136 (682)
Q Consensus 91 ~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~ 136 (682)
....+|.++.+|.+|..+|.-..... ...+..+.+||+++.+..
T Consensus 141 ~~~~~~~v~~~d~~G~~~w~~~~~~~--~~~~~~~~~g~~~v~~~~ 184 (276)
T 3no2_A 141 PLFATSEVREIAPNGQLLNSVKLSGT--PFSSAFLDNGDCLVACGD 184 (276)
T ss_dssp EETTTTEEEEECTTSCEEEEEECSSC--CCEEEECTTSCEEEECBT
T ss_pred EecCCCEEEEECCCCCEEEEEECCCC--ccceeEcCCCCEEEEeCC
Confidence 33456778888999999999886432 223456778888886543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 682 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-61 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-22 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-05 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 9e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-10 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-14 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-09 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-61
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQH 526
++F +LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V G GE + +E+M SL+ L K + Q ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
+ +I+HRD+K SNIL++ K+ DFG++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+S++SD++S G+ ++E +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-61
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
++ ++G G FG VYKG+ V + ++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+G + ++ ++ SL L + + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-- 648
IIHRDLK++NI L +D+ KI DFGLA + +Q+ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 649 -DGLFSIKSDVFSFGILMLETLSSKK 673
+S +SDV++FGI++ E ++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 9e-59
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C+EQ L+ E+M + L + T++ L + + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
+IHRDL A N L+ ++ K+SDFG+ R D+ ++ + SPE
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 651 LFSIKSDVFSFGILMLETLSSKK 673
+S KSDV+SFG+LM E S K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 9e-58
Identities = 71/203 (34%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL Q +I EYM N SL FL + +L + + IA+G+ ++ + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
IHRDL+A+NIL+ ++ KI+DFGLAR+ +E + +PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 651 LFSIKSDVFSFGILMLETLSSKK 673
F+IKSDV+SFGIL+ E ++ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ + + +LG+G FG VYK + A K + +S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+LL + +++E+ +++ + + +R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+IIHRDLKA NIL D + K++DFG++ + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 649 -----DGLFSIKSDVFSFGILMLETLSSK 672
D + K+DV+S GI ++E +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 6e-56
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 527
E++ + +G G +G K R +G+ + K L + + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 528 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQGLL 584
N+VR +++ L ++EY L + TK+R L+ + +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 585 YLHQYSR--FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
H+ S ++HRDLK +N+ LD N K+ DFGLAR+ D K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE 667
SPE ++ KSD++S G L+ E
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYE 206
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 2e-55
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 7/203 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C +Q +I EYM N L + + Q + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
+ +HRDL A N L++ K+SDFGL+R DE + + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 651 LFSIKSDVFSFGILMLETLSSKK 673
FS KSD+++FG+LM E S K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 2e-55
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 531 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LLG VE+ + ++ EYM SL +L + +L ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+HRDL A N+L+ +D K+SDFGL + E + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 650 GLFSIKSDVFSFGILMLETLSSKK 673
FS KSDV+SFGIL+ E S +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-55
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L + ++ EYM SL FL T K L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
+HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 651 LFSIKSDVFSFGILMLETLSSKK 673
F+IKSDV+SFGIL+ E + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR 212
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-55
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 9/205 (4%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 528
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+ G E + L LEY L + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 649 DGLF-SIKSDVFSFGILMLETLSSK 672
F + DV+S GI++ L+ +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 6e-55
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 525
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N ++ GC + + L++EY + ++ K+ L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH + +IHRD+KA NILL + K+ DFG A + VGT +M+PE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 646 YAL---DGLFSIKSDVFSFGILMLETLSSK 672
L +G + K DV+S GI +E K
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 10/212 (4%)
Query: 462 SLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMML 520
S+ S+ + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 580
+ + ++ N+V L + E +++EY+ S L D + ++ +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+M+PE + K D++S GI+ +E + +
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-53
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 469 ATENFSMQ-CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 523
+N + +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L + +VRL+G C + +L++E L+ FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-QIVGTYGYM 642
YL + +HRDL A N+LL KISDFGL++ G D+ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+PE FS +SDV+S+G+ M E LS +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 3e-53
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
++G G F VYKG EVA L ++ + + FK E ++ LQH N+VR
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 535 CCVEQGEK----ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+ +L+ E M + +L +L + +++ + I +GL +LH +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 591 RFRIIHRDLKASNILL-DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
IIHRDLK NI + + KI D GLA + K ++GT +M+PE +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186
Query: 650 GLFSIKSDVFSFGILMLETLSSKK 673
+ DV++FG+ MLE +S+
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (462), Expect = 8e-53
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 22/230 (9%)
Query: 461 FSLASITAATENFS---------MQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQ 506
F+ A F+ ++ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 507 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL 566
+ + ++F +E ++ + H N++ L G + ++I E+M N SL+ FL + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 567 LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626
V ++ GIA G+ YL +HRDL A NIL++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 627 ELQGNTKQIVG---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+G + +PE F+ SDV+S+GI+M E +S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 8e-53
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQH 526
E+F + LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
N++RL G + LILEY P ++ L K + Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+ K D++S G+L E L K
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (460), Expect = 1e-52
Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V+LLG C + +I E+M +L +L + ++ ++ + + I+ + YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 134
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
IHRDL A N L+ ++ K++DFGL+R+ GD + + +PE
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 650 GLFSIKSDVFSFGILMLETLSSKK 673
FSIKSDV++FG+L+ E +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-52
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
+G+G FG V++G+ G+EVAVK S++ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 538 EQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ----- 588
+ L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEY 646
+ I HRDLK+ NIL+ K+ I+D GLA D + VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 647 ALDGL------FSIKSDVFSFGILMLETLSSKKNTG 676
D + ++D+++ G++ E G
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 478 KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRL 532
+LG G FG V KG + VAVK L N++ E E ++ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+G C E +L++E LN +L + R + + + ++ ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-QIVGTYGYMSPEYALDGL 651
+HRDL A N+LL KISDFGL++ DE + + +PE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 652 FSIKSDVFSFGILMLETLSSKK 673
FS KSDV+SFG+LM E S +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 1e-51
Identities = 62/240 (25%), Positives = 103/240 (42%), Gaps = 31/240 (12%)
Query: 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-KEF 514
L S+ N +GEG FG V++ R VAVK L ++ + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 515 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------- 566
+ E L+A+ + N+V+LLG C L+ EYM LN FL + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 567 -------------LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613
L+ ++ I +A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
I+DFGL+R + +M PE ++ +SDV+++G+++ E S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 6e-51
Identities = 65/231 (28%), Positives = 97/231 (41%), Gaps = 31/231 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 523
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK------------------ 564
L H N+V LLG C G LI EY L +L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 565 --RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622
+L ++ + +A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
D +M+PE +G+++IKSDV+S+GIL+ E S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-50
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 478 KLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 532
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 533 LGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
LG C+ +G +++L YM + L F + + + +A+G+ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDL--RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ--IVGTYGYMSPEYALD 649
+ +HRDL A N +LD+ K++DFGLAR E + +M+ E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 650 GLFSIKSDVFSFGILMLETLSSKK 673
F+ KSDV+SFG+L+ E ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-50
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
V+L + + L Y N L + R A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTR----FYTAEIVSAL 121
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
IIHRDLK NILL++DM+ +I+DFG A++ + Q VGT Y+SPE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+ SD+++ G ++ + ++
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-49
Identities = 62/226 (27%), Positives = 91/226 (40%), Gaps = 26/226 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 523
S LG G FG V + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL---------------L 567
L H N+V LLG C G ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+ + + +A+G+ +L IHRDL A NILL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+M+PE + +++ +SDV+S+GI + E S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-49
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-NQSGQGLKEFKNEMMLIAKL 524
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
+ ++ RLLG C+ LI + MP L + K + Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YL R++HRDL A N+L+ + KI+DFGLA++ G +E + + + +M+
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 645 EYALDGLFSIKSDVFSFGILMLETLSSKK 673
E L +++ +SDV+S+G+ + E ++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (438), Expect = 7e-49
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 11/205 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+++ + +LG G FG V++ G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V L + E ++I E+M L + D + ++ V + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 590 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+H DLK NI+ + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 648 LDGLFSIKSDVFSFGILMLETLSSK 672
+D++S G+L LS
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-48
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-Q 525
+ Q +GEG FG V K R+ + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQAR 572
H N++ LLG C +G L +EY P+ +L FL ++ L+ Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632
+ +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+M+ E +++ SDV+S+G+L+ E +S
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-48
Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 14/211 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAK 523
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L HRNL+RL G ++ E P SL + R +A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYM 642
YL R IHRDL A N+LL KI DFGL R ++ + + +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+PE FS SD + FG+ + E + +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSGQG-LKEFKNEMMLIAKL 524
+ Q +G G FG VYKG L VA+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H N++RL G + ++I EYM N +L+ FL + K + V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMS 643
YL +HRDL A NIL++ ++ K+SDFGL+R+ D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSKK 673
PE F+ SDV+SFGI+M E ++ +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE 211
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (426), Expect = 4e-47
Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+ + + +LG G FG V++ G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+ L ++ E +LILE++ L F + + ++ + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 590 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
I+H D+K NI+ + KI DFGLA DE+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 648 LDGLFSIKSDVFSFGILMLETLSSK 672
+D+++ G+L LS
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-46
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 525
E + +GEG FG V++G ++ VA+K N + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H ++V+L+G E +I+E L F +K L+ + + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
L R +HRD+ A N+L+ + K+ DFGL+R + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKK 673
F+ SDV+ FG+ M E L
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 5e-45
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 523
E +M +LG+G FG VY+G VA+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRII 576
++VRLLG + ++I+E M L +L + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636
IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+MSPE DG+F+ SDV+SFG+++ E + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-44
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 521
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 522 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLL 567
+ +H+N++ LLG C + G +I+EY +L +L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+ + V +A+G+ YL + IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
T +M+PE D +++ +SDV+SFG+L+ E +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-44
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 522
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 523 KLQHRNLVRLLGCCVEQGEKILIL-EYMPNKSLNVFLF-------------DSTKKRLLN 568
H N+V LLG C + G ++++ E+ +L+ +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628
+ + +A+G+ +L + IHRDL A NILL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 7/207 (3%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 527
++ +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N++ + + + Y+ + L+ K + L+ + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEY 646
++HRDLK SN+LL+ + KI DFGLAR+ D + V T Y +PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 647 ALDGLFSIKS-DVFSFGILMLETLSSK 672
L+ KS D++S G ++ E LS++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (396), Expect = 2e-43
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
++F + LG G FG V+ R NG+ A+K L + + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++R+ G + + +I++Y+ L F +R N A+ A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYA----AEVCLAL 117
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
II+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKK 673
++ D +SFGIL+ E L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (399), Expect = 3e-43
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNE---MMLIAK 523
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
+V + + IL+ M L+ L + + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 644 PEYALDGL-FSIKSDVFSFGILMLETLSSK 672
PE G+ + +D FS G ++ + L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 12/205 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E + + LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+ L E ++I E++ + + +T LN + V + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 590 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
I H D++ NI+ + KI +FG AR + N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 648 LDGLFSIKSDVFSFGILMLETLSSK 672
+ S +D++S G L+ LS
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (390), Expect = 5e-43
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 15/212 (7%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQ 525
++ + + LG GG V+ R L ++VAVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 526 HRNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
H +V + + +++EY+ +L + + + + + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDELQGNTKQIVGTYG 640
L + H + IIHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
Y+SPE A +SDV+S G ++ E L+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 7e-43
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 8/205 (3%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 527
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V L G LI++ + L + +K + R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ LD+D ISDFGL++M + GT GY++PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 648 LDGLFSIKSDVFSFGILMLETLSSK 672
+S D +S G++ L
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 13/207 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 525
E+F + LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H L + + ++EY+ L + + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH I++RDLK NILLDKD + KI+DFG+ + + + NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
L ++ D +SFG+L+ E L +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (384), Expect = 4e-42
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL---------KEFKNEMML 520
EN+ + LG G V + +E AVK + G + E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 521 IAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
+ K+ H N+++L L+ + M L +L T+K L+ + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
+ + LH + I+HRDLK NILLD DMN K++DFG + E +++ GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 640 GYMSPEYALDGL------FSIKSDVFSFGILMLETLSSK 672
Y++PE + + + D++S G++M L+
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 527
ENF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+LL + + L+ E++ D++ + + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-Y 646
+ R++HRDLK N+L++ + K++DFGLAR FG V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+S D++S G + E ++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (369), Expect = 5e-40
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E + K+GEG +G VYK + G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+L + +L+ E++ + + L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R++HRDLK N+L++++ KI+DFGLAR FG + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLM 173
Query: 649 -DGLFSIKSDVFSFGILMLETLSSK 672
+S D++S G + E ++
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-40
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 478 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQHRNLVR 531
LGEG F VYK R N Q VA+K++ K+ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
LL + L+ ++M + +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-G 650
I+HRDLK +N+LLD++ K++DFGLA+ FG V T Y +PE
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176
Query: 651 LFSIKSDVFSFGILMLETLSSK 672
++ + D+++ G ++ E L
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV 198
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 6e-40
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+++ +G G FG VY+ +L +G+ VA+K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 531 RLLGCCVEQGEK------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
RL GEK L+L+Y+P V S K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 585 YLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
Y+H + I HRD+K N+LLD D K+ DFG A+ E + + + Y +
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 644 PEYALDGL-FSIKSDVFSFGILMLETLSSK 672
PE ++ DV+S G ++ E L +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 9e-40
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 16/214 (7%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQG--LKEFKNE---MMLI 521
A + + ++GEG +G V+K R L G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN---VFLFDSTKKRLLNWQARVRIIEG 578
+H N+VRL C + + ++ D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+ +GL +LH R++HRDLK NIL+ K++DFGLAR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
Y +PE L ++ D++S G + E K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (364), Expect = 3e-39
Identities = 41/213 (19%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
++ + ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+ + ++G +++ + SL L R + + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 590 SRFRIIHRDLKASNILLDKDMNP-----KISDFGLARMFGGDELQGN-----TKQIVGTY 639
+++RD+K N L+ + + + DFG+ + + + + K + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
YMS L S + D+ + G + + L
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 20/213 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLKEFKNEMMLIAK 523
+ + +LG G F V K R G + A K + S++ G ++ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
+QH N++ L + + ILILE + L +K L + ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKESLTEEEATEFLKQILNG- 125
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMFGGDELQGNTKQIVGTY 639
++ +I H DLK NI+L P KI DFGLA K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+++PE +++D++S G++ LS
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 8e-38
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 527
+ K+G+G FG V+K R GQ+VA+K++ N+ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 528 NLVRLLGCCVEQGEKI--------LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
N+V L+ C + L+ ++ + + K R+++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT--KQIVG 637
GL Y+H+ +I+HRD+KA+N+L+ +D K++DFGLAR F + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 638 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSK 672
T Y PE L + + D++ G +M E +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 9e-38
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 20/211 (9%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE------FKNEMMLIAKLQ 525
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 526 --HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
++RLL +LILE T++ L + + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ H ++HRD+K NIL+D + K+ DFG + GT Y
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176
Query: 643 SPEYAL-DGLFSIKSDVFSFGILMLETLSSK 672
PE+ + V+S GIL+ + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 1e-37
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 16/204 (7%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+G G FG +Y G + G+EVA+K ++ + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+G+ +++ + SL + R + + + + + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 597 RDLKASNIL---LDKDMNPKISDFGLARMFGGDELQGN-----TKQIVGTYGYMSPEYAL 648
RD+K N L K I DFGLA+ + + K + GT Y S L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 649 DGLFSIKSDVFSFGILMLETLSSK 672
S + D+ S G +++
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGS 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 12/206 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
L L ++EY LF + + + R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFY--GAEIVSAL 118
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
+++RD+K N++LDKD + KI+DFGL + D K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
D + D + G++M E + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-35
Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 10/206 (4%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 527
+ + K+GEG +G V+K + + VA+K RL + E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+VRL + L+ E+ F + + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
++HRDLK N+L++++ K+++FGLAR F G ++ + ++V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKK 673
L+S D++S G + E ++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-35
Identities = 41/198 (20%), Positives = 79/198 (39%), Gaps = 21/198 (10%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 536
LG G G V + ++ A+K L + + + E+ L + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 537 ----VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ ++++E + L + D + + I++ I + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHSI--- 130
Query: 593 RIIHRDLKASNILLDKDMNP---KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
I HRD+K N+L K++DFG A+ T Y++PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 650 GLFSIKSDVFSFGILMLE 667
+ D++S G++M
Sbjct: 188 EKYDKSCDMWSLGVIMYI 205
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 1e-34
Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
+ F LG G FG V + +G A+K L Q + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
LV+L + +++EY+ + L + + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H +I+RDLK N+L+D+ +++DFG A+ +G T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
L ++ D ++ G+L+ E +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 527
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 528 NLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
N++ LL + L++ +M + K L ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GL Y+H IIHRDLK N+ +++D KI DFGLAR + V T Y
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 642 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK 672
+PE L+ + ++ D++S G +M E ++ K
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLS----NQSGQGLKEFKNEMMLIA 522
ENF + LG G +G V+ R + G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 523 KLQHR-NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
++ LV L + + LIL+Y+ L L + Q + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
+L L + II+RD+K NILLD + + ++DFGL++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 642 MSPEYALDGL--FSIKSDVFSFGILMLETLSSK 672
M+P+ G D +S G+LM E L+
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (314), Expect = 3e-32
Identities = 44/208 (21%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN 528
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 529 LVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++ L + + L+ E++ N + L ++ R + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145
Query: 587 HQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
H I+HRD+K N+++D + ++ D+GLA + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 646 YALD-GLFSIKSDVFSFGILMLETLSSK 672
+D ++ D++S G ++ + K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 527
+ + +G G G V + + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 528 NLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
N++ LL Q + L++E M V + L+ + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
G+ +LH IIHRDLK SNI++ D KI DFGLAR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+PE L + D++S G +M E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 1e-29
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 526
E + +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 527 RNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
N++ LL + ++ ++ L + K + L +I I +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD----LNNIVKCQKLTDDHVQFLIYQILR 132
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GL Y+H IIHRDLK SN+ +++D KI DFGLAR V T Y
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWY 184
Query: 642 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK 672
+PE L+ + ++ D++S G +M E L+ +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 3e-28
Identities = 41/210 (19%), Positives = 84/210 (40%), Gaps = 18/210 (8%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
KLG G F V+ + ++N VA+K + + ++E+ L+ ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 537 VEQGEKIL-------------ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
K+L ++ + + L + R + +I + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 584 LYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
Y+H+ R IIH D+K N+L++ D + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSK 672
SPE L + +D++S L+ E ++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (255), Expect = 1e-25
Identities = 28/158 (17%), Positives = 57/158 (36%), Gaps = 28/158 (17%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLK--------EFKNEMMLIAKLQHR 527
+GEG V+ E VK ++ + S + +K F + A+ + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 528 NLVRLLGCCV----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L +L G V +++E + K + + + +++ I + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEV 116
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621
+ I+H DL N+L+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 90.4 bits (224), Expect = 2e-22
Identities = 22/118 (18%), Positives = 47/118 (39%), Gaps = 13/118 (11%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTIS 93
+ +GE L + Q ++ + + L + VW +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
++GN V+ + ++W+++ N V L++DGN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 38.8 bits (90), Expect = 2e-04
Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 2/78 (2%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNP-VAQLRDDGNLVIRDNSSGNAT 141
+ + + NLVL + + ++W++N K A L+ DGN V+ D +
Sbjct: 16 LDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLW 74
Query: 142 ESYLWQSFDYPTDTLLQD 159
S+ + L +D
Sbjct: 75 ASHSVRGNGNYVLVLQED 92
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 69.8 bits (170), Expect = 3e-15
Identities = 26/130 (20%), Positives = 50/130 (38%), Gaps = 18/130 (13%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
+D + + G L + + + VW + + S
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNLVLYD--------NNRAVWASGTNGKAS 50
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
VL + N+GNLV+ + + IW++N + + N L+ D N+VI DNS+ +
Sbjct: 51 --GCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 145 LWQSFDYPTD 154
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 69.3 bits (169), Expect = 4e-15
Identities = 26/126 (20%), Positives = 45/126 (35%), Gaps = 20/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + GE L + F L + D +W N
Sbjct: 2 NILYSGETLSTGEFL--NYGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ L++ +GNLV+ N +N IW++N + N V L+ D N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 146 WQSFDY 151
W + +
Sbjct: 102 WATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 40.8 bits (95), Expect = 5e-05
Identities = 18/80 (22%), Positives = 35/80 (43%), Gaps = 1/80 (1%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
++ + V + + NLVL + + IW+TN ++ ++ DGNLV+ + S+
Sbjct: 16 LNYGSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWA 74
Query: 143 SYLWQSFDYPTDTLLQDMKL 162
S L +D +
Sbjct: 75 SNTGGQNGNYVCILQKDRNV 94
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.8 bits (168), Expect = 9e-15
Identities = 16/89 (17%), Positives = 37/89 (41%), Gaps = 8/89 (8%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
D + + + + L++ + NLVL ++ + +WSTN + + A L+ +G +
Sbjct: 20 DNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRM 78
Query: 131 VIRDNSSGNATESYLWQSFD--YPTDTLL 157
+ N + +W S + +
Sbjct: 79 DVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 56.1 bits (135), Expect = 3e-10
Identities = 19/96 (19%), Positives = 34/96 (35%), Gaps = 5/96 (5%)
Query: 41 VSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVL 100
+ ++Q +L + L + + D VW N + NG + +
Sbjct: 26 LHATQSLQLSPYRLSMETDCNLVLFDR---DDRVWSTNT--AGKGTGCRAVLQPNGRMDV 80
Query: 101 LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136
L N +W++ S V L+ D NL I +
Sbjct: 81 LTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.6 bits (162), Expect = 6e-14
Identities = 19/112 (16%), Positives = 41/112 (36%), Gaps = 18/112 (16%)
Query: 40 LVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLV 99
++ + + + L + + +W N N + +G LV
Sbjct: 25 ILFGTHVYRFIMQTDCN-----LVLYD---NNNPIWATNTGGL--GNGCRAVLQPDGVLV 74
Query: 100 LLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
++ N T+W + V+ + + V L+ D N+VI ++ LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.2 bits (130), Expect = 1e-09
Identities = 26/134 (19%), Positives = 43/134 (32%), Gaps = 23/134 (17%)
Query: 12 SLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD 71
+++F LS T+ A + F S L + D
Sbjct: 2 NILFGLS-HEGSHPQTLHAAQSLELS--------SFRFTMQSDCN-----LVLFD---SD 44
Query: 72 AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLV 131
VW +N + ++G LV+L N WS+ + N V L+ D +
Sbjct: 45 VRVWASNTA---GATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVT 101
Query: 132 IRDN---SSGNATE 142
I SG + +
Sbjct: 102 IYGPGLWDSGTSNK 115
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 682 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.88 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.88 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.7 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.63 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.58 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.43 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.36 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.08 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.0 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.89 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.59 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.74 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.3 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.04 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 81.15 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 80.06 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=373.04 Aligned_cols=203 Identities=30% Similarity=0.410 Sum_probs=177.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.++||+|+||+||+|++. +|+.||||++.... .+..+++.+|+.+|++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999985 58899999986543 33456799999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++|+|.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999983 3456999999999999999999999998 99999999999999999999999999998754433
Q ss_pred ccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......+||+.|||||++.+..+ +.++|||||||+||||++|++||...+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 333455789999999999988876 578999999999999999999997654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=369.82 Aligned_cols=201 Identities=26% Similarity=0.431 Sum_probs=181.1
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|++.++||+|+||.||+|++. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999874 5899999999766555678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+....
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 999999988733 45999999999999999999999998 9999999999999999999999999999875432
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 23345689999999999999999999999999999999999999997543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=364.51 Aligned_cols=199 Identities=30% Similarity=0.431 Sum_probs=179.2
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||.||+|++. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 5889999998643 2334678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999843 346999999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......||+.|||||++.+..++.++|||||||+||||++|+.||...+
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 2345689999999999999999999999999999999999999997654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=369.84 Aligned_cols=203 Identities=29% Similarity=0.422 Sum_probs=178.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++.+.||+|+||+||+|++. +++.||||++.+. .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999984 5889999998653 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|.+++. ..+.+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999874 3456999999999999999999999998 999999999999999999999999999987544
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..........||+.|||||++.+..++.++|||||||+||||++|+.||...+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence 33334455689999999999999999999999999999999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=375.69 Aligned_cols=201 Identities=26% Similarity=0.371 Sum_probs=178.8
Q ss_pred hhcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..++|++.++||+|+||+||+|++. +|+.||||+++.. .+...+++.+|+.+|++++|||||++++++.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 5889999998654 3444678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++ + |+||||||+|||++.++++||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999853 34699999999999999999999975 6 99999999999999999999999999987532
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 22345689999999999999999999999999999999999999997654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=366.29 Aligned_cols=202 Identities=27% Similarity=0.444 Sum_probs=179.5
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
+.|++++.||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999985 58899999998776677788999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++|+|..++... ...+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 999999987542 346999999999999999999999998 999999999999999999999999999765321 1
Q ss_pred cccccccccccccCccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.......||+.|||||++. +..|+.++|||||||+||||++|+.||...+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 2233568999999999984 4568999999999999999999999997654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=363.42 Aligned_cols=203 Identities=32% Similarity=0.488 Sum_probs=170.2
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
..++|++.++||+|+||+||+|+.. ..||||+++.. .....++|.+|+.+|.+++|||||++++++.+ +..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 3567999999999999999999864 36999998643 45567899999999999999999999998754 5689999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|.+++.. .+..+++.+++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999854 2346999999999999999999999998 999999999999999999999999999877544
Q ss_pred ccccccccccccccccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..........||+.|||||++.+ ..|+.++|||||||+||||+||+.||...+
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 33334456789999999999864 358999999999999999999999997543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=362.49 Aligned_cols=208 Identities=28% Similarity=0.433 Sum_probs=169.1
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--cCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 544 (682)
.++|++.+.||+|+||.||+|+.. +|+.||||.+... .+...+.|.+|++++++++|||||++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 468999999999999999999875 5889999998654 34456779999999999999999999999865 456899
Q ss_pred EEEecCCCChhHHhhhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 545 ILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSR--FRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~--~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+++. .+||||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999985432 34579999999999999999999998752 349999999999999999999999999999
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.+.... .......||+.|||||++.+..++.++|||||||++|||+||++||...+
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 875332 22345689999999999999999999999999999999999999997654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=358.87 Aligned_cols=203 Identities=32% Similarity=0.493 Sum_probs=169.1
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.++|++.++||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||++++++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35789999999999999999999888999999997543 44578999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~- 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 156 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence 99999999854 3356899999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.......||+.|+|||++.+..++.++|||||||+||||+| |++||...+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~ 207 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC
Confidence 22334578999999999999999999999999999999999 566665443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-43 Score=360.42 Aligned_cols=205 Identities=30% Similarity=0.482 Sum_probs=179.8
Q ss_pred HhhhcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
+...++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|++++|||||++++++.+++..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 345678999999999999999999986 48899999997543 3567899999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++|+|..++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 92 ~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999999998543 3457899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
... .......|++.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 168 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 168 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp SSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 332 223345688999999999999999999999999999999997766543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=364.89 Aligned_cols=202 Identities=26% Similarity=0.344 Sum_probs=181.3
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
-++|++++.||+|+||.||+|+.. +++.||||++++. .....+.+.+|+.+|++++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999984 6899999999753 234567889999999999999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++|+|..++. +...+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999984 3456899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. ......+||+.|+|||++.+..|+.++|||||||+||||++|++||...+
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 22 23445789999999999999999999999999999999999999998765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=357.63 Aligned_cols=202 Identities=35% Similarity=0.504 Sum_probs=175.4
Q ss_pred hhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
..++|++.++||+|+||.||+|++++++.||||+++... ...++|.+|+.++++++|||||++++++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 357899999999999999999999888899999997543 345789999999999999999999998754 567899999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++|+|.+++... ....+++.++++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999987443 2345899999999999999999999998 99999999999999999999999999998754332
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCC-CCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK-NTGL 677 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~-pf~~ 677 (682)
. ......||+.|||||++.+..++.++|||||||+||||+||++ |+..
T Consensus 165 ~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred c-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 2 2334578999999999999999999999999999999999655 4544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-42 Score=361.68 Aligned_cols=198 Identities=29% Similarity=0.427 Sum_probs=178.6
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|++++.||+|+||+||+|++. +|+.||||++++. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999984 5899999999653 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999998884 3456889999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....+||+.|||||++.+..++.++|||||||+||||++|+.||...+
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 334689999999999999999999999999999999999999997654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-42 Score=364.69 Aligned_cols=202 Identities=24% Similarity=0.378 Sum_probs=181.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
-++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999874 5899999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC--CCCeEEeeeccccccCCC
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGD 626 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~ 626 (682)
+++|+|.+++.. ....+++.++..++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999998843 2346999999999999999999999998 999999999999964 578999999999887543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 2 2344689999999999999999999999999999999999999997543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=350.72 Aligned_cols=197 Identities=30% Similarity=0.455 Sum_probs=169.5
Q ss_pred cccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----cCeEEEE
Q 005705 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILI 545 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 545 (682)
|++.++||+|+||+||+|++. +++.||+|.+... .....+.|.+|+++|++++|||||++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 466678999999999999885 5789999998654 34456789999999999999999999999875 3457899
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc-CCCCeEEeeeccccccC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFG 624 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~ 624 (682)
|||+++|+|.+++.. ...+++.+++.++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999843 356999999999999999999999875 3499999999999996 57899999999998643
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.. ......||+.|||||++.+ .++.++|||||||+||||++|+.||...
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 32 2345689999999998865 5999999999999999999999999643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-42 Score=360.41 Aligned_cols=201 Identities=26% Similarity=0.367 Sum_probs=162.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
.+.|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999985 58899999996543 2334668899999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc---CCCCeEEeeeccccccC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFG 624 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kL~DFGla~~~~ 624 (682)
|+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999984 3456999999999999999999999998 99999999999995 57899999999998764
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .....+||+.|||||++.+..++.++|||||||+||||++|++||...+
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 322 2344689999999999999999999999999999999999999997543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=348.33 Aligned_cols=203 Identities=31% Similarity=0.460 Sum_probs=181.2
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.++|++.++||+|+||.||+|++++++.||||+++... ...++|++|+.++++++||||+++++++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 36899999999999999999999888899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++|+|..++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999998744 3346899999999999999999999998 999999999999999999999999999876544322
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+..+
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 2334578999999999999999999999999999999998 899998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-42 Score=359.19 Aligned_cols=205 Identities=30% Similarity=0.463 Sum_probs=166.7
Q ss_pred hcCcccccccccCCceeEEEEEEcC-C---ceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g---~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|++.++||+|+||+||+|++.. + ..||||.+... .....++|.+|+.+|++++|||||++++++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568888999999999999998753 3 25899998654 44566789999999999999999999999999999999
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++|+|.+++.. ....+++.+++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+.
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998853 3346999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCcccc---ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQG---NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
...... ......||+.|||||.+.+..++.++|||||||+||||+| |++||...+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 432211 1223467899999999999999999999999999999998 899997543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=358.64 Aligned_cols=196 Identities=33% Similarity=0.501 Sum_probs=173.5
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
+.|+++++||+|+||+||+|++. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999874 58899999986542 344567999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+++|+|..++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987663 3356999999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccccccccccccCcccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 234579999999999864 46899999999999999999999999654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-42 Score=362.32 Aligned_cols=202 Identities=25% Similarity=0.340 Sum_probs=181.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|+++++||+|+||.||+|++. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999874 6899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEc--CCCCeEEeeeccccccCCC
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kL~DFGla~~~~~~ 626 (682)
+++|+|.+++.. ....+++.+++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887632 3346999999999999999999999998 99999999999998 5789999999999987543
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2344688999999999999999999999999999999999999997543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=362.30 Aligned_cols=209 Identities=31% Similarity=0.457 Sum_probs=177.1
Q ss_pred hhcCcccccccccCCceeEEEEEEcCC------ceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~g------~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~ 540 (682)
..++|++.++||+|+||+||+|++... ..||||.+... .......|.+|+.+|.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 457899999999999999999987532 26999998654 334456799999999998 8999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCC
Q 005705 541 EKILILEYMPNKSLNVFLFDSTK--------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlk 600 (682)
..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999964321 245899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 601 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
|+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |++||...+
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654333333345678999999999999999999999999999999998 899997654
Q ss_pred C
Q 005705 680 M 680 (682)
Q Consensus 680 ~ 680 (682)
.
T Consensus 272 ~ 272 (325)
T d1rjba_ 272 V 272 (325)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=351.86 Aligned_cols=204 Identities=29% Similarity=0.462 Sum_probs=175.8
Q ss_pred hcCccccc-ccccCCceeEEEEEEc---CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~-~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|.+.+ +||+|+||.||+|.+. ++..||||+++.. .....++|.+|+++|++++|||||++++++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 46777777 4999999999999764 3557999999754 34456889999999999999999999999865 46899
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++|+|.+++.. .+..+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998743 3356999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCcc-ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.... ........||+.|||||++.+..++.++|||||||++|||+| |++||...+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 4322 222334578999999999999999999999999999999998 999997654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-42 Score=351.76 Aligned_cols=201 Identities=28% Similarity=0.409 Sum_probs=178.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~------~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.+.|++.+.||+|+||+||+|++. +|+.||||++++.. ....+.|.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999984 68999999986432 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC----CeEEeeec
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFG 618 (682)
++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999843 346999999999999999999999998 99999999999998776 49999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+|+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 998764332 2334578999999999999999999999999999999999999997654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=350.94 Aligned_cols=196 Identities=32% Similarity=0.447 Sum_probs=166.8
Q ss_pred cccccCCceeEEEEEEcC---CceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEecCC
Q 005705 477 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 551 (682)
++||+|+||.||+|.+.+ ++.||||+++.. .+...++|.+|+.+|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 467999999653 33446789999999999999999999999864 467899999999
Q ss_pred CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc-cc
Q 005705 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-QG 630 (682)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~ 630 (682)
|+|.+++.. ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999843 356999999999999999999999998 99999999999999999999999999987754322 22
Q ss_pred ccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
......||+.|||||.+.+..++.++|||||||++|||+| |++||...+
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 2334578999999999999999999999999999999998 899997543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-42 Score=360.16 Aligned_cols=198 Identities=24% Similarity=0.323 Sum_probs=179.0
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 546 (682)
++|+++++||+|+||.||+|++. +|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999885 6899999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCC
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (682)
||+.+|+|..++.. ...+++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999843 346999999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.....||+.|||||++.+..++.++|||||||+||||+||++||...+
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 334689999999999999999999999999999999999999997654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=347.24 Aligned_cols=202 Identities=33% Similarity=0.486 Sum_probs=166.9
Q ss_pred hcCcccccccccCCceeEEEEEEcCC-----ceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g-----~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
.+.|++.++||+|+||.||+|++.+. ..||||+++.. ......+|.+|+.++++++|||||++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45688899999999999999987542 36999999654 3445668999999999999999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+.++++.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999988754 3346999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 005705 624 GGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (682)
Q Consensus 624 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~ 676 (682)
...... .......||+.|||||++.+..++.++|||||||+||||++|+.|+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 443221 22334578999999999999999999999999999999999655554
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=350.83 Aligned_cols=201 Identities=27% Similarity=0.403 Sum_probs=177.1
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHH-hcCCCCeeeEEEEEEecCeEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lV 545 (682)
++|++.++||+|+||+||+|++. +++.||||++++. .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999885 5889999999653 2334566777777765 68999999999999999999999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (682)
|||+++|+|..++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 32 23344689999999999999999999999999999999999999997654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=347.82 Aligned_cols=202 Identities=34% Similarity=0.536 Sum_probs=170.2
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEec
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 549 (682)
.++|++.+.||+|+||+||+|++.+++.||||+++... ...++|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 46899999999999999999999888899999996543 345789999999999999999999999854 5688999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++|+|..++... ....+++.+++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 999999888543 2346999999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......||+.|+|||++....++.++|||||||+||||++|++|+...
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 2233457899999999999999999999999999999999976665443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-41 Score=344.72 Aligned_cols=204 Identities=27% Similarity=0.401 Sum_probs=170.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC----e
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----E 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~----~ 541 (682)
.++|++.+.||+|+||.||+|++. +++.||||+++.. .....++|.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999874 6899999999753 2344668999999999999999999999998654 3
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+++++|..++.. .+.+++.+++.++.||++||+|||+++ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999988743 346999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCc-cccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDE-LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
...... .........||+.|||||++.+..++.++|||||||+||||+||++||...+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 654322 2223445689999999999999999999999999999999999999997654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.4e-41 Score=355.87 Aligned_cols=200 Identities=28% Similarity=0.375 Sum_probs=172.7
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccC---hhhHHHH---HHHHHHHHhcCCCCeeeEEEEEEecCeEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEF---KNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~~f---~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 543 (682)
++|++.++||+|+||.||+|++. +|+.||||++.+.. ......+ .+|+.+++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999985 58999999986431 1222333 34577777788999999999999999999
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
+||||+++|+|..++.. ...+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999843 356899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGSM 680 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~~ 680 (682)
... ......||+.|+|||++.. ..++.++|||||||+||||+||++||...+.
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 533 2344689999999999874 5689999999999999999999999976543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-41 Score=349.19 Aligned_cols=213 Identities=29% Similarity=0.443 Sum_probs=181.1
Q ss_pred hHHHhhhcCcccccccccCCceeEEEEEEc------CCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 005705 464 ASITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536 (682)
Q Consensus 464 ~~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~ 536 (682)
.+++...++|++.+.||+|+||+||+|+.. +++.||||+++... .+..++|.+|+.+|++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344556789999999999999999999864 35689999997643 34567899999999999999999999999
Q ss_pred EecCeEEEEEEecCCCChhHHhhhcc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 005705 537 VEQGEKILILEYMPNKSLNVFLFDST---------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595 (682)
Q Consensus 537 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ii 595 (682)
.+.+..+++|||+++|+|.+++.... ....+++.+++.|+.||+.||+|||+++ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999985422 1234899999999999999999999998 99
Q ss_pred eccCCCCCEEEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCC-CC
Q 005705 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KN 674 (682)
Q Consensus 596 H~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~-~p 674 (682)
||||||+|||++.++.+||+|||+|+.+.............|++.|+|||.+.+..++.++|||||||+||||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998765443333344567899999999999999999999999999999999985 56
Q ss_pred CCCCC
Q 005705 675 TGLGS 679 (682)
Q Consensus 675 f~~~~ 679 (682)
|...+
T Consensus 243 ~~~~~ 247 (301)
T d1lufa_ 243 YYGMA 247 (301)
T ss_dssp TTTSC
T ss_pred CCCCC
Confidence 76543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-40 Score=338.40 Aligned_cols=201 Identities=27% Similarity=0.373 Sum_probs=176.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh---------hhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE 538 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---------~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~ 538 (682)
.++|++.+.||+|+||+||+|++. +++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999874 688999999865321 12346889999999997 9999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
++..++||||+++|+|.+++.. ...+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999953 346999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccC------CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+++.+.... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||...+
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 999875432 2344689999999999853 447889999999999999999999998654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-41 Score=349.10 Aligned_cols=203 Identities=31% Similarity=0.492 Sum_probs=170.8
Q ss_pred cCcccccccccCCceeEEEEEEc-CCc----eEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
++|+++++||+|+||+||+|++. +|+ +||||+++.. .....++|.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999874 343 6899988653 445678899999999999999999999999865 5678
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
++||+.+++|.+++.. ....+++..+++++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999988754 3456999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
............||+.|||||++.+..++.++|||||||+||||+| |++||...+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 5444334445678999999999999999999999999999999999 899998654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=344.73 Aligned_cols=201 Identities=22% Similarity=0.310 Sum_probs=178.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.++|++.+.||+|+||+||+|++. +++.||||.++.... ....+.+|+++|++++||||+++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 578999999999999999999885 588999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCC--CCeEEeeeccccccCCC
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--MNPKISDFGLARMFGGD 626 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kL~DFGla~~~~~~ 626 (682)
+++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999843 2336999999999999999999999998 9999999999999854 47999999999876433
Q ss_pred ccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 2 2344578999999999999999999999999999999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=341.80 Aligned_cols=210 Identities=30% Similarity=0.449 Sum_probs=169.8
Q ss_pred HhhhcCcccccccccCCceeEEEEEEcC------CceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 005705 467 TAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (682)
Q Consensus 467 ~~~~~~y~i~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~ 538 (682)
+...++|++.++||+|+||.||+|++.. ++.||||+++.. .....+++.+|..++.++ +|+||+++++++.+
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 3445789999999999999999998642 468999999754 334566788888888887 68999999999876
Q ss_pred cC-eEEEEEEecCCCChhHHhhhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCE
Q 005705 539 QG-EKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (682)
Q Consensus 539 ~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NI 604 (682)
.+ ..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ ||||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccce
Confidence 54 68999999999999999964322 345899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcC-CCCCCCCC
Q 005705 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTGLGS 679 (682)
Q Consensus 605 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG-~~pf~~~~ 679 (682)
||++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+|| ++||...+
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999876554444444556899999999999999999999999999999999996 56776544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=338.76 Aligned_cols=203 Identities=27% Similarity=0.376 Sum_probs=165.3
Q ss_pred hcCcccccccccCCceeEEEEEEcC----CceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|++.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 5689999999999999999998743 346899998654 3445678999999999999999999999985 467899
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccC
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (682)
||||+++|+|..++.. ....+++.+++.++.||++||+|||+++ |+||||||+||++++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998743 3346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |++||...+
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 4322 23344578999999999999999999999999999999998 899998654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-40 Score=343.27 Aligned_cols=198 Identities=21% Similarity=0.297 Sum_probs=170.2
Q ss_pred hcCccccc-ccccCCceeEEEEEE-cCCceEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----cCeE
Q 005705 470 TENFSMQC-KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGEK 542 (682)
Q Consensus 470 ~~~y~i~~-~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~----~~~~ 542 (682)
.++|.+.+ .||+|+||+||+|++ .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788875 699999999999987 46899999998642 4567899887665 89999999999875 3568
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEEeeecc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 619 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGl 619 (682)
++||||+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999998542 2346999999999999999999999998 999999999999985 55799999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
|+...... ......||+.|||||++.+..|+.++|||||||+||||+||++||...+
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 98765432 2344689999999999999999999999999999999999999996543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=334.83 Aligned_cols=199 Identities=32% Similarity=0.492 Sum_probs=167.1
Q ss_pred hcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-CeEEEEEEe
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILEY 548 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~ 548 (682)
.++|++.++||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||+++++++.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46788999999999999999998 5789999999754 3457899999999999999999999998654 568999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+++|+|.+++... ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999998543 2335899999999999999999999997 999999999999999999999999999875332
Q ss_pred ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGSM 680 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~~ 680 (682)
.....+|+.|+|||++.+..++.++||||||+++|||+| |++||...+.
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~ 206 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence 233467899999999999999999999999999999998 7888876553
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-40 Score=335.07 Aligned_cols=204 Identities=29% Similarity=0.393 Sum_probs=165.8
Q ss_pred hcCcccccccccCCceeEEEEEEcC--C--ceEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~--g--~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 542 (682)
.++|++.+.||+|+||.||+|++.. + ..||||++.+. .++..++|.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4679999999999999999998642 2 37899998653 34456789999999999999999999999965 467
Q ss_pred EEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 543 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
++||||+++++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999887543 345999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccc-cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
+...... .......||..|+|||.+.+..++.++|||||||++|||+| |++||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 7544322 22334567889999999999999999999999999999998 899997543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-40 Score=339.81 Aligned_cols=196 Identities=29% Similarity=0.386 Sum_probs=166.6
Q ss_pred cccccccCCceeEEEEEEc-CCceEEEEEecccChh-----hHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 475 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 475 i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
.+++||+|+||+||+|++. +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 5889999998643221 234688999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
++++++..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 9998777665 34456899999999999999999999998 9999999999999999999999999998764432
Q ss_pred ccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 22334579999999999865 45799999999999999999999999654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=337.08 Aligned_cols=201 Identities=29% Similarity=0.428 Sum_probs=171.3
Q ss_pred cCcccccccccCCceeEEEEEE-cCCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|+++++||+|+||+||+|++ .+++.||||+++... ....+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999998 468999999996532 2345789999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
|+.++.+.... . .....+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765444333 2 23456999999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......||+.|+|||++.... ++.++|||||||++|||++|+.||...
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 2234458999999999887766 478999999999999999999999754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=335.89 Aligned_cols=208 Identities=30% Similarity=0.478 Sum_probs=176.7
Q ss_pred hhcCcccccccccCCceeEEEEEEcC--------CceEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~ 538 (682)
..++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 45789999999999999999998633 2479999997643 34567899999999998 79999999999999
Q ss_pred cCeEEEEEEecCCCChhHHhhhcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEE
Q 005705 539 QGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIL 605 (682)
++..++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+++ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 999999999999999999996432 1245899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
++.++.+||+|||+++...............+|+.|+|||.+.+..|+.++|||||||++|||++ |++||...+
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999998765444444555788999999999999999999999999999999998 788887554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=337.04 Aligned_cols=203 Identities=27% Similarity=0.389 Sum_probs=165.9
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC----eEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILIL 546 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~ 546 (682)
++|.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++||||+++++++.+++ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5688899999999999999987 689999999965432 2222345666667789999999999998764 578999
Q ss_pred EecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
||+++|+|..++.. ..+++.++++++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 35899999999999999999999741 1249999999999999999999999999998
Q ss_pred ccCCCcc--ccccccccccccccCcccccCCC------CCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDEL--QGNTKQIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
....... ........||+.|+|||++.+.. ++.++|||||||+||||+||.+||+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 7743221 22334568999999999987653 5778999999999999999999887654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=337.04 Aligned_cols=208 Identities=30% Similarity=0.419 Sum_probs=179.9
Q ss_pred hhcCcccccccccCCceeEEEEEEc------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecC
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~ 540 (682)
..++|++.++||+|+||.||+|++. +++.||||+++.. ......+|.+|+.++.++ +|||||++++++.+++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 4578999999999999999999863 3568999999754 344566899999999999 6999999999999999
Q ss_pred eEEEEEEecCCCChhHHhhhcc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEE
Q 005705 541 EKILILEYMPNKSLNVFLFDST---------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NIL 605 (682)
..++||||+++|+|.+++.... ....+++..+++++.||++||+|||+++ |+||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999986432 2236899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC
Q 005705 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGLGS 679 (682)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~ellt-G~~pf~~~~ 679 (682)
++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |++||...+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999998765443344455688999999999999999999999999999999999 566665443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-39 Score=332.81 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=173.0
Q ss_pred cCcccccccccCCceeEEEEEEcCCceEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEEe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 548 (682)
++|++.++||+|+||+||+|++++|+.||||+++... ....+++.+|+.+|++++||||+++++++..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999899999999996542 33467899999999999999999999999999999999999
Q ss_pred cCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCcc
Q 005705 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (682)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (682)
+.++.+..+. .....+++.++..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9888777765 34467999999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 23345789999999998754 5689999999999999999999999654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-39 Score=334.41 Aligned_cols=208 Identities=30% Similarity=0.449 Sum_probs=179.7
Q ss_pred hhcCcccccccccCCceeEEEEEEc------CCceEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCe
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~ 541 (682)
..++|++.++||+|+||.||+|.+. +++.||||+++.. .......|.+|++++++++||||+++++++..+..
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3578999999999999999999763 2578999999754 33455679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhHHhhhcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 542 KILILEYMPNKSLNVFLFDST-------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
.++||||+++|+|.+++.... ....+++..+.+++.|+++||.|||+++ |+||||||+|||++.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 999999999999999985322 2235789999999999999999999997 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCC-CCCCCCC
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGLGS 679 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~-~pf~~~~ 679 (682)
+|||+|+.+.............||+.|+|||.+.+..++.++||||||++||||+||+ +||...+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 9999998775444333444557899999999999999999999999999999999984 7776443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=332.82 Aligned_cols=197 Identities=24% Similarity=0.371 Sum_probs=168.9
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEecccCh------hhHHHHHHHHHHHHhcC--CCCeeeEEEEEEecCe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQGE 541 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~--HpnIv~l~~~~~~~~~ 541 (682)
++|++.++||+|+||.||+|+.. +++.||||++..... ....++.+|+.+|++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999874 689999999864321 12244678999999997 8999999999999999
Q ss_pred EEEEEEecCC-CChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-CCCeEEeeecc
Q 005705 542 KILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGL 619 (682)
Q Consensus 542 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGl 619 (682)
.++||||+.+ +++.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 57777763 3456999999999999999999999998 999999999999985 47899999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCCC-CccccHHHHHHHHHHHHcCCCCCCC
Q 005705 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGL 677 (682)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwSlGvil~elltG~~pf~~ 677 (682)
|+..... ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||..
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 9875432 2344689999999999987765 5678999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-39 Score=334.13 Aligned_cols=203 Identities=33% Similarity=0.483 Sum_probs=171.1
Q ss_pred hcCcccccccccCCceeEEEEEEcC-Cc--eEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEecCeEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 544 (682)
.++|++.++||+|+||.||+|++.+ +. .||||+++.. .....++|.+|+++|.++ +|||||++++++.+++..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3688999999999999999998854 33 5788988643 344567899999999999 79999999999999999999
Q ss_pred EEEecCCCChhHHhhhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCC
Q 005705 545 ILEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 611 (682)
||||+++|+|.+++... .....+++.++++++.||++||.|||+.+ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999998643 23467999999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCC-CCCCCC
Q 005705 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGLG 678 (682)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~-~pf~~~ 678 (682)
+||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|. +||...
T Consensus 166 ~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 999999999865322 2223457899999999999999999999999999999999976 567543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=330.74 Aligned_cols=198 Identities=30% Similarity=0.487 Sum_probs=169.7
Q ss_pred ccccccCCceeEEEEEEcCC----ceEEEEEecc-cChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-CeEEEEEEec
Q 005705 476 QCKLGEGGFGPVYKGRLLNG----QEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILEYM 549 (682)
Q Consensus 476 ~~~LG~G~fG~Vyk~~~~~g----~~vAVK~l~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~~ 549 (682)
.++||+|+||+||+|++.++ ..||||+++. ......++|.+|+++|++++||||++++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999987542 2689999975 3555678899999999999999999999998764 5889999999
Q ss_pred CCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCccc
Q 005705 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (682)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (682)
++++|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998853 3445788999999999999999999998 999999999999999999999999999877543222
Q ss_pred --cccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 630 --GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 630 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
.......||+.|+|||.+....++.++||||||++||||+||+.||...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 1223357899999999999999999999999999999999988887654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-39 Score=331.93 Aligned_cols=203 Identities=28% Similarity=0.420 Sum_probs=169.0
Q ss_pred hhcCcccccccccCCceeEEEEEEc-C-CceEEEEEecccC--hhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEe---
Q 005705 469 ATENFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVE--- 538 (682)
Q Consensus 469 ~~~~y~i~~~LG~G~fG~Vyk~~~~-~-g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l---~HpnIv~l~~~~~~--- 538 (682)
..++|+++++||+|+||+||+|++. + ++.||||+++... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999874 4 5679999986432 22233456677776665 79999999999863
Q ss_pred --cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEee
Q 005705 539 --QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (682)
Q Consensus 539 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D 616 (682)
....+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 246789999999887765542 34456899999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|++||...+
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 9999865322 23445689999999999999999999999999999999999999997553
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=329.22 Aligned_cols=203 Identities=26% Similarity=0.376 Sum_probs=169.9
Q ss_pred hcCcccccccccCCceeEEEEEE-cCCceEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC----eEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKI 543 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~ 543 (682)
+++|+++++||+|+||+||+|++ .+|+.||||+++... ....+++++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999987 468999999997543 345678999999999999999999999987653 345
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccccc
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (682)
++++|+.+++|.+++.. ..+++.+++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66677889999999843 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-ccccccccccccccCccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDEL-QGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... .......+||+.|+|||++. +..++.++||||+||++|||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 44322 12234567999999999984 4567899999999999999999999997543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-37 Score=320.62 Aligned_cols=202 Identities=21% Similarity=0.284 Sum_probs=173.0
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 547 (682)
.++|++.++||+|+||+||+|++. +++.||||++..... ...+.+|++++..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 588999999865432 2456788899999975 899999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC-----CCCeEEeeeccccc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARM 622 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kL~DFGla~~ 622 (682)
|+ +++|..++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. .+.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6899888743 3346899999999999999999999998 999999999999974 56899999999998
Q ss_pred cCCCcc-----ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 623 FGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 623 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+..... ........||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 643221 112345689999999999999999999999999999999999999997544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=329.33 Aligned_cols=198 Identities=29% Similarity=0.409 Sum_probs=166.5
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC------eEEE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKIL 544 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l 544 (682)
+|...++||+|+||+||+|++. +|+.||||++..... .+.+|+.+|++++||||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999985 589999999965432 2347999999999999999999986432 4689
Q ss_pred EEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeecccccc
Q 005705 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMF 623 (682)
Q Consensus 545 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~ 623 (682)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755555433345567999999999999999999999998 99999999999999775 8999999999876
Q ss_pred CCCccccccccccccccccCcccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 624 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|++||...+
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 5432 2234589999999998875 568999999999999999999999997553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=323.63 Aligned_cols=203 Identities=27% Similarity=0.427 Sum_probs=169.7
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-------- 538 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~-------- 538 (682)
.++|+++++||+|+||+||+|++. +|+.||||++... .....+++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 6899999998543 33456778999999999999999999998865
Q ss_pred cCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeec
Q 005705 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (682)
Q Consensus 539 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG 618 (682)
+...++||||++++.+..+. .....+++.++..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34578999999888776554 34456899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc--cccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 619 LARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 619 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 99876543221 222335799999999998765 6899999999999999999999999643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=327.73 Aligned_cols=197 Identities=27% Similarity=0.393 Sum_probs=165.5
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecC------
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~------ 540 (682)
.++|+++++||+|+||+||+|++. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 568999999999999999999874 5899999999753 3345678899999999999999999999997654
Q ss_pred eEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccc
Q 005705 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (682)
Q Consensus 541 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla 620 (682)
..++||||+ +.+|..+.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 569999999 556776653 346999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
+.... ......||+.|+|||++.+. .++.++||||+||++|||++|++||...+
T Consensus 169 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 169 RQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp EECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 87543 23446899999999998764 56899999999999999999999997653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-38 Score=326.20 Aligned_cols=204 Identities=28% Similarity=0.409 Sum_probs=174.9
Q ss_pred cCcccccccccCCceeEEEEEEc----CCceEEEEEeccc----ChhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEecCe
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGE 541 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~----~~~~~~~f~~E~~~l~~l~H-pnIv~l~~~~~~~~~ 541 (682)
++|+++++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999862 3789999998643 22345678899999999966 899999999999999
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.+++|||+.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999843 345788999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGLGSME 681 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwSlGvil~elltG~~pf~~~~~e 681 (682)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...+.+
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 76543322 23446899999999998764 4688999999999999999999999776543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-37 Score=314.14 Aligned_cols=200 Identities=26% Similarity=0.371 Sum_probs=174.5
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEecCeEEEEEE
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 547 (682)
++|+++++||+|+||+||+|++. +++.||||+++.. .....+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999984 6889999998543 33457889999999999999999999999999999999999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeeccccccCCCc
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (682)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888763 3456899999999999999999999998 9999999999999999999999999998865432
Q ss_pred cccccccccccccccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCC
Q 005705 628 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLG 678 (682)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~pf~~~ 678 (682)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 1 223346788999999987665 689999999999999999999997443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9e-37 Score=319.80 Aligned_cols=195 Identities=23% Similarity=0.394 Sum_probs=169.4
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEec--CeEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ--GEKILI 545 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV 545 (682)
.++|+++++||+|+||+||+|++. +++.||||+++.. ..+++.+|+.+|.+++ ||||+++++++... ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 368999999999999999999984 6889999999754 3467899999999995 99999999998754 468999
Q ss_pred EEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCC-CeEEeeeccccccC
Q 005705 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFG 624 (682)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kL~DFGla~~~~ 624 (682)
|||+++++|..+. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+...
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999987654 35899999999999999999999998 99999999999998655 59999999998765
Q ss_pred CCccccccccccccccccCcccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 432 23445789999999998765 47999999999999999999999997654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-37 Score=316.77 Aligned_cols=202 Identities=22% Similarity=0.300 Sum_probs=166.6
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCee-eEEEEEEecCeEEEEEE
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILE 547 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E 547 (682)
.++|++.++||+|+||.||+|++. +++.||||++..... .+++..|++++++++|+|++ .+..+..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999874 588999999865432 24578899999999877654 55566677788899999
Q ss_pred ecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcC---CCCeEEeeeccccccC
Q 005705 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLARMFG 624 (682)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kL~DFGla~~~~ 624 (682)
|+. ++|...+.. ....+++..+..++.|++.||+|||+++ ||||||||+|||++. +..+||+|||+|+.+.
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 985 455555432 3356999999999999999999999998 999999999999864 5579999999999875
Q ss_pred CCcc-----ccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 625 GDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 625 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
.... ........||+.|||||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 4321 122345689999999999999999999999999999999999999997654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-36 Score=319.03 Aligned_cols=198 Identities=30% Similarity=0.402 Sum_probs=167.8
Q ss_pred hcCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec-----Ce
Q 005705 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 541 (682)
Q Consensus 470 ~~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 541 (682)
.++|+++++||+|+||+||+|++. +|+.||||+++.. .....+++.+|+.+|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999874 6899999999754 334456789999999999999999999998643 34
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++++||+.+++|.+++. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788899999999983 345999999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCccccccccccccccccCcccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
... .......|++.|+|||++.+.. ++.++|||||||++|||++|++||...+
T Consensus 170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 643 2234467899999999877654 6899999999999999999999996543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-36 Score=317.41 Aligned_cols=197 Identities=29% Similarity=0.348 Sum_probs=161.3
Q ss_pred cCcccccccccCCceeEEEEEEc-CCceEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEEEEec------Ce
Q 005705 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GE 541 (682)
Q Consensus 471 ~~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 541 (682)
++|+++++||+|+||+||+|++. +|+.||||++... .....+++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999985 5899999999653 334556789999999999999999999999643 57
Q ss_pred EEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEEeeecccc
Q 005705 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (682)
Q Consensus 542 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (682)
.++||||+.++.+..+. ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999776554432 34899999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 75432 23345678999999999999999999999999999999999999997543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=6.6e-32 Score=286.48 Aligned_cols=199 Identities=22% Similarity=0.313 Sum_probs=163.1
Q ss_pred CcccccccccCCceeEEEEEEc-CCceEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCCeeeEEEEEEec
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCVEQ 539 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----------HpnIv~l~~~~~~~ 539 (682)
+|+++++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5999999999999999999984 68999999997543 33567888999988885 47899999888653
Q ss_pred --CeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcCCCC-----
Q 005705 540 --GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMN----- 611 (682)
Q Consensus 540 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~----- 611 (682)
...++++++...+..............+++..+..++.||++||+|||+ .+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 4667777777666554444444556678999999999999999999998 65 999999999999986653
Q ss_pred -eEEeeeccccccCCCccccccccccccccccCcccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 005705 612 -PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGLGS 679 (682)
Q Consensus 612 -~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwSlGvil~elltG~~pf~~~~ 679 (682)
++++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||...+
T Consensus 170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 99999999986532 2334579999999999999999999999999999999999999997543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.88 E-value=1.1e-22 Score=176.09 Aligned_cols=112 Identities=24% Similarity=0.411 Sum_probs=97.5
Q ss_pred cccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCC
Q 005705 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (682)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (682)
+|+|.|||.|.+|+.|+| |.|.|+|+.+|+ +.++. ..++||.||++.|.. ++.|.|+.||+|||+++
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccCCC--CcEEEEeccccEEEEec-
Confidence 489999999999999974 999999999887 77776 679999999988754 57899999999999996
Q ss_pred CCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCCCcc
Q 005705 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTD 154 (682)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~Ptd 154 (682)
+.++|+|++.+..+..+|+|+|+||||||+.+ +.++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-----CcEEecCCCccCC
Confidence 57888888776667788999999999999863 4689999999985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.88 E-value=8.6e-23 Score=175.02 Aligned_cols=107 Identities=24% Similarity=0.355 Sum_probs=95.3
Q ss_pred cccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCC
Q 005705 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (682)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (682)
.|+|.+||.|.+|+.|. +|.|.|.|+.+|+ +.+|. ..++||.||++.|.. .+.|.|+.||+|||++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLSR--SCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCCCC--ccEEEEeccceEEEECCC
Confidence 47899999999999994 6999999999987 88876 568999999988743 578999999999999999
Q ss_pred CCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCC
Q 005705 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (682)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~ 151 (682)
|.+||+|++.+.....+|+|+||||||||+. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999987776777899999999999975 29999988
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.87 E-value=3.2e-22 Score=171.45 Aligned_cols=108 Identities=19% Similarity=0.342 Sum_probs=94.4
Q ss_pred cccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCC
Q 005705 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (682)
Q Consensus 25 ~~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 104 (682)
.|+|.|||.|.+|+.|. +|.|.|+|+.+|+ +.++. ..++||+||++.|... .+.|.|+.||+|||+|++
T Consensus 1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCC
Confidence 37899999999999996 4889999998886 66655 5689999999999875 688999999999999999
Q ss_pred CCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecCC
Q 005705 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (682)
Q Consensus 105 ~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd~ 151 (682)
|.+||+|+++...+.++|+|+||||||||+. .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 9999999987666677899999999999964 39999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=6.6e-23 Score=196.21 Aligned_cols=162 Identities=17% Similarity=0.188 Sum_probs=120.4
Q ss_pred cccccccccCCceeEEEEEEcCCceEEEEEecccCh------------------hhHHHHHHHHHHHHhcCCCCeeeEEE
Q 005705 473 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKLQHRNLVRLLG 534 (682)
Q Consensus 473 y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~------------------~~~~~f~~E~~~l~~l~HpnIv~l~~ 534 (682)
+.+.++||+|+||+||+|++.+|+.||||+++.... .....+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999998999999998753110 01234567889999999999998876
Q ss_pred EEEecCeEEEEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCCEEEcCCCCeEE
Q 005705 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (682)
Q Consensus 535 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kL 614 (682)
+. ..+++|||+++..+.. ++......++.|++++++|||+++ |+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 52 2379999998876533 333445679999999999999998 9999999999999965 4899
Q ss_pred eeeccccccCCCccccccccccccccccC------cccccCCCCCccccHHHHHH
Q 005705 615 SDFGLARMFGGDELQGNTKQIVGTYGYMS------PEYALDGLFSIKSDVFSFGI 663 (682)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~k~DVwSlGv 663 (682)
+|||+|......... .|.. .| +..+.|+.++|+||..-
T Consensus 144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCCTTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHH
T ss_pred EECCCcccCCCCCcH----------HHHHHHHHHHHH-HHcCCCCCcccHHHHHH
Confidence 999999765322110 1111 11 12466788999999743
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.70 E-value=4.4e-17 Score=140.88 Aligned_cols=103 Identities=17% Similarity=0.328 Sum_probs=84.4
Q ss_pred ccccCCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCCC
Q 005705 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN 105 (682)
Q Consensus 26 ~~l~~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~ 105 (682)
++|.+||+| .+.+..|.|.|.|+.+|+ +.++- ..++||.+|+..+.. .+.|.|+.||+|||+|++|
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLYD---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTTC
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEEE---CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCCC
Confidence 455555554 236679999999999997 66653 568999999987643 4789999999999999999
Q ss_pred CeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecC
Q 005705 106 GTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (682)
Q Consensus 106 ~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd 150 (682)
.+||++++.+..+..+++|+||||||||++ ++|||-.
T Consensus 81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~--------~~W~S~T 117 (119)
T d1b2pa_ 81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQT 117 (119)
T ss_dssp CEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEECCC
T ss_pred cEEEECCCcCCCCceEEEEcCCCCEEEECC--------CEeccCC
Confidence 999999988777777899999999999964 4999954
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.63 E-value=2e-16 Score=137.22 Aligned_cols=83 Identities=20% Similarity=0.322 Sum_probs=71.9
Q ss_pred EEEEEecC-CCeEEEecCCCCCCcCCCceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCC
Q 005705 62 LGIRFQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNA 140 (682)
Q Consensus 62 ~~i~~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~ 140 (682)
..|||..+ .++.+|++|++.|+....-+|.|+.||||||++. +.++|++++.+.+....|.|+++|||||++.+
T Consensus 10 n~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~---- 84 (120)
T d1dlpa2 10 NSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ---- 84 (120)
T ss_dssp CEECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT----
T ss_pred CeEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC----
Confidence 35888887 7899999999999988777899999999999985 68899999887767788999999999999874
Q ss_pred CccceeeecC
Q 005705 141 TESYLWQSFD 150 (682)
Q Consensus 141 ~~~~~WqsFd 150 (682)
++++||||.
T Consensus 85 -~~~lW~S~t 93 (120)
T d1dlpa2 85 -NIAVWTSGN 93 (120)
T ss_dssp -TEEEEECCC
T ss_pred -CCEEEEeCC
Confidence 478999973
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=1.1e-15 Score=131.00 Aligned_cols=99 Identities=23% Similarity=0.347 Sum_probs=82.1
Q ss_pred CCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCCCCeEEE
Q 005705 31 ASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWS 110 (682)
Q Consensus 31 g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~w~ 110 (682)
.|+|.++|.| .+|.|.|.|..+|+ |.++. ...+||.+|+..+ ..+.+.|+.||||||+|.++.+||+
T Consensus 14 ~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 14 PQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp CSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred cceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEE
Confidence 3566666667 57889999999987 77765 5688999997542 3678999999999999999999999
Q ss_pred EeccCCcCCceEEEecCCceEEecCCCCCCCccceeeecC
Q 005705 111 TNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (682)
Q Consensus 111 s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqsFd 150 (682)
|++....+.++++|++|||||||+. .+|+|-.
T Consensus 81 S~t~~~~g~y~l~Lq~DGNlvlY~~--------~~Wssgt 112 (115)
T d1dlpa1 81 SGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGT 112 (115)
T ss_dssp CCCCCCSSCCEEEECSSSCEEEECS--------EEEECSC
T ss_pred cCCCCCCCCEEEEECCCCcEEEeCC--------CeecCCC
Confidence 9988777788899999999999964 4999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.43 E-value=1.5e-13 Score=118.77 Aligned_cols=99 Identities=21% Similarity=0.330 Sum_probs=78.5
Q ss_pred CCCccCCCCeEeeCCCeEEEEEecCCCCCCeEEEEEEecCCCeEEEecCCCCCCcCCCceEEEecCCcEEEecCCCCeEE
Q 005705 30 PASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIW 109 (682)
Q Consensus 30 ~g~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~w 109 (682)
+.+.|.+++.| ..|.|.|.|..+|+ |.++. ...+||.++... ....+.+.|+.+|||||+|.++.++|
T Consensus 22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred cccEEcCCCee--EcCCEEEEEcCCCc-----EEEec---CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 34556666666 45778888988886 66654 457889998543 33467899999999999999999999
Q ss_pred EEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 110 STNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 110 ~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
+|++.+..+..+++|++|||||||+. .+|.|
T Consensus 90 ~S~t~~~~~~~~l~Lq~DGnlvlY~~--------~~W~t 120 (120)
T d1dlpa2 90 TSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 120 (120)
T ss_dssp ECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred EeCCCCCCCcEEEEECCCCcEEEeCC--------CcccC
Confidence 99988777788899999999999964 38986
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.36 E-value=1.4e-13 Score=117.62 Aligned_cols=79 Identities=23% Similarity=0.338 Sum_probs=65.5
Q ss_pred EEEecC-CCeEEEecCCCCCCcCCCceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCc
Q 005705 64 IRFQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142 (682)
Q Consensus 64 i~~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~ 142 (682)
|||.-. +.+..|+.+.+.++.+...+|.|+.||||||++ .+.++|++++.+. ....+.|+++|||||++.+ +
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d~~-----~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGA-TGCRAVLQSDGLLVILTAQ-----N 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSC-SCCBCCBCSSSCBCCBCTT-----T
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCC-CceEEEEeccCCEEEEccC-----C
Confidence 455433 567779999999998877889999999999998 5789999998754 4677899999999999874 4
Q ss_pred cceeeec
Q 005705 143 SYLWQSF 149 (682)
Q Consensus 143 ~~~WqsF 149 (682)
.+||||+
T Consensus 76 ~~vWsS~ 82 (115)
T d1dlpa1 76 TIRWSSG 82 (115)
T ss_dssp CCSCCCC
T ss_pred CEEEEcC
Confidence 7899986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.08 E-value=1.9e-10 Score=97.22 Aligned_cols=55 Identities=31% Similarity=0.580 Sum_probs=47.3
Q ss_pred ceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 88 AVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 88 ~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
-+|.|+.||||||++ .+.+||++++.+.+....+.|+++|||||++.+ +.++|+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWAS 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC-----ccceEEc
Confidence 458999999999998 568999999887766778999999999999874 4789986
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.00 E-value=9e-10 Score=94.28 Aligned_cols=54 Identities=35% Similarity=0.540 Sum_probs=46.5
Q ss_pred eEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 89 VLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 89 ~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
.|.|+.||||||+++ +.++|++++.+......+.|+++|||||++.. +.++|+|
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS 86 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQS 86 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC-----CcEEEEC
Confidence 588999999999975 57899999887766788999999999999874 4789976
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.89 E-value=3.3e-09 Score=89.42 Aligned_cols=56 Identities=30% Similarity=0.500 Sum_probs=46.0
Q ss_pred CceEEEecCCcEEEecCCCCeEEEEeccCCc-CCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
.-.|.|+.||||||++ .+.+||++++.... ....+.|+++|||||++. .+.++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-----~g~~vW~s 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA-----EGRSLWAS 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS-----SSCEEEEC
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC-----CCcEEEEE
Confidence 3568899999999997 56899999987543 356789999999999987 34789987
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.83 E-value=7.7e-09 Score=87.77 Aligned_cols=55 Identities=33% Similarity=0.642 Sum_probs=45.1
Q ss_pred CceEEEecCCcEEEecCCCCeEEEEeccCCcCCceEEEecCCceEEecCCCCCCCccceeee
Q 005705 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (682)
Q Consensus 87 ~~~l~~~~~g~lvl~~~~~~~~w~s~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~Wqs 148 (682)
.-.|.|+.||||||++ .+.+||++++.+......++|+.+|||||++.. +.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE
Confidence 4569999999999997 568999999876666778999999999999852 456654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=1e-07 Score=93.50 Aligned_cols=149 Identities=17% Similarity=0.131 Sum_probs=106.1
Q ss_pred HHHhhhcCcccccccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEecCeEE
Q 005705 465 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 543 (682)
Q Consensus 465 ~~~~~~~~y~i~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~ 543 (682)
++....+.|+..+..+.++...||+... +++.++||+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3445567788777666566678998864 56678899887655444556778888888774 444667788888888899
Q ss_pred EEEEecCCCChhHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 005705 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS--------------------------------- 590 (682)
Q Consensus 544 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------- 590 (682)
+||+++++..+....... .....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999999886554211 112335566677777777521
Q ss_pred -----------------------CCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 591 -----------------------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 591 -----------------------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11269999999999999877778999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.02 E-value=9.8e-06 Score=78.44 Aligned_cols=131 Identities=18% Similarity=0.173 Sum_probs=87.5
Q ss_pred ccccCC-ceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcC--CCCeeeEEEEEEecCeEEEEEEecCCCCh
Q 005705 478 KLGEGG-FGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (682)
Q Consensus 478 ~LG~G~-fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 554 (682)
.+..|. -+.||+....++..+++|....... ..+..|+..++.+. .-.+.+++.+..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 3679999887788899998765432 34566777777664 33466778888888889999999998776
Q ss_pred hHHhhhccccCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 005705 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY--------------------------------------------- 589 (682)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------------------------------------------- 589 (682)
.+.. .... .++.++++.|+-||+.
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3321 1111 1223334444444421
Q ss_pred ----------CCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 590 ----------SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 590 ----------~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
.+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 112379999999999999877778999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.59 E-value=7.6e-05 Score=77.11 Aligned_cols=75 Identities=11% Similarity=0.150 Sum_probs=48.2
Q ss_pred cccccCCceeEEEEEEcC-CceEEEEEeccc-------ChhhHHHHHHHHHHHHhcC-C-C-CeeeEEEEEEecCeEEEE
Q 005705 477 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQ-H-R-NLVRLLGCCVEQGEKILI 545 (682)
Q Consensus 477 ~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~-------~~~~~~~f~~E~~~l~~l~-H-p-nIv~l~~~~~~~~~~~lV 545 (682)
+.||.|....||+....+ ++.++||.-... .+....+...|...|..+. + | .+.+++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998754 678999965321 1122344556777777662 3 2 34555543 45567899
Q ss_pred EEecCCCC
Q 005705 546 LEYMPNKS 553 (682)
Q Consensus 546 ~E~~~~gs 553 (682)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.74 E-value=0.0034 Score=62.44 Aligned_cols=135 Identities=14% Similarity=0.140 Sum_probs=77.7
Q ss_pred eeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCCCCe--eeEE-----EEEEecCeEEEEEEecCCCChhH-
Q 005705 485 GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLL-----GCCVEQGEKILILEYMPNKSLNV- 556 (682)
Q Consensus 485 G~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnI--v~l~-----~~~~~~~~~~lV~E~~~~gsL~~- 556 (682)
-.||+++..+|+.+++|+.+... ...+++..|...+..|....+ +..+ ......+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999986532 245677888888888753221 1111 12234566788999998754311
Q ss_pred ----H------h---hh------ccccCCCC-------------------HHHHHHHHHHHHHHHHHHHh----cCCCCc
Q 005705 557 ----F------L---FD------STKKRLLN-------------------WQARVRIIEGIAQGLLYLHQ----YSRFRI 594 (682)
Q Consensus 557 ----~------l---~~------~~~~~~l~-------------------~~~~~~i~~qi~~~L~yLH~----~~~~~i 594 (682)
+ + +. ......++ ......+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1 0 00 00011111 11111122222333333332 223458
Q ss_pred EeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 595 IHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 595 iH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
||+|+.|.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 46899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.31 E-value=0.0037 Score=64.01 Aligned_cols=76 Identities=20% Similarity=0.306 Sum_probs=49.7
Q ss_pred CcccccccccCCceeEEEEEEcCC--------ceEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEecCeE
Q 005705 472 NFSMQCKLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEK 542 (682)
Q Consensus 472 ~y~i~~~LG~G~fG~Vyk~~~~~g--------~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~~~~~~~~~~ 542 (682)
.+++ +.|+.|-.=.+|+....++ +.|.+++... .. ......+|..+++.+.-.++ .++++++..
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 4444 5788888889999987543 3566666643 22 23345678888888853344 466666532
Q ss_pred EEEEEecCCCCh
Q 005705 543 ILILEYMPNKSL 554 (682)
Q Consensus 543 ~lV~E~~~~gsL 554 (682)
.+|+||+++..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 588999987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.30 E-value=0.063 Score=52.31 Aligned_cols=158 Identities=11% Similarity=0.004 Sum_probs=79.6
Q ss_pred chhHHHhhhcCccccc-----ccccCCceeEEEEEEcCCceEEEEEecccChhhHHHHHHHHHHHHhcCC-----CCeee
Q 005705 462 SLASITAATENFSMQC-----KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-----RNLVR 531 (682)
Q Consensus 462 ~~~~~~~~~~~y~i~~-----~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H-----pnIv~ 531 (682)
+.+++....++|.+.+ .|..|---+.|+.+..+| .+++|+...... .+++..|+.++..|.+ |..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 4455566666776643 345666677899887555 589999865321 2344455666666632 22111
Q ss_pred EE---EEEEecCeEEEEEEecCCCChhHH-----------h---hh------ccccC------------------CCCHH
Q 005705 532 LL---GCCVEQGEKILILEYMPNKSLNVF-----------L---FD------STKKR------------------LLNWQ 570 (682)
Q Consensus 532 l~---~~~~~~~~~~lV~E~~~~gsL~~~-----------l---~~------~~~~~------------------~l~~~ 570 (682)
.. .+.........++.++.+...... + +. ..... .....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 10 011223455667777765432110 0 00 00000 00011
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCCEEEcCCCCeEEeeeccccc
Q 005705 571 ARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (682)
Q Consensus 571 ~~~~i~~qi~~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (682)
.....+..+...+...+. .-+.++||+|+.+.||+++.+...-|+||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111122222222222221 1123589999999999999888789999998864
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.04 E-value=0.14 Score=31.26 Aligned_cols=32 Identities=31% Similarity=0.579 Sum_probs=24.7
Q ss_pred CCCcCCcCCCCCccccCC-CCCcccccCCCeeCC
Q 005705 244 QYCGKYGYCGANTICSLD-QKPMCECLEGFKLES 276 (682)
Q Consensus 244 ~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 276 (682)
|.|.+-..|| ||.|+.- ..--|.|-+||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6788988998 5788743 334699999999864
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.15 E-value=0.52 Score=36.31 Aligned_cols=54 Identities=15% Similarity=0.348 Sum_probs=33.7
Q ss_pred CeeEEeccccCCCccchhc---ccccChHHHHHHhhc----CCceEeEeeccccCCcceeecc
Q 005705 298 DQFIELDEIKAPDFIDVSL---NQRMNLEQCKAECLK----NCSCRAYANSNVKESSGCLMWY 353 (682)
Q Consensus 298 ~~f~~l~~~~~p~~~~~~~---~~~~s~~~C~~~Cl~----nCsC~a~~~~~~~~~~~C~~w~ 353 (682)
+.|.+..+..+........ ....+.++|.+.|++ +-.|.+|.|.. ....|.+-.
T Consensus 5 ~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~--~~~~C~Ls~ 65 (91)
T d2qj2a1 5 HEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDK--ARKQCLWFP 65 (91)
T ss_dssp GGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEET--TTTEEEEES
T ss_pred HhhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEEC--CCCeEEEcc
Confidence 3466665555443222111 123489999999987 46799999963 446788754
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.06 E-value=0.3 Score=31.74 Aligned_cols=30 Identities=23% Similarity=0.575 Sum_probs=23.4
Q ss_pred CCCcC-CcCCCCCccccCC-CCCcccccCCCe
Q 005705 244 QYCGK-YGYCGANTICSLD-QKPMCECLEGFK 273 (682)
Q Consensus 244 ~~C~~-~g~CG~~g~C~~~-~~~~C~C~~Gf~ 273 (682)
+.|.. ...|..+|.|... ..-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 56765 4679999999754 345799999997
|